PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jefferson, T; Wager, E; Davidoff, F				Jefferson, T; Wager, E; Davidoff, F			Measuring the quality of editorial peer review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				RANDOMIZED CONTROLLED TRIAL; MANUSCRIPT REVIEWS; INTERNAL-MEDICINE; ARTICLES; JOURNALS; IMPROVE; INSTRUMENT; READERS; ANNALS	Context The quality of a process can only be tested against its agreed objectives. Editorial peer-review is widely used, yet there appears to be little agreement about how to measure its effects or processes. Methods To identify outcome measures used to assess editorial peer review as performed by biomedical journals, we analyzed studies identified from 2 systematic reviews that measured the effects of editorial peer review on the quality of the output (le, published articles) or of the process itself (eg, reviewers' comments). Results Ten studies used a variety of instruments to assess the quality of articles that had undergone peer review. Only 1, nonrandomized study compared the quality of articles published in peer-reviewed and non-peer-reviewed journals. The others measured the effects of variations in the peer-review process or used a before-and-after design to measure the effects of standard peer review on accepted articles. Eighteen studies measured the quality of reviewers' reports under different conditions such as blinding or after training. One study compared the time and cost of different review processes. Conclusions Until we have properly defined the objectives of peer-review, it will remain almost impossible to assess or improve its effectiveness. The research needed to understand the broader effects of peer review poses many methodologic problems and would require the cooperation of many parts of the scientific community.	Sideview, Princes Risborough HP27 9DE, England; Hlth Reviews Ltd, Rome, Italy; Annals Internal Med, Philadelphia, PA USA		Wager, E (corresponding author), Sideview, Princes Risborough HP27 9DE, England.	liz@sideview.demon.co.uk		Wager, Elizabeth/0000-0002-4202-7813				ALDERSON P, 2001, EDITORIAL PEER REV I; Biddle C, 1996, AANA J, V64, P65; BINGHAM C, 1999, PEER REV HLTH SCI, P205; Bingham CM, 1998, LANCET, V352, P441, DOI 10.1016/S0140-6736(97)11510-0; BLANK RM, 1991, AM ECON REV, V81, P1041; Callaham ML, 1998, ANN EMERG MED, V32, P318, DOI 10.1016/S0196-0644(98)70007-1; Das Sinha S, 1999, NATL MED J INDIA, V12, P210; Donovan B, 1998, LEARN PUBL, V11, P179, DOI 10.1087/09531519850146346; Elvik R, 1998, ACCIDENT ANAL PREV, V30, P101, DOI 10.1016/S0001-4575(97)00068-7; Ernst E, 1999, Complement Ther Med, V7, P19, DOI 10.1016/S0965-2299(99)80054-5; ERNST E, 1994, J LAB CLIN MED, V124, P178; FEURER ID, 1994, JAMA-J AM MED ASSOC, V272, P98, DOI 10.1001/jama.272.2.98; FISHER M, 1994, JAMA-J AM MED ASSOC, V272, P143, DOI 10.1001/jama.272.2.143; GARDNER MJ, 1990, JAMA-J AM MED ASSOC, V263, P1355, DOI 10.1001/jama.263.10.1355; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2784, DOI 10.1001/jama.287.21.2784; Jefferson T, 1998, JAMA-J AM MED ASSOC, V280, P275, DOI 10.1001/jama.280.3.275; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; JUSTICE AC, 1994, JAMA-J AM MED ASSOC, V272, P117, DOI 10.1001/jama.272.2.117; KRONICK DA, 1990, JAMA-J AM MED ASSOC, V263, P1321, DOI 10.1001/jama.263.10.1321; MCNUTT RA, 1990, JAMA-J AM MED ASSOC, V263, P1371, DOI 10.1001/jama.263.10.1371; NEUHAUSER D, 1989, MED CARE, V27, P664, DOI 10.1097/00005650-198906000-00009; NYLENNA M, 1994, JAMA-J AM MED ASSOC, V272, P149, DOI 10.1001/jama.272.2.149; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P91, DOI 10.1016/0895-4356(91)90205-N; Pierie JPEN, 1996, LANCET, V348, P1480, DOI 10.1016/S0140-6736(96)05016-7; Ray J, 2000, AM J MED, V109, P131, DOI 10.1016/S0002-9343(00)00450-2; ROBERTS JC, 1994, JAMA-J AM MED ASSOC, V272, P119, DOI 10.1001/jama.272.2.119; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; STRAYHORN J, 1993, AM J PSYCHIAT, V150, P947; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5; van Rooyen S, 1999, BRIT MED J, V318, P23; Wager E, 2002, JAMA-J AM MED ASSOC, V287, P2821, DOI 10.1001/jama.287.21.2821; Wager E, 2001, LEARN PUBL, V14, P257, DOI 10.1087/095315101753141356; WAGER E, 2001, TECHNICAL EDITING RE; Walsh E, 2000, BRIT J PSYCHIAT, V176, P47, DOI 10.1192/bjp.176.1.47	39	130	138	4	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2786	2790		10.1001/jama.287.21.2786	http://dx.doi.org/10.1001/jama.287.21.2786			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038912				2022-12-28	WOS:000176002200009
J	Rozema, J; van Geel, B; Bjorn, LO; Lean, J; Madronich, S				Rozema, J; van Geel, B; Bjorn, LO; Lean, J; Madronich, S			Paleoclimate: Toward solving the UV puzzle	SCIENCE			English	Editorial Material							MAUNDER MINIMUM; COUMARIC ACID; TOTAL OZONE; CLIMATE; SPOROPOLLENIN; VARIABILITY; POLLEN; CYCLE; SUN		Vrije Univ Amsterdam, Dept Syst Ecol, NL-1081 HV Amsterdam, Netherlands; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1090 GB Amsterdam, Netherlands; Lund Univ, Dept Plant Physiol, S-22100 Lund, Sweden; EO Hulburt Ctr Space Res, Washington, DC 20375 USA; Div Atmospher Sci, Boulder, CO 80307 USA	Vrije Universiteit Amsterdam; University of Amsterdam; Lund University	Rozema, J (corresponding author), Vrije Univ Amsterdam, Dept Syst Ecol, NL-1081 HV Amsterdam, Netherlands.		Madronich, Sasha/D-3284-2015	Madronich, Sasha/0000-0003-0983-1313; Lean, Judith/0000-0002-0087-9639				BOJKOV RD, 1995, J GEOPHYS RES-ATMOS, V100, P16537, DOI 10.1029/95JD00692; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Chandra S, 1999, GEOPHYS RES LETT, V26, P185, DOI 10.1029/1998GL900272; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Haigh JD, 2001, SCIENCE, V294, P2109, DOI 10.1126/science.1067013; HARRIS N, 1998, 1 SPAARC; HODGSON DA, 2001, SCAR 8 C ABSTR; Labitzke K, 1997, J ATMOS SOL-TERR PHY, V59, P9, DOI 10.1016/S1364-6826(96)00005-3; Lean J, 2000, GEOPHYS RES LETT, V27, P2425, DOI 10.1029/2000GL000043; Lean J, 2001, SCIENCE, V292, P234, DOI 10.1126/science.1060082; LEAVITT PR, 2002, COMPREHENSIVE SERIES, V2; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; Markham KR, 1990, B LIAISON GROUP POLY, P230; McKenzie RL, 2001, J GEOPHYS RES-ATMOS, V106, P24051, DOI 10.1029/2001JD000545; Reid GC, 1999, J ATMOS SOL-TERR PHY, V61, P3, DOI 10.1016/S1364-6826(98)00111-4; Rozema J, 2001, J PHOTOCH PHOTOBIO B, V62, P108, DOI 10.1016/S1011-1344(01)00155-5; Rozema J, 2001, PLANT ECOL, V154, P9, DOI 10.1023/A:1012913608353; Shindell DT, 2001, SCIENCE, V294, P2149, DOI 10.1126/science.1064363; Staehelin J, 2001, REV GEOPHYS, V39, P231, DOI 10.1029/1999RG000059; WEHLING K, 1989, PLANTA, V179, P376, DOI 10.1007/BF00391083	20	81	86	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1621	1622		10.1126/science.1070024	http://dx.doi.org/10.1126/science.1070024			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040167	Green Submitted			2022-12-28	WOS:000175976200030
J	Labinger, JA; Bercaw, JE				Labinger, JA; Bercaw, JE			Understanding and exploiting C-H bond activation	NATURE			English	Review							CARBON-HYDROGEN-BONDS; SATURATED-HYDROCARBONS; OXIDATIVE ADDITION; ALKANE COMPLEXES; METAL-COMPLEXES; PLATINUM SALTS; METHANE; FUNCTIONALIZATION; MECHANISM; CHEMISTRY	The selective transformation of ubiquitous but inert C-H bonds to other functional groups has far-reaching practical implications, ranging from more efficient strategies for fine chemical synthesis to the replacement of current petrochemical feedstocks by less expensive and more readily available alkanes. The past twenty years have seen many examples of C-H bond activation at transition-metal centres, often under remarkably mild conditions and with high selectivity. Although profitable practical applications have not yet been developed, our understanding of how these organometallic reactions occur, and what their inherent advantages and limitations for practical alkane conversion are, has progressed considerably. In fact, the recent development of promising catalytic systems highlights the potential of organometallic chemistry for useful C-H bond activation strategies that will ultimately allow us to exploit Earth's alkane resources more efficiently and cleanly.	CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Pasadena, CA 91125 USA	California Institute of Technology	Labinger, JA (corresponding author), CALTECH, Arnold & Mabel Beckman Labs Chem Synth, Pasadena, CA 91125 USA.	jal@its.caltech.edu						BENGALI AA, 1994, J AM CHEM SOC, V116, P9585, DOI 10.1021/ja00100a024; Bennett JL, 1997, J AM CHEM SOC, V119, P10696, DOI 10.1021/ja9707419; BENNETT MA, 1967, CHEM COMMUN, P581, DOI 10.1039/c19670000581; Brazeau BJ, 2000, ENZYME CATALYZED ELE, P233; Bromberg SE, 1997, SCIENCE, V278, P260, DOI 10.1126/science.278.5336.260; BROOKHART M, 1983, J ORGANOMET CHEM, V250, P395, DOI 10.1016/0022-328X(83)85065-7; Chen HY, 1999, ANGEW CHEM INT EDIT, V38, P3391, DOI 10.1002/(SICI)1521-3773(19991115)38:22<3391::AID-ANIE3391>3.0.CO;2-N; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Collman J. P., 1987, PRINCIPLES APPLICATI; CRABTREE RH, 1979, J AM CHEM SOC, V101, P7738, DOI 10.1021/ja00520a030; CUMMINS CC, 1988, J AM CHEM SOC, V110, P8731, DOI 10.1021/ja00234a044; DAWOODI Z, 1982, J CHEM SOC CHEM COMM, P802, DOI 10.1039/c39820000802; de Montellano PR Ortiz, 1995, CYTOCHROME P450 STRU; Duetz WA, 2001, CURR OPIN BIOTECH, V12, P419, DOI 10.1016/S0958-1669(00)00237-8; FOLEY P, 1979, J AM CHEM SOC, V101, P2732, DOI 10.1021/ja00504a041; FREUND MS, 1994, J MOL CATAL, V87, pL11, DOI 10.1016/0304-5102(93)E0230-E; Fryzuk MD, 2000, COORDIN CHEM REV, V200, P379, DOI 10.1016/S0010-8545(00)00264-2; Geftakis S, 1998, J AM CHEM SOC, V120, P9953, DOI 10.1021/ja981702f; GELETII YV, 1983, KINET CATAL+, V24, P413; GRADASSI MJ, 1995, FUEL PROCESS TECHNOL, V42, P65, DOI 10.1016/0378-3820(94)00094-A; GREEN MLH, 1970, J CHEM SOC CHEM COMM, P1677, DOI 10.1039/c29700001677; Gross CL, 1998, J AM CHEM SOC, V120, P6605, DOI 10.1021/ja972971t; Hall C, 1996, CHEM REV, V96, P3125, DOI 10.1021/cr9502615; HALPERN J, 1985, INORG CHIM A-ART LET, V100, P41, DOI 10.1016/S0020-1693(00)88292-4; HEINEKEY DM, 1993, CHEM REV, V93, P913, DOI 10.1021/cr00019a004; Holtcamp MW, 1998, INORG CHIM ACTA, V270, P467, DOI 10.1016/S0020-1693(97)06102-1; HOYANO JK, 1982, J AM CHEM SOC, V104, P3723, DOI 10.1021/ja00377a032; Iverson CN, 1999, J AM CHEM SOC, V121, P7696, DOI 10.1021/ja991258w; JANOWICZ AH, 1982, J AM CHEM SOC, V104, P352, DOI 10.1021/ja00365a091; JANOWICZ AH, 1983, J AM CHEM SOC, V105, P3929, DOI 10.1021/ja00350a031; Jensen CM, 1999, CHEM COMMUN, P2443, DOI 10.1039/a903573g; Jia CG, 2000, SCIENCE, V287, P1992, DOI 10.1126/science.287.5460.1992; Johansson L, 2000, J AM CHEM SOC, V122, P10846, DOI 10.1021/ja0017460; JONES WD, 1984, J AM CHEM SOC, V106, P1650, DOI 10.1021/ja00318a018; JORDAN RF, 1989, J AM CHEM SOC, V111, P778, DOI 10.1021/ja00184a081; LABINGER JA, 1993, ORGANOMETALLICS, V12, P895, DOI 10.1021/om00027a045; Lin MR, 2001, J AM CHEM SOC, V123, P1000, DOI 10.1021/ja001926+; Liu FC, 1999, CHEM COMMUN, P655, DOI 10.1039/a900631a; Liu FC, 1999, J AM CHEM SOC, V121, P4086, DOI 10.1021/ja983460p; LUINSTRA GA, 1995, J ORGANOMET CHEM, V504, P75, DOI 10.1016/0022-328X(95)05567-9; Matsumoto T, 2000, J AM CHEM SOC, V122, P7414, DOI 10.1021/ja0009830; McNamara BK, 1999, J AM CHEM SOC, V121, P6437, DOI 10.1021/ja9904282; Niccolai GP, 1996, APPL CATAL A-GEN, V146, P145, DOI 10.1016/0926-860X(96)00120-2; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Rostovtsev VV, 1998, ORGANOMETALLICS, V17, P4530, DOI 10.1021/om980541l; ROTHWELL IP, 1988, ACCOUNTS CHEM RES, V21, P153, DOI 10.1021/ar00148a004; RUSSELL GA, 1973, FREE RADICALS, V1, P275; Schafer DF, 1998, J AM CHEM SOC, V120, P4881, DOI 10.1021/ja980115r; SEN A, 1994, J AM CHEM SOC, V116, P998, DOI 10.1021/ja00082a022; SHELDON RA, 1981, METAL CATALYZED OXID, pCH4; SHERRY AE, 1990, J AM CHEM SOC, V112, P1259, DOI 10.1021/ja00159a064; Shilov A.E., 2000, ACTIVATION CATALYTIC; Shilov A. E., 1984, ACTIVATION SATURATED; SHILOV AE, 1977, COORDIN CHEM REV, V24, P97, DOI 10.1016/S0010-8545(00)80336-7; Shul'pin G.B., 1987, RUSS CHEM REV, V56; Stahl SS, 1998, ANGEW CHEM INT EDIT, V37, P2181, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2180::AID-ANIE2180>3.0.CO;2-A; THOMPSON ME, 1987, J AM CHEM SOC, V109, P203, DOI 10.1021/ja00235a031; Tran E, 1997, J AM CHEM SOC, V119, P5071, DOI 10.1021/ja9704850; Vidal V, 1996, J AM CHEM SOC, V118, P4595, DOI 10.1021/ja953524l; WALSH PJ, 1988, J AM CHEM SOC, V110, P8729, DOI 10.1021/ja00234a043; Waltz KM, 1997, SCIENCE, V277, P211, DOI 10.1126/science.277.5323.211; WATSON PL, 1983, J AM CHEM SOC, V105, P6491, DOI 10.1021/ja00359a023; WAYLAND BB, 1991, J AM CHEM SOC, V113, P5305, DOI 10.1021/ja00014a025; WEILLER BH, 1989, J AM CHEM SOC, V111, P8288, DOI 10.1021/ja00203a045; WU JX, 1989, J AM CHEM SOC, V111, P7628, DOI 10.1021/ja00201a062	65	2192	2227	33	1442	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					507	514		10.1038/417507a	http://dx.doi.org/10.1038/417507a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037558				2022-12-28	WOS:000175860300032
J	Preston, NJ; Kisely, S; Xiao, JG				Preston, NJ; Kisely, S; Xiao, JG			Assessing the outcome of compulsory psychiatric treatment in the community: epidemiological study in Western Australia	BRITISH MEDICAL JOURNAL			English	Article							INVOLUNTARY OUTPATIENT COMMITMENT; MENTALLY-ILL; HEALTH	Objective To examine whether community treatment orders for psychiatric patients reduce subsequent use of health services in comparison with control patients not placed on an order. Design Epidemiological study with a before and after, two stage design of matching and multivariate analysis, controlling lot, sociodemographic variables, clinical features, and psychiatric history. Setting All Community based and inpatient Psychiatric services in Western Australia, covering a population of 1.7 million people. Participants 228 subjects placed on a community treatment order, matched with an equal number of controls to give a total of 456 patients. Main outcome measures Inpatient admissions, bed days, and outpatient contacts one year after subjects were placed on a community treatment order or the index date of matched controls. Results Both subjects and their matched controls had reduced inpatient admissions and bed days in hospital. Subjects had significantly more outpatient contacts. Multivariate analysis indicated that being placed on a community treatment order was associated with increased outpatient contacts in the subsequent bear compared with the control group. Otherwise, orders did not affect subsequent use of health services. Other factors associated with increased use of health services were age and inpatient admissions, bed days, and outpatient contacts before the order or index date. No covariates were shown to be associated with changes in within pair differences in inpatient admissions or bed days. Conclusions The introduction of compulsory treatment in the community does not lead to reduced use of health services.	Fremantle Hosp & Hlth Serv, Mental Hlth Directorate, Fremantle, WA 6160, Australia; Univ Western Australia, Fremantle Hosp, Univ Dept Psychiat, Fremantle, WA, Australia; Hlth Dept Western Australia, Hlth Informat Ctr, Perth, WA 6004, Australia	University of Western Australia; University of Western Australia	Preston, NJ (corresponding author), Fremantle Hosp & Hlth Serv, Mental Hlth Directorate, POB 480, Fremantle, WA 6160, Australia.		Kisely, Steve/B-4680-2012	Kisely, Steve/0000-0003-4021-2924				BURSTEN B, 1986, AM J PSYCHIAT, V143, P1255; Davies P, 2001, BRIT MED J, V323, P294, DOI 10.1136/bmj.323.7308.294; DEDMAN P, 1990, PSYCHIAT B, V14, P462; *DEP HLTH, 2000, REF MENTAL HLTH ACT; Geller J, 1998, ADM POLICY MENT HLTH, V25, P271, DOI 10.1023/A:1022239322212; HALLOWAY F, 1996, PSYCHIAT B, V20, P193; HOOPER JL, 1994, NEW ENGL J MED, V330, P387; McIvor R, 1998, AUST NZ J PSYCHIAT, V32, P223, DOI 10.3109/00048679809062732; MULVANY J, 1993, AUSTR J MENTAL HLTH, V2, P183; SCHEIDCOOK TL, 1987, COMMUNITY MENT HLT J, V23, P173, DOI 10.1007/BF00754429; SENSKY T, 1991, BRIT J PSYCHIAT, V158, P792, DOI 10.1192/bjp.158.6.792; SWARTZ MS, 1995, PSYCHIATR SERV, V46, P381; Swartz MS, 1999, AM J PSYCHIAT, V156, P1968; TORREY EF, 1995, PSYCHIATR SERV, V46, P778; Vaughan K, 2000, AUST NZ J PSYCHIAT, V34, P801, DOI 10.1046/j.1440-1614.2000.00813.x; WILK RJ, 1988, AM J ORTHOPSYCHIAT, V58, P580, DOI 10.1111/j.1939-0025.1988.tb01622.x	16	64	66	1	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1244	+		10.1136/bmj.324.7348.1244	http://dx.doi.org/10.1136/bmj.324.7348.1244			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	557EJ	12028977	Green Published, Bronze			2022-12-28	WOS:000175894900017
J	Atkins, JF; Gesteland, R				Atkins, JF; Gesteland, R			Biochemistry - The 22nd amino acid	SCIENCE			English	Editorial Material							ESCHERICHIA-COLI; TRANSFER-RNA; SELENOCYSTEINE; UAG		Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Sci Fdn Ireland, Dublin 2, Ireland	Utah System of Higher Education; University of Utah	Atkins, JF (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA.	john.atkins@genetics.utah.edu		Atkins, John/0000-0001-7933-0165				Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Ibba M, 2001, EMBO REP, V2, P382; Osawa S., 1995, EVOLUTION GENETIC CO; Rother M, 2000, J MOL BIOL, V299, P351, DOI 10.1006/jmbi.2000.3756; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; ZINONI F, 1986, P NATL ACAD SCI USA, V83, P4650, DOI 10.1073/pnas.83.13.4650	10	78	82	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1409	1410		10.1126/science.1073339	http://dx.doi.org/10.1126/science.1073339			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029118				2022-12-28	WOS:000175910300030
J	Mercader, J; Panger, M; Boesch, C				Mercader, J; Panger, M; Boesch, C			Excavation of a chimpanzee stone tool site in the African rainforest	SCIENCE			English	Article							OLDOWAN; PLIOCENE; KENYA; ETHIOPIA; TURKANA; WEST	Chimpanzees from the Tai forest of Cote d'lvoire produce unintentional flaked stone assemblages at nut-cracking sites, leaving behind a record of tool use and plant consumption that is recoverable with archaeological methods. About 40 kilograms of nutshell and 4 kilograms of stone were excavated at the Panda 100 site. The data unearthed show that chimpanzees transported stones from outcrops and soils to focal points, where they used them as hammers to process foodstuff. The repeated use of activity areas led to refuse accumulation and site formation. The implications of these data for the interpretation of the earliest hominin archaeological record are explored.	George Washington Univ, Dept Anthropol, Washington, DC 20052 USA; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	George Washington University; Max Planck Society	Mercader, J (corresponding author), George Washington Univ, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.		Mercader, Julio/G-5182-2010					BOESCH C, 1983, BEHAVIOUR, V83, P265, DOI 10.1163/156853983X00192; BOESCH C, 1984, Primates, V25, P160, DOI 10.1007/BF02382388; Boesch C, 2000, CHIMPANZEES TAI FORE; Chavaillon J., 1976, EARLIEST MAN ENV LAK, P565; GOODWIN AM, 1991, PRECAMBRIAN GEOLOGY; ISAAC GL, 1976, EARLIEST MAN ENV LAK, P552; JOULIAN F, 1996, MODELLING EARLY HUMA, P173; KIBUNJIA M, 1992, J HUM EVOL, V23, P431, DOI 10.1016/0047-2484(92)90091-M; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; KORTLANDT A, 1986, J HUM EVOL, V15, P77, DOI 10.1016/S0047-2484(86)80068-9; Leakey M.D., 1971, OLDUVAI GORGE; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Merrick H.V., 1976, EARLIEST MAN ENV LAK, P574; PETERS CR, 1987, AM J PHYS ANTHROPOL, V73, P333, DOI 10.1002/ajpa.1330730306; Plummer T, 1999, J HUM EVOL, V36, P151, DOI 10.1006/jhev.1998.0256; POTTS R, 1991, J ANTHROPOL RES, V47, P153, DOI 10.1086/jar.47.2.3630323; ROBYNS W, 1958, FLORE CONGO BELGE RU, P1; Roche H, 1999, NATURE, V399, P57, DOI 10.1038/19959; ROMPAEY RV, 1994, PARC NAT TAI COTE IV, P42; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; TOTH N, 1985, J ARCHAEOL SCI, V12, P101, DOI 10.1016/0305-4403(85)90056-1; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; WYNN T, 1989, MAN, V24, P383, DOI 10.2307/2802697	23	173	186	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1452	1455		10.1126/science.1070268	http://dx.doi.org/10.1126/science.1070268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	557LP	12029130				2022-12-28	WOS:000175910300044
J	Enomoto, A; Kimura, H; Chairoungdua, A; Shigeta, Y; Jutabha, P; Cha, SH; Hosoyamada, M; Takeda, M; Sekine, T; Igarashi, T; Matsuo, H; Kikuchi, Y; Oda, T; Ichida, K; Hosoya, T; Shimokata, K; Niwa, T; Kanai, Y; Endou, H				Enomoto, A; Kimura, H; Chairoungdua, A; Shigeta, Y; Jutabha, P; Cha, SH; Hosoyamada, M; Takeda, M; Sekine, T; Igarashi, T; Matsuo, H; Kikuchi, Y; Oda, T; Ichida, K; Hosoya, T; Shimokata, K; Niwa, T; Kanai, Y; Endou, H			Molecular identification of a renal urate-anion exchanger that regulates blood urate levels	NATURE			English	Article							P-AMINOHIPPURATE TRANSPORT; BRUSH-BORDER MEMBRANE; URIC-ACID; KIDNEY; PEROXYNITRITE; HYPERURICEMIA; DYSFUNCTION; EXCRETION; VESICLES; EXERCISE	Urate, a naturally occurring product of purine metabolism, is a scavenger of biological oxidants implicated in numerous disease processes(1-3), as demonstrated by its capacity of neuroprotection(4,5). It is present at higher levels in human blood (200-500 muM) than in other mammals 6, because humans have an effective renal urate reabsorption system, despite their evolutionary loss of hepatic uricase by mutational silencing(6-8). The molecular basis for urate handling in the human kidney remains unclear because of difficulties in understanding diverse urate transport systems and species differences(6,9,10). Here we identify the long-hypothesized(9-11) urate transporter in the human kidney (URAT1, encoded by SLC22A12), a urate-anion exchanger regulating blood urate levels and targeted by uricosuric and anti-uricosuric agents (which affect excretion of uric acid). Moreover, we provide evidence that patients with idiopathic renal hypo-uricaemia (lack of blood uric acid) have defects in SLC22A12. Identification of URAT1 should provide insights into the nature of urate homeostasis, as well as lead to the development of better agents against hyperuricaemia, a disadvantage concomitant with human evolution.	Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan; Nagoya Univ, Sch Med, Dept Clin Prevent Med, Nagoya, Aichi 4668560, Japan; Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo 1058461, Japan; Chiba Univ, Sch Med, Dept Urol, Chiba 2608670, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 1138655, Japan; Natl Def Med Coll, Dept Physiol 1, Saitama 3598513, Japan; Natl Def Med Coll, Dept Internal Med 2, Saitama 3598513, Japan; JSDF Kumamoto Hosp, Dept Med, Kumamoto 8620902, Japan	Kyorin University; Nagoya University; Jikei University; Chiba University; University of Tokyo; National Defense Medical College - Japan; National Defense Medical College - Japan	Endou, H (corresponding author), Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo 1818611, Japan.	endouh@kyorin-u.ac.jp	Enomoto, Atsushi/I-7272-2014; Jutabha, Promsuk/AFF-4363-2022; Jutabha, Promsuk/AAE-9872-2022	Enomoto, Atsushi/0000-0002-9206-6116; Oda, Takashi/0000-0002-6131-7752; Matsuo, Hirotaka/0000-0003-4302-8719				ABRAMSON RG, 1990, BASIC PRINCIPLES TRA, V3, P115; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BERLINER RW, 1950, J CLIN INVEST, V29, P396, DOI 10.1172/JCI102271; Cha SH, 2000, J BIOL CHEM, V275, P4507, DOI 10.1074/jbc.275.6.4507; CULLEN JH, 1957, AM J MED, V23, P587, DOI 10.1016/0002-9343(57)90229-2; CUTLER RG, 1991, AM J CLIN NUTR, V53, P373; Emmerson BT, 1996, NEW ENGL J MED, V334, P445, DOI 10.1056/NEJM199602153340707; GRUNDEMANN D, 1994, NATURE, V372, P549, DOI 10.1038/372549a0; GUGGINO SE, 1983, AM J PHYSIOL, V244, pF612, DOI 10.1152/ajprenal.1983.244.6.F612; HALABE A, 1994, MINER ELECTROL METAB, V20, P424; Halliwell B, 1996, HDB ANTIOXIDANTS, P243; Hooper DC, 1998, P NATL ACAD SCI USA, V95, P675, DOI 10.1073/pnas.95.2.675; IGARASHI T, 1993, PEDIATR NEPHROL, V7, P292, DOI 10.1007/BF00853226; Johnson RJ, 1999, AM J KIDNEY DIS, V33, P225, DOI 10.1016/S0272-6386(99)70295-7; KAHN AM, 1983, AM J PHYSIOL, V245, pF151, DOI 10.1152/ajprenal.1983.245.2.F151; Keller JN, 1998, J NEUROSCI, V18, P687; Kikuchi Y, 2000, CLIN NEPHROL, V53, P467; Koepsell H, 1998, ANNU REV PHYSIOL, V60, P243, DOI 10.1146/annurev.physiol.60.1.243; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lipkowitz MS, 2001, J CLIN INVEST, V107, P1103, DOI 10.1172/JCI12471; Maesaka JK, 1998, AM J KIDNEY DIS, V32, P917, DOI 10.1016/S0272-6386(98)70067-8; MANDEL LJ, 1985, ANNU REV PHYSIOL, V47, P85; RochRamel F, 1996, AM J PHYSIOL-RENAL, V270, pF61, DOI 10.1152/ajprenal.1996.270.1.F61; ROCHRAMEL F, 1994, AM J PHYSIOL, V266, pF797, DOI 10.1152/ajprenal.1994.266.5.F797; Sekine T, 1997, J BIOL CHEM, V272, P18526, DOI 10.1074/jbc.272.30.18526; Sica DA, 2000, KIDNEY, P680; Sweet DH, 1997, J BIOL CHEM, V272, P30088, DOI 10.1074/jbc.272.48.30088; WU XW, 1989, P NATL ACAD SCI USA, V86, P9412, DOI 10.1073/pnas.86.23.9412; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854	30	1005	1124	16	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					447	452		10.1038/nature742	http://dx.doi.org/10.1038/nature742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024214				2022-12-28	WOS:000175730900040
J	Kent, PD; Poterucha, TH				Kent, PD; Poterucha, TH			Aberrant right subclavian artery and dysphagia lusoria.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Kent, PD (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.								0	12	12	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1637	1637		10.1056/NEJMicm010093	http://dx.doi.org/10.1056/NEJMicm010093			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023996				2022-12-28	WOS:000175728600006
J	Voelkel, NF				Voelkel, NF			Perspective: High altitude pulmonary edema.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Voelkel, NF (corresponding author), Univ Colorado, Hlth Sci Ctr, 4200 E 9th Ave, Denver, CO 80262 USA.								0	19	20	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1606	1607		10.1056/NEJM200205233462102	http://dx.doi.org/10.1056/NEJM200205233462102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023991				2022-12-28	WOS:000175728600001
J	Abu-Laban, RB; Christenson, JM; Innes, GD; van Beek, CA; Wanger, KP; McKnight, RD; MacPhail, IA; Puskaric, J; Sadowski, RP; Singer, J; Schechter, MT; Wood, VM				Abu-Laban, RB; Christenson, JM; Innes, GD; van Beek, CA; Wanger, KP; McKnight, RD; MacPhail, IA; Puskaric, J; Sadowski, RP; Singer, J; Schechter, MT; Wood, VM			Tissue plasminogen activator in cardiac arrest with pulseless electrical activity	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EMBOLIC PULMONARY-HYPERTENSION; BOLUS THROMBOLYTIC INFUSIONS; CARDIOPULMONARY-RESUSCITATION; ELECTROMECHANICAL DISSOCIATION; PRIMARY-CARE; THERAPY; INJECTION; EFFICACY; TRIAL; CPR	Background: Coronary thrombosis and pulmonary thromboembolism are common causes of cardiac arrest. We assessed whether the administration of tissue plasminogen activator (t-PA) during cardiopulmonary resuscitation would benefit patients with cardiac arrest and pulseless electrical activity of unknown or presumed cardiovascular cause. Methods: Patients who were older than 16 years of age and who had more than one minute of pulseless electrical activity that was unresponsive to initial therapy outside the hospital or in the emergency department were eligible. Patients were randomly assigned to receive 100 mg of t-PA or placebo intravenously over a 15-minute period in a double-blind fashion. Standard resuscitation was then continued for at least 15 minutes. The primary outcome was survival to hospital discharge. Results: During the study period, 1583 patients with cardiac arrest were treated and 233 patients were enrolled (117 in the t-PA group and 116 in the placebo group). The characteristics of the patients in the two groups were similar. One patient in the t-PA group survived to hospital discharge, as compared with none in the placebo group (absolute difference between groups, 0.9; 95 percent confidence interval, -2.6 to 4.8; P=0.99). The proportion of patients with return of spontaneous circulation was 21.4 percent in the t-PA group and 23.3 percent in the placebo group (absolute difference between groups, -1.9; 95 percent confidence interval, -12.6 to 8.8; P=0.85). Conclusions: We found no evidence of a beneficial effect of fibrinolysis in patients with cardiac arrest and pulseless electrical activity of unknown or presumed cardiovascular cause. Our study had limited statistical power, and it remains unknown whether there is a small treatment effect or whether selected subgroups may benefit.	Vancouver Gen Hosp, Dept Emergency Med, Div Emergency Med, Vancouver, BC V5Z 1M9, Canada; British Columbia Ambulance Serv, Victoria, BC, Canada; Ctr Hlth Evaluat Outcome Serv, Vancouver, BC, Canada	University of British Columbia	Abu-Laban, RB (corresponding author), Vancouver Gen Hosp, Dept Emergency Med, Div Emergency Med, 855 W 12th Ave, Vancouver, BC V5Z 1M9, Canada.			Schechter, Martin/0000-0001-6063-2155				Abu-Laban RB, 1998, ANN EMERG MED, V32, P392, DOI 10.1016/S0196-0644(98)70026-5; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; BONNIN MJ, 1993, JAMA-J AM MED ASSOC, V270, P1457, DOI 10.1001/jama.270.12.1457; Bottiger BW, 2001, LANCET, V357, P1583, DOI 10.1016/S0140-6736(00)04726-7; BOTTIGER BW, 1994, CHEST, V106, P1281, DOI 10.1378/chest.106.4.1281; Calinas-Correia J, 1999, RESUSCITATION, V41, P201, DOI 10.1016/S0300-9572(99)00055-6; CRIPPS T, 1991, RESUSCITATION, V22, P173, DOI 10.1016/0300-9572(91)90009-N; CUMMINS RO, 1993, ANN EMERG MED, V22, P37, DOI 10.1016/S0196-0644(05)80247-1; Dagenais GR, 1996, CAN J CARDIOL, V12, P914; Eisenberg MS, 2001, NEW ENGL J MED, V344, P1304, DOI 10.1056/NEJM200104263441707; *EM CARD CAR COMM, 1992, JAMA-J AM MED ASSOC, V268, P2171; Gando S, 1997, THROMB HAEMOSTASIS, V77, P278; Gray J D, 2001, CJEM, V3, P213; JENNETT B, 1975, LANCET, V1, P480; JETTE AM, 1986, J GEN INTERN MED, V1, P143, DOI 10.1007/BF02602324; JETTE AM, 1986, J GEN INTERN MED, V1, P427; KELSEY SF, 1986, AM J EMERG MED, V4, P72; Kern KB, 2001, LANCET, V357, P1549, DOI 10.1016/S0140-6736(00)04780-2; KOHLE W, 1984, ANAESTHESIST, V33, P469; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; LANGDON RW, 1989, ANN EMERG MED, V18, P678, DOI 10.1016/S0196-0644(89)80527-X; Lapostolle F, 2001, AM J EMERG MED, V19, P327, DOI 10.1053/ajem.2001.24504; Lederer W, 2001, RESUSCITATION, V50, P71, DOI 10.1016/S0300-9572(01)00317-3; Levine M, 1996, NEW ENGL J MED, V334, P677, DOI 10.1056/NEJM199603143341101; LONGRIDGE DJ, 1991, CARDIOVASC RES, V25, P184, DOI 10.1093/cvr/25.3.184; MARTIN U, 1993, J CARDIOVASC PHARM, V21, P455, DOI 10.1097/00005344-199303000-00016; Newman DH, 2000, ANN EMERG MED, V35, P472, DOI 10.1067/mem.2000.105600; PHARO GH, 1995, ANESTH ANALG, V81, P188, DOI 10.1097/00000539-199507000-00040; PIROLO JS, 1985, HUM PATHOL, V16, P485, DOI 10.1016/S0046-8177(85)80087-3; PREWITT RM, 1989, CIRCULATION, V79, P929, DOI 10.1161/01.CIR.79.4.929; SCHOLZ KH, 1990, DEUT MED WOCHENSCHR, V115, P930, DOI 10.1055/s-2008-1065101; Schulte-Sinkus D, 1998, ANASTH INTENSIV NOTF, V33, P124, DOI 10.1055/s-2007-994226; SHIFFMAN F, 1988, CIRCULATION, V78, P214, DOI 10.1161/01.CIR.78.1.214; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; STUEVEN HA, 1989, RESUSCITATION, V17, P173, DOI 10.1016/0300-9572(89)90069-5; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tiffany PA, 1998, ANN EMERG MED, V31, P124, DOI 10.1016/S0196-0644(98)70295-1; vanderWouw PA, 1997, J AM COLL CARDIOL, V30, P780, DOI 10.1016/S0735-1097(97)00218-0; Varriale P, 1997, CRIT CARE MED, V25, P1717, DOI 10.1097/00003246-199710000-00023; WESTHOFFBLECK M, 1991, Z KARDIOL S3, V80, P139	41	124	129	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1522	1528		10.1056/NEJMoa012885	http://dx.doi.org/10.1056/NEJMoa012885			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015391	Bronze			2022-12-28	WOS:000175563900003
J	Shen, ZJ; Zhao, Z; Peng, H; Nygren, M				Shen, ZJ; Zhao, Z; Peng, H; Nygren, M			Formation of tough interlocking microstructures in silicon nitride ceramics by dynamic ripening	NATURE			English	Article							ALPHA-SIALON CERAMICS; GRAINS; SI3N4	Ceramics based on Si3N4 have been comprehensively studied and are widely used in structural applications(1,2). The development of an interlocking microstructure of elongated grains is vital to ensure that this family of ceramics have good damage tolerance(3,4). Until now this has been accomplished by heating the appropriate powder compacts to temperatures above 1,700 degreesC for extended periods. This procedure involves a necessary step of controlling the size and population of seeds-added ex situ or formed in situ-to ensure selective grain growth(5,6). Here we report the very fast (within minutes) in situ formation of a tough interlocking microstructure in Si3N4-based ceramics. The microstructures are obtained by a dynamic ripening mechanism, an anisotropic Ostwald ripening process that results from the rapid heating rate. The resulting microstructures are uniform and reproducible in terms of grain size distribution and mechanical properties, and are easily tailored by manipulating the kinetics. This process is very efficient and opens up new possibilities to optimize mechanical properties and cost-effectively manufacture ceramics.	Univ Stockholm, Arrhenius Lab, Dept Inorgan Chem, BRIIE Ctr Inorgan Interfacial Engn, S-10691 Stockholm, Sweden	Stockholm University	Shen, ZJ (corresponding author), Univ Stockholm, Arrhenius Lab, Dept Inorgan Chem, BRIIE Ctr Inorgan Interfacial Engn, S-10691 Stockholm, Sweden.		Zhao, Zhe/C-3951-2012	Zhao, Zhe/0000-0003-3060-9987				Chen IW, 1997, NATURE, V389, P701, DOI 10.1038/39542; Emoto H, 1997, J EUR CERAM SOC, V17, P797, DOI 10.1016/S0955-2219(96)00139-2; HIRAO K, 1994, J AM CERAM SOC, V77, P1857, DOI 10.1111/j.1151-2916.1994.tb07062.x; Jack K. H., 1997, P 6 INT S CER MAT CO, P203; Kim J, 2000, J AM CERAM SOC, V83, P1819; Kitayama M, 1998, ACTA MATER, V46, P6541, DOI 10.1016/S1359-6454(98)00290-0; LANGE FF, 1973, J AM CERAM SOC, V56, P518, DOI 10.1111/j.1151-2916.1973.tb12401.x; MITORNO M, 1997, P 6 INT S CER MAT CO, P85; Park DS, 1998, J AM CERAM SOC, V81, P1876, DOI 10.1111/j.1151-2916.1998.tb02560.x; TANI E, 1986, AM CERAM SOC BULL, V65, P1311; Thompson D, 1997, NATURE, V389, P675, DOI 10.1038/39475; Zhang C, 2000, J EUR CERAM SOC, V20, P939, DOI 10.1016/S0955-2219(99)00208-3	12	437	449	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					266	269		10.1038/417266a	http://dx.doi.org/10.1038/417266a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015597	Green Published			2022-12-28	WOS:000175592100041
J	Raffaelli, D				Raffaelli, D			Ecology - From Elton to mathematics and back again	SCIENCE			English	Editorial Material							TROPHIC INTERACTIONS		Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England	University of York - UK	Raffaelli, D (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.							DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Elton C., 1927, ANIMAL ECOLOGY; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Neutel AM, 2002, SCIENCE, V296, P1120, DOI 10.1126/science.1068326; ODUM E. P, 1959, FUNDAMENTALS ECOLOGY; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; Yodzis P., 1989, INTRO THEORETICAL EC	8	11	14	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1035	+		10.1126/science.1072080	http://dx.doi.org/10.1126/science.1072080			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004106				2022-12-28	WOS:000175565000028
J	Tram, U; Sullivan, W				Tram, U; Sullivan, W			Rote of delayed nuclear envelope breakdown and mitosis in Wolbachia-induced cytoplasmic incompatibility	SCIENCE			English	Article							DROSOPHILA-SIMULANS; CHROMOSOME CONDENSATION; CYCLIN-B; CENTROSOMES; CELL; FERTILIZATION; POPULATIONS; BACTERIA; NASONIA; CROSSES	The bacterium Wolbachia manipulates reproduction in millions of insects worldwide; the most common effect is cytoplasmic incompatibility (CI). We found that CI resulted from delayed nuclear envelope breakdown of the mate pronucleus in Nasonia vitripennis. This caused asynchrony between the male and female pronuclei and, ultimately, loss of paternal chromosomes at the first mitosis. When Wolbachia were present in the egg, synchrony was restored, which explains suppression of CI in these crosses. These results suggest that Wolbachia target cell cycle regulatory proteins. A striking consequence of Cl is that it alters the normal pattern of reciprocal centrosome inheritance in Nasonia.	Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sullivan, W (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, 319 Sinsheimer Labs, Santa Cruz, CA 95064 USA.				NIGMS NIH HHS [GM16409] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BRESSAC C, 1993, J INVERTEBR PATHOL, V61, P226, DOI 10.1006/jipa.1993.1044; Callaini G, 1996, J INVERTEBR PATHOL, V67, P55, DOI 10.1006/jipa.1996.0009; Callaini G, 1997, J CELL SCI, V110, P271; CALLAINI G, 1994, J CELL SCI, V107, P673; CHARLAT S, 2002, SYMBIOSIS MECH MODEL; DEBEC A, 1992, BIOL CELL, V75, P121, DOI 10.1016/0248-4900(92)90131-J; Debec A, 1996, J CELL BIOL, V134, P103, DOI 10.1083/jcb.134.1.103; Elwell CA, 2000, MOL MICROBIOL, V37, P952, DOI 10.1046/j.1365-2958.2000.02070.x; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HOFFMANN AA, 1986, EVOLUTION, V40, P692, DOI 10.1111/j.1558-5646.1986.tb00531.x; Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Karr TL, 1996, CURR TOP DEV BIOL, V34, P89, DOI 10.1016/S0070-2153(08)60709-7; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; KOSE H, 1995, THESIS U ILLINOIS UR; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8; ONEILL SL, 1990, NATURE, V348, P178, DOI 10.1038/348178a0; ONeill SL, 1997, INFLUENTIAL PASSENGE; PINES J, 1991, J CELL BIOL, V115, P1, DOI 10.1083/jcb.115.1.1; Presgraves DC, 2000, GENETICS, V154, P771; REED KM, 1995, MOL REPROD DEV, V40, P408, DOI 10.1002/mrd.1080400404; RYAN SL, 1968, MOL GEN GENET, V103, P29, DOI 10.1007/BF00271154; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Tram U, 2000, CURR BIOL, V10, P1413, DOI 10.1016/S0960-9822(00)00795-8; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V262, P197, DOI 10.1098/rspb.1995.0196; Yu KR, 2000, NAT CELL BIOL, V2, P609, DOI 10.1038/35023555	30	182	199	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1124	1126		10.1126/science.1070536	http://dx.doi.org/10.1126/science.1070536			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004132				2022-12-28	WOS:000175565000055
J	Ito, J; Ghosh, A; Moreira, LA; Wimmer, EA; Jacobs-Lorena, M				Ito, J; Ghosh, A; Moreira, LA; Wimmer, EA; Jacobs-Lorena, M			Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite	NATURE			English	Article							YELLOW-FEVER MOSQUITO; AEDES-AEGYPTI; GERMLINE TRANSFORMATION; GENE-EXPRESSION; BLOOD MEAL; GAMBIAE; VECTOR; GUT	Malaria is estimated to cause 0.7 to 2.7 million deaths per year, but the actual figures could be substantially higher owing to under-reporting and difficulties in diagnosis(1). If no new control measures are developed, the malaria death toll is projected to double in the next 20 years(1). Efforts to control the disease are hampered by drug resistance in the Plasmodium parasites, insecticide resistance in mosquitoes, and the lack of an effective vaccine. Because mosquitoes are obligatory vectors for malaria transmission, the spread of malaria could be curtailed by rendering them incapable of transmitting parasites. Many of the tools required for the genetic manipulation of mosquito competence for malaria transmission have been developed. Foreign genes can now be introduced into the germ line of both culicine(2,3) and anopheline(4) mosquitoes, and these transgenes can be expressed in a tissue-specific manner(5,6). Here we report on the use of such tools to generate transgenic mosquitoes that express antiparasitic genes in their midgut epithelium, thus rendering them inefficient vectors for the disease. These findings have significant implications for the development of new strategies for malaria control.	Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Bayreuth, Lehrstuhl Genet, D-95447 Bayreuth, Germany	Case Western Reserve University; University of Bayreuth	Jacobs-Lorena, M (corresponding author), Case Western Reserve Univ, Dept Genet, 10900 Euclid Ave, Cleveland, OH 44106 USA.		Wimmer, Ernst A./I-3333-2019	Wimmer, Ernst A./0000-0002-2480-2804				Breman JG, 2001, AM J TROP MED HYG, V64, P1; Catteruccia F, 2000, NATURE, V405, P959, DOI 10.1038/35016096; Coates CJ, 1998, P NATL ACAD SCI USA, V95, P3748, DOI 10.1073/pnas.95.7.3748; Edwards MJ, 1997, INSECT BIOCHEM MOLEC, V27, P1063, DOI 10.1016/S0965-1748(97)00093-3; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743; Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197; Lemos FJA, 1996, INSECT BIOCHEM MOLEC, V26, P651, DOI 10.1016/S0965-1748(96)00014-8; Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895; PRINGLE G, 1966, T ROY SOC TROP MED H, V60, P626, DOI 10.1016/0035-9203(66)90009-5	14	401	437	0	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					452	455		10.1038/417452a	http://dx.doi.org/10.1038/417452a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024215				2022-12-28	WOS:000175730900041
J	Fischer, B; Palkovic, S				Fischer, B; Palkovic, S			Neonatal vein of Galen malformation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Univ Munster, D-48129 Munster, Germany	University of Munster	Fischer, B (corresponding author), Univ Munster, D-48129 Munster, Germany.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1553	1553		10.1056/NEJMicm010903	http://dx.doi.org/10.1056/NEJMicm010903			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015395				2022-12-28	WOS:000175563900007
J	Saneyoshi, T; Kume, S; Amasaki, Y; Mikoshiba, K				Saneyoshi, T; Kume, S; Amasaki, Y; Mikoshiba, K			The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; WNT SIGNALING PATHWAY; TRANSCRIPTION FACTORS; SPEMANN ORGANIZER; AXIS FORMATION; BETA-CATENIN; EXPRESSION; LAEVIS; FAMILY	It is thought that inositol-1,4,5-trisphosphate (Ins(1,4,5) P-3)-Ca2+ signalling has a function in dorsoventral axis formation in Xenopus embryos(1-3;) however, the immediate target of free Ca2+ is unclear. The secreted Wnt protein family comprises two functional groups, the canonical Wnt and Wnt/Ca2+ pathways(4). The Wnt/Ca2+ pathway interferes with the canonical Wnt pathway(5), but the underlying molecular mechanism is poorly understood. Here, we cloned the complementary DNA coding for the Xenopus homologue of nuclear factor of activated T cells (XNF-AT). A gain-of-function, calcineurin-independent active XNF-AT mutation (CA XNF-AT) inhibited anterior development of the primary axis, as well as Xwnt-8-induced ectopic dorsal axis development in embryos. A loss-of-function, dominant negative XNF-AT mutation (DN XNF-AT) induced ectopic dorsal axis formation and expression of the canonical Wnt signalling target molecules siamois and Xnr3 (ref. 4). Xwnt-5A induced translocation of XNF-AT from the cytosol to the nucleus. These data indicate that XNF-AT functions as a downstream target of the Wnt/Ca2+ and Ins(1,4,5) P-3-Ca2+ pathways, and has an essential role in mediating ventral signals in the Xenopus embryo through suppression of the canonical Wnt pathway.	Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, ERATO, Mikoshiba Calciosignal Net Project, Minato Ku, Tokyo 1080071, Japan; Japan Sci & Technol Corp, ICORP, Calcium Oscillat Project, Minato Ku, Tokyo 1080071, Japan; Univ Tokyo, CREST, Inst Med Sci, Dept Mol & Dev Biol,Minato Ku, Tokyo 1088639, Japan; RIKEN, Brain Res Inst, Wako, Saitama 35101, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); University of Tokyo; RIKEN	Kume, S (corresponding author), Kumamoto Univ, Inst Mol Embryol & Genet, Dept Regenerat Med, Div Stem Cell Biol, Kuhonji 4-24-1, Kumamoto 8620976, Japan.		Saneyoshi, Takeo/AAF-5170-2019; Kume, Shoen/M-4356-2016; Mikoshiba, Katsuhiko/N-7943-2015	Kume, Shoen/0000-0002-4292-205X; 				Ault KT, 1996, DEVELOPMENT, V122, P2033; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Chow CW, 1999, MOL CELL BIOL, V19, P2300; GIMLICH RL, 1984, DEV BIOL, V104, P117, DOI 10.1016/0012-1606(84)90042-3; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kume S, 1999, CELL MOL LIFE SCI, V56, P296, DOI 10.1007/s000180050431; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MOON RT, 1993, DEVELOPMENT, V119, P97; MUSCI TJ, 1990, P NATL ACAD SCI USA, V87, P8365, DOI 10.1073/pnas.87.21.8365; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Saneyoshi T, 2000, BBA-MOL CELL RES, V1499, P164, DOI 10.1016/S0167-4889(00)00083-5; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; TSURUTA L, 1995, J IMMUNOL, V154, P5255; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; WOODLAND HR, 1987, DEVELOPMENT, V101, P925; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	29	234	252	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					295	299		10.1038/417295a	http://dx.doi.org/10.1038/417295a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015605				2022-12-28	WOS:000175592100049
J	Reysenbach, AL; Shock, E				Reysenbach, AL; Shock, E			Merging genomes with geochemistry in hydrothermal ecosystems	SCIENCE			English	Review							YELLOWSTONE-NATIONAL-PARK; HYPERTHERMOPHILIC ARCHAEA; GEN. NOV.; SP. NOV.; METHANOCOCCUS-JANNASCHII; THERMOPHILIC BACTERIA; PYROCOCCUS-FURIOSUS; THERMOTOGA-MARITIMA; COMMUNITY STRUCTURE; AQUIFEX-PYROPHILUS	Thermophilic microbial inhabitants of active seafloor and continental hot springs populate the deepest branches of the universal phylogenetic tree, making hydrothermal ecosystems the most ancient continuously inhabited ecosystems on Earth. Geochemical consequences of hot water-rock interactions render these environments habitable and supply a diverse array of energy sources. Clues to the strategies for how life thrives in these dynamic ecosystems are beginning to be elucidated through a confluence of biogeochemistry, microbiology, ecology, molecular biology, and genomics. These efforts have the potential to reveal how ecosystems originate, the extent of the subsurface biosphere, and the driving forces of evolution.	Portland State Univ, Dept Biol, Portland, OR 97201 USA; Washington Univ, Dept Earth & Planetary Sci, Grp Exploring Organ Proc Geochem, St Louis, MO 63130 USA	Portland State University; Washington University (WUSTL)	Reysenbach, AL (corresponding author), Portland State Univ, Dept Biol, Portland, OR 97201 USA.			Shock, Everett/0000-0002-4283-0163				Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; BARNES HL, 1987, HYDROTHERMAL EXPT TE; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2002, APPL ENVIRON MICROB, V68, P335, DOI 10.1128/AEM.68.1.335-345.2002; Blochl E, 1997, EXTREMOPHILES, V1, P14; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; Brock T.D., 1978, THERMOPHILIC MICROOR; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Burggraf S, 1997, NATURE, V385, P780, DOI 10.1038/385780a0; Campbell BJ, 2001, APPL ENVIRON MICROB, V67, P4566, DOI 10.1128/AEM.67.10.4566-4572.2001; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; DavidBajar KM, 1997, LUPUS, V6, P145, DOI 10.1177/096120339700600210; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; DiRuggiero J, 1997, J BACTERIOL, V179, P4643, DOI 10.1128/jb.179.14.4643-4645.1997; Faguy DM, 1999, MICROBIOL-SGM, V145, P279, DOI 10.1099/13500872-145-2-279; Fisk MR, 1998, SCIENCE, V281, P978, DOI 10.1126/science.281.5379.978; Forterre P, 2000, TRENDS GENET, V16, P152, DOI 10.1016/S0168-9525(00)01980-6; GOTZ D, 2001, INT J SYST EVOL MICR; Grogan DW, 2000, TRENDS MICROBIOL, V8, P180, DOI 10.1016/S0966-842X(00)01729-7; HOEK J, UNPUB; HOLDEN JF, 1993, J BACTERIOL, V175, P2839, DOI 10.1128/JB.175.10.2839-2843.1993; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Huber R, 1998, APPL ENVIRON MICROB, V64, P3576; HUBER R, 1992, SYST APPL MICROBIOL, V15, P340, DOI 10.1016/S0723-2020(11)80206-7; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Jackson CR, 2001, ENVIRON MICROBIOL, V3, P532, DOI 10.1046/j.1462-2920.2001.00221.x; Jahnke LL, 2001, APPL ENVIRON MICROB, V67, P5179, DOI 10.1128/AEM.67.11.5179-5189.2001; JARMAN TR, 1984, ARCH MICROBIOL, V137, P231, DOI 10.1007/BF00414549; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; KASHEFI K, 2001, INT J SYST EVOL MICR; Klenk HP, 1999, J MOL EVOL, V48, P528, DOI 10.1007/PL00006496; L'Haridon S, 1998, INT J SYST BACTERIOL, V48, P701, DOI 10.1099/00207713-48-3-701; Langner HW, 2001, ENVIRON SCI TECHNOL, V35, P3302, DOI 10.1021/es0105562; Longnecker K, 2001, FEMS MICROBIOL ECOL, V35, P287, DOI 10.1111/j.1574-6941.2001.tb00814.x; LONGNECKER K, 2001, THESIS OREGON STATE; Maeder DL, 1999, GENETICS, V152, P1299; Marchesi JR, 2001, FEMS MICROBIOL ECOL, V34, P221, DOI 10.1016/S0168-6496(00)00099-4; Marteinsson VT, 1999, EXTREMOPHILES, V3, P277, DOI 10.1007/s007920050128; Marteinsson VT, 2001, APPL ENVIRON MICROB, V67, P827, DOI 10.1128/AEM.67.2.827-833.2001; Martins LO, 1996, J BACTERIOL, V178, P5644, DOI 10.1128/jb.178.19.5644-5651.1996; McCollom TM, 1997, GEOCHIM COSMOCHIM AC, V61, P4375, DOI 10.1016/S0016-7037(97)00241-X; MIROSHNICKENKO ML, 2002, INT J SYST EVOL MICR; Muralidharan V, 1997, BIOTECHNOL BIOENG, V56, P268, DOI 10.1002/(SICI)1097-0290(19971105)56:3<268::AID-BIT4>3.0.CO;2-H; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; Philippe H, 1999, J MOL EVOL, V49, P509, DOI 10.1007/PL00006573; Reysenbach A.-L., 2002, BIODIVERSITY MICROBI, P345; Reysenbach AL, 2000, NATURE, V404, P835, DOI 10.1038/35009029; Reysenbach AL, 2000, APPL ENVIRON MICROB, V66, P3798, DOI 10.1128/AEM.66.9.3798-3806.2000; Reysenbach AL, 2000, EXTREMOPHILES, V4, P61, DOI 10.1007/s007920050008; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2113, DOI 10.1128/AEM.60.6.2113-2119.1994; REYSENBACH AL, UNPUB; Rinker KD, 2000, BIOTECHNOL BIOENG, V69, P537, DOI 10.1002/1097-0290(20000905)69:5<537::AID-BIT8>3.0.CO;2-7; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Sandman K, 2000, ARCH MICROBIOL, V173, P165, DOI 10.1007/s002039900122; Santos H, 2001, METHOD ENZYMOL, V334, P302; Schopf JW, 2002, NATURE, V416, P73, DOI 10.1038/416073a; Setchell W A, 1903, Science, V17, P934, DOI 10.1126/science.17.441.934; SHOCK EL, 2000, ORIGIN EARTH MOON, P527; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; Stohr R, 2001, INT J SYST EVOL MICR, V51, P1853, DOI 10.1099/00207713-51-5-1853; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; Takacs C. J., UNPUB; Takai K, 1999, FEMS MICROBIOL ECOL, V28, P177, DOI 10.1111/j.1574-6941.1999.tb00573.x; Takai K, 1999, GENETICS, V152, P1285; Takai K, 2001, APPL ENVIRON MICROB, V67, P3618, DOI 10.1128/AEM.67.8.3618-3629.2001; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; TRENT JD, 1991, NATURE, V354, P490, DOI 10.1038/354490a0; Tumbula D, 1999, GENETICS, V152, P1269; VANDOVER CL, 2001, SCIENCE, V294; VOLKL P, 1993, APPL ENVIRON MICROB, V59, P2918; Von Damm K. L., 1995, GEOPHYS MONOGR SER, P222, DOI [10.1029/GM091, DOI 10.1029/GM091]; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Ward Donald E., 2002, Archaea, V1, P63, DOI 10.1155/2002/503191; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Yamamoto H, 1998, APPL ENVIRON MICROB, V64, P1680	79	185	212	2	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1077	1082		10.1126/science.1072483	http://dx.doi.org/10.1126/science.1072483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004120				2022-12-28	WOS:000175565000042
J	Hanayama, R; Tanaka, M; Miwa, K; Shinohara, A; Iwamatsu, A; Nagata, S				Hanayama, R; Tanaka, M; Miwa, K; Shinohara, A; Iwamatsu, A; Nagata, S			Identification of a factor that links apoptotic cells to phagocytes	NATURE			English	Article							VITRONECTIN RECEPTOR; PHOSPHATIDYLSERINE EXPRESSION; ANIONIC PHOSPHOLIPIDS; IN-VIVO; CLEARANCE; SURFACE; INTEGRIN; CLONING; DEATH; FRAGMENTATION	Apoptotic cells are rapidly engulfed by phagocytes to prevent the release of potentially noxious or immunogenic intracellular materials from the dying cells, thereby preserving the integrity and function of the surrounding tissue(1). Phagocytes engulf apoptotic but not healthy cells, indicating that the apoptotic cells present a signal to the phagocytes, and the phagocytes recognize the signal using a specific receptor(2). Here, we report a factor that links apoptotic cells to phagocytes. We found that milk fat globule-EGF-factor 8 (MFG-E8)(3,4), a secreted glycoprotein, was produced by thioglycollate-elicited macrophages. MFG-E8 specifically bound to apoptotic cells by recognizing aminophospholipids such as phosphatidylserine. MFG-E8, when engaged by phospholipids, bound to cells via its RGD (arginine-glycine-aspartate) motif-it bound particularly strongly to cells expressing alpha(v)beta(3) integrin. The NIH3T3 cell transformants that expressed a high level of alpha(v)beta(3) integrin were found to engulf apoptotic cells when MFG-E8 was added. MFG-E8 carrying a point mutation in the RGD motif behaved as a dominant-negative form, and inhibited the phagocytosis of apoptotic cells by peritoneal macrophages in vitro and in vivo. These results indicate that MFG-E8 secreted from activated macrophages binds to apoptotic cells, and brings them to phagocytes for engulfment.	Osaka Univ, Sch Med, Dept Genet, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Suita, Osaka 5650871, Japan; Kirin Brewery Co Ltd, Cent Labs Key Technol, Kanagawa 2360004, Japan	Osaka University; Japan Science & Technology Agency (JST); Kirin Brewery Company Limited	Nagata, S (corresponding author), Osaka Univ, Sch Med, Dept Genet, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.		Hanayama, Rikinari/AAO-4959-2021; Nagata, Shigekazu/AAG-3203-2019; Hanayama, Rikinari/D-2940-2011	Hanayama, Rikinari/0000-0003-2102-3386; Nagata, Shigekazu/0000-0001-9758-8426; 				Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Emoto K, 1997, EXP CELL RES, V232, P430, DOI 10.1006/excr.1997.3521; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Fadok VA, 2001, J BIOL CHEM, V276, P1071, DOI 10.1074/jbc.M003649200; Fadok VA, 1999, J MAMMARY GLAND BIOL, V4, P203, DOI 10.1023/A:1011384009787; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Hengartner MO, 2001, CELL, V104, P325, DOI 10.1016/S0092-8674(01)00219-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M; McIlroy D, 2000, GENE DEV, V14, P549; Nakano T, 1997, J BIOL CHEM, V272, P29411, DOI 10.1074/jbc.272.47.29411; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oshima K, 1999, BIOCHEM BIOPH RES CO, V254, P522, DOI 10.1006/bbrc.1998.0107; Platt N, 1998, TRENDS CELL BIOL, V8, P365, DOI 10.1016/S0962-8924(98)01329-4; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Taylor PR, 2000, J EXP MED, V192, P359, DOI 10.1084/jem.192.3.359; Wada J, 1996, J CELL BIOL, V132, P1161, DOI 10.1083/jcb.132.6.1161; Wilde CJ, 1999, J MAMMARY GLAND BIOL, V4, P129, DOI 10.1023/A:1018717006152	30	993	1045	2	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					182	187		10.1038/417182a	http://dx.doi.org/10.1038/417182a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000961				2022-12-28	WOS:000175460200045
J	Stein, L				Stein, L			Creating a bioinformatics nation - A web-services model will allow biological data to be fully exploited.	NATURE			English	Editorial Material									Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stein, L (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.								0	208	214	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					119	120		10.1038/417119a	http://dx.doi.org/10.1038/417119a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000935				2022-12-28	WOS:000175460200018
J	Wong, AM; Wang, JW; Axel, R				Wong, AM; Wang, JW; Axel, R			Spatial representation of the glomerular map in the Drosophila protocerebrum	CELL			English	Article							OCULAR DOMINANCE COLUMNS; OLFACTORY SENSORY MAP; LONG-RANGE ACTION; ANTENNAL LOBE; MORPHOGEN GRADIENT; NEURONAL-ACTIVITY; GENE-EXPRESSION; MICE DEFICIENT; MELANOGASTER; BULB	In the fruit fly, Drosophila, olfactory sensory neurons expressing a given receptor project to spatially invariant loci in the antennal lobe to create a topographic map of receptor activation. We have asked how the map in the antennal lobe is represented in higher sensory centers in the brain. Random labeling of individual projection neurons using the FLP-out technique reveals that projection neurons that innervate the same glomerulus exhibit strikingly similar axonal topography, whereas neurons from different glomeruli display very different patterns of projection in the protocerebrum. These results demonstrate that a topographic map of olfactory information is retained in higher brain centers, but the character of the map differs from that of the antennal lobe, affording an opportunity for integration of olfactory sensory input.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	ra27@columbia.edu	Wang, Jing W/C-3885-2008	Wang, Jing W/0000-0001-6291-5802; Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [MH 50733] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Belluscio L, 1998, NEURON, V20, P69, DOI 10.1016/S0896-6273(00)80435-3; BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082; BRAND AH, 1993, DEVELOPMENT, V118, P401; BURROWS M, 1982, J COMP PHYSIOL, V145, P447, DOI 10.1007/BF00612810; Cajal S., 1889, MANUAL HISTOLOGIA NO; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; HOMBERG U, 1984, J COMP PHYSIOL, V154, P825, DOI 10.1007/BF00610683; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; Ito K, 1998, LEARN MEMORY, V5, P52; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; JOHANSEN J, 1989, J NEUROSCI, V9, P710; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; RAPER JA, 1983, J NEUROSCI, V3, P20; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RODRIGUES V, 1984, BRAIN RES, V324, P374, DOI 10.1016/0006-8993(84)90053-2; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stortkuhl KF, 2001, P NATL ACAD SCI USA, V98, P9381, DOI 10.1073/pnas.151105698; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; White LE, 2001, NATURE, V411, P1049, DOI 10.1038/35082568; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	55	435	439	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					229	241		10.1016/S0092-8674(02)00707-9	http://dx.doi.org/10.1016/S0092-8674(02)00707-9			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007409	Bronze			2022-12-28	WOS:000175082600012
J	Jefferson, T; Alderson, P; Wager, E; Davidoff, F				Jefferson, T; Alderson, P; Wager, E; Davidoff, F			Effects of editorial peer review - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				QUALITY; JOURNALS; IMPROVE	Context Editorial peer review is widely used to select submissions to journals for publication and is presumed to improve their usefulness. Sufficient research on peer review has been published to consider a synthesis of its effects. Methods To examine the evidence of the effects of editorial peer-review processes in biomedical journals, we conducted electronic and full-text searches of private and public databases to June 2000 and corresponded with the World Association of Medical Editors, European Association of Science Editors, Council of Science Editors, and researchers in the field to locate comparative studies assessing the effects of any stage of the peer-review process that made some attempt to control for confounding. Nineteen of 135 identified studies fulfilled our criteria. Because of the diversity of study questions, methods, and outcomes, we did not pool results. Results Nine studies considered the effects of concealing reviewer/author identity. Four studies suggested that concealing reviewer or author identity affected review quality (mostly positively); however, methodological limitations make their findings ambiguous, and other studies' results were either negative or inconclusive. One study suggested that a statistical checklist can improve report quality, but another failed to find an effect of publishing another checklist. One study found no evidence that training referees improves performance and another showed increased interrater reliability; both used open designs, making interpretation difficult. Two studies of how journals communicate with reviewers did not demonstrate any effect on review quality, One study failed to show reviewer bias, but the findings may not be generalizable. One nonrandomized study compared the quality of articles published in peer-reviewed vs other journals. Two studies showed that editorial processes make articles more readable and improve the quality of reporting, but the findings may have limited generalizability to other journals. Conclusions Editorial peer review, although widely used, is largely untested and its effects are uncertain.	Hlth Reviews Ltd, Rome, Italy; UK Cochrane Ctr, Oxford, England; Annals Internal Med, Philadelphia, PA USA; Sideview, Princes Risborough, England	Cochrane Centre	Jefferson, T (corresponding author), Ist Super Sanita, Reparto Epidemiol Clin, Viale Regina Elena 299, I-00161 Rome, Italy.	toj1@aol.com		Wager, Elizabeth/0000-0002-4202-7813				ALDERSON P, 2001, EDITORIAL PEER REV I; Bingham CM, 1998, LANCET, V352, P441, DOI 10.1016/S0140-6736(97)11510-0; Callaham ML, 1998, ANN EMERG MED, V32, P318, DOI 10.1016/S0196-0644(98)70007-1; Das Sinha S, 1999, NATL MED J INDIA, V12, P210; Elvik R, 1998, ACCIDENT ANAL PREV, V30, P101, DOI 10.1016/S0001-4575(97)00068-7; Ernst E, 1999, Complement Ther Med, V7, P19, DOI 10.1016/S0965-2299(99)80054-5; FISHER M, 1994, JAMA-J AM MED ASSOC, V272, P143, DOI 10.1001/jama.272.2.143; GARDNER MJ, 1990, JAMA-J AM MED ASSOC, V263, P1355, DOI 10.1001/jama.263.10.1355; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; Jefferson T, 1998, JAMA-J AM MED ASSOC, V280, P275, DOI 10.1001/jama.280.3.275; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; KRONICK DA, 1990, JAMA-J AM MED ASSOC, V263, P1321, DOI 10.1001/jama.263.10.1321; MCNUTT RA, 1990, JAMA-J AM MED ASSOC, V263, P1371, DOI 10.1001/jama.263.10.1371; NEUHAUSER D, 1989, MED CARE, V27, P664, DOI 10.1097/00005650-198906000-00009; Overbeke J, 1999, PEER REV HLTH SCI, P32; Pierie JPEN, 1996, LANCET, V348, P1480, DOI 10.1016/S0140-6736(96)05016-7; RENNIE D, 1990, JAMA-J AM MED ASSOC, V263, P1317, DOI 10.1001/jama.1990.03440100011001; Rennie D, 1998, JAMA-J AM MED ASSOC, V280, P213, DOI 10.1001/jama.280.3.213; RENNIE D, 1994, JAMA-J AM MED ASSOC, V272, P91, DOI 10.1001/jama.1994.03520020017003; STRAYHORN J, 1993, AM J PSYCHIAT, V150, P947; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; van Rooyen S, 1999, BRIT MED J, V318, P23; Wager E, 2002, JAMA-J AM MED ASSOC, V287, P2821, DOI 10.1001/jama.287.21.2821; Walsh E, 2000, BRIT J PSYCHIAT, V176, P47, DOI 10.1192/bjp.176.1.47	27	208	211	6	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2784	2786		10.1001/jama.287.21.2784	http://dx.doi.org/10.1001/jama.287.21.2784			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038911	Bronze			2022-12-28	WOS:000176002200008
J	Mowatt, G; Shirran, L; Grimshaw, JJM; Rennie, D; Flanagin, A; Yank, V; MacLennan, G; Gotzsche, PC; Bero, LA				Mowatt, G; Shirran, L; Grimshaw, JJM; Rennie, D; Flanagin, A; Yank, V; MacLennan, G; Gotzsche, PC; Bero, LA			Prevalence of honorary and ghost authorship in Cochrane reviews	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				ARTICLES	Context To determine the prevalence of honorary and ghost authorship in Cochrane reviews, how authorship is assigned, and the ways in which authors and Cochrane editorial teams contribute. Methods Using a Web-based, self-administered survey, corresponding authors for 577 reviews published in issues 1 and 2 from 1999 of The Cochrane Library were invited to report on the prevalence of honorary and ghost authors, contributions by authors listed in the byline and members of Cochrane editorial teams, and identification of methods of assigning authorship. Responses were received for 362 reviews (63% response rate), which contained 913 authors. Results One hundred forty-one reviews (39%) had evidence of honorary authors, 32 (9%) had evidence of ghost authors (most commonly a member of the Cochrane editorial team), and 9 (2%) had evidence of both honorary and ghost authors. The editorial teams contributed in a wide variety of ways to 301 reviews (83%). Authorship was decided by the group of authors (31%) or lead author (25%) in most reviews. Authorship order was assigned according to contribution in most reviews (76%). The 3 functions contributed to most by those listed in the byline were assessing the quality of included studies (83%), interpreting data (82%), and abstracting data from included studies (77%). Conclusions A substantial proportion of reviews had evidence of honorary and ghost authorship. The Cochrane editorial teams contributed to most Cochrane reviews.	Univ Aberdeen, Hlth Serv Res Unit, Aberdeen AB25 2ZD, Scotland; Univ Aberdeen, Dept Gen Practice & Primary Care, Aberdeen, Scotland; JAMA, Chicago, IL USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA; Nord Cochrane Ctr, Copenhagen, Denmark; Univ Calif San Francisco, Dept Clin Pharm, San Francisco, CA 94143 USA	University of Aberdeen; University of Aberdeen; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mowatt, G (corresponding author), Univ Aberdeen, Hlth Serv Res Unit, Polwarth Bldg, Aberdeen AB25 2ZD, Scotland.	g.mowatt@abdn.ac.uk	Glidewell, Liz/G-7338-2011; Grimshaw, Jeremy/D-8726-2013	Glidewell, Liz/0000-0003-2519-2654; MacLennan, Graeme/0000-0002-1039-5646; Grimshaw, Jeremy/0000-0001-8015-8243				BERO L, 1995, JAMA-J AM MED ASSOC, V274, P1935, DOI 10.1001/jama.274.24.1935; Bhopal R, 1997, BRIT MED J, V314, P1009, DOI 10.1136/bmj.314.7086.1009; Clarke M, 2001, COCHRANE REV HDB 4 1; Clever LH, 1997, CAN MED ASSOC J, V156, P270; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; GOODMAN NW, 1994, BRIT MED J, V309, P1482, DOI 10.1136/bmj.309.6967.1482; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; SHAPIRO DW, 1994, JAMA-J AM MED ASSOC, V271, P438, DOI 10.1001/jama.271.6.438; Yank V, 1999, ANN INTERN MED, V130, P661, DOI 10.7326/0003-4819-130-8-199904200-00013	10	146	154	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2769	2771		10.1001/jama.287.21.2769	http://dx.doi.org/10.1001/jama.287.21.2769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038907	Bronze			2022-12-28	WOS:000176002200004
J	Silagy, CA; Middleton, P; Hopewell, S				Silagy, CA; Middleton, P; Hopewell, S			Publishing Protocols of systematic reviews - Comparing what was done to what was planned	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context Publication of research protocols minimizes bias by explicitly stating a priori hypotheses and methods without prior knowledge of results. Methods We conducted a retrospective comparative study to assess the extent to which the content of published Cochrane reviews had changed compared with their previously published protocols and to assess any potential impact these changes may have had in introducing bias to the study. We identified previously published protocols for new Cochrane reviews appearing in The Cochrane Library; 2000 issue 3. The texts of published protocols and completed reviews were compared. Two raters independently identified changes to the different sections of the protocol and classified the changes as noner minor, or major. Results Of the 66 new Cochrane reviews, we identified a previously published protocol for 47 reviews. Of these, 43 reviews had at least I section that had undergone a major change compared with the most recently published protocol. The greatest variation between protocols and reviews was in the methods section, in which 68% of reviews (n=32) had undergone a major change. Changes made in other sections that may have resulted in the introduction of bias included narrowing of objectives, addition of comparisons or new outcome measures, broadening of criteria for the types of study design included, and narrowing of types of participants included. Conclusions Research protocols, even if published, are likely to remain, at least to some extent, iterative documents. We found that a large number of changes were made to Cochrane reviews, some of which could be prone to influence by prior knowledge of results. Even if many of the changes between protocol and review improve the overall study, the reasons for making these should be clearly identified and documented within the final review.	UK Cochrane Ctr, Oxford OX2 7LG, England; Monash Med Ctr, Monash Inst Hlth Serv Res, Clayton, Vic 3168, Australia	Cochrane Centre; Monash University	Hopewell, S (corresponding author), UK Cochrane Ctr, Summertown Pavil,Middle Way, Oxford OX2 7LG, England.			Hopewell, Sally/0000-0002-6881-6984				Clarke M, 2001, COCHRANE REV HDB 4 1; JADAD AR, 1998, RANDOMISED CONTROLLE, P28	2	122	123	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2831	2834		10.1001/jama.287.21.2831	http://dx.doi.org/10.1001/jama.287.21.2831			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038926	Bronze			2022-12-28	WOS:000176002200023
J	Weller, AC				Weller, AC			Qualitative and quantitative measures of indexed health sciences electronic journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context Little is known about qualitative and quantitative characteristics of indexed health sciences electronic journals (e-journals). Methods To determine peer-review practices and qualitative and quantitative characteristics of different types of indexed health sciences e-journals, 3 types of e-journals indexed in MEDLINE were compared (type 1, completely electronic with no print counterpart; type 2, print and electronic versions with the same title but each publishing some unique content; and type 3, print and electronic versions containing equal content). Results There were 13 type I journals, 16 type 2 journals, and 16 type 3 journals. Most journals in each category (85%-94%) imply or state the use of peer review. Significant differences (P<.05, analysis of variance) exist among the e-journals for the inclusion of complex types of publications (clinical trials, randomized controlled trials, meta-analyses, and practice guidelines) (15% -100%), editorials (0% -75%), letters to the editor (10%-88%), and case reports (17%-94%); the average number of items indexed in MEDLINE (22.5-544.5); and the number of complex publication types, editorials, letters, and case reports. Conclusions Type I e-journals do not have the qualitative or quantitative complexity of traditional print journals. Although editors' statements on editorial peer review are similar, there are differences in number and type of materials included in the 3 different types of e-journals.	Univ Illinois, Univ Lib, Lib Hlth Sci, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Weller, AC (corresponding author), Univ Illinois, Univ Lib, Lib Hlth Sci, 1750 W Polk St, Chicago, IL 60612 USA.							Harter SP, 1998, J AM SOC INFORM SCI, V49, P507, DOI 10.1002/(SICI)1097-4571(19980501)49:6<507::AID-ASI3>3.0.CO;2-X; STEFFENS DL, 1991, LIB INFORMATION SCI; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; WELLER AC, 1987, B MED LIBR ASSOC, V75, P310; Wright SM, 2001, AM J MED, V110, P373, DOI 10.1016/S0002-9343(01)00626-X	5	1	2	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2865	2866		10.1001/jama.287.21.2865	http://dx.doi.org/10.1001/jama.287.21.2865			2	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559AP	12038935	Bronze			2022-12-28	WOS:000176002200032
J	Poland, GA; Murray, D; Bonilla-Guerrero, R				Poland, GA; Murray, D; Bonilla-Guerrero, R			Science, medicine, and the future - New vaccine development	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEPATITIS-B-VIRUS; TRANSCUTANEOUS IMMUNIZATION; THERAPEUTIC VACCINES; DNA; LIVE; IMMUNOGENICITY; EXPRESSION; INDUCTION; TRIVALENT; ADJUVANTS		Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Rochester, MN 55905 USA; Michigan State Univ, Dept Pediat & Human Dev, E Lansing, MI 48824 USA	Mayo Clinic; Michigan State University	Poland, GA (corresponding author), Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, 611C Guggenheim Bldg,200 1st St SW, Rochester, MN 55905 USA.	Poland.Gregory@mayo.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048793, R01AI033144, R01AI048793] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI048793, R01 AI033144, AI 48793, R37 AI048793, AI 33144] Funding Source: Medline; PHS HHS [AVA 001] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; CDC, 1999, MMWR-MORBID MORTAL W, V48, p[241, 241]; Chen Y, 2001, GENE THER, V8, P316, DOI 10.1038/sj.gt.3301396; Chow YH, 1998, J IMMUNOL, V160, P1320; Cieslak TJ, 2000, CLIN INFECT DIS, V30, P843, DOI 10.1086/313812; Coon B, 1999, J CLIN INVEST, V104, P189, DOI 10.1172/JCI7209; Dhiman N, 2001, VACCINE, V20, P22, DOI 10.1016/S0264-410X(01)00319-X; Glenn GM, 1999, INFECT IMMUN, V67, P1100, DOI 10.1128/IAI.67.3.1100-1106.1999; Gupta RK, 1998, DEV BIOLOGICALS, V92, P63; Hasegawa A, 2002, J REPROD IMMUNOL, V53, P91, DOI 10.1016/S0165-0378(01)00084-5; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; King JC, 1998, J INFECT DIS, V177, P1394, DOI 10.1086/517822; Knutson KL, 2001, J CLIN INVEST, V107, P477, DOI 10.1172/JCI11752; Kochenderfer J N, 2001, Curr Oncol Rep, V3, P193, DOI 10.1007/s11912-001-0050-3; Langridge WHR, 2000, SCI AM, V283, P66; Lillibridge SR, 1999, AM J INFECT CONTROL, V27, P463, DOI 10.1016/S0196-6553(99)70020-9; Mancini M, 1996, P NATL ACAD SCI USA, V93, P12496, DOI 10.1073/pnas.93.22.12496; McHugh RS, 1999, CANCER RES, V59, P2433; Moingeon P, 2001, VACCINE, V19, P1305, DOI 10.1016/S0264-410X(00)00372-8; Naz RK, 2001, MOL REPROD DEV, V60, P116, DOI 10.1002/mrd.1068; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Oka Y, 2001, IMMUNOLOGY, V103, P90, DOI 10.1046/j.1365-2567.2001.01202.x; Plotkin SA, 2001, INFECT DIS CLIN N AM, V15, P307, DOI 10.1016/S0891-5520(05)70280-4; Poland GA, 2001, VACCINE, V19, P2440, DOI 10.1016/S0264-410X(00)00469-2; Poland GA, 2000, MAYO CLIN PROC, V75, P135; Poland GA, 2001, VACCINE, V19, P2692, DOI 10.1016/S0264-410X(00)00505-3; Poland GA, 1999, VACCINE, V17, P1605, DOI 10.1016/S0264-410X(98)00417-4; POLAND GA, 2001, 4 ANN C VACC RES ARL, pS37; Poloso NJ, 2001, VACCINE, V19, P2029, DOI 10.1016/S0264-410X(00)00424-2; Santhanam R, 2001, MOL REPROD DEV, V60, P1, DOI 10.1002/mrd.1055; Scharton-Kersten T, 1999, VACCINE, V17, pS37, DOI 10.1016/S0264-410X(99)00233-9; Simone EA, 1999, DIABETES CARE, V22, pB7; Sivanandham M, 1998, CANCER IMMUNOL IMMUN, V46, P261, DOI 10.1007/s002620050486; Tacket CO, 1998, NAT MED, V4, P607, DOI 10.1038/nm0598-607; Tartaglia J, 2001, VACCINE, V19, P2571, DOI 10.1016/S0264-410X(00)00491-6; von Herrath MG, 2000, ANN MED, V32, P285, DOI 10.3109/07853890008995930; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Zhao Z, 1996, J PHARM SCI-US, V85, P1261, DOI 10.1021/js9602812	38	34	40	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1315	1319		10.1136/bmj.324.7349.1315	http://dx.doi.org/10.1136/bmj.324.7349.1315			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039828	Green Published			2022-12-28	WOS:000176041500021
J	Richards, HM; Reid, ME; Watt, CM				Richards, HM; Reid, ME; Watt, CM			Socioeconomic variations in responses to chest pain: qualitative study	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE MORTALITY; ANGINA; RATES; REVASCULARIZATION; QUESTIONNAIRE; PREVALENCE; BARRIERS; SERVICES	Objective To explore and explain socioeconomic variations in perceptions of and behavioural responses to chest pain. Design Qualitative interviews. Setting Community based study in Glasgow, Scotland. Participants 30 respondents (15 men and 15 women) from a socioeconomically deprived area of Glasgow and 30 respondents (15 men and 15 women) from an affluent area of Glasgow. Outcome measures Participants' reports of their perceptions of and actions in response to chest pain. Results Residents of the deprived area reported greater perceived vulnerability to heart disease, stemming from greater exposure to heart disease in family members and greater identification with high risk groups and stereotypes of cardiac patients. This greater perceived vulnerability was not associated with more frequent reporting of presenting to a general practitioner. People from the deprived area reported greater exposure to ill health, which allowed them to normalise their chest pain, led to confusion with other conditions, and gave rise to a belief that they were overusing medical services. These factors were associated with a reported tendency not to present with chest pain. Anxiety about presenting among respondents in the deprived area was heightened by self blame and fear that they would be chastised by their general practitioner for their risk behaviours. Conclusions Important socioeconomic variations in responses to chest pain may contribute to the known inequities in uptake of secondary cardiology services' Primary care professionals and health promoters should be aware of die ways in which perceptions of symptoms and illness behaviour are shaped by social and cultural factors.	Univ Aberdeen, Highlands & Isl Hlth Res Inst, Inverness IV2 3ED, Scotland; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland; Univ Glasgow, Dept Gen Practice, Glasgow G12 0RR, Lanark, Scotland	UHI Millennium Institute; University of Aberdeen; University of Glasgow; University of Glasgow	Richards, HM (corresponding author), Univ Aberdeen, Highlands & Isl Hlth Res Inst, Green House,Beechwood Business Pk, Inverness IV2 3ED, Scotland.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BLACK N, 1995, J EPIDEMIOL COMMUN H, V49, P408, DOI 10.1136/jech.49.4.408; Blaxter M., 1990, HLTH LIFESTYLES; Butler CC, 1998, BMJ-BRIT MED J, V316, P1878; CARTWRIGHT A, 1978, BASIC READINGS MED S, P89; COOK DG, 1989, INT J EPIDEMIOL, V18, P607, DOI 10.1093/ije/18.3.607; CORNWELL J, 1984, HARD EARNED LIVES, P79; COWIE B, 1976, SOC SCI MED, V10, P87, DOI 10.1016/0037-7856(76)90059-7; Gardner K, 1999, BRIT MED J, V319, P418, DOI 10.1136/bmj.319.7207.418; Hart CL, 1997, INT J EPIDEMIOL, V26, P508, DOI 10.1093/ije/26.3.508; MacLeod MCM, 1999, HEART, V81, P252, DOI 10.1136/hrt.81.3.252; Payne N, 1997, BRIT MED J, V314, P257, DOI 10.1136/bmj.314.7076.257; *REG GEN SCOTL, 1998, ANN REP REG GEN BIRT, V3, P156; *REG GEN SCOTL, 1998, ANN REP REG GEN BIRT, P156; Richards H, 2000, J EPIDEMIOL COMMUN H, V54, P714, DOI 10.1136/jech.54.9.714; Richards H, 2000, FAM PRACT, V17, P71, DOI 10.1093/fampra/17.1.71; RICHARDS HM, 2002, IN PRESS J AM MED WO, V57; ROGERS A, 1999, DEMANDING PATIENTS A; ROSE G, 1977, BRIT J PREV SOC MED, V31, P42; SMITH WCS, 1990, J CLIN EPIDEMIOL, V43, P637, DOI 10.1016/0895-4356(90)90033-L; Tod AM, 2001, BRIT MED J, V323, P214, DOI 10.1136/bmj.323.7306.214; Tunstall-Pedoe H, 1999, LANCET, V353, P1547, DOI 10.1016/S0140-6736(99)04021-0	21	51	52	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1308	1310A		10.1136/bmj.324.7349.1308	http://dx.doi.org/10.1136/bmj.324.7349.1308			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039824	Bronze, Green Published			2022-12-28	WOS:000176041500017
J	Chen, GQ; Goeddel, DV				Chen, GQ; Goeddel, DV			TNF-R1 signaling: A beautiful pathway	SCIENCE			English	Editorial Material								Tumor necrosis factor (TNF) is a major mediator of apoptosis as well a! inflammation and immunity, and it has been implicated in the pathogenesis of a wide spectrum of human diseases, including sepsis, diabetes, cancer osteoporosis, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel diseases. The interaction of TNF with TNF receptor-1 (TNF-R1) activated several signal transduction pathways. A common feature of each pathway h the TNF-induced formation of a multiprotein signaling complex at the cell membrane. Over the past decade, many of the components and mechanisms of these signaling pathways have been elucidated. We provide an overview of current knowledge of TNF signaling and introduce an STKE Connections Map that depicts a canonical view of this process.	Tularik Inc, San Francisco, CA 94080 USA		Goeddel, DV (corresponding author), Tularik Inc, 2 Corp Dr, San Francisco, CA 94080 USA.							CHEN G, 2002, SCI STKE; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9	4	1397	1476	23	227	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1634	1635		10.1126/science.1071924	http://dx.doi.org/10.1126/science.1071924			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040173				2022-12-28	WOS:000175976200036
J	Julian, B				Julian, B			Plate tectonics: Seismological detection of slab metamorphism	SCIENCE			English	Editorial Material							SUBDUCTION; SOUTHWEST; TREMOR		US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Julian, B (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	julian@usgs.gov						Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Dragert H, 2001, SCIENCE, V292, P1525, DOI 10.1126/science.1060152; JULIAN BR, 1994, J GEOPHYS RES-SOL EA, V99, P11859, DOI 10.1029/93JB03129; MATSUMOTO N, 1992, GEOPHYS RES LETT, V19, P1193, DOI 10.1029/92GL01042; Miller MM, 2002, SCIENCE, V295, P2423, DOI 10.1126/science.1071193; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Peacock SM, 1999, SCIENCE, V286, P937, DOI 10.1126/science.286.5441.937	7	15	17	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1625	1626		10.1126/science.1072602	http://dx.doi.org/10.1126/science.1072602			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040170				2022-12-28	WOS:000175976200033
J	Itkis, ME; Chi, X; Cordes, AW; Haddon, RC				Itkis, ME; Chi, X; Cordes, AW; Haddon, RC			Magneto-opto-electronic bistability in a phenalenyl-based neutral radical	SCIENCE			English	Article							ROOM-TEMPERATURE; SPINTRONICS; SYSTEM	A new organic molecular conductor, based on a spiro-biphenalenyl neutral radical, simultaneously exhibits bistability in three physical channels: electrical, optical, and magnetic. In the paramagnetic state, the unpaired electrons are located in the exterior phenalenyl units of the dimer, whereas in the diamagnetic state the electrons migrate to the interior phenalenyl units and spin pair as a pi-dimer. Against all expectations, the conductivity increases by two orders of magnitude in the diamagnetic state, and the band gap decreases. This type of multifunctional material has the potential to be used as the basis for new types of electronic devices, where multiple physical channels are used for writing, reading, and transferring information.	Univ Calif Riverside, Dept Chem, Ctr Nanoscale Sci & Engn, Riverside, CA 92521 USA; Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Haddon, RC (corresponding author), Univ Calif Riverside, Dept Chem, Ctr Nanoscale Sci & Engn, Riverside, CA 92521 USA.		Haddon, Robert C/A-2528-2008	Haddon, Robert C/0000-0002-7903-5139				BALLESTER M, 1985, ACCOUNTS CHEM RES, V18, P380, DOI 10.1021/ar00120a004; Chi X, 2001, J AM CHEM SOC, V123, P4041, DOI 10.1021/ja0039785; Chi X, 1999, J AM CHEM SOC, V121, P10395, DOI 10.1021/ja992040c; Das Sarma S, 2001, AM SCI, V89, P516; Fujita W, 1999, SCIENCE, V286, P261, DOI 10.1126/science.286.5438.261; Goto K, 1999, J AM CHEM SOC, V121, P1619, DOI 10.1021/ja9836242; HADDON RC, 1975, NATURE, V256, P394, DOI 10.1038/256394a0; Kahn O, 1998, SCIENCE, V279, P44, DOI 10.1126/science.279.5347.44; Koutentis PA, 2001, J AM CHEM SOC, V123, P3864, DOI 10.1021/ja0018015; KROBER J, 1993, J AM CHEM SOC, V115, P9810, DOI 10.1021/ja00074a062; Nakatani K, 2001, ADV MATER, V13, P1411, DOI 10.1002/1521-4095(200109)13:18<1411::AID-ADMA1411>3.0.CO;2-Y; Peierls R.F., 1955, QUANTUM THEORY SOLID; SITZMANN H, 1993, J AM CHEM SOC, V115, P12003, DOI 10.1021/ja00078a043; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389	14	482	486	3	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1443	1445		10.1126/science.1071372	http://dx.doi.org/10.1126/science.1071372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029128				2022-12-28	WOS:000175910300041
J	Matsubayashi, Y; Ogawa, M; Morita, A; Sakagami, Y				Matsubayashi, Y; Ogawa, M; Morita, A; Sakagami, Y			An LRR receptor kinase involved in perception of a peptide plant hormone, phytosulfokine	SCIENCE			English	Article							LEUCINE-RICH REPEAT; GROWTH-FACTOR; SULFATED PENTAPEPTIDE; MESOPHYLL-CELLS; BINDING-SITES; ALPHA; PROLIFERATION; ARABIDOPSIS; ANALOGS	The sulfated peptide phytosulfokine (PSK) is an intercellular signal that plays a key role in cellular dedifferentiation and proliferation in plants. Using ligand-based affinity chromatography, we purified a 120-kilodalton membrane protein, specifically interacting with PSK, from carrot microsomal fractions. The corresponding complementary DNA encodes a 1021-amino acid receptor kinase that contains extracellular leucine-rich repeats, a single transmembrane domain, and a cytoplasmic kinase domain. Overexpression of this receptor kinase in carrot cells caused enhanced callus growth in response to PSK and a substantial increase in the number of tritium-labeled PSK binding sites, suggesting that PSK and this receptor kinase act as a ligand-receptor pair.	Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Matsubayashi, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	matsu@agr.nagoya-u.ac.jp	MATSUBAYASHI, Yoshikatsu/AAA-9705-2019	Ogawa-Ohnishi, Mari/0000-0002-7581-2607; Matsubayashi, Yoshikatsu/0000-0002-2669-2119				BELLINCAMPI D, 1987, PLANT SCI, V51, P83, DOI 10.1016/0168-9452(87)90223-8; BIRNBERG PR, 1988, J PLANT PHYSIOL, V132, P316, DOI 10.1016/S0176-1617(88)80113-5; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Hanai H, 2000, PLANT CELL PHYSIOL, V41, P27, DOI 10.1093/pcp/41.1.27; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; Kobayashi T, 1999, J EXP BOT, V50, P1123, DOI 10.1093/jexbot/50.336.1123; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Matsubayashi Y, 1999, BIOSCI BIOTECH BIOCH, V63, P1847, DOI 10.1271/bbb.63.1847; Matsubayashi Y, 2000, J BIOL CHEM, V275, P15520, DOI 10.1074/jbc.275.20.15520; Matsubayashi Y, 1999, EUR J BIOCHEM, V262, P666, DOI 10.1046/j.1432-1327.1999.00409.x; Matsubayashi Y, 1997, P NATL ACAD SCI USA, V94, P13357, DOI 10.1073/pnas.94.24.13357; Matsubayashi Y, 1999, PLANTA, V207, P559, DOI 10.1007/s004250050518; Matsubayashi Y, 1999, PLANT PHYSIOL, V120, P1043, DOI 10.1104/pp.120.4.1043; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Matsubayashi Y, 1996, BIOCHEM BIOPH RES CO, V225, P209, DOI 10.1006/bbrc.1996.1155; Yang HP, 2001, PLANT PHYSIOL, V127, P842, DOI 10.1104/pp.010452	17	248	273	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1470	1472		10.1126/science.1069607	http://dx.doi.org/10.1126/science.1069607			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029134				2022-12-28	WOS:000175910300049
J	Fish, SA; Shepherd, TJ; McGenity, TJ; Grant, WD				Fish, SA; Shepherd, TJ; McGenity, TJ; Grant, WD			Recovery of 16S ribosomal RNA gene fragments from ancient halite	NATURE			English	Article							FLUID INCLUSIONS; SEAWATER CHEMISTRY; SALT; MARINE; HALOBACTERIA; EVAPORITES; EDS	During the last decade, sensitive techniques for detecting DNA have been successfully applied to archaeological and other samples that were a few hundred to a few thousand years old(1,2). Nevertheless, there is still controversy and doubt over claims of exceptionally ancient DNA(3). Additional accounts stretching back nearly a century suggest that microorganisms may survive over geological time in evaporite deposits(4,5). There is, however, often doubt over the age relationship between evaporite formation and the incorporation of microorganisms(6). Here, we have used petrographic and geochemical techniques (laser ablation microprobe-inductively coupled plasma-mass spectrometry) to verify the estimated geological age of halite (NaCl) evaporite samples. Fragments of 16S ribosomal RNA genes were detected by polymerase chain reaction amplification of DNA extracted from halite samples ranging in age from 11 to 425 Myr (millions of years). Haloarchaeal 16S rDNA amplicons were present in one sample (11-16 Myr), whereas other samples (65-425 Myr) yielded only bacterial 16S rDNA amplicons. Terminal restriction fragment length polymorphism analyses indicate complex and different populations of microorganisms or their free DNA in ancient halites of different ages.	Univ Leicester, Dept Microbiol & Immunol, Leicester LE1 9HN, Leics, England; British Geol Survey, Keyworth NG12 5GG, Notts, England; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Leicester; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Geological Survey; University of Essex	Shepherd, TJ (corresponding author), Univ Leicester, Dept Microbiol & Immunol, Leicester LE1 9HN, Leics, England.		McGenity, Terry/B-8661-2011	McGenity, Terence/0000-0002-1497-8822				CANO R J, 1992, Medical Science Research, V20, P249; GEMMELL RT, 1998, ANCIENT BIOMOLECULES, V2, P125; Grant WD, 1998, EXTREMOPHILES, V2, P279, DOI 10.1007/s007920050070; Gunther D, 1998, J ANAL ATOM SPECTROM, V13, P263, DOI 10.1039/a707372k; HARDIE LA, 1984, AM J SCI, V284, P193, DOI 10.2475/ajs.284.3.193; Hardie LA, 1996, GEOLOGY, V24, P279, DOI 10.1130/0091-7613(1996)024<0279:SVISCA>2.3.CO;2; Hazen RM, 2001, NATURE, V411, P155, DOI 10.1038/35075663; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kalmbach S, 1999, INT J SYST BACTERIOL, V49, P769, DOI 10.1099/00207713-49-2-769; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; MULLER A, 1953, Z DTSCH GEOL GES, V105, P789; NORTON CF, 1993, J GEN MICROBIOL, V139, P1077, DOI 10.1099/00221287-139-5-1077; NORTON CF, 1988, J GEN MICROBIOL, V134, P1365; ROEDDER E, 1984, AM MINERAL, V69, P413; ROSLER HJ, 1972, GEOCHEMICAL TABLES T; RYCHLIK W, 1995, BIOTECHNIQUES, V18, P84; RYCHLIK W, 1990, NUCLEIC ACIDS RES, V18, P6409, DOI 10.1093/nar/18.21.6409; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shepherd TJ, 1998, EUR J MINERAL, V10, P1097; SMITH A, 1998, GEOSCIENTIST, V7, P8; SOMMERS R, 1989, NUCLEIC ACIDS RES, V17, P674; Timofeeff MN, 2000, CHEM GEOL, V164, P171, DOI 10.1016/S0009-2541(99)00153-9; Timofeeff MN, 2001, GEOCHIM COSMOCHIM AC, V65, P2293, DOI 10.1016/S0016-7037(01)00591-9; TIMOFEEFF MN, 1999, 9 ANN VM GOLDSCHM C, P299; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; WARDLAW NC, 1966, GEOL SOC AM BULL, V77, P331, DOI 10.1130/0016-7606(1966)77[331:HSLITM]2.0.CO;2; WOODWARD SR, 1994, SCIENCE, V266, P1229; Zimmermann H, 2001, GEOCHIM COSMOCHIM AC, V65, P35, DOI 10.1016/S0016-7037(00)00508-1	29	89	101	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					432	436		10.1038/417432a	http://dx.doi.org/10.1038/417432a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024211				2022-12-28	WOS:000175730900036
J	Darby, C; Hsu, JW; Ghori, N; Falkow, S				Darby, C; Hsu, JW; Ghori, N; Falkow, S			Caenorhabditis elegans - Plague bacteria biofilm blocks food intake	NATURE			English	Article							YERSINIA-PESTIS; STAPHYLOCOCCUS-EPIDERMIDIS		Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Darby, C (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.							AVERY L, 1993, GENETICS, V133, P897; Bacot A. W., 1914, Journal of Hygiene Cambridge Plague Suppl, V3; BRUBAKER RR, 1991, CLIN MICROBIOL REV, V4, P309, DOI 10.1128/CMR.4.3.309-324.1991; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hinnebusch BJ, 1998, J INFECT DIS, V178, P1406, DOI 10.1086/314456; Hinnebusch BJ, 1996, SCIENCE, V273, P367, DOI 10.1126/science.273.5273.367; Hinnebusch BJ, 1997, J MOL MED, V75, P645, DOI 10.1007/s001090050148; Jones HA, 1999, MICROBIOL-SGM, V145, P2117, DOI 10.1099/13500872-145-8-2117	10	205	223	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					243	244		10.1038/417243a	http://dx.doi.org/10.1038/417243a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015591				2022-12-28	WOS:000175592100035
J	Nusbaum, MP; Beenhakker, MP				Nusbaum, MP; Beenhakker, MP			A small-systems approach to motor pattern generation	NATURE			English	Review							STOMATOGASTRIC NERVOUS-SYSTEM; NEURAL-NETWORK; SYNAPTIC-TRANSMISSION; NEURONAL NETWORKS; MODULATION; CIRCUIT; MECHANISMS; PACEMAKER; RHYTHM; PROJECTION		Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Nusbaum, MP (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 215 Stemmler Hall, Philadelphia, PA 19104 USA.	nusbaum@mail.med.upenn.edu		Nusbaum, Michael/0000-0001-5935-0046	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042813] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS042813] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ayali A, 1999, J NEUROSCI, V19, P6712; Baro DJ, 1998, ANN NY ACAD SCI, V860, P281, DOI 10.1111/j.1749-6632.1998.tb09056.x; Baro DJ, 2000, J NEUROSCI, V20, P6619, DOI 10.1523/JNEUROSCI.20-17-06619.2000; Bartos M, 1997, J NEUROSCI, V17, P2247; Bartos M, 1999, J NEUROSCI, V19, P6650; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; Clemens S, 1998, J NEUROPHYSIOL, V79, P1396, DOI 10.1152/jn.1998.79.3.1396; COLEMAN MJ, 1995, NATURE, V378, P502, DOI 10.1038/378502a0; COLEMAN MJ, 1994, J NEUROSCI, V14, P6544; Combes D, 1999, J NEUROSCI, V19, P3610; Combes D, 1999, J NEUROSCI, V19, P3620; DICKINSON PS, 1990, NATURE, V344, P155, DOI 10.1038/344155a0; Earhart GM, 2000, J NEUROPHYSIOL, V84, P2181, DOI 10.1152/jn.2000.84.5.2181; Edwards DH, 1998, P NATL ACAD SCI USA, V95, P7145, DOI 10.1073/pnas.95.12.7145; ELSON RC, 1992, J NEUROPHYSIOL, V68, P890, DOI 10.1152/jn.1992.68.3.890; Elson RC, 1999, J NEUROPHYSIOL, V82, P115, DOI 10.1152/jn.1999.82.1.115; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Goldman MS, 2001, J NEUROSCI, V21, P5229, DOI 10.1523/JNEUROSCI.21-14-05229.2001; GRAUBARD K, 1987, SCIENCE, V237, P535, DOI 10.1126/science.2885921; Gutovitz S, 2001, J NEUROSCI, V21, P5935, DOI 10.1523/JNEUROSCI.21-16-05935.2001; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; Harris-Warrick RM, 1998, ANN NY ACAD SCI, V860, P155, DOI 10.1111/j.1749-6632.1998.tb09046.x; Harris-Warrick Ronald M., 1992, P87; HARRISWARRICK RM, 1987, J NEUROSCI, V7, P2113; Hartline Daniel K., 1992, P31; HEINZEL HG, 1993, J NEUROSCI, V13, P1793; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; Hooper SL, 1998, NAT NEUROSCI, V1, P720, DOI 10.1038/3721; HOOPER SL, 1987, J NEUROSCI, V7, P2097; Hooper SL, 1997, J COMPUT NEUROSCI, V4, P191, DOI 10.1023/A:1008822218061; HOOPER SL, 1990, J NEUROPHYSIOL, V64, P1574, DOI 10.1152/jn.1990.64.5.1574; Hooper SL, 2000, CURR OPIN NEUROBIOL, V10, P676, DOI 10.1016/S0959-4388(00)00158-6; Jaeger D, 1999, J NEUROSCI, V19, P6090, DOI 10.1523/JNEUROSCI.19-14-06090.1999; JOHNSON BR, 1994, J COMP PHYSIOL A, V175, P233, DOI 10.1007/BF00215119; Jorge-Rivera JC, 1998, J NEUROPHYSIOL, V80, P2559, DOI 10.1152/jn.1998.80.5.2559; Katz Paul S., 1992, P221; Katz PS, 1999, CURR OPIN NEUROBIOL, V9, P628, DOI 10.1016/S0959-4388(99)00012-4; KATZ PS, 1990, J NEUROSCI, V10, P1495; KATZ PS, 1993, J NEUROSCI, V13, P3075; KAWAHARA K, 1989, J APPL PHYSIOL, V67, P110, DOI 10.1152/jappl.1989.67.1.110; KEMENES G, 1994, J NEUROSCI, V14, P153; Kiehn O, 2002, TRENDS NEUROSCI, V25, P108, DOI 10.1016/S0166-2236(02)02038-6; Kiehn O, 2000, BRAIN RES BULL, V53, P649, DOI 10.1016/S0361-9230(00)00398-1; Kloppenburg P, 2000, J NEUROSCI, V20, P2523; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; LARSON CR, 1994, J NEUROPHYSIOL, V71, P2294, DOI 10.1152/jn.1994.71.6.2294; Le Feuvre Y, 2001, J NEUROSCI, V21, P1313; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Manor Y, 2001, J NEUROSCI, V21, P9460, DOI 10.1523/JNEUROSCI.21-23-09460.2001; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARDER E, 1993, AM ZOOL, V33, P29; Marder E., 1985, P319; MARDER E, 1984, J EXP BIOL, V112, P147; MARDER E, 1989, NEURONAL CELLULAR OS, P317; Marder E, 1995, INVERTEBR NEUROSCI, V1, P105, DOI 10.1007/BF02331908; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; MEYRAND P, 1994, J NEUROSCI, V14, P630; MEYRAND P, 1991, NATURE, V351, P60, DOI 10.1038/351060a0; Meyrand P, 2000, EUR J NEUROSCI, V12, P2585, DOI 10.1046/j.1460-9568.2000.00121.x; Miller J.P., 1987, P109; Mizrahi A, 2001, J NEUROSCI, V21, P7331, DOI 10.1523/JNEUROSCI.21-18-07331.2001; Morris LG, 2000, NAT NEUROSCI, V3, P245, DOI 10.1038/72955; Nadim F, 2000, CURR OPIN NEUROBIOL, V10, P683, DOI 10.1016/S0959-4388(00)00159-8; Nadim F, 1998, J NEUROSCI, V18, P5053; NAGY F, 1994, J NEUROPHYSIOL, V71, P2490, DOI 10.1152/jn.1994.71.6.2490; Norris BJ, 1996, J NEUROPHYSIOL, V75, P97, DOI 10.1152/jn.1996.75.1.97; Nusbaum MP, 2001, TRENDS NEUROSCI, V24, P146, DOI 10.1016/S0166-2236(00)01723-9; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Parker D, 1999, J NEUROSCI, V19, P1647; Parker D, 2000, PROG BRAIN RES, V125, P381; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Perrins R, 1998, J NEUROSCI, V18, P3977; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Richards KS, 2000, J NEUROBIOL, V44, P31, DOI 10.1002/1097-4695(200007)44:1<31::AID-NEU4>3.0.CO;2-F; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Scholz NL, 2001, J NEUROSCI, V21, P1610, DOI 10.1523/JNEUROSCI.21-05-01610.2001; SELVERSTON AI, 1985, J NEUROSCI, V5, P1283; Selverston AI, 2000, J PHYSIOLOGY-PARIS, V94, P357, DOI 10.1016/S0928-4257(00)01101-3; SHARP AA, 1993, TRENDS NEUROSCI, V16, P389, DOI 10.1016/0166-2236(93)90004-6; Skiebe P, 2001, J EXP BIOL, V204, P2035; SOFFE SR, 1993, J NEUROSCI, V13, P4456; Soto-Trevino C, 2001, NAT NEUROSCI, V4, P297, DOI 10.1038/85147; Stein P. S. G., 1997, NEURONS NETWORKS MOT; Swensen AM, 2001, J NEUROSCI, V21, P4050, DOI 10.1523/JNEUROSCI.21-11-04050.2001; Swensen AM, 2000, J NEUROSCI, V20, P6752, DOI 10.1523/JNEUROSCI.20-18-06752.2000; Thoby-Brisson M, 2000, J NEUROSCI, V20, P5858, DOI 10.1523/JNEUROSCI.20-15-05858.2000; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Turrigiano Gina G., 1992, P197; Ulrich D, 1997, J NEUROPHYSIOL, V78, P1748, DOI 10.1152/jn.1997.78.3.1748; Velazquez JLP, 2000, TRENDS NEUROSCI, V23, P68; WARZECHA AK, 1993, J NEUROPHYSIOL, V69, P329, DOI 10.1152/jn.1993.69.2.329; WEIMANN JM, 1994, CURR BIOL, V4, P896, DOI 10.1016/S0960-9822(00)00199-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wood DE, 2000, J NEUROSCI, V20, P8943; Wood DE, 2002, J NEUROSCI, V22, P4185, DOI 10.1523/JNEUROSCI.22-10-04185.2002	99	257	258	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					343	350		10.1038/417343a	http://dx.doi.org/10.1038/417343a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015615	Green Accepted			2022-12-28	WOS:000175592100059
J	Sun, Y; Olson, R; Horning, M; Armstrong, N; Mayer, M; Gouaux, E				Sun, Y; Olson, R; Horning, M; Armstrong, N; Mayer, M; Gouaux, E			Mechanism of glutamate receptor desensitization	NATURE			English	Article							LIGAND-BINDING CORE; AMPA RECEPTOR; ION CHANNELS; TETRAMERIC STRUCTURE; HIPPOCAMPAL-NEURONS; CRYSTAL-STRUCTURES; CYCLOTHIAZIDE; KAINATE; CELLS; SELECTIVITY	Ligand-gated ion channels transduce chemical signals into electrical impulses by opening a transmembrane pore in response to binding one or more neurotransmitter molecules. After activation, many ligand-gated ion channels enter a desensitized state in which the neurotransmitter remains bound but the ion channel is closed. Although receptor desensitization is crucial to the functioning of many ligand-gated ion channels in vivo, the molecular basis of this important process has until now defied analysis. Using the GluR2 AMPA-sensitive glutamate receptor, we show here that the ligand-binding cores form dimers and that stabilization of the intradimer interface by either mutations or allosteric modulators reduces desensitization. Perturbations that destabilize the interface enhance desensitization. Receptor activation involves conformational changes within each subunit that result in an increase in the separation of portions of the receptor that are linked to the ion channel. Our analysis defines the dimer interface in the resting and activated state, indicates how ligand binding is coupled to gating, and suggests modes of dimer-dimer interaction in the assembled tetramer. Desensitization occurs through rearrangement of the dimer interface, which disengages the agonist-induced conformational change in the ligand-binding core from the ion channel gate.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; NICHHD, Lab Cellular & Mol Neurophysiol, NIH, Bethesda, MD 20892 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Gouaux, E (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 W 168th St, New York, NY 10032 USA.		Gouaux, Eric/Y-4370-2019; Mayer, Mark/AAE-7356-2019; Mayer, Mark L/H-5500-2013	Gouaux, Eric/0000-0002-8549-2360; Mayer, Mark/0000-0003-4378-8451; 				Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; ANSEVIN AT, 1970, ANAL BIOCHEM, V34, P237, DOI 10.1016/0003-2697(70)90103-X; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; AYOLAN G, 2001, NEURON, V31, P103; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Clark RB, 1999, TRENDS PHARMACOL SCI, V20, P279, DOI 10.1016/S0165-6147(99)01351-6; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; CORDI AA, 1994, BIOORG MED CHEM LETT, V4, P1957, DOI 10.1016/S0960-894X(01)80542-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; HALL RA, 1993, BRAIN RES, V628, P345, DOI 10.1016/0006-8993(93)90978-V; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; KISKIN NI, 1986, NEUROSCI LETT, V63, P225, DOI 10.1016/0304-3940(86)90360-5; Kleywegt GJ, 1994, CCP4 ESF EACBM NEWSL, P9; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Laube B, 1998, J NEUROSCI, V18, P2954; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; MAYER ML, 1995, EXCITATORY AMINO ACI, P89; Nagarajan N, 2001, NEUROPHARMACOLOGY, V41, P650, DOI 10.1016/S0028-3908(01)00133-2; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panchenko VA, 2001, J GEN PHYSIOL, V117, P345, DOI 10.1085/jgp.117.4.345; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Partin KM, 2001, J NEUROSCI, V21, P1939, DOI 10.1523/JNEUROSCI.21-06-01939.2001; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Regalado MP, 2001, NEURON, V32, P1085, DOI 10.1016/S0896-6273(01)00539-6; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; TRUSSELL LO, 1988, P NATL ACAD SCI USA, V85, P4562, DOI 10.1073/pnas.85.12.4562-a; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882	46	575	600	0	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					245	253		10.1038/417245a	http://dx.doi.org/10.1038/417245a			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015593				2022-12-28	WOS:000175592100037
J	Coats, TJ; Davies, G				Coats, TJ; Davies, G			Prehospital care for road traffic casualties	BRITISH MEDICAL JOURNAL			English	Review							TRAUMA PATIENTS; SURVIVAL; INJURY		Univ London, Sch Med & Dent, London E1 2AD, England; Barts & London NHS Trust, London E1 1BB, England	University of London; Barts Health NHS Trust	Coats, TJ (corresponding author), Univ London, Sch Med & Dent, London E1 2AD, England.		Coats, Timothy/AAW-1254-2021	Coats, Timothy/0000-0003-2736-2784				Bunn F, 2001, EFFECTIVENESS PREHOS; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; HUSSAIN LM, 1994, BRIT MED J, V308, P1077, DOI 10.1136/bmj.308.6936.1077; Kwan I, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002803; KWAN I, 2001, COCHRANE DB SYST REV; Lockey D, 2001, BRIT MED J, V323, P141, DOI 10.1136/bmj.323.7305.141; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; NICHOLL JP, 1995, BRIT MED J, V311, P217, DOI 10.1136/bmj.311.6999.217; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Royal College of Surgeons of England and the British Orthopaedic Society, 2000, BETT CAR SEV INJ; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28	11	34	36	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1135	1138		10.1136/bmj.324.7346.1135	http://dx.doi.org/10.1136/bmj.324.7346.1135			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003887	Green Published			2022-12-28	WOS:000175622800025
J	Yuan, L; Liu, JG; Hoja, MR; Wilbertz, J; Nordqvist, K; Hoog, C				Yuan, L; Liu, JG; Hoja, MR; Wilbertz, J; Nordqvist, K; Hoog, C			Female germ cell aneuploidy and embryo death in mice lacking the meiosis-specific protein SCP3	SCIENCE			English	Article							SYNAPTONEMAL COMPLEX PROTEIN; SACCHAROMYCES-CEREVISIAE; CROSSOVER INTERFERENCE; LOCALIZATION	Aneuploidy (trisomy or monosomy) is the leading genetic cause of pregnancy loss in humans and results from errors in meiotic chromosome segregation. Here, we show that the absence of synaptonemal complex protein 3 (SCP3) promotes aneuploidy in murine oocytes by inducing defective meiotic chromosome segregation. The abnormal oocyte karyotype is inherited by embryos, which die in utero at an early stage of development. In addition, embryo death in SCP3-deficient females increases with advancing maternal age. We found that SCP3 is required for chiasmata formation and for the structural integrity of meiotic chromosomes, suggesting that altered chromosomal structure triggers nondisjunction. SCP3 is thus linked to inherited aneuploidy in female germ cells and provides a model system for studying age-dependent degeneration in oocytes.	Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden; Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hoog, C (corresponding author), Karolinska Inst, Ctr Genom & Bioinformat, SE-17177 Stockholm, Sweden.		Dalton-O'Reilly, Jessica/AAM-8569-2021; Nordqvist, Katarina/B-7964-2016	Nordqvist, Katarina/0000-0001-9561-5590				Anderson LK, 1999, GENETICS, V151, P1569; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hodges CA, 2001, J CELL SCI, V114, P2417; HOJA MR, UNPUB; Kaback DB, 1999, GENETICS, V152, P1475; Kline J, 2000, AM J HUM GENET, V67, P395, DOI 10.1086/303009; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; LAWRIE NM, 1995, CHROMOSOMA, V140, P308; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Peltier JW, 2000, MARK HEALTH SERV, V20, P5; Schalk JAC, 1998, CHROMOSOMA, V107, P540, DOI 10.1007/s004120050340; SCHMEKEL K, 1995, TRENDS CELL BIOL, V5, P239, DOI 10.1016/S0962-8924(00)89017-0; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; Tung KS, 1998, GENETICS, V149, P817; Yuan L, 1998, J CELL BIOL, V142, P331, DOI 10.1083/jcb.142.2.331; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	18	266	291	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1115	1118		10.1126/science.1070594	http://dx.doi.org/10.1126/science.1070594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004129				2022-12-28	WOS:000175565000052
J	Yin, YH; Wang, ZY; Mora-Garcia, S; Li, JM; Yoshida, S; Asami, T; Chory, J				Yin, YH; Wang, ZY; Mora-Garcia, S; Li, JM; Yoshida, S; Asami, T; Chory, J			BES1 accumulates in the nucleus in response to brassinosteroids to regulate gene expression and promote stem elongation	CELL			English	Article							PLANT-GROWTH; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; CELL ELONGATION; KINASE; CYTOCHROME-P450; TRANSFORMATION; PATHWAYS; CATENIN; MUTANT	Plant steroid hormones, known as brassinosteroids (BRs), signal through a plasma membrane localized receptor kinase BRI1. We identified bes1, a semidominant suppressor of bri1, which exhibits constitutive BR response phenotypes including long and bending petioles, curly leaves, accelerated senescence, and constitutive expression of BR-response genes. BES1 accumulates in the nucleus in response to BRs. BES1 is phosphorylated and appears to be destabilized by the glycogen synthase kinase-3 (GSK-3) BIN2, a negative regulator of the BR pathway. These results establish a signaling cascade for BRs with similarities to the Wnt pathway, in which signaling through cell surface receptors leads to inactivation of a GSK-3 allowing accumulation of a nuclear protein that regulates target gene expression.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; RIKEN, Inst Phys & Chem Res, Plant Funct Lab, Wako, Saitama 3510198, Japan	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of Michigan System; University of Michigan; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.		Wang, Zhi-Yong/E-3810-2012; Li, Jianming/O-1772-2014	Wang, Zhi-Yong/0000-0003-4602-3390; Li, Jianming/0000-0003-3231-0778	NIGMS NIH HHS [F32 GM020558, R01 GM060519] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Beato M, 2000, HUM REPROD UPDATE, V6, P225, DOI 10.1093/humupd/6.3.225; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Clouse SD, 1996, PLANT PHYSIOL, V111, P671, DOI 10.1104/pp.111.3.671; Clouse SD, 1996, PLANT J, V10, P1, DOI 10.1046/j.1365-313X.1996.10010001.x; Darley CP, 2001, PLANT MOL BIOL, V47, P179, DOI 10.1023/A:1010687600670; Dornelas MC, 1998, GENE, V212, P249, DOI 10.1016/S0378-1119(98)00147-4; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; Friedrichsen D, 2001, BIOESSAYS, V23, P1028, DOI 10.1002/bies.1148; Friedrichsen DM, 2000, PLANT PHYSIOL, V123, P1247, DOI 10.1104/pp.123.4.1247; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Kang JG, 2001, CELL, V105, P625, DOI 10.1016/S0092-8674(01)00370-1; Kauschmann A, 1996, PLANT J, V9, P701, DOI 10.1046/j.1365-313X.1996.9050701.x; Lamport DTA, 2001, CELL MOL LIFE SCI, V58, P1363, DOI 10.1007/PL00000782; LI J, 1999, J EXP BOT, V50, P332; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 2002, SCIENCE, V295, P1299; Li JM, 2001, PLANT PHYSIOL, V127, P14, DOI 10.1104/pp.127.1.14; MANDAVA NB, 1988, ANNU REV PLANT PHYS, V39, P23, DOI 10.1146/annurev.arplant.39.1.23; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MUSSIG C, 1999, PLANT PHYSIOL BIOCH, V37, P757; Neff MM, 1999, P NATL ACAD SCI USA, V96, P15316, DOI 10.1073/pnas.96.26.15316; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Noguchi T, 2000, PLANT PHYSIOL, V124, P201, DOI 10.1104/pp.124.1.201; Oh MH, 2000, PLANT PHYSIOL, V124, P751, DOI 10.1104/pp.124.2.751; Perez-Perez JM, 2002, DEV BIOL, V242, P161, DOI 10.1006/dbio.2001.0543; POCH HLC, 1993, PLANT J, V4, P671, DOI 10.1046/j.1365-313X.1993.04040671.x; Polakis P, 2000, GENE DEV, V14, P1837; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sharpe C, 2001, BIOESSAYS, V23, P311, DOI 10.1002/bies.1045; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; WANG ZY, 2002, IN PRESS DEV CELL; WOODGETT JR, 2001, JUDGING PROTEIN MORE; XU W, 1995, PLANT CELL, V7, P1555, DOI 10.1105/tpc.7.10.1555; ZUREK DM, 1994, PLANT PHYSIOL, V104, P161, DOI 10.1104/pp.104.1.161	45	794	865	22	189	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					181	191		10.1016/S0092-8674(02)00721-3	http://dx.doi.org/10.1016/S0092-8674(02)00721-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007405	Bronze			2022-12-28	WOS:000175082600008
J	Donley, EA; Claussen, NR; Thompson, ST; Wieman, CE				Donley, EA; Claussen, NR; Thompson, ST; Wieman, CE			Atom-molecule coherence in a Bose-Einstein condensate	NATURE			English	Article							FESHBACH RESONANCES; DYNAMICS; COLLISIONS	Recent advances in the precise control of ultracold atomic systems have led to the realisation of Bose-Einstein condensates (BECs) and degenerate Fermi gases. An important challenge is to extend this level of control to more complicated molecular systems. One route for producing ultracold molecules is to form them from the atoms in a BEC. For example, a two-photon stimulated Raman transition in a Rb-87 BEC has been used to produce Rb-87(2) molecules in a single rotational-vibrational state(1), and ultracold molecules have also been formed(2) through photo-association of a sodium BEC. Although the coherence properties of such systems have not hitherto been probed, the prospect of creating a superposition of atomic and molecular condensates has initiated much theoretical work(3-7). Here we make use of a time-varying magnetic field near a Feshbach resonance(8-12) to produce coherent coupling between atoms and molecules in a Rb-85 BEC. A mixture of atomic and molecular states is created and probed by sudden changes in the magnetic field, which lead to oscillations in the number of atoms that remain in the condensate. The oscillation frequency, measured over a large range of magnetic fields, is in excellent agreement with the theoretical molecular binding energy, indicating that we have created a quantum superposition of atoms and diatomic molecules-two chemically different species.	Univ Colorado, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; Natl Inst Stand & Technol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA	Claussen, NR (corresponding author), Univ Colorado, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	nclausse@jilau1.colorado.edu	Donley, Elizabeth/A-4525-2010; Donley, Elizabeth/O-4916-2019	Donley, Elizabeth/0000-0002-3439-4322				Anglin JR, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.013605; Calsamiglia J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.160403; Claussen NR, 2001, AIP CONF PROC, V551, P325, DOI 10.1063/1.1354358; CLAUSSEN NR, UNPUB PHYS REV LETT; CLAUSSEN NR, 2002, CONDMAT0201400; Cornish SL, 2000, PHYS REV LETT, V85, P1795, DOI 10.1103/PhysRevLett.85.1795; Cusack BJ, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.013609; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; Drummond PD, 1998, PHYS REV LETT, V81, P3055, DOI 10.1103/PhysRevLett.81.3055; DRUMMOND PD, 2002, CONDMAT0110578; Goral K, 2001, PHYS REV LETT, V86, P1397, DOI 10.1103/PhysRevLett.86.1397; Heinzen DJ, 2000, PHYS REV LETT, V84, P5029, DOI 10.1103/PhysRevLett.84.5029; Holland M, 2001, PHYS REV LETT, V86, P1915, DOI 10.1103/PhysRevLett.86.1915; McKenzie C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.120403; Mies FH, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.022721; MOERDIJK AJ, 1995, PHYS REV A, V51, P4852, DOI 10.1103/PhysRevA.51.4852; PerezGarcia VM, 1997, PHYS REV A, V56, P1424, DOI 10.1103/PhysRevA.56.1424; Roberts JL, 2001, PHYS REV LETT, V86, P4211, DOI 10.1103/PhysRevLett.86.4211; Roberts JL, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.024702; SAKURAI JJ, 1994, MODERN QUANTUM MECH, P410; Stenger J, 1999, PHYS REV LETT, V82, P2422, DOI 10.1103/PhysRevLett.82.2422; TIESINGA E, 1992, PHYS REV A, V46, pR1167, DOI 10.1103/PhysRevA.46.R1167; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; Timmermans E, 1999, PHYS REP, V315, P199, DOI 10.1016/S0370-1573(99)00025-3; Timmermans E, 1999, PHYS REV LETT, V83, P2691, DOI 10.1103/PhysRevLett.83.2691; van Abeelen FA, 1999, PHYS REV LETT, V83, P1550, DOI 10.1103/PhysRevLett.83.1550; van Abeelen FA, 1998, PHYS REV A, V57, pR4102, DOI 10.1103/PhysRevA.57.R4102; van Kempen EGM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.093201; Vardi A, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.063611; Wynar R, 2000, SCIENCE, V287, P1016, DOI 10.1126/science.287.5455.1016	31	582	592	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					529	533		10.1038/417529a	http://dx.doi.org/10.1038/417529a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037562	Green Submitted			2022-12-28	WOS:000175860300036
J	Needleman, J; Buerhaus, P; Mattke, S; Stewart, M; Zelevinsky, K				Needleman, J; Buerhaus, P; Mattke, S; Stewart, M; Zelevinsky, K			Nurse-staffing levels and the quality of care in hospitals	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the Academy-for-Health-Services-Research-and-Health-Policy	JUN 10-11, 2001	ATLANTA, GA	Acad Hlth Serv Res & Hlth Policy			INTENSIVE-CARE; MORTALITY; OUTCOMES; RATES; EMPLOYMENT; PERSONNEL; UNITS	Background: It is uncertain whether lower levels of staffing by nurses at hospitals are associated with an increased risk that patients will have complications or die. Methods: We used administrative data from 1997 for 799 hospitals in 11 states (covering 5,075,969 discharges of medical patients and 1,104,659 discharges of surgical patients) to examine the relation between the amount of care provided by nurses at the hospital and patients' outcomes. We conducted regression analyses in which we controlled for patients' risk of adverse outcomes, differences in the nursing care needed for each hospital's patients, and other variables. Results: The mean number of hours of nursing care per patient-day was 11.4, of which 7.8 hours were provided by registered nurses, 1.2 hours by licensed practical nurses, and 2.4 hours by nurses' aides. Among medical patients, a higher proportion of hours of care per day provided by registered nurses and a greater absolute number of hours of care per day provided by registered nurses were associated with a shorter length of stay (P=0.01 and P<0.001, respectively) and lower rates of both urinary tract infections (P<0.001 and P=0.003, respectively) and upper gastrointestinal bleeding (P=0.03 and P=0.007, respectively). A higher proportion of hours of care provided by registered nurses was also associated with lower rates of pneumonia (P=0.001), shock or cardiac arrest (P=0.007), and "failure to rescue,'' which was defined as death from pneumonia, shock or cardiac arrest, upper gastrointestinal bleeding, sepsis, or deep venous thrombosis (P=0.05). Among surgical patients, a higher proportion of care provided by registered nurses was associated with lower rates of urinary tract infections (P=0.04), and a greater number of hours of care per day provided by registered nurses was associated with lower rates of ``failure to rescue'' (P=0.008). We found no associations between increased levels of staffing by registered nurses and the rate of in-hospital death or between increased staffing by licensed practical nurses or nurses' aides and the rate of adverse outcomes. Conclusions: A higher proportion of hours of nursing care provided by registered nurses and a greater number of hours of care by registered nurses per day are associated with better care for hospitalized patients.	Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; Vanderbilt Univ, Sch Nursing, Nashville, TN 37240 USA; ABT Associates Inc, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Vanderbilt University; ABT Associates	Needleman, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Rm 305,677 Huntington Ave, Boston, MA 02115 USA.	needlema@hsph.harvard.edu	Needleman, Jack/I-5461-2013	Needleman, Jack/0000-0002-2875-0589	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS009958] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS09958] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		*AG HLTH CAR POL R, 2001, CONQUEST OV; AIKEN LH, 1994, MED CARE, V32, P771, DOI 10.1097/00005650-199408000-00002; Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; Aiken LH, 1996, HEALTH AFFAIR, V15, P88, DOI 10.1377/hlthaff.15.4.88; ALHAIDER AS, 1991, HEALTH SERV RES, V26, P303; *AM HOSP ASS, 1999, AHA ANN SURV DAT FIS; *AM HOSP ASS, 1998, AHA ANN SURV DAT FIS; *AM HOSP ASS, 2001, TREND WATCH, V3, P1; Anderson GF, 1996, HEALTH AFFAIR, V15, P152, DOI 10.1377/hlthaff.15.1.152; Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; Ballard K A, 1993, Nurs Manage, V24, P33; BALLARD KA, 1993, NURS MANAGE, V24, P40; Blegen MA, 1998, NURS RES, V47, P43, DOI 10.1097/00006199-199801000-00008; BRADBURY RC, 1991, HEALTH SERV RES, V26, P407; Bryan YE, 1998, J NURS ADMIN, V28, P21, DOI 10.1097/00005110-199809000-00006; Buerhaus P, 2001, NURS ECON, V19, P198; Buerhaus P I, 1999, Image J Nurs Sch, V31, P179; Buerhaus PI, 1996, JAMA-J AM MED ASSOC, V276, P1487, DOI 10.1001/jama.276.18.1487; Buerhaus PI, 2000, JAMA-J AM MED ASSOC, V283, P2948, DOI 10.1001/jama.283.22.2948; Czaplinski C, 1998, MED CARE, V36, P1626, DOI 10.1097/00005650-199812000-00002; Flood A.B, 1987, HOSP STRUCTURE PERFO; FLOOD AB, 1984, MED CARE, V22, P115, DOI 10.1097/00005650-198402000-00003; Flood S D, 1988, Nurs Manage, V19, P34; Flood S D, 1988, NURS MANAGE, V19, P38; Flood S D, 1988, NURS MANAGE, V19, P42; Fridkin SK, 1996, INFECT CONT HOSP EP, V17, P150; Greene W. H., 1993, ECONOMETRIC ANAL; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; HCUP Cost to Charge Ratio Files (CCR), 2000, HEALTHC COST UT PROJ; Iezzoni L I, 1992, QRB Qual Rev Bull, V18, P361; Iezzoni LI, 1997, MED CARE, V35, P158, DOI 10.1097/00005650-199702000-00006; Iezzoni LI, 1996, AM J PUBLIC HEALTH, V86, P1379, DOI 10.2105/AJPH.86.10.1379; IEZZONI LI, 1994, INQUIRY-J HEALTH CAR, V31, P40; Iezzoni LI, 1994, COMPLICATIONS SCREEN; IEZZONI LI, 1999, SCREENING QUALITY CA; Karon SL, 1999, MED CARE, V37, P570, DOI 10.1097/00005650-199906000-00006; Keyes M A, 2000, J Healthc Qual, V22, P29; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; KOVNER CT, 2000, POLICY POLITICS NURS, V1, P194; KRAKAUER H, 1992, HEALTH SERV RES, V27, P317; LAKE ET, 1999, THESIS U PENNSYLVANI; Lichtig LK, 1999, J NURS ADMIN, V29, P25, DOI 10.1097/00005110-199902000-00008; MANHEIM LM, 1992, INQUIRY-J HEALTH CAR, V29, P55; Needleman J, 2001, NURSE STAFFING PATIE; NEIDLINGER SH, 1993, J NURS ADMIN, V23, P29, DOI 10.1097/00005110-199303000-00009; PALMER RH, 1996, CONQUEST 1 0 OVERVIE; *PRES ADV COMM CON, 1997, QUAL 1 BETT CAR ALL; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Robert J, 2000, INFECT CONT HOSP EP, V21, P12, DOI 10.1086/501690; SCHULTZ MA, 2000, NURS HLTH SCI, V2, P103; SCOTT WR, 1976, ORG RES HOSPITALS, P72; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; SILBER JH, 1995, J AM STAT ASSOC, V90, P7, DOI 10.2307/2291124; Silber JH, 1997, MED CARE, V35, pOS77, DOI 10.1097/00005650-199710001-00011; Silber JH, 2000, ANESTHESIOLOGY, V93, P152, DOI 10.1097/00000542-200007000-00026; SILBER JH, 1995, JAMA-J AM MED ASSOC, V274, P317, DOI 10.1001/jama.274.4.317; Spetz J, 1998, J NURS ADMIN, V28, P20, DOI 10.1097/00005110-199803000-00006; *STAT, 1999, STAT REF MAN REL 6; TAUNTON RL, 1994, J NURS ADMIN, V24, P48; Thomas L., 1983, YOUNGEST SCI NOTES M; Wan T T, 1987, QRB Qual Rev Bull, V13, P61; Wunderlich G, 1996, NURSING STAFF HOSP N; ZIMMERMAN JE, 1993, CRIT CARE MED, V21, P1443, DOI 10.1097/00003246-199310000-00010	64	1411	1445	2	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1715	1722		10.1056/NEJMsa012247	http://dx.doi.org/10.1056/NEJMsa012247			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	556DM	12037152				2022-12-28	WOS:000175834100007
J	Edhouse, J; Thakur, RK; Khalil, JM				Edhouse, J; Thakur, RK; Khalil, JM			ABC of clinical electrocardiography - Conditions affecting the left side of the heart	BRITISH MEDICAL JOURNAL			English	Review									Michigan State Univ, Thorac & Cardiovasc Inst, Lansing, MI USA; Stepping Hill Hosp, Stockport SK2 7JE, Lancs, England	Michigan State University	Edhouse, J (corresponding author), Stepping Hill Hosp, Stockport SK2 7JE, Lancs, England.								0	17	18	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1264	1267		10.1136/bmj.324.7348.1264	http://dx.doi.org/10.1136/bmj.324.7348.1264			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028984	Green Published			2022-12-28	WOS:000175894900025
J	Schenk, PM				Schenk, PM			Thickness constraints on the icy shells of the galilean satellites from a comparison of crater shapes	NATURE			English	Article							SUBSURFACE OCEAN; IMPACT FEATURES; EUROPA; CALLISTO; GANYMEDE; MISSION; WATER	A thin outer ice shell on Jupiter's large moon Europa would imply easy exchange between the surface and any organic or biotic material in its putative subsurface ocean(1-4). The thickness of the outer ice shell is poorly constrained, however, with model-dependent estimates ranging from a few kilometres(5,6) to ten or more kilometres(7). Here I present measurements of depths of impact craters on Europa, Ganymede and Callisto that reveal two anomalous transitions in crater shape with diameter. The first transition is probably related to temperature-dependent ductility of the crust at shallow depths (7-8 km on Europa). The second transition is attributed to the influence of subsurface oceans on all three satellites(3,8,9), which constrains Europa's icy shell to be at least 19 km thick. The icy lithospheres of Ganymede and Callisto are equally ice-rich, but Europa's icy shell has a thermal structure about 0.25-0.5 times the thicknesses of Ganymede's or Callisto's shells, depending on epoch. The appearances of the craters on Europa are inconsistent with thin-ice-shell models(1) and indicate that exchange of oceanic and surface material could be difficult.	Lunar & Planetary Inst, Houston, TX 77058 USA		Schenk, PM (corresponding author), Lunar & Planetary Inst, 3600 Bay Area Blvd, Houston, TX 77058 USA.							Anderson JD, 1996, NATURE, V384, P541, DOI 10.1038/384541a0; Anderson JD, 2001, ICARUS, V153, P157, DOI 10.1006/icar.2001.6664; Collins GC, 2000, J GEOPHYS RES-PLANET, V105, P1709, DOI 10.1029/1999JE001143; Dombard AJ, 2000, GEOPHYS RES LETT, V27, P3663, DOI 10.1029/2000GL011695; Durham WB, 1997, J GEOPHYS RES-PLANET, V102, P16293, DOI 10.1029/97JE00916; Greenberg R, 2002, AM SCI, V90, P48; Greenberg R, 2000, J GEOPHYS RES-PLANET, V105, P17551, DOI 10.1029/1999JE001147; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; IVELSON M, IN PRESS ICARUS; Kivelson MG, 2000, SCIENCE, V289, P1340, DOI 10.1126/science.289.5483.1340; Kivelson MG, 1999, J GEOPHYS RES-SPACE, V104, P4609, DOI 10.1029/1998JA900095; MCKINNON W, 1998, ICARUS, V44, P454; MCKINNON WB, 1995, GEOPHYS RES LETT, V22, P1829, DOI 10.1029/95GL01422; McKinnon WB, 1999, GEOPHYS RES LETT, V26, P951, DOI 10.1029/1999GL900125; Melosh H. J., 1983, Journal of Geophysical Research, V88, P830, DOI 10.1029/JB088iS02p0A830; MELOSH HJ, 1909, IMPACT CRATERING; Moore JM, 1998, ICARUS, V135, P127, DOI 10.1006/icar.1998.5973; Moore JM, 2001, ICARUS, V151, P93, DOI 10.1006/icar.2000.6558; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; Passey Q. R., 1982, SATELLITES JUPITER, P379; PIKE RJ, 1988, MERCURY, P165; Rathbun JA, 1998, GEOPHYS RES LETT, V25, P4157, DOI 10.1029/1998GL900135; SCHENK P, IN PRESS GEOPHYS RES; SCHENK PM, 1993, J GEOPHYS RES-PLANET, V98, P7475, DOI 10.1029/93JE00176; SCHENK PM, 1991, J GEOPHYS RES-PLANET, V96, P15635, DOI 10.1029/91JE00932; Turtle EP, 2001, SCIENCE, V294, P1326, DOI 10.1126/science.1062492; TURTLE EP, 2002, LUNAR PLANET SCI, V33; Williams KK, 1998, ICARUS, V131, P107, DOI 10.1006/icar.1997.5856; Zimmer C, 2000, ICARUS, V147, P329, DOI 10.1006/icar.2000.6456	29	174	176	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					419	421		10.1038/417419a	http://dx.doi.org/10.1038/417419a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024207	Green Submitted			2022-12-28	WOS:000175730900032
J	Ding, ZF; Quinn, BM; Haram, SK; Pell, LE; Korgel, BA; Bard, AJ				Ding, ZF; Quinn, BM; Haram, SK; Pell, LE; Korgel, BA; Bard, AJ			Electrochemistry and electrogenerated chemiluminescence from silicon nanocrystal quantum dots	SCIENCE			English	Article							SEMICONDUCTOR NANOCRYSTALS; COULOMB STAIRCASE; POROUS SILICON; NANOCLUSTERS; LUMINESCENCE; ELECTRODES; CLUSTERS; SIZE	Reversible electrochemical injection of discrete numbers of electrons into sterically stabilized silicon nanocrystals (NCs) (similar to2 to 4 nanometers in diameter) was observed by differential pulse voltammetry (DPV) in N,N'-dimethylformamide and acetonitrile. The electrochemical gap between the onset of electron injection and hole injection-related to the highest occupied and lowest unoccupied molecular orbitals;-grew with decreasing nanocrystal size, and the DPV peak potentials above the onset for electron injection roughly correspond to expected Coulomb blockade or quantized double-layer charging energies. Electron transfer reactions between positively and negatively charged nanocrystals (or between charged nanocrystals and molecular redox-active coreactants) occurred that led to electron and hole annihilation, producing visible tight. The electrogenerated chemiluminescence spectra exhibited a peak maximum at 640 nanometers, a significant red shift from the photoluminescence maximum (420 nanometers) of the same silicon NC solution. These results demonstrate that the chemical stability of silicon NCs could enable their use as redox-active macromolecular species with the combined optical and charging properties of semiconductor quantum dots.	Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Texas Mat Inst, Ctr Nano & Mol Sci & Technol, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Bard, AJ (corresponding author), Univ Texas, Dept Chem & Biochem, Austin, TX 78712 USA.		Haram, Santosh K/C-4324-2011; Korgel, Brian A/I-5771-2013; Haram, Santosh K/D-6321-2016; Quinn, Bernadette M/A-9524-2010	Haram, Santosh K/0000-0002-0618-1215; Quinn, Bernadette/0000-0001-9937-1298				Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Andres RP, 1996, SCIENCE, V272, P1323, DOI 10.1126/science.272.5266.1323; Bard A. J., 2001, ELECTROCHEMICAL METH; Chen SW, 1998, J PHYS CHEM B, V102, P9898, DOI 10.1021/jp982822c; Chen SW, 2000, CHEM MATER, V12, P3864, DOI 10.1021/cm000653e; Chen SW, 1998, SCIENCE, V280, P2098, DOI 10.1126/science.280.5372.2098; Choi HC, 2000, CHEM MATER, V12, P2151, DOI 10.1021/cm000067l; Fan FRF, 1997, SCIENCE, V277, P1791, DOI 10.1126/science.277.5333.1791; FAULKNER LR, 1977, ELECTROANALYTICAL CH, V20, P1; Franceschetti A, 2000, PHYS REV B, V62, P2614, DOI 10.1103/PhysRevB.62.2614; HANNA AE, 1992, PHYS REV LETT, V68, P3228, DOI 10.1103/PhysRevLett.68.3228; Haram SK, 2001, J AM CHEM SOC, V123, P8860, DOI 10.1021/ja0158206; Holmes JD, 2001, J AM CHEM SOC, V123, P3743, DOI 10.1021/ja002956f; Holmes JD, 2000, SCIENCE, V287, P1471, DOI 10.1126/science.287.5457.1471; HOYER P, 1994, CHEM PHYS LETT, V224, P75, DOI 10.1016/0009-2614(94)00518-4; IYER SS, 1993, SCIENCE, V260, P40, DOI 10.1126/science.260.5104.40; KNIGHT AW, 1994, ANALYST, V119, P879, DOI 10.1039/an9941900879; Kovalev D, 1998, PHYS REV LETT, V81, P2803, DOI 10.1103/PhysRevLett.81.2803; Makimura T, 1998, APPL SURF SCI, V127, P388, DOI 10.1016/S0169-4332(97)00661-2; MCCORD P, 1992, SCIENCE, V257, P68, DOI 10.1126/science.257.5066.68; Nirmal M, 1999, ACCOUNTS CHEM RES, V32, P407, DOI 10.1021/ar9700320; RICHARDS TC, 1995, ANAL CHEM, V67, P3140, DOI 10.1021/ac00114a007; Shim M, 2000, NATURE, V407, P981, DOI 10.1038/35039577; Wang CJ, 2001, SCIENCE, V291, P2390, DOI 10.1126/science.291.5512.2390; WHITE HS, 1982, J AM CHEM SOC, V104, P6891, DOI 10.1021/ja00389a001; Wilcoxon JP, 1999, PHYS REV B, V60, P2704, DOI 10.1103/PhysRevB.60.2704	26	912	939	30	707	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1293	1297		10.1126/science.1069336	http://dx.doi.org/10.1126/science.1069336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016309				2022-12-28	WOS:000175713000047
J	Marder, E				Marder, E			Non-mammalian models for studying neural development and function	NATURE			English	Article							WEAKLY ELECTRIC FISH; CAENORHABDITIS-ELEGANS; OSCILLATORY DYNAMICS; AUDITORY-SYSTEM; WORKING-MEMORY; EYE-POSITION; RETINAL RODS; BRAIN-STEM; RESPONSES; NETWORK		Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA	Brandeis University	Marder, E (corresponding author), Brandeis Univ, Volen Ctr, MS 013, Waltham, MA 02454 USA.	marder@brandeis.edu						Aksay E, 2000, J NEUROPHYSIOL, V84, P1035, DOI 10.1152/jn.2000.84.2.1035; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; BAYLOR DA, 1984, J PHYSIOL-LONDON, V354, P203, DOI 10.1113/jphysiol.1984.sp015372; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; BAYLOR DA, 1982, J PHYSIOL-LONDON, V328, P49, DOI 10.1113/jphysiol.1982.sp014252; Buschbeck E, 1999, SCIENCE, V286, P1178, DOI 10.1126/science.286.5442.1178; Calabrese RL, 1998, CURR OPIN NEUROBIOL, V8, P710, DOI 10.1016/S0959-4388(98)80112-8; CARR CE, 1986, BRAIN BEHAV EVOLUT, V28, P122, DOI 10.1159/000118697; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; CARR CE, 1990, J NEUROSCI, V10, P3227; Cocroft RB, 2000, J COMP PHYSIOL A, V186, P695, DOI 10.1007/s003590000123; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Cooke IRC, 2001, J NEUROBIOL, V46, P126, DOI 10.1002/1097-4695(20010205)46:2<126::AID-NEU50>3.3.CO;2-L; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; Ermentrout B, 2001, J NEUROPHYSIOL, V85, P1444, DOI 10.1152/jn.2001.85.4.1444; Farris HE, 2002, J ACOUST SOC AM, V111, P1475, DOI 10.1121/1.1451069; Faure PA, 2000, J COMP PHYSIOL A, V186, P129, DOI 10.1007/s003590050013; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; Gabbiani F, 2001, J NEUROSCI, V21, P314, DOI 10.1523/JNEUROSCI.21-01-00314.2001; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; GAZE R M, 1970, Experimental Brain Research, V10, P171; GAZE RM, 1969, J PHYSIOL-LONDON, V200, pP128; Gelperin A, 1999, J EXP BIOL, V202, P1855; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; GETTING PA, 1985, J NEUROPHYSIOL, V53, P466, DOI 10.1152/jn.1985.53.2.466; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; HAMBURGER V, 1988, J NEUROSCI, V8, P3535; HAMBURGER V, 1992, J NEUROBIOL, V23, P1116, DOI 10.1002/neu.480230904; HAMBURGER V, 1993, J NEUROBIOL, V24, P893, DOI 10.1002/neu.480240702; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Jacobs GA, 2000, J NEUROSCI, V20, P2934; JACOBSON M, 1965, EXP NEUROL, V13, P418, DOI 10.1016/0014-4886(65)90128-7; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; KONISHI M, 1990, HARVEY LECT, V85, P47; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; Kreiman G, 2000, J NEUROPHYSIOL, V84, P189, DOI 10.1152/jn.2000.84.1.189; KUFFLER SW, 1967, PROC R SOC SER B-BIO, V168, P1, DOI 10.1098/rspb.1967.0047; KUFFLER SW, 1966, J NEUROPHYSIOL, V29, P768; LANGE D, 1966, ANN NY ACAD SCI, V128, P955; Lewis JE, 2001, J NEUROSCI, V21, P2842, DOI 10.1523/JNEUROSCI.21-08-02842.2001; Lorent K, 2001, DEVELOPMENT, V128, P2131; Marder E., 1985, P319; Mason AC, 2001, NATURE, V410, P686, DOI 10.1038/35070564; Paydar S, 1999, J NEUROSCI, V19, P1771; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Rose JK, 2001, LEARN MEMORY, V8, P63, DOI 10.1101/lm.37801; SENGUPTA P, 1994, CELL, V79, P971, DOI 10.1016/0092-8674(94)90028-0; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Seung HS, 2000, J COMPUT NEUROSCI, V9, P171, DOI 10.1023/A:1008971908649; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Tobias ML, 1998, P NATL ACAD SCI USA, V95, P1870, DOI 10.1073/pnas.95.4.1870; VOLMAN SF, 1989, J NEUROSCI, V9, P3083; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489	59	24	26	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					318	321		10.1038/417318a	http://dx.doi.org/10.1038/417318a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015611				2022-12-28	WOS:000175592100055
J	Williams, RSB; Cheng, LL; Mudge, AW; Harwood, AJ				Williams, RSB; Cheng, LL; Mudge, AW; Harwood, AJ			A common mechanism of action for three mood-stabilizing drugs	NATURE			English	Article							PROLYL ENDOPEPTIDASE; VALPROIC ACID; LITHIUM; DICTYOSTELIUM; PEPTIDASES; DEPRESSION; INHIBITORS; DECREASE; INCREASE; CATENIN	Lithium, carbamazepine and valproic acid are effective mood-stabilizing treatments for bipolar affective disorder. The molecular mechanisms underlying the actions of these drugs and the illness itself are unknown. Berridge and colleagues(1) suggested that inositol depletion may be the way that lithium works in bipolar affective disorder, but others have suggested that glycogen synthase kinase(2,3) (GSK3) may be the relevant target. The action of valproic acid has been linked to both inositol depletion(4,5) and to inhibition of histone deacetylase(6) (HDAC). We show here that all three drugs inhibit the collapse of sensory neuron growth cones and increase growth cone area. These effects do not depend on GSK3 or HDAC inhibition. Inositol, however, reverses the effects of the drugs on growth cones, thus implicating inositol depletion in their action. Moreover, the development of Dictyostelium is sensitive to lithium(7) and to valproic acid, but resistance to both is conferred by deletion of the gene that codes for prolyl oligopeptidase, which also regulates inositol metabolism. Inhibitors of prolyl oligopeptidase reverse the effects of all three drugs on sensory neuron growth cone area and collapse. These results suggest a molecular basis for both bipolar affective disorder and its treatment.	UCL, MRC, Mol Cell Biol Lab, Intracellular Signalling Grp, London WC1E 6BT, England; UCL, MRC, Mol Cell Biol Lab, Cellular Neurobiol Grp, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Mudge, AW (corresponding author), UCL, MRC, Mol Cell Biol Lab, Intracellular Signalling Grp, Gower St, London WC1E 6BT, England.	a.mudge@ucl.ac.uk	Williams, Robin/G-6807-2011; Harwood, Adrian/A-4350-2010	Harwood, Adrian/0000-0003-3124-5169				AUGUSTYNS K, 1995, BIOORG MED CHEM LETT, V5, P1265, DOI 10.1016/0960-894X(95)00206-9; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Cheng LL, 1996, NEURON, V16, P309, DOI 10.1016/S0896-6273(00)80049-5; Cramer LP, 1997, J CELL BIOL, V136, P1287, DOI 10.1083/jcb.136.6.1287; DEMUTH HU, 1993, FEBS LETT, V320, P23, DOI 10.1016/0014-5793(93)81649-K; Goold RG, 1999, J CELL SCI, V112, P3373; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HARWOOD AJ, 1995, CELL, V80, P139, DOI 10.1016/0092-8674(95)90458-1; Kerwin R, 1999, BETHLEM MAUDSLEY NHS; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; MAES M, 1994, BIOL PSYCHIAT, V35, P545, DOI 10.1016/0006-3223(94)90101-5; MAES M, 1995, PSYCHIAT RES, V58, P217, DOI 10.1016/0165-1781(95)02698-V; O'Donnell T, 2000, BRAIN RES, V880, P84, DOI 10.1016/S0006-8993(00)02797-9; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Tillner J, 1998, TOXICOL IN VITRO, V12, P463, DOI 10.1016/S0887-2333(98)00016-2; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Williams RSB, 1999, EMBO J, V18, P2734, DOI 10.1093/emboj/18.10.2734; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	23	503	521	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					292	295		10.1038/417292a	http://dx.doi.org/10.1038/417292a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015604				2022-12-28	WOS:000175592100048
J	Wong, TY; Klein, R; Sharrett, AR; Schmidt, MI; Pankow, JS; Couper, DJ; Klein, BEK; Hubbard, LD; Duncan, BB				Wong, TY; Klein, R; Sharrett, AR; Schmidt, MI; Pankow, JS; Couper, DJ; Klein, BEK; Hubbard, LD; Duncan, BB		ARIC Investigators	Retinal arteriolar narrowing and risk of diabetes mellitus in middle-aged persons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MUSCLE BLOOD-FLOW; ATHEROSCLEROSIS RISK; MICROVASCULAR ABNORMALITIES; INSULIN-RESISTANCE; CIGARETTE-SMOKING; COMMUNITIES; HYPERTENSION; ADULTS; NIDDM	Context Microvascular processes have been hypothesized to play a role in the pathogenesis of type 2 diabetes mellitus, but prospective clinical data regarding this hypothesis are unavailable. Objective To examine the relation of retinal arteriolar narrowing, a marker of microvascular damage from aging, hypertension, and inflammation, to incident diabetes in healthy middle-aged persons. Design, Setting, and Participants The Atherosclerosis Risk in Communities Study, an ongoing population-based, prospective cohort study in 4 US communities that began in 1987-1989. Included in this analysis were 7993 persons aged 49 to 73 years without diabetes, of whom retinal photographs were taken during the third examination (1993-1995). Main Outcome Measures Incident diabetes (defined as fasting glucose levels of greater than or equal to126 mg/dL [7.0 mmol/L], casual levels of greater than or equal to200 mg/dL [11.1 mmol/L], diabetic medications use, or physician diagnosis of diabetes at the fourth examination) by quartile of retinal arteriole-to-venule ratio (AVR). Results After a median follow-up of 3.5 years, 291 persons (3.6%) had incident diabetes. The incidence of diabetes was higher in persons with lower AVR at baseline (2.4%, 3.1%,4.0%, and 5.2%, from highest to lowest AVR quartile; P for trend<.001). After controlling for fasting glucose and insulin levels, family history of diabetes, adiposity, physical activity, blood pressure, and other factors, persons in the lowest quartile of AVR were 71 % more likely to develop diabetes than those in the highest quartile (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.13-2.57; P for trend=.002). This association persisted with different diagnostic criteria (OR, 1.92; 95% CI, 1.10-3.36; P for trend=.01, using a fasting glucose level of &GE;141 mg/dL [7,8 mmol/L] as a cutoff), and was seen even in people at lower risk of diabetes, including those without a family history of diabetes, without impaired fasting glucose, and with lower measures of adiposity. Conclusions Retinal arteriolar narrowing is independently associated with risk of diabetes, supporting a microvascular role in the development of clinical diabetes.	Univ Wisconsin, Dept Ophthalmol, Madison, WI USA; Singapore Natl Eye Ctr, Singapore, Singapore; NHLBI, Bethesda, MD 20892 USA; Univ Fed Rio Grande Sul, Sch Med, Dept Social Med, Porto Alegre, RS, Brazil; Univ Minnesota, Div Epidemiol, Minneapolis, MN USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of Wisconsin System; University of Wisconsin Madison; Singapore National Eye Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Universidade Federal do Rio Grande do Sul; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill	Wong, TY (corresponding author), Natl Univ Singapore, Dept Ophthalmol, 10 Kent Ridge Crescent, Singapore 119260, Singapore.		Duncan, Bruce B/L-4140-2016; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022; Wong, Tien Yin/AAC-9724-2020; Schmidt, Maria/V-3196-2019	Duncan, Bruce B/0000-0002-7491-2630; Schmidt, Maria Inês/0000-0002-3837-0731; Wong, Tien Yin/0000-0002-8448-1264; Klein, Ronald/0000-0002-4428-6237; Pankow, James/0000-0001-7076-483X; Couper, David/0000-0002-4313-9235	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035126, N01HC055018, N01HC055022, N01HC055019, N01HC055021, N01HC055016, N01HC035125, N01HC055015, N01HC055020] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55015, N1-HC-55021, N01-HC-55019, NN01-HC-35126, N01-HC-35125, N01-HC-55020, N01-HC-55018, N01-HC-55022, N01-HC-55016] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1997, Diabetes Care, V20 Suppl 1, pS1; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balletshofer BM, 2000, CIRCULATION, V101, P1780, DOI 10.1161/01.CIR.101.15.1780; Baron AD, 1997, ANNU REV NUTR, V17, P487, DOI 10.1146/annurev.nutr.17.1.487; BAUMBACH GL, 1989, HYPERTENSION, V13, P968, DOI 10.1161/01.HYP.13.6.968; Brancati FL, 2000, JAMA-J AM MED ASSOC, V283, P2253, DOI 10.1001/jama.283.17.2253; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Caballero AE, 1999, DIABETES, V48, P1856, DOI 10.2337/diabetes.48.9.1856; FELDMAN RD, 1993, LANCET, V342, P707, DOI 10.1016/0140-6736(93)91708-T; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Hsueh WA, 1998, J INVEST MED, V46, P387; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; HULTHEN UL, 1995, HYPERTENSION, V25, P214, DOI 10.1161/01.HYP.25.2.214; JAAP AJ, 1994, DIABETIC MED, V11, P883, DOI 10.1111/j.1464-5491.1994.tb00373.x; JAAP AJ, 1994, DIABETOLOGIA, V37, P214, DOI 10.1007/s001250050096; Jaap AJ, 1997, DIABETOLOGIA, V40, P238, DOI 10.1007/s001250050669; Klein R, 2000, ARTERIOSCL THROM VAS, V20, P1644, DOI 10.1161/01.ATV.20.6.1644; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; LAAKSO M, 1992, DIABETES, V41, P1076, DOI 10.2337/diabetes.41.9.1076; Manson JE, 2000, AM J MED, V109, P538, DOI 10.1016/S0002-9343(00)00568-4; MORALES PA, 1993, DIABETES, V42, P154, DOI 10.2337/diabetes.42.1.154; MORRIS SJ, 1995, DIABETOLOGIA, V38, P1337, DOI 10.1007/BF00401767; PAPP AC, 1989, THROMB HAEMOSTASIS, V61, P15; PELL SIDNEY, 1967, J AMER MED ASS, V202, P104, DOI 10.1001/jama.202.1.104; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; RIMM EB, 1993, AM J PUBLIC HEALTH, V83, P211, DOI 10.2105/AJPH.83.2.211; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Sharrett AR, 1999, AM J EPIDEMIOL, V150, P263; TOOKE JE, 1993, DIABETES METAB REV, V9, P57, DOI 10.1002/dmr.5610090106; TOOKE JE, 1995, DIABETES, V44, P721, DOI 10.2337/diabetes.44.7.721; *U NC SCH PUBL HLT, 1988, ATH RISK COMM STUD O, V2; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wong TY, 2001, SURV OPHTHALMOL, V46, P59, DOI 10.1016/S0039-6257(01)00234-X; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	34	240	248	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2528	2533		10.1001/jama.287.19.2528	http://dx.doi.org/10.1001/jama.287.19.2528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020333				2022-12-28	WOS:000175566200021
J	Weinrauch, Y; Drujan, D; Shapiro, SD; Weiss, J; Zychlinsky, A				Weinrauch, Y; Drujan, D; Shapiro, SD; Weiss, J; Zychlinsky, A			Neutrophil elastase targets virulence factors of enterobacteria	NATURE			English	Article							HUMAN POLYMORPHONUCLEAR LEUKOCYTES; III SECRETION SYSTEMS; SHIGELLA-FLEXNERI; PROTEINS; DESTRUCTION; ACTIVATION; INHIBITORS; EFFECTORS; CELLS; PART	Shigellae cause bacillary dysentery, a bloody form of diarrhoea that affects almost 200 million people and causes nearly 2 million deaths per year(1). Shigella invades the colonic mucosa, where it initiates an acute inflammation, rich in neutrophils, that initially contributes to tissue damage and eventually resolves the infection(2). Neutrophils are phagocytic cells that kill microorganisms(3,4) but it is unclear how neutrophils control pathogenic bacteria expressing virulence factors that manipulate host cells. In contrast to other cells, neutrophils prevent the escape of Shigella from phagocytic vacuoles in which the bacteria are killed(5). Here we identify human neutrophil elastase (NE) as a key host defence protein: NE degrades Shigella virulence factors at a 1,000-fold lower concentration than that needed to degrade other bacterial proteins. In neutrophils in which NE is inactivated pharmacologically or genetically, Shigella escapes from phagosomes, increasing bacterial survival. NE also preferentially cleaves virulence factors of Salmonella and Yersinia. These findings establish NE as the first neutrophil factor that targets bacterial virulence proteins.	NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; Univ Iowa, Coll Med, Iowa City Vet Adm Med Ctr, Dept Microbiol,Inflammat Program, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Iowa City Vet Adm Med Ctr, Dept Internal Med,Inflammat Program, Iowa City, IA 52242 USA; Max Planck Inst Infect Biol, D-10117 Berlin, Germany	New York University; New York University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Iowa; University of Iowa; Max Planck Society	Zychlinsky, A (corresponding author), NYU, Sch Med, Skirball Inst, 540 1st Ave, New York, NY 10016 USA.			Weiss, Jerrold/0000-0003-1476-4485				Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x; CAMPBELL EJ, 1989, J IMMUNOL, V143, P2961; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; EISENHAUER PB, 1992, INFECT IMMUN, V60, P3556, DOI 10.1128/IAI.60.9.3556-3565.1992; Elsbach P, 1999, INFLAMMATION BASIC P, P801; Francois M, 2000, INFECT IMMUN, V68, P1289, DOI 10.1128/IAI.68.3.1289-1296.2000; GBARAH A, 1993, INFECT IMMUN, V61, P1687, DOI 10.1128/IAI.61.5.1687-1693.1993; GINOCCHIO CC, 1995, INFECT IMMUN, V63, P729, DOI 10.1128/IAI.63.2.729-732.1995; HALE TL, 1991, MICROBIOL REV, V55, P206, DOI 10.1128/MMBR.55.2.206-224.1991; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Huang YI, 1998, J LEUKOCYTE BIOL, V64, P322, DOI 10.1002/jlb.64.3.322; Klebanoff S.J., 1999, INFLAMMATION BASIC P, P721; Kotloff KL, 1999, B WORLD HEALTH ORGAN, V77, P651; Lee VT, 1999, MOL MICROBIOL, V31, P1619, DOI 10.1046/j.1365-2958.1999.01270.x; MandicMulec I, 1997, INFECT IMMUN, V65, P110, DOI 10.1128/IAI.65.1.110-115.1997; MENARD R, 1993, J BACTERIOL, V175, P5899; Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Pallen MJ, 1997, MOL MICROBIOL, V25, P423, DOI 10.1046/j.1365-2958.1997.4901850.x; Panyutich A, 1997, INFECT IMMUN, V65, P978, DOI 10.1128/IAI.65.3.978-985.1997; PERDOMO OJJ, 1994, J EXP MED, V180, P1307, DOI 10.1084/jem.180.4.1307; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874; Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876; Veale CA, 1997, J MED CHEM, V40, P3173, DOI 10.1021/jm970250z; WEISS J, 1985, J CLIN INVEST, V76, P206, DOI 10.1172/JCI111947; WEISS J, 1978, J BIOL CHEM, V253, P2664; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108	30	224	239	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 2	2002	417	6884					91	94		10.1038/417091a	http://dx.doi.org/10.1038/417091a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546ZM	12018205				2022-12-28	WOS:000175307200044
J	Wassarman, KM				Wassarman, KM			Small RNAs in bacteria: Diverse regulators of gene expression in response to environmental changes	CELL			English	Review							ESCHERICHIA-COLI; DSRA RNA; OXYS RNA; PROTEIN; RPOS; CSRA; HFQ	Bacterial small, untranslated RNAs are important regulators that often act to transmit environmental signals when cells encounter suboptimal or stressful growth conditions. These RNAs help modulate changes in cellular metabolism to optimize utilization of available nutrients and improve the probability for survival.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wassarman, KM (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	wassarman@bact.wisc.edu						Argaman L, 2000, J MOL BIOL, V300, P1101, DOI 10.1006/jmbi.2000.3942; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Hengge-Aronis R, 2000, BACTERIAL STRESS RESPONSES, P161; Jackson DW, 2002, J BACTERIOL, V184, P290, DOI 10.1128/JB.184.1.290-301.2002; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Lease RA, 2000, MOL MICROBIOL, V38, P667, DOI 10.1046/j.1365-2958.2000.02162.x; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Majdalani N, 2001, MOL MICROBIOL, V39, P1382, DOI 10.1111/j.1365-2958.2001.02329.x; MASSE E, 2002, IN PRESS P NATL ACAD; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	15	152	162	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					141	144		10.1016/S0092-8674(02)00717-1	http://dx.doi.org/10.1016/S0092-8674(02)00717-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007399	Bronze			2022-12-28	WOS:000175082600002
J	Boynton, WV; Feldman, WC; Squyres, SW; Prettyman, TH; Bruckner, J; Evans, LG; Reedy, RC; Starr, R; Arnold, JR; Drake, DM; Englert, PAJ; Metzger, AE; Mitrofanov, I; Trombka, JI; d'Uston, C; Wanke, H; Gasnault, O; Hamara, DK; Janes, DM; Marcialis, RL; Maurice, S; Mikheeva, I; Taylor, GJ; Tokar, R; Shinohara, C				Boynton, WV; Feldman, WC; Squyres, SW; Prettyman, TH; Bruckner, J; Evans, LG; Reedy, RC; Starr, R; Arnold, JR; Drake, DM; Englert, PAJ; Metzger, AE; Mitrofanov, I; Trombka, JI; d'Uston, C; Wanke, H; Gasnault, O; Hamara, DK; Janes, DM; Marcialis, RL; Maurice, S; Mikheeva, I; Taylor, GJ; Tokar, R; Shinohara, C			Distribution of hydrogen in the near surface of Mars: Evidence for subsurface ice deposits	SCIENCE			English	Article							GROUND ICE; WATER	Using the Gamma-Ray Spectrometer on the Mars Odyssey, we have identified two regions near the poles that are enriched in hydrogen. The data indicate the presence of a subsurface layer enriched in hydrogen overlain by a hydrogen-poor layer. The thickness of the upper layer decreases with decreasing distance to the pole, ranging from a column density of about 150 grams per square centimeter at -42degrees latitude to about 40 grams per square centimeter at -77degrees. The hydrogen-rich regions correlate with regions of predicted ice stability. We suggest that the host of the hydrogen in the subsurface layer is ice, which constitutes 35 +/- 15% of the layer by weight.	Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Max Planck Inst Chem, D-55020 Mainz, Germany; Comp Sci Corp, Sci Programs, Lanham, MD 20706 USA; Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; Catholic Univ Amer, Dept Phys, Washington, DC 20064 USA; Univ Calif San Diego, Dept Chem, La Jolla, CA 92093 USA; TechSource, Santa Fe, NM 87505 USA; Victoria Univ Wellington, Wellington, New Zealand; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Russian Acad Sci, Inst Space Res, Moscow, Russia; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Ctr Etud Spatiale Rayonnements, Toulouse, France; Observ Midi Pyrenees, F-31400 Toulouse, France; Univ Hawaii, Honolulu, HI 96822 USA	University of Arizona; United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University; Max Planck Society; University of New Mexico; Catholic University of America; University of California System; University of California San Diego; Victoria University Wellington; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hawaii System	Boynton, WV (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.		Gasnault, Olivier/F-4327-2010	Gasnault, Olivier/0000-0002-6979-9012; Mitrofanov, Igor/0000-0001-7204-2101; Prettyman, Thomas/0000-0003-0072-2831; Reedy, Robert/0000-0002-2189-1303				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; BOYNTON W, UNPUB; BOYNTON WV, 1992, J GEOPHYS RES-PLANET, V97, P7681, DOI 10.1029/92JE00538; BOYNTON WV, 1993, REMOTE GEOCHEMICAL A, pCH17; Carr M.H, 1996, WATER MARS; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FELDMAN WC, 1993, REMOTE GEOCHEMICAL A, pCH10; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; MOORE HJ, 1989, ICARUS, V81, P164, DOI 10.1016/0019-1035(89)90132-2; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; PAIGE DA, 1994, J GEOPHYS RES, V99, P26013; PRETTYMAN TH, 2002, LUNAR PLANET SCI C, V33; SQUYRES SW, 1992, MARS, pCH16; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645; WATERS LS, 1999, MCNPX USERS GUIDE	21	710	726	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					81	85		10.1126/science.1073722	http://dx.doi.org/10.1126/science.1073722			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040090				2022-12-28	WOS:000176711000036
J	Atwood, JL; Barbour, LJ; Jerga, A				Atwood, JL; Barbour, LJ; Jerga, A			Storage of methane and freon by interstitial van der Waals confinement	SCIENCE			English	Article								A known host-guest assembly, organized only by means of relatively weak dispersive forces, exhibits hitherto unappreciated thermal stability. The hexagonal close-packed arrangement of calix [4] arene contains lattice voids that can occlude small, highly volatile molecules. This host-guest system can be exploited to retain range of freons, as well as methane, not only well above their normal boiling points, but also at relatively high temperatures and low pressures. The usually overlooked van der Waals interactions in organic crystals can indeed be used in highly stable supramolecular system for gas storage.	Univ Missouri, Dept Chem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Atwood, JL (corresponding author), Univ Missouri, Dept Chem, Columbia, MO 65211 USA.		atwood, jerry/ABA-8947-2021					Akdas H, 1998, TETRAHEDRON LETT, V39, P2311, DOI 10.1016/S0040-4039(98)00067-7; Atwood J. L., 1996, COMPREHENSIVE SUPRAM, V1; Atwood JL, 2002, J AM CHEM SOC, V124, P2122, DOI 10.1021/ja017722q; Atwood JL, 2001, CHEM COMMUN, P2376, DOI 10.1039/b106250f; ATWOOD JL, 1996, COMPREHENSIVE SUPRAM, V9; Caira M. R., 1996, COMPREHENSIVE SUPRAM, V6; Caira MR, 2001, CHEM COMMUN, P2128, DOI 10.1039/b106080p; DIANIN AP, 1914, J RUSS PHYS CHEM SOC, V46, P1310; Gavezzotti A., 1997, THEORETICAL ASPECTS; Gutsche C.D., 1989, CALIXARENES; HARROWFIELD JM, 1993, J CHEM SOC PERK T 2, P2183, DOI 10.1039/p29930002183; IRNGARTINGER H, 1987, ANGEW CHEM INT EDIT, V26, P356, DOI 10.1002/anie.198703561; Kitaigorodsky A., 1973, MOL CRYSTALS MOL; Kitaigorodsky A., 1984, MIXED CRYSTALS; MacGillivray LR, 1997, NATURE, V389, P469, DOI 10.1038/38985; MACNICOL DD, 1984, INCLUSION COMPOUNDS, V2; Orr GW, 1999, SCIENCE, V285, P1049, DOI 10.1126/science.285.5430.1049; PALIN DE, 1945, NATURE, V156, P334, DOI 10.1038/156334a0; UNGARO R, 1984, J CHEM SOC P2, V2, P1979; ZHANG P, 1992, HUAXUE XUEBAO, V50, P209	20	354	356	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2367	2369		10.1126/science.1072252	http://dx.doi.org/10.1126/science.1072252			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12004074				2022-12-28	WOS:000176467200033
J	Day, JJ; Upchurch, P; Norman, DB; Gale, AS; Powell, HP				Day, JJ; Upchurch, P; Norman, DB; Gale, AS; Powell, HP			Sauropod trackways, evolution, and behavior	SCIENCE			English	Article							DINOSAURS		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; Univ Greenwich, Sch Earth & Environm Sci, Greenwich HE4 4TB, Kent, England; Univ Oxford, Museum Hist Nat, Oxford OX1 3PW, England	University of Cambridge; University of Greenwich; University of Oxford	Day, JJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.		Upchurch, Paul/C-1654-2008	Day, Julia/0000-0002-6765-7782				Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; HARLAND WB, 1992, GEOLOGIC TIME SCALE; Ishigaki S., 1989, P83; SANTOS VF, 1994, GAIA, V10, P5; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Upchurch Paul, 2000, P79, DOI 10.1017/CBO9780511549717.005; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543	8	73	76	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1659	1659		10.1126/science.1070167	http://dx.doi.org/10.1126/science.1070167			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040187	Green Submitted			2022-12-28	WOS:000175976200050
J	Kiss, IZ; Zhai, YM; Hudson, JL				Kiss, IZ; Zhai, YM; Hudson, JL			Emerging coherence in a population of chemical oscillators	SCIENCE			English	Article							DISTRIBUTED FREQUENCIES; PHASE SYNCHRONIZATION; POPULATIONS; DYNAMICS; ARRAYS; ONSET	Coherence of interacting oscillating entities has importance in biological, chemical, and physical systems. We report experiments on populations of chemical oscillators and verify a 25-year-old theory of Kuramoto that predicts that global coupling in a set of smooth limit-cycle oscillators with different frequencies produces a phase transition in which some of the elements synchronize. Both the critical point and the predicted dependence of order on coupling are seen in the experiments. We extend the studies both to relaxation and to chaotic oscillators and characterize the quantitative similarities and differences among the types of systems.	Univ Virginia, Dept Chem Engn, Charlottesville, VA 22904 USA	University of Virginia	Hudson, JL (corresponding author), Univ Virginia, Dept Chem Engn, 102 Engineers Way, Charlottesville, VA 22904 USA.		Kiss, Istvan Z/C-1801-2008	Kiss, Istvan Z/0000-0003-0993-3184				Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; DAIDO H, 1989, PROG THEOR PHYS, V81, P727, DOI 10.1143/PTP.81.727; Daido H, 1996, PHYSICA D, V91, P24, DOI 10.1016/0167-2789(95)00260-X; ERTL G, 1991, SCIENCE, V254, P1750, DOI 10.1126/science.254.5039.1750; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Kuramoto, 1975, LECT NOTE PHYS, V30, P420, DOI DOI 10.1007/BFB0013365; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; Kuramoto Y., 1984, PROG THEOR PHYS SUPP, V79, P223, DOI DOI 10.1143/PTPS.79.223; LEV O, 1988, CHEM ENG SCI, V43, P1339, DOI 10.1016/0009-2509(88)85107-8; MICHAELS DC, 1987, CIRC RES, V61, P704, DOI 10.1161/01.RES.61.5.704; Mikhailov AS, 1996, FDN SYNERGETICS 2 CH; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Oliva RA, 2001, INT J BIFURCAT CHAOS, V11, P2359, DOI 10.1142/S0218127401003450; Pikovsky AS, 1997, PHYSICA D, V104, P219, DOI 10.1016/S0167-2789(96)00301-6; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; WALKER TJ, 1969, SCIENCE, V166, P891, DOI 10.1126/science.166.3907.891; Wang W, 2001, PHYS REV LETT, V86, P4954, DOI 10.1103/PhysRevLett.86.4954; WIENER N, 1958, NONLINEAR PROBLEMS R; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; YORK RA, 1991, IEEE T MICROW THEORY, V39, P1000, DOI 10.1109/22.81670	24	384	393	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1676	1678		10.1126/science.1070757	http://dx.doi.org/10.1126/science.1070757			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040190				2022-12-28	WOS:000175976200054
J	Bostock, MG; Hyndman, RD; Rondenay, S; Peacock, SM				Bostock, MG; Hyndman, RD; Rondenay, S; Peacock, SM			An inverted continental Moho and serpentinization of the forearc mantle	NATURE			English	Article							SUBDUCTION; LITHOSPHERE; EARTHQUAKES; DEPTHS; MODELS; PLATE; WEDGE	Volatiles that are transported by subducting lithospheric plates to depths greater than 100 km are thought to induce partial melting in the overlying mantle wedge, resulting in arc magmatism and the addition of significant quantities of material to the overlying lithosphere(1). Asthenospheric flow and upwelling within the wedge produce increased lithospheric temperatures in this back-arc region, but the forearc mantle (in the corner of the wedge) is thought to be significantly cooler. Here we explore the structure of the mantle wedge in the southern Cascadia subduction zone using scattered teleseismic waves recorded on a dense portable array of broadband seismometers. We find very low shear-wave velocities in the cold forearc mantle indicated by the exceptional occurrence of an 'inverted' continental Moho, which reverts to normal polarity seaward of the Cascade arc. This observation provides compelling evidence for a highly hydrated and serpentinized forearc region(2), consistent with thermal and petrological models of the forearc mantle wedge. This serpentinized material is thought to have low strength and may therefore control the down-dip rupture limit of great thrust earthquakes, as well as the nature of large-scale flow in the mantle wedge.	Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada; Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA	University of British Columbia; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Victoria; Arizona State University; Arizona State University-Tempe	Bostock, MG (corresponding author), Univ British Columbia, Dept Earth & Ocean Sci, Vancouver, BC V6T 1Z4, Canada.		Rondenay, Stéphane/B-9764-2013	Rondenay, Stéphane/0000-0003-0805-249X				AHRENS TJ, 1975, REV GEOPHYS, V13, P383, DOI 10.1029/RG013i002p00383; BLACKWELL DD, 1990, J GEOPHYS RES-SOLID, V95, P19475, DOI 10.1029/JB095iB12p19475; Bostock MG, 2001, J GEOPHYS RES-SOL EA, V106, P30771, DOI 10.1029/2001JB000330; Christensen NI, 1996, J GEOPHYS RES-SOL EA, V101, P3139, DOI 10.1029/95JB03446; CHRISTENSEN NI, 1966, J GEOPHYS RES, V71, P5921, DOI 10.1029/JZ071i024p05921; Escartin J, 2001, GEOLOGY, V29, P1023, DOI 10.1130/0091-7613(2001)029<1023:SOSSPI>2.0.CO;2; Fisher AT, 1998, REV GEOPHYS, V36, P143, DOI 10.1029/97RG02916; Fryer P, 1996, REV GEOPHYS, V34, P89, DOI 10.1029/95RG03476; FYFE WS, 1975, AM J SCI, VA275, P285; Gill J., 1981, OROGENIC ANDESITES P; Graeber FM, 1999, J GEOPHYS RES-SOL EA, V104, P20237, DOI 10.1029/1999JB900037; HACKER BR, 1996, SUBDUCTION TOP BOTTO, P105; Kamiya S, 2000, GEOPHYS RES LETT, V27, P819, DOI 10.1029/1999GL011080; LEWIS TJ, 1988, J GEOPHYS RES-SOLID, V93, P15207, DOI 10.1029/JB093iB12p15207; MCMAHON A, 2001, THERMAL STRUCTURE CA; NABELEK J, 1993, EOS T AM GEOPHYS UN, V74, P431; Oleskevich DA, 1999, J GEOPHYS RES-SOL EA, V104, P14965, DOI 10.1029/1999JB900060; PEACOCK SM, 1993, CHEM GEOL, V108, P49, DOI 10.1016/0009-2541(93)90317-C; Peacock SM, 1999, GEOPHYS RES LETT, V26, P2517, DOI 10.1029/1999GL900558; RALEIGH CB, 1965, J GEOPHYS RES, V70, P3965, DOI 10.1029/JZ070i016p03965; Reinen LA, 2000, GEOLOGY, V28, P135; Rondenay S, 2001, J GEOPHYS RES-SOL EA, V106, P30795, DOI 10.1029/2000JB000039; TICHELAAR BW, 1993, J GEOPHYS RES-SOL EA, V98, P2017, DOI 10.1029/92JB02045; ULMER P, 1995, SCIENCE, V268, P858, DOI 10.1126/science.268.5212.858	24	490	497	3	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					536	538		10.1038/417536a	http://dx.doi.org/10.1038/417536a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037564				2022-12-28	WOS:000175860300038
J	Gembris, D; Taylor, JG; Suter, D				Gembris, D; Taylor, JG; Suter, D			Sports statistics - Trends and random fluctuations in athletics	NATURE			English	Article							RESONANCE		Forschungszentrum Julich, Inst Med, D-52425 Julich, Germany; Kings Coll London, Dept Math, London WC2R 2LS, England; Univ Dortmund, Dept Phys, D-44221 Dortmund, Germany	Helmholtz Association; Research Center Julich; University of London; King's College London; Dortmund University of Technology	Gembris, D (corresponding author), Forschungszentrum Julich, Inst Med, Postfach 1913, D-52425 Julich, Germany.	d.gembris@fz-juelich.de	Gembris, Daniel/AGO-7456-2022					David H.A., 1981, ORDER STAT, V1st; Galambos J., 1978, ASYMPTOTIC THEORY EX; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Gembris D, 2000, MAGN RESON MED, V43, P259, DOI 10.1002/(SICI)1522-2594(200002)43:2<259::AID-MRM13>3.0.CO;2-P; Hammond KA, 1997, NATURE, V386, P457, DOI 10.1038/386457a0; KOPONEN M, 2000, TRACK FIELD ATHLETE; SCHERER KA, 1997, CHRONIK HDB SPORTGES; STEINMETZ F, 2000, DTSCH MEISTERSCHAFTE, V1; TRYFOS P, 1985, J AM STAT ASSOC, V80, P46, DOI 10.2307/2288039	9	47	46	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					506	506		10.1038/417506a	http://dx.doi.org/10.1038/417506a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037557				2022-12-28	WOS:000175860300031
J	Kauff, ND; Satagopan, JM; Robson, ME; Scheuer, L; Hensley, M; Hudis, CA; Ellis, NA; Boyd, J; Borgen, PI; Barakat, RR; Norton, L; Offit, K				Kauff, ND; Satagopan, JM; Robson, ME; Scheuer, L; Hensley, M; Hudis, CA; Ellis, NA; Boyd, J; Borgen, PI; Barakat, RR; Norton, L; Offit, K			Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BILATERAL PROPHYLACTIC OOPHORECTOMY; PAPILLARY SEROUS CARCINOMA; SURGICAL ADJUVANT BREAST; OVARIAN-CANCER; HEART-DISEASE; HYSTERECTOMY; SURGERY; COMPLICATIONS; PREDISPOSITION; PREVENTION	Background: Risk-reducing salpingo-oophorectomy is often considered by carriers of BRCA mutations who have completed childbearing. However, there are limited data supporting the efficacy of this approach. We prospectively compared the effect of risk-reducing salpingo-oophorectomy with that of surveillance for ovarian cancer on the incidence of subsequent breast cancer and BRCA-related gynecologic cancers in women with BRCA mutations. Methods: All women with BRCA1 or BRCA2 mutations identified during a six-year period were offered enrollment in a prospective follow-up study. A total of 170 women 35 years of age or older who had not undergone bilateral oophorectomy chose to undergo either surveillance for ovarian cancer or risk-reducing salpingo-oophorectomy. Follow-up involved an annual questionnaire, telephone contact, and reviews of medical records. The time to cancer in the two groups was compared by Kaplan-Meier analysis and a Cox proportional-hazards model. Results: During a mean follow-up of 24.2 months, breast cancer was diagnosed in 3 of the 98 women who chose risk-reducing salpingo-oophorectomy and peritoneal cancer was diagnosed in 1 woman in this group. Among the 72 women who chose surveillance, breast cancer was diagnosed in 8, ovarian cancer in 4, and peritoneal cancer in 1. The time to breast cancer or BRCA-related gynecologic cancer was longer in the salpingo-oophorectomy group, with a hazard ratio for subsequent breast cancer or BRCA-related gynecologic cancer of 0.25 (95 percent confidence interval, 0.08 to 0.74). Conclusions: Salpingo-oophorectomy in carriers of BRCA mutations can decrease the risk of breast cancer and BRCA-related gynecologic cancer. (N Engl J Med 2002;346:1609-15.) Copyright (C) 2002 Massachusetts Medical Society.	Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Med, Dev Chemotherapy Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, Gynecol Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org	Hudis, Clifford/AAW-9482-2021; Pillay, Nischalan/F-9536-2012; Hall, Geoff D/A-1717-2010	Hudis, Clifford/0000-0001-7144-8791; Hall, Geoff D/0000-0002-8864-5932; Norton, Larry/0000-0003-3701-9250; Robson, Mark/0000-0002-3109-1692; Satagopan, Jaya/0000-0001-7102-5633; Castiel, Mercedes/0000-0002-4062-7364; Kauff, Noah/0000-0001-7242-6156				AITKEN JM, 1973, BRIT MED J, V2, P325, DOI 10.1136/bmj.2.5862.325; Aziz S, 2001, GYNECOL ONCOL, V80, P341, DOI 10.1006/gyno.2000.6095; Bandera CA, 1998, OBSTET GYNECOL, V92, P596, DOI 10.1016/S0029-7844(98)00223-3; Bateman BG, 1996, FERTIL STERIL, V66, P30, DOI 10.1016/S0015-0282(16)58383-6; BOURNE TH, 1991, GYNECOL ONCOL, V43, P92, DOI 10.1016/0090-8258(91)90051-6; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; BRINTON LA, 1988, CANCER INVEST, V6, P245, DOI 10.3109/07357908809080645; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; EASTON DF, 1995, AM J HUM GENET, V56, P265; Eisen A, 2000, J CLIN ONCOL, V18, P1980, DOI 10.1200/JCO.2000.18.9.1980; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Fry A, 2001, PSYCHO-ONCOL, V10, P231, DOI 10.1002/pon.512; Gabriel SE, 1997, NEW ENGL J MED, V336, P677, DOI 10.1056/NEJM199703063361001; Jacobs IJ, 1999, LANCET, V353, P1207, DOI 10.1016/S0140-6736(98)10261-1; King MC, 2001, JAMA-J AM MED ASSOC, V286, P2251, DOI 10.1001/jama.286.18.2251; Kovac SR, 2000, OBSTET GYNECOL, V95, P787, DOI 10.1016/S0029-7844(99)00641-9; KritzSilverstein D, 1997, AM J PUBLIC HEALTH, V87, P676, DOI 10.2105/AJPH.87.4.676; Levine DA, 2001, GYNECOL ONCOL, V80, P395, DOI 10.1006/gyno.2000.6082; Liede A, 2002, J CLIN ONCOL, V20, P1570, DOI 10.1200/JCO.20.6.1570; Makinen J, 2001, HUM REPROD, V16, P1473, DOI 10.1093/humrep/16.7.1473; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Mirhashemi R, 1998, OBSTET GYNECOL, V92, P327, DOI 10.1016/S0029-7844(98)00209-9; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Paley PJ, 2001, GYNECOL ONCOL, V80, P176, DOI 10.1006/gyno.2000.6071; Parazzini F, 1997, OBSTET GYNECOL, V90, P453, DOI 10.1016/S0029-7844(97)00295-0; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Robson M, 1998, J CLIN ONCOL, V16, P1642, DOI 10.1200/JCO.1998.16.5.1642; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Schorge JO, 1998, J NATL CANCER I, V90, P841, DOI 10.1093/jnci/90.11.841; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Therneau TM, 2000, MODELING SURVIVAL DA; TOBACMAN JK, 1982, LANCET, V2, P795; van Nagell JR, 2000, GYNECOL ONCOL, V77, P350, DOI 10.1006/gyno.2000.5816; Weber BL, 2000, AM J HUM GENET, V67, P59	41	923	949	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1609	1615		10.1056/NEJMoa020119	http://dx.doi.org/10.1056/NEJMoa020119			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023992				2022-12-28	WOS:000175728600002
J	Veldink, JH; Wokke, JHJ; van der Wal, G; de Jong, JMBV; van den Berg, LH				Veldink, JH; Wokke, JHJ; van der Wal, G; de Jong, JMBV; van den Berg, LH			Euthanasia and physician-assisted suicide among patients with amyotrophic lateral sclerosis in the netherlands.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OF-LIFE DECISIONS; MEDICAL-PRACTICE; END; CARE; ALS; EXPERIENCES; POPULATION; NEUROLOGY; ATTITUDES; OUTCOMES	Background: Amyotrophic lateral sclerosis (ALS) is a disease that causes progressive paralysis leading to respiratory failure. Patients with ALS may consider physician-assisted suicide. However, it is not known how many patients, if given the option, would actually decide to end their lives by physician-assisted suicide or euthanasia nor at what stage of the disease they would choose to do so. Methods: We identified physicians of 279 patients in the Netherlands with a diagnosis of ALS who died between 1994 and 1999. Physicians were asked to fill out a validated questionnaire about the end-of-life decisions that were made. Of 241 eligible physicians, 203 returned the questionnaire (84 percent). Results: Of the 203 patients, 35 (17 percent) chose euthanasia and died that way. An additional six patients (3 percent) died as a result of physician-assisted suicide. Patients to whom religion was important were less likely to have died as a result of euthanasia or physician-assisted suicide. The choice of euthanasia or physician-assisted suicide was not associated with any particular characteristics of the disease or of the patient's care, nor was it associated with income or educational level. Disability before death was significantly more severe in patients who died as a result of euthanasia than among those who died in other ways. Physician-assisted suicide appeared to occur somewhat earlier in the course of the disease than did euthanasia. An additional 48 patients (24 percent) received palliative treatment, which probably shortened their lives. Conclusions: In the Netherlands, we found that one in five patients with ALS died as a result of euthanasia or physician-assisted suicide. (N Engl J Med 2002;346:1638-44.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Med Ctr Utrecht, Dept Neurol, NL-3508 GA Utrecht, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Social Med, Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van den Berg, LH (corresponding author), Univ Med Ctr Utrecht, Dept Neurol, G-03-228,POB 85500, NL-3508 GA Utrecht, Netherlands.			Veldink, Jan/0000-0001-5572-9657				Albert SM, 1999, J NEUROL SCI, V169, P108, DOI 10.1016/S0022-510X(99)00227-0; Bannink M, 2000, LANCET, V356, P2067, DOI 10.1016/S0140-6736(00)03407-3; Bindels PJE, 1996, LANCET, V347, P499, DOI 10.1016/S0140-6736(96)91138-1; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Carver AC, 1999, NEUROLOGY, V53, P284, DOI 10.1212/WNL.53.2.284; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Ganzini L, 2000, NEW ENGL J MED, V342, P1538; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hendin H, 1997, JAMA-J AM MED ASSOC, V277, P1720, DOI 10.1001/jama.277.21.1720; Horikx A, 2000, Ned Tijdschr Geneeskd, V144, P2497; Jochemsen H, 1999, J MED ETHICS, V25, P16, DOI 10.1136/jme.25.1.16; Kuhse H, 1997, MED J AUSTRALIA, V166, P191, DOI 10.5694/j.1326-5377.1997.tb140074.x; Lacomblez L, 1996, NEUROLOGY, V47, pS242, DOI 10.1212/WNL.47.6_Suppl_4.242S; Lavery JV, 2001, LANCET, V358, P362, DOI 10.1016/S0140-6736(01)05555-6; Miller RG, 1999, NEUROLOGY, V52, P1311, DOI 10.1212/WNL.52.7.1311; Murphy PL, 2000, NEUROLOGY, V55, P1581, DOI 10.1212/WNL.55.10.1581; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; Voltz R, 1997, J NEUROL, V244, pS2, DOI 10.1007/PL00007721	22	93	93	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1638	1644		10.1056/NEJMsa012739	http://dx.doi.org/10.1056/NEJMsa012739			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023997				2022-12-28	WOS:000175728600007
J	Hoving, JL; Koes, BW; de Vet, HCW; van der Windt, DAWM; Assendelft, WJJ; van Mameren, H; Deville, WLJM; Pool, JJM; Scholten, RJPM; Bouter, LM				Hoving, JL; Koes, BW; de Vet, HCW; van der Windt, DAWM; Assendelft, WJJ; van Mameren, H; Deville, WLJM; Pool, JJM; Scholten, RJPM; Bouter, LM			Manual therapy, physical therapy, or continued care by a general practitioner for patients with neck pain - A randomized, controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							DISABILITY INDEX; CLINICAL-TRIAL; POPULATION; PREVALENCE; COMPLAINTS; HEALTH; BACK; PHYSIOTHERAPY; MANIPULATION; RELIABILITY	Background: Neck pain is a common problem, but the effectiveness of frequently applied conservative therapies has never been directly compared. Objective: To determine the effectiveness of manual therapy, physical therapy, and continued care by a general practitioner. Design: Randomized, controlled trial. Setting: Outpatient care setting in the Netherlands. Patients: 183 patients, 18 to 70 years of age, who had had nonspecific neck pain for at least 2 weeks. Intervention: 6 weeks of manual therapy (specific mobilization techniques) once per week, physical therapy (exercise therapy) twice per week, or continued care by a general practitioner (analgesics, counseling, and education). Measurements: Treatment was considered successful if the patient reported being "completely recovered" or "much improved" on an ordinal six-point scale. Physical dysfunction, pain intensity, and disability were also measured. Results: At 7 weeks, the success rates were 68.3% for manual therapy, 50.8% for physical therapy, and 35.9% for continued care. Statistically significant differences in pain intensity with manual therapy compared with continued care or physical therapy ranged from 0.9 to 1.5 on a scale of 0 to 10. Disability scores also favored manual therapy, but the differences among groups were small. Manual therapy scored consistently better than the other two interventions on most outcome measures. Physical therapy scored better than continued care on some outcome measures, but the differences were not statistically significant. Conclusion: in daily practice, manual therapy is a favorable treatment option for patients with neck pain compared with physical therapy or continued care by a general practitioner.	Cabrini Hosp, Dept Clin Epidemiol, Malvern, Vic 3144, Australia; Monash Univ, Dept Epidemiol & Prevent Med, Cabrini Med Ctr, Malvern, Vic 3144, Australia; Vrije Univ Amsterdam, Med Ctr, Inst Res Extramural Med, Amsterdam, Netherlands; Erasmus Univ, Rotterdam, Netherlands; Univ Maastricht, Maastricht, Netherlands; Dutch Coll Gen Practitioners, Utrecht, Netherlands; Nivel Netherlands Inst Hlth Serv Res, Utrecht, Netherlands	Cabrini Health; Cabrini Health; Monash University; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Maastricht University; Netherlands Institute for Health Services Research	Hoving, JL (corresponding author), Cabrini Hosp, Dept Clin Epidemiol, Suite 41 183 Wattletree Rd, Malvern, Vic 3144, Australia.	Jan.Hoving@med.monash.edu.au	assendelft, willem/AAW-1854-2021; Deville, Walter/B-5160-2013; Hoving, Jan/C-3744-2017; Hoving, Jan L/O-2235-2013; Assendelft, W.J.J./H-8008-2014; Koes, Bart w/K-4614-2016	assendelft, willem/0000-0002-2966-3778; Hoving, Jan L/0000-0002-0461-4013; Assendelft, W.J.J./0000-0002-2966-3778; Koes, Bart w/0000-0002-0450-9969; de Vet, Henrica/0000-0002-5454-2804; Bouter, Lex/0000-0002-2659-5482				ANDERSSON HI, 1993, CLIN J PAIN, V9, P174, DOI 10.1097/00002508-199309000-00004; Assendelft WJJ, 1996, J FAM PRACTICE, V42, P475; Basmajian JV, 1993, RATIONAL MANUAL THER; BAUMGARTEN K, 1996, FUNCTIEPROFIEL MANUE; Borghouts J, 1999, SCAND J PRIM HEALTH, V17, P215; Borghouts JAJ, 1999, PAIN, V80, P629, DOI 10.1016/S0304-3959(98)00268-1; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; BOVIM G, 1994, SPINE, V19, P1307, DOI 10.1097/00007632-199406000-00001; BRATTBERG G, 1989, PAIN, V37, P215, DOI 10.1016/0304-3959(89)90133-4; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; COOKSON JC, 1979, PHYS THER, V59, P259, DOI 10.1093/ptj/59.3.259; Cote P, 1998, SPINE, V23, P1689, DOI 10.1097/00007632-199808010-00015; Cote P, 2000, SPINE, V25, P1109; Di Fabio RP, 1999, PHYS THER, V79, P50; EssinkBot ML, 1997, MED CARE, V35, P522, DOI 10.1097/00005650-199705000-00008; Faris N, 1996, SOLID STATE TECHNOL, V39, P18; FARRELL JP, 1992, PHYS THER, V72, P843, DOI 10.1093/ptj/72.12.843; FEINSTEIN AR, 1987, CLINIMETRICS, P91; FITZGERALD GK, 1994, PHYS THER, V74, P227, DOI 10.1093/ptj/74.3.227; Gross AR, 1996, RHEUM DIS CLIN N AM, V22, P579, DOI 10.1016/S0889-857X(05)70289-1; GROSS AR, 2000, COCHRANE DB SYST REV, P61; GROSS AR, 1996, ONLINE J CURR CLIN T; Hains F, 1998, J MANIP PHYSIOL THER, V21, P75; Hoving JL, 2001, SPINE, V26, P196, DOI 10.1097/00007632-200101150-00015; JACOBSSON L, 1989, SCAND J RHEUMATOL, V18, P353, DOI 10.3109/03009748909102096; JAESCHKE R, 1990, CONTROL CLIN TRIALS, V11, P43, DOI 10.1016/0197-2456(90)90031-V; Jette AM, 1997, PHYS THER, V77, P145, DOI 10.1093/ptj/77.2.145; Jette DU, 1996, PHYS THER, V76, P930, DOI 10.1093/ptj/76.9.930; Jette DU, 1996, PHYS THER, V76, P945, DOI 10.1093/ptj/76.9.945; KOES BW, 1992, SPINE, V17, P28, DOI 10.1097/00007632-199201000-00005; KOES BW, 1993, J MANIP PHYSIOL THER, V16, P211; KOES BW, 1990, NEDERLANDS TIJDSCHRI, V100, P31; KROESE ME, 1999, INVENTARISATIE BEH 1; LANSER K, 1994, NEKSCHOOL NEKKLACHTE; MAKELA M, 1991, AM J EPIDEMIOL, V134, P1356; NORUSIS MJ, 1999, SPSS 9 0 GUIDE DATA; PICAVET HSJ, 2000, KLACHTEN BEWEGINGSAP; POCOCK SJ, 1989, CLIN TRIALS PRACTICA, P125; Stratford PW, 1999, PHYSIOTHER CANADA, V51, P107; TAKALA EP, 1994, SCAND J REHABIL MED, V26, P17; van Tulder MW, 2000, NECK BACK PAIN SCI E; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; 1993, MANUELE THERAPIE WER	44	211	216	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					713	722		10.7326/0003-4819-136-10-200205210-00006	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020139	Green Published			2022-12-28	WOS:000175664600001
J	Verghese, A				Verghese, A			Perspective: Physicians and addiction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Texas Tech Hlth Sci Ctr, El Paso, TX 79905 USA	Texas Tech University System; Texas Tech University Health Science Center	Verghese, A (corresponding author), Texas Tech Hlth Sci Ctr, El Paso, TX 79905 USA.								0	26	26	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1510	1511		10.1056/NEJM200205163462002	http://dx.doi.org/10.1056/NEJM200205163462002			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015389				2022-12-28	WOS:000175563900001
J	Crandall, JR; Bhalla, KS; Madeley, NJ				Crandall, JR; Bhalla, KS; Madeley, NJ			Designing road vehicles for pedestrian protection	BRITISH MEDICAL JOURNAL			English	Article									Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22902 USA	University of Virginia	Crandall, JR (corresponding author), Univ Virginia, Ctr Appl Biomech, 1011 Linden Ave, Charlottesville, VA 22902 USA.		Crandall, Jeff R/N-2210-2014					Brainard B, 1986, ANN EMERG MED, V18, P881; BUNKETORP O, 1983, P 27 STAPP CAR CRASH; CHIDESTER AB, 2001, P 17 INT C ENH SAF V, P5; *DEP ENV TRANSP RE, 1998, TRANSP STAT ROAD ACC; *DEP TRANSP LOC GO, 2000, 1 DEP TRANSP LOC GOV; European Enhanced Vehicle-safety Committee, 1998, IMPR TEST METH EV PE; FREDRIKSSON R, 2001, P 17 INT C ENH SAF V, P5; KALLISKE I, P 17 INT C ENH SAF V; KONOSU A, 2001, P 17 INT C ENH SAF V, P5; LEFLER DE, 2001, P 17 INT C ENH SAF V; MIZUNO K, 2000, P SAE SOC AUT ENG 20; Pohlemann T., 2001, P INT RES COUNC BIOM; SCHUSTER P, 1998, P SAE SOC AUT ENG IN; U.S. Department of Transportation, 2000, TRAFF SAF FACTS 2000; WITTEK A, 2001, P 17 INT C ENH SAF V; World Bank Group, 2002, ROAD SAF; Yang J.K., 2000, J CRASH PREV INJURY, V2, P131, DOI DOI 10.1080/10286580008902559; 2002, EUROPEAN NEW CAT ASS	18	81	85	0	15	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1145	1148		10.1136/bmj.324.7346.1145	http://dx.doi.org/10.1136/bmj.324.7346.1145			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003890	Green Published			2022-12-28	WOS:000175622800028
J	Nantulya, VM; Reich, MR				Nantulya, VM; Reich, MR			The neglected epidemic: road traffic injuries in developing countries	BRITISH MEDICAL JOURNAL			English	Article									Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health	Nantulya, VM (corresponding author), Harvard Ctr Populat & Dev Studies, Cambridge, MA 02138 USA.		Gomaa, Ahmed/I-6442-2017	Gomaa, Ahmed/0000-0003-0869-7888				ELECHI EN, 1990, INJURY, V21, P234, DOI 10.1016/0020-1383(90)90011-I; *GLOB ROAD SAF PAR, 2001, MOV AH EM LESS; Hijaar M.C., 1999, TRAFFIC INJURIES LAT; *INT FED RED CROSS, 2000, MUST MILL MOR DIE; Jacobs G., 2000, 445 TRL; KAPILA S., 1982, MATATU MODE PUBLIC T; Krug E., 1999, INJURY LEADING CAUSE; Mock CN, 1997, J TRAUMA, V42, P504, DOI 10.1097/00005373-199703000-00019; MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1; Nantulya VM., 2001, CHALLENGING INEQUITI; *NAT HIGHW TRAFF S, 2002, TRAFF SAF FACTS 1999; TRUNKEY DD, 1990, EARLY CARE INJURED P, P3; UNDP, 1994, 1994 HUM DEV REP; *WORLD BANK GROUP, 2002, GLOSS; *XEN NEWS AG, 2001, TRAFF ACC VIETN RIS; 2002, BBC NEWS        0302; [No title captured]	17	396	409	0	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1139	1141		10.1136/bmj.324.7346.1139	http://dx.doi.org/10.1136/bmj.324.7346.1139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003888	Green Submitted, Green Published			2022-12-28	WOS:000175622800026
J	MacDonald, MP; Paterson, L; Volke-Sepulveda, K; Arlt, J; Sibbett, W; Dholakia, K				MacDonald, MP; Paterson, L; Volke-Sepulveda, K; Arlt, J; Sibbett, W; Dholakia, K			Creation and manipulation of three-dimensional optically trapped structures	SCIENCE			English	Article							ORBITAL ANGULAR-MOMENTUM; MICROSCOPIC PARTICLES; LASER-BEAMS; SINGLE; LIGHT; PROPAGATION; ALIGNMENT; ENERGY; FIELDS; WAVE	An interferometric pattern between two annular laser beams is used to construct three-dimensional (3D) trapped structures within an optical tweezers setup. In addition to being fully translatable in three dimensions, the trapped structure can be rotated controllably and continuously by introducing a frequency difference between the two laser beams. These interference patterns could play an important rote in the creation of extended 3D crystalline structures.	Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; Inst Nacl Astron Opt & Elect, Puebla 72000, Mexico; Univ Edinburgh, Dept Phys & Astron, Edinburgh EH9 3JZ, Midlothian, Scotland	University of St Andrews; Instituto Nacional de Astrofisica, Optica y Electronica; University of Edinburgh	Dholakia, K (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.		MacDonald, Michael P/F-5880-2011; Arlt, Jochen/B-7435-2009; Dholakia, Kishan/C-9873-2009	MacDonald, Michael P/0000-0003-4415-5437; Arlt, Jochen/0000-0002-4152-5896; Paterson, Lynn/0000-0003-0493-5041; Volke-Sepulveda, Karen/0000-0001-6048-4244; Dholakia, Kishan/0000-0001-6534-9009				ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Arlt J, 2001, OPT COMMUN, V197, P239, DOI 10.1016/S0030-4018(01)01479-1; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; BRETENAKER F, 1990, PHYS REV LETT, V65, P2316, DOI 10.1103/PhysRevLett.65.2316; BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; Chiou AE, 1997, OPT COMMUN, V133, P7, DOI 10.1016/S0030-4018(96)00456-7; Dufresne ER, 2001, REV SCI INSTRUM, V72, P1810, DOI 10.1063/1.1344176; Eriksen RL, 2002, OPT LETT, V27, P267, DOI 10.1364/OL.27.000267; Friese MEJ, 1998, NATURE, V394, P348, DOI 10.1038/28566; Galajda P, 2001, APPL PHYS LETT, V78, P249, DOI 10.1063/1.1339258; GARETZ BA, 1981, J OPT SOC AM, V71, P609, DOI 10.1364/JOSA.71.000609; Gauthier RC, 1998, APPL OPTICS, V37, P6421, DOI 10.1364/AO.37.006421; Higurashi E, 1999, PHYS REV E, V59, P3676, DOI 10.1103/PhysRevE.59.3676; Kuhr S, 2001, SCIENCE, V293, P278, DOI 10.1126/science.1062725; MacDonald MP, 2002, OPT COMMUN, V201, P21, DOI 10.1016/S0030-4018(01)01652-2; Paterson L, 2001, SCIENCE, V292, P912, DOI 10.1126/science.1058591; Piestun R, 2000, J OPT SOC AM A, V17, P294, DOI 10.1364/JOSAA.17.000294; SCHECHNER YV, 1996, PHYS REV E, V54, P50; Simpson NB, 1997, OPT LETT, V22, P52, DOI 10.1364/OL.22.000052; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Tovar AA, 2000, J OPT SOC AM A, V17, P2010, DOI 10.1364/JOSAA.17.002010; Zemanek P, 1999, OPT LETT, V24, P1448, DOI 10.1364/OL.24.001448	23	385	413	5	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1101	1103		10.1126/science.1069571	http://dx.doi.org/10.1126/science.1069571			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004124				2022-12-28	WOS:000175565000047
J	Emerson, BM				Emerson, BM			Specificity of gene regulation	CELL			English	Review							CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION; SELECTIVITY; ACTIVATION	The physiologically coordinated expression of our genome requires exquisite regulation of gene specificity. Recent advances demonstrate that this formidable task is accomplished by diverse mechanisms and networks that operate at distinct levels within the nucleus.	Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Emerson, BM (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Boyer LA, 2000, J BIOL CHEM, V275, P18864, DOI 10.1074/jbc.M002810200; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Francastel C, 2001, P NATL ACAD SCI USA, V98, P12120, DOI 10.1073/pnas.211444898; Freiman RN, 2001, SCIENCE, V293, P2084, DOI 10.1126/science.1061935; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hassan AH, 2001, FRONT BIOSCI, V6, pD1054, DOI 10.2741/Hassan; Hassan AH, 2001, CELL, V104, P817, DOI 10.1016/S0092-8674(01)00279-3; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; Kal AJ, 2000, GENE DEV, V14, P1058; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; Rollini P, 1999, SOMAT CELL MOLEC GEN, V25, P207, DOI 10.1023/A:1019279809728; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Tutter AV, 2001, GENE DEV, V15, P3342, DOI 10.1101/gad.946501; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597	20	99	101	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					267	270		10.1016/S0092-8674(02)00740-7	http://dx.doi.org/10.1016/S0092-8674(02)00740-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015975	Bronze			2022-12-28	WOS:000175412100001
J	Bhunia, AK; Piontek, K; Boletta, A; Liu, LJ; Qian, F; Xu, PN; Germino, FJ; Germino, GG				Bhunia, AK; Piontek, K; Boletta, A; Liu, LJ; Qian, F; Xu, PN; Germino, FJ; Germino, GG			PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2	CELL			English	Article							POLYCYSTIC KIDNEY-DISEASE; JANUS TYROSINE KINASE; TARGETED DISRUPTION; GROWTH-FACTOR; CYTOKINE RECEPTORS; GENE-PRODUCT; C-MYC; PROTEIN; INDUCTION; APOPTOSIS	Autosomal dominant polycystic kidney disease is characterized by cyst formation in the kidney and other organs and results from mutations of PKD1 or PKD2. Previous studies suggest that their gene products have an important role in growth regulation. We now show that expression of polycystin-1 activates the JAK-STAT pathway, thereby upregulating p21(waf1) and inducing cell cycle arrest in G0/G1. This process requires polycystin-2, a channel protein, as an essential cofactor. Mutations that disrupt polycystin-1/2 binding prevent activation of the pathway. Mouse embryos lacking Pkd1 have defective STAT1 phosphorylation and p21(waf1) induction. These results suggest that one function of the polycystin-1/2 complex is to regulate the JAK/STAT pathway and explain how mutations of either gene can result in dysregulated growth.	Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA; Univ Med & Dent New Jersey, Dept Med, Div Oncol, New Brunswick, NJ 08901 USA	Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Germino, GG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21205 USA.			Germino, Gregory/0000-0002-3609-5588	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK057325, T32DK007712, R01DK048006] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 48006, P50 DK 57325, T32 DK 07712] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boccaccio C, 1998, NATURE, V391, P285, DOI 10.1038/34657; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bromberg JF, 1998, CELL GROWTH DIFFER, V9, P505; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Duncan SA, 1997, DEV DYNAM, V208, P190, DOI 10.1002/(SICI)1097-0177(199702)208:2<190::AID-AJA6>3.0.CO;2-D; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Frank DA, 1997, J CLIN INVEST, V100, P3140, DOI 10.1172/JCI119869; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hou XS, 1997, TRENDS GENET, V13, P105, DOI 10.1016/S0168-9525(97)01006-8; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibraghimov-Beskrovnaya O, 2000, HUM MOL GENET, V9, P1641, DOI 10.1093/hmg/9.11.1641; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; KLINGEL R, 1992, AM J KIDNEY DIS, V19, P22, DOI 10.1016/S0272-6386(12)70198-1; Krebs DL, 2000, J CELL SCI, V113, P2813; Lanoix J, 1996, ONCOGENE, V13, P1153; Leaman DW, 1996, FASEB J, V10, P1578, DOI 10.1096/fasebj.10.14.9002549; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; Lu WN, 2001, HUM MOL GENET, V10, P2385, DOI 10.1093/hmg/10.21.2385; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Takeshita T, 1997, IMMUNITY, V6, P449, DOI 10.1016/S1074-7613(00)80288-5; TORRES VE, 1990, CYSTIC KIDNEY; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; WARD CJ, 1994, CELL, V77, P881; Watnick T, 2000, NAT GENET, V25, P143, DOI 10.1038/75981; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yeh TC, 1999, CELL MOL LIFE SCI, V55, P1523, DOI 10.1007/s000180050392	53	336	346	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					157	168		10.1016/S0092-8674(02)00716-X	http://dx.doi.org/10.1016/S0092-8674(02)00716-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007403	Bronze			2022-12-28	WOS:000175082600006
J	Dickersin, K; Olson, CM; Rennie, D; Cook, D; Flanagin, A; Zhu, Q; Reiling, J; Pace, B				Dickersin, K; Olson, CM; Rennie, D; Cook, D; Flanagin, A; Zhu, Q; Reiling, J; Pace, B			Association between time interval to publication and statistical significance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				BIAS	Context Studies have shown that reports from clinical trials with statistically significant results tend to be submitted and published more rapidly than reports from studies with null or nonsignficant findings. Methods We wanted to determine whether manuscripts reporting positive results from controlled clinical trials are published more quickly than those reporting negative results. We tracked manuscripts from submission to JAMA until the publication decision. We classified results as positive if a statistically significant difference was reported for the primary outcome. Manuscripts were further classified according to indicators of methodologic quality and other study characteristics. We included manuscripts if they were submitted from February 1996 through August 1999, reported results of a prospective study in which participants were assigned to a treatment or comparison group, used statistical tests to compare differences between groups, and were accepted for publication. Results One hundred thirty-three manuscripts met our inclusion criteria, 78 (59%) reported positive results, 51 (38%) reported negative results. We were unable to classify the direction of results for 4 articles (3%). The time interval between submission and publication was not associated with positive results: median time between submission and publication was 7.8 months for reports with positive vs 7.6 months for reports with negative results (P=.44). Time to publication also was not associated with any marker of study quality or study characteristic. Conclusions Among 133 published controlled trials, time to publication was not associated with statistical significance, methodologic quality, or other study characteristics.	Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, Dept Community Hlth, Providence, RI 02912 USA; JAMA, Chicago, IL USA; Univ Washington, Dept Med, Div Emergency Med, Seattle, WA USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	Brown University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; McMaster University; McMaster University	Dickersin, K (corresponding author), Brown Univ, Ctr Clin Trials & Evidence Based Healthcare, Dept Community Hlth, 169 Angell St,Box G-S2, Providence, RI 02912 USA.		Dickersin, Kay/A-4576-2008					Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640	5	42	42	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2829	2831		10.1001/jama.287.21.2829	http://dx.doi.org/10.1001/jama.287.21.2829			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559AP	12038925	Bronze			2022-12-28	WOS:000176002200022
J	Qasim, A; Malpass, K; O'Gorman, DJ; Heber, ME				Qasim, A; Malpass, K; O'Gorman, DJ; Heber, ME			Quality improvement report - Safety and efficacy of nurse initiated thrombolysis in patients with acute myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DELAY	Problem Delay in starting thrombolytic treatment in patients arriving at hospital with chest pain who are diagnosed as having acute myocardial infarction. Design Audit of "door to needle times" for patients presenting with chest pain and an electrocardiogram on admission that confirmed acute myocardial infarction. A one year period in each of three phases of development was studied. Background and setting The goal of the national service framework for coronary heart disease is that by April 2002, 75% of eligible patients should receive thrombolysis within 30 minutes of arriving at hospital. A district general hospital introduced a strategy to improve door to needle times. In phase 1 (1989-95), patients with suspected acute myocardial infarction, referred by general practitioners, were assessed in the coronary care unit; all other patients were seen first in the accident and emergency department. In phase 2 (1995-7), all patients with suspected acute myocardial infarction were transferred directly to a fast track area within the coronary care unit, where nurses assess patients and doctors started treatment. Key measures for improvement Median door to needle time in phase 1 of 45 minutes (range 5-300 minutes), with 38% of patients treated within 30 minutes. Median door to needle time in phase 2 of 40 minutes (range 5-180 minutes), with 47% treated within 30 minutes. Strategies for change In phase 3 (1997-2001), all patients with suspected acute myocardial infarction were transferred directly to the fast truck area and assessed by a "coronary care thrombolysis nurse," If electrocardiography confirmed the diagnosis of acute myocardial infarction, the nurse could initiate thrombolytic therapy (subject to guidelines and exclusions determined by the consultant cardiologists). Effects of change Median door to needle time in phase 3 of 15 minutes (range 5-70 minutes), with 80% of patients treated within 30 minutes. Systematic clinical review showed no cases in which a nurse initiated inappropriate thrombolysis. Lessons learnt Thrombolysis started by nurses is safe and effective in patients with acute myocardial infarction. It may provide a way by which tire national service framework's targets for door to needle times can be achieved.	Princess Royal Hosp, Dept Cardiol, Coronary Care Unit, Telford TF6 6TF, Shrops, England		Qasim, A (corresponding author), Princess Royal Hosp, Dept Cardiol, Coronary Care Unit, Apley Castle, Telford TF6 6TF, Shrops, England.	dr@asifqasim.freeserve.co.uk		Qasim, Asif/0000-0003-2394-5819				[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; BIRKHEAD JS, 1992, BMJ-BRIT MED J, V305, P445, DOI 10.1136/bmj.305.6851.445; *DEP HLTH, 2000, NAT SERV FRAM COR HE; FOSTER DB, 1994, AM J EMERG MED, V12, P25, DOI 10.1016/0735-6757(94)90192-9; GATENBY R, 1992, BMJ-BRIT MED J, V305, P548; PELL ACH, 1992, BMJ-BRIT MED J, V304, P83, DOI 10.1136/bmj.304.6819.83; Quinn T, 1998, Intensive Crit Care Nurs, V14, P219, DOI 10.1016/S0964-3397(98)80614-9; Somauroo JD, 1999, J ROY COLL PHYS LOND, V33, P46; WESTON C, 1991, J ROY COLL PHYS LOND, V25, P312; WESTON CFM, 1994, BMJ-BRIT MED J, V308, P767, DOI 10.1136/bmj.308.6931.767	12	22	22	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1328	1331		10.1136/bmj.324.7349.1328	http://dx.doi.org/10.1136/bmj.324.7349.1328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039831	Green Published			2022-12-28	WOS:000176041500024
J	Nadeau, JA; Sack, FD				Nadeau, JA; Sack, FD			Control of stomatal distribution on the Arabidopsis leaf surface	SCIENCE			English	Article							RECEPTOR-LIKE KINASE; RICH REPEAT PROTEINS; GENE ENCODES; 4 LIPS; RESISTANCE; MOUTHS; TOO; ORGAN	Stomata regulate gas exchange and are distributed across the leaf epidermis with characteristic spacing. Arabidopsis stomata are produced by asymmetric cell divisions. Mutations in the gene TOO MANY MOUTHS (TMM) disrupt patterning by randomizing the plane of formative asymmetric divisions and by permitting ectopic divisions. TMM encodes a leucine-rich repeat-containing receptor-like protein expressed in proliferative postprotodermal cells. TMM appears to function in a position-dependent signaling pathway that controls the plane of patterning divisions as well as the balance between stem cell renewal and differentiation in stomatal and epidermal development.	Ohio State Univ, Dept Plant Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Sack, FD (corresponding author), Ohio State Univ, Dept Plant Biol, 1735 Neil Ave, Columbus, OH 43210 USA.							Berger D, 2000, GENE DEV, V14, P1119; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Dixon MS, 1996, CELL, V84, P451, DOI 10.1016/S0092-8674(00)81290-8; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; GEISLER MJ, UNPUB; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Jinn TL, 2000, GENE DEV, V14, P108; JONES DA, 1994, SCIENCE, V266, P789, DOI 10.1126/science.7973631; Kajava AV, 1998, J MOL BIOL, V277, P519, DOI 10.1006/jmbi.1998.1643; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Nadeau JA, 2002, THE ARABIDOPSIS BOOK; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Wang GL, 1996, MOL PLANT MICROBE IN, V9, P850, DOI 10.1094/MPMI-9-0850; Wang GL, 1998, PLANT CELL, V10, P765, DOI 10.1105/tpc.10.5.765; Yang M, 1995, PLANT CELL, V7, P2227, DOI 10.1105/tpc.7.12.2227	20	377	409	5	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1697	1700		10.1126/science.1069596	http://dx.doi.org/10.1126/science.1069596			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040198				2022-12-28	WOS:000175976200062
J	Wajant, H				Wajant, H			The Fas signaling pathway: More than a paradigm	SCIENCE			English	Editorial Material							DEATH	Apoptosis and related forms of cell death have central importance in development, homeostasis, tumor surveillance, and the function of the immune system. Apoptosis is initiated by two principal pathways. The intrinsic pathway emerges from mitochondria, whereas the extrinsic pathway is activated by the ligation of death receptors. This Viewpoint introduces the basic mechanisms of the extrinsic pathway, using the example of the prototypical death receptor Fas and its rote in apoptosis, but it also points out the increasingly understood importance of this receptor as a non-apoptotic signal transducer.	Univ Stuttgart, Inst Cell Biol & Immunol, D-70569 Stuttgart, Germany	University of Stuttgart	Wajant, H (corresponding author), Univ Stuttgart, Inst Cell Biol & Immunol, Allmandring 31, D-70569 Stuttgart, Germany.		Wajant, Harald/A-3020-2017	Wajant, Harald/0000-0002-2005-3949	NCI NIH HHS [CA-81050] Funding Source: Medline; NIDDK NIH HHS [DK-38761] Funding Source: Medline; NIGMS NIH HHS [GM-54508, F31GM65065] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM065065, R01GM054508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Badorff C, 2002, J CLIN INVEST, V109, P373, DOI 10.1172/JCI200213779; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Krueger A, 2001, MOL CELL BIOL, V21, P8247, DOI 10.1128/MCB.21.24.8247-8254.2001; Pinkoski MJ, 1999, CELL DEATH DIFFER, V6, P1174, DOI 10.1038/sj.cdd.4400611; Siegel RM, 2000, NAT IMMUNOL, V1, P469, DOI 10.1038/82712; WAJANT H, 2002, SCI STKE	7	646	691	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1635	1636		10.1126/science.1071553	http://dx.doi.org/10.1126/science.1071553			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040174				2022-12-28	WOS:000175976200037
J	Brand, A; Behrend, O; Marquardt, T; McAlpine, D; Grothe, B				Brand, A; Behrend, O; Marquardt, T; McAlpine, D; Grothe, B			Precise inhibition is essential for microsecond interaural time difference coding	NATURE			English	Article							MEDIAL SUPERIOR OLIVE; AUDITORY-NERVE FIBERS; COCHLEAR NUCLEUS; TRAPEZOID BODY; SOUND LOCALIZATION; DELAY-LINES; NEURONS; PROJECTIONS; CELLS; SENSITIVITY	Microsecond differences in the arrival time of a sound at the two ears (interaural time differences, ITDs) are the main cue for localizing low-frequency sounds in space. Traditionally, ITDs are thought to be encoded by an array of coincidence-detector neurons, receiving excitatory inputs from the two ears via axons of variable length ('delay lines'), to create a topographic map of azimuthal auditory space(1,2). Compelling evidence for the existence of such a map in the mammalian ITD detector, the medial superior olive (MSO), however, is lacking. Equally puzzling is the role of a-temporally very precise(3)-glycine-mediated inhibitory input to MSO neurons. Using in vivo recordings from the MSO of the Mongolian gerbil, we found the responses of ITD-sensitive neurons to be inconsistent with the idea of a topographic map of auditory space. Moreover, local application of glycine and its antagonist strychnine by iontophoresis (through glass pipette electrodes, by means of an electric current) revealed that precisely timed glycine-controlled inhibition is a critical part of the mechanism by which the physiologically relevant range of ITDs is encoded in the MSO. A computer model, simulating the response of a coincidence-detector neuron with bilateral excitatory inputs and a temporally precise contralateral inhibitory input, supports this conclusion.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; UCL, Dept Physiol, London WC1E 6BT, England	Max Planck Society; University of London; University College London	Grothe, B (corresponding author), Max Planck Inst Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.	bgrothe@neuro.mpg.de	Grothe, Benedikt/A-7877-2010	Grothe, Benedikt/0000-0001-7317-0615; McAlpine, David/0000-0001-5467-6725				Brand A, 2000, J NEUROPHYSIOL, V84, P1790, DOI 10.1152/jn.2000.84.4.1790; Brughera AR, 1996, AUDIT NEUROSCI, V2, P219; CANT NB, 1992, HEARING RES, V58, P26, DOI 10.1016/0378-5955(92)90005-8; CARNEY LH, 1993, J ACOUST SOC AM, V93, P401, DOI 10.1121/1.405620; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; GROTHE B, 1994, J NEUROSCI, V14, P1701, DOI 10.1523/JNEUROSCI.14-03-01701.1994; GROTHE B, 1993, J NEUROPHYSIOL, V69, P1192, DOI 10.1152/jn.1993.69.4.1192; Grothe B, 2000, PROG NEUROBIOL, V61, P581, DOI 10.1016/S0301-0082(99)00068-4; Grothe B, 1998, J NEUROSCI, V18, P6608; Grothe B, 1997, J NEUROPHYSIOL, V77, P1553, DOI 10.1152/jn.1997.77.3.1553; GROTHE B, 1994, J NEUROPHYSIOL, V71, P706, DOI 10.1152/jn.1994.71.2.706; HAVEY DC, 1980, ELECTROEN CLIN NEURO, V48, P249, DOI 10.1016/0013-4694(80)90313-2; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; Klumpp R, 1956, J ACOUST SOC AM, V28, P215; KUWABARA N, 1992, J COMP NEUROL, V324, P522, DOI 10.1002/cne.903240406; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; OVERHOLT EM, 1992, J NEUROSCI, V12, P1698; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Smith AJ, 2000, J PHYSIOL-LONDON, V529, P681, DOI 10.1111/j.1469-7793.2000.00681.x; Smith PH, 1998, J NEUROPHYSIOL, V79, P3127, DOI 10.1152/jn.1998.79.6.3127; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; SPITZER MW, 1995, J NEUROPHYSIOL, V73, P1668, DOI 10.1152/jn.1995.73.4.1668; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Willott JF, 1997, J COMP NEUROL, V385, P405; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1020, DOI 10.1152/jn.1983.50.4.1020	30	424	430	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					543	547		10.1038/417543a	http://dx.doi.org/10.1038/417543a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037566				2022-12-28	WOS:000175860300041
J	GrandPre, T; Li, SX; Strittmatter, SM				GrandPre, T; Li, SX; Strittmatter, SM			Nogo-66 receptor antagonist peptide promotes axonal regeneration	NATURE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NEURITE GROWTH-INHIBITORS; FUNCTIONAL RECOVERY; IDENTIFICATION; PLASTICITY; OUTGROWTH; INJURY; SITES; RATS	Myelin-derived axon outgrowth inhibitors, such as Nogo, may account for the lack of axonal regeneration in the central nervous system (CNS) after trauma in adult mammals. A 66-residue domain of Nogo (Nogo-66) is expressed on the surface of oligodendrocytes(1) and can inhibit axonal outgrowth through an axonal Nogo-66 receptor (NgR)(2). The IN-1 monoclonal antibody recognizes Nogo-A and promotes corticospinal tract regeneration and locomotor recovery(3-5); however, the undefined nature of the IN-1 epitope in Nogo, the limited specificity of IN-1 for Nogo, and nonspecific anti-myelin effects have prevented a firm conclusion about the role of Nogo-66 or NgR. Here, we identify competitive antagonists of NgR derived from amino-terminal peptide fragments of Nogo-66. The Nogo-66(1-40) antagonist peptide (NEP1-40) blocks Nogo-66 or CNS myelin inhibition of axonal outgrowth in vitro, demonstrating that NgR mediates a significant portion of axonal outgrowth inhibition by myelin. Intrathecal administration of NEP1-40 to rats with mid-thoracic spinal cord hemisection results in significant axon growth of the corticospinal tract, and improves functional recovery. Thus, Nogo-66 and NgR have central roles in limiting axonal regeneration after CNS injury, and NEP1-40 provides a potential therapeutic agent.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06520 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, POB 208018, New Haven, CT 06520 USA.		Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; BREGMAN BS, 1995, NATURE, V378, P498, DOI 10.1038/378498a0; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Merkler D, 2001, J NEUROSCI, V21, P3665, DOI 10.1523/JNEUROSCI.21-10-03665.2001; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Takahashi T, 1997, J NEUROSCI, V17, P9183; Thallmair M, 1998, NAT NEUROSCI, V1, P124, DOI 10.1038/373; Weidner N, 2001, P NATL ACAD SCI USA, V98, P3513, DOI 10.1073/pnas.051626798	14	579	678	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					547	551		10.1038/417547a	http://dx.doi.org/10.1038/417547a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037567				2022-12-28	WOS:000175860300042
J	Dziak, RP; Johnson, HP				Dziak, RP; Johnson, HP			Hydrothermal systems - Stirring the oceanic incubator	SCIENCE			English	Editorial Material							EAST PACIFIC RISE; MIDOCEAN RIDGE; WATER-LEVEL; EARTHQUAKE; SEISMICITY; CALIFORNIA		Oregon State Univ, NOAA, Newport, OR 97365 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Oregon State University; University of Washington; University of Washington Seattle	Dziak, RP (corresponding author), Oregon State Univ, NOAA, Newport, OR 97365 USA.		Dziak, Robert/AAC-6107-2020					Brodsky EE, 2000, GEOPHYS RES LETT, V27, P2741, DOI 10.1029/2000GL011534; BRODSKY EE, 2001, EOS S, V82, pF830; Davis EE, 2001, J GEOPHYS RES-SOL EA, V106, P21953, DOI 10.1029/2000JB000040; DZIAK RP, 2001, EOS S, V82, pF832; Fisher AT, 2000, NATURE, V403, P71, DOI 10.1038/47463; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Hooft EEE, 1996, EARTH PLANET SC LETT, V142, P289, DOI 10.1016/0012-821X(96)00101-X; Huber JA, 2002, APPL ENVIRON MICROB, V68, P1585, DOI 10.1128/AEM.68.4.1585-1594.2002; Johnson H.P., 2001, EOS T AM GEOPHYS UN, V82, P233; Johnson HP, 2000, NATURE, V407, P174, DOI 10.1038/35025040; MATSUMOTO N, 1992, GEOPHYS RES LETT, V19, P1193, DOI 10.1029/92GL01042; *NOAA, 2466 NOAA; Roeloffs E, 1996, ADV GEOPHYS, V37, P135, DOI 10.1016/S0065-2687(08)60270-8; Roeloffs EA, 1998, J GEOPHYS RES-SOL EA, V103, P869, DOI 10.1029/97JB02335; Sohn RA, 1998, NATURE, V396, P159, DOI 10.1038/24146; Summit M, 2001, P NATL ACAD SCI USA, V98, P2158, DOI 10.1073/pnas.051516098; [No title captured]	17	14	16	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1406	1407		10.1126/science.1072075	http://dx.doi.org/10.1126/science.1072075			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029115				2022-12-28	WOS:000175910300027
J	Bent, S; Nallamothu, BK; Simel, DL; Fihn, SD; Saint, S				Bent, S; Nallamothu, BK; Simel, DL; Fihn, SD; Saint, S			Does this woman have an acute uncomplicated urinary tract infection?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CLINICAL-PRACTICE GUIDELINE; RISK-FACTORS; ASYMPTOMATIC BACTERIURIA; MANAGEMENT; DIAGNOSIS; WOMEN; DYSURIA; ASSOCIATION; SYMPTOMS; PATIENT	Context Symptoms suggestive of acute urinary tract infection (UTI) constitute one of the most common reasons for women to visit clinicians. Although the clinical en typically involves taking a history and performing a physical examination, the diagnostic accuracy of the clinical assessment for UTI remains uncertain. Objective To review the accuracy and precision of history taking and physical examination for the diagnosis of UTI in women. Data Sources We conducted a MEDLINE search for articles published from 1966 through September 2001 and manually reviewed bibliographies, 3 commonly used clinical skills textbooks, and contacted experts in the field. Study Selection Studies were included if they contained original data on the accuracy or precision of history or physical examination for diagnosing acute uncomplicated UTI in women. One author initially screened titles and abstracts found by our search. Nine of 464 identified studies met inclusion criteria. Data Extraction Two authors independently abstracted data from the included studies. Disagreements were resolved by discussion and consensus with a third author. Data Synthesis Four symptoms and 1 sign significantly increased the probability of UTI: dysuria (summary positive likelihood ratio [LR], 1.5; 95% confidence interval [CI], 1.2-2.0), frequency (LR, 1,8; 95% CI, 1.1-3.0), hematuria (LR, 2.0; 95% CI, 1.3-2.9), back pain (LR, 1.6; 95% CI, 1.2-2.1), and costovertebral angle tenderness (LR, 1.7; 95% CI, 1.1-2.5). Four symptoms and 1 sign significantly decreased the probability of UTI: absence of dysuria (summary negative LR, 0.5; 95% CI, 0.3-0.7), absence of back pain (LR, 0.8; 95% CI, 0.7-0.9), history of vaginal discharge (LR, 0.3; 95% CI, 0.1-0.9), history of vaginal irritation (LR, 0.2; 95% CI, 0.1-0.9), and vaginal discharge on examination (LR, 0.7; 95% CI, 0.5-0.9). Of all individual diagnostic signs and symptoms, the 2 most powerful were history of vaginal discharge and history of vaginal irritation, which significantly decreased the likelihood of UTI when present (LRs, 0.3 and 0.2, respectively). One study examined combinations of symptoms, and the resulting LRs were more powerful (24.6 for the combination of dysuria and frequency but no vaginal discharge or irritation). One study of patients with recurrent UTI found that self-diagnosis significantly increased the probability of UTI (LR, 4.0). Conclusions In women who present with 1 or more symptoms of UTI, the probability of infection is approximately 50%. Specific combinations of symptoms (eg, dysuria and frequency without vaginal discharge or irritation) raise the probability of UTI to more than 90%, effectively ruling in the diagnosis based on history alone. In contrast, history taking, physical examination, and dipstick urinalysis are not able to reliably lower the posttest probability of disease to a level where a UTI can be ruled out when a patient presents with 1 or more symptoms.	San Francisco VA Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; Durham VA Med Ctr, Dept Med, Durham, NC USA; Duke Univ, Sch Med, Durham, NC USA; VA Puget Sound Hlth Care Syst, Hlth Serv Res & Dev Ctr Excellence, Seattle, WA USA; Ann Arbor VA Med Ctr, Dept Med, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Patient Safety Enhancement Program, Ann Arbor, MI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Michigan System; University of Michigan	Bent, S (corresponding author), San Francisco VA Med Ctr, Gen Internal Med Sect, 111-A1,4150 Clement St, San Francisco, CA 94121 USA.	bent@itsa.ucsf.edu	Fihn, Stephan/ABA-1040-2020; Saint, Sanjay/AAF-5126-2019					Bacheller CD, 1997, MED CLIN N AM, V81, P719, DOI 10.1016/S0025-7125(05)70542-3; Barry HC, 2001, J FAM PRACTICE, V50, P589; Bengtsson C, 1998, SCAND J UROL NEPHROL, V32, P284; Berg A O, 1991, J Am Board Fam Pract, V4, P327; BERG AO, 1984, JAMA-J AM MED ASSOC, V251, P620, DOI 10.1001/jama.251.5.620; Berg AO, 2001, AM J PREV MED, V20, P90, DOI 10.1016/S0749-3797(01)00254-9; BICKLEY LS, 1999, BATES GUIDE PHYSICAL; DANS PE, 1976, JOHNS HOPKINS MED J, V138, P13; DeGowin R. L., 1994, DEGOWIN DEGOWINS DIA; Eddy DM, 1992, METAANALYSIS CONFIDE; EDDY DM, 1992, FAST PRO V1 8 SOFTWA; Fihn SD, 1996, AM J EPIDEMIOL, V144, P512, DOI 10.1093/oxfordjournals.aje.a008958; FIHN SD, 1985, JAMA-J AM MED ASSOC, V254, P240, DOI 10.1001/jama.254.2.240; Foxman B, 1997, EPIDEMIOLOGY, V8, P637, DOI 10.1097/00001648-199710000-00004; Foxman B, 2000, AM J EPIDEMIOL, V151, P1194, DOI 10.1093/oxfordjournals.aje.a010170; FOXMAN B, 1995, EPIDEMIOLOGY, V6, P162, DOI 10.1097/00001648-199503000-00013; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; GALLAGHER DJ, 1965, BMJ-BRIT MED J, V1, P622, DOI 10.1136/bmj.1.5435.622; GREENFIE.S, 1974, ANN INTERN MED, V81, P452, DOI 10.7326/0003-4819-81-4-452; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Harmanli OH, 2000, OBSTET GYNECOL, V95, P710, DOI 10.1016/S0029-7844(99)00632-8; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Hooton TM, 1999, INT J ANTIMICROB AG, V11, P241, DOI 10.1016/S0924-8579(99)00023-0; HOOTON TM, 1991, MED CLIN N AM, V75, P339, DOI 10.1016/S0025-7125(16)30458-8; Hooton TM, 1996, NEW ENGL J MED, V335, P468, DOI 10.1056/NEJM199608153350703; HOOTON TM, 1995, HOSP PRACT, V30, P23, DOI 10.1080/21548331.1995.11443143; Hooton TM, 2000, NEW ENGL J MED, V343, P992, DOI 10.1056/NEJM200010053431402; HURLBUT TA, 1991, AM J CLIN PATHOL, V96, P582, DOI 10.1093/ajcp/96.5.582; Johnson J R, 1987, Infect Dis Clin North Am, V1, P773; JOHNSON JR, 1989, ANN INTERN MED, V111, P906, DOI 10.7326/0003-4819-111-11-906; KOMAROFF AL, 1984, NEW ENGL J MED, V310, P368, DOI 10.1056/NEJM198402093100607; KOMAROFF AL, 1978, ARCH INTERN MED, V138, P1069, DOI 10.1001/archinte.138.7.1069; Kunin CM, 1997, URINARY TRACT INFECT; Lawson D H, 1973, J R Coll Gen Pract, V23, P548; Mendelson T., 1998, EVIDENCE BASED MED F; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; MOND NC, 1965, LANCET, V1, P514; NAZARETH I, 1993, BRIT MED J, V306, P1103, DOI 10.1136/bmj.306.6885.1103; OConnor PJ, 1996, JOINT COMM J QUAL IM, V22, P673, DOI 10.1016/S1070-3241(16)30274-7; Orenstein R, 1999, AM FAM PHYSICIAN, V59, P1225; Orient JM., 2000, SAPIRAS ART SCI BEDS; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; REMIS RS, 1987, AM J EPIDEMIOL, V126, P685, DOI 10.1093/oxfordjournals.aje.a114708; Saint S, 1999, AM J MED, V106, P636, DOI 10.1016/S0002-9343(99)00122-9; SCHAPPERT SM, 1994, VITAL HLTH STAT, V253, P94; Scholes D, 2000, J INFECT DIS, V182, P1177, DOI 10.1086/315827; STAMM WE, 1982, NEW ENGL J MED, V307, P463, DOI 10.1056/NEJM198208193070802; STAMM WE, 1993, NEW ENGL J MED, V329, P1328, DOI 10.1056/NEJM199310283291808; STROM BL, 1987, ANN INTERN MED, V107, P816, DOI 10.7326/0003-4819-107-6-816; WIGTON RS, 1985, ARCH INTERN MED, V145, P2222, DOI 10.1001/archinte.145.12.2222; WONG ES, 1984, SEX TRANSM DIS, V11, P18, DOI 10.1097/00007435-198401000-00004	52	296	303	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2701	2710		10.1001/jama.287.20.2701	http://dx.doi.org/10.1001/jama.287.20.2701			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020306				2022-12-28	WOS:000175732400030
J	Nelson, DE; Bland, S; Powell-Griner, E; Klein, R; Wells, HE; Hogelin, G; Marks, JS				Nelson, DE; Bland, S; Powell-Griner, E; Klein, R; Wells, HE; Hogelin, G; Marks, JS			State trends in health risk factors and receipt of clinical preventive services among US adults during the 1990s	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; MAMMOGRAPHY; OBESITY; PREVALENCE; CANCER; POPULATION; OVERWEIGHT; MORTALITY; ATTITUDES; EPIDEMIC	Context Monitoring trends is essential for evaluating past activities and guiding current preventive health program and policy efforts. Although tracking progress toward national health goals is helpful, use of national estimates is limited because most preventive health care activities, policies, and other efforts occur at the state or community level. There may be important state trends that are obscured by national data. Objective To estimate state-specific trends for 5 health risk factors and 6 clinical preventive services. Design Telephone surveys were conducted from 1991 through 2000 as part of the Behavioral Risk Factor Surveillance System. Setting and Participants Randomly selected adults aged 18 years or older from 49 US states. Annual state sample sizes ranged from 1188 to 7543. Main Outcome Measures Statistically significant changes (P<.01) instate prevalences of cigarette smoking, binge alcohol use, physical inactivity, obesity, safety belt use, and mammography; screening for cervical cancer, colorectal cancer, and cholesterol levels; and receipt of influenza and pneumococcal disease vaccination. Results There were statistically significant increases in safety belt use for 39 of 47 states and receipt of mammography in the past 2 years for women aged 40 years or older for 43 of 47 states. For persons aged 65 years or older, there were increases in receipt of influenza vaccination for 44 of 49 states and ever receiving pneumococcal vaccination for 48 of 49 states. State trends were mixed for binge alcohol use (increasing in 19 of 47 states and declining in 3), physical inactivity (increasing in 3 of 48 states and declining in 11), and cholesterol screening (increasing in 13 of 47 states and decreasing in 5). Obesity increased in all states and smoking increased in 14 of 47 states (declining only in Minnesota). Cervical cancer screening increased in 8 of 48 states and colorectal cancer screening increased in 13 of 49 states. New York experienced improvements for 8 of 11 measures, while 7 of 11 measures improved in Delaware, Kentucky, and Maryland; in contrast, Alaska experienced improvements for no measures and at least 4 of 11 measures worsened in Iowa, North Dakota, and South Dakota. Conclusions Most states experienced increases in safety belt use, mammography, and adult vaccinations. Trends for smoking and binge alcohol use are disturbing, and obesity data support previous findings. Trend data are useful for targeting state preventive health efforts.	Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Res Triangle Inst, Res Triangle Pk, NC 27709 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Research Triangle Institute	Nelson, DE (corresponding author), NCI, Div Canc Control & Populat Sci, 6130 Execut Blvd,MSC 7365,EPN 4068, Bethesda, MD 20892 USA.	nelsond@mail.nih.gov						*AM CANC SOC, 1999, PUBL AM CANC SOC; American Cancer Society, 1993, GUID CANC REL CHECK; ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; [Anonymous], 1997, NIH Consens Statement, V15, P1; [Anonymous], 1985, ANN INTERN MED, V103, P1073, DOI 10.7326/0003-4819-103-6-1073; [Anonymous], 1988, FUT PUBL HLTH; ATKINSON W, 1997, EPIDEMIOLOGY PREVENT; Blackman D K, 1999, MMWR CDC Surveill Summ, V48, P1; Blaine TM, 1997, HEALTH EDUC BEHAV, V24, P640, DOI 10.1177/109019819702400510; Byers T, 1998, PREV MED, V27, P311, DOI 10.1006/pmed.1998.0303; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P162; CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P229, DOI 10.1016/0001-4575(86)90007-2; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Galuska DA, 1996, AM J PUBLIC HEALTH, V86, P1729, DOI 10.2105/AJPH.86.12.1729; Greenfield TK, 2000, AM J PUBLIC HEALTH, V90, P47, DOI 10.2105/AJPH.90.1.47; HAHN RA, 1990, JAMA-J AM MED ASSOC, V264, P2654, DOI 10.1001/jama.264.20.2654; HINGSON R, 1993, AM J PREV MED, V9, P62, DOI 10.1016/S0749-3797(18)30770-0; Holtzman D, 2000, MMWR CDC Surveill Summ, V49, P1; Horton JA, 1996, WOMEN HEALTH ISS, V6, P239, DOI 10.1016/1049-3867(96)00037-0; JACOBS DR, 1993, MED SCI SPORT EXER, V25, P81, DOI 10.1249/00005768-199301000-00012; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; KING ES, 1990, AM J PUBLIC HEALTH, V80, P1386, DOI 10.2105/AJPH.80.11.1386; KORN EL, 1999, WILEY S PRO STAT SUR, P1; Liu S, 1997, JAMA-J AM MED ASSOC, V277, P122, DOI 10.1001/jama.277.2.122; Lussky R, 1998, Minn Med, V81, P35; MARKS J, 1985, AM J PREV MED, V6, P1; MASSEY JT, 1997, P 1997 AM STAT ASS S; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; Mokdad AH, 2000, JAMA-J AM MED ASSOC, V284, P1650, DOI 10.1001/jama.284.13.1650; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; NAJAR MF, 1987, VITAL HLTH STAT, V11, P238; *NAT CTR HLTH STAT, 1994, HLTH PEOPL 200 REV 1; *NAT CTR HLTH STAT, 2000, HLTH US 2000 AD CHAR; *NAT I ALC AB ALC, 1997, NIH PUBL; National Cholesterol Education Program, 1993, NIH PUBL; *NCI, 2000, NIH PUBL; Nelson D E, 1996, Inj Prev, V2, P67, DOI 10.1136/ip.2.1.67; Nelson DE, 1998, AM J PUBLIC HEALTH, V88, P245, DOI 10.2105/AJPH.88.2.245; Nelson DE, 1996, AM J PUBLIC HEALTH, V86, P1300, DOI 10.2105/AJPH.86.9.1300; NELSON DE, 1998, P 1998 AM STAT ASS S; Nephew T. M., 2000, 55 NAT I ALC AB ALC; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; Newell SA, 1999, AM J PREV MED, V17, P211, DOI 10.1016/S0749-3797(99)00069-0; Perry CL, 2000, HEALTH EDUC BEHAV, V27, P29, DOI 10.1177/109019810002700105; Powell-Griner Eve, 1997, Morbidity and Mortality Weekly Report, V46, P1; *RES TRIANGL I, 2000, SUDAAN US MAN REL 8, V1, P233; Ross HL, 1996, ACCIDENT ANAL PREV, V28, P53, DOI 10.1016/0001-4575(95)00048-8; RYAN C, 2000, 17 NAT CTR HLTH STAT; RYAN C, 2000, 11 NAT CTR HLTH STAT; Siegel M, 2000, AM J PUBLIC HEALTH, V90, P372, DOI 10.2105/AJPH.90.3.372; Siegel PZ, 2001, AM J PUBLIC HEALTH, V91, P817, DOI 10.2105/AJPH.91.5.817; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; STREFF FM, 1989, ACCIDENT ANAL PREV, V21, P509, DOI 10.1016/0001-4575(89)90066-3; SUDMAN S, 1973, J AM STAT ASSOC, V68, P805, DOI 10.2307/2284504; THORNBERRY OT, 1988, WILEY S PRO, P25; *U MN ALC EP PROGR, 2000, ALC POL US HIGHL 50; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; *US DEP HHS, 1990, HLTH PEOPL 2000 NAT; *US DEP HHS, 1989, DHHS PUBL CDC; US Department of Health and Human Services, 2000, RED TOB US REP SURG; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; *US PHS, 1980, PROM HLTH PREV DIS O; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; World Health Organization Expert Committee on Physical Status, 1995, WHO TECHN REP SER, V854; 2001, STATE ESTIMATES METH; 1994, MMWR MORB MORTAL WKL, V43, P342; 1999, MMWR MORB MORTAL WKL, V48, P116; 2000, MMWR MORB MORTAL WKL, V49, P750	70	116	121	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2659	2667		10.1001/jama.287.20.2659	http://dx.doi.org/10.1001/jama.287.20.2659			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020301	Bronze			2022-12-28	WOS:000175732400025
J	Attrill, MJ; Power, M				Attrill, MJ; Power, M			Climatic influence on a marine fish assemblage	NATURE			English	Article							NORTH-ATLANTIC OSCILLATION; TEMPORAL ABUNDANCE; GROWTH; VARIABILITY; ESTUARINE; SEA	Understanding the fluctuations in marine fish stocks is important for the management of fisheries, and attempts have been made to demonstrate links with oceanographic and climatic variability(1-3), including the North Atlantic Oscillation (NAO)(4,5). The NAO has been correlated with a range of long-term ecological measures(6,7), including certain fish stocks(8,9). Such environmental influences are most likely to affect susceptible juveniles(10) during estuarine residency, as estuaries are critical juvenile nursery or over-wintering habitats(11). Here we show that, during a 16-year period, climatic forcing (by means of the NAO) is consistently the most important parameter explaining variation in assemblage composition, abundance and growth of juvenile marine fish during estuarine residency. A possible mechanism for the effect of the NAO is a temperature differential between estuarine and marine waters that allows fish to facultatively exploit optimal thermal habitats. The connection has potentially important implications for the size and numbers of individuals recruited to the fishery, for understanding and predicting the composition of juvenile fish stocks using estuaries, and for the appropriate conservation of estuarine systems in relation to fish stocks.	Univ Plymouth, Dept Biol Sci, Plymouth PL4 8AA, Devon, England; Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Plymouth; University of Waterloo	Attrill, MJ (corresponding author), Univ Plymouth, Dept Biol Sci, Drake Circus, Plymouth PL4 8AA, Devon, England.	mattrill@plymouth.ac.uk		Attrill, Martin/0000-0002-4039-031X				Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Attrill MJ, 2000, MAR ECOL PROG SER, V203, P133, DOI 10.3354/meps203133; Bettoso N, 1999, J MAR BIOL ASSOC UK, V79, P1145, DOI 10.1017/S0025315499001496; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BLAXTER JHS, 1982, ADV MAR BIOL, V20, P3; BRANDER KM, 1995, ICES J MAR SCI, V52, P1, DOI 10.1016/1054-3139(95)80010-7; Corten A, 1996, ICES J MAR SCI, V53, P1113, DOI 10.1006/jmsc.1996.0137; DIPPNER J. W., 1997, DTSCH HYDROGR Z, V49, P277; DRINKWATER KF, 1987, CAN J FISH AQUAT SCI, V44, P1568, DOI 10.1139/f87-189; ELLIOTT M, 1989, P 21 EUR MAR BIOL S; Haddon M., 2011, MODELLING QUANTITATI; HILBORN R, 1992; HOVGARD H, 1992, LARGE MARINE ECOSYST, P36; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Kroncke I, 1998, MAR ECOL PROG SER, V167, P25, DOI 10.3354/meps167025; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; POTTER IC, 1988, J MAR BIOL ASSOC UK, V68, P295, DOI 10.1017/S0025315400052206; Power M, 2000, J FISH BIOL, V56, P1408; Reid PC, 1998, FISH OCEANOGR, V7, P282, DOI 10.1046/j.1365-2419.1998.00073.x; Rodwell MJ, 1999, NATURE, V398, P320, DOI 10.1038/18648; ROGERS JC, 1984, MON WEATHER REV, V112, P1999, DOI 10.1175/1520-0493(1984)112<1999:TABTNA>2.0.CO;2; Thomas M, 1998, REHABILITATED ESTUARINE ECOSYSTEMS, P115; Wheeler A.C., 1969, FISHES BRIT ISLES N; Wootton R.J., 1990, ECOLOGY TELEOST FISH	27	236	242	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					275	278		10.1038/417275a	http://dx.doi.org/10.1038/417275a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015600				2022-12-28	WOS:000175592100044
J	Knudsen, EI				Knudsen, EI			Instructed learning in the auditory localization pathway of the barn owl	NATURE			English	Review							EXPERIENCE-DEPENDENT PLASTICITY; INTERAURAL TIME DIFFERENCE; MONAURAL OCCLUSION ALTERS; FOREBRAIN GAZE FIELDS; SOUND-LOCALIZATION; SPACE MAP; INFERIOR COLLICULUS; OPTIC TECTUM; VISUAL CALIBRATION; NEURAL REPRESENTATION		Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Knudsen, EI (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	eknudsen@stanford.edu						[Anonymous], [No title captured]; ASHMEAD DH, 1986, DEV PSYCHOBIOL, V19, P91, DOI 10.1002/dev.420190202; Baizer JS, 1999, J NEUROPHYSIOL, V81, P1960, DOI 10.1152/jn.1999.81.4.1960; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Blauert J., 1997, SPATIAL HEARING PSYC; Brainard MS, 1998, J NEUROSCI, V18, P3929; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; Carr CE, 1996, J COMP NEUROL, V373, P467, DOI 10.1002/(SICI)1096-9861(19960930)373:4<467::AID-CNE1>3.0.CO;2-#; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; Cohen YE, 1999, TRENDS NEUROSCI, V22, P128, DOI 10.1016/S0166-2236(98)01295-8; Cohen YE, 1998, J NEUROPHYSIOL, V79, P879, DOI 10.1152/jn.1998.79.2.879; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.neuro.11.1.61; DeBello WM, 2001, J NEUROSCI, V21, P3161, DOI 10.1523/JNEUROSCI.21-09-03161.2001; DULAC S, 1990, J NEUROPHYSIOL, V63, P131, DOI 10.1152/jn.1990.63.1.131; FELDMAN DE, 1994, J NEUROSCI, V14, P5939; Feldman DE, 1998, J NEUROSCI, V18, P3073; Feldman DE, 1997, J NEUROSCI, V17, P6820; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; FIELD J, 1980, CHILD DEV, V51, P295, DOI 10.2307/1129628; FUJITA I, 1991, J NEUROSCI, V11, P722; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Gold JI, 2000, J NEUROSCI, V20, P3469, DOI 10.1523/JNEUROSCI.20-09-03469.2000; HEFFNER HE, 1990, J NEUROPHYSIOL, V64, P915, DOI 10.1152/jn.1990.64.3.915; Hess E. H., 1973, IMPRINTING EARLY EXP; Hofman PM, 1998, NAT NEUROSCI, V1, P417, DOI 10.1038/1633; Hyde PS, 2000, J COMP NEUROL, V421, P146, DOI 10.1002/(SICI)1096-9861(20000529)421:2<146::AID-CNE2>3.0.CO;2-5; Hyde PS, 2002, NATURE, V415, P73, DOI 10.1038/415073a; Hyde PS, 2001, J NEUROSCI, V21, P8586, DOI 10.1523/JNEUROSCI.21-21-08586.2001; IRVINE DRF, 1992, MAMMALIAN AUDITORY P, P153; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; King AJ, 2001, TRENDS COGN SCI, V5, P261, DOI 10.1016/S1364-6613(00)01660-0; KING AJ, 1993, EXP PHYSIOL, V78, P559, DOI 10.1113/expphysiol.1993.sp003708; King AJ, 1998, J NEUROSCI, V18, P9394; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; KNUDSEN EI, 1984, J NEUROSCI, V4, P1001; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KNUDSEN EI, 1985, J NEUROSCI, V5, P3094; KNUDSEN EI, 1994, J NEUROSCI, V14, P3985; Knudsen EI, 1999, J COMP PHYSIOL A, V185, P305, DOI 10.1007/s003590050391; Knudsen EI, 1996, NATURE, V383, P428, DOI 10.1038/383428a0; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; KNUDSEN EI, 1991, J NEUROSCI, V11, P1727; KNUDSEN EI, 1989, J NEUROSCI, V9, P3297; KNUDSEN EI, 1992, J NEUROSCI, V12, P3485; KNUDSEN EI, 1993, J NEUROSCI, V13, P2837; KNUDSEN EI, 1984, J NEUROSCI, V4, P1012; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P1, DOI 10.1007/BF00663105; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Konishi M., 1988, AUDITORY FUNCTION NE, P721; Lackner J. R., 1981, INTERSENSORY PERCEPT, P143; Luksch H, 2000, J NEUROSCI, V20; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Miller GL, 1999, J NEUROSCI, V19, P2326; Miller GL, 2001, J NEUROPHYSIOL, V85, P2184, DOI 10.1152/jn.2001.85.5.2184; MOGDANS J, 1993, BRAIN RES, V619, P29, DOI 10.1016/0006-8993(93)91593-H; Newport E. L., 2001, LANGUAGE BRAIN COGNI, P481, DOI DOI 10.1067/MHN.2001.115372; Rauschecker JP, 2000, P NATL ACAD SCI USA, V97, P11800, DOI 10.1073/pnas.97.22.11800; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; Rucci M, 1997, J NEUROSCI, V17, P334, DOI 10.1523/JNEUROSCI.17-01-00334.1997; SCHREINER CE, 1995, CURR OPIN NEUROBIOL, V5, P489, DOI 10.1016/0959-4388(95)80010-7; SCOTT JP, 1962, SCIENCE, V138, P949, DOI 10.1126/science.138.3544.949; Shinn-Cunningham B, 2000, PERCEPT PSYCHOPHYS, V62, P33, DOI 10.3758/BF03212059; Stein BE., 1993, MERGING SENSES; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; WAGNER H, 1987, J NEUROSCI, V7, P3105; WAGNER H, 1993, J NEUROSCI, V13, P371; WITHINGTONWRAY DJ, 1990, NEUROSCI LETT, V116, P280, DOI 10.1016/0304-3940(90)90087-P; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962; Zheng WM, 2001, J NEUROSCI, V21, P4356, DOI 10.1523/JNEUROSCI.21-12-04356.2001	72	198	199	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					322	328		10.1038/417322a	http://dx.doi.org/10.1038/417322a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015612				2022-12-28	WOS:000175592100056
J	Melosh, HJ				Melosh, HJ			Asteroids - Traces of an unusual impact	SCIENCE			English	Editorial Material									Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	University of Arizona	Melosh, HJ (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.							Bland PA, 2002, SCIENCE, V296, P1109, DOI 10.1126/science.1068345; O'Keefe J. A., 1976, TEKTITES THEIR ORIGI; Poag CW, 1997, SEDIMENT GEOL, V108, P45, DOI 10.1016/S0037-0738(96)00048-6; SCHULTZ PH, 1992, NATURE, V355, P234, DOI 10.1038/355234a0; TAYLOR SR, 1973, EARTH-SCI REV, V9, P101, DOI 10.1016/0012-8252(73)90074-3	5	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1037	1038		10.1126/science.1071199	http://dx.doi.org/10.1126/science.1071199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004107				2022-12-28	WOS:000175565000029
J	Geng, E; Kreiswirth, B; Driver, C; Li, JH; Burzynski, J; DellaLatta, P; LaPaz, A; Schluger, NW				Geng, E; Kreiswirth, B; Driver, C; Li, JH; Burzynski, J; DellaLatta, P; LaPaz, A; Schluger, NW			Changes in the transmission of tuberculosis in New York City from 1990 to 1999.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOREIGN-BORN PERSONS; SAN-FRANCISCO; COMPLEX STRAINS; EPIDEMIOLOGY; IS6110; STATES	Background: Over the past decade, there has been a reduction in the incidence of tuberculosis in New York City and in the United States. However, the reduction has been confined mainly to U.S.-born persons. Understanding the reasons for the lack of reduction among non-U.S>born persons may lead to new strategies for tuberculosis control. Methods: We performed DNA fingerprinting with the IS6110 insertion sequence of the organisms isolated from patients with culture-positive tuberculosis in northern Manhattan from 1990 to 1999. The goal was to identify the strains responsible for multiple infections, presumably through recent transmission (clusters of cases), as well as the strains found in only one patient, presumably representing reactivation of latent infection. Results: Of 546 available isolates of Mycobacterium tuberculosis, 261 (48 percent) belonged to a cluster and 285 (52 percent) did not. In multivariate analysis, significant predictors of noncluster status included birth outside the United States (odds ratio for a strain causing a cluster among non-Hispanic foreign-born patients, 0.31; 95 percent confidence interval, 0.14 to 0.66; odds ratio among Hispanic foreign-born patients, 0.51; 95 percent confidence interval, 0.30 to 0.88), age greater than 60 years (odds ratio, 0.37), and diagnosis after 1993 (odds ratio, 0.50). All these characteristics appeared to be associated with reactivation disease rather than with tuberculosis due to recent transmission. Homelessness was associated with clustering (odds ratio, 1.78; 95 percent confidence interval, 0.99 to 3.20) and therefore with recent transmission. Conclusions: These findings from northern Manhattan suggest that among foreign-born persons, tuberculosis is largely caused by reactivation of latent infection, whereas among U.S.-born persons, many cases result from recent transmission. Strategies for the control and elimination of tuberculosis among foreign-born persons at high risk should be directed toward the treatment of latent tuberculosis infection.	Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; Publ Hlth Res Inst, New York, NY USA; New York City Dept Hlth, TB Control Program, New York, NY 10013 USA	Columbia University; Columbia University; New York City Department of Health & Mental Hygiene	Schluger, NW (corresponding author), Columbia Univ Coll Phys & Surg, Div Pulm Allergy & Crit Care Med, PH-8 Ctr,622 W 168th St, New York, NY 10032 USA.		Schluger, Neil/ABA-1793-2021	Li, Jiehui/0000-0002-7812-8878	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004074] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL04074] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; *AM THOR SOC, 2001, AM J RESP CRIT CARE, V164, P1319; Bauer J, 1999, J CLIN MICROBIOL, V37, P2602, DOI 10.1128/JCM.37.8.2602-2606.1999; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P287; *CDCP, 2001, REP TUB US 2000; *CDCP, 2000, REP TUB US 1999; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Geiter L, 2000, ENDING NEGLECT ELIMI, P292; Jasmer RM, 1999, ANN INTERN MED, V130, P971, DOI 10.7326/0003-4819-130-12-199906150-00004; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; LOBO PA, 1996, NEWEST NEW YORKERS 1, P298; SAHLY HM, 2001, J INFECT DIS, V183, P461; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SNIDER DE, 1984, AM REV RESPIR DIS, V130, P355; Soini H, 2001, J CLIN MICROBIOL, V39, P217, DOI 10.1128/JCM.39.1.217-221.2001; SUMARTOJO E, 1993, AM REV RESPIR DIS, V147, P1311, DOI 10.1164/ajrccm/147.5.1311; Talbot EA, 2000, JAMA-J AM MED ASSOC, V284, P2894, DOI 10.1001/jama.284.22.2894; Tornieporth NG, 1997, INT J TUBERC LUNG D, V1, P528; van Soolingen D, 2001, J INTERN MED, V249, P1, DOI 10.1046/j.1365-2796.2001.00772.x; Wells CD, 1999, AM J RESP CRIT CARE, V159, P834, DOI 10.1164/ajrccm.159.3.9712122; Yamada S, 1999, Fam Med, V31, P477; 2000, AM J RESP CRIT CAR S, V161, pS221	23	186	189	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1453	1458		10.1056/NEJMoa012972	http://dx.doi.org/10.1056/NEJMoa012972			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000815				2022-12-28	WOS:000175433200004
J	Vaudry, D; Stork, PJS; Lazarovici, P; Eiden, LE				Vaudry, D; Stork, PJS; Lazarovici, P; Eiden, LE			Signaling pathways for PC12 cell differentiation: Making the right connections	SCIENCE			English	Editorial Material							NERVE GROWTH-FACTOR; NEURITE OUTGROWTH; REGULATED KINASE; RAS; TRANSCRIPTION; ACTIVATION; PROTEIN; FORM; CBP	A key issue in signal transduction is how signaling pathways common to many systems-so-called canonical signaling cassettes-integrate signals from molecules having a wide spectrum of activities, such as hormones and neurotrophins, to deliver distinct biological outcomes. The neuroendocrine cell line PC12, derived from rat pheochromocytoma, provides an example of how one canonical signaling cassette-the Raf --> mitogen-activated protein kinase kinase (MEK) --> extracellular signal-regulated kinase (ERK) pathway-can promote distinct outcomes, which in this case include neuritogenesis, gene induction, and proliferation. Two growth hormones, epidermal growth factor (EGF) and nerve growth factor (NGF), use the same pathway to cause PC12 proliferation and differentiation, respectively. In addition, pituitary adenylate cyclase-activating polypeptide (PACAP), a neurotransmitter that, also causes differentiation, uses the same canonical cassette as NGF but in a different way. The Connections Map for PC12 Cell Differentiation brings into focus the complex array of specific cellular responses that rely on canonical signal transduction systems.	NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Oregon Health & Science University; Hebrew University of Jerusalem	Eiden, LE (corresponding author), NIMH, Mol Neurosci Sect, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA.	eiden@codon.nih.gov	VAUDRY, David/M-1454-2018	VAUDRY, David/0000-0003-3567-7452; Eiden, Lee/0000-0001-7524-944X	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002386, ZIAMH002386] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; DARCANGELO G, 1993, MOL CELL BIOL, V13, P3146, DOI 10.1128/MCB.13.6.3146; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HAMELINK C, IN PRESS J NEUROSCI; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; LAZAROVICI P, 1997, TOXINS SIGNAL TRANSD, P69; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; Liu YZ, 1999, NEUROREPORT, V10, P1239, DOI 10.1097/00001756-199904260-00016; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Tanaka K, 1996, ENDOCRINOLOGY, V137, P956, DOI 10.1210/en.137.3.956; VAUDRY D, IN PRESS ANN NY ACAD; VAUDRY D, 2002, SCI STKE; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000	21	677	694	4	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1648	1649		10.1126/science.1071552	http://dx.doi.org/10.1126/science.1071552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040181				2022-12-28	WOS:000175976200044
J	Wynia, MK; Gostin, L				Wynia, MK; Gostin, L			Medicine - The bioterrorist threat and access to health care	SCIENCE			English	Editorial Material									Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA; Univ Chicago, Div Infect Dis, Chicago, IL 60637 USA; Georgetown Univ, Ctr Law & Publ Hlth, Washington, DC 20001 USA; Johns Hopkins Univ, Baltimore, MD USA	American Medical Association; University of Chicago; Georgetown University; Johns Hopkins University	Wynia, MK (corresponding author), Amer Med Assoc, Inst Eth, 515 N State St, Chicago, IL 60610 USA.		Wynia, Matthew/T-2210-2019					BREWER S, 2001, HOUSTON CHRONIC 1211, pA1; *COMM CONS UN BOAR, IN PRESS CARE COVERA; HALSTEAD T, 2001, US TODAY        1112, pA17; JANISON D, 2002, NEWSDAY         0307, pA5; NOVELLO A, 2001, AM PUBL HLTH ASS 129; YARDLEY J, 2001, NY TIMES        0812, pA18; ZIV TA, 1995, NEW ENGL J MED, V332, P1095, DOI 10.1056/NEJM199504203321612	7	8	8	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1613	1613		10.1126/science.1072921	http://dx.doi.org/10.1126/science.1072921			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040164				2022-12-28	WOS:000175976200025
J	Singh, PK; Parsek, MR; Greenberg, EP; Welsh, MJ				Singh, PK; Parsek, MR; Greenberg, EP; Welsh, MJ			A component of innate immunity prevents bacterial biofilm development	NATURE			English	Article							LOWER RESPIRATORY-TRACT; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; ANTIMICROBIAL ACTIVITY; CHRONIC-BRONCHITIS; LACTOFERRIN; IRON; LYSOZYME; TRANSFERRIN; INFECTION	Antimicrobial factors form one arm of the innate immune system, which protects mucosal surfaces from bacterial infection(1-3). These factors can rapidly kill bacteria deposited on mucosal surfaces and prevent acute invasive infections(1-4). In many chronic infections, however, bacteria live in biofilms, which are distinct, matrix-encased communities specialized for surface persistence(5-7). The transition from a free-living, independent existence to a biofilm lifestyle can be devastating, because biofilms notoriously resist killing by host defence mechanisms and antibiotics(5,8). We hypothesized that the innate immune system possesses specific activity to protect against biofilm infections. Here we show that lactoferrin, a ubiquitous and abundant constituent of human external secretions, blocks biofilm development by the opportunistic pathogen Pseudomonas aeruginosa. This occurs at lactoferrin concentrations below those that kill or prevent growth. By chelating iron, lactoferrin stimulates twitching, a specialized form of surface motility, causing the bacteria to wander across the surface instead of forming cell clusters and biofilms. These findings reveal a specific anti-biofilm defence mechanism acting at a critical juncture in biofilm development, the time bacteria stop roaming as individuals and aggregate into durable communities.	Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Microbiol, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Northwestern Univ, Dept Civil Engn, Evanston, IL 60208 USA; WM Keck Fdn Microbial Communities & Cell Signalin, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Northwestern University	Singh, PK (corresponding author), Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.			Welsh, Michael/0000-0002-1646-6206; Greenberg, Everett/0000-0001-9474-8041	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL102246] Funding Source: NIH RePORTER; NHLBI NIH HHS [K24 HL102246] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe T, 1999, BRIT J OPHTHALMOL, V83, P684, DOI 10.1136/bjo.83.6.684; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Burns J L, 1993, Adv Pediatr Infect Dis, V8, P53; Cole AM, 1999, INFECT IMMUN, V67, P3267, DOI 10.1128/IAI.67.7.3267-3275.1999; Coonrod J D, 1986, Semin Respir Infect, V1, P118; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; ELLISON RT, 1994, ADV EXP MED BIOL, V357, P71; Ganz T, 2001, Semin Respir Infect, V16, P4; HARBITZ O, 1984, EUR J RESPIR DIS, V65, P512; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HIRAI Y, 1990, J NUTR SCI VITAMINOL, V36, P531, DOI 10.3177/jnsv.36.531; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoiby N, 2001, MICROBES INFECT, V3, P23, DOI 10.1016/S1286-4579(00)01349-6; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Leitch EC, 1999, CURR EYE RES, V19, P12, DOI 10.1076/ceyr.19.1.12.5342; MARTIN PR, 1995, MOL MICROBIOL, V16, P497, DOI 10.1111/j.1365-2958.1995.tb02414.x; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; SAMSON RR, 1979, IMMUNOLOGY, V38, P367; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; SOHNLE PG, 1991, J INFECT DIS, V164, P137, DOI 10.1093/infdis/164.1.137; Stites SW, 1999, AM J RESP CRIT CARE, V160, P796, DOI 10.1164/ajrccm.160.3.9811018; Stites SW, 1998, CHEST, V114, P814, DOI 10.1378/chest.114.3.814; THOMPSON AB, 1990, J LAB CLIN MED, V115, P148; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Ward CG, 1996, J TRAUMA, V41, P356, DOI 10.1097/00005373-199608000-00030; Xiao R, 1997, MICROBIOL-UK, V143, P2509, DOI 10.1099/00221287-143-7-2509; Xu KD, 2000, MICROBIOL-UK, V146, P547, DOI 10.1099/00221287-146-3-547	30	751	810	4	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					552	555		10.1038/417552a	http://dx.doi.org/10.1038/417552a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037568				2022-12-28	WOS:000175860300043
J	Jewkes, R; Brown, H; Dickson-Tetteh, K; Levin, J; Rees, H				Jewkes, R; Brown, H; Dickson-Tetteh, K; Levin, J; Rees, H			Prevalence of morbidity associated with abortion before and after legalisation in South Africa	BRITISH MEDICAL JOURNAL			English	Article							INCOMPLETE ABORTION		MRC, Gender & Hlth Grp, ZA-0001 Pretoria, South Africa; MRC, Biostat Unit, ZA-0001 Pretoria, South Africa; Baragwanath Hosp, Reprod Hlth Res Unit, ZA-2013 Johannesburg, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Grp, Private Bag X385, ZA-0001 Pretoria, South Africa.			Jewkes, Rachel/0000-0002-4330-6267; Rees, Helen/0000-0003-1442-6734				Brown H, 2002, EPIDEMIOLOGY INCOMPL; Jewkes RK, 1997, STUD FAMILY PLANN, V28, P228, DOI 10.2307/2137890; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Rees H, 1997, S AFR MED J, V87, P432; *REPR RIGHTS ALL, 1999, BAROMETER, V3, P4	5	47	47	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1252	1253		10.1136/bmj.324.7348.1252	http://dx.doi.org/10.1136/bmj.324.7348.1252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028979	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000175894900020
J	Burnham, D; Kitamura, C; Vollmer-Conna, U				Burnham, D; Kitamura, C; Vollmer-Conna, U			What's new, pussycat? On talking to babies and animals	SCIENCE			English	Article							MOTHERESE		Univ Western Sydney, MARCS Auditory Labs, Sydney, NSW 1797, Australia; Univ New S Wales, Sch Psychiat, Dept Human Behav, Sydney, NSW 2052, Australia	Western Sydney University; University of New South Wales Sydney	Burnham, D (corresponding author), Univ Western Sydney, MARCS Auditory Labs, POB 1797, Sydney, NSW 1797, Australia.			Burnham, Denis/0000-0002-1980-3458				Andruski J.E., 1999, J ACOUST SOC AM, V105, P1095, DOI [10.1121/1.425135, DOI 10.1121/1.425135]; FERNALD A, 1987, INFANT BEHAV DEV, V10, P279, DOI 10.1016/0163-6383(87)90017-8; HIRSHPASEK K, 1982, J CHILD LANG, V9, P229, DOI 10.1017/S0305000900003731; Kitamura C., 1998, ADV INFANCY RES, V12, P221; Kuhl PK, 1997, SCIENCE, V277, P684, DOI 10.1126/science.277.5326.684	5	251	255	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1435	1435		10.1126/science.1069587	http://dx.doi.org/10.1126/science.1069587			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	557LP	12029126				2022-12-28	WOS:000175910300038
J	von Mering, C; Krause, R; Snel, B; Cornell, M; Oliver, SG; Fields, S; Bork, P				von Mering, C; Krause, R; Snel, B; Cornell, M; Oliver, SG; Fields, S; Bork, P			Comparative assessment of large-scale data sets of protein-protein interactions	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME; YEAST; COMPLEX; INFORMATION; PHOSPHATASE; PROFILES; GLYCINE; SYSTEM; ARRAYS	Comprehensive protein-protein interaction maps promise to reveal many aspects of the complex regulatory network underlying cellular function. Recently, large-scale approaches have predicted many new protein interactions in yeast. To measure their accuracy and potential as well as to identify biases, strengths and weaknesses, we compare the methods with each other and with a reference set of previously reported protein interactions.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Cellzome AG, D-69117 Heidelberg, Germany; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Univ Washington, Howard Hughes Med Inst, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Dept Med, Seattle, WA 98195 USA	European Molecular Biology Laboratory (EMBL); GlaxoSmithKline; Cellzome GmbH; University of Manchester; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bork, P (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.		Snel, Berend/B-8886-2011; von Mering, Christian/B-3300-2008; Bork, Peer/F-1813-2013	Snel, Berend/0000-0002-5804-8547; von Mering, Christian/0000-0001-7734-9102; Bork, Peer/0000-0002-2627-833X; Krause, Roland/0000-0001-9938-7126				Bader GD, 2001, NUCLEIC ACIDS RES, V29, P242, DOI 10.1093/nar/29.1.242; Benson DA, 2002, NUCLEIC ACIDS RES, V30, P17, DOI 10.1093/nar/30.1.17; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Gerstein M, 2002, SCIENCE, V295, P284, DOI 10.1126/science.1068664; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; HOFFMANN R, 1994, YEAST, V10, P567, DOI 10.1002/yea.320100502; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204; Huynen MA, 1998, P NATL ACAD SCI USA, V95, P5849, DOI 10.1073/pnas.95.11.5849; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; KAHN P, 1995, SCIENCE, V270, P369, DOI 10.1126/science.270.5235.369; Kalhor HR, 2001, ARCH BIOCHEM BIOPHYS, V395, P239, DOI 10.1006/abbi.2001.2558; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Mann M, 2001, ANNU REV BIOCHEM, V70, P437, DOI 10.1146/annurev.biochem.70.1.437; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mellor JC, 2002, NUCLEIC ACIDS RES, V30, P306, DOI 10.1093/nar/30.1.306; Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Paton NW, 2000, BIOINFORMATICS, V16, P548, DOI 10.1093/bioinformatics/16.6.548; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Piper MD, 2000, J BIOL CHEM, V275, P30987, DOI 10.1074/jbc.M004248200; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; SINCLAIR DA, 1995, GENETICS, V140, P1213; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tucker CL, 2001, TRENDS CELL BIOL, V11, P102, DOI 10.1016/S0962-8924(00)01902-4; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Zamir E, 2001, J CELL SCI, V114, P3583; Zhou HH, 2001, TRENDS BIOTECHNOL, V19, pS34, DOI 10.1016/S0167-7799(01)01798-X; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	44	1700	1754	0	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					399	403		10.1038/nature750	http://dx.doi.org/10.1038/nature750			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12000970				2022-12-28	WOS:000175730900029
J	Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH				Berg, AO; Allan, JD; Frame, PS; Homer, CJ; Johnson, MS; Klein, JD; Lieu, TA; Mulrow, CD; Orleans, CT; Peipert, JF; Pender, NJ; Siu, AL; Teutsch, SM; Westhoff, C; Woolf, SH		US Preventive Services Task Force	Screening for depression: Recommendations and rationale	ANNALS OF INTERNAL MEDICINE			English	Article								This statement summarizes the current U.S. Preventive Services Task Force (USPSTF) recommendations for screening for depression and the supporting scientific evidence and updates the 1996 USPSTF recommendations on this topic. At that time, the USPSTF concluded that there was insufficient evidence to recommend for or against routine use of standardized questionnaires to screen for depression in primary care patients. The complete information on which the current statement is based, including evidence tables and references, is available in the accompanying article in this issue and in the systematic evidence review on this topic, which can be obtained through the USPSTF Web site (www.ahrq.gov/clinic/uspstfix.htm) and in print through the Agency for Healthcare Research and Quality Publications Cleaninghouse (800-358-9295).	USPSTF, Agcy Healthcare Res & Qual, Rockville, MD USA	Agency for Healthcare Research & Quality	Berg, AO (corresponding author), USPSTF, Agcy Healthcare Res & Qual, Rockville, MD USA.							American College of Obstetricians and Gynecologists, 2002, GUID WOM HLTH CAR, p[126, 235]; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; *GAPS, 1997, GAPS REC MON; *HLTH CAN CAN TASK, 1994, CAN GUID CLIN PREV H, P450; Kaplan DW, 2000, PEDIATRICS, V105, P871; Mulrow CD, 2000, AM J MED, V108, P54, DOI 10.1016/S0002-9343(99)00316-2; Murray C. J. L., 1996, GLOBAL BURDEN DIS; Pignone MP, 2002, ANN INTERN MED, V136, P765, DOI 10.7326/0003-4819-136-10-200205210-00013; Pignone MP, 2001, AHRQ PUBLICATION, VAHRQ 01-S004; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; *US DEP HHS, 1993, AHCPR PUBL; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160	13	349	351	3	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					760	764		10.7326/0003-4819-136-10-200205210-00012	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00012			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020145				2022-12-28	WOS:000175664600007
J	Edwards, P; Roberts, I; Clarke, M; DiGuiseppi, C; Pratap, S; Wentz, R; Kwan, I				Edwards, P; Roberts, I; Clarke, M; DiGuiseppi, C; Pratap, S; Wentz, R; Kwan, I			Increasing response rates to postal questionnaires: systematic review	BRITISH MEDICAL JOURNAL			English	Article							CONTROLLED TRIALS; METAANALYSIS; BIAS	Objective To identify methods to increase response to postal questionnaires. Design Systematic review of randomised controlled trials of any method to influence response to postal questionnaires. Studies reviewed 292 randomised controlled trials including 258 315 participants Intervention reviewed 75 strategies for influencing response to postal questionnaires. Main outcome measure The proportion of completed or partially completed questionnaires returned. Results The odds of response were more than doubled when a monetary incentive was used (odds ratio 2.02; 95% confidence interval 1.79 to 2.27) and almost doubled when incentives were not conditional on response (1.71; 1.29 to 2.26). Response was more likely when short questionnaires were used (1.86; 1.55 to 2.24). Personalised questionnaires and letters increased response (1.16; 1.06 to 1.28), as did the use of coloured ink (1.39; 1.16 to 1.67). The odds of response were more than doubled when the questionnaires were sent by recorded delivery (2.21; 1.51 to 3.25) and increased when stamped return envelopes were used (1.26; 1.13 to 1.41) and questionnaires were sent by first class post (1.12; 1.02 to 1.23). Contacting participants before sending questionnaires increased response (1.54; 1.24 to 1.92), as did follow up contact (1.44; 1.22 to 1.70) and providing non-respondents with a second copy of the questionnaire (1.41; 1.02 to 1.94). Questionnaires designed to be of more interest to participants were more likely to be returned (2.44; 1.99 to 3.01), but questionnaires containing questions of a sensitive nature were less likely to be returned (0.92; 0.87 to 0.98). Questionnaires originating from universities were more likely to be returned than were questionnaires from other sources, such as commercial organisations (1.31; 1.11 to 1.54). Conclusions Health researchers using postal questionnaires can improve the quality of their research by using the strategies shown to be effective in this systematic review.	London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, CRASH Trial Coordinating Ctr, London WC1B 1DP, England; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA; UK Cochrane Ctr, Dept Epidemiol & Populat Hlth, Cochrane Injuries Grp, Oxford OX2 7LG, England	University of London; London School of Hygiene & Tropical Medicine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Cochrane Centre	Edwards, P (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, CRASH Trial Coordinating Ctr, London WC1B 1DP, England.		Greiver, Michelle/N-8764-2015; DiGuiseppi, Carolyn/AAU-1341-2020	Greiver, Michelle/0000-0001-8957-0285; DiGuiseppi, Carolyn/0000-0002-6440-7817; Edwards, Phil/0000-0003-4431-8822				Armstrong B, 1995, MONOGRAPHS EPIDEMIOL, P294; CLARKE MJ, 1994, BRIT MED J, V309, P1007, DOI 10.1136/bmj.309.6960.1007; EDWARDS P, 2002, COCHRANE LIB, V2; EDWARDS P, IN PRESS STAT MED; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engels EA, 2000, STAT MED, V19, P1707, DOI 10.1002/1097-0258(20000715)19:13<1707::AID-SIM491>3.0.CO;2-P; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; YAMMARINO FJ, 1991, PUBLIC OPIN QUART, V55, P613, DOI 10.1086/269284	8	1218	1227	0	88	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1183	1185		10.1136/bmj.324.7347.1183	http://dx.doi.org/10.1136/bmj.324.7347.1183			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016181	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000175763200015
J	Wylie, G; Hungin, APS; Neely, J				Wylie, G; Hungin, APS; Neely, J			Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE; HEALTH; CARE; PREVENTION; GUIDELINES; PEOPLE; TRIAL; DIET	Objective To investigate general practitioners' knowledge of and attitudes to impaired glucose tolerance. Design Mixed methodology qualitative and quantitative study with semistructured interviews, focus groups, and questionnaires. Setting 34 general practitioners in live primary care groups in the north east of England. Results All the general practitioners had knowledge of impaired glucose tolerance as a clinical entity, but they had little awareness of the clinical Significance of impaired glucose tolerance and were uncertain about managing and following up these patients. Attitudes to screening were mixed and were associated with reservations about increased workload, concern about lack of resources, and pessimism about the effectiveness of lifestyle interventions. Some general practitioners felt strongly that screening patients for impaired glucose tolerance and subsequent lifestyle intervention medicalised an essentially social problem and that a health educational approach, involving schools and the media, should be adopted instead. A minority expressed a positive attitude towards a pharmacological approach. Conclusion Awareness of impaired glocose tolerance needs to be raised, and guidelines for management are needed. General practitioners remain to be convinced that they have a role in attempting to reduce the incidence of type 2 diabetes by targeting interventions at patients with impaired glucose tolerance.	Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England	Durham University	Wylie, G (corresponding author), Univ Durham, Wolfson Res Inst, Ctr Integrated Hlth Care Res, Stockton On Tees TS17 6BH, England.	graeme.wylie@dur.ac.uk		hungin, amritpal Pali/0000-0001-7275-8927				Alberti KGMM, 1998, DIABETES RES CLIN PR, V40, pS3; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; BOULTON M, 1994, SOCIOLOGY HLTH ILLNE, V16, P372; Bourn DM, 1996, DIABETIC MED, V13, P938, DOI 10.1002/(SICI)1096-9136(199611)13:11<938::AID-DIA274>3.0.CO;2-P; COULTER A, 1991, BRIT J GEN PRACT, V41, P140; Davies MJ, 1996, BRIT MED J, V312, P264; *DEP HLTH, 2000, COMP CLIN HLTH IND 2; Dixon S, 2000, DIABETIC MED, V17, P820, DOI 10.1046/j.1464-5491.2000.00391.x; Eriksson KF, 1998, DIABETOLOGIA, V41, P1010, DOI 10.1007/s001250051024; Glaser B.G., 1965, AWARENESS DYING; Goyder E, 1998, BMJ-BRIT MED J, V317, P1644, DOI 10.1136/bmj.317.7173.1644; Khunti K, 2000, J ROY SOC MED, V93, P183, DOI 10.1177/014107680009300407; Lawlor DA, 2000, BRIT J GEN PRACT, V50, P455; Li CL, 1999, DIABETIC MED, V16, P477, DOI 10.1046/j.1464-5491.1999.00090.x; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; McAvoy BR, 1999, BRIT J GEN PRACT, V49, P187; Melia K.M, 1997, CONTEXT METHOD QUALI, P26; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patton M., 2015, QUALITATIVE RES EVAL, V4th; Pierce M, 2000, BRIT J GEN PRACT, V50, P542; Pill R, 1998, FAM PRACT, V15, P229, DOI 10.1093/fampra/15.3.229; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Watkins C, 1999, BRIT J GEN PRACT, V49, P11; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	25	44	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2002	324	7347					1190	1192		10.1136/bmj.324.7347.1190	http://dx.doi.org/10.1136/bmj.324.7347.1190			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016185	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000175763200020
J	Ballentine, CJ				Ballentine, CJ			Geochemistry - Tiny tracers tell tall tales	SCIENCE			English	Editorial Material							NOBLE-GASES; MANTLE		Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England	University of Manchester	Ballentine, CJ (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.			Ballentine, Chris/0000-0001-9382-070X				Ballentine C J, 2001, Science, V291, P2269; Ballentine CJ, 2001, NATURE, V409, P327, DOI 10.1038/35053046; Caffee MW, 1999, SCIENCE, V285, P2115, DOI 10.1126/science.285.5436.2115; Hofmann AW, 1997, NATURE, V385, P219, DOI 10.1038/385219a0; PEPIN RO, 1991, ICARUS, V92, P1; PEPIN RO, 1976, LUNAR SCI, V7, P682; Porcelli D, 2001, EARTH PLANET SC LETT, V193, P237, DOI 10.1016/S0012-821X(01)00493-9; Porcelli D, 2001, EARTH PLANET SC LETT, V192, P45, DOI 10.1016/S0012-821X(01)00418-6; Trieloff M, 2000, SCIENCE, V288, P1036, DOI 10.1126/science.288.5468.1036; van Keken PE, 1999, J GEOPHYS RES-SOL EA, V104, P7137, DOI 10.1029/1999JB900003; vanderHilst RD, 1997, NATURE, V386, P578, DOI 10.1038/386578a0; ZAHNLE K, 1990, ICARUS, V84, P502, DOI 10.1016/0019-1035(90)90050-J	12	6	6	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1247	1248		10.1126/science.1070399	http://dx.doi.org/10.1126/science.1070399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016295				2022-12-28	WOS:000175713000031
J	Li, HW; Li, WX; Ding, SW				Li, HW; Li, WX; Ding, SW			Induction and suppression of RNA silencing by an animal virus	SCIENCE			English	Article							RESISTANCE; DEFENSE; SPREAD; PLANTS	RNA silencing is a sequence-specific RNA degradation mechanism that is operational in plants and animals. Here, we show that flock house virus (FHV) is both an initiator and a target of RNA silencing in Drosophila host cells and that FHV infection requires suppression of RNA silencing by an FHV-encoded protein, B2. These findings establish RNA silencing as an adaptive antiviral defense in animal cells. B2 also inhibits RNA silencing in transgenic plants, providing evidence for a conserved RNA silencing pathway in the plant and animal kingdoms.	Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA; Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ding, SW (corresponding author), Univ Calif Riverside, Dept Plant Pathol, Riverside, CA 92521 USA.	shou-wei.ding@ucr.edu	Ding, Shou Wei/AAC-2533-2020	Ding, SW/0000-0002-4697-8413				Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x; BALL LA, 1995, J VIROL, V69, P720, DOI 10.1128/JVI.69.2.720-727.1995; BALL LA, 2000, VIRUS TAXONOMY, P747; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Billecocq A, 2000, J GEN VIROL, V81, P2161, DOI 10.1099/0022-1317-81-9-2161; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Dasgupta R, 2001, P NATL ACAD SCI USA, V98, P4910, DOI 10.1073/pnas.081288198; Ding SW, 1996, P NATL ACAD SCI USA, V93, P7470, DOI 10.1073/pnas.93.15.7470; DING SW, 1995, EMBO J, V14, P5762, DOI 10.1002/j.1460-2075.1995.tb00265.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Guo HS, 2002, EMBO J, V21, P398, DOI 10.1093/emboj/21.3.398; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Johnson KL, 1999, J VIROL, V73, P7933, DOI 10.1128/JVI.73.10.7933-7942.1999; Li HW, 1999, EMBO J, V18, P2683, DOI 10.1093/emboj/18.10.2683; Li WX, 2001, CURR OPIN BIOTECH, V12, P150, DOI 10.1016/S0958-1669(00)00190-7; Rose NF, 2001, CELL, V106, P539, DOI 10.1016/S0092-8674(01)00482-2; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 2000, CELL, V103, P157, DOI 10.1016/S0092-8674(00)00095-7; WHITTON JL, FIELDS VIROLOGY, V1, pCH11	23	655	725	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1319	1321		10.1126/science.1070948	http://dx.doi.org/10.1126/science.1070948			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016316				2022-12-28	WOS:000175713000055
J	Murakami, KS; Masuda, S; Darst, SA				Murakami, KS; Masuda, S; Darst, SA			Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 angstrom resolution	SCIENCE			English	Article							SIGMA(70) SUBUNIT; ABORTIVE INITIATION; SIGMA-70 SUBUNIT; IN-VITRO; PROMOTER; RECOGNITION; BINDING; MUTANT; SPECIFICITY; REGIONS	The crystal structure of the initiating form of Thermus aquaticus RNA polymerase, containing core RNA polymerase (alpha(2)betabeta'omega) and the promoter specificity or subunit, has been determined at 4 angstrom resolution. Important structural features of the RNA polymerase and their roles in positioning or within the initiation complex are delineated, as well as the role played by or in modulating the opening of the RNA polymerase active-site channel. The two carboxyl-terminal domains of a are separated by 45 angstroms on the surface of the RNA polymerase, but are linked by an extended loop. The loop winds near the RNA polymerase active site, where it may play a role in initiating nucleotide substrate binding, and out through the RNA exit channel. The advancing RNA transcript must displace the loop, leading to abortive initiation and ultimately to a release.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu		Murakami, Katsuhiko/0000-0003-2244-0501	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759, R01GM061898] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Bhargava P, 1999, J BIOL CHEM, V274, P26550, DOI 10.1074/jbc.274.37.26550; CAMARERO JA, IN PRESS P NATL ACAD; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cramer P, 2001, SCIENCE, V292, P1863, DOI 10.1126/science.1059493; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Darst SA, 2002, P NATL ACAD SCI USA, V99, P4296, DOI 10.1073/pnas.052054099; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; DARST SA, 1997, NUCL ACIDS MOL BIOL, V11, P27; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 1997, J BACTERIOL, V179, P1734, DOI 10.1128/jb.179.5.1734-1747.1997; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Joo DM, 1997, P NATL ACAD SCI USA, V94, P4907, DOI 10.1073/pnas.94.10.4907; Kornberg Roger D., 1999, Trends in Cell Biology, V9, pM46, DOI 10.1016/S0962-8924(99)01679-7; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 2001, CURR OPIN MICROBIOL, V4, P119, DOI 10.1016/S1369-5274(00)00176-4; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI [10.1128/jb.174.12.3843-3849.1992, :10.1128/jb.174.12.3843-3849.1992, DOI 10.1128/JB.174.12.3843-3849.1992]; LUSE DS, 1987, J BIOL CHEM, V262, P14990; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Nagai H, 1997, GENES CELLS, V2, P725, DOI 10.1046/j.1365-2443.1997.1600357.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Sen R, 1998, J BIOL CHEM, V273, P9872, DOI 10.1074/jbc.273.16.9872; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SHIMAMOTO N, 1986, J BIOL CHEM, V261, P1859; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Vuthoori S, 2001, J MOL BIOL, V309, P561, DOI 10.1006/jmbi.2001.4690; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	43	441	462	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1280	1284		10.1126/science.1069594	http://dx.doi.org/10.1126/science.1069594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016306				2022-12-28	WOS:000175713000044
J	Pascalis, O; de Haan, M; Nelson, CA				Pascalis, O; de Haan, M; Nelson, CA			Is face processing species-specific during the first year of life?	SCIENCE			English	Article							RECOGNITION	Between 6 and 10 months of age, the infant's ability to discriminate among native speech sounds improves, whereas the same ability to discriminate among foreign speech sounds decreases. Our study aimed to determine whether this perceptual narrowing is unique to language or might also apply to face processing. We tested discrimination of human and monkey faces by 6-month-olds, 9-month-olds, and adults, using the visual paired-comparison procedure. Only the youngest group showed discrimination between individuals of both species; older infants and adults only showed evidence of discrimination of their own species. These results suggest that the "perceptual narrowing" phenomenon may represent a more general change in neural networks involved in early cognition.	Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; UCL, Inst Child Hlth, Dev Cognit Neurosci Unit, London WC1N 2AP, England; Univ Minnesota, Ctr Neurobehav Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pediat, Inst Child Dev, Minneapolis, MN 55455 USA	University of Sheffield; University of London; University College London; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pascalis, O (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.	o.pascalis@sheffield.ac.uk	de Haan, Michelle/C-5070-2008	pascalis, olivier/0000-0003-4609-3233				Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; De Haan M, 2001, DEV COGN NEUROSCI, P381; de Haan M, 2001, COGNITIVE DEV, V16, P659, DOI 10.1016/S0885-2014(01)00051-X; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Nelson CA, 2001, INFANT CHILD DEV, V10, P3, DOI 10.1002/icd.239; NELSON CA, 1993, DEV NEUROCOGNITION S, P165; Pascalis O, 2000, J COGNITIVE NEUROSCI, P76; Pascalis O, 1998, BEHAV PROCESS, V43, P87, DOI 10.1016/S0376-6357(97)00090-9; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	12	531	535	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1321	1323		10.1126/science.1070223	http://dx.doi.org/10.1126/science.1070223			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554BL	12016317				2022-12-28	WOS:000175713000056
J	Brainard, MS; Doupe, AJ				Brainard, MS; Doupe, AJ			What songbirds teach us about learning	NATURE			English	Review							MALE ZEBRA FINCHES; SONG CONTROL PATHWAY; VOCAL CONTROL-SYSTEM; ANTERIOR FOREBRAIN; AUDITORY-FEEDBACK; NEURAL SELECTIVITY; SENSITIVE PERIOD; CONTROL NUCLEUS; NEURONS; BIRDSONG		Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brainard, MS (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	msb@phy.ucsf.edu		Brainard, Michael/0000-0002-9425-9907				AAMODT SM, 1992, J NEUROBIOL, V23, P997, DOI 10.1002/neu.480230806; AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; AlvarezBuylla A, 1997, J NEUROBIOL, V33, P585, DOI 10.1002/(SICI)1097-4695(19971105)33:5<585::AID-NEU7>3.0.CO;2-0; [Anonymous], [No title captured]; ARNOLD AP, 1986, BRAIN BEHAV EVOLUT, V28, P22, DOI 10.1159/000118689; Ball GF, 1999, DESIGN OF ANIMAL COMMUNICATION, P213; BAPTISTA LF, 1986, ANIM BEHAV, V34, P1359, DOI 10.1016/S0003-3472(86)80207-X; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; Boettiger CA, 2001, NEURON, V31, P809, DOI 10.1016/S0896-6273(01)00403-2; BOHNER J, 1990, HORM BEHAV, V24, P582, DOI 10.1016/0018-506X(90)90043-W; Bolhuis JJ, 2000, P NATL ACAD SCI USA, V97, P2282, DOI 10.1073/pnas.030539097; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; BOTTJER SW, 1992, J NEUROBIOL, V23, P337, DOI 10.1002/neu.480230402; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Brainard MS, 2000, NAT REV NEUROSCI, V1, P31, DOI 10.1038/35036205; Brainard MS, 2001, J NEUROSCI, V21, P2501, DOI 10.1523/JNEUROSCI.21-07-02501.2001; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; BROWN SD, 1993, J NEUROSCI, V13, P2024; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; Chi ZY, 2001, NEURON, V32, P899, DOI 10.1016/S0896-6273(01)00524-4; Cowie R., 1992, POSTLINGUALLY ACQUIR; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; DOOLING R, 1980, DEV PSYCHOBIOL, V13, P499, DOI 10.1002/dev.420130508; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Gentner TQ, 2000, J NEUROBIOL, V42, P117, DOI 10.1002/(SICI)1097-4695(200001)42:1<117::AID-NEU11>3.0.CO;2-M; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Gould E, 2002, J NEUROSCI, V22, P619, DOI 10.1523/JNEUROSCI.22-03-00619.2002; HERRMANN K, 1991, J NEUROSCI, V11, P2063; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hessler NA, 1999, J NEUROSCI, V19, P10461; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Hough GE, 2002, J NEUROSCI, V22, P1177, DOI 10.1523/JNEUROSCI.22-03-01177.2002; HULTSCH H, 1989, NATURWISSENSCHAFTEN, V76, P83, DOI 10.1007/BF00396717; Iyengar S, 2002, J NEUROSCI, V22, P901, DOI 10.1523/JNEUROSCI.22-03-00901.2002; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; Janata P, 1999, J NEUROSCI, V19, P5108; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; KIRN JR, 1991, J NEUROSCI, V11, P1756; Kittelberger JM, 1999, J NEUROSCI, V19, P9385; KONISHI M, 1985, ANNU REV NEUROSCI, V8, P125, DOI 10.1146/annurev.ne.08.030185.001013; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; KORSIA S, 1991, J NEUROSCI, V11, P2362; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Li XC, 2000, P NATL ACAD SCI USA, V97, P8584, DOI 10.1073/pnas.140222497; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; Lombardino AJ, 2000, J NEUROSCI, V20, P5054; Luo MM, 2001, J NEUROSCI, V21, P6836, DOI 10.1523/JNEUROSCI.21-17-06836.2001; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MARLER P, 1988, ETHOLOGY, V77, P125; MARLER P, 1988, NATURE, V336, P770, DOI 10.1038/336770a0; Marler P, 2000, P NATL ACAD SCI USA, V97, P2965, DOI 10.1073/pnas.97.7.2965; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MCCASLAND JS, 1987, J NEUROSCI, V7, P23; MELLO CV, 1994, J NEUROSCI, V14, P6652; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NELSON DA, 1993, ANIM BEHAV, V46, P806, DOI 10.1006/anbe.1993.1258; NELSON DA, 1994, P NATL ACAD SCI USA, V91, P10498, DOI 10.1073/pnas.91.22.10498; Nordby JC, 2000, ANIM BEHAV, V59, P1187, DOI 10.1006/anbe.1999.1412; Nordeen KW, 1997, J NEUROBIOL, V33, P532, DOI 10.1002/(SICI)1097-4695(19971105)33:5<532::AID-NEU4>3.0.CO;2-5; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1987, BEHAV NEURAL BIOL, V47, P197, DOI 10.1016/S0163-1047(87)90327-X; Okanoya K, 1997, J NEUROBIOL, V33, P343; PEARSON KG, 1993, ANNU REV NEUROSCI, V16, P265, DOI 10.1146/annurev.ne.16.030193.001405; PRICE PH, 1979, J COMP PHYSIOL PSYCH, V93, P260, DOI 10.1037/h0077553; Pytte CL, 2000, J NEUROBIOL, V42, P172, DOI 10.1002/(SICI)1097-4695(20000205)42:2<172::AID-NEU2>3.0.CO;2-I; Rasika S, 1999, NEURON, V22, P53, DOI 10.1016/S0896-6273(00)80678-9; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schmidt MF, 1998, NAT NEUROSCI, V1, P513, DOI 10.1038/2232; Slater P.J.B., 1988, Advances in the Study of Behavior, V18, P1; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Solis MM, 1999, J NEUROSCI, V19, P4559; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Tchernichovski O, 1999, P NATL ACAD SCI USA, V96, P12901, DOI 10.1073/pnas.96.22.12901; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Tramontin AD, 1999, J NEUROBIOL, V40, P316, DOI 10.1002/(SICI)1097-4695(19990905)40:3<316::AID-NEU4>3.0.CO;2-S; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Vates GE, 1996, J COMP NEUROL, V366, P613, DOI 10.1002/(SICI)1096-9861(19960318)366:4<613::AID-CNE5>3.0.CO;2-7; VOLMAN SF, 1993, J NEUROSCI, V13, P4737; VU ET, 1994, J NEUROSCI, V14, P6924; WALLHAUSSERFRANKE E, 1995, NEUROBIOL LEARN MEM, V64, P25, DOI 10.1006/nlme.1995.1041; Wang NG, 1999, J NEUROSCI, V19, P10554; WEST MJ, 1988, NATURE, V334, P244, DOI 10.1038/334244a0; Whaling CS, 1998, ANIM BEHAV, V56, P1075, DOI 10.1006/anbe.1998.0905; WHALING CS, 1995, DEV PSYCHOBIOL, V28, P367, DOI 10.1002/dev.420280703; Wild JM, 1997, J NEUROBIOL, V33, P653, DOI 10.1002/(SICI)1097-4695(19971105)33:5<653::AID-NEU11>3.0.CO;2-A; WILLIAMS H, 1992, BEHAV NEURAL BIOL, V57, P67, DOI 10.1016/0163-1047(92)90768-Y; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; Woolley SMN, 1997, J NEUROSCI, V17, P6380; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	100	379	390	0	136	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					351	358		10.1038/417351a	http://dx.doi.org/10.1038/417351a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551YT	12015616				2022-12-28	WOS:000175592100060
J	Schrot, RJ; Muizelaar, JP				Schrot, RJ; Muizelaar, JP			Mannitol in acute traumatic brain injury	LANCET			English	Editorial Material							CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; BLOOD-FLOW; INTRACRANIAL-PRESSURE; VISCOSITY		Univ Calif Davis, Dept Neurosurg, Sacramento, CA 95817 USA	University of California System; University of California Davis	Schrot, RJ (corresponding author), Univ Calif Davis, Dept Neurosurg, Sacramento, CA 95817 USA.							ALDERSON P, 2000, COCHRANE DB SYST REV, V2; BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BURKE AM, 1981, J NEUROSURG, V55, P550, DOI 10.3171/jns.1981.55.4.0550; Cruz J, 2001, NEUROSURGERY, V49, P864; CRUZ J, IN PRESS NEUROSURGER; Haines SJ, 2001, NEUROSURG CLIN N AM, V12, P211, DOI 10.1016/S1042-3680(18)30079-2; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MENDELOW AD, 1985, J NEUROSURG, V63, P43, DOI 10.3171/jns.1985.63.1.0043; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MUIZELAAR JP, 1983, J NEUROSURG, V59, P822, DOI 10.3171/jns.1983.59.5.0822; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Sayre MR, 1996, ACAD EMERG MED, V3, P840, DOI 10.1111/j.1553-2712.1996.tb03528.x; Schierhout G., 2000, COCHRANE DB SYST REV, V2; SCHROT RJ, IN PRESS IS THERE BE; SCHWARTZ ML, 1984, CAN J NEUROL SCI, V11, P434, DOI 10.1017/S0317167100045960; SMITH HP, 1986, J NEUROSURG, V65, P820, DOI 10.3171/jns.1986.65.6.0820; Verweij BH, 2001, J NEUROSURG, V95, P569, DOI 10.3171/jns.2001.95.4.0569; WISE B, 1963, J NEUROSURG, V19, P1038	18	30	32	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1633	1634		10.1016/S0140-6736(02)08545-8	http://dx.doi.org/10.1016/S0140-6736(02)08545-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020522				2022-12-28	WOS:000175593300005
J	Bland, PA; de Souza, CR; Jull, AJT; Kelley, SP; Hough, RM; Artemieva, NA; Pierazzo, E; Coniglio, J; Pinotti, L; Evers, V; Kearsley, AT				Bland, PA; de Souza, CR; Jull, AJT; Kelley, SP; Hough, RM; Artemieva, NA; Pierazzo, E; Coniglio, J; Pinotti, L; Evers, V; Kearsley, AT			A possible tektite strewn field in the Argentinian pampa	SCIENCE			English	Article							CUARTO CRATER FIELD; RIO-CUARTO; PLEISTOCENE; BE-10; GLASS	Impact glass associated with 11 elongate depressions in the Pampean Plain of Argentina, north of the city of Rio Cuarto, was suggested to be proximal ejecta related to a highly oblique impact event. We have identified about 400 additional elongate features in the area that indicate an aeolian, rather than an impact, origin. We have also dated fragments of glass found at the Rio Cuarto depressions; the age is similar to that of glass recovered 800 kilometers to the southeast. This material may be tektite glass from an impact event around 0.48 million years ago, representing a new tektite strewn field.	Open Univ, Planetary Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; Univ Estadual Campinas, Inst Geociencias, Campinas, SP, Brazil; Univ Arizona, NSF Arizona Accelerator Mass Spect Lab, Tucson, AZ 85721 USA; Open Univ, Dept Earth Sci, Milton Keynes MK7 6AA, Bucks, England; Western Australian Museum, Perth, WA 6000, Australia; Russian Acad Sci, Inst Dynam Geospheres, Moscow 117939, Russia; Planetary Sci Inst, Tucson, AZ 85705 USA; Univ Nacl Rio Cuarto, Dept Geol, RA-5800 Rio Cuarto, Argentina; Open Univ, Inst Educ Technol, Milton Keynes MK7 6AA, Bucks, England; Oxford Brookes Univ, Oxford OX3 OBP, England	Open University - UK; Universidade Estadual de Campinas; University of Arizona; Open University - UK; Western Australian Museum; Russian Academy of Sciences; Sadovsky Institute of Geosphere Dynamics of the Russian Academy of Sciences; Universidad Nacional Rio Cuarto; Open University - UK; Oxford Brookes University	Bland, PA (corresponding author), Open Univ, Planetary Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England.	p.a.bland@open.ac.uk	Kelley, Simon/AAR-7075-2020; Bland, Phil/M-9392-2018	Kelley, Simon/0000-0002-1756-0480; Bland, Phil/0000-0002-4681-7898; Pinotti, Lucio/0000-0002-3582-7417				Aldahan AA, 1997, GFF, V119, P67, DOI 10.1080/11035899709546456; ALLIONE JL, 1987, UNPUB TRABAJO FINAL; [Anonymous], 1993, DESERT GEOMORPHOLOGY; ARTEMIEVA NA, 2001, LUNAR PLANET SCI, V32, P1216; Blarasin M. T., 1987, 10 C GEOL ARG ACT, P297; BLOOM AL, 1992, GSA ABSTR PROG, V24, P136; Cantu P, 1984, 9 C GEOL ARG AS GEOL, V4, P76; Gilbert G. K., 1893, B PHILOS SOC WASHING, V12, P241; GRANT J, 1992, LUNAR PLANET SCI, V23, P439; Haines PW, 2001, GEOLOGY, V29, P899, DOI 10.1130/0091-7613(2001)029<0899:PGITAD>2.0.CO;2; Hughes DW, 2000, LECT NOTES EARTH SCI, V91, P327; Iriondo M, 1999, QUATERN INT, V57-8, P93, DOI 10.1016/S1040-6182(98)00053-6; KOEBERL C, 1992, LUNAR PLANET SCI, V23, P706; Melosh H. J, 1989, IMPACT CRATERING GEO, DOI DOI 10.1103/PHYSREVB.46.10411; Montanari A., 2000, IMPACT STRATIGRAPHY, P364; MORRISON D, 1994, HAZARDS DUE COMETS A, P59; PAL DK, 1982, SCIENCE, V218, P787, DOI 10.1126/science.218.4574.787; RAISBECK GM, CHEM GEOL, V70, P120; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; SCHULTZ PH, 1994, GEOLOGY, V22, P889, DOI 10.1130/0091-7613(1994)022<0889:GTFOIP>2.3.CO;2; SCHULTZ PH, 1992, NATURE, V355, P234, DOI 10.1038/355234a0; Schultz PH, 2000, METEORIT PLANET SCI, V35, pA143; SCHULTZ PH, 1993, LUNAR PLANET SCI, V24, P1259; SCHULTZ PH, 1992, LUNAR PLANET SCI, V23, P1237; SEILER RA, PUBLICATION CATEDRA, V1, P68; Shoemaker EM, 1962, PHYS ASTRONOMY MOON, P283, DOI 10.1016/C2013-0-12487-7; ZOLENSKY ME, 1992, METEORITICS, V27, P460, DOI 10.1111/j.1945-5100.1992.tb00228.x	27	20	20	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1109	1111		10.1126/science.1068345	http://dx.doi.org/10.1126/science.1068345			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004127				2022-12-28	WOS:000175565000050
J	Spoor, F; Bajpal, S; Hussaim, ST; Kumar, K; Thewissen, JGM				Spoor, F; Bajpal, S; Hussaim, ST; Kumar, K; Thewissen, JGM			Vestibular evidence for the evolution of aquatic behaviour in early cetaceans	NATURE			English	Article							INNER-EAR; LOCOMOTOR EVOLUTION; HEARING; PETROSAL; WHALE; ORIGIN; FEET	Early cetaceans evolved from terrestrial quadrupeds to obligate swimmers, a change that is traditionally studied by functional analysis of the postcranial skeleton(1). Here we assess the evolution of cetacean locomotor behaviour from an independent perspective by looking at the semicircular canal system, one of the main sense organs involved in neural control of locomotion(2). Extant cetaceans are found to be unique in that their canal arc size, corrected for body mass, is approximately three times smaller than in other mammals. This reduces the sensitivity of the canal system, most plausibly to match the fast body rotations that characterize cetacean behaviour. Eocene fossils show that the new sensory regime, incompatible with terrestrial competence, developed quickly and early in cetacean evolution, as soon as the taxa are associated with marine environments. Dedicated agile swimming of cetaceans thus appeared to have originated as a rapid and fundamental shift in locomotion rather than as the gradual transition suggested by postcranial evidence. We hypothesize that the unparalleled modification of the semicircular canal system represented a key 'point of no return' event in early cetacean evolution, leading to full independence from life on land.	Indian Inst Technol, Dept Earth Sci, Roorkee 247667, Uttar Pradesh, India; UCL, Dept Anat & Dev Biol, London WC1E 6JJ, England; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India; Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; University of London; University College London; Howard University; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG); Northeast Ohio Medical University (NEOMED)	Spoor, F (corresponding author), Indian Inst Technol, Dept Earth Sci, Roorkee 247667, Uttar Pradesh, India.	f.spoor@ucl.ac.uk	Spoor, Fred/C-1718-2008; KUMAR, Kishor/H-7232-2013	KUMAR, Kishor/0000-0003-0875-9735; Thewissen, J. G. M./0000-0002-0973-4137				Bajpai S, 2000, CURR SCI INDIA, V79, P1478; Buchholtz EA, 1998, ADV VERT PALEOBIOL, P325; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Geisler JH, 1996, J PALEONTOL, V70, P1045, DOI 10.1017/S0022336000038749; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; Gingerich PD, 1998, ADV VERT PALEOBIOL, P423; Gingerich PD, 2001, SCIENCE, V293, P2239, DOI 10.1126/science.1063902; Gingerich Philip D., 1995, Contributions from the Museum of Paleontology University of Michigan, V29, P291; GRAY AA, 1908, LABYRINTH ANIMALS, V2; HOHNE KH, 1995, NAT MED, V1, P506, DOI 10.1038/nm0695-506; Hulbert RC, 1998, ADV VERT PALEOBIOL, P235; Hyrtl J., 1845, VERGLEICHEND ANATOMI; KETTEN DR, 1992, MARINE MAMMAL SENSORY SYSTEMS, P53; LUO ZX, 1995, J VERTEBR PALEONTOL, V15, P431, DOI 10.1080/02724634.1995.10011239; Luo ZX, 1996, J VERTEBR PALEONTOL, V16, P328, DOI 10.1080/02724634.1996.10011320; Madar SI, 1998, ADV VERT PALEOBIOL, P353; Marino Lori, 2000, Journal of Mammalian Evolution, V7, P81, DOI 10.1023/A:1009417831601; MULLER M, 1994, J THEOR BIOL, V167, P239, DOI 10.1006/jtbi.1994.1066; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; Schwarz DWF, 1994, NEUROTOLOGY, P59; SPOOR F, 1995, J ANAT, V186, P271; Spoor F, 1998, YEARB PHYS ANTHROPOL, V41, P211; SPOOR F, IN PRESS COURIER FOR; Thewissen JGM, 1997, PALEOBIOLOGY, V23, P482, DOI 10.1017/S0094837300019850; THEWISSEN JGM, 1994, SCIENCE, V263, P210, DOI 10.1126/science.263.5144.210; Thewissen JGM, 1998, ADV VERT PALEOBIOL, P451; Thewissen JGM, 2001, NATURE, V413, P277, DOI 10.1038/35095005; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Williams EM, 1998, ADV VERT PALEOBIOL, P1; Yamada M., 1959, Scientific Reports of the Whales Research Institute Tokyo, VNo. 14, P291	30	169	178	10	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					163	166		10.1038/417163a	http://dx.doi.org/10.1038/417163a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000957				2022-12-28	WOS:000175460200040
J	Oboler, SK; Prochazka, AV; Gonzales, R; Xu, S; Anderson, RJ				Oboler, SK; Prochazka, AV; Gonzales, R; Xu, S; Anderson, RJ			Public expectations and attitudes for annual physical examinations and testing	ANNALS OF INTERNAL MEDICINE			English	Article							CARE	Background: Recent guidelines for adult prevention do not recommend a comprehensive annual physical examination, but current public expectations in light of this change are unknown. Objective: To determine public belief in the need for and content of an annual physical examination and to examine the effect of financial charges on these beliefs. Design: Telephone survey. Setting: Three U.S. cities. Participants: Adult English-speaking respondents. Measurements: Percentage of respondents answering that an annual physical examination is necessary and percentage desiring individual components of the history, physical examination, and laboratory testing, with and without knowledge of charges. Results: Of 1203 respondents, 66% (67% in Denver, Colorado; 71% in Boston, Massachusetts; and 58% in San Diego, California) believed that in addition to regular care, an annual physical examination is necessary, Among the 600 respondents presented with charge information, interest decreased from 63% to 33% if payment were required. For history, greater than 90% believed that diet, exercise, and tobacco and alcohol use should be discussed, while 60% believed that seatbelt use and sexual history should be discussed. For the physical examination, greater than 90% felt that blood pressure should be measured and that the heart and lungs, abdomen, reflexes, and prostate should be examined. However, fewer than 80% thought that hearing and vision should be tested. Many tests, including the Papanicolaou smear (75%), mammography (71%), cholesterol measurement (65%), prostate-specific antigen test (65%), urinalysis (40%), blood glucose measurement (41%), fecal occult blood testing (39%), and chest radiography (36%), were desired. Interest in these tests decreased substantially when the charges were known. Conclusion: Public desire for a comprehensive annual physical examination is high across the United States and is sensitive to charges.	Denver Kaiser Permanente, Denver Vet Affairs Med Ctr, Denver, CO 80220 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80202 USA	Kaiser Permanente; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Oboler, SK (corresponding author), Denver Kaiser Permanente, Denver Vet Affairs Med Ctr, 1055 Clermont St, Denver, CO 80220 USA.							BRODY DS, 1989, MED CARE, V27, P1027, DOI 10.1097/00005650-198911000-00004; COLBURN D, 1995, WASHINGTON POST 0704; Emerson H, 1923, J AMER MED ASSOC, V80, P1376, DOI 10.1001/jama.1923.26430460003011; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; Frame P S, 1975, J Fam Pract, V2, P189; Frame P S, 1975, J Fam Pract, V2, P283; Frame P S, 1975, J Fam Pract, V2, P123; Frame P S, 1975, J Fam Pract, V2, P29; Gordon PR, 1999, ARCH INTERN MED, V159, P909, DOI 10.1001/archinte.159.9.909; GREENE HL, 1998, HEALTHNEWS      0808; GREIDER K, 1996, HARPERS BAZAAR, V3418, P288; HALLOWELL C, 1998, TIME            0615; HAYWARD RSA, 1991, ANN INTERN MED, V114, P758, DOI 10.7326/0003-4819-114-9-758; JONES RJ, 1983, JAMA-J AM MED ASSOC, V249, P1626; KRAVITZ RL, 1994, J GEN INTERN MED, V9, P75, DOI 10.1007/BF02600205; LEVINE JA, 1991, J ROY SOC MED, V84, P280, DOI 10.1177/014107689108400512; LUCKMANN R, 1995, J FAM PRACTICE, V40, P547; *MED PRACT COMM AM, 1981, ANN INTERN MED, V95, P729; OBOLER SK, 1989, ANN INTERN MED, V110, P214, DOI 10.7326/0003-4819-110-3-214; ROMM FJ, 1984, J FAM PRACTICE, V19, P191; ROMM FJ, 1985, SOUTHERN MED J, V78, P1330, DOI 10.1097/00007611-198511000-00015; ROMM FJ, 1985, SOUTH MED J, V78, P1340; SOLOMON GL, 1996, MED ECON, V73, P79; *US DEP HHS PUBL H, 1994, CLIN HDB PREV SERV P; *US OFF PERS MAN, 1998, BLUE CROSS BLUE SHIE; *US PREV SERV TASK, 1989, ASS EFF 169 INT REP; *US PREV SERV TASK, 1996, REP US PREV SERV TAS; 1998, CONSUMER REPORT 0808, P17; 1979, CAN MED ASS J, V121, P1193	29	90	92	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					652	659		10.7326/0003-4819-136-9-200205070-00007	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547XK	11992300				2022-12-28	WOS:000175357900002
J	Elderfield, H				Elderfield, H			Climate change: Carbonate mysteries	SCIENCE			English	Editorial Material							CALCIFICATION		Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Elderfield, H (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.							Anderson DM, 2002, NATURE, V416, P70, DOI 10.1038/416070a; Broecker WS, 2001, SCIENCE, V294, P2152, DOI 10.1126/science.1064171; BROECKER WS, 2002, GEOCHEM GEOPHYS GEOS, V3; ELDERFIELD H, 2001, EOS T AGU S, V82; Houghton JT., 1995, CLIMATE CHANGE 1994; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Wolf-Gladrow DA, 1999, TELLUS B, V51, P461, DOI 10.1034/j.1600-0889.1999.00023.x; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321	10	41	57	2	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1618	+		10.1126/science.1072079	http://dx.doi.org/10.1126/science.1072079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040166				2022-12-28	WOS:000175976200029
J	Gupta, R; He, ZY; Luan, S				Gupta, R; He, ZY; Luan, S			Functional relationship of cytochrome c(6) and plastocyanin in Arabidopsis	NATURE			English	Article							PROTEIN PHOSPHATASE; GENE-EXPRESSION; PHOTOSYSTEM-I; COPPER; CYANOBACTERIUM; SPECIFICITY	Photosynthetic electron carriers are important in converting light energy into chemical energy in green plants. Although protein components in the electron transport chain are largely conserved among plants, algae and prokaryotes, there is thought to be a major difference concerning a soluble protein in the thylakoid lumen. In cyanobacteria and eukaryotic algae, both plastocyanin and cytochrome c(6) mediate electron transfer from cytochrome b(6)f complex to photosystem I1-4. In contrast, only plastocyanin has been found to play the same role in higher plants. It is widely accepted that cytochrome c(6) has been evolutionarily eliminated from higher-plant chloroplasts(5,6). Here we report characterization of a cytochrome c(6)-like protein from Arabidopsis (referred to as Atc6). Atc6 is a functional cytochrome c localized in the thylakoid lumen. Electron transport reconstruction assay showed that Atc6 replaced plastocyanin in the photosynthetic electron transport process. Genetic analysis demonstrated that neither plastocyanin nor Atc6 was absolutely essential for Arabidopsis growth and development. However, plants lacking both plastocyanin and Atc6 did not survive.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Luan, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	sluan@nature.berkeley.edu		Gupta, Rajeev/0000-0002-1451-215X				ATTAASAFOADJEI E, 1985, ARCH BIOCHEM BIOPHYS, V243, P660, DOI 10.1016/0003-9861(85)90544-2; Chuang CF, 2000, P NATL ACAD SCI USA, V97, P4985, DOI 10.1073/pnas.060034297; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Crofts A. R., 1978, CURR TOP BIOENERG, V7, P175; De la Cerda B, 1999, J BIOL CHEM, V274, P13292, DOI 10.1074/jbc.274.19.13292; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Gupta R, 1998, PLANT J, V16, P581, DOI 10.1046/j.1365-313x.1998.00327.x; HAUSKA GA, 1971, J BIOL CHEM, V246, P3524; HERVAS M, 1993, FEBS LETT, V319, P257, DOI 10.1016/0014-5793(93)80558-C; Hippler M, 1999, J BIOL CHEM, V274, P4180, DOI 10.1074/jbc.274.7.4180; KATOH SJ, 1959, BIOCHEMISTRY-US, V46, P629; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Lin YK, 1996, PLANT CELL, V8, P293, DOI 10.1105/tpc.8.2.293; LUAN S, 1992, PLANT CELL, V4, P971, DOI 10.1105/tpc.4.8.971; MALKIN R, 2000, PLANT BIOCH MOL BIOL, P568; Merchant S, 1997, CH MICROBIOL SER, P450; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; Quinn JM, 1998, METHOD ENZYMOL, V297, P263; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sigfridsson K, 1998, PHOTOSYNTH RES, V57, P1, DOI 10.1023/A:1006067631076; SOMERVILLE CR, 1981, PLANT SCI LETT, V21, P89, DOI 10.1016/0304-4211(81)90073-0; TOBIN EM, 1985, ANNU REV PLANT PHYS, V36, P569, DOI 10.1146/annurev.pp.36.060185.003033; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x; ZHANG L, 1992, J BIOL CHEM, V267, P19054	27	74	85	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					567	571		10.1038/417567a	http://dx.doi.org/10.1038/417567a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037572				2022-12-28	WOS:000175860300047
J	Bacchetti, P				Bacchetti, P			Peer review of statistics in medical research: the other problem	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; QUALITY; JOURNALS		Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bacchetti, P (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.							ALBERTS BM, 2001, RECOMMENDATIONS CHAN; Altman DG, 1998, STAT MED, V17, P2661, DOI 10.1002/(SICI)1097-0258(19981215)17:23<2661::AID-SIM33>3.0.CO;2-B; [Anonymous], 1999, NAT NEUROSCI, V2, P197; Black N, 1998, JAMA-J AM MED ASSOC, V280, P231, DOI 10.1001/jama.280.3.231; Bloom FE, 1999, SCIENCE, V283, P789, DOI 10.1126/science.283.5403.789; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229; Gleick J., 1999, FASTER ACCELERATION; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; Goldbeck-Wood S, 1999, BMJ-BRIT MED J, V318, P44; Goodman SN, 1998, AM J EPIDEMIOL, V147, P807, DOI 10.1093/oxfordjournals.aje.a009531; Goodman SN, 1998, J GEN INTERN MED, V13, P753, DOI 10.1046/j.1525-1497.1998.00227.x; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; KASSIRER JP, 1994, JAMA-J AM MED ASSOC, V272, P96, DOI 10.1001/jama.272.2.96; MATTHEWS JNS, 1995, STAT MED, V14, P115, DOI 10.1002/sim.4780140204; MEINERT CL, 1986, CLIN TRIALS DESIGN C, P276; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; TANNEN D, 1998, THE ARGUMENT CULTURE; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; van Rooyen S, 1999, BRIT MED J, V318, P23	19	109	109	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1271	1273		10.1136/bmj.324.7348.1271	http://dx.doi.org/10.1136/bmj.324.7348.1271			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028986	Green Published			2022-12-28	WOS:000175894900027
J	Hippisley-Cox, J; Groom, L; Kendrick, D; Coupland, C; Webber, E; Savelyich, B				Hippisley-Cox, J; Groom, L; Kendrick, D; Coupland, C; Webber, E; Savelyich, B			Cross sectional survey of socioeconomic variations in severity and mechanism of childhood injuries in Trent 1992-7	BRITISH MEDICAL JOURNAL			English	Article							ACCIDENTAL INJURY; SOCIAL-CLASS; EMERGENCY; MORTALITY; CHILDREN; HOME	Objective To determine the relation between morbidity from injury and deprivation for different levels of injury severity and for different injury mechanisms for children aged 0-14 years. Design Cross sectional survey of routinely collected hospital admission data for injury 1992-7. Setting 862 electoral wards in Trent Region. Subjects 21 587 injury related hospital admissions for children aged 04 years and 35 042 admissions for children aged 5-14. Main outcome measures Rate ratios for hospital admission for all injuries,all injuries involving long bone fracture, and all injuries invoking long bone fracture requiring an operation; rate ratios for hospital admission for six tapes of injury mechanism divided by quintiles of the electoral wards' Townsend scores for deprivation. Rate ratios calculated by Poisson regression, with adjustment for distance from nearest hospital admitting patients with injuries, rurality, ethnicity, mid percentage of males in cacti electoral ward. Results Both total number of admissions for injury and admissions for injuries of higher severity increased with increasing socioeconomic deprivation. These gradients were more marked for 0-4 year old children than 5-14 year olds. In terms of injury mechanisms, the steepest socioeconomic gradients ( where the rate for the fifth of electoral wards with die highest deprivation scores was greater than or equal to3 times that of the fifth with the lowest scores) were for pedestrian injuries (adjusted rate ratio 3.65 (9511,0 confidence interval 2.94 to 4.54)), burns and scalds (adjusted rate ratio 3.49 (2.81 to 4.34)), and poisoning (adjusted rate ratio 2.98 (2.65 to 3.34)). Conclusion There are steep socioeconomic gradients for injury morbidity including die most common mechanisms of injury. This has implications for targeting injury prevention interventions mid resources.	Div Gen Practice, Nottingham NG7 2RD, England		Hippisley-Cox, J (corresponding author), Div Gen Practice, Tower Bldg,Univ Pk, Nottingham NG7 2RD, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Kendrick, Denise/0000-0003-3603-6542; Coupland, Carol/0000-0002-2327-3306				ALWASH R, 1988, ARCH DIS CHILD, V63, P635, DOI 10.1136/adc.63.6.635; ALWASH R, 1988, BRIT MED J, V296, P1450, DOI 10.1136/bmj.296.6634.1450; *BRIT MED ASS, 2001, INJ PREV; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; Carstairs V, 1991, DEPRIVATION HLTH; Cryer PC, 2000, PUBLIC HEALTH, V114, P232; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Gorman DR, 1999, PUBLIC HEALTH, V113, P285, DOI 10.1016/S0033-3506(99)00181-X; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; KENDRICK D, 1993, J PUBLIC HEALTH MED, V15, P171; Laing GJ, 1999, PUBLIC HEALTH, V113, P291, DOI 10.1016/S0033-3506(99)00182-1; LANGLEY J, 1983, AUST PAEDIATR J, V19, P237; Lyons R A, 1995, Inj Prev, V1, P173, DOI 10.1136/ip.1.3.173; Lyons RA, 2000, BRIT MED J, V320, P149, DOI 10.1136/bmj.320.7228.149; MAJEED FA, 1994, BMJ-BRIT MED J, V308, P1426, DOI 10.1136/bmj.308.6941.1426; MCKEE CM, 1990, BRIT J GEN PRACT, V40, P150; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; Roberts I, 1996, BRIT MED J, V313, P784; Roberts I, 1997, J EPIDEMIOL COMMUN H, V51, P334, DOI 10.1136/jech.51.3.334; Townsend P, 1982, THE BLACK REPORT; Walsh S S, 1996, Inj Prev, V2, P16, DOI 10.1136/ip.2.1.16; WALSH SS, 1992, J EPIDEMIOL COMMUN H, V46, P26, DOI 10.1136/jech.46.1.26; Williams JM, 1997, SOC SCI MED, V44, P1881, DOI 10.1016/S0277-9536(96)00297-3	24	142	144	0	9	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1132	1134C		10.1136/bmj.324.7346.1132	http://dx.doi.org/10.1136/bmj.324.7346.1132			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552LX	12003886	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000175622800024
J	Kaeberlein, T; Lewis, K; Epstein, SS				Kaeberlein, T; Lewis, K; Epstein, SS			Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment	SCIENCE			English	Article							MICROBIAL DIVERSITY; SEDIMENTS; DNA	The majority (>99%) of microorganisms from the environment resist cultivation in the laboratory. Ribosomal RNA analysis suggests that uncultivated organisms are found in nearly every prokaryotic group, and several divisions have no known cultivable representatives. We designed a diffusion chamber that allowed the growth of previously uncultivated microorganisms in a simulated natural environment. Colonies of representative marine organisms were isolated in pure culture. These isolates did not grow on artificial media alone but formed colonies in the presence of other microorganisms. This observation may help explain the nature of microbial uncultivability.	Northeastern Univ, Dept Biol, Boston, MA 02115 USA; Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Northeastern University; Northeastern University	Epstein, SS (corresponding author), Northeastern Univ, Dept Biol, Boston, MA 02115 USA.	s.epstein@neu.edu	chen, qi/C-8585-2011					Allsopp D., 1995, MICROBIAL DIVERSITY; Barer MR, 1999, ADV MICROB PHYSIOL, V41, P93, DOI 10.1016/S0065-2911(08)60166-6; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Bergey DH., 2001, BERGEYS MANUAL SYSTE; BUTKEVICH VL. S., 1932, TRUDY GOS SUDARSTVENNOGO OKEANOGRAFICHESKOGO INSTITUTA [TRANS OCEANOGR INST [MOSCOW]], V2, P5; Cifuentes A, 2000, APPL ENVIRON MICROB, V66, P1715, DOI 10.1128/AEM.66.4.1715-1719.2000; Colwell RR, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P1; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Dojka MA, 2000, APPL ENVIRON MICROB, V66, P1617, DOI 10.1128/AEM.66.4.1617-1621.2000; Dunny GM, 1999, CELL-CELL SIGNALING IN BACTERIA, P1; Eaton A. D., 1998, STANDARD METHODS EXA; Epstein SS, 1997, MICROBIAL ECOL, V34, P199, DOI 10.1007/s002489900049; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; Giovannoni SJ., 2000, MICROBIAL ECOLOGY OC, P47; Grimes DJ, 2000, NONCULTURABLE MICROORGANISMS IN THE ENVIRONMENT, P209; JANNASCH HW, 1959, LIMNOL OCEANOGR, V4, P128, DOI 10.4319/lo.1959.4.2.0128; LEWIN RA, 1970, CAN J MICROBIOL, V16, P517, DOI 10.1139/m70-087; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; MEYERREIL LA, 1978, APPL ENVIRON MICROB, V36, P506, DOI 10.1128/AEM.36.3.506-512.1978; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Staley J. T., 1989, BERGEYS MANUAL SYSTE; STALEY JT, 1985, ANNU REV MICROBIOL, V39, P321, DOI 10.1146/annurev.mi.39.100185.001541; Tenover F. C., 1992, The Prokaryotes. A handbook on the biology of bacteria: ecophysiology, isolation, identification, applications. Volume IV.., P3488; TIEDJE JM, 1994, ASM NEWS, V60, P524; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; WARD DM, 1990, NATURE, V345, P63, DOI 10.1038/345063a0; Young P, 1997, ASM NEWS, V63, P417; ZoBell C., 1946, MARINE MICROBIOLOGY	29	793	907	39	516	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1127	1129		10.1126/science.1070633	http://dx.doi.org/10.1126/science.1070633			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004133				2022-12-28	WOS:000175565000056
J	Lo, B; Dornbrand, L; Wolf, LE; Groman, M				Lo, B; Dornbrand, L; Wolf, LE; Groman, M			The Wendland case - Withdrawing life support from incompetent patients who are not terminally ill.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ADVANCE DIRECTIVES; CARE; PERSPECTIVE; PREFERENCES		Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.			Wolf, Leslie/0000-0002-4660-8383	NIMH NIH HHS [MH42459] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH042459] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alpers A, 1999, J LAW MED ETHICS, V27, P74, DOI 10.1111/j.1748-720X.1999.tb01438.x; ANNAS GJ, 1994, NEW ENGL J MED, V330, P1542, DOI 10.1056/NEJM199405263302120; Beauchamp TL, 2009, PRINCIPLES BIOMEDICA; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; Brown JB, 1999, J GEN INTERN MED, V14, P21, DOI 10.1046/j.1525-1497.1999.00276.x; CHIANG H, 2001, SAN FRANCISCO C 0810, pA1; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; DOLAN M, 2001, LOS ANGELES TIM 0718, pB1; DOLAN M, 2001, LOS ANGELES TIM 0810, pA1; Gordon NP, 1999, ARCH INTERN MED, V159, P701, DOI 10.1001/archinte.159.7.701; Halevy A, 1996, JAMA-J AM MED ASSOC, V276, P571, DOI 10.1001/jama.276.7.571; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LO B, 2000, RESOLVING ETHICAL DI; Lynn J, 1997, JAMA-J AM MED ASSOC, V277, P1633, DOI 10.1001/jama.277.20.1633; MCKEE M, 2001, AM LAWYER MEDIA 0810, P1; Meier DE, 1996, ARCH INTERN MED, V156, P1227, DOI 10.1001/archinte.156.11.1227; MEISEL A, 1995, RIGHT DIE; MENIKOFF JA, 1992, NEW ENGL J MED, V327, P1165, DOI 10.1056/NEJM199210153271612; *PC STUD ETH PROBL, 1983, DEC FOR LIF SUST TRE; Pellegrino E., 1988, PATIENTS GOOD RESTOR; SEHGAL A, 1992, JAMA-J AM MED ASSOC, V267, P59, DOI 10.1001/jama.267.1.59; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; STEINBROOK R, 1990, LOS ANGELES TIM 1227, pA17; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Weeks JC, 2000, JAMA-J AM MED ASSOC, V283, P203	26	22	22	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1489	1493		10.1056/NEJM200205093461912	http://dx.doi.org/10.1056/NEJM200205093461912			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000822				2022-12-28	WOS:000175433200011
J	Zorzi, M; Priftis, K; Umilta, C				Zorzi, M; Priftis, K; Umilta, C			Brain damage - Neglect disrupts the mental number line	NATURE			English	Article							REPRESENTATION		Univ Padua, Dipartimento Psicol Gen, I-35131 Padua, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Padua; Vita-Salute San Raffaele University	Zorzi, M (corresponding author), Univ Padua, Dipartimento Psicol Gen, Via Venezia 8, I-35131 Padua, Italy.		Zorzi, Marco/B-7863-2008; Priftis, Konstantinos/B-7862-2008	Zorzi, Marco/0000-0002-4651-6390; Priftis, Konstantinos/0000-0002-5215-4621				Bachtold D, 1998, NEUROPSYCHOLOGIA, V36, P731, DOI 10.1016/S0028-3932(98)00002-5; Bisiach E., 2000, HDB NEUROPSYCHOLOGY, P459; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; CARAMAZZA A, 1990, NATURE, V346, P267, DOI 10.1038/346267a0; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; HADAMARD J, 1996, MATH MIND PSYCHOL IN; MARSHALL JC, 1989, CORTEX, V25, P503, DOI 10.1016/S0010-9452(89)80065-6; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; RESTLE F, 1970, J EXP PSYCHOL, V83, P274, DOI 10.1037/h0028573; SERON X, 1992, COGNITION, V44, P159, DOI 10.1016/0010-0277(92)90053-K	13	503	517	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					138	139		10.1038/417138a	http://dx.doi.org/10.1038/417138a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549RH	12000950				2022-12-28	WOS:000175460200031
J	Peifer, M; McEwen, DG				Peifer, M; McEwen, DG			The ballet of morphogenesis: Unveiling the hidden choreographers	CELL			English	Review							PLANAR CELL POLARITY; XENOPUS	Several recent papers reveal new insights into the mechanisms by which cells turn their perceptions about fate into action, focusing on the role of Wnt signal transduction in cell polarization and migration.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Peifer, M (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Peifer, Mark/A-1152-2010	Peifer, Mark/0000-0003-1412-3987				Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 2002, NAT CELL BIOL, V4, pE6, DOI 10.1038/ncb0102-e6; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cohen ED, 2002, DEV CELL, V2, P437, DOI 10.1016/S1534-5807(02)00142-9; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Holme RH, 2001, TRENDS MOL MED, V7, P138, DOI 10.1016/S1471-4914(01)01932-3; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; McEwen DG, 2000, DEVELOPMENT, V127, P3607; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Strutt DI, 2001, MOL CELL, V7, P367, DOI 10.1016/S1097-2765(01)00184-8; Tree DRP, 2002, CELL, V109, P371, DOI 10.1016/S0092-8674(02)00715-8; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 1999, GENE DEV, V13, P1342, DOI 10.1101/gad.13.10.1342	21	40	41	2	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					271	274		10.1016/S0092-8674(02)00739-0	http://dx.doi.org/10.1016/S0092-8674(02)00739-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015976	Bronze			2022-12-28	WOS:000175412100002
J	Artsimovitch, I; Landick, R				Artsimovitch, I; Landick, R			The transcriptional regulator RfaH stimulates RNA chain synthesis after recruitment to elongation complexes by the exposed nontemplate DNA strand	CELL			English	Article							ESCHERICHIA-COLI HEMOLYSIN; SALMONELLA-TYPHIMURIUM; TERMINATION EFFICIENCY; POLYMERASE-II; GENE-CLUSTER; PROTEIN; ANTITERMINATION; EXPRESSION; MUTANTS; MECHANISM	The transcriptional regulatory protein RfaH controls expression of several operons that encode extracytoplasmic components in bacteria. Regulation by RfaH occurs during transcript elongation and depends on a 5'-proximal, transcribed nucleic acid sequence called ops that induces transcriptional pausing in vitro and in vivo. We report that RfaH recognizes RNA polymerase transcribing RfaH-regulated operons by interacting with the ops sequence in the exposed nontemplate DNA strand of ops-paused transcription complexes. Although RfaH delays escape from the ops pause, once escape occurs, RfaH enhances elongation by suppressing pausing and p-dependent termination without apparent involvement of other accessory proteins. This activity predicts a cumulative antitermination model for RfaH's regulation of ops-containing operons in vivo.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Bacteriol, 1550 Linden Dr, Madison, WI 53706 USA.	landick@bact.wisc.edu	Artsimovitch, Irina/L-3467-2019		NIGMS NIH HHS [GM 38660] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R29GM038660, R01GM038660] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Bailey MJA, 1996, MOL MICROBIOL, V22, P729, DOI 10.1046/j.1365-2958.1996.d01-1726.x; Bailey MJA, 1997, MOL MICROBIOL, V26, P845, DOI 10.1046/j.1365-2958.1997.6432014.x; Bailey MJA, 2000, MOL GEN GENET, V262, P1052, DOI 10.1007/PL00008648; BENTLEY DL, 1995, CURR OPIN GENET DEV, V5, P210, DOI 10.1016/0959-437X(95)80010-7; BEUTIN L, 1979, J BACTERIOL, V139, P730, DOI 10.1128/JB.139.3.730-737.1979; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; Choy HE, 1996, METHOD ENZYMOL, V274, P3; Conaway JW, 1999, ANNU REV BIOCHEM, V68, P301, DOI 10.1146/annurev.biochem.68.1.301; Danese PN, 2000, J BACTERIOL, V182, P3593, DOI 10.1128/JB.182.12.3593-3596.2000; DENISOVA LJ, 1982, DOKL AKAD NAUK SSSR+, V267, P475; FAREWELL A, 1991, J BACTERIOL, V173, P5188, DOI 10.1128/jb.173.16.5188-5193.1991; FRIEDEN C, 1994, METHOD ENZYMOL, V240, P311; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gorke B, 2001, J MOL BIOL, V308, P131, DOI 10.1006/jmbi.2001.4590; GRAYHACK EJ, 1985, CELL, V42, P259, DOI 10.1016/S0092-8674(85)80121-5; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; Guo DC, 1996, J BACTERIOL, V178, P1631, DOI 10.1128/jb.178.6.1631-1639.1996; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; KORONAKIS V, 1988, NUCLEIC ACIDS RES, V16, P4789, DOI 10.1093/nar/16.11.4789; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Kyrpides NC, 1996, TRENDS BIOCHEM SCI, V21, P425, DOI 10.1016/S0968-0004(96)30036-4; Landick R, 1996, METHOD ENZYMOL, V274, P334; LAU LF, 1983, J BIOL CHEM, V258, P9391; Leeds JA, 1997, J BACTERIOL, V179, P3519, DOI 10.1128/jb.179.11.3519-3527.1997; Leeds JA, 1996, J BACTERIOL, V178, P1850, DOI 10.1128/jb.178.7.1850-1857.1996; MASON SW, 1992, J BIOL CHEM, V267, P19418; MCDOWELL JC, 1994, SCIENCE, V266, P822, DOI 10.1126/science.7526463; Nagy G, 2001, INFECT IMMUN, V69, P1924, DOI 10.1128/IAI.69.3.1924-1928.2001; Nesper J, 2001, INFECT IMMUN, V69, P435, DOI 10.1128/IAI.69.1.435-445.2001; NunezValdez ME, 1996, GENE, V172, P75, DOI 10.1016/0378-1119(96)00055-8; Opalka N, 2000, P NATL ACAD SCI USA, V97, P617, DOI 10.1073/pnas.97.2.617; Paitan Y, 1999, FEMS MICROBIOL LETT, V170, P221, DOI 10.1111/j.1574-6968.1999.tb13377.x; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Rees WA, 1997, J MOL BIOL, V273, P797, DOI 10.1006/jmbi.1997.1327; Richardson J. P., 1996, ESCHERICHIA COLI SAL, P822; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; Roberts CW, 1996, CELL, V86, P495; Roberts JW, 1998, COLD SPRING HARB SYM, V63, P319, DOI 10.1101/sqb.1998.63.319; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Stanley P, 1998, MICROBIOL MOL BIOL R, V62, P309, DOI 10.1128/MMBR.62.2.309-333.1998; Stevens MP, 1997, MOL MICROBIOL, V24, P1001, DOI 10.1046/j.1365-2958.1997.4241780.x; STOCKER BAD, 1980, J GEN MICROBIOL, V116, P17; SULLIVAN SL, 1992, CELL, V68, P989, DOI 10.1016/0092-8674(92)90041-A; Torres M, 2001, EMBO J, V20, P3811, DOI 10.1093/emboj/20.14.3811; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; Wang L, 1998, FEMS MICROBIOL LETT, V165, P201, DOI 10.1016/S0378-1097(98)00264-X; Weisberg RA, 1999, J BACTERIOL, V181, P359, DOI 10.1128/JB.181.2.359-367.1999; WILKINSON RG, 1972, J GEN MICROBIOL, V70, P527, DOI 10.1099/00221287-70-3-527; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611	56	192	195	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					193	203		10.1016/S0092-8674(02)00724-9	http://dx.doi.org/10.1016/S0092-8674(02)00724-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007406	Bronze			2022-12-28	WOS:000175082600009
J	Mitrofanov, I; Anfimov, D; Kozyrev, A; Litvak, M; Sanin, A; Tret'yakov, V; Krylov, A; Shvetsov, V; Boynton, W; Shinohara, C; Hamara, D; Saunders, RS				Mitrofanov, I; Anfimov, D; Kozyrev, A; Litvak, M; Sanin, A; Tret'yakov, V; Krylov, A; Shvetsov, V; Boynton, W; Shinohara, C; Hamara, D; Saunders, RS			Maps of subsurface hydrogen from the high energy neutron detector, Mars Odyssey	SCIENCE			English	Article							ORBITER LASER ALTIMETER; WATER; ICE	After 55 days of mapping by the High Energy Neutron Detector onboard Mars Odyssey, we found deficits of high-energy neutrons in the southern highlands and northern lowlands of Mars. These deficits indicate that hydrogen is concentrated in the subsurface. Modeling suggests that water ice rich layers that are tens of centimeters in thickness provide one possible fit to the data.	Inst Space Res, Moscow 117997, Russia; Joint Inst Nucl Res, Dubna 141980, Russia; Univ Arizona, Tucson, AZ 85721 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Joint Institute for Nuclear Research - Russia; University of Arizona; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Mitrofanov, I (corresponding author), Inst Space Res, Moscow 117997, Russia.		Litvak, Maxim/C-6453-2017; Sanin, Anton/T-9393-2017	Mitrofanov, Igor/0000-0001-7204-2101				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; BOYNTON W, UNPUB; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; DRAKE DM, 1986, P LUNAR PLANET SCI C, V17, pD186; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; Jakosky BM, 2001, NATURE, V412, P237, DOI 10.1038/35084184; KIEFFER HH, 1976, SCIENCE, V194, P1341, DOI 10.1126/science.194.4271.1341; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Masarik J, 1996, J GEOPHYS RES-PLANET, V101, P18891, DOI 10.1029/96JE01563; MOHLMAN D, 2002, P WORKSH POTSD GERM; SAUNDERS RS, 2001, AGU FALL M 2001; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053	15	309	318	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					78	81		10.1126/science.1073616	http://dx.doi.org/10.1126/science.1073616			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040089				2022-12-28	WOS:000176711000035
J	Lee, KP; Schotland, M; Bacchetti, P; Bero, LA				Lee, KP; Schotland, M; Bacchetti, P; Bero, LA			Association of journal quality indicators with methodological quality of clinical research articles	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				RANDOMIZED CONTROLLED-TRIALS; CITATION ANALYSIS; IMPACT FACTORS; BIAS; HEALTH; PUBLICATIONS; DRUG	Context The ability to identify scientific journals that publish high-quality research would help clinicians, scientists, and health-policy analysts to select the most up-to-date medical literature to review. Methods To assess whether journal characteristics of (1) peer-review status, (2) citation rate, (3) impact factor, (4) circulation, (5) manuscript acceptance rate, (6) MEDLINE indexing, and (7) Brandon/Hill Library List indexing are predictors of methodological quality of research articles, we conducted a cross-sectional study of 243 original research articles involving human subjects published in general internal medical journals. Results The mean (SD) quality score of the 243 articles was 1.37 (0.22). All journals reported a peer-review process and were indexed on MEDLINE. In models that controlled for article type (randomized controlled trial [RCT] or non-RCT), journal citation rate was the most statistically significant predictor (0.051 increase per doubling; 95% confidence interval [CI], 0.037-0.065; P<.001). In separate analyses by article type, acceptance rate was the strongest predictor for RCT quality (-0.113 per doubling; 95% Cl, -0.148 to -0.078; P<.001), while journal citation rate was the most predictive factor for non-RCT quality (0.051 per doubling; 95% Cl, 0.044-0.059; P<.001). Conclusions High citation rates, impact factors, and circulation rates, and low manuscript acceptance rates and indexing on Brandon/Hill Library List appear to be predictive of higher methodological quality scores for journal articles.	Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; NYU, Dept Psychol, New York, NY 10003 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; New York University	Bero, LA (corresponding author), Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, Suite 420,Box 0613,3333 Calif St, San Francisco, CA 94143 USA.	bero@medicine.ucsf.edu						ARNDT KA, 1992, ARCH DERMATOL, V128, P1249, DOI 10.1001/archderm.128.9.1249; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; BERLIN J, 2001, ONLINE J CURR CLIN T; Berlin JA, 1999, JAMA-J AM MED ASSOC, V282, P1083, DOI 10.1001/jama.282.11.1083; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; Birken CS, 1999, PEDIATRICS, V103, P941, DOI 10.1542/peds.103.5.941; Bloom BS, 2000, INT J TECHNOL ASSESS, V16, P13, DOI 10.1017/S0266462300016123; BRUER JT, 1982, AM J PUBLIC HEALTH, V72, P1119, DOI 10.2105/AJPH.72.10.1119; CAMPBELL FM, 1990, B MED LIBR ASSOC, V78, P376; CHO MK, 1994, JAMA-J AM MED ASSOC, V272, P101, DOI 10.1001/jama.272.2.101; Clark HD, 1999, CONTROL CLIN TRIALS, V20, P448, DOI 10.1016/S0197-2456(99)00026-4; Clever LH, 1997, ANN INTERN MED, V126, P36, DOI 10.7326/0003-4819-126-1-199701010-00006; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; deJong JW, 1996, EUR HEART J, V17, P35; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; EVANS JT, 1990, JAMA-J AM MED ASSOC, V263, P1353, DOI 10.1001/jama.263.10.1353; Gallagher EJ, 1998, ANN EMERG MED, V31, P83, DOI 10.1016/S0196-0644(98)70286-0; Gehanno JF, 2000, OCCUP ENVIRON MED, V57, P706, DOI 10.1136/oem.57.10.706; GOTZSCHE PC, 1987, BRIT MED J, V295, P654, DOI 10.1136/bmj.295.6599.654; Haggard E.A., 1958, INTRACLASS CORRELATI; Hill DR, 1999, B MED LIBR ASSOC, V87, P145; *I SCI INF, 1998, SCI CIT IND J CIT RE; Joyce J, 1998, JAMA-J AM MED ASSOC, V280, P264, DOI 10.1001/jama.280.3.264; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; LARSSON KS, 1995, J INTERN MED, V238, P445, DOI 10.1111/j.1365-2796.1995.tb01222.x; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; MacLehose R R, 2000, Health Technol Assess, V4, P1; MACROBERTS MH, 1989, J AM SOC INFORM SCI, V40, P342, DOI 10.1002/(SICI)1097-4571(198909)40:5<342::AID-ASI7>3.0.CO;2-U; Moed HF, 1996, SCIENTOMETRICS, V37, P105, DOI 10.1007/BF02093487; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; MORAVCSIK MJ, 1975, SOC STUD SCI, V5, P86, DOI 10.1177/030631277500500106; Opthof T, 1997, CARDIOVASC RES, V33, P1, DOI 10.1016/S0008-6363(96)00215-5; Pittler MH, 2000, J CLIN EPIDEMIOL, V53, P485, DOI 10.1016/S0895-4356(99)00220-6; Rennie D, 1998, LANCET, V352, P18; Schoonbaert D, 1996, TROP MED INT HEALTH, V1, P739; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; SEGLEN PO, 1994, J AM SOC INFORM SCI, V45, P1, DOI 10.1002/(SICI)1097-4571(199401)45:1<1::AID-ASI1>3.0.CO;2-Y; Seglen PO, 1997, BRIT MED J, V314, P498; Seglen PO, 1997, ALLERGY, V52, P1050, DOI 10.1111/j.1398-9995.1997.tb00175.x; 2000, ULRICHS INT PERIODIC	42	193	199	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2805	2808		10.1001/jama.287.21.2805	http://dx.doi.org/10.1001/jama.287.21.2805			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038918	Bronze			2022-12-28	WOS:000176002200015
J	Liechti, R; Farmer, EE				Liechti, R; Farmer, EE			The jasmonate pathway	SCIENCE			English	Editorial Material							PLANT DEFENSE; ARABIDOPSIS-THALIANA; OCTADECANOID PATHWAY; ACID; BIOSYNTHESIS; RESISTANCE; METABOLISM; ACTIVATE; PATHOGEN; MUTANTS	Plants are faced with many of the same problems as animals-a need for regulation of metabolic processes and reproduction and for defense against enemies. Jasmonates in plants serve key roles in gene and metabolic regulation, defense, responses to trauma, reproduction, and possibly communication. Some remarkable features of plant responses, such as production of repellent volatiles as a defense against herbivorous insects, or the massive transcriptional reprogramming that occurs in response to wounding, are under the control of the jasmonate pathway. Details of the jasmonate signaling pathway are currently at the center of active research that is generating exciting results. The Jasmonate Biochemical Pathway at the STKE Connections Maps is designed to present and keep pace with these developments.	Univ Lausanne, Inst Ecol, Gene Express Lab, CH-1015 Lausanne, Switzerland	University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, Inst Ecol, Gene Express Lab, CH-1015 Lausanne, Switzerland.		Farmer, Edward E/H-1635-2011					Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; FARMER EE, 1992, PLANT CELL, V4, P129, DOI 10.1105/tpc.4.2.129; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; HAMBERG M, 1990, ARCH BIOCHEM BIOPHYS, V276, P518, DOI 10.1016/0003-9861(90)90753-L; Hilpert B, 2001, PLANT J, V26, P435, DOI 10.1046/j.1365-313X.2001.2641036.x; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; LIECHTI R, 2002, SCI STKE; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Stelmach BA, 2001, J BIOL CHEM, V276, P12832, DOI 10.1074/jbc.M010743200; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; van der Fits L, 2000, SCIENCE, V289, P295, DOI 10.1126/science.289.5477.295; VICK BA, 1984, PLANT PHYSIOL, V75, P458, DOI 10.1104/pp.75.2.458; Vijayan P, 1998, P NATL ACAD SCI USA, V95, P7209, DOI 10.1073/pnas.95.12.7209; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu LH, 2001, FEBS LETT, V494, P161, DOI 10.1016/S0014-5793(01)02331-6	19	153	191	9	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1649	1650		10.1126/science.1071547	http://dx.doi.org/10.1126/science.1071547			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040182				2022-12-28	WOS:000175976200045
J	McDonnell, DP; Norris, JD				McDonnell, DP; Norris, JD			Connections and regulation of the human estrogen receptor	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; NUCLEAR RECEPTOR; B-ISOFORM; BINDING; PHOSPHORYLATION; TRANSCRIPTION; MOTIF	Estrogen regulates a plethora of functionally dissimilar processes in a broad range of tissues. Recent progress in the study of the molecular mechanism of action of estrogen(s) has revealed why different cells can respond to the same hormone in a different manner. Three of these findings are of particular importance: (I) There are two genetically and functionally distinct estrogen receptors that have distinct expression patterns in vivo; (ii) the positive and negative transcriptional activities of these receptors require them to engage transcription cofactors (coactivators or corepressors) in target cells; and (iii) not all cofactors are functionally equivalent, nor are they expressed in the same manner in all, cells. Thus, although the estrogen receptor is required for a cell to respond to an estrogenic stimulus, the nature and extent of that response are determined by the proteins, pathways, and processes with which the receptor interacts.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	McDonnell, DP (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	donald.mcdonnell@duke.edu		Norris, John/0000-0001-6553-8053				Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; Hall JM, 1999, ENDOCRINOLOGY, V140, P5566, DOI 10.1210/en.140.12.5566; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; KLEINHITPASS L, 1989, MOL CELL BIOL, V9, P43, DOI 10.1128/MCB.9.1.43; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; McDonnell DP, 1999, TRENDS ENDOCRIN MET, V10, P301, DOI 10.1016/S1043-2760(99)00177-0; McDonnell DP, 2001, ANN NY ACAD SCI, V949, P16; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; McKenna NJ, 2001, ANN NY ACAD SCI, V949, P3; MEANS AR, 1972, P NATL ACAD SCI USA, V69, P1146, DOI 10.1073/pnas.69.5.1146; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Mulac-Jericevic B, 2000, SCIENCE, V289, P1751, DOI 10.1126/science.289.5485.1751; NORRIS J, 2002, SCI STKE; Norris JD, 2002, MOL ENDOCRINOL, V16, P459, DOI 10.1210/me.16.3.459; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; TZUKERMAN MT, 1994, MOL ENDOCRINOL, V8, P21, DOI 10.1210/me.8.1.21; Webb P, 1998, MOL ENDOCRINOL, V12, P1605, DOI 10.1210/me.12.10.1605; WEN DX, 1994, MOL CELL BIOL, V14, P8356, DOI 10.1128/MCB.14.12.8356; Zhang WH, 2000, P NATL ACAD SCI USA, V97, P5936, DOI 10.1073/pnas.97.11.5936	28	459	476	4	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1642	1644		10.1126/science.1071884	http://dx.doi.org/10.1126/science.1071884			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040178				2022-12-28	WOS:000175976200041
J	Smith, GCS; Pell, JP; Cameron, AD; Dobbie, R				Smith, GCS; Pell, JP; Cameron, AD; Dobbie, R			Risk of perinatal death associated with labor after previous cesarean delivery in uncomplicated term pregnancies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VAGINAL BIRTH; SECTION; SCOTLAND; TRIAL; MORTALITY; WALES	Context Trial of labor after previous cesarean delivery is associated with increased risk of uterine rupture. However, no reliable data exist on the effect of a trial of labor on the risk of perinatal death in otherwise uncomplicated term pregnancies. Objective To determine the risk of intrapartum stillbirth or neonatal death not related to congenital abnormality among women with uncomplicated term pregnancies who had a trial of labor after previous cesarean delivery, compared with women having a planned repeat cesarean delivery, and multiparous and nulliparous women at term not delivered by planned cesarean method. Design and Setting Population-based, retrospective cohort study of data from the linked Scottish Morbidity Record and Stillbirth and Neonatal Death Enquiry encompassing births in Scotland between January 1, 1992, and December 31, 1997 Population A total of 313 238 singleton births between 37 and 43 weeks' gestational age in which the fetus was in a cephalic presentation. Main Outcome Measure Delivery-related perinatal death, defined as intrapartum stillbirth or neonatal death unrelated to congenital anomaly, compared among the 4 groups. Results Among women who had a trial of labor following previous cesarean delivery (n =15515), the overall rate of delivery-related perinatal death was 12.9 (95% confidence interval [CI], 7.9-19.9) per 10000 women. This was approximately 11 times greater (odds ratio [OR], 11.6; 95% CI, 1.6-86.7) than the risk associated with planned repeat cesarean delivery (n=9014), more than twice (OR, 2.2; 95% CI, 1.3-3.5) the risk associated with other multiparous women in labor (n = 151549), and similar to the risk among nulliparous women in labor (n=137160; OR 1.3; 95% CI 0.8-2.1) The associations were not explained by differences in maternal height, smoking status so, cioeconomic status, age, fetal growth, or week of gestation at delivery. Among women having a trial of labor, the rate of death due to mechanical causes, including uterine rupture, was 4.5 (95% CI, 1.8-9.3) per 10000 women. This was more than 8 times greater than other multiparous women (OR, 8.5; 95% CI, 3.2-22.3) and nulliparous women (OR, 8.8; 95% CI, 3.2-24.2). Conclusions The absolute risk of perinatal death associated with trial of labor following previous cesarean delivery is low. However, in our study, the risk was significantly higher than that associated with planned repeat cesarean delivery, and there was a marked excess of deaths due to uterine rupture compared with other women in labor.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Queen Mothers Hosp, Dept Fetal Med, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge	Smith, GCS (corresponding author), Univ Cambridge, Rosie Matern Hosp, Dept Obstet & Gynaecol, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008	Smith, Gordon/0000-0003-2124-0997; Pell, Jill/0000-0002-8898-7035				Alberman E, 1997, BRIT J OBSTET GYNAEC, V104, P1043, DOI 10.1111/j.1471-0528.1997.tb12064.x; Campbell S., 1993, ULTRASOUND OBSTET GY, P1432; COLE SK, 1980, PERINATAL AUDIT SURV, P39; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; HOSMER DW, 1989, APPL LOGISTIC REGRES; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Magowan BA, 1998, BRIT J OBSTET GYNAEC, V105, P1005, DOI 10.1111/j.1471-0528.1998.tb10265.x; Mastrobattista JM, 1999, OBSTET GYN CLIN N AM, V26, P295, DOI 10.1016/S0889-8545(05)70076-0; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; Mozurkewich EL, 2000, AM J OBSTET GYNECOL, V183, P1187, DOI 10.1067/mob.2000.108890; *NAT HLTH SERV SCO, 2001, SCOTT PER INF MORT M; Rageth JC, 1999, OBSTET GYNECOL, V93, P332, DOI 10.1016/S0029-7844(98)00446-3; Robson MS, 2001, BEST PRACT RES CL OB, V15, P179, DOI 10.1053/beog.2000.0156; Smith GCS, 2000, AM J EPIDEMIOL, V151, P614, DOI 10.1093/oxfordjournals.aje.a010249; Smith GCS, 2001, HUM REPROD, V16, P1497, DOI 10.1093/humrep/16.7.1497; Stewart JH, 1998, BRIT MED J, V316, P657, DOI 10.1136/bmj.316.7132.657; Westergaard HB, 1997, ACTA OBSTET GYN SCAN, V76, P959, DOI 10.3109/00016349709034909	20	185	192	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2684	2690		10.1001/jama.287.20.2684	http://dx.doi.org/10.1001/jama.287.20.2684			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020304	Bronze			2022-12-28	WOS:000175732400028
J	Ghali, WA; Faris, PD; Galbraith, D; Norris, CM; Curtis, MJ; Saunders, LD; Dzavik, V; Mitchell, LB; Knudtson, ML				Ghali, WA; Faris, PD; Galbraith, D; Norris, CM; Curtis, MJ; Saunders, LD; Dzavik, V; Mitchell, LB; Knudtson, ML		Alberta Provincial Project Outcome	Sex differences in access to coronary revascularization after cardiac catheterization: Importance of detailed clinical data	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; GENDER-DIFFERENCES; ARTERY-DISEASE; HEART-DISEASE; HOSPITAL MORTALITY; TEMPORAL TRENDS; YENTL-SYNDROME; WOMEN; BIAS; PERSPECTIVE	Background: Although some studies suggest that access to cardiac procedures may differ by sex, others have found no evidence of gender bias in cardiac care. Objective: To study rates of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) surgery in men and women after cardiac catheterization. Design: Cohort study with prospective data collection. Setting: Alberta, Canada. Patients: Persons undergoing cardiac catheterization between I January 1995 and 31 December 1998 (n = 21 816). Measurements: The occurrence of revascularization procedures (PC[ or CAM in the year after cardiac catheterization was measured. Unadjusted revascularization rates, partially adjusted rates (adjusted for clinical variables available in most databases, including administrative databases), and fully adjusted rates (additionally adjusted for extent of coronary artery disease and ejection fraction) were also evaluated. Results: The unadjusted relative risk was 0.67 (95% Cl, 0.65 to 0.71) for the end point of any revascularization in women relative to men. The relative risk increased to 0.69 (Cl, 0.66 to 0.72) with partial adjustment and to 0.98 (Cl, 0.94 to 1.03) with full adjustment, indicating equivalent access to revascularization for men and women. For PCI, the corresponding relative risks were 0.77 (Cl, 0.73 to 0.82), 0.84 (C], 0.80 to 0.89), and 1.02 (Cl, 0.96 to 1.08). For CABG surgery, the relative risks were 0.54 (Cl, 0.51 to 0.58), 0.51 (Cl, 0.48 to 0.55), and 0.93 (Cl, 0.87 to 1.01). Conclusions: In Alberta, Canada, clinical variables fully explain sex differences in rates of revascularization after cardiac catheterization, and misleading conclusions would arise without full adjustment for clinical differences between men and women. Extreme caution is needed in interpreting reports on access to care that use sparsely detailed clinical data sources.	Univ Calgary, Fac Med, Calgary, AB T2N 4N1, Canada; Approach Project Off, Edmonton, AB, Canada	University of Calgary	Ghali, WA (corresponding author), Univ Calgary, Fac Med, 3330 Hosp Dr Northwest, Calgary, AB T2N 4N1, Canada.	wghali@ucalgary.ca	Faris, Peter/AAJ-3436-2020	Faris, Peter/0000-0001-5208-817X; Norris, Colleen/0000-0002-6793-9333				AYANIAN JZ, 1991, NEW ENGL J MED, V325, P221, DOI 10.1056/NEJM199107253250401; BEARDEN D, 1994, J AM GERIATR SOC, V42, P1143, DOI 10.1111/j.1532-5415.1994.tb06979.x; BELL MR, 1995, J AM COLL CARDIOL, V25, P1650, DOI 10.1016/0735-1097(95)00044-5; BICKELL NA, 1992, ANN INTERN MED, V116, P791, DOI 10.7326/0003-4819-116-10-791; BREWSTER AC, 1985, INQUIRY-J HEALTH CAR, V22, P377; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; CHIRIBOGA DE, 1993, AM J CARDIOL, V71, P268, DOI 10.1016/0002-9149(93)90789-F; Dong W, 1998, SOC SCI MED, V47, P1773, DOI 10.1016/S0277-9536(98)00242-1; Ghali WA, 2000, CAN J CARDIOL, V16, P1225; Goldberg RJ, 1998, AM HEART J, V136, P189, DOI 10.1053/hj.1998.v136.88874; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Iezzoni LI, 1997, MED CARE, V35, P158, DOI 10.1097/00005650-199702000-00006; JAGLAL SB, 1994, CAN J CARDIOL, V10, P239; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; Leape LL, 1999, ANN INTERN MED, V130, P183, DOI 10.7326/0003-4819-130-3-199902020-00003; LINCOFF AM, 1993, J AM COLL CARDIOL, V22, P1780, DOI 10.1016/0735-1097(93)90757-R; MARK DB, 1994, NEW ENGL J MED, V330, P1101, DOI 10.1056/NEJM199404213301601; Miller TD, 2001, J AM COLL CARDIOL, V38, P690, DOI 10.1016/S0735-1097(01)01413-9; Milner KA, 1999, AM J CARDIOL, V84, P396, DOI 10.1016/S0002-9149(99)00322-7; NAYLOR CD, 1993, CAN MED ASSOC J, V149, P965; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Raine RA, 1999, INT J TECHNOL ASSESS, V15, P136, DOI 10.1017/S0266462399152231; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; STEEN PM, 1993, INQUIRY-J HEALTH CAR, V30, P128; STEINGART RM, 1991, NEW ENGL J MED, V325, P226, DOI 10.1056/NEJM199107253250402; van Lennep JER, 2000, EUR HEART J, V21, P911, DOI 10.1053/euhj.1999.1941; Zucker DR, 1997, J GEN INTERN MED, V12, P79, DOI 10.1046/j.1525-1497.1997.00011.x	31	103	103	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					723	732		10.7326/0003-4819-136-10-200205210-00007	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020140				2022-12-28	WOS:000175664600002
J	Conaway, RC; Brower, CS; Conaway, JW				Conaway, RC; Brower, CS; Conaway, JW			Gene expression - Emerging roles of ubiquitin in transcription regulation	SCIENCE			English	Review							TUMOR-SUPPRESSOR PROTEIN; F-BOX PROTEIN; GLYCINE-RICH REGION; ELONGIN BC COMPLEX; BETA-CATENIN; ACTIVATION DOMAIN; LIGASE COMPLEX; DEPENDENT PROTEOLYSIS; PROLYL HYDROXYLATION; PRECURSOR P105	Ubiquitin is a small protein that was initially found to function as a tag that can be covalently attached to proteins to mark them for destruction by a multisubunit, adenosine 5'-triphosphate- dependent protease called the proteasome. Ubiquitin is now emerging as a key regulator of eukaryotic messenger RNA synthesis, a process that depends on the RNA synthetic enzyme RNA polymerase 11 and the transcription factors that control its activity. Ubiquitin controls messenger RNA synthesis not only by mechanisms involving ubiquitin-dependent destruction of transcription factors by the proteasome, but also by an Intriguing collection of previously unknown and unanticipated mechanisms that appear to be independent of the proteasome.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; California Institute of Technology; University of Oklahoma System; University of Oklahoma Health Sciences Center	Conaway, JW (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.			Conaway, Joan/0000-0002-2786-0663	PHS HHS [R37 6M41628] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Amson RB, 1996, P NATL ACAD SCI USA, V93, P3953, DOI 10.1073/pnas.93.9.3953; Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; BROWER CS, UNPUB; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Heissmeyer V, 2001, MOL CELL BIOL, V21, P1024, DOI 10.1128/MCB.21.4.1024-1035.2001; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; IMOF MO, 1996, MOL CELL BIOL, V16, P2594; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Meimoun A, 2000, MOL BIOL CELL, V11, P915, DOI 10.1091/mbc.11.3.915; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Nemani M, 1996, P NATL ACAD SCI USA, V93, P9039, DOI 10.1073/pnas.93.17.9039; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Orian A, 2000, EMBO J, V19, P2580, DOI 10.1093/emboj/19.11.2580; Orian A, 1999, MOL CELL BIOL, V19, P3664; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Ravi R, 2000, GENE DEV, V14, P34; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Zhang JG, 1999, P NATL ACAD SCI USA, V96, P2071, DOI 10.1073/pnas.96.5.2071; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	63	322	340	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1254	1258		10.1126/science.1067466	http://dx.doi.org/10.1126/science.1067466			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016299				2022-12-28	WOS:000175713000036
J	Plasterk, RHA				Plasterk, RHA			RNA silencing: The genome's immune system	SCIENCE			English	Editorial Material							DNA METHYLATION; C-ELEGANS; GENE; INTERFERENCE; TRANSGENE; PLANTS; ARABIDOPSIS; SUPPRESSION; HELICASE; PETUNIA	Genomes are databases sensitive to invasion by viruses. In recent years, a defense mechanism has been discovered, which turns out to be conserved among eukaryotes. The system can be compared to the immune system in several ways: It has specificity against foreign elements and the ability to amplify and raise a massive response against an invading nucleic acid. The latter property is beginning to be understood at the molecular level.	Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Plasterk, RHA (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Ctr Biomed Genet, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.							Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird A, 1997, TRENDS GENET, V13, P469, DOI 10.1016/S0168-9525(97)01310-3; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GRISHOK A, UNPUB; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; KETTING R, UNPUB; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; LINDBO JA, 1992, VIROLOGY, V189, P725, DOI 10.1016/0042-6822(92)90595-G; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; SIJEN T, UNPUB; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; VAISTIJ FE, IN PRESS PLANT CELL; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	32	311	379	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1263	1265		10.1126/science.1072148	http://dx.doi.org/10.1126/science.1072148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016302				2022-12-28	WOS:000175713000039
J	Vivier, E; Biron, CA				Vivier, E; Biron, CA			Immunology - A pathogen receptor on natural killer cells	SCIENCE			English	Editorial Material							MURINE CYTOMEGALOVIRUS; CUTTING EDGE; ACTIVATION		Univ Mediterranee, CNR, INSERM, Ctr Immunol Marseille Luminy, Marseille, France; Brown Univ, Div Biol & Med, Providence, RI 02912 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Brown University	Vivier, E (corresponding author), Univ Mediterranee, CNR, INSERM, Ctr Immunol Marseille Luminy, Marseille, France.	vivier@ciml.univ-mrs.fr; christine_biron@brown.edu	Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287				Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Olcese L, 1996, J IMMUNOL, V156, P4531; Olcese L, 1997, J IMMUNOL, V158, P5083; Pien GC, 2000, J IMMUNOL, V165, P4787, DOI 10.4049/jimmunol.165.9.4787; Salazar-Mather TP, 2000, J CLIN INVEST, V105, P985, DOI 10.1172/JCI9232; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; Smith KM, 1998, J IMMUNOL, V161, P7; Tay CH, 1997, J VIROL, V71, P267, DOI 10.1128/JVI.71.1.267-275.1997; Vely F, 1997, J IMMUNOL, V159, P2075; Vivier E, 2002, CURR OPIN IMMUNOL, V14, P306, DOI 10.1016/S0952-7915(02)00337-0	16	27	28	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1248	1249		10.1126/science.1072447	http://dx.doi.org/10.1126/science.1072447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016296				2022-12-28	WOS:000175713000032
J	Mettler, FA; Voelz, GL				Mettler, FA; Voelz, GL			Major radiation exposure - What to expect and how to respond.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACCIDENTS		Univ New Mexico, Hlth Sci Ctr, Dept Radiol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Mettler, FA (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Radiol, 915 Camino Salud, Albuquerque, NM 87131 USA.							[Anonymous], 1977, EFFECTS NUCL WEAPONS; Becker SM, 1997, ENVIRON HEALTH PERSP, V105, P1557, DOI 10.2307/3433670; Browne D, 1990, TREATMENT RAD INJURI; *COMM BIOL EFF ION, 1990, HLTH EFF EXP LOW LEV; *COMM RAD BATTL CR, 1999, POT RAD EXP MIL OP P; Committee on the Biological Effects of Ionizing Radiation, 1988, HLTH RISKS RAD OTH I; DiGiovanni C, 1999, AM J PSYCHIAT, V156, P1500, DOI 10.1176/ajp.156.10.1500; Fajardo L.F., 2001, RAD PATHOLOGY; *FED BUR INV, 1998, WEAP MASS DESTR INC; *FED EM MAN AG, 1999, 229 FEMA; Fliedner TM, 1996, HEALTH PHYS, V70, P787, DOI 10.1097/00004032-199606000-00002; Fliedner TM, 1995, STEM CELLS, V13, P1; Giaccia J., 2018, RADIOBIOLOGY RADIOLO; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; GUSEV IA, 2001, MED MANAGEMENT RAD A; *INT AT EN AG, 1996, RAD ACC NESV; *INT AT EN AG, 1993, RAD ACC SOR; *INT AT EN AG, 2000, REC IN RESP ACC RAD; *INT AT EN AG, 1990, RAD ACC SAN SALV; *INT AT EN AG, 1996, 1 DEC CHERN SUMM CON; *INT AT EN AG, 1994, SAF SER, V109; *INT AT ENAG, 2000, RAD ACC YAN; *INT COMM RAD PROT, 1992, ANN ICRP, V4; *INT COMM RAD PROT, 1990, ANN ICRP, V1; *INT COMM RAD PROT, 1984, ANN ICRP, V2; International Atomic Energy Agency, 1988, RAD ACC GOIAN; International Atomic Energy Agency, 1998, SAF REP SER SAF REP SER, V4; International Atomic Energy Agency, 1998, DIAGN TREATM RAD INJ; JARRETT D, 1999, AFRRI SPECIAL PUBLIC, V992; Macintyre AG, 2000, JAMA-J AM MED ASSOC, V283, P242, DOI 10.1001/jama.283.2.242; MACVITTIE TJ, 1996, ADV BIOSCIENCES, V94; MITTLER FA, 1995, MED EFFECTS IONIZING; *NAT COUNC RAD PRO, 1977, 55 NAT COUNC RAD PRO; *NAT COUNC RAD PRO, 1982, CONTR EXP PUBL ION R; *NAT COUNC RAD PRO, 1985, 65 NAT COUNC RAD PRO; *NAT COUNC RAD PRO, 1991, 111 NAT COUNC RAD PR; National Council on Radiation Protection and Measurements, 2001, 138 NCRP; NCRP 116. National Council on Radiation Protection and Measurements, 1993, 116 NCRP; *OFF RAD PROGR, 1993, EPA PUBL; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Ricks RC, 2002, MED BASIS RAD ACCIDE; Sidell Frederick R., 1997, MED ASPECTS CHEM BIO; TSUJII H, 2000, CRIT ACC TOK MED ASP; *UN SCI COMM EFF A, 2000, SOURC EFF ION RAD; *US DEP HHS, 1996, DHHS SMA PUBL; Walker R.I., 1989, MED CONSEQUENCES NUC	46	202	208	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1554	1561		10.1056/NEJMra000365	http://dx.doi.org/10.1056/NEJMra000365			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015396				2022-12-28	WOS:000175563900008
J	Baron, R; Schattschneider, J; Binder, A; Siebrecht, D; Wasner, G				Baron, R; Schattschneider, J; Binder, A; Siebrecht, D; Wasner, G			Relation between sympathetic vasoconstrictor activity and pain and hyperalgesia in complex regional pain syndromes: a case-control study	LANCET			English	Article							DYSTROPHY CRPS-I; VASCULAR ABNORMALITIES; EVOKED PAIN; MECHANISMS; ACTIVATION; CAUSALGIA; INJECTION; SUDOMOTOR; NEURONS	Background Complex regional pain syndromes can be relieved by sympathetic blockage. The mechanisms of sympathetically maintained pain (SMP) are unclear. We aimed to establish the effect of physiological sympathetic cutaneous vasoconstrictor activity on pain and hyperalgesia in patients with complex regional pain syndromes. Methods High and low cutaneous vasoconstrictor activity was produced by whole-body cooling and warming (thermal suit) in 13 patients with type I disease and in ten controls. The degree of cutaneous vasoconstrictor discharge was monitored by measurement of skin blood flow and temperature at the arm and leg. Local skin temperature at the affected region was fixed at 35 C. Pain was quantified during high and low cutaneous vasoconstrictor activity (intensity of spontaneous pain, area of mechanical hyperalgesias, heat-pain thresholds). Furthermore, pain was measured before and after diagnostic sympathetic blockage to identify patients with SMP and sympathetically independent pain. Findings In patients with SMP, intensity of spontaneous pain significantly increased, by 22%, and spatial distribution of mechanical dynamic and punctate hyperalgesia increased by 42% and 27%, respectively, during high sympathetic activity compared with low activity. Heat-pain thresholds did not differ during high and low cutaneous vasoconstrictor activity (cold and warm state, 43.6degreesC vs 44.6degreesC). Pain relief after sympathetic blockage correlated with augmentation of spontaneous pain after experimental stimulation of cutaneous vasoconstrictor activity (r=0.6, p=0.0244). Interpretation We have shown that in complex regional pain syndromes with SMP, physiological activation of cutaneous vasoconstrictor neurons projecting to the painful arm or leg enhances spontaneous pain and hyperalgesia. We postulate that there is a pathological interaction between sympathetic and afferent neurons within the skin.	Univ Kiel, Neurol Klin, D-24105 Kiel, Germany; Univ Kiel, Klin Anasthesiol & Operat Intens Med, D-24105 Kiel, Germany	University of Kiel; University of Kiel	Baron, R (corresponding author), Univ Kiel, Neurol Klin, Niemannsweg 147, D-24105 Kiel, Germany.	r.baron@neurologie.uni-kiel.de	Baron, Ralf/E-4298-2010					Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; Baron R, 1999, NEUROLOGY, V52, P923, DOI 10.1212/WNL.52.5.923; Baron R, 2001, Curr Pain Headache Rep, V5, P114, DOI 10.1007/s11916-001-0079-x; Baron R, 1999, MUSCLE NERVE, V22, P678, DOI 10.1002/(SICI)1097-4598(199906)22:6<678::AID-MUS4>3.0.CO;2-P; Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; BINI G, 1980, J PHYSIOL-LONDON, V306, P537, DOI 10.1113/jphysiol.1980.sp013413; BONICA JJ, 1990, MANAGEMENT PAIN, V2, P220; CHABAL C, 1992, PAIN, V49, P9, DOI 10.1016/0304-3959(92)90181-A; Choi B, 1997, PAIN, V69, P55, DOI 10.1016/S0304-3959(96)03245-9; Drummond PD, 1996, CLIN SCI, V91, P73, DOI 10.1042/cs0910073; EVANS JA, 1946, SURG CLIN N AM, V26, P780; Fields H. L., 1987, PAIN; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Janig W, 1996, PROG BRAIN RES, V113, P161, DOI 10.1016/S0079-6123(08)61087-0; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; LEVINE JD, 1986, NATURE, V323, P158, DOI 10.1038/323158a0; Merskey H., 1994, CLASSIFICATION CHRON, V2nd ed; Price DD, 1998, CLIN J PAIN, V14, P216, DOI 10.1097/00002508-199809000-00008; RAJA SN, 1991, ANESTHESIOLOGY, V74, P691, DOI 10.1097/00000542-199104000-00012; RAJA SN, 1998, ANESTHESIOLOGY, V89, pA1083; Shi TJS, 2000, PAIN, V84, P319, DOI 10.1016/S0304-3959(99)00224-9; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; TOREBJORK E, 1995, PAIN, V63, P11, DOI 10.1016/0304-3959(95)00140-N; VELDMAN PHJM, 1993, LANCET, V342, P1012, DOI 10.1016/0140-6736(93)92877-V; Wasner G, 1998, NEUROL CLIN, V16, P851, DOI 10.1016/S0733-8619(05)70101-8; Wasner G, 2001, BRAIN, V124, P587, DOI 10.1093/brain/124.3.587; Wasner G, 1999, ARCH NEUROL-CHICAGO, V56, P613, DOI 10.1001/archneur.56.5.613; Wasner G, 2000, PAIN, V84, P331, DOI 10.1016/S0304-3959(99)00222-5; Wu G, 2001, J NEUROSCI, V21	29	171	174	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1655	1660		10.1016/S0140-6736(02)08589-6	http://dx.doi.org/10.1016/S0140-6736(02)08589-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020526				2022-12-28	WOS:000175593300009
J	Pocock, SJ; Clayton, TC; Altman, DG				Pocock, SJ; Clayton, TC; Altman, DG			Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls	LANCET			English	Article							CAPTOPRIL; LOSARTAN; TREAT	Survival plots of time-to-event data are a key component for reporting results of many clinical trials (and cohort studies). However, mistakes and distortions often arise in the display and Interpretation of survival plots. This article aims to highlight such pitfalls and provide recommendations for future practice. Findings are illustrated by topical examples and also based on a survey of recent clinical trial publications In four major journals. Specific issues are: should plots go up or down (we recommend up), how far in time to extend the plot, showing the extent of follow-up, displaying statistical uncertainty by including SEs or CIS, and exercising caution when Interpreting the shape of plots and the time-pattern of treatment difference.	Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England; Ctr Stat Med, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Pocock, SJ (corresponding author), Univ London London Sch Hyg & Trop Med, Med Stat Unit, Keppel St, London WC1E 7HT, England.	stuart.pocock@lshtm.ac.uk		Clayton, Tim/0000-0002-1266-3288				Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; ALTMAN DG, 1995, BRIT J CANCER, V72, P511, DOI 10.1038/bjc.1995.364; Altman DG, 1991, PRACTICAL STAT MED R; ALTMAN DG, 2000, STAT CONFIDENCE, pCH9; Boutitie F, 1998, STAT MED, V17, P2883, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2883::AID-SIM900>3.0.CO;2-L; Chamberlain DA, 1997, LANCET, V350, P461; Collett D, 1994, MODELLING SURVIVAL D; Hall A, 2000, LANCET, V356, P851, DOI 10.1016/S0140-6736(00)02667-2; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lubsen J, 2000, LANCET, V356, P1757, DOI 10.1016/S0140-6736(00)03215-3; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; PEDERSEN TR, 1994, LANCET, V344, P1383; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Tonkin AM, 2000, LANCET, V356, P1871, DOI 10.1016/S0140-6736(00)03257-8	15	336	341	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1686	1689		10.1016/S0140-6736(02)08594-X	http://dx.doi.org/10.1016/S0140-6736(02)08594-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020548				2022-12-28	WOS:000175593300031
J	Kim, SO; Merchant, K; Nudelman, R; Beyer, WF; Keng, T; DeAngelo, J; Hausladen, A; Stamler, JS				Kim, SO; Merchant, K; Nudelman, R; Beyer, WF; Keng, T; DeAngelo, J; Hausladen, A; Stamler, JS			OxyR: A molecular code for redox-related signaling	CELL			English	Article							DNA-BINDING ACTIVITY; NF-KAPPA-B; TRANSCRIPTIONAL REGULATOR OXYR; CALCIUM-RELEASE CHANNEL; OXIDATIVE STRESS; S-NITROSYLATION; SULFENIC ACID; NITRIC-OXIDE; MUTATIONAL ANALYSIS; NITROSATIVE STRESS	Redox regulation has been perceived as a simple on-off switch in proteins (corresponding to reduced and oxidized states). Using the transcription factor OxyR as a model, we have generated, in vitro, several stable, posttranslational modifications of the single regulatory thiol (SH), including S-NO, S-OH, and S-SG, and shown that each occurs in vivo. These modified forms of OxyR are transcriptionally active but differ in structure, cooperative properties, DNA binding affinity, and promoter activities. OxyR can thus process different redox-related signals into distinct transcriptional responses. More generally, our data suggest a code for redox control through which allosteric proteins can subserve either graded (cooperative) or maximal (noncooperative) responses, and through which differential responsivity to redox-related signals can be achieved.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Apex Biosci Inc, Res Triangle Pk, NC 27713 USA	Duke University; Duke University; Duke University; Duke University; Howard Hughes Medical Institute	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	staml001@mc.duke.edu		Stamler, Jonathan/0000-0002-6866-1572	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059130, R01HL052529] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL59130, HL52529] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; ARNELLE DR, 1995, ARCH BIOCHEM BIOPHYS, V318, P279, DOI 10.1006/abbi.1995.1231; Becker K, 1998, NAT STRUCT BIOL, V5, P267, DOI 10.1038/nsb0498-267; BRENNAN P, 1995, BBA-GENE STRUCT EXPR, V1260, P167, DOI 10.1016/0167-4781(94)00186-7; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CLAIBORNE A, 1993, FASEB J, V7, P1483, DOI 10.1096/fasebj.7.15.8262333; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DelaTorre A, 1997, BIOCHEM BIOPH RES CO, V238, P703, DOI 10.1006/bbrc.1997.7279; DEMASTER EG, 1995, BIOCHEMISTRY-US, V34, P11494, DOI 10.1021/bi00036a023; Demple B, 1998, SCIENCE, V279, P1655, DOI 10.1126/science.279.5357.1655; Ellis HR, 1997, BIOCHEMISTRY-US, V36, P15013, DOI 10.1021/bi972191x; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; GILBERT HF, 1990, ADV ENZYMOL RAMB, V63, P69; GITLER C, 1994, METHOD ENZYMOL, V233, P403; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Hare P E, 1977, Methods Enzymol, V47, P3; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hess DT, 2001, NAT CELL BIOL, V3, pE46, DOI 10.1038/35055152; Hidalgo E, 1997, CELL, V88, P121, DOI 10.1016/S0092-8674(00)81864-4; HUTCHISON KA, 1991, J BIOL CHEM, V266, P10505; Irani K, 2000, CIRC RES, V87, P179, DOI 10.1161/01.RES.87.3.179; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; KULLIK I, 1995, J BACTERIOL, V177, P1285, DOI 10.1128/jb.177.5.1285-1291.1995; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Marshall HE, 2000, FASEB J, V14, P1889, DOI 10.1096/fj.00.011rev; MATTHEWS JR, 1995, NUCLEIC ACIDS RES, V23, P3393, DOI 10.1093/nar/23.17.3393; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Pineda-Molina E, 2001, BIOCHEMISTRY-US, V40, P14134, DOI 10.1021/bi011459o; RADI R, 1991, J BIOL CHEM, V266, P4244; Rarey M, 1996, J MOL BIOL, V261, P470, DOI 10.1006/jmbi.1996.0477; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; SAVILLE B, 1958, ANALYST, V83, P670, DOI 10.1039/an9588300670; SAXENA VP, 1971, P NATL ACAD SCI USA, V68, P969, DOI 10.1073/pnas.68.5.969; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Sen CK, 1998, BIOCHEM PHARMACOL, V55, P1747, DOI 10.1016/S0006-2952(97)00672-2; Smith J.A., 2000, CURRENT PROTOCOLS MO; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; STAMLER JS, 1996, METHODS NITRIC OXIDE, P521; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Sun JH, 2001, P NATL ACAD SCI USA, V98, P11158, DOI 10.1073/pnas.201289098; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; TARTAGLIA LA, 1992, J BIOL CHEM, V267, P2038; Tell G, 1998, J BIOL CHEM, V273, P25062, DOI 10.1074/jbc.273.39.25062; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; Torchinsky Y.M., 1981, SULFUR PROTEINS, P53; WEISS V, 1992, P NATL ACAD SCI USA, V89, P5088, DOI 10.1073/pnas.89.11.5088; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	56	368	386	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2002	109	3					383	396		10.1016/S0092-8674(02)00723-7	http://dx.doi.org/10.1016/S0092-8674(02)00723-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015987	Bronze			2022-12-28	WOS:000175412100013
J	Peier, AM; Reeve, AJ; Andersson, DA; Moqrich, A; Earley, TJ; Hergarden, AC; Story, GM; Colley, S; Hogenesch, JB; McIntyre, P; Bevan, S; Patapoutian, A				Peier, AM; Reeve, AJ; Andersson, DA; Moqrich, A; Earley, TJ; Hergarden, AC; Story, GM; Colley, S; Hogenesch, JB; McIntyre, P; Bevan, S; Patapoutian, A			A heat-sensitive TRP channel expressed in keratinocytes	SCIENCE			English	Article							CAPSAICIN-RECEPTOR; MICE LACKING; NOXIOUS HEAT; CA2+ CHANNEL; ION-CHANNEL; PAIN; CURRENTS; HOMOLOG; RAT	Mechanical and thermal cues stimulate a specialized group of sensory neurons that terminate in the skin. Three members of the transient receptor potential (TRP) family of channels are expressed in subsets of these neurons and are activated at distinct physiological temperatures. Here, we describe the cloning and characterization of a novel thermosensitive TRP channel. TRPV3 has a unique threshold: It is activated at innocuous (warm) temperatures and shows an increased response at noxious temperatures. TRPV3 is specifically expressed in keratinocytes; hence, skin cells are capable of detecting heat via molecules similar to those in heat-sensing neurons.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Novartis Inst Med Sci, London WC1E 6BN, England; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	ardem@scripps.edu	Mcintyre, Peter/N-4109-2013; Andersson, David A/C-3435-2008; Bevan, Stuart/A-8821-2008	Andersson, David A/0000-0001-7451-8548; moqrich, aziz/0000-0002-1937-1675; Bevan, Stuart John/0000-0002-8977-1797; McIntyre, Peter/0000-0001-9506-5998				Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; CAUNA N, 1973, J ANAT, V115, P277; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Cockayne DA, 2000, NATURE, V407, P1011, DOI 10.1038/35039519; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Funayama M, 1996, MOL BRAIN RES, V43, P259, DOI 10.1016/S0169-328X(96)00208-2; HENSEL H, 1969, J PHYSIOL-LONDON, V204, P99, DOI 10.1113/jphysiol.1969.sp008901; HENSEL H, 1971, PFLUG ARCH EUR J PHY, V329, P1, DOI 10.1007/BF00586896; HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Nilius B, 2000, J PHYSIOL-LONDON, V527, P239, DOI 10.1111/j.1469-7793.2000.00239.x; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Peng JB, 2001, GENOMICS, V76, P99, DOI 10.1006/geno.2001.6606; ROZA C, 2001, ANN M SOC NEUR SAN D; Souslova V, 2000, NATURE, V407, P1015, DOI 10.1038/35039526; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; WILKENSEN DG, 1993, ESSENTIAL DEV BIOL P, P258	24	639	684	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2046	2049		10.1126/science.1073140	http://dx.doi.org/10.1126/science.1073140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12016205				2022-12-28	WOS:000176273300059
J	Nandy, D; Choudhuri, AR				Nandy, D; Choudhuri, AR			Explaining the latitudinal distribution of sunspots with deep meridional flow	SCIENCE			English	Article							SEATED GENERATING LAYER; TOROIDAL MAGNETIC-FIELD; SOLAR CONVECTION ZONE; DIFFERENTIAL ROTATION; DYNAMO MODELS; CIRCULATION; TACHOCLINE; REGIONS	Sunspots, dark magnetic regions occurring at tow latitudes on the Sun's surface, are tracers of the magnetic field generated by the dynamo mechanism. Recent solar dynamo models, which use the helioseismically determined solar rotation, indicate that sunspots should form at high latitudes, contrary to observations. We present a dynamo model with the correct latitudinal distribution of sunspots and demonstrate that this requires a meridional flow of material that penetrates deeper than hitherto believed, into the stable layers below the convection zone. Such a deep material flow may have important implications for turbulent convection and elemental abundance in the Sun and similar stars.	Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Choudhuri, AR (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.		Choudhuri, Arnab/E-9559-2011	Nandi, Dibyendu/0000-0001-5205-2302				BABCOCK HW, 1961, ASTROPHYS J, V133, P572, DOI 10.1086/147060; Braun DC, 1998, ASTROPHYS J, V508, pL105, DOI 10.1086/311727; Brummell NH, 1998, ASTROPHYS J, V493, P955, DOI 10.1086/305137; Charbonneau P, 1999, ASTROPHYS J, V527, P445, DOI 10.1086/308050; CHOUDHURI AR, 1987, ASTROPHYS J, V316, P788, DOI 10.1086/165243; CHOUDHURI AR, 1995, ASTRON ASTROPHYS, V303, pL29; Dikpati M, 1999, ASTROPHYS J, V518, P508, DOI 10.1086/307269; DSILVA S, 1993, ASTRON ASTROPHYS, V272, P621; Durney BR, 2000, ASTROPHYS J, V528, P486, DOI 10.1086/308166; Durney BR, 1997, ASTROPHYS J, V486, P1065, DOI 10.1086/304546; DURNEY BR, 1995, SOL PHYS, V160, P213, DOI 10.1007/BF00732805; Elliott JR, 1999, ASTROPHYS J, V516, P475, DOI 10.1086/307092; FAN Y, 1993, ASTROPHYS J, V405, P390, DOI 10.1086/172370; Giles PM, 1997, NATURE, V390, P52, DOI 10.1038/36294; Hale GE, 1908, ASTROPHYS J, V28, P315, DOI 10.1086/141602; Kosovichev AG, 1997, SOL PHYS, V170, P43, DOI 10.1023/A:1004949311268; Kuker M, 2001, ASTRON ASTROPHYS, V374, P301, DOI 10.1051/0004-6361:20010868; LEIGHTON RB, 1969, ASTROPHYS J, V156, P1, DOI 10.1086/149943; Markiel JA, 1999, ASTROPHYS J, V523, P827, DOI 10.1086/307774; Miesch MS, 2000, ASTROPHYS J, V532, P593, DOI 10.1086/308555; Nandy D, 2001, ASTROPHYS J, V551, P576, DOI 10.1086/320057; NANDY D, UNPUB; OBIAS SM, 2001, ASTROPHYS J, V549, P1183; Parker E.N., 1979, COSMICAL MAGNETIC FI; PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; Schou J, 1998, ASTROPHYS J, V505, P390, DOI 10.1086/306146; SCHWABE SH, 1844, ASTRON NACHR, V21, P2; SPIEGEL EA, 1980, NATURE, V287, P616, DOI 10.1038/287616a0; VANBALLEGOOIJEN AA, 1982, ASTRON ASTROPHYS, V113, P99; WANG YM, 1991, ASTROPHYS J, V383, P431, DOI 10.1086/170800; ZAHN JP, 1992, ASTRON ASTROPHYS, V265, P115; [No title captured]	32	184	188	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1671	1673		10.1126/science.1070955	http://dx.doi.org/10.1126/science.1070955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040189	Green Accepted			2022-12-28	WOS:000175976200052
J	Chandler, D				Chandler, D			Hydrophobicity: Two faces of water	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Chandler, D (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.							Ball Philip., 1999, H2O BIOGRAPHY WATER; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; Tanford C., 2001, NATURES ROBOTS HIST, Vfirst	5	289	295	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					491	491		10.1038/417491a	http://dx.doi.org/10.1038/417491a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037545	Bronze			2022-12-28	WOS:000175860300021
J	Jonas, MM; Kelley, DA; Mizerski, J; Badia, IB; Areias, JA; Schwarz, KB; Little, NR; Greensmith, MJ; Gardner, SD; Bell, MS; Sokal, EM; Alonso, EM; Alvarez, F; Balistreri, W; Bortolotti, F; Cabral, J; Conjeevaram, HS; Crissinger, KF; Ferreira, G; Fitzgerald, JF; Gremse, DA; Hann, HI; Harmatz, P; Jara, P; Karyda, S; Lewis, JD; Maller, E; Manolaki, N; Mohan, P; Murray, KF; Pollack, H; Porta, G; Rhoads, MJ; Schreiber, RA; Sluzewski, W; Sokol, R; Squires, R; Tassopoulos, N; Tormo, T; Treem, WR; Vajro, P; Weisdorf, S; Woynarowski, M				Jonas, MM; Kelley, DA; Mizerski, J; Badia, IB; Areias, JA; Schwarz, KB; Little, NR; Greensmith, MJ; Gardner, SD; Bell, MS; Sokal, EM; Alonso, EM; Alvarez, F; Balistreri, W; Bortolotti, F; Cabral, J; Conjeevaram, HS; Crissinger, KF; Ferreira, G; Fitzgerald, JF; Gremse, DA; Hann, HI; Harmatz, P; Jara, P; Karyda, S; Lewis, JD; Maller, E; Manolaki, N; Mohan, P; Murray, KF; Pollack, H; Porta, G; Rhoads, MJ; Schreiber, RA; Sluzewski, W; Sokol, R; Squires, R; Tassopoulos, N; Tormo, T; Treem, WR; Vajro, P; Weisdorf, S; Woynarowski, M		Int Pediat Lamivudine Investigator	Clinical trial of lamivudine in children with chronic hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; THERAPY	Background: Lamivudine therapy is effective for chronic hepatitis B infection in adults. We evaluated the efficacy and tolerability of lamivudine as a treatment for chronic infection with hepatitis B virus (HBV) in children. Methods: Children with chronic hepatitis B were randomly assigned in a 2:1 ratio to receive either oral lamivudine (3 mg per kilogram of body weight; maximum, 100 mg) or placebo once daily for 52 weeks. The primary end point was virologic response (defined by the absence of serum hepatitis B e antigen and serum HBV DNA) at week 52 of treatment. Results: Of the 403 children screened, 191 were randomly assigned to receive lamivudine and 97 to receive placebo. The rate of virologic response at week 52 was higher among children who received lamivudine than among those who received placebo (23 percent vs. 13 percent, P=0.04). Lamivudine therapy was well tolerated and was also associated with higher rates of seroconversion from hepatitis B e antigen to hepatitis B e antibody, normalization of alanine aminotransferase levels, and suppression of HBV DNA. Conclusions: In children with chronic hepatitis B, 52 weeks of treatment with lamivudine was associated with a significantly higher rate of virologic response than was placebo.	Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Diana Princess Wales Hosp, Birmingham, W Midlands, England; John Paul II Hosp, Krakow, Poland; Hosp Ninos Dr Ricardo Gutierrez, Buenos Aires, DF, Argentina; Hosp Geral de Santo Antonio, Oporto, Portugal; Johns Hopkins Univ, Baltimore, MD USA; GlaxoSmithKline, Res Triangle Pk, NC USA; GlaxoSmithKline, Greenford, Middx, England; Clin Univ St Luc, B-1200 Brussels, Belgium	Harvard University; Boston Children's Hospital; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Johns Hopkins University; GlaxoSmithKline; GlaxoSmithKline; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Jonas, MM (corresponding author), Childrens Hosp, Div Gastroenterol, 300 Longwood Ave, Boston, MA 02115 USA.		Jonas, Maureen M/E-6712-2017; Woynarowski, Marek/AAQ-7188-2020; Harmatz, Paul/AAY-5866-2020	Woynarowski, Marek/0000-0003-4533-4699; Harmatz, Paul/0000-0001-5603-2085; Sokal, Etienne/0000-0001-5597-4708				Allen MI, 1999, J CLIN MICROBIOL, V37, P3338, DOI 10.1128/JCM.37.10.3338-3347.1999; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Comanor L, 2001, J VIRAL HEPATITIS, V8, P139, DOI 10.1046/j.1365-2893.2001.00262.x; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Hoofnagle JH, 1997, NEW ENGL J MED, V336, P347, DOI 10.1056/NEJM199701303360507; HSIEH CC, 1992, AM J EPIDEMIOL, V136, P1115, DOI 10.1093/oxfordjournals.aje.a116577; Jara P, 1999, J PEDIATR GASTR NUTR, V29, P163, DOI 10.1097/00005176-199908000-00012; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Mahoney FJ, 1999, CLIN MICROBIOL REV, V12, P351, DOI 10.1128/CMR.12.2.351; Malik AH, 2000, ANN INTERN MED, V132, P723, DOI 10.7326/0003-4819-132-9-200005020-00007; Melegari M, 1998, HEPATOLOGY, V27, P628, DOI 10.1002/hep.510270243; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503; Schalm SW, 2000, GUT, V46, P562, DOI 10.1136/gut.46.4.562; Schiff E, 1998, HEPATOLOGY, V28, p388A; Sokal EM, 2000, ANTIMICROB AGENTS CH, V44, P590, DOI 10.1128/AAC.44.3.590-597.2000; Sokal EM, 1998, GASTROENTEROLOGY, V114, P988, DOI 10.1016/S0016-5085(98)70318-X; World Health Organisation (WHO), 2000, FACT SHEETS HEP B	20	204	240	0	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1706	1713		10.1056/NEJMoa012452	http://dx.doi.org/10.1056/NEJMoa012452			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037150	Green Published			2022-12-28	WOS:000175834100005
J	Skyler, JS; Brown, D; Chase, HP; Collier, E; Cowie, C; Eisenbarth, GS; Fradkin, J; Grave, G; Greenbaum, C; Jackson, RA; Kaufman, FR; Krischer, JP; Marks, JB; Palmer, JP; Ricker, A; Schatz, DA; Wilson, D; Winter, WE; Wolfsdorf, J; Zeidler, A; Dickler, H; Eastman, RC; Maclaren, NK; Malone, JI; Robertson, PR; Skyler, JS; Krischer, JP; Wolfsdorf, J; Cowie, C; Palmer, JP; Greenbaum, C; Cuthbertson, D; Rafkin-Mervis, LM; Kaufman, FR; Chase, HP; Palmer, JP; Chase, HP; Cowie, C; Fradkin, J; Eisenbarth, GS; Greenbaum, C; Herold, K; Kaufman, FR; Krischer, JP; Marks, JB; Rafkin-Mervis, L; Schatz, DA; Skyler, JS; Aneju, B; Conboy, D; Cook, R; Dennis, MA; Finney, L; Harris, S; Matheson, D; McCulloch-Olsen, M; Smith, T; Valenzuela, J; Vega, N; Crofford, OB; DeMets, D; Lachin, JM; Nerup, J; Rossini, A; Schiffrin, A; Steffes, M; Tsiatis, A; Zinman, B				Skyler, JS; Brown, D; Chase, HP; Collier, E; Cowie, C; Eisenbarth, GS; Fradkin, J; Grave, G; Greenbaum, C; Jackson, RA; Kaufman, FR; Krischer, JP; Marks, JB; Palmer, JP; Ricker, A; Schatz, DA; Wilson, D; Winter, WE; Wolfsdorf, J; Zeidler, A; Dickler, H; Eastman, RC; Maclaren, NK; Malone, JI; Robertson, PR; Skyler, JS; Krischer, JP; Wolfsdorf, J; Cowie, C; Palmer, JP; Greenbaum, C; Cuthbertson, D; Rafkin-Mervis, LM; Kaufman, FR; Chase, HP; Palmer, JP; Chase, HP; Cowie, C; Fradkin, J; Eisenbarth, GS; Greenbaum, C; Herold, K; Kaufman, FR; Krischer, JP; Marks, JB; Rafkin-Mervis, L; Schatz, DA; Skyler, JS; Aneju, B; Conboy, D; Cook, R; Dennis, MA; Finney, L; Harris, S; Matheson, D; McCulloch-Olsen, M; Smith, T; Valenzuela, J; Vega, N; Crofford, OB; DeMets, D; Lachin, JM; Nerup, J; Rossini, A; Schiffrin, A; Steffes, M; Tsiatis, A; Zinman, B		Diabetes Prevention Trial-Type 1 D	Effects of insulin in relatives of patients with type 1 diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	61st Annual Meeting of the American-Diabetes-Association	JUN 22-26, 2001	PHILADELPHIA, PA	Amer Diabet Assoc			BB WOR RATS; ISLET-CELL; HIGH-RISK; POSITIVE RELATIVES; ADOPTIVE TRANSFER; NOD MICE; IDDM; AUTOANTIBODY; PREVENTION; PROPHYLAXIS	Background: It is unknown whether insulin therapy can delay or prevent diabetes in nondiabetic relatives of patients with diabetes. Methods: In a randomized, controlled, nonblinded clinical trial, we screened 84,228 first-degree and second-degree relatives of patients with diabetes for islet-cell antibodies; 3152 tested positive; 2103 of the 3152 underwent genetic, immunologic, and metabolic staging to quantify their risk; 372 of the 2103 had a projected five-year risk of more than 50 percent; 339 of the 372 (median age, 11.2 years) were randomly assigned to undergo either close observation or an intervention that consisted of low-dose subcutaneous ultralente insulin, administered twice daily for a total dose of 0.25 unit per kilogram of body weight per day, plus annual four-day continuous intravenous infusions of insulin. Oral glucose-tolerance tests were performed every six months. Median follow-up was 3.7 years. The primary end point was a diagnosis of diabetes. Results: Diabetes was diagnosed in 69 subjects in the intervention group and 70 subjects in the observation group. The annualized rate of progression to diabetes was 15.1 percent in the intervention group and 14.6 percent in the observation group. The cumulative incidence of diabetes was similar in the two groups (relative risk in the intervention group as compared with the observation group, 0.96). Most subjects in whom diabetes developed were asymptomatic. Progression to diabetes occurred at a faster rate among subjects with abnormal base-line glucose tolerance (22 percent per year) than among those with normal base-line glucose tolerance (10 percent per year, P<0.001). There were no episodes of severe hypoglycemia. The incidence of chemical hypoglycemia, assessed without ascertainment bias, was similar in the two groups. Conclusions: In persons at high risk for diabetes, insulin at the dosage used in this study does not delay or prevent type 1 diabetes.	Univ Miami, Miami, FL 33101 USA; Univ Minnesota, Minneapolis, MN 55455 USA; Univ Colorado, Boulder, CO 80309 USA; NIDDK, Bethesda, MD 20892 USA; Childrens Hosp Los Angeles, Los Angeles, CA USA; Univ S Florida, Tampa, FL 33620 USA; Univ Miami, Coral Gables, FL 33124 USA; Univ Washington, Seattle, WA 98195 USA; Childrens Hosp, Boston, MA 02115 USA; Univ Florida, Gainesville, FL 32611 USA; Stanford Univ, Stanford, CA 94305 USA; Univ So Calif, Los Angeles, CA 90089 USA; Columbia Univ, New York, NY 10027 USA; Univ Wisconsin, Madison, WI 53706 USA; George Washington Univ, Washington, DC 20052 USA; Univ Copenhagen, DK-1168 Copenhagen, Denmark; Univ Massachusetts, Amherst, MA 01003 USA; McGill Univ, Montreal, PQ H3A 2T5, Canada; N Carolina State Univ, Raleigh, NC 27695 USA; Univ Toronto, Toronto, ON, Canada	University of Miami; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Boulder; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's Hospital Los Angeles; State University System of Florida; University of South Florida; University of Miami; University of Washington; University of Washington Seattle; Harvard University; Boston Children's Hospital; State University System of Florida; University of Florida; Stanford University; University of Southern California; Columbia University; University of Wisconsin System; University of Wisconsin Madison; George Washington University; University of Copenhagen; University of Massachusetts System; University of Massachusetts Amherst; McGill University; University of North Carolina; North Carolina State University; University of Toronto	Skyler, JS (corresponding author), Univ Miami, POB 016960, Miami, FL 33101 USA.	jskyler@miami.edu	Skyler, Jay S/F-4211-2016; Cuthbertson, David/AAC-7703-2019; Díaz, Nicanor Vega/R-4903-2019; Krischer, Jeffrey P/I-5004-2012	Skyler, Jay/0000-0003-1136-8110; Metzger, Daniel/0000-0002-1715-4319; Lachin, John/0000-0001-9838-2841	NIDDK NIH HHS [UC4 DK117009] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [UC4DK117009] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AAEN K, 1990, DIABETES, V39, P697, DOI 10.2337/diabetes.39.6.697; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; ATKINSON MA, 1990, DIABETES, V39, P933, DOI 10.2337/diabetes.39.8.933; BERTRAND S, 1992, DIABETES, V41, P1273, DOI 10.2337/diabetes.41.10.1273; BINGLEY PJ, 1992, DIABETES CARE, V15, P1313, DOI 10.2337/diacare.15.10.1313; BJORK E, 1992, DIABETOLOGIA, V35, P490, DOI 10.1007/BF02342450; BJORK E, 1992, J CLIN ENDOCR METAB, V75, P1574, DOI 10.1210/jc.75.6.1574; Bowman MA, 1996, DIABETES, V45, P205, DOI 10.2337/diabetes.45.2.205; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Fuchtenbusch M, 1998, DIABETOLOGIA, V41, P536, DOI 10.1007/s001250050943; Gavin JR, 1997, DIABETES CARE, V20, P1183; GOTFREDSEN CF, 1985, DIABETOLOGIA, V28, P933, DOI 10.1007/BF00703140; GOTTLIEB PA, 1991, DIABETOLOGIA, V34, P296, DOI 10.1007/BF00404999; Greenbaum CJ, 2000, J CLIN ENDOCR METAB, V85, P1255, DOI 10.1210/jc.85.3.1255; Haist RE, 1940, NEW ENGL J MED, V223, P607, DOI 10.1056/NEJM194010172231601; Karounos DG, 1997, J CLIN INVEST, V100, P1344, DOI 10.1172/JCI119654; KELLER RJ, 1993, LANCET, V341, P927, DOI 10.1016/0140-6736(93)91215-8; LERNMARK A, 1991, DIABETOLOGIA, V34, P534, DOI 10.1007/BF00403293; LIKE AA, 1986, J IMMUNOL, V136, P3254; NEUFELD M, 1980, DIABETES, V29, P589, DOI 10.2337/diabetes.29.8.589; PUGLIESE A, 1995, DIABETES, V44, P608, DOI 10.2337/diabetes.44.6.608; Rovet J, 1997, DIABETES CARE, V20, P803, DOI 10.2337/diacare.20.5.803; ROVET JF, 1988, CHILD DEV, V59, P226; RYAN C, 1985, PEDIATRICS, V75, P921; THIVOLET CH, 1991, DIABETOLOGIA, V34, P314, DOI 10.1007/BF00405002; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; Verge CF, 1998, DIABETES, V47, P1857, DOI 10.2337/diabetes.47.12.1857; VLAHOS WD, 1991, METABOLISM, V40, P825, DOI 10.1016/0026-0495(91)90010-T; Wilkinson G.S., 1993, WRAT 3 WIDE RANGE AC; ZIEGLER AG, 1993, DIABETES METAB REV, V9, P289, DOI 10.1002/dmr.5610090409; ZIEGLER AG, 1989, DIABETES, V38, P1320, DOI 10.2337/diabetes.38.10.1320	31	574	588	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1685	1691B						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	556DM	12037147				2022-12-28	WOS:000175834100002
J	Randall, L				Randall, L			Extra dimensions and warped geometries	SCIENCE			English	Review							SUPERSYMMETRY; HIERARCHY; SYMMETRY	The field of extra dimensions, as well as the hypothesized sizes of extra dimensions, have grown by leaps and bounds over the past few years. I summarize the new results and the reasons for the recent activity in this field. These include the observations that extra dimensions can be macroscopic or even infinite in size. Another new development is the application of extra dimensions to the determination of particle physics parameters and properties.	Harvard Univ, Jefferson Phys Lab, Cambridge, MA 02138 USA	Harvard University	Randall, L (corresponding author), Harvard Univ, Jefferson Phys Lab, Cambridge, MA 02138 USA.	randall@physics.harvard.edu						Arkani-Hamed N., 1999, Physical Review D, V59, p086004/1, DOI 10.1103/PhysRevD.59.086004; Arkani-Hamed N, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.033005; Arkani-Hamed N, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/08/017; Arkani-Hamed N, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.052003; Arkani-Hamed N, 2001, J HIGH ENERGY PHYS; Arkani-Hamed N, 1998, PHYS LETT B, V429, P263, DOI 10.1016/S0370-2693(98)00466-3; Chacko Z, 2000, J HIGH ENERGY PHYS; Chacko Z, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.055009; Cullen S, 1999, PHYS REV LETT, V83, P268, DOI 10.1103/PhysRevLett.83.268; Davoudiasl H, 2000, PHYS REV LETT, V84, P2080, DOI 10.1103/PhysRevLett.84.2080; DIMOPOULOS S, 1981, NUCL PHYS B, V193, P150, DOI 10.1016/0550-3213(81)90522-8; DIMOPOULOS S, 1981, PHYS REV D, V24, P1681, DOI 10.1103/PhysRevD.24.1681; Dvali G, 2001, PHYS REV D, V63, DOI 10.1103/PhysRevD.63.065007; Dvali G, 2000, PHYS LETT B, V485, P208, DOI 10.1016/S0370-2693(00)00669-9; Feng JL, 1999, PHYS REV LETT, V83, P1731, DOI 10.1103/PhysRevLett.83.1731; GEORGI H, 1974, PHYS REV LETT, V32, P438, DOI 10.1103/PhysRevLett.32.438; GEORGI H, 1974, PHYS REV LETT, V33, P451, DOI 10.1103/PhysRevLett.33.451; Giddings SB, 2000, J HIGH ENERGY PHYS; Goldberger WD, 1999, PHYS REV LETT, V83, P4922, DOI 10.1103/PhysRevLett.83.4922; Hawking S, 2001, J HIGH ENERGY PHYS; Hill CT, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.105005; Horava P, 1996, NUCL PHYS B, V475, P94, DOI 10.1016/0550-3213(96)00308-2; Horava P, 1996, NUCL PHYS B, V460, P506, DOI 10.1016/0550-3213(95)00621-4; Jack I, 2000, PHYS LETT B, V482, P167, DOI 10.1016/S0370-2693(00)00501-3; Kaluza T, 1921, SITZBER K PREUSS AKA, P966; Karch A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.061601; Karch A, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/06/063; Karch A, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/05/008; Katz E, 1999, J HIGH ENERGY PHYS; Klein O, 1926, Z PHYS, V37, P895, DOI 10.1007/BF01397481; Luty MA, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.066004; Lykken J, 2000, J HIGH ENERGY PHYS; LYKKEN J, 2002, PHYS TODAY PHYS RE D, V54, P40; Lykken JD, 1996, PHYS REV D, V54, pR3693, DOI 10.1103/PhysRevD.54.R3693; PATI JC, 1973, PHYS REV D, V8, P1240, DOI 10.1103/PhysRevD.8.1240; Polchinski J, 1995, PHYS REV LETT, V75, P4724, DOI 10.1103/PhysRevLett.75.4724; Pomarol A, 1999, J HIGH ENERGY PHYS; Randall L, 1999, NUCL PHYS B, V557, P79, DOI 10.1016/S0550-3213(99)00359-4; Randall L, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.081801; Randall L, 1999, PHYS REV LETT, V83, P3370, DOI 10.1103/PhysRevLett.83.3370; Rattazzi R, 2001, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2001/04/021; Verlinde H, 2000, NUCL PHYS B, V580, P264, DOI 10.1016/S0550-3213(00)00224-8	44	48	48	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1422	1427		10.1126/science.1072567	http://dx.doi.org/10.1126/science.1072567			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029124				2022-12-28	WOS:000175910300036
J	Sartori, C; Allemann, Y; Duplain, H; Lepori, M; Egli, M; Lipp, E; Hutter, D; Turini, P; Hugli, O; Cook, S; Nicod, P; Scherrer, U				Sartori, C; Allemann, Y; Duplain, H; Lepori, M; Egli, M; Lipp, E; Hutter, D; Turini, P; Hugli, O; Cook, S; Nicod, P; Scherrer, U			Salmeterol for the prevention of high-altitude pulmonary edema.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-ADRENERGIC AGONIST; ALVEOLAR FLUID CLEARANCE; LUNG LIQUID CLEARANCE; EPITHELIAL SODIUM; POTENTIAL-DIFFERENCE; TRANSPORT; SUSCEPTIBILITY; TERBUTALINE; DYSFUNCTION; MECHANISMS	Background: Pulmonary edema results from a persistent imbalance between forces that drive water into the air space and the physiologic mechanisms that remove it. Among the latter, the absorption of liquid driven by active alveolar transepithelial sodium transport has an important role; a defect of this mechanism may predispose patients to pulmonary edema. Beta-adrenergic agonists up-regulate the clearance of alveolar fluid and attenuate pulmonary edema in animal models. Methods: In a double-blind, randomized, placebo-controlled study, we assessed the effects of prophylactic inhalation of the beta-adrenergic agonist salmeterol on the incidence of pulmonary edema during exposure to high altitudes (4559 m, reached in less than 22 hours) in 37 subjects who were susceptible to high-altitude pulmonary edema. We also measured the nasal transepithelial potential difference, a marker of the transepithelial sodium and water transport in the distal airways, in 33 mountaineers who were prone to high-altitude pulmonary edema and 33 mountaineers who were resistant to this condition. Results: Prophylactic inhalation of salmeterol decreased the incidence of high-altitude pulmonary edema in susceptible subjects by more than 50 percent, from 74 percent with placebo to 33 percent (P=0.02). The nasal potential-difference value under low-altitude conditions was more than 30 percent lower in the subjects who were susceptible to high-altitude pulmonary edema than in those who were not susceptible (P<0.001). Conclusions: Prophylactic inhalation of a beta-adrenergic agonist reduces the risk of high-altitude pulmonary edema. Sodium-dependent absorption of liquid from the airways may be defective in patients who are susceptible to high-altitude pulmonary edema. These findings support the concept that sodium-driven clearance of alveolar fluid may have a pathogenic role in pulmonary edema in humans and therefore represent an appropriate target for therapy. (N Engl J Med 2002;346:1631-6.) Copyright (C) 2002 Massachusetts Medical Society.	CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; CHU Vaudois, Botnar Ctr Clin Res, CH-1011 Lausanne, Switzerland; Univ Hosp Bern, Swiss Cardiovasc Ctr, CH-3010 Bern, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern; University Hospital of Bern	Scherrer, U (corresponding author), CHU Vaudois, Dept Internal Med, BH 10-642, CH-1011 Lausanne, Switzerland.	urs.scherrer@chuv.hospvd.ch	Hugli, Olivier/AAA-7057-2020	Sartori, Claudio/0000-0002-8172-3002; Hugli, Olivier/0000-0003-2312-1625				Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; Barker PM, 1997, J PEDIATR-US, V130, P373, DOI 10.1016/S0022-3476(97)70198-7; BERTHIAUME Y, 1988, J APPL PHYSIOL, V65, P585, DOI 10.1152/jappl.1988.65.2.585; BERTHIAUME Y, 1987, J CLIN INVEST, V79, P335, DOI 10.1172/JCI112817; Campbell AR, 1999, J APPL PHYSIOL, V86, P139, DOI 10.1152/jappl.1999.86.1.139; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; CRANDALL ED, 1986, J APPL PHYSIOL, V60, P289, DOI 10.1152/jappl.1986.60.1.289; Egli M, 2000, FASEB J, V14, pA127; Frank JA, 2000, J APPL PHYSIOL, V89, P1255, DOI 10.1152/jappl.2000.89.4.1255; Garat C, 1997, CHEST, V111, P1381, DOI 10.1378/chest.111.5.1381; Garat C, 1998, J APPL PHYSIOL, V84, P1763, DOI 10.1152/jappl.1998.84.5.1763; Geiser T, 2001, AM J RESP CRIT CARE, V163, P1384, DOI 10.1164/ajrccm.163.6.2006131; Hofmann T, 1997, AM J RESP CRIT CARE, V155, P1908; Hummler E, 1996, NAT GENET, V12, P325, DOI 10.1038/ng0396-325; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Lasnier JM, 1996, J APPL PHYSIOL, V81, P1723, DOI 10.1152/jappl.1996.81.4.1723; Lepori M, 1998, FASEB J, V12, pA39; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matalon S, 1996, AM J PHYSIOL-LUNG C, V271, pL1, DOI 10.1152/ajplung.1996.271.1.L1; Matthay MA, 1998, P ASSOC AM PHYSICIAN, V110, P496; MATTHAY MA, 1990, AM REV RESPIR DIS, V142, P1250, DOI 10.1164/ajrccm/142.6_Pt_1.1250; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; SAKUMA T, 1994, AM J RESP CRIT CARE, V150, P305, DOI 10.1164/ajrccm.150.2.8049807; Saldias FJ, 2000, AM J RESP CRIT CARE, V162, P282, DOI 10.1164/ajrccm.162.1.9809058; Scherrer U, 1996, NEW ENGL J MED, V334, P624, DOI 10.1056/NEJM199603073341003; STAUB NC, 1974, PHYSIOL REV, V54, P678, DOI 10.1152/physrev.1974.54.3.678; SUZUKI S, 1995, AM J PHYSIOL-LUNG C, V268, pL983, DOI 10.1152/ajplung.1995.268.6.L983; Tomlinson LA, 1999, AM J PHYSIOL-LUNG C, V277, pL881, DOI 10.1152/ajplung.1999.277.5.L881; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; WHELAN CJ, 1992, BRIT J PHARMACOL, V105, P831, DOI 10.1111/j.1476-5381.1992.tb09065.x	32	281	296	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1631	1636		10.1056/NEJMoa013183	http://dx.doi.org/10.1056/NEJMoa013183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023995	Green Published			2022-12-28	WOS:000175728600005
J	Williams, A; Sheldon, CD; Riordan, T				Williams, A; Sheldon, CD; Riordan, T			Lesson of the week - Cat scratch disease	BRITISH MEDICAL JOURNAL			English	Review							ROCHALIMAEA; BARTONELLA		St Thomas Hlth Ctr, Exeter EX4 1HJ, Devon, England; Royal Devon & Exeter Hosp, Publ Hlth Lab, Exeter EX2 5DW, Devon, England	University of Exeter	Williams, A (corresponding author), St Thomas Hlth Ctr, Exeter EX4 1HJ, Devon, England.							Bass JW, 1998, PEDIATR INFECT DIS J, V17, P447, DOI 10.1097/00006454-199806000-00002; BRENNER DJ, 1993, INT J SYST BACTERIOL, V43, P777, DOI 10.1099/00207713-43-4-777; CARITHERS HA, 1969, J AMER MED ASSOC, V207, P312, DOI 10.1001/jama.207.2.312; DANIELS WB, 1954, JAMA-J AM MED ASSOC, V154, P1247, DOI 10.1001/jama.1954.02940490011003; KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531; Margileth A M, 1993, Adv Pediatr Infect Dis, V8, P1; Relman DA, 1998, CLIN INFECT DIS, V26, P1300, DOI 10.1086/516347; SCHWARTZMAN WA, 1992, CLIN INFECT DIS, V15, P893, DOI 10.1093/clind/15.6.893; VINSON JW, 1969, AM J TROP MED HYG, V18, P713, DOI 10.4269/ajtmh.1969.18.713; Zangwrill K. M., 1996, NEW ENGL J MED, V329, P8	10	4	4	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1199	1200		10.1136/bmj.324.7347.1199	http://dx.doi.org/10.1136/bmj.324.7347.1199			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016189	Green Published			2022-12-28	WOS:000175763200024
J	Colman, SM				Colman, SM			Paleoclimate - A fresh look at glacial floods	SCIENCE			English	Editorial Material							LAURENTIDE ICE-SHEET; CLIMATE-CHANGE; YOUNGER DRYAS; MELTWATER; RECORD; OCEAN		US Geol Survey, Woods Hole, MA 02543 USA	United States Department of the Interior; United States Geological Survey	Colman, SM (corresponding author), US Geol Survey, 384 Woods Hole Rd, Woods Hole, MA 02543 USA.		Colman, Steven M/E-4658-2012					BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Clark PU, 2001, SCIENCE, V293, P283, DOI 10.1126/science.1062517; CLARK PU, 1994, QUATERNARY RES, V41, P19, DOI 10.1006/qres.1994.1002; CLAYTON L, 1985, BOREAS, V14, P235; COLMAN S M, 1990, Journal of Paleolimnology, V4, P269; COLMAN SM, 1994, GEOLOGY, V22, P547, DOI 10.1130/0091-7613(1994)022<0547:TEOMIF>2.3.CO;2; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Fanning AF, 1997, PALEOCEANOGRAPHY, V12, P307, DOI 10.1029/96PA03726; Licciardi JM, 1999, GEOPH MONOG SERIES, V112, P177; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; Moore TC, 2000, PALEOCEANOGRAPHY, V15, P4, DOI 10.1029/1999PA000437; Patterson CJ, 1998, GEOLOGY, V26, P643, DOI 10.1130/0091-7613(1998)026<0643:LGLTRO>2.3.CO;2; REA DK, 1994, GEOLOGY, V22, P1059, DOI 10.1130/0091-7613(1994)022<1059:GLPCIO>2.3.CO;2; Schmittner A, 2002, SCIENCE, V295, P1489, DOI 10.1126/science.1066174; Stuiver M, 1995, QUATERNARY RES, V44, P341, DOI 10.1006/qres.1995.1079; Teller JT, 2002, QUATERNARY SCI REV, V21, P879, DOI 10.1016/S0277-3791(01)00145-7	17	7	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1251	1252		10.1126/science.1073377	http://dx.doi.org/10.1126/science.1073377			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016297				2022-12-28	WOS:000175713000034
J	Makishima, M; Lu, TT; Xie, W; Whitfield, GK; Domoto, H; Evans, RM; Haussler, MR; Mangelsdorf, DJ				Makishima, M; Lu, TT; Xie, W; Whitfield, GK; Domoto, H; Evans, RM; Haussler, MR; Mangelsdorf, DJ			Vitamin D receptor as an intestinal bile acid sensor	SCIENCE			English	Article							LITHOCHOLIC ACID; NUCLEAR RECEPTORS; INTRARECTAL INSTILLATION; COLON CARCINOGENESIS; RATS; IDENTIFICATION; CALCIUM; CYP3A4; CANCER	The vitamin D receptor (VDR) mediates the effects of the calcemic hormone 1alpha-,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3]. We show that VDR also functions as a receptor for the secondary bile acid lithocholic acid (LCA), which is hepatotoxic and a potential enteric carcinogen. VDR is an order of magnitude more sensitive to LCA and its metabolites than are other nuclear receptors. Activation of VDR by LCA or vitamin D induced expression in vivo of CYP3A, a cytochrome P450 enzyme that detoxifies LCA in the liver and intestine. These studies offer a mechanism that may explain the proposed protective effects of vitamin D and its receptor against colon cancer.	Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, Dallas, TX 75390 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, San Diego, CA 92186 USA; Univ Arizona, Coll Med, Dept Biochem & Mol Biophys, Tucson, AZ 85724 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Salk Institute; University of Arizona	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Xie, Wen/M-1768-2016; Evans, Ronald/AAF-4001-2019	Evans, Ronald/0000-0002-9986-5965; Haussler, Mark/0000-0002-7097-1801; Mangelsdorf, David/0000-0002-4355-0796				Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Garland CF, 1999, ANN NY ACAD SCI, V889, P107, DOI 10.1111/j.1749-6632.1999.tb08728.x; HAMADA K, 1994, CARCINOGENESIS, V15, P1911, DOI 10.1093/carcin/15.9.1911; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Kallay E, 2001, CARCINOGENESIS, V22, P1429, DOI 10.1093/carcin/22.9.1429; KAWAURA A, 1989, CARCINOGENESIS, V10, P647, DOI 10.1093/carcin/10.4.647; Kissmeyer AM, 1997, BIOCHEM PHARMACOL, V53, P1087, DOI 10.1016/S0006-2952(96)00816-7; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Lipkin M, 1999, ANNU REV NUTR, V19, P545, DOI 10.1146/annurev.nutr.19.1.545; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; NARISAWA T, 1974, JNCI-J NATL CANCER I, V53, P1093, DOI 10.1093/jnci/53.4.1093; Ogawa A, 1998, JPN J CANCER RES, V89, P1154, DOI 10.1111/j.1349-7006.1998.tb00510.x; OWEN R W, 1987, Nutrition and Cancer, V9, P73; PENCE BC, 1988, CARCINOGENESIS, V9, P187, DOI 10.1093/carcin/9.1.187; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; Sippel CJ, 1997, J BIOL CHEM, V272, P18290, DOI 10.1074/jbc.272.29.18290; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398	23	868	897	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1313	1316		10.1126/science.1070477	http://dx.doi.org/10.1126/science.1070477			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016314				2022-12-28	WOS:000175713000053
J	Shaw, PJ; Tononi, G; Greenspan, RJ; Robinson, DF				Shaw, PJ; Tononi, G; Greenspan, RJ; Robinson, DF			Stress response genes protect against lethal effects of sleep deprivation in Drosophila	NATURE			English	Article							HEAT-SHOCK; MELANOGASTER; TRANSCRIPTION; TIMELESS; MUTANTS; RATS; HOMEOSTASIS; RHYTHMS; LESIONS; PERIOD	Sleep is controlled by two processes: a homeostatic drive that increases during waking and dissipates during sleep, and a circadian pacemaker that controls its timing(1). Although these two systems can operate independently(2,3), recent studies indicate a more intimate relationship(4,5). To study the interaction between homeostatic and circadian processes in Drosophila, we examined homeostasis in the canonical loss-of-function clock mutants period (per(01)), timeless (tim(01)), clock (Clk(jrk)) and cycle (cyc(01))(6-9). cyc(01) mutants showed a disproportionately large sleep rebound and died after 10 hours of sleep deprivation, although they were more resistant than other clock mutants to various stressors. Unlike other clock mutants, cyc(01) flies showed a reduced expression of heat-shock genes after sleep loss. However, activating heat-shock genes before sleep deprivation rescued cyc(01) flies from its lethal effects. Consistent with the protective effect of heat-shock genes, was the observation that flies carrying a mutation for the heat-shock protein Hsp83 (Hsp83(08445))(10) showed exaggerated homeostatic response and died after sleep deprivation. These data represent the first step in identifying the molecular mechanisms that constitute the sleep homeostat.	Inst Neurosci, San Diego, CA 92121 USA		Shaw, PJ (corresponding author), Inst Neurosci, 10640 John J Hopkins Dr, San Diego, CA 92121 USA.		Tononi, Giulio/B-8387-2009					Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antle MC, 2000, J NEUROSCI, V20, P9326; Armitage R., 2001, SLEEP, V4, P33; ASHBURNER M, 1970, CHROMOSOMA, V31, P356, DOI 10.1007/BF00321231; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; CASTRILLON DH, 1993, GENETICS, V135, P489; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; CORNELIUS G, 1995, CELL SIGNAL, V7, P611, DOI 10.1016/0898-6568(95)00027-M; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Ekengren S, 2001, CURR BIOL, V11, P714, DOI 10.1016/S0960-9822(01)00203-2; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; HOMYK T, 1980, MOL GEN GENET, V177, P553; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Ma E, 1999, MOL BRAIN RES, V73, P11, DOI 10.1016/S0169-328X(99)00224-7; Marchler G, 2001, EMBO J, V20, P499, DOI 10.1093/emboj/20.3.499; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Naylor E, 2000, J NEUROSCI, V20, P8138; ORNELLES DA, 1990, J CELL SCI, V95, P393; Perezgasga L, 1999, FEBS LETT, V456, P269, DOI 10.1016/S0014-5793(99)00963-1; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RECHTSCHAFFEN A, 1989, SLEEP, V12, P68; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sapolsky RM, 2000, NEUROBIOL DIS, V7, P540, DOI 10.1006/nbdi.2000.0350; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; Yoshida EN, 1999, GENOME, V42, P1077, DOI 10.1139/gen-42-6-1077	30	322	340	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					287	291		10.1038/417287a	http://dx.doi.org/10.1038/417287a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015603				2022-12-28	WOS:000175592100047
J	Hodgson, H				Hodgson, H			Hormonal therapy for gastrointestinal angiodysplasia	LANCET			English	Editorial Material							HEREDITARY HEMORRHAGIC TELANGIECTASIA; ESTROGEN-PROGESTERONE; VASCULAR MALFORMATIONS; CLINICAL-TRIAL; ABNORMALITIES; TRACT		UCL Royal Free & Univ Coll Sch Med, Dept Med, London NW3 2PF, England	University of London; University College London	Hodgson, H (corresponding author), UCL Royal Free & Univ Coll Sch Med, Dept Med, London NW3 2PF, England.	h.hodgson@rfc.ucl.ac.uk						BOLEY SJ, 1977, RADIOLOGY, V125, P615, DOI 10.1148/125.3.615; BRONNER MH, 1986, ANN INTERN MED, V105, P371, DOI 10.7326/0003-4819-105-3-371; Gordon FH, 2001, BEST PRACT RES CL GA, V15, P41, DOI 10.1053/bega.2000.0155; GUPTA N, 1995, DIS COLON RECTUM, V38, P979, DOI 10.1007/BF02049736; Junquera F, 2001, GASTROENTEROLOGY, V121, P1073, DOI 10.1053/gast.2001.28650; LEWIS BS, 1992, J CLIN GASTROENTEROL, V15, P99, DOI 10.1097/00004836-199209000-00004; LIU YK, 1984, LANCET, V2, P887; Marshall JK, 1997, EUR J GASTROEN HEPAT, V9, P521, DOI 10.1097/00042737-199705000-00020; MATHUSVLIEGEN EMH, 1989, INT J COLORECTAL DIS, V4, P20, DOI 10.1007/BF01648545; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; Schmit A, 1996, DIGEST DIS SCI, V41, P2348, DOI 10.1007/BF02100126; Shovlin CL, 1997, THROMB HAEMOSTASIS, V78, P145; Tran A, 1999, AM J GASTROENTEROL, V94, P2909, DOI 10.1111/j.1572-0241.1999.01436.x; VANCUTSEM E, 1990, LANCET, V335, P953, DOI 10.1016/0140-6736(90)91010-8; VASE P, 1981, ACTA MED SCAND, V209, P393	15	24	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1630	1631		10.1016/S0140-6736(02)08542-2	http://dx.doi.org/10.1016/S0140-6736(02)08542-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020519				2022-12-28	WOS:000175593300002
J	Darveau, CA; Suarez, RK; Andrews, RD; Hochachka, PW				Darveau, CA; Suarez, RK; Andrews, RD; Hochachka, PW			Allometric cascade as a unifying principle of body mass effects on metabolism	NATURE			English	Article							OXYGEN-CONSUMPTION; SKELETAL-MUSCLE; ATP UTILIZATION; MAMMALS; TURNOVER; BIRDS; HEART; CAPACITIES; ANIMALS; RATES	The power function of basal metabolic rate scaling is expressed as aM(b), where a corresponds to a scaling constant (intercept), M is body mass, and b is the scaling exponent. The 3/4 power law (the best-fit b value for mammals) was developed from Kleiber's original analysis(1) and, since then, most workers have searched for a single cause to explain the observed allometry. Here we present a multiple-causes model of allometry, where the exponent b is the sum of the influences of multiple contributors to metabolism and control. The relative strength of each contributor, with its own characteristic exponent value, is determined by the control contribution. To illustrate its use, we apply this model to maximum versus basal metabolic rates to explain the differing scaling behaviour of these two biological states in mammals. The main difference in scaling is that, for the basal metabolic rate, the O-2 delivery steps contribute almost nothing to the global b scaling exponent, whereas for the maximum metabolic rate, the O-2 delivery steps significantly increase the global b value.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of British Columbia; University of California System; University of California Santa Barbara	Hochachka, PW (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	pwh@zoology.ubc.ca		Andrews, Russel/0000-0002-4545-137X				ARMSTRONG RB, 1985, J EXP BIOL, V115, P201; Banavar JR, 1999, NATURE, V399, P130, DOI 10.1038/20144; Bishop CM, 1997, PHILOS T R SOC B, V352, P447, DOI 10.1098/rstb.1997.0032; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Brody S., 1945, BIOENERGETICS GROWTH; Fuery CJ, 1998, COMP BIOCHEM PHYS A, V119, P459, DOI 10.1016/S1095-6433(97)00452-2; HAMILTON N, 1991, MOL CELL BIOCHEM, V106, P133; HEGLUND NC, 1974, SCIENCE, V186, P1112, DOI 10.1126/science.186.4169.1112; HOCHACHKA PW, 1991, P NATL ACAD SCI USA, V88, P5764, DOI 10.1073/pnas.88.13.5764; Hochachka PW., 1994, MUSCLES MOL METABOLI; HOCHACHKA PW, 2002, ADAPTATION MECH PROC; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Jeneson JAL, 2000, AM J PHYSIOL-CELL PH, V279, pC813, DOI 10.1152/ajpcell.2000.279.3.C813; Jones JH, 1998, COMP BIOCHEM PHYS B, V120, P125, DOI 10.1016/S0305-0491(98)00027-3; KLEIBER MAX, 1932, HILGARDIA, V6, P315; LINDSTEDT SL, 1985, AM J PHYSIOL, V249, pR699, DOI 10.1152/ajpregu.1985.249.6.R699; Lovegrove BG, 2000, AM NAT, V156, P201, DOI 10.1086/303383; Nagy KA, 1999, ANNU REV NUTR, V19, P247, DOI 10.1146/annurev.nutr.19.1.247; PORTER RK, 1993, NATURE, V362, P628, DOI 10.1038/362628a0; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Szentesi P, 2001, J PHYSIOL-LONDON, V531, P393, DOI 10.1111/j.1469-7793.2001.0393i.x; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; WAGNER PD, 1993, RESP PHYSIOL, V93, P221, DOI 10.1016/0034-5687(93)90007-W; WATERLOW JC, 1984, Q J EXP PHYSIOL CMS, V69, P409, DOI 10.1113/expphysiol.1984.sp002829; Weber JM, 1997, COMP BIOCHEM PHYS A, V118, P713, DOI 10.1016/S0300-9629(97)00020-0; Weibel E.R., 2000, SYMMORPHOSIS FORM FU; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677	30	364	378	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					166	170		10.1038/417166a	http://dx.doi.org/10.1038/417166a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000958				2022-12-28	WOS:000175460200041
J	Ramaley, PA; French, N; Kaleebu, P; Gilks, C; Whitworth, J; Hill, AVS				Ramaley, PA; French, N; Kaleebu, P; Gilks, C; Whitworth, J; Hill, AVS			HIV in Africa - Chemokine-receptor genes and AIDS risk	NATURE			English	Article							DISEASE PROGRESSION; CCR5; POLYMORPHISM; HAPLOTYPES; VARIANTS		Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; Uganda Virus Res Inst Med Res Council UK Programm, Entebbe, Uganda	University of Oxford; Wellcome Centre for Human Genetics; Liverpool School of Tropical Medicine; University of Liverpool	Ramaley, PA (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.		HILL, Adrian V>S>/C-1306-2008; Gilks, Charles/B-4184-2012; French, Neil/A-2994-2012	Gilks, Charles/0000-0002-8953-3123; French, Neil/0000-0003-4814-8293				An P, 2000, AIDS, V14, P2117, DOI 10.1097/00002030-200009290-00007; AnsariLari MA, 1997, NAT GENET, V16, P221, DOI 10.1038/ng0797-221; Carrington M, 1997, AM J HUM GENET, V61, P1261, DOI 10.1086/301645; Clegg AO, 2000, AIDS, V14, P103, DOI 10.1097/00002030-200001280-00004; French N, 2000, LANCET, V355, P2106, DOI 10.1016/S0140-6736(00)02377-1; Gonzalez E, 1999, P NATL ACAD SCI USA, V96, P12004, DOI 10.1073/pnas.96.21.12004; Kostrikis LG, 1999, J VIROL, V73, P10264, DOI 10.1128/JVI.73.12.10264-10271.1999; Martin MP, 1998, SCIENCE, V282, P1907, DOI 10.1126/science.282.5395.1907; McDermott DH, 1998, LANCET, V352, P866, DOI 10.1016/S0140-6736(98)04158-0; Mummidi S, 1998, NAT MED, V4, P786, DOI 10.1038/nm0798-786; Petersen DC, 2001, AIDS, V15, P171, DOI 10.1097/00002030-200101260-00005; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Smith MW, 1997, SCIENCE, V277, P959, DOI 10.1126/science.277.5328.959	13	20	21	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					140	140		10.1038/417140a	http://dx.doi.org/10.1038/417140a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000952	Bronze			2022-12-28	WOS:000175460200033
J	McQuillan, GM; Kruszon-Moran, D; Deforest, A; Chu, SY; Wharton, M				McQuillan, GM; Kruszon-Moran, D; Deforest, A; Chu, SY; Wharton, M			Serologic immunity to diphtheria and tetanus in the United States	ANNALS OF INTERNAL MEDICINE			English	Article								Background: Serologic data on diseases that are preventable by vaccine are useful to evaluate the success of immunization programs and to identify susceptible subgroups. Objective: To provide national estimates of immunity to diphtheria and tetanus by measurement of serum antibody levels. Design: Examination of data from the Third National Health and Nutrition Examination Survey, a representative cross-sectional sample of the U.S. population. Setting: 89 randomly selected locations throughout the United States. Participants: 18 045 persons 6 years of age or older who were examined from 1988 to 1994. Measurements: Serum samples obtained at a single time point were tested for diphtheria and tetanus antitoxin. Results: Overall, 60.5% of Americans 6 years of age or older had fully protective levels of diphtheria antibody (greater than or equal to0.10 IU/mL) and 72.3% had protective levels of tetanus antibody (>0.15 IU/mL). Ninety-one percent of Americans 6 to 11 years of age had protective levels of both diphtheria and tetanus antibody; this proportion decreased to approximately 30% among persons 70 years of age (29.5% for diphtheria and 31.0% for tetanus). Adult Mexican-Americans were slightly less likely to have protective levels of antibody to both toxins. Only 47% of persons 20 years of age or older had levels that were protective against both diseases, and only 63% of adults who were protected against tetanus were also protected against diphtheria. Conclusions: A substantial proportion of adults in the United States do not have antibody levels that are protective against diphtheria and tetanus. In addition, although the recommended vaccine is a combination of tetanus and diphtheria, only 63% of adults with protective antibody to tetanus also had protective antibody to diphtheria.	Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Examinat Stat, Hyattsville, MD 20782 USA; St Christophers Hosp Children, Philadelphia, PA 19133 USA; Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	McQuillan, GM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Div Hlth Examinat Stat, 6525 Belcrest Rd,Room 1000, Hyattsville, MD 20782 USA.	gmm2@cdc.gov						*ADV COMM IMM PRAC, 1996, MMWR-MORBID MORTAL W, V45, P1; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1994, VITAL HLTH STAT, P1; BALESTRA DJ, 1993, J GEN INTERN MED, V8, P405, DOI 10.1007/BF02599616; DEFOREST A, 1988, PEDIATRICS, V81, P237; EZZATI T, 1993, 1992 P SURV RES METH, P339; GERGEN P, 1995, NEW ENGL J MED, V332, P761, DOI 10.1056/NEJM199503233321201; IPSEN J, 1954, NEW ENGL J MED, V251, P459, DOI 10.1056/NEJM195409162511202; IPSEN J, 1946, J IMMUNOL, V54, P325; Kahn HA, 1989, STAT METHODS EPIDEMI; MIYAMURA K, 1974, J BIOL STAND, V2, P189, DOI 10.1016/0092-1157(74)90015-8; MOHADJER L, 1996, NATL HLTH NUTR EXAMI; ORENSTEIN WA, 1983, SCI PUBLICATION, V451, P30; SHAH BV, 1991, SUDAAN USERS MANUAL; SIMONSEN O, 1986, J BIOL STAND, V14, P231, DOI 10.1016/0092-1157(86)90008-9; Singleton J A, 2000, MMWR CDC Surveill Summ, V49, P39; VIRELLA G, 1991, J CLIN LAB ANAL, V5, P43, DOI 10.1002/jcla.1860050108; Vitek CR, 1998, EMERG INFECT DIS, V4, P539, DOI 10.3201/eid0404.980404; 1997, MMWR MORB MORTAL WKL, V46, P506; 2001, MMWR MORB MORTAL WKL, V50, P19; 2001, MMWR MORB MORTAL WKL, V50, P7; 2000, MMWR MORB MORTAL WKL, V49, P39; 2000, MMWR MORB MORTAL WKL, V49, P585; 2002, MMWR MORB MORTAL WKL, V50, P1159	24	124	136	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					660	666		10.7326/0003-4819-136-9-200205070-00008	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547XK	11992301				2022-12-28	WOS:000175357900003
J	Brembs, B; Lorenzetti, FD; Reyes, FD; Baxter, DA; Byrne, JH				Brembs, B; Lorenzetti, FD; Reyes, FD; Baxter, DA; Byrne, JH			Operant reward learning in Aplysia: Neuronal correlates and mechanisms	SCIENCE			English	Article							IN-VITRO ANALOG; CELLULAR MECHANISM; FUNCTIONAL DYNAMICS; REINFORCEMENT; IDENTIFICATION; MEMORY; FOOD	Operant conditioning is a form of associative learning through which an animal learns about the consequences of its behavior, Here, we report an appetitive operant conditioning procedure in Aplysia that induces long-term memory. Biophysical changes that accompanied the memory were found in an identified neuron (cell B51) that is considered critical for the expression of behavior that was rewarded. Similar cellular changes in B51 were produced by contingent reinforcement of B51 with dopamine in a single-cell analog of the operant procedure. These findings allow for the detailed analysis of the cellular and molecular processes underlying operant conditioning.	Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77030 USA	University of Texas System	Byrne, JH (corresponding author), Univ Texas, Sch Med, WM Keck Ctr Neurobiol Learning & Memory, Dept Neurobiol & Anat, Houston, TX 77030 USA.	john.h.byrne@uth.tmc.edu	Brembs, Björn/A-9970-2008	Brembs, Björn/0000-0001-7824-7650	NIMH NIH HHS [MH 58321] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Benjamin PR, 2000, LEARN MEMORY, V7, P124, DOI 10.1101/lm.7.3.124; Botzer D, 1998, LEARN MEMORY, V5, P204; COOK DG, 1989, J NEUROSCI, V9, P3115; Cropper EC, 1996, CURR OPIN NEUROBIOL, V6, P833, DOI 10.1016/S0959-4388(96)80035-3; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HOYLE G, 1979, TRENDS NEUROSCI, V2, P153, DOI 10.1016/0166-2236(79)90060-2; Kabotyanski EA, 1998, J NEUROPHYSIOL, V79, P605, DOI 10.1152/jn.1998.79.2.605; Kim JJ, 1998, SCIENCE, V279, P570, DOI 10.1126/science.279.5350.570; Lechner HA, 2000, J NEUROSCI, V20, P3377, DOI 10.1523/JNEUROSCI.20-09-03377.2000; Lechner HA, 2000, J NEUROSCI, V20, P3369, DOI 10.1523/JNEUROSCI.20-09-03369.2000; MORTON DW, 1993, J COMP PHYSIOL A, V172, P17, DOI 10.1007/BF00214712; MOZZACHIODI R, 2001, 31 ANN M SOC NEUR SA; Nargeot R, 1999, J NEUROSCI, V19, P2261; Nargeot R, 1999, J NEUROSCI, V19, P2247; Nargeot R, 1999, J NEUROPHYSIOL, V81, P1983, DOI 10.1152/jn.1999.81.4.1983; Nargeot R, 1997, J NEUROSCI, V17, P8093; Pavlov I.P., 1927, CONDITIONED REFLEXES; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHWARZ M, 1986, J NEUROSCI, V6, P1528; Skinner B. F., 1938, BEHAV ORGAN EXP ANAL; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; WALTERS ET, 1983, SCIENCE, V219, P405, DOI 10.1126/science.6294834; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672	25	183	187	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1706	1709		10.1126/science.1069434	http://dx.doi.org/10.1126/science.1069434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040200	Green Submitted			2022-12-28	WOS:000175976200065
J	Lucht, W; Prentice, IC; Myneni, RB; Sitch, S; Friedlingstein, P; Cramer, W; Bousquet, P; Buermann, W; Smith, B				Lucht, W; Prentice, IC; Myneni, RB; Sitch, S; Friedlingstein, P; Cramer, W; Bousquet, P; Buermann, W; Smith, B			Climatic control of the high-latitude vegetation greening trend and Pinatubo effect	SCIENCE			English	Article							MOUNT-PINATUBO; LAND; INDEX; CO2	A biogeochemical model of vegetation using observed climate data predicts the high northern latitude greening trend over the past two decades observed by satellites and a marked setback in this trend after the Mount Pinatubo, volcano eruption in 1991. The observed trend toward earlier spring budburst and increased maximum leaf area is produced by the model as a consequence of biogeochemical vegetation responses mainly to changes in temperature. The post-Pinatubo decline in vegetation in 1992-1993 is apparent as the effect of temporary cooling caused by the eruption. High-latitude CO2 uptake during these years is predicted as a consequence of the differential response of heterotrophic respiration and net primary production.	Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; Max Planck Inst Biogeochem, D-07745 Jena, Germany; Boston Univ, Dept Geog, Boston, MA 02215 USA; Lab Sci Climat & Environm, F-91198 Gif Sur Yvette, France; Lund Univ, Dept Phys Geog & Ecosyst Anal, S-22362 Lund, Sweden	Potsdam Institut fur Klimafolgenforschung; Max Planck Society; Boston University; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Lund University	Lucht, W (corresponding author), Potsdam Inst Climate Impact Res, POB 601203, D-14412 Potsdam, Germany.	Wolfgang.Lucht@pik-potsdam.de	Friedlingstein, Pierre/H-2700-2014; Smith, Benjamin/I-1212-2016; Myneni, Ranga B/F-5129-2012; Sitch, Stephen A/F-8034-2015; Cramer, Wolfgang/B-8221-2008; Lucht, Wolfgang/G-2180-2011; Myneni, Ranga B./AAU-6088-2021	Friedlingstein, Pierre/0000-0003-3309-4739; Smith, Benjamin/0000-0002-6987-5337; Myneni, Ranga B/0000-0002-0234-6393; Sitch, Stephen A/0000-0003-1821-8561; Cramer, Wolfgang/0000-0002-9205-5812; Lucht, Wolfgang/0000-0002-3398-8575; Bousquet, Philippe/0000-0002-4444-2703				Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Cihlar J, 1998, J GEOPHYS RES-ATMOS, V103, P23163, DOI 10.1029/98JD00050; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; GROISMAN PY, 1994, SCIENCE, V263, P198, DOI 10.1126/science.263.5144.198; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; McGuire AD, 2001, GLOBAL BIOGEOCHEM CY, V15, P183, DOI 10.1029/2000GB001298; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Myneni RB, 2001, P NATL ACAD SCI USA, V98, P14784, DOI 10.1073/pnas.261555198; Roderick ML, 2001, OECOLOGIA, V129, P21, DOI 10.1007/s004420100760; SELF S, 1995, REV GEOPHYS, V33, P257, DOI 10.1029/95RG00556; SITCH S, UNPUB; SITCH S, 2000, THESIS LUND U SWEDEN; Stenchikov GL, 1998, J GEOPHYS RES-ATMOS, V103, P13837, DOI 10.1029/98JD00693; Timmreck C, 1999, J GEOPHYS RES-ATMOS, V104, P9337, DOI 10.1029/1999JD900088; Tucker CJ, 2001, INT J BIOMETEOROL, V45, P184, DOI 10.1007/s00484-001-0109-8; Yang FL, 2001, J GEOPHYS RES-ATMOS, V106, P14757, DOI 10.1029/2001JD900146	19	540	593	14	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1687	1689		10.1126/science.1071828	http://dx.doi.org/10.1126/science.1071828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040194				2022-12-28	WOS:000175976200058
J	Singer, AL; Koretzky, GA				Singer, AL; Koretzky, GA			Control of T cell function by positive and negative regulators	SCIENCE			English	Editorial Material							PROTEIN-TYROSINE KINASES; ANTIGEN	T cells are an essential element of the body's immune system. Engagement of the T cell receptor is responsible for initiating the signaling events that can activate, inactivate, or eliminate T cells, depending on the magnitude and duration of the signal. Control of T cell signaling occurs through both positive and negative regulation, as well as through the actions of molecular scaffolds that contribute to the formation of signaling complexes. The T Cell Signal Transduction Pathway at the STKE Connections Maps highlights the molecular components that are responsible for T cell activation. Understanding the mechanisms that regulate T cell responsiveness will aid in the development of therapeutic agents to treat infection, cancer, and autoimmune disease and immune deficiency.	Univ Penn, Abramson Family Canc Res Inst, Dept Lab Med & Pathol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Koretzky, GA (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Dept Lab Med & Pathol, Philadelphia, PA 19104 USA.		Koretzky, Gary/AAU-5381-2021					Chun HJ, 2001, ADV EXP MED BIOL, V490, P49; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; GERSHON RK, 1971, IMMUNOLOGY, V21, P903; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; KORETZKY GA, 2002, SCI STKE; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Latour S, 2001, CURR OPIN IMMUNOL, V13, P299, DOI 10.1016/S0952-7915(00)00219-3; Myung PS, 2000, CURR OPIN IMMUNOL, V12, P256, DOI 10.1016/S0952-7915(00)00085-6; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Thomas M L, 1995, Semin Immunol, V7, P279, DOI 10.1006/smim.1995.0032	14	58	60	3	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1639	1640		10.1126/science.1071551	http://dx.doi.org/10.1126/science.1071551			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040176				2022-12-28	WOS:000175976200039
J	Steinbrook, R				Steinbrook, R			Nursing in the crossfire	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE; SHORTAGE; NURSES											*1 CONS GROUP, 2001, HEALTHC WORKF SHORT; Abel-Smith Brian, 1960, HIST NURSING PROFESS; *AHA COMM WORKF HO, 2002, OUR HANDS HOSP LEAD; Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; AIKEN LH, 1987, NEW ENGL J MED, V317, P641, DOI 10.1056/NEJM198709033171030; Aiken LH, 1996, HEALTH AFFAIR, V15, P88, DOI 10.1377/hlthaff.15.4.88; AIKEN LH, IN PRESS MAGNET HOSP; *AM HOSP ASS, 2001, TREND WATCH, V3, P1; Auerbach DI, 2000, NURS ECON, V18, P178; BARNARD A, 2002, BOSTON GLOBE    0207, pA28; BARNARD A, 2002, BOSTON GLOBE    0520, pA1; BREWER CS, 2000, REPORT SUPPLY DEMAND; BRUBAKER B, 2001, WASHINGTON POST 0611, pA1; Buerhaus P, 2001, NURS ECON, V19, P198; Buerhaus PI, 1996, JAMA-J AM MED ASSOC, V276, P1487, DOI 10.1001/jama.276.18.1487; Buerhaus PI, 2000, JAMA-J AM MED ASSOC, V283, P2948, DOI 10.1001/jama.283.22.2948; Buerhaus PI, 2000, NURS ECON, V18, P278; Buerhaus PI, 1999, HEALTH AFFAIR, V18, P214, DOI 10.1377/hlthaff.18.1.214; BUERHAUS PI, 2000, NURS ECON, V18, P1; Coffman J, 1999, Image J Nurs Sch, V31, P389; COFFMAN J, 2001, NURSING CALIFORNIA W; DEMORO R, 2002, LOS ANGELES TIM 0131, pB19; *FL HOSP ASS, 2001, FLOR NURS SHORT IT I; FOLEY M, 2002, COMMUNICATION   0307; FREUDENHEIM M, 2001, NY TIMES        0313, pA1; *GEN ACC OFF, 2001, GAO01944; Grumbach K, 2001, MED CARE RES REV, V58, P387, DOI 10.1177/107755870105800401; Hecker DE, 2001, MON LABOR REV, V124, P57; HIRSCH BT, 2001, UNION MEMBERSHIP CAR; IGLEHART JK, 1987, NEW ENGL J MED, V317, P646, DOI 10.1056/NEJM198709033171031; LANDRO L, 2002, WALL STREET J   0315, pB1; LEVINE L, 2001, SHORTAGE REGISTERED; MILLER DR, 2000, HLTH NURSES TEXAS SU, V1; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; *NURS AM ORG NURS, 2002, NAT SURV REG NURS; PACKHAM JF, 2001, NURSING WORKFORCE NU; RICHMOND E, 2002, LAS VEGAS SUN   0114, P1; ROJASBURKE J, 2001, OREGONIAN       1219, pC1; ROJASBURKE J, 2002, OREGONIAN       0207, pA1; SPETZ J, 2002, REVISED COST ESTIMAT; Spetz J., 2000, MINIMUM NURSE STAFFI; SPRATLEY E, 2002, REGISTERED NURSE POP; Staiger DO, 2000, NURS ECON, V18, P230; Tieman Jeff, 2002, Mod Healthc, V32, P13; Wunderlich G, 1996, NURSING STAFF HOSP N; ZUGER A, 2002, NY TIMES        0416, pD6; ZUGER A, 2002, NY TIMES        0416, pD1	47	79	80	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1757	1766		10.1056/NEJM200205303462225	http://dx.doi.org/10.1056/NEJM200205303462225			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556DM	12037165				2022-12-28	WOS:000175834100031
J	Somasundaram, D				Somasundaram, D			Child soldiers: understanding the context	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Jaffna, Fac Med, Dept Psychiat, Jaffna, Sri Lanka	University Jaffna	Somasundaram, D (corresponding author), Univ Jaffna, Fac Med, Dept Psychiat, Jaffna, Sri Lanka.	psych@sltnet.lk						*AMN INT, 1998, CHILDR S AS; Amnesty International, 1996, SRI LANK WAV COMM HU; Bruderlein C, 1999, BRIT MED J, V319, P430, DOI 10.1136/bmj.319.7207.430; *CHILDR REH CTR, 1986, PSYCH HELTP CHILD VI; COX JL, 1988, ACTA PSYCHIAT SCAND, V78, P179, DOI 10.1111/j.1600-0447.1988.tb09019.x; GEEVATHASAN MG, 1993, PSYCHOL CONSEQUENCE; *HLTH REACH, 1996, HLTH CHILDR CONFL ZO; HOOLE MRR, 1988, BROKEN PALMYRAH; JAREG E, 1993, REHABILITATION FORME; Machel G., 1996, IMPACT ARMED CONFLIC; NATCHINARKINIAN CS, 1994, VICTIMS WAR SRI LANK, P15; NISSAN E, 1990, SRI LANKA BITTER HAR; RICHMAN H, 1988, REPORT PSYCHOL EFFEC; ROSENBECK R, 1985, AM J ORTHOPSYCHIAT, V55, P2319; *SAV CHILD, 1998, SIT REP CHILD AFF AR; SIVARAJAH N, 1993, NUTR STATUS CHILDREN; SOMASUNDARAM D, 1998, SCARRED MINDS; SOMASUNDARAM DJ, 1993, CHILD TRAUMA; TRAWICK M, 1999, CONFLICT COMMUNITY C, P139; *U TEACH HUM RIGHS, 1999, DIS ACC; *U TEACH HUM RIGHT, 2000, SUN GODS CHILDR BIG; *U TEACH HUM RIGHT, 1995, CHILDR NE WAR 1985 1; *U TEACH HUM RIGHT, 1994, MAN AR WEL OYA; *UN, US CHILDR SOLD AS PA	24	35	36	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2002	324	7348					1268	1271		10.1136/bmj.324.7348.1268	http://dx.doi.org/10.1136/bmj.324.7348.1268			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028985	Green Published			2022-12-28	WOS:000175894900026
J	Rebbeck, TR; Lynch, HT; Neuhausen, SL; Narod, SA; van't Veer, L; Garber, JE; Evans, G; Isaacs, C; Daly, MB; Matloff, E; Olopade, OI; Weber, BL				Rebbeck, TR; Lynch, HT; Neuhausen, SL; Narod, SA; van't Veer, L; Garber, JE; Evans, G; Isaacs, C; Daly, MB; Matloff, E; Olopade, OI; Weber, BL		Prevention Observation Surg End Po	Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY PERITONEAL CARCINOMA; PAPILLARY SEROUS CARCINOMA; BREAST-CANCER RISK; OVARIAN-CANCER; ORAL-CONTRACEPTIVES; WOMEN	Background: Data concerning the efficacy of bilateral prophylactic oophorectomy for reducing the risk of gynecologic cancer in women with BRCA1 or BRCA2 mutations are limited. We investigated whether this procedure reduces the risk of cancers of the coelomic epithelium and breast in women who carry such mutations. Methods: A total of 551 women with disease-associated germ-line BRCA1 or BRCA2 mutations were identified from registries and studied for the occurrence of ovarian and breast cancer. We determined the incidence of ovarian cancer in 259 women who had undergone bilateral prophylactic oophorectomy and in 292 matched controls who had not undergone the procedure. In a subgroup of 241 women with no history of breast cancer or prophylactic mastectomy, the incidence of breast cancer was determined in 99 women who had undergone bilateral prophylactic oophorectomy and in 142 matched controls. The length of postoperative follow-up for both groups was at least eight years. Results: Six women who underwent prophylactic oophorectomy (2.3 percent) received a diagnosis of stage I ovarian cancer at the time of the procedure; two women (0.8 percent) received a diagnosis of papillary serous peritoneal carcinoma 3.8 and 8.6 years after bilateral prophylactic oophorectomy. Among the controls, 58 women (19.9 percent) received a diagnosis of ovarian cancer, after a mean follow-up of 8.8 years. With the exclusion of the six women whose cancer was diagnosed at surgery, prophylactic oophorectomy significantly reduced the risk of coelomic epithelial cancer (hazard ratio, 0.04; 95 percent confidence interval, 0.01 to 0.16). Of 99 women who underwent bilateral prophylactic oophorectomy and who were studied to determine the risk of breast cancer, breast cancer developed in 21 (21.2 percent), as compared with 60 (42.3 percent) in the control group (hazard ratio, 0.47; 95 percent confidence interval, 0.29 to 0.77). Conclusions: Bilateral prophylactic oophorectomy reduces the risk of coelomic epithelial cancer and breast cancer in women with BRCA1 or BRCA2 mutations. (N Engl J Med 2002;346:1616-22.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Ctr Canc, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Inst, Philadelphia, PA 19104 USA; Creighton Univ, Omaha, NE 68178 USA; Univ Utah, Div Genet Epidemiol, Salt Lake City, UT USA; Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; Netherlands Canc Inst, Amsterdam, Netherlands; Dana Farber Canc Inst, Boston, MA 02115 USA; St Marys Hosp, Manchester M13 0JH, Lancs, England; Georgetown Univ, Lombardi Canc Ctr, Washington, DC USA; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; Yale Univ, New Haven, CT USA; Univ Chicago, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Creighton University; Utah System of Higher Education; University of Utah; University of Toronto; University Toronto Affiliates; Womens College Hospital; Netherlands Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Manchester; Georgetown University; Fox Chase Cancer Center; Yale University; University of Chicago	Rebbeck, TR (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 904 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.		Rebbeck, Timothy/GLU-8348-2022; Narod, Steven A/AAA-6112-2022; Evans, D Gareth/AAB-4308-2022	Rebbeck, Timothy/0000-0002-4799-1900; Evans, D Gareth/0000-0002-8482-5784	NCI NIH HHS [N01-CN-6700, CA57601, R01-CA83855, CA74415] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057601, R01CA083855, R01CA074415] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRINTON LA, 1988, CANCER INVEST, V6, P245, DOI 10.3109/07357908809080645; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; COLDITZ GA, 1987, NEW ENGL J MED, V316, P1105, DOI 10.1056/NEJM198704303161801; EASTON DF, 1994, LANCET, V344, P761, DOI 10.1016/S0140-6736(94)92256-X; Eltabbakh GH, 1998, ONCOLOGY-NY, V12, P813; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; FROMM GL, 1990, OBSTET GYNECOL, V75, P89; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; MEIJER WJ, 1992, EUR J OBSTET GYN R B, V47, P59, DOI 10.1016/0028-2243(92)90215-K; Modan B, 2001, NEW ENGL J MED, V345, P235, DOI 10.1056/NEJM200107263450401; Narod SA, 1998, NEW ENGL J MED, V339, P424, DOI 10.1056/NEJM199808133390702; Narod SA, 2001, LANCET, V357, P1467, DOI 10.1016/S0140-6736(00)04642-0; Parazzini F, 1997, OBSTET GYNECOL, V90, P453, DOI 10.1016/S0029-7844(97)00295-0; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P2751, DOI 10.1002/1097-0142(19930501)71:9<2751::AID-CNCR2820710911>3.0.CO;2-J; Prior JC, 1997, J BONE MINER RES, V12, P1851, DOI 10.1359/jbmr.1997.12.11.1851; Rebbeck TR, 1999, J NATL CANCER I, V91, P1475, DOI 10.1093/jnci/91.17.1475; Schairer C, 1997, INT J CANCER, V70, P150, DOI 10.1002/(SICI)1097-0215(19970117)70:2<150::AID-IJC2>3.0.CO;2-W; Struewing J P, 1995, J Natl Cancer Inst Monogr, P33; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; ZHOU J, 1995, CANCER, V76, P429, DOI 10.1002/1097-0142(19950801)76:3<429::AID-CNCR2820760313>3.0.CO;2-8	20	1052	1083	0	44	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1616	1622		10.1056/NEJMoa012158	http://dx.doi.org/10.1056/NEJMoa012158			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023993				2022-12-28	WOS:000175728600003
J	Roberts, RJ				Roberts, RJ			Head lice	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOUSE PEDICULUS-CAPITIS; PERMETHRIN; RESISTANCE; MALATHION; SCHOOL; INSECTICIDES; INFESTATIONS; EFFICACY		N Wales Hlth Author, Dept Publ Hlth Med, Mold, Flint, Wales		Roberts, RJ (corresponding author), N Wales Hlth Author, Dept Publ Hlth Med, Hendy Rd, Mold, Flint, Wales.	richard.roberts@nwales-ha.wales.nhs.uk						ASTON R, 1998, HEAD LICE REPORT CON; BOULTON A, 1995, BRIT MED J, V311, P1322, DOI 10.1136/bmj.311.7016.1322a; BURGESS I, 1996, PRESCRIBER, V7, P87; BURGESS IF, 1994, CLIN THER, V16, P57; BURGESS IF, 1995, BRIT MED J, V311, P752, DOI 10.1136/bmj.311.7007.752; BURGESS IF, 1995, BRIT MED J, V311, P1369, DOI 10.1136/bmj.311.7016.1369a; BURGESS IF, 1995, ADV PARASIT, V36, P272; Burkholder TJ, 2000, MOTOR CONTROL, V4, P201, DOI 10.1123/mcj.4.2.201; *CDCP, 2002, HEAD LIC INF; CHIN J, 2000, CONTROL COMMUNICABLE; Choudhary S, 1999, BURNS, V25, P184, DOI 10.1016/S0305-4179(98)00135-1; CHUNGE RN, 1991, CAN J PUBLIC HEALTH, V82, P207; *COMM SAF MED, 2000, CURR PROB PHARM, V26, P2; De Maeseneer J, 2000, BRIT MED J, V321, P1187, DOI 10.1136/bmj.321.7270.1187; Dennis GA, 1999, CLIN DRUG INVEST, V18, P105, DOI 10.2165/00044011-199918020-00003; *DEP HLTH, 2001, HEADL PRODIGY DAT; *DEP HLTH, 2000, PREV TREATM HEAD LIC; DODD CS, 2001, COCHRANE LIB, V3; Downs AMR, 1999, BRIT J DERMATOL, V141, P508, DOI 10.1046/j.1365-2133.1999.03046.x; Hemingway J, 1999, MED VET ENTOMOL, V13, P89, DOI 10.1046/j.1365-2915.1999.00141.x; Hipolito RB, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e30; Ibarra J, 1996, ARCH DIS CHILD, V75, P471, DOI 10.1136/adc.75.6.471; *INF DIS IMM COMM, 1996, PAEDIAT CHILD HLTH, V1, P237; LANG JD, 1975, THESIS TUCSON; Maunder J.W., 1983, Proceedings of the Royal Institution of Great Britain, V55, P1; Maunder JW, 1971, MED OFFICERS, V125, P27, DOI DOI 10.1542/peds.2008-3762; Meinking TL, 2001, ARCH DERMATOL, V137, P287; MUMCUOGLU KY, 1995, MED VET ENTOMOL, V9, P427, DOI 10.1111/j.1365-2915.1995.tb00018.x; MUMCUOGLU KY, 1991, J AM ACAD DERMATOL, V25, P248, DOI 10.1016/0190-9622(91)70190-D; Mumcuoglu KY, 2001, PEDIATR DERMATOL, V18, P9, DOI 10.1046/j.1525-1470.2001.018001009.x; Picollo MI, 2000, J MED ENTOMOL, V37, P721, DOI 10.1603/0022-2585-37.5.721; Pollack RJ, 1999, ARCH PEDIAT ADOL MED, V153, P969, DOI 10.1001/archpedi.153.9.969; Pollack RJ, 2000, PEDIATR INFECT DIS J, V19, P689, DOI 10.1097/00006454-200008000-00003; Price JH, 1999, J SCHOOL HEALTH, V69, P153, DOI 10.1111/j.1746-1561.1999.tb04174.x; Roberts RJ, 2000, LANCET, V356, P540, DOI 10.1016/S0140-6736(00)02578-2; ROBERTS RJ, 2000, BMJ; Speare R, 1999, INT J DERMATOL, V38, P285, DOI 10.1046/j.1365-4362.1999.00680.x; TAPLIN D, 1982, JAMA-J AM MED ASSOC, V247, P3103, DOI 10.1001/jama.247.22.3103; Taplin D, 1986, Pediatr Dermatol, V3, P344, DOI 10.1111/j.1525-1470.1986.tb00538.x; Williams LK, 2001, PEDIATRICS, V107, P1011, DOI 10.1542/peds.107.5.1011; WILSON BB, 1995, MANDELL DOUGLAS BENN, V2, P2558	41	65	70	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1645	1650		10.1056/NEJMcp012640	http://dx.doi.org/10.1056/NEJMcp012640			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023998				2022-12-28	WOS:000175728600008
J	Black, N; Payne, M				Black, N; Payne, M			Infopoints - Improving the use of clinical databases	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Black, N (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.							Black N, 1999, LANCET, V353, P1205, DOI 10.1016/S0140-6736(99)00108-7; Departement of Health, 2002, NATL PUBLIC RAD 0110; MCGLYNN EA, 1998, HLTH INFORMATION SYS; PRYOR DB, 1985, MED CARE, V23, P623, DOI 10.1097/00005650-198505000-00020	4	8	9	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1194	1194		10.1136/bmj.324.7347.1194	http://dx.doi.org/10.1136/bmj.324.7347.1194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016187	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000175763200022
J	Frisch, U; Matarrese, S; Mohayaee, R; Sobolevski, A				Frisch, U; Matarrese, S; Mohayaee, R; Sobolevski, A			A reconstruction of the initial conditions of the Universe by optimal mass transportation	NATURE			English	Article							PRIMORDIAL DENSITY-FLUCTUATIONS; LARGE-SCALE STRUCTURE; GRAVITATIONAL-INSTABILITY; ZELDOVICH APPROXIMATION; LEAST ACTION; FIELDS; VELOCITY; BACK; TIME	Reconstructing the density fluctuations in the early Universe that evolved into the distribution of galaxies we see today is a challenge to modern cosmology(1). An accurate reconstruction would allow us to test cosmological models by simulating the evolution starting from the reconstructed primordial state and comparing it to observations. Several reconstruction techniques have been proposed(2-9), but they all suffer from lack of uniqueness because the velocities needed to produce a unique reconstruction usually are not known. Here we show that reconstruction can be reduced to a well-determined problem of optimization, and present a specific algorithm that provides excellent agreement when tested against data from N-body simulations. By applying our algorithm to the redshift surveys now under way(10), we will be able to recover reliably the properties of the primeval fluctuation field of the local Universe, and to determine accurately the peculiar velocities (deviations from the Hubble expansion) and the true positions of many more galaxies than is feasible by any other method.	Observ Cote Azur, CNRS, UMR 6529, F-06304 Nice 4, France; Dipartimento Fis G Galilei, I-35131 Padua, Italy; Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119899, Russia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Lomonosov Moscow State University	Frisch, U (corresponding author), Observ Cote Azur, CNRS, UMR 6529, BP 4229, F-06304 Nice 4, France.		Matarrese, Sabino/C-8296-2018; Sobolevski, Andrei/D-9361-2012; Mohayaee, Roya/ABG-9242-2021	Matarrese, Sabino/0000-0002-2573-1243; Sobolevski, Andrei/0000-0002-3082-5113; 				Ampere A.M., 1820, J ECOLE R POLYTECH, V11, P1; Arnold V.I., 1978, MATH METHODS CLASSIC, DOI 10.1007/978-1-4757-1693-1; BALINSKI ML, 1986, MATH PROGRAM, V34, P125, DOI 10.1007/BF01580579; Benamou JD, 2000, NUMER MATH, V84, P375, DOI 10.1007/s002119900117; BERTSCHINGER E, 1989, ASTROPHYS J, V336, pL5, DOI 10.1086/185348; BRANCHINI E, 2001, UNPUB MON NOT R ASTR; BRANCHINI E, 2001, ASTROPH0110618; BRENIER Y, 1987, CR ACAD SCI I-MATH, V305, P805; BUCHERT T, 1992, MON NOT R ASTRON SOC, V254, P729, DOI 10.1093/mnras/254.4.729; CATELAN P, 1995, MON NOT R ASTRON SOC, V276, P115; COUCHMAN HMP, 1995, ASTROPHYS J, V452, P797, DOI 10.1086/176348; Croft RAC, 1997, MON NOT R ASTRON SOC, V285, P793, DOI 10.1093/mnras/285.4.793; Frieman JA, 2000, PHYS REP, V333, P215, DOI 10.1016/S0370-1573(00)00045-4; Gangbo W, 1996, ACTA MATH-DJURSHOLM, V177, P113, DOI 10.1007/BF02392620; Goldberg DM, 2000, ASTROPHYS J, V544, P21, DOI 10.1086/317182; Gurbatov S. N., 1984, Radiophysics and Quantum Electronics, V27, P303, DOI 10.1007/BF01036611; HENON M, 1995, CR ACAD SCI I-MATH, V321, P741; Kantorovich L. V., 1942, DOKL AKAD NAUK SSSR, V37, P199; Monge G., 1781, HIST ACAD ROYALE SCI; MOUTARDE F, 1991, ASTROPHYS J, V382, P377, DOI 10.1086/170728; MUNSHI D, 1994, ASTROPHYS J, V436, P517, DOI 10.1086/174925; Narayanan VK, 1999, ASTROPHYS J, V515, P471, DOI 10.1086/307040; Nusser A, 2000, MON NOT R ASTRON SOC, V313, P587, DOI 10.1046/j.1365-8711.2000.03261.x; NUSSER A, 1992, ASTROPHYS J, V391, P443, DOI 10.1086/171360; PEEBLES PJE, 1989, ASTROPHYS J, V344, pL53, DOI 10.1086/185529; Rockafellar R., 1970, CONVEX ANAL; SHANDARIN SF, 1989, REV MOD PHYS, V61, P185, DOI 10.1103/RevModPhys.61.185; Valentine H, 2000, MON NOT R ASTRON SOC, V319, pL13, DOI 10.1046/j.1365-8711.2000.04106.x; VERGASSOLA M, 1994, ASTRON ASTROPHYS, V289, P325; WEINBERG DH, 1992, MON NOT R ASTRON SOC, V254, P315, DOI 10.1093/mnras/254.2.315; ZELDOVICH YB, 1970, ASTRON ASTROPHYS, V5, P84	31	100	105	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					260	262		10.1038/417260a	http://dx.doi.org/10.1038/417260a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015595	Green Submitted			2022-12-28	WOS:000175592100039
J	Henikoff, S; Malik, HS				Henikoff, S; Malik, HS			Selfish drivers	NATURE			English	Article									Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave, Seattle, WA 98109 USA.		Malik, Harmit S/E-8519-2012	Henikoff, Steven/0000-0002-7621-8685				de Villena FPM, 2001, GENETICS, V159, P1179; HERIKOFF S, 2001, SCIENCE, V293, P1098; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Zwick ME, 1999, GENETICS, V152, P1605	4	102	102	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					227	227		10.1038/417227a	http://dx.doi.org/10.1038/417227a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015578	Bronze			2022-12-28	WOS:000175592100024
J	Weissman, IL				Weissman, IL			Stem cells - Scientific, medical, and political issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOUSE EMBRYOS		Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; *CA ADV COMM HUM C, 2002, FIN REP CAL ADV COMM; *COMM BIOL BIOM AP, 2002, STEM CELLS FUT REG M; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Kawase E, 2000, GENESIS, V28, P156, DOI 10.1002/1526-968X(200011/12)28:3/4<156::AID-GENE100>3.3.CO;2-K; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; *PAN SCI MED ASP H, 2002, SCI MED ASP HUM REPR; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; Thomson JA, 1998, SCIENCE, V282, P1827; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Weissman IL, 2000, SCIENCE, V287, P1442, DOI 10.1126/science.287.5457.1442; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081	19	75	85	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1576	1579		10.1056/NEJMsb020693	http://dx.doi.org/10.1056/NEJMsb020693			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	11994551				2022-12-28	WOS:000175563900012
J	Creese, A; Floyd, K; Alban, A; Guinness, L				Creese, A; Floyd, K; Alban, A; Guinness, L			Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence	LANCET			English	Article							SUB-SAHARAN AFRICA; HUMAN-IMMUNODEFICIENCY-VIRUS; CHILD HIV TRANSMISSION; RURAL SOUTH-AFRICA; TUBERCULOSIS-CONTROL; SEXUAL TRANSMISSION; INFECTION; HEALTH; NEVIRAPINE; PREVENTION	Background Evidence for cost-effectiveness of interventions for HIV/AIDS in Africa is fragmentary. Cost-effectiveness is, however, highly relevant. African governments face difficult choices in striking the right balance between prevention, treatment, and care, all of which are necessary to deal comprehensively with the epidemic. Reductions in drug prices have raised the priority of treatment, though treatment access is restricted. We assessed the existing cost-effectiveness data and its implications for value-for-money strategies to combat HIV/AIDS in Africa. Methods We undertook a systematic review using databases and consultations with experts. We identified over 60 reports that measured both the cost and effectiveness of HIV/AIDS interventions in Africa. 24 studies met our inclusion criteria and were used to calculate standardised estimates of the cost (US$ for year 2000) per HIV infection prevented and per disability-adjusted life-year (DALY) gained for 31 interventions. Findings Cost-effectiveness varied greatly between interventions. A case of HIV/AIDS can be prevented for $11, and a DALY gained for $1, by selective blood safety measures, and by targeted condom distribution with treatment of sexually transmitted diseases. Single-dose nevirapine and short-course zidovudine for prevention of mother-to-child transmission, voluntary counselling and testing, and tuberculosis treatment, cost under $75 per DALY gained. Other interventions, such as formula feeding for infants, home care programmes, and antiretroviral therapy for adults, cost several thousand dollars per infection prevented, or several hundreds of dollars per DALY gained. Interpretation A strong economic case exists for prioritisation of preventive interventions and tuberculosis treatment. Where potentially exclusive alternatives exist, cost-effectiveness analysis points to an intervention that offers the best value for money. Cost-effectiveness analysis is an essential component of informed debate about priority setting for HIV/AIDS.	WHO, Essential Drugs & Med Policy Dept, CH-1211 Geneva, Switzerland; WHO, Stop TB Dept, CH-1211 Geneva, Switzerland; Univ Copenhagen, DK-1168 Copenhagen, Denmark; London Sch Hyg & Trop Med, London WC1, England	World Health Organization; World Health Organization; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine	Creese, A (corresponding author), WHO, Essential Drugs & Med Policy Dept, CH-1211 Geneva, Switzerland.		Embrett, Mark G./H-4466-2014; Guinness, Lorna/AAN-3875-2020	Embrett, Mark G./0000-0002-3969-0219; Guinness, Lorna/0000-0002-1013-4200				[Anonymous], 1999, WORLD HLTH REPORT 19; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BAIL R, 2000, COSTING ZAMBIA NATL; Bell JC, 1999, AIDS, V13, P1549, DOI 10.1097/00002030-199908200-00016; CHELA CM, 1994, COST IMPACT HOME BAS; de Jonghe E, 1994, Int J Health Plann Manage, V9, P151, DOI 10.1002/hpm.4740090204; Drummond MF, 2015, METHODS EC EVALUATIO; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; ELLIOTT AM, 1995, T ROY SOC TROP MED H, V89, P78, DOI 10.1016/0035-9203(95)90668-1; Floyd K, 1997, BRIT MED J, V315, P1407, DOI 10.1136/bmj.315.7120.1407; FOSTER S, 1995, LANCET, V346, P225, DOI 10.1016/S0140-6736(95)91272-X; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Glynn JR, 1998, B WORLD HEALTH ORGAN, V76, P295; Gold MR, 1996, COST EFFECTIVENESS H; Guinness L., 2000, EC IMPACT AIDS AFRIC; Hansen K, 1998, AIDS CARE, V10, P751, DOI 10.1080/09540129848361; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Jacobs B, 1999, HEALTH POLICY PLANN, V14, P354, DOI 10.1093/heapol/14.4.354; Kahn JG, 2000, AIDS, V14, P2609, DOI 10.1097/00002030-200011100-00026; Kumaranayake L, 2000, AIDS, V14, pS239; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Mansergh G, 1996, JAMA-J AM MED ASSOC, V276, P139, DOI 10.1001/jama.276.2.139; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Marseille E, 1998, AIDS, V12, P939, DOI 10.1097/00002030-199808000-00017; MCFARLAND W, 1995, J ACQ IMMUN DEF SYND, V9, P183; *MED SANS FRONT, 2002, AIDS TRIPL THER LESS; *MIN HLTH CHILD WE, 1988, HIV AIDS ZIMB BACKGR; MOSES S, 1991, AIDS, V5, P407, DOI 10.1097/00002030-199104000-00008; MSOBI N, 2002, HIV AIDS OTHER CHRON; MURRAY CJL, 1991, LANCET, V338, P1305, DOI 10.1016/0140-6736(91)92600-7; Musgrove P, 1999, HEALTH POLICY, V47, P207, DOI 10.1016/S0168-8510(99)00024-X; Newell ML, 1998, AIDS, V12, P1571, DOI 10.1097/00002030-199813000-00003; Pinkerton SD, 2001, AIDS, V15, P917, DOI 10.1097/00002030-200105040-00012; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; SAUNDERSON PR, 1995, SOC SCI MED, V40, P1203, DOI 10.1016/0277-9536(94)00240-T; Schrappe M, 1998, AIDS, V12 Suppl A, pS231; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Stringer JSA, 2000, J ACQ IMMUN DEF SYND, V24, P369, DOI 10.1097/00126334-200008010-00012; Sweat M, 2000, LANCET, V356, P113, DOI 10.1016/S0140-6736(00)02447-8; *UN, 1989, P UN WHO WORKSH MOD; *UNAIDS, 2002, EUR COMM WHO JOINT U; Wilkinson D, 2000, S AFR MED J, V90, P794; Wilkinson D, 1998, AIDS, V12, P1675, DOI 10.1097/00002030-199813000-00016; WINSBURY R, 1995, SAFE BLOOD DEV COUNT; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; *WORLD BANK, 1998, MAL AIDS ASS STUD; *WORLD BANK, 1993, WORLD DEV REP 1993 I; World Health Organization, 2000, WORLD HLTH REP 2000	48	261	265	0	33	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1635	1642		10.1016/S0140-6736(02)08595-1	http://dx.doi.org/10.1016/S0140-6736(02)08595-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551ZF	12020523				2022-12-28	WOS:000175593300006
J	Feig, DS; Palda, VA				Feig, DS; Palda, VA			Type 2 diabetes in pregnancy: a growing concern	LANCET			English	Editorial Material							GLUCOSE-TOLERANCE; WOMEN; MELLITUS; EPIDEMIOLOGY; EXPOSURE; RISK; US		Mt Sinai Hosp, Div Endocrinol & Metab, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Feig, DS (corresponding author), Mt Sinai Hosp, Div Endocrinol & Metab, Toronto, ON M5G 1X5, Canada.		Feig, Denice/C-4606-2015					[Anonymous], 1992, WORLD HLTH STAT Q, V45, P321; Brydon P, 2000, INT J CLIN PRACT, V54, P418; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; COETZEE E J, 1985, Diabetes Research and Clinical Practice, V1, P281, DOI 10.1016/S0168-8227(86)80036-5; Cundy T, 2000, DIABETIC MED, V17, P33, DOI 10.1046/j.1464-5491.2000.00215.x; Dabelea D, 1998, DIABETOLOGIA, V41, P904, DOI 10.1007/s001250051006; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; ENGELGAU MM, 1995, DIABETES CARE, V18, P1029, DOI 10.2337/diacare.18.7.1029; Harris SB, 1997, DIABETES CARE, V20, P1422, DOI 10.2337/diacare.20.9.1422; Hawthorne G, 1997, BRIT MED J, V315, P279, DOI 10.1136/bmj.315.7103.279; Holing EV, 1998, DIABETES CARE, V21, P889, DOI 10.2337/diacare.21.6.889; LIVINGSTON RC, 1993, DIABETES CARE, V16, P318, DOI 10.2337/diacare.16.1.318; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; OMORI Y, 1994, DIABETES RES CLIN PR, V24, pS273, DOI 10.1016/0168-8227(94)90261-5; PETTITT DJ, 1980, DIABETES CARE, V3, P458, DOI 10.2337/diacare.3.3.458; Rosenbloom AL, 1999, DIABETES CARE, V22, P345, DOI 10.2337/diacare.22.2.345; Sacks DA, 1997, AM J OBSTET GYNECOL, V177, P1113, DOI 10.1016/S0002-9378(97)70025-5; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; TOWNER D, 1995, DIABETES CARE, V18, P1446, DOI 10.2337/diacare.18.11.1446; Zhu L, 1997, J Obstet Gynaecol Res, V23, P555	20	141	145	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1690	1692		10.1016/S0140-6736(02)08599-9	http://dx.doi.org/10.1016/S0140-6736(02)08599-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020549				2022-12-28	WOS:000175593300032
J	Paton, NI; Aboulhab, J; Karim, F				Paton, NI; Aboulhab, J; Karim, F			Hydroxychloroquine, hydroxycarbamide, and didanosine as economic treatment for HIV-1	LANCET			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MARKERS; CELLS	Most people who have HIV-1 and live in less-developed countries cannot afford standard combination antiretroviral therapy, and more economical approaches to treatment are therefore needed. We treated 22 patients who were Infected with HIV-1 (viral load <100 000 copies/mL and CD4 count >150 cells/muL) with hydroxychloroquine (200 mg), hydroxycarbamide (hydroxyurea) (500 mg), and didanosine (125-200 mg), taken twice daily. Treatment was well tolerated, with few serious adverse events. Viral load showed a sustained decrease of 1.3 log, and CD4 count was maintained (percentage increase; 2.9%) over 48 weeks in the 16 evaluable patients. This new combination of drugs could be suitable for countries that have restricted resources, but should first be further investigated.	Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore	Tan Tock Seng Hospital	Paton, NI (corresponding author), Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore.							Boelaert JR, 1999, AIDS RES HUM RETROV, V15, P1241, DOI 10.1089/088922299310133; Katzenstein DA, 1996, NEW ENGL J MED, V335, P1091, DOI 10.1056/NEJM199610103351502; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; SPERBER K, 1993, AIDS RES HUM RETROV, V9, P91, DOI 10.1089/aid.1993.9.91; Sperber K, 1997, CLIN THER, V19, P913, DOI 10.1016/S0149-2918(97)80045-8	5	42	45	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1667	1668		10.1016/S0140-6736(02)08557-4	http://dx.doi.org/10.1016/S0140-6736(02)08557-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020529				2022-12-28	WOS:000175593300012
J	Fabian, AC				Fabian, AC			Radio galaxies - Bubbles, flows, and fields	SCIENCE			English	Editorial Material							CLUSTER; SPECTROSCOPY		Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England	University of Cambridge	Fabian, AC (corresponding author), Univ Cambridge, Inst Astron, Madingley Rd, Cambridge CB3 0HA, England.							BOHRINGER H, 1993, MNRAS L, V264, P25; Bruggen M, 2002, MON NOT R ASTRON SOC, V331, P545, DOI 10.1046/j.1365-8711.2002.05233.x; Churazov E, 2001, ASTROPHYS J, V554, P261, DOI 10.1086/321357; Clarke TE, 2001, ASTROPHYS J, V547, pL111, DOI 10.1086/318896; Fabian AC, 2002, MON NOT R ASTRON SOC, V331, P369, DOI 10.1046/j.1365-8711.2002.05182.x; McNamara BR, 2000, ASTROPHYS J, V534, pL135, DOI 10.1086/312662; Narayan R, 2001, ASTROPHYS J, V562, pL129, DOI 10.1086/338325; Peterson JR, 2001, ASTRON ASTROPHYS, V365, pL104, DOI 10.1051/0004-6361:20000021; Quilis V, 2001, MON NOT R ASTRON SOC, V328, P1091, DOI 10.1046/j.1365-8711.2001.04927.x; Reynolds CS, 2002, MON NOT R ASTRON SOC, V332, P271, DOI 10.1046/j.1365-8711.2002.04724.x; Sanders JS, 2002, MON NOT R ASTRON SOC, V331, P273, DOI 10.1046/j.1365-8711.2002.05211.x; Tamura T, 2001, ASTRON ASTROPHYS, V365, pL87, DOI 10.1051/0004-6361:20000038; VOIGT LM, UNPUB; YOUNG AM, UNPUB	15	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1040	1041		10.1126/science.1072074	http://dx.doi.org/10.1126/science.1072074			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004109				2022-12-28	WOS:000175565000031
J	Keller, LP; Hony, S; Bradley, JP; Molster, FJ; Waters, LBFM; Bouwman, J; de Koter, A; Brownlee, DE; Flynn, GJ; Henning, T; Mutschke, H				Keller, LP; Hony, S; Bradley, JP; Molster, FJ; Waters, LBFM; Bouwman, J; de Koter, A; Brownlee, DE; Flynn, GJ; Henning, T; Mutschke, H			Identification of iron sulphide grains in protoplanetary disks	NATURE			English	Article							INTERPLANETARY DUST; CIRCUMSTELLAR DUST; INTERSTELLAR ABUNDANCES; OPTICAL-PROPERTIES; ISO SPECTROSCOPY; AB-AUR; HD-163296; SPECTRUM; SYSTEMS; STARS	Sulphur is depleted in cold dense molecular clouds with embedded young stellar objects(1), indicating that most of it probably resides in solid grains. Iron sulphide grains are the main sulphur species in cometary dust particles(2,3), but there has been no direct evidence for FeS in astronomical sources(4), which poses a considerable problem, because sulphur is a cosmically abundant element. Here we report laboratory infrared spectra of FeS grains from primitive meteorites, as well as from pyrrhotite ([Fe,Ni](1-x)S) grains in interplanetary dust, which show a broad FeS feature centred at similar to23.5 micrometres. A similar broad feature is seen in the infrared spectra of young stellar objects, implying that FeS grains are an important but previously unrecognized component of circumstellar dust. The feature had previously been attributed to FeO5-7. The observed astronomical line strengths are generally consistent with the depletion of sulphur from the gas phase(1), and with the average Galactic sulphur/silicon abundance ratio(8). We conclude that the missing sulphur has been found.	NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; ESA, ESTEC, RSSD ST, NL-2201 AZ Noordwijk, Netherlands; Univ Washington, Dept Astron, Seattle, WA 98195 USA; SUNY Coll Plattsburgh, Dept Phys, Plattsburgh, NY 12901 USA; Astrophys Inst & Univ Observ, Jena, Germany; Katholieke Univ Leuven, Inst Sterrenkunde, B-3001 Heverlee, Belgium; CENS, CEA, DSM, DAPNIA,Serv Astrophys, F-91191 Gif Sur Yvette, France	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Amsterdam; University System of Georgia; Georgia Institute of Technology; European Space Agency; University of Washington; University of Washington Seattle; State University of New York (SUNY) System; SUNY Plattsburgh; KU Leuven; CEA; UDICE-French Research Universities; Universite Paris Saclay	Keller, LP (corresponding author), NASA, Lyndon B Johnson Space Ctr, Mail Code SR, Houston, TX 77058 USA.		Henning, Thomas K/O-4372-2018	Henning, Thomas K/0000-0002-1493-300X; Bouwman, Jeroen/0000-0003-4757-2500				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BEGEMANN B, 1994, ASTROPHYS J, V423, pL71, DOI 10.1086/187238; Bouwman J, 2000, ASTRON ASTROPHYS, V360, P213; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; Christoffersen R, 1996, METEORIT PLANET SCI, V31, P835, DOI 10.1111/j.1945-5100.1996.tb02117.x; Crovisier J, 1997, SCIENCE, V275, P1904, DOI 10.1126/science.275.5308.1904; Dai ZR, 2001, GEOCHIM COSMOCHIM AC, V65, P3601, DOI 10.1016/S0016-7037(01)00692-5; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; HENNING T, 1995, ASTRON ASTROPHYS SUP, V112, P143; Hofmeister AM, 2000, ASTR SOC P, V196, P291; JOSEPH CL, 1986, ASTROPHYS J, V309, P771, DOI 10.1086/164647; Keller LP, 2000, J GEOPHYS RES-SPACE, V105, P10397, DOI 10.1029/1999JA900395; KELLER LP, 1997, LUNAR PLANET SCI, V28, P1811; Kessler M.F., 1996, ASTRON ASTROPHYS, V315, P27; LENNIE AR, 1992, AM MINERAL, V77, P1166; Lodders K., 1999, IAU S, V191, P279; Malfait K, 1998, ASTRON ASTROPHYS, V332, pL25; Meeus G, 2001, ASTRON ASTROPHYS, V365, P476, DOI 10.1051/0004-6361:20000144; Mutschke H, 1998, ASTRON ASTROPHYS, V333, P188; NUTH JA, 1985, ASTROPHYS J, V290, pL41, DOI 10.1086/184438; Palumbo ME, 1997, ASTROPHYS J, V479, P839, DOI 10.1086/303905; Savage BD, 1996, ANNU REV ASTRON ASTR, V34, P279, DOI 10.1146/annurev.astro.34.1.279; WATERS LBF, 1998, SOLID INTERSTELLAR M, P219	25	95	95	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					148	150		10.1038/417148a	http://dx.doi.org/10.1038/417148a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000914	Green Published			2022-12-28	WOS:000175460200035
J	Lallena, MJ; Chalmers, KJ; Llamazares, S; Lamond, AI; Valcarcel, J				Lallena, MJ; Chalmers, KJ; Llamazares, S; Lamond, AI; Valcarcel, J			Splicing regulation at the second catalytic step by sex-lethal involves 3 ' splice site recognition by SPF45	CELL			English	Article							PRE-MESSENGER-RNA; MAMMALIAN INTRONS; FACTOR U2AF(35); MASS-SPECTROMETRY; FACTOR HSLU7; 2ND STEP; PROTEIN; 3'-SPLICE-SITE; DROSOPHILA; YEAST	The Drosophila protein Sex-lethal (SXL) promotes skipping of exon 3 from its own pre-mRNA. An unusual sequence arrangement of two AG dinucleotides and an intervening polypyrimidine (Py)-tract at the 3' end of intron 2 is important for Sxl autoregulation. Here we show that U2AF interacts with the Py-tract and downstream AG, whereas the spliceosomal protein SPF45 interacts with the upstream AG and activates it for the second catalytic step of the splicing reaction. SPF45 represents a new class of second step factors, and its interaction with SXL blocks splicing at the second step. These results are in contrast with other known mechanisms of splicing regulation, which target early events of spliceosome assembly. A similar role for SPF45 is demonstrated in the activation of a cryptic 3' ss generated by a mutation that causes human beta-thalassemia.	European Mol Biol Lab, Gene Express Programme, D-69117 Heidelberg, Germany; European Mol Biol Lab, Cell Biol & Biophys Programme, D-69117 Heidelberg, Germany; Univ Dundee, Sch Life Sci, Dundee DD1 5EH, Scotland	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); University of Dundee	Valcarcel, J (corresponding author), European Mol Biol Lab, Gene Express Programme, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Valcarcel, Juan/O-9814-2014	Valcarcel, Juan/0000-0001-5398-3571; Lamond, Angus/0000-0001-6204-6045; Llamazares, Salud/0000-0002-8771-2312				Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; ANSARI A, 1995, EMBO J, V14, P4001, DOI 10.1002/j.1460-2075.1995.tb00071.x; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Brys A, 1996, RNA, V2, P707; Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; Chiara MD, 1997, EMBO J, V16, P4746, DOI 10.1093/emboj/16.15.4746; Chua K, 1999, NATURE, V402, P207, DOI 10.1038/46086; Chua K, 1999, GENE DEV, V13, P841, DOI 10.1101/gad.13.7.841; Chua K, 2001, MOL CELL BIOL, V21, P1509, DOI 10.1128/MCB.21.5.1509-1514.2001; Cline TW, 1996, ANNU REV GENET, V30, P637, DOI 10.1146/annurev.genet.30.1.637; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Forch P, 2001, RNA, V7, P1185, DOI 10.1017/S1355838201010536; FRANK D, 1992, GENE DEV, V6, P2112, DOI 10.1101/gad.6.11.2112; GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975; GE H, 1990, P NATL ACAD SCI USA, V87, P3338, DOI 10.1073/pnas.87.9.3338; Gebauer F, 1998, RNA, V4, P142; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; Granadino B, 1997, P NATL ACAD SCI USA, V94, P7343, DOI 10.1073/pnas.94.14.7343; Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; HORABIN JI, 1993, MOL CELL BIOL, V13, P7734, DOI 10.1128/MCB.13.12.7734; INOUE K, 1990, NATURE, V344, P461, DOI 10.1038/344461a0; JONES MH, 1995, P NATL ACAD SCI USA, V92, P9687, DOI 10.1073/pnas.92.21.9687; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KRAINER AR, 1985, RA WELCH FDN C CHEM, V29, P353; LUUKKONEN BG, 1997, EMBO J, V17, P779; Merendino L, 1999, NATURE, V402, P838, DOI 10.1038/45602; Moore MJ, 2000, NAT STRUCT BIOL, V7, P14, DOI 10.1038/71207; MOORE MJ, 1992, SCIENCE, V256, P992, DOI 10.1126/science.1589782; Neubauer G, 1998, NAT GENET, V20, P46, DOI 10.1038/1700; Penalva LOF, 2001, MOL CELL BIOL, V21, P1986, DOI 10.1128/MCB.21.6.1986-1996.2001; REED R, 1989, GENE DEV, V3, P2113, DOI 10.1101/gad.3.12b.2113; RUSKIN B, 1986, P NATL ACAD SCI USA, V83, P2022, DOI 10.1073/pnas.83.7.2022; SAKAMOTO H, 1992, NUCLEIC ACIDS RES, V20, P5533, DOI 10.1093/nar/20.21.5533; SAWA H, 1991, NUCLEIC ACIDS RES, V19, P3953, DOI 10.1093/nar/19.14.3953; Schutt C, 2000, DEVELOPMENT, V127, P667; SCHWER B, 1992, EMBO J, V11, P5033, DOI 10.1002/j.1460-2075.1992.tb05610.x; SCHWER B, 1991, NATURE, V349, P494, DOI 10.1038/349494a0; Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2; SMITH CWJ, 1989, NATURE, V342, P243, DOI 10.1038/342243a0; SMITH CWJ, 1993, MOL CELL BIOL, V13, P4939, DOI 10.1128/MCB.13.8.4939; SOSNOWSKI BA, 1989, CELL, V58, P449, DOI 10.1016/0092-8674(89)90426-1; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; UMEN JG, 1995, RNA, V1, P584; Umen JG, 1995, RNA, V1, P869; VALCARCEL J, 1993, NATURE, V362, P171, DOI 10.1038/362171a0; WANG JW, 1994, GENE DEV, V8, P2072, DOI 10.1101/gad.8.17.2072; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Wu SP, 1999, NATURE, V402, P832, DOI 10.1038/45590; Wu SP, 1997, EMBO J, V16, P4421, DOI 10.1093/emboj/16.14.4421; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZHUANG Y, 1990, GENE, V90, P263, DOI 10.1016/0378-1119(90)90189-X; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814; Zorio DAR, 1999, NATURE, V402, P835, DOI 10.1038/45597; Zuo P, 1996, GENE DEV, V10, P1356, DOI 10.1101/gad.10.11.1356	57	121	123	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					285	296		10.1016/S0092-8674(02)00730-4	http://dx.doi.org/10.1016/S0092-8674(02)00730-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015979	Bronze			2022-12-28	WOS:000175412100005
J	Harvey, CF				Harvey, CF			Groundwater flow in the Ganges delta	SCIENCE			English	Editorial Material									MIT, CEE, Ralph M Parsons Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Harvey, CF (corresponding author), MIT, CEE, Ralph M Parsons Lab, 48-321, Cambridge, MA 02139 USA.		harvey, charles F/A-8601-2012	harvey, charles F/0000-0002-7759-4447				*BANGL MIN AGR, 1997, NAT MIN IRR DEV PROJ; Basu AR, 2001, SCIENCE, V293, P1470, DOI 10.1126/science.1060524; *BRIT GEOL SURV DE, 1999, GROUNDW STUD ARS CON; *GOV BANGL MIN IRR, 1986, NAT WAT PLAN PROJ FI, V2, P2; Kinniburgh DG, 2001, ARSENIC CONTAMINATIO; Moore WS, 1997, EARTH PLANET SC LETT, V150, P141, DOI 10.1016/S0012-821X(97)00083-6; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; TOTH J, 1963, J GEOPHYS RES, V68, P16; YOKOTA H, 2001, ENG GEOL, V60	9	30	30	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573												1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040147				2022-12-28	WOS:000175976200001
J	Martin, KH; Slack, JK; Boerner, SA; Martin, CC; Parsons, JT				Martin, KH; Slack, JK; Boerner, SA; Martin, CC; Parsons, JT			Integrin connections map: To infinity and beyond	SCIENCE			English	Editorial Material							CELL BIOLOGY; DYNAMICS; ADHESIONS; RAC	Integrins are transmembrane proteins that serve as primary sensors of the extracellular matrix (ECM) environment. In response to interactions with the ECM, integrins initiate signaling pathways that regulate cell migration, growth, and survival. Advances in imaging have contributed to the understanding of the dynamic nature of these cell-ECM interactions and the complexes that form at these sites and have provided insights into their regulation and signal organizing functions.	Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Parsons, JT (corresponding author), Univ Virginia Hlth Syst, Dept Microbiol, Box 800734, Charlottesville, VA 22908 USA.	jtp@virginial.edu		Boerner, Scott/0000-0003-1388-9665; Martin, Karen/0000-0001-8916-4092				BOERNER SA, 2002, SCI STKE; Chew TL, 2002, J CELL BIOL, V156, P543, DOI 10.1083/jcb.200110161; Fincham VJ, 2000, EMBO J, V19, P2911, DOI 10.1093/emboj/19.12.2911; Geiger B, 2001, SCIENCE, V294, P1661, DOI 10.1126/science.1066919; Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kraynov VS, 2000, SCIENCE, V290, P333, DOI 10.1126/science.290.5490.333; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Rajfur Z, 2002, NAT CELL BIOL, V4, P286, DOI 10.1038/ncb772; Rottner K, 1999, CURR BIOL, V9, P640, DOI 10.1016/S0960-9822(99)80286-3	10	184	190	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1652	1653		10.1126/science.296.5573.1652	http://dx.doi.org/10.1126/science.296.5573.1652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040184				2022-12-28	WOS:000175976200047
J	Fkeland, I				Fkeland, I			Equilibrium: In the balance	NATURE			English	Editorial Material									Univ Paris 09, Inst Finance, F-75775 Paris, France	UDICE-French Research Universities; PSL Research University Paris; Universite Paris-Dauphine	Fkeland, I (corresponding author), Univ Paris 09, Inst Finance, F-75775 Paris, France.							BARKAI A, 1988, SCIENCE, V242, P62, DOI 10.1126/science.242.4875.62; CROZIER M, 1983, ACETUER SYSTEME; Sigmund K., 1993, GAMES LIFE EXPLORATI	3	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					385	385		10.1038/417385a	http://dx.doi.org/10.1038/417385a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024195	Bronze			2022-12-28	WOS:000175730900020
J	Burness, GP				Burness, GP			Ecology - Elephants, mice, and red herrings	SCIENCE			English	Editorial Material									Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Burness, GP (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.							Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Brown J., 2000, SCALING BIOL; Darveau CA, 2002, NATURE, V417, P166, DOI 10.1038/417166a; Hochachka P. W., 2002, BIOCH ADAPTATION MEC, DOI 10.1002/bmb.2002.494030030071; Kleiber M., 1961, FIRE LIFE INTRO ANIM; Weibel E.R., 2000, SYMMORPHOSIS FORM FU; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122	7	7	7	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1245	+		10.1126/science.1072300	http://dx.doi.org/10.1126/science.1072300			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016294				2022-12-28	WOS:000175713000030
J	Springer, TA				Springer, TA			Retrospective - Cesar Milstein (1927-2002)	SCIENCE			English	Biographical-Item									Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA.	springeroffice@cbr.med.harvard.edu							0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1253	1253		10.1126/science.1073325	http://dx.doi.org/10.1126/science.1073325			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016298				2022-12-28	WOS:000175713000035
J	Panda, S; Hogenesch, JB; Kay, SA				Panda, S; Hogenesch, JB; Kay, SA			Circadian rhythms from flies to human	NATURE			English	Review							SILKMOTH ANTHERAEA-PERNYI; PERIOD PROTEIN; CLOCK GENE; SUPRACHIASMATIC NUCLEUS; DROSOPHILA-PERIOD; BEHAVIORAL RHYTHMS; PACEMAKER NEURONS; DOUBLE-TIME; EXPRESSION; MUTATION		Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA	Scripps Research Institute; Novartis	Panda, S (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.	stevek@scripps.edu	Panda, Satchidananda/J-6891-2012; Jansen, Heiko T./A-5770-2008; Kay, Steve A/F-6025-2011	Jansen, Heiko T./0000-0003-0178-396X; Kay, Steve A/0000-0002-0402-2878				Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bao S, 2001, J NEUROSCI, V21, P7117, DOI 10.1523/JNEUROSCI.21-18-07117.2001; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CERIANI MF, UNPUB GENOME WIDE EX; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; COLOT HV, 1988, EMBO J, V7, P3929, DOI 10.1002/j.1460-2075.1988.tb03279.x; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; HANDLER AM, 1979, NATURE, V279, P236, DOI 10.1038/279236a0; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; Kloss B, 2001, NEURON, V30, P699, DOI 10.1016/S0896-6273(01)00320-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Krishnan B, 2001, NATURE, V411, P313, DOI 10.1038/35077094; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; LEVINE JD, 1995, NEURON, V15, P147, DOI 10.1016/0896-6273(95)90072-1; Lin FJ, 2001, MOL CELL BIOL, V21, P7287, DOI 10.1128/MCB.21.21.7287-7294.2001; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Lucas RJ, 2001, BEHAV BRAIN RES, V125, P97, DOI 10.1016/S0166-4328(01)00274-1; Martinek S, 2001, CELL, V105, P769, DOI 10.1016/S0092-8674(01)00383-X; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NEWBY LM, 1993, GENETICS, V135, P1077; PANDA S, IN PRESS CELL; PITTENDRIGH CS, 1967, P NATL ACAD SCI USA, V58, P1762, DOI 10.1073/pnas.58.4.1762; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; REDDY P, 1984, CELL, V38, P701, DOI 10.1016/0092-8674(84)90265-4; Regier JC, 1998, MOL BIOL EVOL, V15, P1172, DOI 10.1093/oxfordjournals.molbev.a026024; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; REPPERT SM, 1994, NEURON, V13, P1167, DOI 10.1016/0896-6273(94)90054-X; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; SIWICKI KK, 1989, NEURON, V3, P51, DOI 10.1016/0896-6273(89)90114-1; SIWICKI KK, 1992, J NEUROGENET, V8, P33, DOI 10.3109/01677069209167270; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Toma DP, 2000, P NATL ACAD SCI USA, V97, P6914, DOI 10.1073/pnas.97.12.6914; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van Esseveldt LKE, 2000, BRAIN RES REV, V33, P34, DOI 10.1016/S0165-0173(00)00025-4; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Weiner J., 1999, TIME LOVE MEMORY; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; ZIMMERMAN WF, 1971, SCIENCE, V171, P1167, DOI 10.1126/science.171.3976.1167	86	696	721	3	165	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					329	335		10.1038/417329a	http://dx.doi.org/10.1038/417329a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015613				2022-12-28	WOS:000175592100057
J	Hauert, C; De Monte, S; Hofbauer, J; Sigmund, K				Hauert, C; De Monte, S; Hofbauer, J; Sigmund, K			Volunteering as Red Queen mechanism for cooperation in public goods games	SCIENCE			English	Article							SIZABLE GROUPS; EVOLUTION; RECIPROCITY; PUNISHMENT	The evolution of cooperation among nonrelated individuals is one of the fundamental problems in biology and social sciences. Reciprocal altruism fails to provide a solution if interactions are not repeated often enough or groups are too large. Punishment and reward can be very effective but require that defectors can be traced and identified. Here we present a simple but effective mechanism operating under full anonymity. Optional participation can foil exploiters and overcome the social dilemma. In voluntary public goods interactions, cooperators and defectors will coexist. We show that this result holds under very diverse assumptions on population structure and adaptation mechanisms, leading usually not to an equilibrium but to an unending cycle of adjustments (a Red Queen type of evolution). Thus, voluntary participation offers an escape hatch out of some social traps. Cooperation can subsist in sizable groups even if interactions are not repeated, defectors remain anonymous, players have no memory, and assortment is purely random.	Univ Vienna, Inst Math, A-1090 Vienna, Austria; Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Danish Tech Univ, Dept Phys, DK-2800 Kgs Lyngby, Denmark; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	University of Vienna; University of British Columbia; Technical University of Denmark; International Institute for Applied Systems Analysis (IIASA)	Sigmund, K (corresponding author), Univ Vienna, Inst Math, Strudlhofgasse 4, A-1090 Vienna, Austria.		Hauert, Christoph/E-5369-2011	Hauert, Christoph/0000-0002-1239-281X; De Monte, Silvia/0000-0001-7953-5494				[Anonymous], 1998, THEORY LEARNING GAME; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Binmore K., 1994, PLAYING FAIR GAME TH; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; BOYD R, 1988, J THEOR BIOL, V132, P337, DOI 10.1016/S0022-5193(88)80219-4; Colman AM, 2013, GAME THEORY ITS APPL; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; DAWES RM, 1980, ANNU REV PSYCHOL, V31, P169, DOI 10.1146/annurev.ps.31.020180.001125; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H., 2000, GAME THEORY EVOLVING; Hamilton W. D., 1975, BIOSOCIAL ANTHR, P133; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HAUERT C, IN PRESS J THEOR BIO; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Kagel JH, 1995, HDB EXPT EC; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; ORBELL JM, 1993, AM SOCIOL REV, V58, P787, DOI 10.2307/2095951; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SOBER E, 1999, UNTO OTHERS EVOLUTIO; Sugden R, 1986, EC RIGHTS COOPERATIO; Szathmary E, 1995, MAJOR TRANSITIONS EV; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850	28	717	735	9	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1129	1132		10.1126/science.1070582	http://dx.doi.org/10.1126/science.1070582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551MG	12004134	Green Submitted			2022-12-28	WOS:000175565000057
J	La Thangue, NB				La Thangue, NB			Transcription - Chromatin control - a place for E2F and Myc to meet	SCIENCE			English	Editorial Material							HISTONE H3; LYSINE 9; PROTEINS; DOMAIN		Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	La Thangue, NB (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.				Cancer Research UK [13058] Funding Source: Medline; Medical Research Council [G9400953] Funding Source: Medline; MRC [G9400953] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2	11	6	7	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1034	1035		10.1126/science.1072446	http://dx.doi.org/10.1126/science.1072446			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004105				2022-12-28	WOS:000175565000027
J	Presley, JF; Ward, TH; Pfeifer, AC; Siggia, ED; Phair, RD; Lippincott-Schwartz, J				Presley, JF; Ward, TH; Pfeifer, AC; Siggia, ED; Phair, RD; Lippincott-Schwartz, J			Dissection of COPI and Arf1 dynamics in vivo and role in Golgi membrane transport	NATURE			English	Article							ADP-RIBOSYLATION FACTOR-1; ENDOPLASMIC-RETICULUM; LIVING CELLS; COATOMER BINDING; BREFELDIN-A; G-PROTEIN; EXCHANGE; VESICLES; MUTATION; CLATHRIN	Cytosolic coat proteins that bind reversibly to membranes have a central function in membrane transport within the secretory pathway(1,2). One well-studied example is COPI or coatomer, a heptameric protein complex that is recruited to membranes by the GTP-binding protein Arf1. Assembly into an electron-dense coat then helps in budding off membrane to be transported between the endoplasmic reticulum (ER) and Golgi apparatus 2. Here we propose and corroborate a simple model for coatomer and Arf1 activity based on results analysing the distribution and lifetime of fluorescently labelled coatomer and Arf1 on Golgi membranes of living cells. We find that activated Arf1 brings coatomer to membranes. However, once associated with membranes, Arf1 and coatomer have different residence times: coatomer remains on membranes after Arf1-GTP has been hydrolysed and dissociated. Rapid membrane binding and dissociation of coatomer and Arf1 occur stochastically, even without vesicle budding. We propose that this continuous activity of coatomer and Arf1 generates kinetically stable membrane domains that are connected to the formation of COPI-containing transport intermediates. This role for Arf1/coatomer might provide a model for investigating the behaviour of other coat protein systems within cells.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Rockefeller Univ, Ctr Studies & Phys Biol, New York, NY 10021 USA; BioInformat Serv, Rockville, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Rockefeller University	Lippincott-Schwartz, J (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.		Ward, Theresa H./E-9650-2013	Ward, Theresa H./0000-0002-9881-8649	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001609] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; DASCHER C, 1994, J BIOL CHEM, V269, P1437; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Klumperman J, 1998, J CELL SCI, V111, P3411; LAHTINEN U, 1992, J CELL SCI, V103, P321; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; MAKLER V, 1995, J BIOL CHEM, V270, P5232, DOI 10.1074/jbc.270.10.5232; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Puertollano R, 2001, CELL, V105, P93, DOI 10.1016/S0092-8674(01)00299-9; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Vasudevan C, 1998, J CELL SCI, V111, P1277; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418	29	207	210	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					187	193		10.1038/417187a	http://dx.doi.org/10.1038/417187a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000962				2022-12-28	WOS:000175460200046
J	Crawley, LM; Marshall, PA; Lo, B; Koenig, BA				Crawley, LM; Marshall, PA; Lo, B; Koenig, BA		End Life Care Consensus Panel	Strategies for culturally effective end-of-life care	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; AFRICAN-AMERICANS; DECISION-MAKING; ETHNIC DISPARITIES; MEDICAL-RESEARCH; ATTITUDES; CANCER; BLACK; PERCEPTIONS; BEREAVEMENT	As a result of profound worldwide demographic change, physicians will increasingly care for patients from cultural backgrounds other than their own. Differences in beliefs, values, and traditional health care practices are of particular relevance at the end of life. Health care providers and patients and families may not have shared understandings of the meaning of illness or death and may not agree on the best strategies to plan for the end of life or to alleviate pain and suffering. Good end-of-life care may be complicated by disagreements between physicians and patients, difficult interactions, or decisions the physician does not understand. Challenges may result from cultural differences between the patient's background and traditional medical practice. Values so ingrained in physicians as to be unquestioned may be alien to patients from different backgrounds. Physicians need to be sensitive to cultural differences and to develop the skills necessary to work with patients from diverse backgrounds. Community and cultural ties provide a source of great comfort as patients and families prepare for death. This paper describes two cases that raise issues about cross-cultural end-of-life practice and suggests strategies for negotiating common problems. Physicians should assess the cultural background of each patient and inquire about values that may affect care at the end of life. They should become aware of the specific beliefs and practices of the populations they serve, always remembering to inquire whether an individual patient adheres to these cultural beliefs. Attention to cultural difference enables the physician to provide comprehensive and compassionate palliative care at the end of life.	Amer Coll Physicians, Amer Soc Internal Med, Philadelphia, PA 19106 USA	American College of Physicians	Crawley, LM (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.				NINR NIH HHS [R01 NR029060] Funding Source: Medline	NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; BARKER JC, 1992, WESTERN J MED, V157, P248; Bates MS, 1997, SOC SCI MED, V45, P1433, DOI 10.1016/S0277-9536(97)00068-3; Blackhall LJ, 1999, SOC SCI MED, V48, P1779, DOI 10.1016/S0277-9536(99)00077-5; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Buckman R., 1992, BREAK BAD NEWS GUIDE; Carrillo JE, 1999, ANN INTERN MED, V130, P829, DOI 10.7326/0003-4819-130-10-199905180-00017; Cleeland CS, 1997, ANN INTERN MED, V127, P813, DOI 10.7326/0003-4819-127-9-199711010-00006; Corbie-Smith G, 1999, AM J MED SCI, V317, P5, DOI 10.1097/00000441-199901000-00002; Corbie-Smith G, 1999, J GEN INTERN MED, V14, P537, DOI 10.1046/j.1525-1497.1999.07048.x; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; CRAWLEY LM, 2000, HLTH PUBLIC ENSURING, V2, P17; *CROSS CULT HLTH C, 2001, PROF ETHN COMM; Culhane-Pera K A, 1997, Fam Med, V29, P719; Doescher MP, 2000, ARCH FAM MED, V9, P1156, DOI 10.1001/archfami.9.10.1156; Donald Irish, 1993, ETHNIC VARIATIONS DY; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; DULA A, 1994, CLIN GERIATR MED, V10, P419, DOI 10.1016/S0749-0690(18)30330-6; EISENBRUCH M, 1984, CULT MED PSYCHIAT, V8, P315, DOI 10.1007/BF00114661; EISENBRUCH M, 1984, CULT MED PSYCHIAT, V8, P283, DOI 10.1007/BF00055172; Engle VF, 1998, J AM GERIATR SOC, V46, P1091, DOI 10.1111/j.1532-5415.1998.tb06646.x; Fiscella K, 2000, JAMA-J AM MED ASSOC, V283, P2579, DOI 10.1001/jama.283.19.2579; FORTIER J, 2002, ASSURING CULTURAL CO; Freeman HP, 2000, NEW ENGL J MED, V342, P1045, DOI 10.1056/NEJM200004063421411; GAMBLE VN, 1993, AM J PREV MED, V9, P35, DOI 10.1016/S0749-3797(18)30664-0; Gamble VN, 1997, AM J PUBLIC HEALTH, V87, P1773, DOI 10.2105/AJPH.87.11.1773; GEISSLER EM, 1998, POCKET GUIDE CULTURA; Green B. Lee, 2000, Ethnicity and Disease, V10, P76; HAHN RA, 1982, CULT MED PSYCHIAT, V6, P215, DOI 10.1007/BF00114191; Hannan EL, 1999, MED CARE, V37, P68, DOI 10.1097/00005650-199901000-00010; Hern HE, 1998, CAMB Q HEALTHC ETHIC, V7, P27, DOI 10.1017/S0963180198701045; Hunt LM, 1998, MED ANTHROPOL Q, V12, P298, DOI 10.1525/maq.1998.12.3.298; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; KAUFERT JM, 1990, SANTE CULTURE HLTH, V7, P209; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; Kleinman Arthur, 1995, WRITING MARGIN DISCO; KOENIG BA, 1995, WESTERN J MED, V163, P244; LaVeist TA, 2000, MED CARE RES REV, V57, P146, DOI 10.1177/107755800773743637; Lipson JG, 1996, CULTURE NURSING CARE; Lo B, 1999, ANN INTERN MED, V130, P744, DOI 10.7326/0003-4819-130-9-199905040-00015; Lock M., 1993, HLTH CULTURES EXPLOR, P139; Marshall P. A., 1998, HDB IMMIGRANT HLTH, P203, DOI DOI 10.1007/978-1-4899-1936-6_; MARSHALL PA, 1998, HLTH CARE ETHICS CRI, P421; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; McKinley ED, 1996, J GEN INTERN MED, V11, P651, DOI 10.1007/BF02600155; Mebane EW, 1999, J AM GERIATR SOC, V47, P579, DOI 10.1111/j.1532-5415.1999.tb02573.x; Morrison RS, 2000, NEW ENGL J MED, V342, P1023, DOI 10.1056/NEJM200004063421406; Murphy ST, 1996, J LAW MED ETHICS, V24, P108, DOI 10.1111/j.1748-720X.1996.tb01843.x; Natl. Comm. Prot. Hum. Subj. Biomed. Behav. Res, 1978, BELM REP ETH PRINC G; Neubauer B J, 1990, Hosp J, V6, P37; Orr R D, 1995, Arch Fam Med, V4, P159; Pan RJ, 1999, PEDIATRICS, V103, P167; Peterson ED, 1997, NEW ENGL J MED, V336, P480, DOI 10.1056/NEJM199702133360706; POULSON J, 1998, PALLIATIVE MED CASE, P244; RUBIN SM, 1994, JAMA-J AM MED ASSOC, V271, P209, DOI 10.1001/jama.271.3.209; Shavers-Hornaday V L, 1997, Ethn Health, V2, P31; Suchman AL, 1997, JAMA-J AM MED ASSOC, V277, P678, DOI 10.1001/jama.277.8.678; Tervalon M, 1998, J HEALTH CARE POOR U, V9, P117; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; TRIANDIS HC, 1984, J PERS SOC PSYCHOL, V47, P1363, DOI 10.1037/0022-3514.47.6.1363; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; WELCH M, 1997, BEHAV MED PRIMARY CA, P97; Zweifler J, 1998, ACAD MED, V73, P1056, DOI 10.1097/00001888-199810000-00012	63	141	142	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					673	679		10.7326/0003-4819-136-9-200205070-00010	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	547XK	11992303				2022-12-28	WOS:000175357900005
J	Sutterlin, C; Hsu, P; Mallabiabarrena, A; Malhotra, V				Sutterlin, C; Hsu, P; Mallabiabarrena, A; Malhotra, V			Fragmentation and dispersal of the pericentriolar Golgi complex is required for entry into mitosis in mammalian cells	CELL			English	Article							POLO-LIKE KINASE; CYCLE; STACKING; GRASP65; REDISTRIBUTION; CHECKPOINT; COMPONENTS; CISTERNAE; DEPENDS; GM130	The pericentriolar Golgi stacks are fragmented and found dispersed in mitotic mammalian cells. Addition of an antibody to the Golgi-associated protein GRASP65 inhibited Golgi fragmentation by mitotic cytosol in permeabilized cells. Microinjecting this antibody or the C-terminal fragment of GRASP65, which contains the antibody binding site, into normal rat kidney cells prevented entry into mitosis. Under these conditions the cells had completed S phase but were not in the prophase stage of mitosis. Fragmentation of the Golgi apparatus by nocodazole or Brefeldin A treatment prior to or post microinjection of the anti-GRASP65 antibody alleviated the block in mitotic entry. Based on our findings, we suggest that the pericentriolar Golgi organization is a sensor for controlling entry into mitosis in mammalian cells.	Univ Calif San Diego, Div Biol, Dept Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Pompeu Fabra, Serv Microscopia Confocal, Dept Ciencies Expt & Salud, Barcelona 08003, Spain	University of California System; University of California San Diego; Pompeu Fabra University	Malhotra, V (corresponding author), Univ Calif San Diego, Div Biol, Dept Cell & Dev Biol, La Jolla, CA 92093 USA.		Malhotra, Vivek/O-9811-2014	Malhotra, Vivek/0000-0001-6198-7943				Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; CELLS JE, 1994, CELL BIOL LAB HDB; Cha HJ, 2001, J CELL BIOL, V153, P1355, DOI 10.1083/jcb.153.7.1355; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Harlow E., 1988, ANTIBODIES LAB MANUA; Hinchcliffe EH, 2001, GENE DEV, V15, P1167, DOI 10.1101/gad.894001; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lowe M, 1998, TRENDS CELL BIOL, V8, P40, DOI 10.1016/S0962-8924(97)01189-6; Nebenfuhr A, 2000, PLANT PHYSIOL, V124, P135, DOI 10.1104/pp.124.1.135; Nelson WJ, 2000, J CELL BIOL, V149, P243, DOI 10.1083/jcb.149.2.243; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; PREUSS D, 1992, MOL BIOL CELL, V3, P789, DOI 10.1091/mbc.3.7.789; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Rossanese OW, 2001, TRAFFIC, V2, P589, DOI 10.1034/j.1600-0854.2001.20901.x; Shima DT, 1997, J CELL BIOL, V137, P1211, DOI 10.1083/jcb.137.6.1211; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Sutterlin C, 2001, P NATL ACAD SCI USA, V98, P9128, DOI 10.1073/pnas.161283998; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Yang J, 1999, TRENDS CELL BIOL, V9, P207, DOI 10.1016/S0962-8924(99)01577-9; ZAAI KJ, 1999, CELL, V99, P589; Zhou BBS, 2000, J BIOL CHEM, V275, P10342, DOI 10.1074/jbc.275.14.10342	29	202	208	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					359	369		10.1016/S0092-8674(02)00720-1	http://dx.doi.org/10.1016/S0092-8674(02)00720-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015985	Bronze			2022-12-28	WOS:000175412100011
J	Kiss, T				Kiss, T			Small nucleolar RNAs: An abundant group of noncoding RNAs with diverse cellular functions	CELL			English	Review							U6 SPLICEOSOMAL RNA; SNRNP	Small nucleolar RNAs represent an abundant, evolutionarily ancient group of noncoding RNAs which possess impressively diverse functions ranging from 2'-O-methylation and pseudouridylation of various classes of RNAs, through nucleolytic processing of rRNAs to the synthesis of telomeric DNA.	Univ Toulouse 3, CNRS, Lab Biol Mol Eucaryote, F-31062 Toulouse, France; Hungarian Acad Sci, Biol Res Ctr, H-6701 Szeged, Hungary	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Kiss, T (corresponding author), Univ Toulouse 3, CNRS, Lab Biol Mol Eucaryote, 118 Route Narbonne, F-31062 Toulouse, France.			Kiss, Tamas/0000-0003-0293-3093				Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Ganot P, 1999, MOL CELL BIOL, V19, P6906; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Jady BE, 2001, EMBO J, V20, P541, DOI 10.1093/emboj/20.3.541; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lange TS, 2000, MOL BIOL CELL, V11, P2419, DOI 10.1091/mbc.11.7.2419; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sleeman JE, 1999, CURR BIOL, V9, P1065, DOI 10.1016/S0960-9822(99)80475-8; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; Yu YT, 1999, RNA WORLD, P487	20	586	626	1	42	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					145	148		10.1016/S0092-8674(02)00718-3	http://dx.doi.org/10.1016/S0092-8674(02)00718-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007400	Bronze			2022-12-28	WOS:000175082600003
J	Godlee, F				Godlee, F			Making reviewers visible - Openness, accountability, and credit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; QUALITY; PUBLICATION; ANONYMITY	Anonymity for peer reviewers remains the overwhelming norm within biomedical journals. While acknowledging that open review is not without challenges, this article presents 4 key arguments in its favor: (1) ethical superiority, (2) lack of important adverse effects, (3) feasibility in practice, and (4) potential to balance greater accountability for reviewers with credit for the work they do. Barriers to more widespread use of open review include conservatism within the research community and the fact that openness makes editors publicly responsible for their choice of reviewers and their interpretation of reviewers' comments. Forces for change include the growing use of preprint servers combined with open commentary. I look forward to a time when open commentary and review replace the current, flawed system of closed prepublication peer review and its false reassurances about the reliability of what is published.	BioMed Cent, London W1T 4LB, England		Godlee, F (corresponding author), BioMed Cent, 34 Cleveland St, London W1T 4LB, England.							Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2765, DOI 10.1001/jama.287.21.2765; FABIATO A, 1994, CARDIOVASC RES, V28, P1134, DOI 10.1093/cvr/28.8.1134; GINSPARG P, 2002, CREATING GLOBAL KNOW; Godlee F, 1998, JAMA-J AM MED ASSOC, V280, P237, DOI 10.1001/jama.280.3.237; GODLEE F, 1999, PEER REV HLTH SCI; Gura T, 2002, NATURE, V416, P258, DOI 10.1038/416258a; HARNAD S, 1995, SCHOLARLY PUBLISHING; INGELFINGER FJ, 1975, NEW ENGL J MED, V293, P1371, DOI 10.1056/NEJM197512252932613; JUDSON HF, 1994, JAMA-J AM MED ASSOC, V272, P92, DOI 10.1001/jama.272.2.92; Justice AC, 1998, JAMA-J AM MED ASSOC, V280, P240, DOI 10.1001/jama.280.3.240; MCNUTT RA, 1990, JAMA-J AM MED ASSOC, V263, P1371, DOI 10.1001/jama.263.10.1371; ODLYZKO AM, 2002, TRAGIC LOSS GOOD RID; RENNIE D, 1994, CARDIOVASC RES, V28, P1142; Rennie D, 1998, JAMA-J AM MED ASSOC, V280, P300, DOI 10.1001/jama.280.3.300; Robertson P, 1976, NEW SCI, V71, P410; Smith R, 1999, BRIT MED J, V318, P4; van Rooyen S, 1998, JAMA-J AM MED ASSOC, V280, P234, DOI 10.1001/jama.280.3.234; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5; van Rooyen S, 1999, BRIT MED J, V318, P23; Walsh E, 2000, BRIT J PSYCHIAT, V176, P47, DOI 10.1192/bjp.176.1.47	20	105	106	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2762	2765		10.1001/jama.287.21.2762	http://dx.doi.org/10.1001/jama.287.21.2762			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038905				2022-12-28	WOS:000176002200002
J	Friedberg, EC; Wagner, R; Radman, M				Friedberg, EC; Wagner, R; Radman, M			Molecular biology - Specialized DNA polymerases, cellular survival, and the genesis of mutations	SCIENCE			English	Review							ESCHERICHIA-COLI DINB; STRAND BREAK REPAIR; XERODERMA-PIGMENTOSUM; POL-IOTA; MUTAGENESIS; ZETA; DAMAGE; HYPERMUTATION; REPLICATION; DISRUPTION		Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX 75235 USA; Gene Check Inc, Ft Collins, CO 80524 USA; Univ Paris 05, Fac Necker Enfants Malad, INSERM, E9916, F-75730 Paris 15, France	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Friedberg, EC (corresponding author), Univ Texas, SW Med Ctr, Dept Pathol, Lab Mol Pathol, Dallas, TX 75235 USA.	errol.friedberg@utsouthwestern.edu	Radman, Miroslav/HDM-5955-2022	Radman, Miroslav/0000-0003-0216-3148; Radman, Miroslav/0000-0002-7034-4365				Bemark M, 2000, CURR BIOL, V10, P1213, DOI 10.1016/S0960-9822(00)00724-7; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Bridges BA, 1998, CURR BIOL, V8, pR886, DOI 10.1016/S0960-9822(07)00552-0; CAILLETFAUQUET P, 1977, J MOL BIOL, V117, P95, DOI 10.1016/0022-2836(77)90025-0; CLEAVER JE, 1972, J INVEST DERMATOL, V58, P124, DOI 10.1111/1523-1747.ep12538913; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Friedberg EC, 2000, P NATL ACAD SCI USA, V97, P5681, DOI 10.1073/pnas.120152397; Friedberg EC, 2000, COLD SPRING HARB SYM, V65, P593, DOI 10.1101/sqb.2000.65.593; Friedberg EC, 2001, CELL, V107, P9, DOI 10.1016/S0092-8674(01)00509-8; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Gearhart PJ, 2001, NAT REV IMMUNOL, V1, P187, DOI 10.1038/35105009; Gerlach VL, 2000, COLD SPRING HARB SYM, V65, P41, DOI 10.1101/sqb.2000.65.41; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Goodman MF, 2000, CURR OPIN GENET DEV, V10, P162, DOI 10.1016/S0959-437X(00)00057-5; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Haracska L, 2001, J BIOL CHEM, V276, P6861, DOI 10.1074/jbc.M008021200; Harfe BD, 2000, MOL CELL, V6, P1491, DOI 10.1016/S1097-2765(00)00145-3; Holbeck SL, 1997, GENETICS, V147, P1017; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; LAWRENCE CW, 1985, MOL GEN GENET, V200, P86, DOI 10.1007/BF00383317; Lenne-Samuel N, 2002, EMBO REP, V3, P45, DOI 10.1093/embo-reports/kvf007; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Masutani C, 2000, COLD SPRING HARB SYM, V65, P71, DOI 10.1101/sqb.2000.65.71; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; McDonald JP, 1997, GENETICS, V147, P1557; McGill CB, 1998, GENETICS, V148, P1525; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Poltoratsky V, 2001, P NATL ACAD SCI USA, V98, P7976, DOI 10.1073/pnas.141222198; Radman M, 1999, NATURE, V401, P866, DOI 10.1038/44738; Radman M, 1974, MOL ENV ASPECTS MUTA, P128; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Roush AA, 1998, MOL GEN GENET, V257, P686; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; Sutton MD, 2001, P NATL ACAD SCI USA, V98, P8342, DOI 10.1073/pnas.111036998; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Taddei F, 1997, NATURE, V387, P700, DOI 10.1038/42696; Tang MJ, 2000, NATURE, V404, P1014, DOI 10.1038/35010020; Tissier A, 2000, GENE DEV, V14, P1642; Vaisman A, 2001, EMBO J, V20, P6520, DOI 10.1093/emboj/20.22.6520; VANSLOUN PPH, IN PRESS MOL CELL BI; Wagner J, 2002, DNA REPAIR, V1, P159, DOI 10.1016/S1568-7864(01)00012-X; Weill JC, 2002, ADV IMMUNOL, V80, P183, DOI 10.1016/S0065-2776(02)80015-3; WITKIN EM, 1976, BACTERIOL REV, V40, P869, DOI 10.1128/MMBR.40.4.869-907.1976; WITKIN EVELYN M., 1967, BROOKHAVEN SYMP BIOL, V20, P17; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zan H, 2001, IMMUNITY, V14, P643, DOI 10.1016/S1074-7613(01)00142-X; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	55	369	381	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1627	1630		10.1126/science.1070236	http://dx.doi.org/10.1126/science.1070236			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040171				2022-12-28	WOS:000175976200034
J	Cheng, MY; Bullock, CM; Li, CY; Lee, AG; Bermak, JC; Belluzzi, J; Weaver, DR; Leslie, FM; Zhou, QY				Cheng, MY; Bullock, CM; Li, CY; Lee, AG; Bermak, JC; Belluzzi, J; Weaver, DR; Leslie, FM; Zhou, QY			Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus	NATURE			English	Article							EFFERENT PROJECTIONS; CLOCK; GENE; LIGHT; EXPRESSION; MUTATION; MPER2; MICE; ORGANIZATION; TRANSPORT	The suprachiasmatic nucleus (SCN) controls the circadian rhythm of physiological and behavioural processes in mammals. Here we show that prokineticin 2 (PK2), a cysteine-rich secreted protein, functions as an output molecule from the SCN circadian clock. PK2 messenger RNA is rhythmically expressed in the SCN, and the phase of PK2 rhythm is responsive to light entrainment. Molecular and genetic studies have revealed that PK2 is a gene that is controlled by a circadian clock (clock-controlled). Receptor for PK2 (PKR2) is abundantly expressed in major target nuclei of the SCN output pathway. Inhibition of nocturnal locomotor activity in rats by intracerebroventricular delivery of recombinant PK2 during subjective night, when the endogenous PK2 mRNA level is low, further supports the hypothesis that PK2 is an output molecule that transmits behavioural circadian rhythm. The high expression of PKR2 mRNA within the SCN and the positive feedback of PK2 on its own transcription through activation of PKR2 suggest that PK2 may also function locally within the SCN to synchronize output.	Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA	University of California System; University of California Irvine; University of Massachusetts System; University of Massachusetts Worcester	Zhou, QY (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92697 USA.	qzhou@uci.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Cheng, Michelle/0000-0003-3241-5174; Weaver, David/0000-0001-7941-6719				Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Boer GJ, 1999, NEUROSCIENCE, V89, P375, DOI 10.1016/S0306-4522(98)00300-5; Buijs RM, 1996, PROG BRAIN RES, V111, P229, DOI 10.1016/S0079-6123(08)60411-2; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cermakian N, 2001, EMBO J, V20, P3967, DOI 10.1093/emboj/20.15.3967; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; Hardin P.E., 2000, GENOME BIOL, V1; Hastings MH, 2000, NAT REV NEUROSCI, V1, P143, DOI 10.1038/35039080; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jilek A, 2000, GENE, V256, P189, DOI 10.1016/S0378-1119(00)00355-3; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kalsbeek A, 1996, J NEUROSCI, V16, P5555, DOI 10.1523/jneurosci.16-17-05555.1996; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Leak RK, 2001, J COMP NEUROL, V433, P312, DOI 10.1002/cne.1142; LeSauter J, 1998, CHRONOBIOL INT, V15, P535, DOI 10.3109/07420529808998706; Li M, 2001, MOL PHARMACOL, V59, P692, DOI 10.1124/mol.59.4.692; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Moore RY, 1997, ANNU REV MED, V48, P253, DOI 10.1146/annurev.med.48.1.253; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; WATTS AG, 1987, J COMP NEUROL, V258, P230, DOI 10.1002/cne.902580205; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Winzer-Serhan UH, 1999, BRAIN RES PROTOC, V3, P229, DOI 10.1016/S1385-299X(98)00043-9; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	50	529	555	2	23	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					405	410		10.1038/417405a	http://dx.doi.org/10.1038/417405a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024206				2022-12-28	WOS:000175730900030
J	Hetzel, R; Niedermann, S; Tao, M; Kubik, PW; Ivy-Ochs, S; Gao, B; Strecker, MR				Hetzel, R; Niedermann, S; Tao, M; Kubik, PW; Ivy-Ochs, S; Gao, B; Strecker, MR			Low slip rates and long-term preservation of geomorphic features in Central Asia	NATURE			English	Article							ALTYN-TAGH FAULT; COSMOGENIC NUCLIDES; ACTIVE DEFORMATION; TIBET PLATEAU; QILIAN-SHAN; CHINA; MANTLE; GANSU; KINEMATICS; TERRACES	In order to understand the dynamics of the India-Asia collision zone, it is important to know the strain distribution in Central Asia, whose determination relies on the slip rates for active faults(1-5). Many previous slip-rate estimates of faults in Central Asia were based on the assumption that offset landforms are younger than the Last Glacial Maximum (similar to20 kyr ago)(6-11). In contrast, here we present surface exposure ages of 40 to 170 kyr, obtained using cosmogenic nuclide dating, for a series of terraces near a thrust at the northern margin of the Tibetan Plateau. Combined with the tectonic offset, the ages imply a long-term slip rate of only about 0.35 mm yr(-1) for the active thrust, an order of magnitude lower than rates obtained from the assumption that the terraces formed after the Last Glacial Maximum. Our data demonstrate that the preservation potential of geomorphic features in Central Asia is higher than commonly assumed.	Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; Univ Potsdam, Inst Geowissensch, D-14415 Potsdam, Germany; Chinese Acad Sci, Lanzhou Inst Geol, State Key Lab Gasgeochem, Lanzhou 730000, Peoples R China; ETH Honggerberg, Inst Particle Phys, Paul Scherrer Inst, CH-8093 Zurich, Switzerland; ETH Honggerberg, Inst Particle Phys, CH-8093 Zurich, Switzerland	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Potsdam; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Swiss Federal Institutes of Technology Domain; ETH Zurich; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hetzel, R (corresponding author), Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany.			Niedermann, Samuel/0000-0003-1626-5284				AVOUAC JP, 1993, GEOPHYS RES LETT, V20, P895, DOI 10.1029/93GL00128; Bendick R, 2000, NATURE, V404, P69, DOI 10.1038/35003555; Bilham R, 1997, NATURE, V386, P61, DOI 10.1038/386061a0; BULL WB, 1979, GEOL SOC AM BULL, V90, P453, DOI 10.1130/0016-7606(1979)90<453:TOCPIS>2.0.CO;2; DEMETS C, 1994, GEOPHYS RES LETT, V21, P2191, DOI 10.1029/94GL02118; Dunai TJ, 2000, EARTH PLANET SC LETT, V176, P157, DOI 10.1016/S0012-821X(99)00310-6; England P, 1997, GEOPHYS J INT, V130, P551, DOI 10.1111/j.1365-246X.1997.tb01853.x; England P, 1997, SCIENCE, V278, P647, DOI 10.1126/science.278.5338.647; GAUDEMER Y, 1995, GEOPHYS J INT, V120, P599, DOI 10.1111/j.1365-246X.1995.tb01842.x; GILLESPIE A, 1995, REV GEOPHYS, V33, P311, DOI 10.1029/95RG00995; Hancock GS, 1999, GEOMORPHOLOGY, V27, P41, DOI 10.1016/S0169-555X(98)00089-0; HETZEL R, UNPUB EARTH PLANET S; Holt WE, 2000, GEOLOGY, V28, P67, DOI 10.1130/0091-7613(2000)28<67:CCAMSF>2.0.CO;2; KOHL CP, 1992, GEOCHIM COSMOCHIM AC, V56, P3583, DOI 10.1016/0016-7037(92)90401-4; Kubik PW, 1998, EARTH PLANET SC LETT, V161, P231, DOI 10.1016/S0012-821X(98)00153-8; Meyer B, 1998, GEOPHYS J INT, V135, P1, DOI 10.1046/j.1365-246X.1998.00567.x; Meyer B, 1996, GEOPHYS J INT, V124, P29, DOI 10.1111/j.1365-246X.1996.tb06350.x; MOLNAR P, 1994, J GEOL, V102, P583, DOI 10.1086/629700; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Niedermann S, 2000, EARTH PLANET SC LETT, V183, P361, DOI 10.1016/S0012-821X(00)00302-2; PELTZER G, 1988, J GEOPHYS RES-SOLID, V93, P7793, DOI 10.1029/JB093iB07p07793; PELTZER G, 1989, SCIENCE, V246, P1285, DOI 10.1126/science.246.4935.1285; Peltzer G, 1996, J GEOPHYS RES-SOL EA, V101, P27943, DOI 10.1029/96JB02698; Repka JL, 1997, EARTH PLANET SC LETT, V152, P59, DOI 10.1016/S0012-821X(97)00149-0; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; TAPPONNIER P, 1990, EARTH PLANET SC LETT, V97, P382, DOI 10.1016/0012-821X(90)90053-Z; THOMPSON LG, 1989, SCIENCE, V246, P474, DOI 10.1126/science.246.4929.474; Van Der Woerd J, 2002, GEOPHYS J INT, V148, P356, DOI 10.1046/j.1365-246x.2002.01556.x; Washburn Z, 2001, GEOLOGY, V29, P1051, DOI 10.1130/0091-7613(2001)029<1051:LHEHOT>2.0.CO;2; [No title captured]	30	138	175	3	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					428	432		10.1038/417428a	http://dx.doi.org/10.1038/417428a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024210				2022-12-28	WOS:000175730900035
J	Storz, G				Storz, G			An expanding universe of noncoding RNAs	SCIENCE			English	Editorial Material							SMALL NUCLEOLAR RNAS; ESCHERICHIA-COLI; GENES; IDENTIFICATION; RIBONUCLEOPROTEINS; EXPRESSION; DATABASE	Noncoding RNAs (ncRNAs) have been found to have roles in a great variety of processes, including transcriptional regulation, chromosome replication, RNA processing and modification, messenger RNA stability and translation, and even protein degradation and translocation. Recent studies indicate that ncRNAs are far more abundant and important than initially imagined. These findings raise several fundamental questions: How many ncRNAs are encoded by a genome? Given the absence of a diagnostic open reading frame, how can these genes be identified? How can all the functions of ncRNAs be elucidated?	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Storz, G (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	storz@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altuvia S, 2000, P NATL ACAD SCI USA, V97, P9824, DOI 10.1073/pnas.97.18.9824; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; CHEN S, IN PRESS BIOSYSTEMS; Chen XG, 2000, GENE DEV, V14, P777; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Erdmann VA, 2000, NUCLEIC ACIDS RES, V28, P197, DOI 10.1093/nar/28.1.197; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Grosshans H, 2002, J CELL BIOL, V156, P17, DOI 10.1083/jcb.200111033; Gu J, 1998, NUCLEIC ACIDS RES, V26, P160, DOI 10.1093/nar/26.1.160; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kable ML, 1997, TRENDS BIOCHEM SCI, V22, P162, DOI 10.1016/S0968-0004(97)01041-4; Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KLEIN RJ, IN PRESS P NATL ACAD; Kuryshev VY, 2001, J MOL BIOL, V309, P1049, DOI 10.1006/jmbi.2001.4725; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Olivas WM, 1997, NUCLEIC ACIDS RES, V25, P4619, DOI 10.1093/nar/25.22.4619; Plant KE, 2001, MOL CELL BIOL, V21, P6507, DOI 10.1128/MCB.21.19.6507-6514.2001; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; Samarsky DA, 1999, NUCLEIC ACIDS RES, V27, P161, DOI 10.1093/nar/27.1.161; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Simpson L, 2000, P NATL ACAD SCI USA, V97, P6986, DOI 10.1073/pnas.97.13.6986; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Souza AE, 1997, NUCLEIC ACIDS RES, V25, P104, DOI 10.1093/nar/25.1.104; TANG TH, IN PRESS P NATL ACAD; Wang W, 2002, P NATL ACAD SCI USA, V99, P4448, DOI 10.1073/pnas.072066399; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	48	430	482	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1260	1263		10.1126/science.1072249	http://dx.doi.org/10.1126/science.1072249			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016301				2022-12-28	WOS:000175713000038
J	Annas, GJ				Annas, GJ			Cloning and the US Congress	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Hlth law Dept, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Hlth law Dept, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 1998, NEW ENGL J MED, V339, P122, DOI 10.1056/NEJM199807093390213; Annas GJ, 2000, NEW ENGL J MED, V343, P373, DOI 10.1056/NEJM200008033430519; Annas GJ, 1999, NAT MED, V5, P1339, DOI 10.1038/70900; ANNAS GJ, 2002, BOSTON GLOBE    0421, pE1; *COMM BIOL BIOM AP, 2002, STEM CELLS FUT REG M; DEECH R, 2000, CROSS CURRENTS FAMIL, P165; Evers K, 2002, NEW ENGL J MED, V346, P1579, DOI 10.1056/NEJMsb020527; Feldbaum C, 2002, SCIENCE, V295, P975, DOI 10.1126/science.1069614; Kass Leon, 2001, NEW REPUBLIC    0521; KRAUTHAMMER C, 2001, WASHINGTON POST 0727, pA33; National Bioethics Advisory Commission, 1997, CLON HUM BEINGS; *PAN SCI MED ASP H, 2002, SCI MED ASP HUM REPR; Weissman IL, 2002, NEW ENGL J MED, V346, P1576, DOI 10.1056/NEJMsb020693; 2001, NY TIMES        0810, pA16	14	9	11	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1599	1602		10.1056/NEJMlim020762	http://dx.doi.org/10.1056/NEJMlim020762			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	11994549				2022-12-28	WOS:000175563900034
J	Innes, KE; Byers, TE; Marshall, JA; Baron, A; Orleans, M; Hamman, RF				Innes, KE; Byers, TE; Marshall, JA; Baron, A; Orleans, M; Hamman, RF			Association of a woman's own birth weight with subsequent risk for gestational diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INSULIN-RESISTANCE SYNDROME; GLUCOSE-TOLERANCE; FETAL ORIGINS; INDIAN CHILDREN; ADULT DISEASE; SHORT STATURE; WOMEN; PREGNANCY; MELLITUS; GROWTH	Context Several studies have reported links between reduced fetal growth and subsequent risk for type 2 diabetes among older adults, but the association between indices of-fetal growth and gestational diabetes mellitus (GDM), a major complication of pregnancy and a strong predictor of type 2 diabetes, remains little explored. Objective To test the hypothesis that a woman's own fetal growth is inversely related to her later risk for GDM. Design and Setting Case-control study of linked hospital discharge and vital record data from the New York State Department of Health. Population Healthy women who completed their first pregnancies in New York State between 1994 and 1998 and who were also born in New York State, Records from each woman's first pregnancy were linked to those from her own birth (1970-1985). Cases were 440 women with a record of GDM. Controls were 22 955 remaining women with no indication of GDM. Main Outcome Measure A woman's own birth weight, alone and adjusted for gestational age. Results Birth weight showed a U-shaped relationship to a woman's risk of GDM in her first pregnancy, with the highest risks associated with low and high birth weights. Odds ratios (ORs) adjusted for gestational age were 2.16 (95% confidence interval [CI], 1.04-4.50) for birth weight of less than 2000 g and 1.53 (95% CI, 1.03-2.27) for a birth weight of 4000 g or more. Adjustment for potential confounding factors, particularly prepregnancy body mass index and maternal diabetes, increased the OR for low birth weight to 4.23 (95% CI, 1.55-11.51), but reduced the OR for high birth weight to 0.92 (95% CI, 0.54-1.57), leaving a strong inverse dose-response relationship between birth weight and risk of GDM (adjusted P for trend <.001). Conclusions In this large population-based study, a woman's own birth weight was strongly and inversely related to her risk of GDM, suggesting that early life factors may be important in the etiology of this disorder.	Univ Virginia, SE Rural Mental Hlth Ctr, Charlottesville, VA 22903 USA; Univ Colorado, Hlth Sci Ctr, Dept Prevent Med & Biometr, Denver, CO 80262 USA	University of Virginia; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Innes, KE (corresponding author), Univ Virginia, SE Rural Mental Hlth Ctr, McLeod Hall,202 15th St SW, Charlottesville, VA 22903 USA.	kei6n@virginia.edu			NHLBI NIH HHS [1R03HL59467-D] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AbuSayeed M, 1997, DIABETES RES CLIN PR, V34, P149, DOI 10.1016/S0168-8227(96)01337-X; Anastasiou E, 1998, DIABETOLOGIA, V41, P997, DOI 10.1007/s001250051022; Anastasiou E, 1998, DIABETES CARE, V21, P2111, DOI 10.2337/diacare.21.12.2111; [Anonymous], 1989, DIABETES CARE, V12, P365; Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; BARKER DJP, 1994, J ROY COLL PHYS LOND, V28, P544; BARKER DJP, 1995, FETUS NEONATE PHYSL, P255; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; BERKOWITZ GS, 1992, AM J EPIDEMIOL, V135, P965, DOI 10.1093/oxfordjournals.aje.a116408; Branchtein L, 2000, DIABETOLOGIA, V43, P848, DOI 10.1007/s001250051460; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P201; *CDCP, 1986, MMWR-MORBID MORTAL W, V35, P213; Centers for Disease Control and Prevention, 1998, MMWR-MORBID MORTAL W, V47, P408; Clark CM, 1997, DIABETES CARE, V20, P867, DOI 10.2337/diacare.20.5.867; Clark PM, 1998, EUR J PEDIATR, V157, pS7, DOI 10.1007/PL00014289; Couch SC, 1998, J REPROD MED, V43, P816; Coustan DR, 1995, DIABETES AM, P703; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Dabelea D, 1999, DIABETES CARE, V22, P944, DOI 10.2337/diacare.22.6.944; DORNHORST A, 1990, BAILLIERE CLIN ENDOC, V4, P291, DOI 10.1016/S0950-351X(05)80052-7; Egeland GM, 2000, BMJ-BRIT MED J, V321, P546, DOI 10.1136/bmj.321.7260.546; Emery ES, 1997, PAEDIATR PERINAT EP, V11, P313; ENGELGAU MM, 1995, DIABETES CARE, V18, P1029, DOI 10.2337/diacare.18.7.1029; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 1998, DIABETES CARE S1, V21, pS5; Fall CH, 2001, INT J DIABETES DEV C, V21, P3; FALL CHD, 1995, BRIT MED J, V310, P428, DOI 10.1136/bmj.310.6977.428; Hoet JJ, 2000, ENVIRON HEALTH PERSP, V108, P563, DOI 10.2307/3454547; Innes KE, 1999, ACTA OBSTET GYN SCAN, V78, P263, DOI 10.1034/j.1600-0412.1999.780401.x; Jang HC, 1998, DIABETOLOGIA, V41, P778, DOI 10.1007/s001250050987; Joseph KS, 1996, EPIDEMIOL REV, V18, P158, DOI 10.1093/oxfordjournals.epirev.a017923; KJOS SL, 1990, AM J OBSTET GYNECOL, V163, P93, DOI 10.1016/S0002-9378(11)90676-0; Kousta E, 2000, DIABETIC MED, V17, P792, DOI 10.1046/j.1464-5491.2000.00393.x; Kramer MS, 2000, AM J EPIDEMIOL, V152, P605, DOI 10.1093/aje/152.7.605; LAW C, 2001, PEDIATR RES, V50, pA59; Law CM, 1996, DIABETIC MED, V13, pS49; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; MAGEE MS, 1993, JAMA-J AM MED ASSOC, V269, P609, DOI 10.1001/jama.269.5.609; MARRERO DG, 1992, DIABETES CARE, V15, P101, DOI 10.2337/diacare.15.1.101; McAllister AS, 1999, DIABETES CARE, V22, P2061, DOI 10.2337/diacare.22.12.2061; MCCANCE DR, 1994, BRIT MED J, V308, P942, DOI 10.1136/bmj.308.6934.942; METZGER BE, 1993, DIABETES CARE, V16, P1598, DOI 10.2337/diacare.16.12.1598; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; MONTELONGO A, 1992, DIABETES, V41, P1651, DOI 10.2337/diabetes.41.12.1651; MOOY JM, 1995, DIABETES CARE, V18, P1270, DOI 10.2337/diacare.18.9.1270; Moses RG, 1999, DIABETES CARE, V22, P1059, DOI 10.2337/diacare.22.7.1059; Pan WH, 2001, CHINESE J PHYSIOL, V44, P44; Petry CJ, 2000, HUM REPROD UPDATE, V6, P578, DOI 10.1093/humupd/6.6.578; PETTITT DJ, 1991, DIABETES, V40, P126, DOI 10.2337/diab.40.2.S126; Phillips DIW, 1998, DIABETES CARE, V21, pB150; PUGNALONI A, 1995, GYNECOL OBSTET INVES, V39, P239, DOI 10.1159/000292418; Reece E A, 1994, Obstet Gynecol Surv, V49, P64, DOI 10.1097/00006254-199401000-00027; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; ROBINSON S, 1992, DIABETOLOGIA, V35, P444, DOI 10.1007/BF02342441; ROSEMAN JM, 1991, DIABETES METAB REV, V7, P93, DOI 10.1002/dmr.5610070203; Ryan EA, 1998, MED CLIN N AM, V82, P823, DOI 10.1016/S0025-7125(05)70026-2; Silverman BL, 1998, DIABETES CARE, V21, pB142; Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078; Solomon CG, 1996, DIABETES CARE, V19, P12, DOI 10.2337/diacare.19.1.12; Stanner SA, 1997, BMJ-BRIT MED J, V315, P1342, DOI 10.1136/bmj.315.7119.1342; Weintrob N, 1996, J DIABETES COMPLICAT, V10, P294, DOI 10.1016/1056-8727(95)00080-1; Whincup PH, 1997, DIABETOLOGIA, V40, P319, DOI 10.1007/s001250050681	61	115	121	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2534	2541		10.1001/jama.287.19.2534	http://dx.doi.org/10.1001/jama.287.19.2534			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020334				2022-12-28	WOS:000175566200022
J	Cummings, P; McKnight, B; Rivara, FP; Grossman, DC				Cummings, P; McKnight, B; Rivara, FP; Grossman, DC			Association of driver air bags with driver fatality: a matched cohort study	BRITISH MEDICAL JOURNAL			English	Article							RISK	Objective To estimate the association of driver air bag presence with driver fatality in road traffic crashes. Design Matched pair cohort study. Setting All passenger vehicle crashes in the United States during 1990-2000 inclusive. Subjects 51 031 driver-passenger pairs in the same vehicle. Main outcome measures Relative risk of death within 30 days of a crash. Results Drivers with an air bag were less likely to die than drivers without an air bag (adjusted relative risk 0.92 (95% confidence interval 0.88 to 0.96)). This estimate was nearly the same whether drivers wore a seat belt (adjusted relative risk 0.93) or not (0.91). Air bags were associated with more protection for women (0.88 (0.82 to 0.93)), than for men (0.94 (0.90 to 0.99)), Drivers wearing a seat belt were less likely to die than unbelted drivers (0.35 (0.33 to 0.36)). Belted drivers with an air bag were less likely to die than unbelted drivers without an air bag (0.32 (0.30 to 0.34)). Conclusions If the associations are causal the average risk of driver death was reduced 8% (95% confidence interval 4% to 12%) by an air bag. Benefit was similar for belted and unbelted drivers and was slightly greater for women. However, seat belts offered much more protection than air bags.	Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cummings, P (corresponding author), Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, 325 9th Ave,Box 359960, Seattle, WA 98104 USA.				ODCDC CDC HHS [R49/CCR002570, R49/CCR019477-01] Funding Source: Medline	ODCDC CDC HHS		Cummings P, 2001, INJURY CONTROL, P139; CUMMINGS P, IN PRESS ACCUL ANAL; CUMMINGS P, IN PRESS ACCID ANAL; EVANS L, 1986, ACCIDENT ANAL PREV, V18, P217, DOI 10.1016/0001-4575(86)90006-0; FERGUSON SA, 1995, DRIVER FATALITIES 19; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Greenlands S, 1994, APPL STAT-J ROY ST C, V43, P223; HARDIN J, 2001, GEN LINEAR MODELS EX, P196; *HIGHW LOSS DAT I, 2001, VIND 2001 REL NO 1; HINCH J, 1999, AIR BAG TECHNOLOGY L; KAHANE CJ, 1996, 808470 DOT HS NAT HI; KLEINBERGER M, 1997, 41 ANN P ORL FL 1997, V41, P465; LONG JS, 1997, REGRESSION MODELS CA, P87; LUND AK, 1995, J TRAUMA, V38, P469, DOI 10.1097/00005373-199504000-00001; *NAT HIGHW TRAFF S, 1999, TRAFF SAF FACTS 199; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P76; *STAT CORP, 2000, STAT STAT SOFTW REL; ZADOR PL, 1993, AM J PUBLIC HEALTH, V83, P661, DOI 10.2105/AJPH.83.5.661	18	63	67	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1119	1122		10.1136/bmj.324.7346.1119	http://dx.doi.org/10.1136/bmj.324.7346.1119			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003882	Green Published, Bronze			2022-12-28	WOS:000175622800016
J	de Boer, HD; Haerkens, MHTM; van der Stappen, W; van Ingen, G; Wobbes, T				de Boer, HD; Haerkens, MHTM; van der Stappen, W; van Ingen, G; Wobbes, T			Testicular carcinoma: postmortem diagnosis after a car accident	LANCET			English	Article							CANCER		Univ Med Ctr St Radbound, Dept Anaesthesiol, Nijmegen, Netherlands; Univ Med Ctr St Radbound, Dept Surg, Nijmegen, Netherlands; Canisius Wilhelmina Hosp, Dept Surg, Nijmegen, Netherlands; Netherlands Forens Inst, Dept Pathol, Rijswijk, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital	de Boer, HD (corresponding author), Univ Med Ctr St Radbound, Dept Anaesthesiol, Nijmegen, Netherlands.			Haerkens, Marck/0000-0003-4708-8030				Hernes EH, 1996, EUR UROL, V30, P349; KHAW H, 1986, J VASC SURG, V4, P384, DOI 10.1067/mva.1986.avs0040384; OBRIEN WM, 1987, J UROLOGY, V137, P303, DOI 10.1016/S0022-5347(17)43990-5; Sonneveld DJA, 2001, CANCER, V91, P1304, DOI 10.1002/1097-0142(20010401)91:7<1304::AID-CNCR1133>3.0.CO;2-A; THORNHILL JA, 1986, BRIT MED J, V293, P480, DOI 10.1136/bmj.293.6545.480	5	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1666	1666		10.1016/S0140-6736(02)08591-4	http://dx.doi.org/10.1016/S0140-6736(02)08591-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020528				2022-12-28	WOS:000175593300011
J	Evans, AT; Husain, S; Durairaj, L; Sadowski, LS; Charles-Damte, M; Wang, Y				Evans, AT; Husain, S; Durairaj, L; Sadowski, LS; Charles-Damte, M; Wang, Y			Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; RESPIRATORY-TRACT ILLNESS; CLINICAL-TRIALS; HEALTH-STATUS; ACUTE COUGH; ERYTHROMYCIN; PLACEBO; ADULTS; ANTIBIOTICS; PHYSICIANS	Background The value of azithromycin for treatment of acute bronchitis is unknown, even though this drug is commonly prescribed. We have investigated this question in a randomised, double-blind, controlled trial. Methods Adults diagnosed with acute bronchitis, without evidence of underlying lung disease, were randomly assigned azithromycin (n=112) or vitamin C (n=108) for 5 days (total dose for each 1.5 g). All individuals were also given liquid dextromethorphan and albuterol inhaler with a spacer. The primary outcome was improvement in health-related quality of life at 7 days; an important difference was defined as 0.5 or greater. Analysis was by intention to treat. Findings The study was stopped by the data-monitoring and safety committee when 220 patients had been recruited. On day 7, the adjusted difference in health-related quality of life was small and not significant (difference 0.03 [95% CI -0.20 to 0.26], p=0.8). 86 (89%) of 97 patients in the azithromycin group and 82 (89%) of 92 in the vitamin C group had returned to their usual activities by day 7 (difference 0.5% [-10% to 9%], p>0.9). There were no differences in the frequency of adverse effects; three patients in the vitamin C group discontinued the study medicine because of perceived adverse effects, compared with none in the azithromycin group. Most patients (81%) reported benefit from the albuterol inhaler. Interpretation Azithromycin is no better than low-dose vitamin C for acute bronchitis. Further studies are needed to identify the best treatment for this disorder.	Cook Cty Hosp, Dept Med, Collaborat Res Unit, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA; Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA USA; Univ Iowa, Coll Med, Div Pulm Crit Care & Occupat Med, Iowa City, IA USA	John H Stroger Junior Hospital Cook County; Rush University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa	Evans, AT (corresponding author), Cook Cty Hosp, Dept Med, Collaborat Res Unit, Room 1600,Adm Bldg,1900 W Polk St, Chicago, IL 60612 USA.	aevans@cchil.org		Husain, Shahid/0000-0002-9216-5229; Durairaj, Lakshmi/0000-0002-8072-3430				Bent S, 1999, AM J MED, V107, P62, DOI 10.1016/S0002-9343(99)00167-9; Biebuyck XA, 1996, J INT MED RES, V24, P407, DOI 10.1177/030006059602400502; BRICKFIELD FX, 1986, J FAM PRACTICE, V23, P119; DOUGLAS RM, 2000, COCHRANE LIB, V4; DUNLAY J, 1987, J FAM PRACTICE, V25, P137; Fahey T, 1998, BRIT MED J, V316, P906, DOI 10.1136/bmj.316.7135.906; FRANKS P, 1984, J FAM PRACTICE, V19, P185; Gonzales R, 2001, ANN INTERN MED, V134, P521, DOI 10.7326/0003-4819-134-6-200103200-00021; GONZALES R, 1995, LANCET, V345, P665, DOI 10.1016/S0140-6736(95)90861-7; Gonzales R, 2000, ANN INTERN MED, V133, P981, DOI 10.7326/0003-4819-133-12-200012190-00014; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; GUYATT GH, 1989, J GEN INTERN MED, V4, P101, DOI 10.1007/BF02602348; GUYATT GH, 1987, THORAX, V42, P773, DOI 10.1136/thx.42.10.773; Hoepelman IM, 1998, INT J ANTIMICROB AG, V9, P141, DOI 10.1016/S0924-8579(97)00043-5; Holmes WF, 2001, BRIT J GEN PRACT, V51, P177; HUESTON WJ, 1991, J FAM PRACTICE, V33, P476; HUESTON WJ, 1994, J FAM PRACTICE, V39, P437; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Irwin RS, 1998, CHEST, V114, p133S, DOI 10.1378/chest.114.2_Supplement.133S; Juniper EF, 1996, J ALLERGY CLIN IMMUN, V98, P843, DOI 10.1016/S0091-6749(96)70135-5; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; JUNIPER EF, 1991, CLIN EXP ALLERGY, V21, P77, DOI 10.1111/j.1365-2222.1991.tb00807.x; JUNIPER EF, 1993, AM REV RESPIR DIS, V147, P832, DOI 10.1164/ajrccm/147.4.832; King DE, 1996, J FAM PRACTICE, V42, P601; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Macfarlane JT, 1997, BRIT J GEN PRACT, V47, P719; MELBYE H, 1991, FAM PRACT, V8, P216, DOI 10.1093/fampra/8.3.216; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nelson C, 1999, VITAL HLTH STAT, V13; Redelmeier DA, 1996, J CLIN EPIDEMIOL, V49, P1215, DOI 10.1016/S0895-4356(96)00206-5; Salit IE, 1998, INFECT MED, V15, P773; Scherl E R, 1987, J Ky Med Assoc, V85, P539; SMUCNY J, 2000, COCHRANE LIB, V4; Smucny JJ, 1998, J FAM PRACTICE, V47, P453; Soepandi P, 1998, Respirology, V3, P113, DOI 10.1111/j.1440-1843.1998.tb00108.x; Sternon J, 1995, J INT MED RES, V23, P413, DOI 10.1177/030006059502300602; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; VERHEIJ T, 1995, SCAND J PRIM HEALTH, V13, P8, DOI 10.3109/02813439508996728; VERHEIJ TJM, 1994, BRIT J GEN PRACT, V44, P400; WILLIAMSON HA, 1984, J FAM PRACTICE, V19, P481	42	83	84	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1648	1654		10.1016/S0140-6736(02)08597-5	http://dx.doi.org/10.1016/S0140-6736(02)08597-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020525				2022-12-28	WOS:000175593300008
J	Kasting, JF; Siefert, JL				Kasting, JF; Siefert, JL			Life and the evolution of Earth's atmosphere	SCIENCE			English	Article							METHANE	Harvesting tight to produce energy and oxygen (photosynthesis) is the signature of all land plants. This ability was co-opted from a precocious and ancient form of life known as cyanobacteria. Today these bacteria, as well as microscopic algae, supply oxygen to the atmosphere and chum out fixed nitrogen in Earth's vast oceans. Microorganisms may also have played a major role in atmosphere evolution before the rise of oxygen. Under the more dim light of a young sun cooler than today's, certain groups of anaerobic bacteria may have been pumping out Large amounts of methane, thereby keeping the early climate warm and inviting. The evolution of Earth's atmosphere is linked tightly to the evolution of its biota.	Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; Rice Univ, Dept Stat, Houston, TX 77251 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Rice University	Kasting, JF (corresponding author), Penn State Univ, Dept Geosci, 443 Deike, University Pk, PA 16802 USA.	kasting@essc.psu.edu	Kasting, James/AAF-6851-2020					Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; COONEY CL, 1975, BIOTECHNOL BIOENG, V17, P1119, DOI 10.1002/bit.260170804; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; FOX GE, 1977, P NATL ACAD SCI USA, V74, P4537, DOI 10.1073/pnas.74.10.4537; Holland H. D., 1994, EARLY LIFE EARTH, V84, P237; Houghton JT, 1994, CLIMATE CHANGE 1994; Kasting JF, 2001, ORIGINS LIFE EVOL B, V31, P271, DOI 10.1023/A:1010600401718; KASTING JF, 1993, SCIENCE, V259, P920, DOI 10.1126/science.11536547; KASTING JF, 1980, J GEOPHYS RES-OCEANS, V85, P3255, DOI 10.1029/JC085iC06p03255; Kral TA, 1998, ORIGINS LIFE EVOL B, V28, P311, DOI 10.1023/A:1006552412928; KUMP LR, 1999, EARTH SYSTEM, P135; LEWIN RA, 1976, NATURE, V261, P697, DOI 10.1038/261697b0; LOVLEY DR, 1985, APPL ENVIRON MICROB, V49, P1530, DOI 10.1128/AEM.49.6.1530-1531.1985; MARGULIS L, 1993, SYMBIOSIS CELL EVOLU, P327; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Prasad N, 1996, CATENA, V27, P105, DOI 10.1016/0341-8162(96)00003-3; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; WALTER FM, 1991, SUN TIME, P633; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Zinder Stephen H., 1993, P128	23	267	295	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1066	1068		10.1126/science.1071184	http://dx.doi.org/10.1126/science.1071184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004117				2022-12-28	WOS:000175565000039
J	Oeppen, J; Vaupel, JW				Oeppen, J; Vaupel, JW			Demography - Broken limits to life expectancy	SCIENCE			English	Editorial Material							MORTALITY; METHUSELAH; COUNTRIES; LONGEVITY; AGES		Univ Cambridge, Cambridge Grp Hist Populat & Social Struct, Cambridge CB2 3EN, England; Max Planck Inst Demog Res, D-18057 Rostock, Germany	University of Cambridge; Max Planck Society	Vaupel, JW (corresponding author), Univ Cambridge, Cambridge Grp Hist Populat & Social Struct, Downing Pl, Cambridge CB2 3EN, England.			Vaupel, James/0000-0003-0783-3905	NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER; NIA NIH HHS [AG-08761] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CAREY JR, 1992, SCIENCE, V258, P457, DOI 10.1126/science.1411540; CURTSINGER JW, 1992, SCIENCE, V258, P461, DOI 10.1126/science.1411541; Dublin L., 1928, Health and Wealth; Fogel RW, 1997, DEMOGRAPHY, V34, P49, DOI 10.2307/2061659; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Keilman N., 1997, J STAT STOCKHOLM, V13, P245; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Martin L. G., 1994, DEMOGRAPHY AGING; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Olshansky SJ, 2001, SCIENCE, V292, P1654; Riley J, 2001, RISING LIFE EXPECTAN; Tuljapurkar S, 2000, NATURE, V405, P789, DOI 10.1038/35015561; Vaupel J, 2000, WASH QUART, V23, P197, DOI 10.1162/016366000561097; VAUPEL JW, 1986, AM J PUBLIC HEALTH, V76, P430, DOI 10.2105/AJPH.76.4.430; VAUPEL JW, 1986, POP STUD-J DEMOG, V40, P147, DOI 10.1080/0032472031000141896; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855	16	1394	1435	5	212	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1029	+		10.1126/science.1069675	http://dx.doi.org/10.1126/science.1069675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551MG	12004104				2022-12-28	WOS:000175565000024
J	Ogawa, H; Ishiguro, K; Gaubatz, S; Livingston, DM; Nakatani, Y				Ogawa, H; Ishiguro, K; Gaubatz, S; Livingston, DM; Nakatani, Y			A complex with chromatin modifiers that occupies E2F-and Myc-responsive genes in G(0) cells	SCIENCE			English	Article							TRANSCRIPTION FACTOR; HISTONE H3; E2F FAMILY; LYSINE 9; PROTEINS; BINDING; DOMAIN; MEMBER; PRB; INTERACTS	E2F-6 contributes to gene silencing in a manner independent of retinoblastoma protein family members. To better elucidate the molecular mechanism of repression by E2F-6, we have purified the factor from cultured cells. E2F-6 is found in a multimeric protein complex that contains Mga and Max, and thus the complex can bind not only to the E2F-binding site but also to Myc- and Brachyury-binding sites. Moreover, the complex contains chromatin modifiers such as a novel histone methyltransferase that modifies lysine 9 of histone H3, Hp1gamma, and Polycomb group (PcG) proteins. The E2F-6 complex preferentially occupies target promoters in G(0) cells rather than in G(1) cells. These data suggest that these chromatin modifiers contribute to silencing of E2F- and Myc-responsive genes in quiescent cells.	Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Ishiguro, Kei-ichiro/K-3340-2019; Ogawa, Hidesato/M-3778-2019; Ogawa, Hidesato/A-2079-2016	Ishiguro, Kei-ichiro/0000-0002-7515-1511; Ogawa, Hidesato/0000-0001-9740-9010; Gaubatz, Stefan/0000-0001-8751-4191				Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brown SE, 2001, MAMM GENOME, V12, P916, DOI 10.1007/s00335-001-3029-3; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; *GENB, AY083210 GENB; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kalenik JL, 1997, NUCLEIC ACIDS RES, V25, P843, DOI 10.1093/nar/25.4.843; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; OGAWA H, UNPUB; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Takahashi Y, 2000, GENE DEV, V14, P804; Technau U, 2001, BIOESSAYS, V23, P788, DOI 10.1002/bies.1114; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698	21	610	636	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1132	1136		10.1126/science.1069861	http://dx.doi.org/10.1126/science.1069861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004135				2022-12-28	WOS:000175565000058
J	Bjerrum, CJ; Canfield, DE				Bjerrum, CJ; Canfield, DE			Ocean productivity before about 1.9 Gyr ago limited by phosphorus adsorption onto iron oxides	NATURE			English	Article							TRANSVAAL SUPERGROUP; FORMATION DEPOSITION; CARBON; SEDIMENTS; PHOSPHATE; OXYGEN; TRANSITION; LIMESTONE; CLIMATE; SULFUR	After the evolution of oxygen-producing cyanobacteria at some time before 2.7 billion years ago(1), oxygen production on Earth is thought to have depended on the availability of nutrients in the oceans, such as phosphorus (in the form of orthophosphate). In the modern oceans, a significant removal pathway for phosphorus occurs by way of its adsorption onto iron oxide deposits(2,3). Such deposits were thought to be more abundant in the past when, under low sulphate conditions, the formation of large amounts of iron oxides resulted in the deposition of banded iron formations(4,5). Under these circumstances, phosphorus removal by iron oxide adsorption could have been enhanced. Here we analyse the phosphorus and iron content of banded iron formations to show that ocean orthophosphate concentrations from 3.2 to 1.9 billion years ago (during the Archaean and early Proterozoic eras) were probably only similar to10-25% of present-day concentrations. We suggest therefore that low phosphorus availability should have significantly reduced rates of photosynthesis and carbon burial, thereby reducing the long-term oxygen production on the early Earth-as previously speculated(4)-and contributing to the low concentrations of atmospheric oxygen during the late Archaean and early Proterozoic.	Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, DK-5230 Odense, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, Danish Ctr Earth Syst Sci, DK-2100 Copenhagen, Denmark	University of Southern Denmark; University of Copenhagen; Niels Bohr Institute	Bjerrum, CJ (corresponding author), Univ Copenhagen, Inst Geol, Oster Voldgade 10, DK-1350 Copenhagen, Denmark.	cjb@geo.geol.ku.dk	Canfield, Don/C-1735-2012; Bjerrum, Christian/A-4247-2015; Bjerrum, Christian Jannik/AAZ-5488-2021	Canfield, Don/0000-0001-7602-8366; Bjerrum, Christian/0000-0002-7804-1633; Bjerrum, Christian Jannik/0000-0002-7804-1633				ANBAR AD, 1999, AM GEOPH UN FALL M; Anderson LD, 2001, GLOBAL BIOGEOCHEM CY, V15, P65, DOI 10.1029/2000GB001270; [Anonymous], 1981, AQUATIC CHEM INTRO E; BERNER EK, 1994, GLOBAL WATER CYCLE G; BERNER RA, 1973, EARTH PLANET SC LETT, V18, P77, DOI 10.1016/0012-821X(73)90037-X; BEUKES NJ, 1990, ECON GEOL BULL SOC, V85, P663, DOI 10.2113/gsecongeo.85.4.663; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 2000, SCIENCE, V288, P658, DOI 10.1126/science.288.5466.658; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Compton J., 2000, SEPM SPECIAL PUBLICA, P21, DOI DOI 10.2110/PEC.00.66.0021; DeRonde CEJ, 1997, GEOCHIM COSMOCHIM AC, V61, P4025, DOI 10.1016/S0016-7037(97)00205-6; Des Marais DJ, 1997, ORG GEOCHEM, V27, P185, DOI 10.1016/S0146-6380(97)00061-2; Feely RA, 1998, GEOPHYS RES LETT, V25, P2253, DOI 10.1029/98GL01546; Filippelli GM, 2001, MAR GEOL, V174, P307, DOI 10.1016/S0025-3227(00)00157-2; Fralick P., 1995, SEDIMENTARY FACIES A, P137, DOI [10.1002/9781444304091.ch6, DOI 10.1002/9781444304091.CH6]; Holland H. D., 1978, CHEM ATMOSPHERE OCEA; Holland HD., 1984, CHEM EVOLUTION ATMOS; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; KAUFMAN AJ, 1990, GEOCHIM COSMOCHIM AC, V54, P3461, DOI 10.1016/0016-7037(90)90298-Y; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Lenton TM, 2000, GLOBAL BIOGEOCHEM CY, V14, P249, DOI 10.1029/1999GB900076; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; Roden EE, 1997, ARCH HYDROBIOL, V139, P347; Schaller T, 2000, GEOCHIM COSMOCHIM AC, V64, P2243, DOI 10.1016/S0016-7037(99)00443-3; SHAFFER G, 1989, J GEOPHYS RES-OCEANS, V94, P1979, DOI 10.1029/JC094iC02p01979; VanCappellen P, 1996, SCIENCE, V271, P493, DOI 10.1126/science.271.5248.493; WALKER JCG, 1984, NATURE, V309, P340, DOI 10.1038/309340a0; Wheat CG, 1996, GEOCHIM COSMOCHIM AC, V60, P3593, DOI 10.1016/0016-7037(96)00189-5	30	281	294	7	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					159	162		10.1038/417159a	http://dx.doi.org/10.1038/417159a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000956				2022-12-28	WOS:000175460200039
J	Thitamadee, S; Tuchihara, K; Hashimoto, T				Thitamadee, S; Tuchihara, K; Hashimoto, T			Microtubule basis for left-handed helical growth in Arabidopsis	NATURE			English	Article							CORTICAL MICROTUBULES; TUBULIN; MUTANT	Left-right asymmetry in plants can be found in helices of stalks, stems and tendrils, and in fan-like petal arrangements. The handedness in these asymmetric structures is often fixed in given species, indicating that genetic factors control asymmetric development(1). Here we show that dominant negative mutations at the tubulin intradimer interface of alpha-tubulins 4 and 6 cause left-handed helical growth and clockwise twisting in elongating organs of Arabidopsis thaliana. We demonstrate that the mutant tubulins incorporate into microtubule polymers, producing right-handed obliquely oriented cortical arrays, in the root epidermal cells. The cortical microtubules in the mutants had increased sensitivity to microtubule-specific drugs. These results suggest that reduced microtubule stability can produce left-handed helical growth in plants.	Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma 6300101, Japan	Nara Institute of Science & Technology	Hashimoto, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Takayama 8916-5, Ikoma 6300101, Japan.	hasimoto@bs.aist-nara.ac.jp						Baskin TI, 2001, PROTOPLASMA, V215, P150, DOI 10.1007/BF01280311; BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; Burns Roy G., 1994, V13, P3; DOLAN L, 1993, DEVELOPMENT, V119, P71; Endress PK, 1999, INT J PLANT SCI, V160, pS3, DOI 10.1086/314211; Furutani I, 2000, DEVELOPMENT, V127, P4443; GARDNER M, 1990, NEW AMBIDEXTROUS UNI, P54; GRIDDINGS TH, 1991, CYTOSKELETAL BASIS P, P85; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; KOPCZAK SD, 1992, PLANT CELL, V4, P539, DOI 10.1105/tpc.4.5.539; Marinelli B, 1997, PLANTA, V202, P196, DOI 10.1007/s004250050119; Morejohn LC., 1991, CYTOSKELETAL BASIS P, P29; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Rutherford R, 1996, PLANT PHYSIOL, V111, P987, DOI 10.1104/pp.111.4.987; Sugimoto K, 2000, PLANT PHYSIOL, V124, P1493, DOI 10.1104/pp.124.4.1493; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Young DH, 2000, PLANT PHYSIOL, V124, P115, DOI 10.1104/pp.124.1.115	17	231	243	1	45	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					193	196		10.1038/417193a	http://dx.doi.org/10.1038/417193a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000963				2022-12-28	WOS:000175460200047
J	Muretto, P; Angelucci, E; Lucarelli, G				Muretto, P; Angelucci, E; Lucarelli, G			Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation	ANNALS OF INTERNAL MEDICINE			English	Article							IRON OVERLOAD; HEPATITIS-C; LIVER FIBROSIS; PHLEBOTOMY; BIOPSY	Background: Cirrhosis is a well-known complication of thalassemia major. In this context, it is a consequence of iron overload and hepatitis C virus infection and generally seems to be irreversible. Objective: To determine whether cirrhosis in thalassemia major can be reversible. Design: Retrospective study. Setting: Bone Marrow Transplantation Unit and Pathology Service, Pesaro Hospital, Pesaro, Italy. Patients: 6 patients who developed liver cirrhosis before or after their thalassemia was cured by bone marrow transplantation (age at transplantation, 11 to 25 years). After diagnosis of cirrhosis, the patients received iron depletion and antiviral therapies. Measurements: Each liver biopsy specimen was coded. A liver pathologist and a member of the transplantation center with expertise in hepatopathology graded the specimens by using the Ishak staging and grading systems. Neither knew the patient's identity or the sequence of biopsy with regard to the time of treatment. Results: After the patients received iron depletion and antiviral therapies, liver biopsy specimens showed impressive reduction in liver iron stores. In 4 patients, iron removal was complete. Serum aminotransferase levels decreased in all patients and normalized in 5; histologic inflammatory activity decreased in all patients and disappeared in 2. Follow-up biopsies showed regression of incomeplete or definite cirrhosis in all patients; 3 patients had presented with portal fibrosis without bridging, and the others had portal fibrosis and portal-to-portal bridging. Several biopsies and the presence of many portal spaces confirmed the diagnosis of cirrhosis; follow-up biopsies confirmed regression of cirrhosis. Conclusion: in some patients in whom bone marrow transplantation has cured thalassemia, cirrhosis may be reversible after iron removal treatment.	Azienda Osped San Salvatore Pesaro, Serv Anat Patol, Unita Operativa Anat Patol, I-61100 Pesaro, Italy; Azienda Osped San Salvatore Pesaro, Unita Operativa Ematol, I-61100 Pesaro, Italy; Azienda Osped San Salvatore Pesaro, Ctr Trapianto Midollo Osseo, I-61100 Pesaro, Italy		Muretto, P (corresponding author), Azienda Osped San Salvatore Pesaro, Serv Anat Patol, Unita Operativa Anat Patol, I-61100 Pesaro, Italy.	p.muretto@ospedalesansalvatore.it	Angelucci, Emanuele/AAC-1855-2021	Muretto, Pietro/0000-0001-8363-0945; Angelucci, Emanuele/0000-0002-6512-6080				Angelucci E, 1998, ANN NY ACAD SCI, V850, P288, DOI 10.1111/j.1749-6632.1998.tb10485.x; ANGELUCCI E, 1994, HAEMATOLOGICA, V79, P353; Angelucci E, 2000, NEW ENGL J MED, V343, P327, DOI 10.1056/NEJM200008033430503; Angelucci E, 1997, BLOOD, V90, P994, DOI 10.1182/blood.V90.3.994.994_994_998; ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757; ANGELUCCI E, 2001, UPTODATE CD ROM; [Anonymous], 1999, J Hepatol, V30, P956; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; FALKMER S, 1970, Pediatrics, V45, P260; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Giardini C, 1997, BONE MARROW TRANSPL, V20, P767, DOI 10.1038/sj.bmt.1700968; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002; MAHARAJ B, 1986, LANCET, V1, P523; MURETTO P, 1994, LIVER, V14, P14; POWELL LW, 1970, AUSTRALAS ANN MED, V19, P54; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817	20	80	92	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					667	672		10.7326/0003-4819-136-9-200205070-00009	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547XK	11992302				2022-12-28	WOS:000175357900004
J	Schmitt, CA; Fridman, JS; Yang, M; Lee, S; Baranov, E; Hoffman, RM; Lowe, SW				Schmitt, CA; Fridman, JS; Yang, M; Lee, S; Baranov, E; Hoffman, RM; Lowe, SW			A senescence program controlled by p53 and p16(INK4a) contributes to the outcome of cancer therapy	CELL			English	Article							NORMAL HUMAN FIBROBLASTS; TUMOR-SUPPRESSOR; DNA-DAMAGE; ANTICANCER AGENTS; CELLULAR SENESCENCE; IN-VIVO; ARREST; CHEMORESISTANCE; LYMPHOMAS; INK4A/ARF	p53 and INK4a/ARF mutations promote tumorigenesis and drug resistance, in part, by disabling apoptosis. We show that primary murine lymphomas also respond to chemotherapy by engaging a senescence program controlled by p53 and p16(INK4a). Hence, tumors with p53 or INK4a/ARF mutations-but not those lacking ARF alone-respond poorly to cyclophosphamide therapy in vivo. Moreover, tumors harboring a Bcl2-mediated apoptotic block undergo a drug-induced cytostasis involving the accumulation of p53, p16(INK4a), and senescence markers, and typically acquire p53 or INK4a mutations upon progression to a terminal stage. Finally, mice bearing tumors capable of drug-induced senescence have a much better prognosis following chemotherapy than those harboring tumors with senescence defects. Therefore, cellular senescence contributes to treatment outcome in vivo.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; AntiCanc Inc, San Diego, CA 92111 USA	Cold Spring Harbor Laboratory; AntiCancer, Inc.	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Lee, Soyoung/T-6669-2019; Lee, Soyoung/AHC-5032-2022; Schmitt, Clemens A/S-9479-2017	Lee, Soyoung/0000-0002-4614-2931; Schmitt, Clemens A/0000-0002-4731-2226	NATIONAL CANCER INSTITUTE [P01CA087497, P30CA008748, R43CA089779] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748, CA87497, CA89779] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; Bearss DJ, 2000, ONCOGENE, V19, P1114, DOI 10.1038/sj.onc.1203275; Brown JM, 1999, CANCER RES, V59, P1391; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Carnero A, 2000, NAT CELL BIOL, V2, P148, DOI 10.1038/35004020; Chang BD, 1999, CANCER RES, V59, P3761; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Elenitoba-Johnson KSJ, 1998, BLOOD, V91, P4677, DOI 10.1182/blood.V91.12.4677.412k40_4677_4685; FERBEYRE G, 2002, IN PRESS MOL CELL BI; Hara E, 1996, MOL CELL BIOL, V16, P859; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kamijo T, 1999, CANCER RES, V59, P2464; KASTAN MB, 1991, CANCER RES, V51, P6304; Krimpenfort P, 2001, NATURE, V413, P83, DOI 10.1038/35092584; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maloney KW, 1999, BLOOD, V93, P2380, DOI 10.1182/blood.V93.7.2380.407k27_2380_2385; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Robles SJ, 1998, ONCOGENE, V16, P1113, DOI 10.1038/sj.onc.1201862; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; SANDER CA, 1993, BLOOD, V82, P1994; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CANCER CELL, V1, P289, DOI 10.1016/S1535-6108(02)00047-8; Schmitt CA, 2000, COLD SPRING HARB SYM, V65, P499, DOI 10.1101/sqb.2000.65.499; Schmitt CA, 2001, BLOOD CELL MOL DIS, V27, P206, DOI 10.1006/bcmd.2000.0372; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sherr CJ, 2001, CELL, V106, P531, DOI 10.1016/S0092-8674(01)00486-X; Suzuki K, 2001, RADIAT RES, V155, P248, DOI 10.1667/0033-7587(2001)155[0248:RISLGA]2.0.CO;2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Waldman T, 1997, NAT MED, V3, P1034, DOI 10.1038/nm0997-1034; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	41	782	821	0	55	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					335	346		10.1016/S0092-8674(02)00734-1	http://dx.doi.org/10.1016/S0092-8674(02)00734-1			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015983	Bronze			2022-12-28	WOS:000175412100009
J	Nakazawa, K; Quirk, MC; Chitwood, RA; Watanabe, M; Yeckel, MF; Sun, LD; Kato, A; Carr, CA; Johnston, D; Wilson, MA; Tonegawa, S				Nakazawa, K; Quirk, MC; Chitwood, RA; Watanabe, M; Yeckel, MF; Sun, LD; Kato, A; Carr, CA; Johnston, D; Wilson, MA; Tonegawa, S			Requirement for hippocampal CA3 NMDA receptors in associative memory recall	SCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; ANIMAL-MODELS; PLACE CELLS; RAT; NEURONS; BRAIN; ORGANIZATION; RETRIEVAL	Pattern completion, the ability to retrieve complete memories on the basis of incomplete sets of cues, is a crucial function of biological memory systems. The extensive recurrent connectivity of the CA3 area of hippocampus has led to suggestions that it might provide this function. We have tested this hypothesis by generating and analyzing a genetically engineered mouse strain in which the N-methyl-D-asparate ( NMDA) receptor gene is ablated specifically in the CA3 pyramidal cells of adult mice. The mutant mice normally acquired and retrieved spatial reference memory in the Morris water maze, but they were impaired in retrieving this memory when presented with a fraction of the original cues. Similarly, hippocampal CA1 pyramidal cells in mutant mice displayed normal place- related activity in a full- cue environment but showed a reduction in activity upon partial cue removal. These results provide direct evidence for CA3 NMDA receptor involvement in associative memory recall.	MIT, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, Cambridge, MA 02139 USA; MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Hokkaido Univ, Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan	Massachusetts Institute of Technology (MIT); RIKEN; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Baylor College of Medicine; Hokkaido University	Tonegawa, S (corresponding author), MIT, RIKEN MIT Neurosci Res Ctr, Picower Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tonegawa@mit.edu	WATANABE, Masahiko/A-4055-2012; Nakazawa, Kazutoshi/J-6195-2015; Watanabe, Masahiko/S-3614-2019	WATANABE, Masahiko/0000-0001-5037-7138; Nakazawa, Kazutoshi/0000-0001-5699-9093; Watanabe, Masahiko/0000-0001-5037-7138; Chitwood, Raymond/0000-0002-2016-5238	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, F32MH067462, F32MH011390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032925] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH058880, F32 MH067462, P50-MH58880, F32 MH011390, F32 MH011390-03] Funding Source: Medline; NINDS NIH HHS [R01 NS032925, R01-NS32925] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Backman L, 1999, NEUROLOGY, V52, P1861, DOI 10.1212/WNL.52.9.1861; BERGER TW, 1991, LONG TERM POTENTIATI, P327; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; CHATTARJI S, UNPUB; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Gallagher M, 1997, ANNU REV PSYCHOL, V48, P339, DOI 10.1146/annurev.psych.48.1.339; GARDNERMEDWIN AR, 1976, PROC R SOC SER B-BIO, V194, P375, DOI 10.1098/rspb.1976.0084; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Kadar T, 1998, J NEURAL TRANSM, V105, P987, DOI 10.1007/s007020050107; LeJeune H, 1996, NEUROSCIENCE, V74, P349; Liu Y, 1996, EXP BRAIN RES, V108, P389; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MIZUMORI SJY, 1989, J NEUROSCI, V9, P3915; MIZUMORI SJY, 1989, BRAIN RES, V500, P99, DOI 10.1016/0006-8993(89)90303-X; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; MULLER RU, 1987, J NEUROSCI, V7, P1951; Nakazawa K., UNPUB; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1978, EXP BRAIN RES, V31, P573; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; ROLLS E, 1989, COMP NEUR S, P125; SCHWARTZKROIN PA, 1978, BRAIN RES, V147, P117, DOI 10.1016/0006-8993(78)90776-X; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; TUOKKO H, 1991, J CLIN EXP NEUROPSYC, V13, P871, DOI 10.1080/01688639108405104; Urban NN, 2001, HIPPOCAMPUS, V11, P408, DOI 10.1002/hipo.1055.abs; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; WATANABE M, UNPUB; WILLIAMS S, 1988, SCIENCE, V242, P84, DOI 10.1126/science.2845578; WISDEN W, 1993, J NEUROSCI, V13, P3582; WONG RKS, 1983, J NEUROPHYSIOL, V49, P442, DOI 10.1152/jn.1983.49.2.442; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	49	762	796	3	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 12	2002	297	5579					211	218		10.1126/science.1071795	http://dx.doi.org/10.1126/science.1071795			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571UT	12040087	Green Accepted			2022-12-28	WOS:000176738100031
J	Vassylyev, DG; Sekine, S; Laptenko, O; Lee, J; Vassylyeva, MN; Borukhov, S; Yokoyama, S				Vassylyev, DG; Sekine, S; Laptenko, O; Lee, J; Vassylyeva, MN; Borukhov, S; Yokoyama, S			Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 angstrom resolution	NATURE			English	Article							ESCHERICHIA-COLI SIGMA-70; SIGMA(70) SUBUNIT; PROMOTER RECOGNITION; MUTATIONAL ANALYSIS; CONSERVED REGIONS; TRANSCRIPTION; BINDING; DNA; ELONGATION; COMPLEX	In bacteria, the binding of a single protein, the initiation factor sigma, to a multi-subunit RNA polymerase core enzyme results in the formation of a holoenzyme, the active form of RNA polymerase essential for transcription initiation. Here we report the crystal structure of a bacterial RNA polymerase holoenzyme from Thermus thermophilus at 2.6 Angstrom resolution. In the structure, two amino-terminal domains of the sigma subunit form a V-shaped structure near the opening of the upstream DNA-binding channel of the active site cleft. The carboxy-terminal domain of sigma is near the outlet of the RNA-exit channel, about 57 Angstrom from the N-terminal domains. The extended linker domain forms a hairpin protruding into the active site cleft, then stretching through the RNA-exit channel to connect the N- and C-terminal domains. The holoenzyme structure provides insight into the structural organization of transcription intermediate complexes and into the mechanism of transcription initiation.	RIKEN, Spring 8, Harima Inst, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; RIKEN, Spring 8, Harima Inst, Structurome Res Grp, Sayo, Hyogo 6795148, Japan; SUNY Hlth Sci Ctr, Dept Microbiol, Brooklyn, NY 11203 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	Japan Synchrotron Radiation Research Institute; RIKEN; Japan Synchrotron Radiation Research Institute; RIKEN; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; RIKEN; University of Tokyo	Vassylyev, DG (corresponding author), RIKEN, Spring 8, Harima Inst, Cellular Signaling Lab, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@yumiyoshi.harima.riken.go.jp; serbor@asan.com; yokoyama@biochem.s.u-tokyo.ac.jp	Yokoyama, Shigeyuki/N-6911-2015; Vassylyev, Dmitry/A-9005-2008; Sekine, Shun-ichi/N-5450-2015; Borukhov, Sergei/AAF-3195-2019	Yokoyama, Shigeyuki/0000-0003-3133-7338; Sekine, Shun-ichi/0000-0001-8174-8704; Borukhov, Sergei/0000-0002-3517-3003				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Arthur TM, 2000, J BIOL CHEM, V275, P23113, DOI 10.1074/jbc.M002040200; Bar-Nahum G, 2001, CELL, V106, P443, DOI 10.1016/S0092-8674(01)00461-5; Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Bown JA, 1999, J BIOL CHEM, V274, P2263, DOI 10.1074/jbc.274.4.2263; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Daube SS, 1999, P NATL ACAD SCI USA, V96, P8390, DOI 10.1073/pnas.96.15.8390; DIECI G, 1995, EMBO J, V14, P3766, DOI 10.1002/j.1460-2075.1995.tb00046.x; DOMBROSKI AJ, 1993, GENE DEV, V7, P2446, DOI 10.1101/gad.7.12a.2446; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Fenton MS, 2000, EMBO J, V19, P1130, DOI 10.1093/emboj/19.5.1130; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; GROSS CA, 1992, TRANSCRIPTIONAL REGU, P129; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang XJ, 1997, NUCLEIC ACIDS RES, V25, P2603, DOI 10.1093/nar/25.13.2603; Ishihama A, 2000, ANNU REV MICROBIOL, V54, P499, DOI 10.1146/annurev.micro.54.1.499; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LESLEY SA, 1989, BIOCHEMISTRY-US, V28, P7728, DOI 10.1021/bi00445a031; Lim HM, 2001, P NATL ACAD SCI USA, V98, P14849, DOI 10.1073/pnas.261517398; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; Malhotra A, 1996, CELL, V87, P127, DOI 10.1016/S0092-8674(00)81329-X; Marr MT, 1997, SCIENCE, V276, P1258, DOI 10.1126/science.276.5316.1258; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; Naryshkin N, 2000, CELL, V101, P601, DOI 10.1016/S0092-8674(00)80872-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owens JT, 1998, BIOCHEMISTRY-US, V37, P7670, DOI 10.1021/bi980188n; Owens JT, 1998, P NATL ACAD SCI USA, V95, P6021, DOI 10.1073/pnas.95.11.6021; Record Jr MT, 1996, ESCHERICHIA COLI SAL, P792; Sharp MM, 1999, GENE DEV, V13, P3015, DOI 10.1101/gad.13.22.3015; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; VASSYLYEVA MN, UNPUB ACTA CRYSTALLO; von Hippel PH, 1998, SCIENCE, V281, P660, DOI 10.1126/science.281.5377.660; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	48	612	636	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 13	2002	417	6890					712	719		10.1038/nature752	http://dx.doi.org/10.1038/nature752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	561QY	12000971				2022-12-28	WOS:000176154700037
J	Clarke, M; Alderson, P; Chalmers, I				Clarke, M; Alderson, P; Chalmers, I			Discussion sections in reports of controlled trials published in General medical journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				RANDOMIZED CONTROLLED TRIALS; CARE	Context Reliable interpretation of the results of a controlled trial entails setting its results in the context of similar research. A previous study showed that most reports of controlled trials published in 5 general medical journals in May 1997 were deficient in this respect. We assessed the extent to which reports of controlled trials published in the same 5 journals discussed new results in light of the totality of evidence from other controlled trials. Methods Assessment of the discussion sections in all 33 reports of randomized trials published during May 2001 in Annals of Internal Medicine, BMJ, JAMA, The Lancet, and The New England Journal of Medicine. Results Three reports appeared to have been the first published trials to address the questions studied. In none of the remaining 30 reports were the results of the new trial discussed in the context of an updated systematic review of other trials. Although reference was made to relevant systematic reviews in 3 of these 30 reports, there was no integration, quantitative or qualitative, of the results of the new trials in an update of these reviews. In the remaining 27 reports, there was no evidence that any systematic attempt had been made to set the new results in the context of previous trials. Conclusions Between 1997 and 2001, there was no evidence of progress in the proportion of reports of trials published in general medical journals that discussed the new results within the context of, or with reference to, up-to-date systematic reviews of relevant evidence from other controlled trials.	UK Cochrane Ctr, Natl Hlth Serv, Res & Dev Programme, Oxford, England	Cochrane Centre; NHS Blood & Transplant (NHSBT)	Clarke, M (corresponding author), UK Cochrane Ctr, Natl Hlth Serv, Res & Dev Programme, Summertown Pavil,Middle Way, Oxford, England.	mclarke@cochrane.co.uk						Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Chalmers I, 1999, LANCET, V353, P490, DOI 10.1016/S0140-6736(98)07618-1; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; CLARKE M, 2002, DEFINITIONS RCTS CCT; Dargie HJ, 2001, LANCET, V357, P1385, DOI 10.1016/s0140-6736(00)04560-8; Eccles M, 2001, LANCET, V357, P1406, DOI 10.1016/S0140-6736(00)04564-5; HILL AB, 1965, BRIT MED J, V4, P870; Lock Stephen P., 1991, FUTURE MED J, P127; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Skelton JR, 2000, BRIT MED J, V320, P1269, DOI 10.1136/bmj.320.7244.1269; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X	12	75	82	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2799	2801		10.1001/jama.287.21.2799	http://dx.doi.org/10.1001/jama.287.21.2799			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038916				2022-12-28	WOS:000176002200013
J	Yank, V; Rennie, D				Yank, V; Rennie, D			Reporting of informed consent and ethics committee approval in clinical trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				BOARD APPROVAL; PUBLICATION	Context To determine whether journals have improved their disclosure of ethical protections in clinical trials. Methods Comparison of clinical trials published before and after 1997 (July 1995 to December 1996 and January 1998 to June 1999) in Annals of Internal Medicine, BMJ, JAMA, The Lancet, and The New England Journal of Medicine. Sixty articles per journal per period were randomly selected and assessed for rate of reporting on informed consent and on ethics committee approval. Results Informed consent was not described in 79 articles (26%) published before 1997 vs 53 (18%) published after 1997 (P=.01), and ethics committee approval was not mentioned in 93 (31%) before 1997 vs 54 (18%) after 1997 (P<.001). Neither protection was described in 48 articles (16%) published before 1997 vs 28 (9%) after 1997 (P=.01). In subgroup analyses, those journals with the worst initial rates generally improved the most. BMJ did not describe informed consent in 25 articles (42%) before 1997 vs 15 (25%) after 1997 (P=.05), and JAMA did not describe ethics committee approval in 25 (42%) before 1997 vs 13 (22%) after 1997 (P=.02). BMJ, JAMA, and Annals had the lowest initial rates of reporting on both protections in the same article, with 25 (42%), 32 (53%), and 34 (57%), respectively, but improved markedly to 38 (63%), 43 (72%), and 45 (75%) (P=,02,.04, and.03, respectively). Conclusions Major medical journals have improved their reporting on informed consent and ethics committee approval; however, 9% of studies still report neither.	Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; JAMA, Chicago, IL USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Yank, V (corresponding author), 1221 Shrader St, San Francisco, CA 94117 USA.							Amdur RJ, 1997, JAMA-J AM MED ASSOC, V277, P909, DOI 10.1001/jama.277.11.909; Bauchner H, 2001, BRIT MED J, V323, P318, DOI 10.1136/bmj.323.7308.318; GOTZSCHE PC, 1989, EUR J CLIN PHARMACOL, V36, P429, DOI 10.1007/BF00558064; Huston P, 1996, LANCET, V347, P1024, DOI 10.1016/S0140-6736(96)90153-1; *INT COMM MED J, 2001, UN REQ MAN SUBM BIOM; Kelch RP, 2002, NEW ENGL J MED, V346, P285, DOI 10.1056/NEJM200201243460413; Matot I, 1998, CRIT CARE MED, V26, P1596, DOI 10.1097/00003246-199809000-00035; MIDDLE C, 1995, BRIT MED J, V311, P659, DOI 10.1136/bmj.311.7006.659; Olson CM, 1996, RESUSCITATION, V31, P255, DOI 10.1016/0300-9572(95)00928-0; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P922, DOI 10.1001/jama.277.11.922; Rikkert MGMO, 1996, BMJ-BRIT MED J, V313, P1117, DOI 10.1136/bmj.313.7065.1117; Ruiz-Canela M, 2001, J MED ETHICS, V27, P172, DOI 10.1136/jme.27.3.172; Ruiz-Canela M, 1999, NEW ENGL J MED, V340, P1114, DOI 10.1056/NEJM199904083401412; RUSSELL S, 2001, SAN FRANCISCO C 0721, pA1; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; Stair TO, 2001, ACAD EMERG MED, V8, P636, DOI 10.1111/j.1553-2712.2001.tb00177.x; STOLBERG SG, 2000, NY TIMES        0525, pA20; Tramer MR, 1997, BMJ-BRIT MED J, V315, P635, DOI 10.1136/bmj.315.7109.635; Willner IR, 1998, ANN INTERN MED, V128, P111, DOI 10.7326/0003-4819-128-2-199801150-00006; WILSON D, 2001, SEATTLE TIMES A  MAR; World Medical Association, 1964, JAMA-J AM MED ASSOC, V189, P33; World Medical Association Declaration of Helsinki, 2002, REC GUID PHYS BIOM R; 1998, LANCET, V351, P1; 1996, BMJ, V313, P1448	24	60	65	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2835	2838		10.1001/jama.287.21.2835	http://dx.doi.org/10.1001/jama.287.21.2835			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038927	Bronze			2022-12-28	WOS:000176002200024
J	Lindsay, R; Gallagher, JC; Kleerekoper, M; Pickar, JH				Lindsay, R; Gallagher, JC; Kleerekoper, M; Pickar, JH			Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HORMONE REPLACEMENT THERAPY; CONTROLLED TRIAL; RANDOMIZED TRIAL; PREVENTION; DENSITY; LIPIDS; OSTEOPOROSIS; LIPOPROTEINS; ENDOMETRIUM; METABOLISM	Context Lower-than-commonly-prescribed doses of conjugated equine estrogens (CEEs) with medroxyprogesterone acetate (MPA) improve vasomotor symptoms and vaginal atrophy, provide acceptable bleeding and lipid profiles, and afford endometrial protection. This lower-dose therapy's protection against loss of bone mineral density (BMD) associated with menopause has not been thoroughly investigated. Objective To determine the effects of lower doses of CEEs only or CEEs-MPA on spine and hip BMD, total body bone mineral content (BMC), and biochemical markers of bone turnover in postmenopausal women. Design and Setting Two-year randomized, double-blind, placebo-control led sub-study of the Women's Health, Osteoporosis, Progestin, Estrogen trial, conducted at 19 US centers between August 1995 and October 2000. Participants Eight hundred twenty-two healthy postmenopausal women aged 40 to 65 years who were within 4 years of their last menstrual period. Interventions Patients were randomly assigned to receive CEEs, 0.625; CEEs, 0.625 and MPA, 2.5; CEEs, 0.45; CEEs, 0.45 and MPA, 2.5; CEEs, 0.45 and AAPA, 1.5; CEES, 0.3; CEEs 0.3 and MPA, 1.5 (all doses in mg/d); or placebo for 2 years. All participants also received elemental calcium at 600 mg/d. Main Outcome Measures Changes from baseline in spine and total hip BMD, total body BMC, and biochemical markers of bone turnover (serum osteocalcin and urinary cross-linked N-telopeptides of type I collagen), assessed at 6-month intervals and compared among treatment groups with a modified intention-to-treat approach. Results At 24 months, women assigned to all of the active treatment groups had significant gains from baseline (P<.001) in spine and hip BMD and total body BMC (except total body BMC in the group receiving CEEs, 0.3 mg/d). These changes were significantly different from those in the placebo group, in which losses of bone mass in spine and total body were evident over the course of the study (P<.001). The loss in hip BMD from baseline in the placebo group was significant at 18 (P=.02) but not at 24 months (P=.06). Osteocalcin and N-telopeptides of type I Collagen were significantly reduced from baseline (P<.001) for all active treatment groups at all time points; no changes were found for the placebo group. For women treated with CEEs alone, the gains in spine BMD for the group taking CEEs, 0.625 mg/d, were significantly higher than those of the group taking CEEs, 0.3 mg/d (P=.02), but not the group treated with CEEs, 0.45 mg/d (P=.48). Conclusions Doses of CEEs or CEEs-MPA lower than 0.625 mg/d effectively increase BMD and BMC in early postmenopausal women.	Helen Hayes Hosp, Dept Internal Med, W Haverstraw, NY 10993 USA; Creighton Univ, Sch Med, Bone Metab Unit, Omaha, NE USA; Wayne State Univ, Sch Med, Div Endocrinol, Detroit, MI USA; Wyeth Ayerst Res, Clin Res & Dev, Philadelphia, PA USA	Creighton University; Wayne State University; Pfizer	Lindsay, R (corresponding author), Helen Hayes Hosp, Dept Internal Med, Rte 9W, W Haverstraw, NY 10993 USA.			gallagher, john christopher/0000-0002-5129-9183				Archer DF, 2001, FERTIL STERIL, V75, P1080, DOI 10.1016/S0015-0282(01)01792-7; Bush TL, 1996, JAMA-J AM MED ASSOC, V276, P1389, DOI 10.1001/jama.276.17.1389; Connelly MT, 1999, ANN INTERN MED, V131, P265, DOI 10.7326/0003-4819-131-4-199908170-00005; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; Ettinger B, 1999, MENOPAUSE, V6, P273, DOI 10.1097/00042192-199906030-00015; GALLAGHER JC, 1991, AM J MED, V90, P171; Gambacciani M, 2001, AM J OBSTET GYNECOL, V185, P1180, DOI 10.1067/mob.2001.117669; Genant HK, 1997, ARCH INTERN MED, V157, P2609, DOI 10.1001/archinte.157.22.2609; GENANT HK, 1982, ANN INTERN MED, V97, P699, DOI 10.7326/0003-4819-97-5-699; Grey A, 1996, CLIN ENDOCRINOL, V44, P293, DOI 10.1046/j.1365-2265.1996.667488.x; Komulainen MH, 1998, MATURITAS, V31, P45, DOI 10.1016/S0378-5122(98)00085-1; LINDSAY R, 1980, LANCET, V2, P1151; LINDSAY R, 1984, OBSTET GYNECOL, V63, P759; Lobo R A, 2001, Climacteric, V4, P110, DOI 10.1080/713605084; Lobo RA, 2001, FERTIL STERIL, V76, P13, DOI 10.1016/S0015-0282(01)01829-5; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MACLENNAN AH, 1993, MED J AUSTRALIA, V159, P102, DOI 10.5694/j.1326-5377.1993.tb137744.x; Mizunuma H, 1997, MATURITAS, V27, P69, DOI 10.1016/S0378-5122(97)01110-9; Pickar JH, 2001, FERTIL STERIL, V76, P25, DOI 10.1016/S0015-0282(01)01828-3; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; RIGGS BL, 1995, BONE S5, V17, P505; Speroff L, 1996, JAMA-J AM MED ASSOC, V276, P1397, DOI 10.1001/jama.276.17.1397; Utian WH, 2001, FERTIL STERIL, V75, P1065, DOI 10.1016/S0015-0282(01)01791-5; WEBBER CE, 1994, MATURITAS, V19, P13, DOI 10.1016/0378-5122(94)90037-X	24	242	256	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2668	2676		10.1001/jama.287.20.2668	http://dx.doi.org/10.1001/jama.287.20.2668			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020302	Bronze			2022-12-28	WOS:000175732400026
J	Owen, PJ; Miles, DPB; Draper, GJ; Vincent, TJ				Owen, PJ; Miles, DPB; Draper, GJ; Vincent, TJ			Retrospective study of mortality incident at Lowermoor in north after a water pollution Cornwall	BRITISH MEDICAL JOURNAL			English	Article							ALUMINUM		Cornwall & Isles Scilly Hlth Author, St Austell PL25 4NQ, Cornwall, England; Univ Oxford, Dept Paediat, Childhood Canc Res Grp, Oxford OX2 6HJ, England	University of Oxford	Owen, PJ (corresponding author), Cornwall & Isles Scilly Hlth Author, St Austell PL25 4NQ, Cornwall, England.							*LOW INC HLTH ADV, 1989, WAT POLL LOW N CORNW; *LOW INC HLTH ADV, 1990, 2 LOW INC HLTH ADV G; OWEN PJ, 1995, J PUBLIC HEALTH MED, V17, P200, DOI 10.1093/oxfordjournals.pubmed.a043093; ROWLAND A, 1990, J ROY SOC HEALTH, V110, P166, DOI 10.1177/146642409011000507	4	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1189	1189		10.1136/bmj.324.7347.1189	http://dx.doi.org/10.1136/bmj.324.7347.1189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554XV	12016184	Bronze, Green Published			2022-12-28	WOS:000175763200019
J	Olsen, PE; Kent, DV; Sues, HD; Koeberl, C; Huber, H; Montanari, A; Rainforth, EC; Fowell, SJ; Szajna, MJ; Hartline, BW				Olsen, PE; Kent, DV; Sues, HD; Koeberl, C; Huber, H; Montanari, A; Rainforth, EC; Fowell, SJ; Szajna, MJ; Hartline, BW			Ascent of dinosaurs linked to an iridium anomaly at the Triassic-Jurassic boundary	SCIENCE			English	Article							NEWARK SUPERGROUP; EXTINCTION; SYSTEM; EVENT	Analysis of tetrapod footprints and skeletal material from more than 70 localities in eastern North America shows that large theropod dinosaurs appeared less than 10,000 years after the Triassic-Jurassic boundary and less than 30,000 years after the last Triassic taxa, synchronous with a terrestrial mass extinction. This extraordinary turnover is associated with an iridium anomaly (up to 285 parts per trillion, with an average maximum of 141 parts per trillion) and a fern spore spike, suggesting that a bolide impact was the cause. Eastern North American dinosaurian diversity reached a stable maximum less than 100,000 years after the boundary, marking the establishment of dinosaur-dominated communities that prevailed for the next 135 million years.	Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ 08854 USA; Royal Ontario Museum, Dept Paleobiol, Toronto, ON M5S 2C6, Canada; Univ Vienna, Inst Geochem, A-1090 Vienna, Austria; Osservatorio Geol Coldigiocom, I-62020 Frontale Di Apiro, Italy; Univ Alaska Fairbanks, Dept Geol & Geophys, Fairbanks, AK 99775 USA; Reading Publ Museum, Reading, PA 19611 USA	Columbia University; Rutgers State University New Brunswick; Royal Ontario Museum; University of Vienna; University of Alaska System; University of Alaska Fairbanks	Olsen, PE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.							BENTON MJ, 1994, IN THE SHADOW OF THE DINOSAURS, P366; BICE DM, 1992, SCIENCE, V255, P443, DOI 10.1126/science.255.5043.443; CHARIG AJ, 1984, S ZOOL SOC LONDON, V52, P597; COHEN AS, 1993, PALEOBIOLOGY, V19, P433; Fowell S.J., 1994, GEOLOGICAL SOC AM SP, V288, P197, DOI [DOI 10.1130/SPE288-P197, 10.1130/SPE288-p197]; FRASER NC, 1994, IN THE SHADOW OF THE DINOSAURS, P398; Kent DV, 1999, J GEOPHYS RES-SOL EA, V104, P12831, DOI 10.1029/1999JB900076; LOCKLEY M, 1995, DINOSAUR TRACKS OTHE; Marzoli A, 1999, SCIENCE, V284, P616, DOI 10.1126/science.284.5414.616; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; Mossman DJ, 1998, CAN J EARTH SCI, V35, P101, DOI [10.1139/cjes-35-2-101, 10.1139/e97-101]; Olsen P.E., 1986, P61; Olsen P. E., 1996, MUSEUM NO ARIZONA B, V60, P11; Olsen PE, 1997, ANNU REV EARTH PL SC, V25, P337, DOI 10.1146/annurev.earth.25.1.337; Olsen PE, 1996, PALAEOGEOGR PALAEOCL, V122, P1, DOI 10.1016/0031-0182(95)00171-9; OLSEN PE, 1987, SCIENCE, V237, P1025, DOI 10.1126/science.3616622; OLSEN PE, 1977, SCIENCE, V197, P983, DOI 10.1126/science.197.4307.983; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; SMITH RC, 1988, PA GEOL, P8; Spray JG, 1998, NATURE, V392, P171, DOI 10.1038/32397; Sues HD, 2000, J VERTEBR PALEONTOL, V20, P275, DOI 10.1671/0272-4634(2000)020[0275:COOHFA]2.0.CO;2; SZAJNA MJ, GREAT RIFT VALLEYS P, V2; TSHUDY RH, 1984, SCIENCE, V225, P1090; Ward PD, 2001, SCIENCE, V292, P1148, DOI 10.1126/science.1058574; WILSON EO, 1961, AM NAT, V95, P169, DOI 10.1086/282174	25	276	295	3	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1305	1307		10.1126/science.1065522	http://dx.doi.org/10.1126/science.1065522			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016313	Green Submitted			2022-12-28	WOS:000175713000051
J	Kitoh, A; Arima, Y; Nishigori, C; Kikuta, K; Miyachi, Y				Kitoh, A; Arima, Y; Nishigori, C; Kikuta, K; Miyachi, Y			Tissue adhesive and postoperative allergic meningitis	LANCET			English	Article							CYANOACRYLATE	Adhesives containing cyanoacrylate are used in many surgical procedures, Including closure of skin wounds and reinforcement of intracranial aneurysm repairs. A 61-year-old woman developed fever, neck stiffness, and cerebrospinal fluid eosinophilia after an operation for an intracranial aneurysm. We suspected allergic meningitis due to a foreign substance. To detect the cause of this disorder, we did 2-day closed patch testing with the substances thought to be possible allergens. We recorded a positive reaction to methyl-2-cyanoacrylate, the main ingredient of Biobond, the tissue adhesive used in the surgery. This substance could have caused postoperative allergic meningitis.	Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Med, Dept Neurosurg, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Kitoh, A (corresponding author), Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan.							BRUZE M, 1995, CONTACT DERMATITIS, V32, P156, DOI 10.1111/j.1600-0536.1995.tb00806.x; Fregert S., 1981, MANUAL CONTACT DERMA, P71; Guin JD, 1998, INT J DERMATOL, V37, P31, DOI 10.1046/j.1365-4362.1998.00252.x; Han MH, 1999, RADIOLOGY, V211, P661, DOI 10.1148/radiology.211.3.r99jn07661; Lux G, 1997, ENDOSCOPY, V29, P241, DOI 10.1055/s-2007-1004183	5	6	7	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1668	1670		10.1016/S0140-6736(02)08558-6	http://dx.doi.org/10.1016/S0140-6736(02)08558-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020530				2022-12-28	WOS:000175593300013
J	Miller, J; Chan, BKS; Nelson, HD				Miller, J; Chan, BKS; Nelson, HD			Postmenopausal estrogen replacement and risk for venous thromboembolism: A systematic review and meta-analysis for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							ORAL-CONTRACEPTIVES; BREAST-CANCER; VASCULAR-DISEASE; RANDOMIZED-TRIAL; PUBLICATION BIAS; HORMONE-THERAPY; WOMEN; TAMOXIFEN; HEART; USERS	Background: Postmenopausal estrogen replacement is widely used in the United States but poses important health risks. Purpose: To assess the risk for venous thromboembolism with postmenopausal estrogen replacement by using literature review and meta-analysis. Data Sources: All relevant English-language studies identified in searches of the MEDLINE (1966 to December 2000), HealthSTAR (1975 to December 2000), and Cochrane Library databases, and references lists of key articles. Study Selection: All published studies of postmenopausal estrogen replacement reporting venous thromboembolism as an outcome or adverse event. Data Extraction: 12 studies of estrogen were identified (3 randomized, controlled trials; 8 case-control studies; and I cohort study). Data were extracted on participants, interventions, event rates, and confounders. Two reviewers independently rated study quality on the basis of established criteria. Data Synthesis: A Bayesian meta-analysis was conducted. When data from all studies were pooled, current estrogen use was associated with an increased risk for venous thromboembolism (relative risk, 2.14 [95% credible interval, 1.64 to 2.81]). Estimates did not significantly change when studies were pooled according to study design, quality score, or whether participants had pre-existing coronary artery disease. The absolute rate increase was 1.5 venous thromboembolic events per 10 000 women in 1 year. Six case-control studies that reported risk according to duration of use found that risk was highest in the first year of use (relative risk, 3.49 [credible interval, 2.33 to 5.59]). Conclusion: Postmenopausal estrogen replacement is associated with an increased risk for venous thromboembolism, and this risk may be highest in the first year of use.	Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Vet Affairs Med Ctr, Portland, OR USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Miller, J (corresponding author), Oregon Hlth & Sci Univ, Mail Code BICC 504,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.							[Anonymous], 1974, NEW ENGL J MED, V290, P15; Crosignani PG, 1996, THROMB HAEMOSTASIS, V75, P476; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Daly E, 1996, LANCET, V348, P1027, DOI 10.1016/S0140-6736(96)24041-3; Daly E, 1996, LANCET, V348, P977, DOI 10.1016/S0140-6736(96)07113-9; DEVOR M, 1992, AM J MED, V92, P275, DOI 10.1016/0002-9343(92)90077-O; Douketis JD, 1997, ARCH INTERN MED, V157, P1522, DOI 10.1001/archinte.157.14.1522; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Glueck CJ, 1999, AM J CARDIOL, V84, P549, DOI 10.1016/S0002-9149(99)00375-6; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Grodstein F, 1996, LANCET, V348, P983, DOI 10.1016/S0140-6736(96)07308-4; Gutthann SP, 1997, BMJ-BRIT MED J, V314, P796, DOI 10.1136/bmj.314.7083.796; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hoibraaten E, 2000, THROMB HAEMOSTASIS, V84, P961; Holbraaten E, 1999, THROMB HAEMOSTASIS, V82, P1218; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Jick H, 1996, LANCET, V348, P981, DOI 10.1016/S0140-6736(96)07114-0; Kearon C, 1998, ANN INTERN MED, V128, P663, DOI 10.7326/0003-4819-128-8-199804150-00011; Keating NL, 1999, ANN INTERN MED, V130, P545, DOI 10.7326/0003-4819-130-7-199904060-00002; Koh KK, 1999, THROMB HAEMOSTASIS, V82, P626, DOI 10.1055/s-0037-1615889; LeBlanc ES, 2001, JAMA-J AM MED ASSOC, V285, P1489, DOI 10.1001/jama.285.11.1489; Lowe G, 2000, THROMB HAEMOSTASIS, V83, P530; Lufkin EG, 1998, J BONE MINER RES, V13, P1747, DOI 10.1359/jbmr.1998.13.11.1747; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; NACHTIGALL LE, 1979, OBSTET GYNECOL, V54, P74, DOI 10.1097/00006250-197907000-00017; PETITTI DB, 1979, JAMA-J AM MED ASSOC, V242, P1150, DOI 10.1001/jama.242.11.1150; PETITTI DB, 1978, AM J EPIDEMIOL, V108, P480, DOI 10.1093/oxfordjournals.aje.a112646; Powles T, 1998, LANCET, V352, P98; Rosenberg L, 1997, AM J OBSTET GYNECOL, V177, P1275, DOI 10.1016/S0002-9378(97)70063-2; Ruehlmann DO, 1997, BIOCHEM SOC T, V25, P40, DOI 10.1042/bst0250040; Scarabin PY, 1997, ARTERIOSCL THROM VAS, V17, P3071, DOI 10.1161/01.ATV.17.11.3071; Spiegelhalter DJ, 1999, WINBUGS VERSION 1 2; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; SUTTON AJ, 2000, METHODS METAANALYSIS, P57; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652, DOI DOI 10.1001/JAMA.1973.03230060030009; Varas-Lorenzo C, 1998, AM J EPIDEMIOL, V147, P387; Veronesi U, 1998, LANCET, V352, P93; VESSEY M, 1986, BRIT MED J, V292, P526, DOI 10.1136/bmj.292.6519.526; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753; Wenger NK, 2000, JAMA-J AM MED ASSOC, V284, P41, DOI 10.1001/jama.284.1.41-a; *WHI DSMB, 2002, STAT REP WHI HRT UPD; Whiteman MK, 1999, AM J HEMATOL, V61, P271	44	141	146	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					680	690		10.7326/0003-4819-136-9-200205070-00011	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547XK	11992304				2022-12-28	WOS:000175357900006
J	Villa, T; Pleiss, JA; Guthrie, C				Villa, T; Pleiss, JA; Guthrie, C			Spliceosomal snRNAs: Mg2+-dependent chemistry at the catalytic core?	CELL			English	Review							METAL-ION COORDINATION; RNA; U6; CONTRIBUTES; INTRONS; SITE	Since the discovery of self-splicing RNAs, it has been suspected that the snRNAs are the catalytic components of the spliceosome. Recent evidence supports both the catalytic potential of the spliceosomal snRNAs and their resemblance to elements of group II introns.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Guthrie, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	guthrie@cgl.ucsf.edu	Villa, Tommaso/AAS-4276-2020	Villa, Tommaso/0000-0002-5002-3468				Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; BURGE CB, 1998, RNA WORLD, V2, P525; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Gordon PM, 2000, RNA, V6, P199, DOI 10.1017/S1355838200992069; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Sigel RKO, 2000, NAT STRUCT BIOL, V7, P1111; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; SUN JS, 1995, GENE DEV, V9, P843, DOI 10.1101/gad.9.7.843; TANI T, 1991, GENE DEV, V5, P1022, DOI 10.1101/gad.5.6.1022; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; WEINER AM, 1993, CELL, V72, P161, DOI 10.1016/0092-8674(93)90654-9; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; YU YT, 1993, CELL, V75, P1049, DOI 10.1016/0092-8674(93)90315-H; Zhang L, 2002, SCIENCE, V295, P2084, DOI 10.1126/science.1069268	17	70	72	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					149	152		10.1016/S0092-8674(02)00726-2	http://dx.doi.org/10.1016/S0092-8674(02)00726-2			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007401	Bronze			2022-12-28	WOS:000175082600004
J	Myllykallio, H; Lipowski, G; Leduc, D; Filee, J; Forterre, P; Liebl, U				Myllykallio, H; Lipowski, G; Leduc, D; Filee, J; Forterre, P; Liebl, U			An alternative flavin-dependent mechanism for thymidylate synthesis	SCIENCE			English	Article							GENERATION; SYNTHASE; DNA	Although deoxythymidylate cannot be provided directly by ribonucleotide reductase, the gene encoding thymidylate synthase ThyA is absent from the genomes of a large number of nonsymbiotic microbes. We show that ThyX (Thy1) proteins of previously unknown function form a large and distinct class of thymidylate synthases. ThyX has a wide but sporadic phylogenetic distribution, almost exclusively limited to microbial genomes lacking thyA. ThyX and ThyA use different reductive mechanisms, because ThyX activity is dependent on reduced flavin nucleotides. Our findings reveal complexity in the evolution of thymidine in present-day DNA. Because ThyX proteins are found in many pathogenic microbes, they present a previously uncharacterized target for antimicrobial compounds.	Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR 8621, Orsay, France; Ecole Polytech, ENSTA, Lab Opt & Biosci, INSERM,U451, Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Polytechnique de Paris	Myllykallio, H (corresponding author), Univ Paris 11, Inst Genet & Microbiol, CNRS, UMR 8621, Orsay, France.		Myllykallio, Hannu/Y-5462-2019; Filée, Jonathan/AAC-9035-2021	Myllykallio, Hannu/0000-0002-0541-1197; LIEBL, Ursula/0000-0003-0869-4388				Adachi J, 1996, MOL PHYLOGENET EVOL, V6, P72, DOI 10.1006/mpev.1996.0059; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aurora R, 1998, P NATL ACAD SCI USA, V95, P2818, DOI 10.1073/pnas.95.6.2818; Capo-chichi CD, 2000, AM J CLIN NUTR, V71, P978; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; DELK AS, 1980, J BIOL CHEM, V255, P4837; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; MICHAELS ML, 1990, P NATL ACAD SCI USA, V87, P3957, DOI 10.1073/pnas.87.10.3957; Myllykallio H, 2000, SCIENCE, V288, P2212, DOI 10.1126/science.288.5474.2212; MYLLYKALLIO H, UNPUB; Neuhard J., 1996, ESCHERICHIA COLI SAL, V2nd, P580; Poole A, 2001, NAT REV MOL CELL BIO, V2, P147, DOI 10.1038/35052091; ROBERTS D, 1966, BIOCHEMISTRY-US, V5, P3546, DOI 10.1021/bi00875a022; WHITE RH, 1991, J BACTERIOL, V173, P1987, DOI 10.1128/jb.173.6.1987-1991.1991	16	211	212	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					105	107		10.1126/science.1072113	http://dx.doi.org/10.1126/science.1072113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12029065				2022-12-28	WOS:000176711000044
J	Read, TD; Salzberg, SL; Pop, M; Shumway, M; Umayam, L; Jiang, LX; Holtzapple, E; Busch, JD; Smith, KL; Schupp, JM; Solomon, D; Keim, P; Fraser, CM				Read, TD; Salzberg, SL; Pop, M; Shumway, M; Umayam, L; Jiang, LX; Holtzapple, E; Busch, JD; Smith, KL; Schupp, JM; Solomon, D; Keim, P; Fraser, CM			Comparative genome sequencing for discovery of novel polymorphisms in Bacillus anthracis	SCIENCE			English	Article							GENE	Comparison of the whole-genome sequence of Bacillus anthracis isolated from a victim of a recent bioterrorist anthrax attack with a reference reveals 60 new markers that include single nucleotide polymorphisms (SNPs), inserted or deleted sequences, and tandem repeats. Genome comparison detected four high-quality SNPs between the two sequenced B. anthracis chromosomes and seven differences among different preparations of the reference genome. These markers have been tested on a collection of anthrax isolates and were found to divide these samples into distinct families. These results demonstrate that genome-based analysis of microbial pathogens will provide a powerful new tool for investigation of infectious disease outbreaks.	Inst Genom Res, Rockville, MD 20850 USA; No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	J. Craig Venter Institute; Northern Arizona University	Fraser, CM (corresponding author), Inst Genom Res, 9712 Ctr Dr, Rockville, MD 20850 USA.	anthrax@tigr.org	Smith, Kimothy/AAI-9775-2020; Read, Timothy/E-6240-2011; Keim, Paul S/A-2269-2010; Salzberg, Steven L/F-6162-2011; Pop, Mihai/A-7987-2013; Salzberg, Steven/Q-6514-2019	Salzberg, Steven L/0000-0002-8859-7432; Pop, Mihai/0000-0001-9617-5304; Salzberg, Steven/0000-0002-8859-7432; Fraser, Claire/0000-0003-1462-2428; Read, Timothy/0000-0001-8966-9680	NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER; NLM NIH HHS [R01-LM06845] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		CDC [Centers for Disease Control and Prevention], 2001, MMWR-MORBID MORTAL W, V50, P877; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P909; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fleischmann R, 2001, EMERG INFECT DIS, V7, P487, DOI 10.3201/eid0703.017335; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; KOLSTO AB, 2002, J BACTERIOL, V184, P621; Okinaka R, 1999, J APPL MICROBIOL, V87, P261, DOI 10.1046/j.1365-2672.1999.00883.x; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Pannucci J, 2002, J BACTERIOL, V184, P134, DOI 10.1128/JB.184.1.134-141.2002; PETERSON XX, UNPUB; Price LB, 1999, J BACTERIOL, V181, P2358, DOI 10.1128/JB.181.8.2358-2362.1999; ROBERTSON DL, 1986, GENE, V44, P71, DOI 10.1016/0378-1119(86)90044-2; Thorne Curtis B., 1993, P113	16	328	428	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					2028	2033		10.1126/science.1071837	http://dx.doi.org/10.1126/science.1071837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12004073				2022-12-28	WOS:000176273300054
J	Dickersin, K; Scherer, R; Suci, EST; Gil-Montero, M				Dickersin, K; Scherer, R; Suci, EST; Gil-Montero, M			Problems with indexing and citation of articles with group authorship	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context It is not known whether articles with group authorship (ie, with a research group name listed as the author) are difficult to identify or whether use of group authorship may lead to problems with citation. Methods To examine ways in which reports of controlled trials with group authorship are indexed and citations counted in bibliographic databases, we conducted a cross-sectional study in January 2000. We identified 47 controlled trials funded by the National Eye Institute and 285 associated articles. Between January and August 2000, we searched PubMed and Science Citation Index (SCI) and recorded the citation practices for these articles. Our main outcome measures were ways in which trial reports were listed in PubMed and SCI and number of citations to each report by type of authorship. Results Of the 285 published reports identified, 126 (44%) had group authorship, 109 (38%) had modified group authorship (listing individual names plus the name of the research group), and 50 (18%) had named authors only. In PubMed, no group authors were listed in the author field (per MEDLINE rules); in SCI, group-authored reports generally were incorrectly attributed (first name on investigator list [35.3%], first name on writing committee [25.5%], contact name [16.7%], anonymous [16.7%], and other [5.9%]). Using the SCI general search, we identified citations to 16.7% of group-authored reports, compared with citations to 96.9% of reports with modified group authorship and 93.9% of citations to reports with named authors only. Other systematic search methods found that more than 98% of group-authored reports actually had been cited and that group-authored reports were cited more than other reports. Conclusions Indexing systems are not optimally adapted to group authorship. We recommend that indexing services change their practices to include group authors in the author field to help correct the problem.	Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; Brown Univ, Dept Sociol, Providence, RI 02912 USA; Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA	Brown University; Brown University; University System of Maryland; University of Maryland Baltimore	Dickersin, K (corresponding author), Brown Univ, Dept Community Hlth, 169 Angell St,Box G-S2, Providence, RI 02912 USA.		Dickersin, Kay/A-4576-2008		NEI NIH HHS [U10 EY09608] Funding Source: Medline; NATIONAL EYE INSTITUTE [U10EY009608] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 2002, NATURE, V415, P101; DICKERSIN K, 1995, JAMA-J AM MED ASSOC, V273, P625, DOI 10.1001/jama.1995.03520320035038; *ISCH OPT NEUR DEC, 1998, CONTROL CLIN TRIALS, V9, P276; MEINERT CL, 1993, CONTROL CLIN TRIALS, V14, P255, DOI 10.1016/0197-2456(93)90223-Z; NEWALL ML, 1995, BRIT MED J, V311, P632; Newman NJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1366; TAIT JA, 1969, AUTHORS TITLES ANAL	7	22	22	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2772	2774		10.1001/jama.287.21.2772	http://dx.doi.org/10.1001/jama.287.21.2772			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038908	Bronze			2022-12-28	WOS:000176002200005
J	Schwartz, LM; Woloshin, S; Baczek, L				Schwartz, LM; Woloshin, S; Baczek, L			Media coverage of scientific meetings - Too much, too soon?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				PROSTATE-CANCER	Context Although they are preliminary and have undergone only limited peer review, research abstracts at scientific meetings may receive prominent attention in the news media. We sought to describe news coverage of abstracts, characterize the research, and determine subsequent full publication in the medical literature. Methods We searched Lexis-Nexis to identify news stories printed in the 2 months following 5 scientific meetings held in 1998 (12th World AIDS Conference, American Heart Association, Society for Neuroscience, American Society of Clinical Oncology, and the Radiological Society of North America). We searched MEDLINE and contacted authors to determine subsequent publication in the medical literature within 3-3.5 years of the meetings. Results A total of 252 news stories reported on 147 research abstracts (average, 50 per meeting); 16% of the covered abstracts were nonhuman studies, 24% randomized trials, and 59% observational studies. Twenty-one percent of the human studies were small (ie, involving <30 subjects). In the 3 years after the meetings, 50% of the abstracts were published in high-impact journals (based on Institute for Scientific Information ratings), 25% in low-impact journals, and 25% remained unpublished. The publication record of the 39 abstracts receiving front-page newspaper coverage was almost identical to the overall rate. Meeting organizers issued press releases for 43 abstracts; these were somewhat more likely to receive prominent news coverage (35% covered on front page vs 23%, P=.14), but were no more likely to be published. Conclusions Abstracts at scientific meetings receive substantial attention in the high-profile media. A substantial number of the studies remain unpublished, precluding evaluation in the scientific community.	Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Norris Cotton Canc Ctr, Lebanon, NH USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center	Woloshin, S (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA.				NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER; NCI NIH HHS [CA91052-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander FE, 1999, PROSTATE, V40, P135; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; Boer R, 1999, PROSTATE, V40, P130; Cates W, 2001, JAMA-J AM MED ASSOC, V286, P2944; Davidoff F, 2001, ANN INTERN MED, V134, P1144, DOI 10.7326/0003-4819-134-12-200106190-00016; Fontanarosa PB, 2000, JAMA-J AM MED ASSOC, V284, P2927, DOI 10.1001/jama.284.22.2927; GROOPMAN J, 2001, NEW YORKER      0604, P32; *MED RES INC, 1998, MED RES MAG TOT AUD; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Ransohoff D F, 2001, Eff Clin Pract, V4, P185; Ray J, 2000, AM J MED, V109, P131, DOI 10.1016/S0002-9343(00)00450-2; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257; 2002, ISI J CITATION REPOR	14	60	61	1	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2859	2863		10.1001/jama.287.21.2859	http://dx.doi.org/10.1001/jama.287.21.2859			5	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038934	Bronze			2022-12-28	WOS:000176002200031
J	Wager, E; Middleton, P				Wager, E; Middleton, P			Effects of technical editing in biomedical journals - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				ORIGINAL RESEARCH ARTICLES; STRUCTURED ABSTRACTS; MANUSCRIPT QUALITY; INTERNAL-MEDICINE; ACCURACY; READERS; ANNALS; TRIAL	Context Technical editing supposedly improves the accuracy and clarity of journal articles. We examined evidence of its effects on research reports in biomedical journals. Methods Subset of a systematic review using Cochrane methods, searching MEDLINE, EMBASE, and other databases from earliest entries to February 2000 by using inclusive search terms; hand searching relevant journals. We selected comparative studies of the effects of editorial processes on original research articles between acceptance and publication in biomedical journals. Two reviewers assessed each study and performed independent data extraction. Results The 11 studies on technical editing indicate that it improves the readability of articles slightly (as measured by Gunning Fog and Flesch reading ease scores), may improve other aspects of their quality, can increase the accuracy of references and quotations, and raises the quality of abstracts. Supplying authors with abstract preparation instructions had no discernible effect. Conclusions Considering the time and resources devoted to technical editing, remarkably little is know about its effects or the effects of imposing different house styles. Studies performed at 3 journals employing relatively large numbers of professional technical editors suggest that their editorial processes are associated with increases in readability and quality of articles, but these findings may not be generalizable to other journals.	Royal Australasian Coll Surg, Australian Safety & Efficacy Register New Interve, Adelaide, SA, Australia		Wager, E (corresponding author), Sideview, 19 Stn Rd, Princes Risborough HP27 9DE, Bucks, England.			Wager, Elizabeth/0000-0002-4202-7813				ALDERSON P, 2002, EDITORIAL PEER REV I; Biddle C, 1996, AANA J, V64, P65; Comans M L, 1990, Ned Tijdschr Geneeskd, V134, P2338; GEORGE PM, 1994, J AM ACAD DERMATOL, V31, P61, DOI 10.1016/S0190-9622(94)70136-9; GOODMAN SN, 1994, ANN INTERN MED, V121, P11, DOI 10.7326/0003-4819-121-1-199407010-00003; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Hartley J, 1998, BRIT J EDUC PSYCHOL, V68, P443, DOI 10.1111/j.2044-8279.1998.tb01303.x; Hartley J, 1996, J INFORM SCI, V22, P349, DOI 10.1177/016555159602200503; Hartley J, 1997, J RES READ, V20, P122, DOI DOI 10.1111/1467-9817.00025; Hobma S O, 1992, Ned Tijdschr Geneeskd, V136, P637; JUSTICE AC, 1994, JAMA-J AM MED ASSOC, V272, P117, DOI 10.1001/jama.272.2.117; LOWRY SR, 1985, BRIT MED J, V291, P1421, DOI 10.1136/bmj.291.6506.1421; *MICR SUPP ONL, 2002, EXPL GRAMM CHECK REA; Pierie JPEN, 1996, LANCET, V348, P1480, DOI 10.1016/S0140-6736(96)05016-7; Pitkin RM, 1998, JAMA-J AM MED ASSOC, V280, P267, DOI 10.1001/jama.280.3.267; Pitkin RM, 1999, JAMA-J AM MED ASSOC, V281, P1110, DOI 10.1001/jama.281.12.1110; Pitkin RM, 2000, JAMA-J AM MED ASSOC, V283, P481, DOI 10.1001/jama.283.4.481-a; PURCELL GP, 2001, 4 INT C PEER REV BIO; ROBERTS JC, 1994, JAMA-J AM MED ASSOC, V272, P119, DOI 10.1001/jama.272.2.119; Scherer RW, 1998, JAMA-J AM MED ASSOC, V280, P269, DOI 10.1001/jama.280.3.269; TADDIO A, 1994, CAN MED ASSOC J, V150, P1611; Trakas K, 1997, ANN PHARMACOTHER, V31, P423, DOI 10.1177/106002809703100406; WAGER E, 2002, TECHNICAL EDITING RE; Winker MA, 1999, JAMA-J AM MED ASSOC, V281, P1129, DOI 10.1001/jama.281.12.1129	24	33	35	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2821	2824		10.1001/jama.287.21.2821	http://dx.doi.org/10.1001/jama.287.21.2821			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038923				2022-12-28	WOS:000176002200020
J	Gauld, SB; Dal Porto, JM; Cambier, JC				Gauld, SB; Dal Porto, JM; Cambier, JC			B cell antigen receptor signaling: Roles in cell development and disease	SCIENCE			English	Editorial Material							X-LINKED AGAMMAGLOBULINEMIA; LYN-DEFICIENT MICE; TYROSINE KINASE; SRC-FAMILY; PHOSPHOINOSITIDE 3-KINASE; AUTOIMMUNE-DISEASE; ACTIVATION; SYK; PHOSPHORYLATION; BTK	Signals propagated through the B cell antigen receptor (BCR) are vital for the development and survival of B lymphocytes in both the bone marrow and the periphery. These signals not only guide maturation and activation but also affect the removal of potentially self-reactive B lymphocytes. interestingly, these signals are known to be either ligand-independent ("tonic" signals) or induced by ligand (antigen) binding to the BCR. We focus on the problems that occur in B cell development due to defects in signals emanating from the BCR. In addition, we present the B Cell Antigen Receptor Pathway, an STKE Connections Map that illustrates the events involved in B cell signaling.	Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA; Natl Jewish Med Res Ctr, Denver, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	Cambier, JC (corresponding author), Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, 1400 Jackson St, Denver, CO 80206 USA.			Cambier, John/0000-0002-7803-242X				Bannish G, 2001, J EXP MED, V194, P1583, DOI 10.1084/jem.194.11.1583; Benschop RJ, 1999, CURR OPIN IMMUNOL, V11, P143, DOI 10.1016/S0952-7915(99)80025-9; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; DeFranco AL, 1998, SEMIN IMMUNOL, V10, P299, DOI 10.1006/smim.1998.0122; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; DOODY GM, 1995, SCIENCE, V269, P242, DOI 10.1126/science.7618087; Ellmeier W, 2000, J EXP MED, V192, P1611, DOI 10.1084/jem.192.11.1611; ENGEL P, 1995, IMMUNITY, V3, P39, DOI 10.1016/1074-7613(95)90157-4; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; GAULD SB, 2002, SCI STKE; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; HOMBACH J, 1990, NATURE, V343, P760, DOI 10.1038/343760a0; Hsueh RC, 1999, CURR TOP MICROBIOL, V246, P299; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Kraus M, 2001, J EXP MED, V194, P455, DOI 10.1084/jem.194.4.455; Kurosaki T, 1998, INT J MOL MED, V1, P515; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; KUROSAKI T, 1994, J EXP MED, V179, P1725, DOI 10.1084/jem.179.5.1725; Meade J, 2002, EUR J IMMUNOL, V32, P1029, DOI 10.1002/1521-4141(200204)32:4<1029::AID-IMMU1029>3.0.CO;2-M; Minegishi Y, 1999, J CLIN INVEST, V104, P1115, DOI 10.1172/JCI7696; NAGAI K, 1995, J BIOL CHEM, V270, P6824, DOI 10.1074/jbc.270.12.6824; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; Pao LI, 1998, J IMMUNOL, V160, P3305; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; Sato S, 1996, J IMMUNOL, V157, P4371; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0	35	187	212	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1641	1642		10.1126/science.1071546	http://dx.doi.org/10.1126/science.1071546			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040177				2022-12-28	WOS:000175976200040
J	Ge, K; Guermah, M; Yuan, CX; Ito, M; Wallberg, AE; Spiegelman, BM; Roeder, RG				Ge, K; Guermah, M; Yuan, CX; Ito, M; Wallberg, AE; Spiegelman, BM; Roeder, RG			Transcription coactivator TRAP220 is required for PPAR gamma 2-stimulated adipogenesis	NATURE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA; NUCLEAR RECEPTORS; COMPLEX; PROTEIN; MEDIATOR; DIFFERENTIATION; COMPONENT; TRAP/SMCC; REGULATOR	The TRAP (thyroid hormone receptor-associated proteins) transcription coactivator complex (also known as Mediator) was first isolated as a group of proteins that facilitate the function of the thyroid hormone receptor(1). This complex interacts physically with several nuclear receptors through the TRAP220 subunit, and with diverse activators through other subunits(2). TRAP220 has been reported to show ligand-enhanced interaction with peroxisome proliferator-activated receptor gamma(2) (PPARgamma2)(3,4),a nuclear receptor essential for adipogenesis(5-8). Here we show that Trap220(-/-) fibroblasts are refractory to PPARgamma(2-)stimulated adipogenesis, but not to MyoD-stimulated myogenesis, and do not express adipogenesis markers or PPARgamma2 target genes. These defects can be restored by expression of exogenous TRAP220. Further indicative of a direct role for TRAP220 in PPARgamma2 function via the TRAP complex, TRAP functions directly as a transcriptional coactivator for PPARgamma2 in a purified in vitro system and interacts with PPARgamma2 in a ligand- and TRAP220-dependent manner. These data indicate that TRAP220 acts, via the TRAP complex, as a PPARgamma2-selective coactivator and, accordingly, that it is specific for one fibroblast differentiation pathway (adipogenesis) relative to another (myogenesis).	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.		Ge, Kai/H-2810-2019	Ge, Kai/0000-0002-7442-5138				Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Fondell JD, 1996, P NATL ACAD SCI USA, V93, P8329, DOI 10.1073/pnas.93.16.8329; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Glass CK, 2000, GENE DEV, V14, P121; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Malik S, 2000, MOL CELL, V5, P753, DOI 10.1016/S1097-2765(00)80254-3; Malik S, 2000, TRENDS BIOCHEM SCI, V25, P277, DOI 10.1016/S0968-0004(00)01596-6; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; Yang W, 2000, MOL CELL BIOL, V20, P8008, DOI 10.1128/MCB.20.21.8008-8017.2000; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhu YJ, 2000, J BIOL CHEM, V275, P14779, DOI 10.1074/jbc.C000121200; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500	30	262	279	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					563	567		10.1038/417563a	http://dx.doi.org/10.1038/417563a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037571				2022-12-28	WOS:000175860300046
J	Wolpert, HA; Faradji, RN; Bonner-Weir, S; Lipes, MA				Wolpert, HA; Faradji, RN; Bonner-Weir, S; Lipes, MA			Metabolic decompensation in pump users due to lispro insulin precipitation	BRITISH MEDICAL JOURNAL			English	Article							INFUSION							Bonner-Weir, Susan/0000-0003-4682-0656				Lougheed WD, 1997, DIABETES CARE, V20, P1061, DOI 10.2337/diacare.20.7.1061; Wright AWD, 1998, DIABETES CARE, V21, P874, DOI 10.2337/diacare.21.5.874a	2	23	25	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1253	1253		10.1136/bmj.324.7348.1253	http://dx.doi.org/10.1136/bmj.324.7348.1253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028980	Bronze, Green Published			2022-12-28	WOS:000175894900021
J	Guet, CC; Elowitz, MB; Hsing, WH; Leibler, S				Guet, CC; Elowitz, MB; Hsing, WH; Leibler, S			Combinatorial synthesis of genetic networks	SCIENCE			English	Article							ESCHERICHIA-COLI; EVOLUTION; ELEMENTS; OPERATOR; PROTEIN; BIOLOGY	A central problem in biology is determining how genes interact as parts of functional networks. Creation and analysis of synthetic networks, composed of well-characterized genetic elements, provide a framework for theoretical modeling. Here, with the use of a combinatorial method, a library of networks with varying connectivity was generated in Escherichia coli. These networks were composed of genes encoding the transcriptional regulators Lacl, TetR, and lambda Cl, as well as the corresponding promoters. They displayed phenotypic behaviors resembling binary logical circuits, with two chemical "inputs" and a fluorescent protein "output." Within this simple system, diverse computational functions arose through changes in network connectivity. Combinatorial synthesis provides an alternative approach for studying biological networks, as well as an efficient method for producing diverse phenotypes in vivo.	Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Princeton Univ, Howard Hughes Med Inst, Dept Mol Biol, Princeton, NJ 08544 USA; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Rockefeller University; Howard Hughes Medical Institute; Princeton University; Princeton University	Leibler, S (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.							BERGER SL, 1994, ANAL BIOCHEM, V222, P1, DOI 10.1006/abio.1994.1445; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Carroll SB, 2000, CELL, V101, P577, DOI 10.1016/S0092-8674(00)80868-5; Davidson E. H., 2001, DEV EVOLUTION; DHaese E, 1997, APPL ENVIRON MICROB, V63, P4116, DOI 10.1128/AEM.63.10.4116-4119.1997; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GLASS L, 1973, J THEOR BIOL, V39, P103, DOI 10.1016/0022-5193(73)90208-7; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; MEYER BJ, 1980, J MOL BIOL, V139, P163, DOI 10.1016/0022-2836(80)90303-4; Muller J, 1996, J MOL BIOL, V257, P21, DOI 10.1006/jmbi.1996.0143; MULLINAX RL, 1992, BIOTECHNIQUES, V12, P864; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Szathmary E, 2001, SCIENCE, V292, P1315, DOI 10.1126/science.1060852; Thomas R., 1990, BIOL FEEDBACK; Zhang YX, 2002, NATURE, V415, P644, DOI 10.1038/415644a	18	392	420	2	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1466	1470		10.1126/science.1067407	http://dx.doi.org/10.1126/science.1067407			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029133				2022-12-28	WOS:000175910300048
J	Tegmark, M				Tegmark, M			Measuring spacetime: From the big bang to black holes	SCIENCE			English	Review							OBSERVATIONAL EVIDENCE; ACCELERATING UNIVERSE; DARK-MATTER; CONSTRAINTS; COSMOLOGY; OMEGA(M); TOPOLOGY; GRAVITY	Space is not a boring static stage on which events unfold over time, but a dynamic entity with curvature, fluctuations, and a rich life of its own. Spectacular measurements of the cosmic microwave background, gravitational lensing, type 1a supernovae, large-scale structure, spectra of the Lyman alpha forest, stellar dynamics, and x-ray binaries are probing the properties of spacetime over 22 orders of magnitude in scale. Current measurements are consistent with an infinite flat everlasting universe containing about 30% cold dark matter, 65% dark energy, and at least two distinct populations of black holes.	Univ Penn, Dept Phys, Philadelphia, PA 19104 USA	University of Pennsylvania	Tegmark, M (corresponding author), Univ Penn, Dept Phys, Philadelphia, PA 19104 USA.							Bahcall NA, 2000, ASTROPHYS J, V541, P1, DOI 10.1086/309423; Bahcall NA, 1999, SCIENCE, V284, P1481, DOI 10.1126/science.284.5419.1481; BAHCALL S, 1990, ASTROPHYS J, V362, P251, DOI 10.1086/169261; Bartelmann M, 2001, PHYS REP, V340, P291, DOI 10.1016/S0370-1573(00)00082-X; BLANDFORD RD, 1977, MON NOT R ASTRON SOC, V179, P433, DOI 10.1093/mnras/179.3.433; Boisseau B, 2000, PHYS REV LETT, V85, P2236, DOI 10.1103/PhysRevLett.85.2236; Bromley BC, 1998, NATURE, V391, P54, DOI 10.1038/34130; CARR B, 1993, RENAISSANCE GR COSMO, P277; Carroll SM, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.063507; Celotti A, 1999, CLASSICAL QUANT GRAV, V16, pA3, DOI 10.1088/0264-9381/16/12A/301; Colless M, 2001, MON NOT R ASTRON SOC, V328, P1039, DOI 10.1046/j.1365-8711.2001.04902.x; deOliveiraCosta A, 1996, ASTROPHYS J, V468, P457, DOI 10.1086/177706; DEOLIVEIRACOSTA A, 1995, ASTROPHYS J, V448, P477, DOI 10.1086/175977; EINSTEIN E, 1920, RELATIVITY SPECIAL G; Eisenstein DJ, 1999, ASTROPHYS J, V518, P2, DOI 10.1086/307261; Frank J., 2002, ACCRETION POWER ASTR, V3rd; GOTT RJ, 1998, PHYS REV D, V58; Griffiths LM, 2001, ASTROPHYS J, V553, pL5, DOI 10.1086/320498; HARTLE JB, 1983, PHYS REV D, V28, P2960, DOI 10.1103/PhysRevD.28.2960; Hoekstra H, 2001, ASTROPHYS J, V548, pL5, DOI 10.1086/318917; Hoyle CD, 2001, PHYS REV LETT, V86, P1418, DOI 10.1103/PhysRevLett.86.1418; Kallosh R, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.123523; Khoury J, 2001, PHYS REV D, V64, DOI 10.1103/PhysRevD.64.123522; Liddle A. R., 2000, COSMOLOGICAL INFLATI; LINDE A, 1990, PARTICLE PHYSICS INF; McGaugh SS, 2000, ASTROPHYS J, V541, pL33, DOI 10.1086/312902; MILGROM M, 1983, ASTROPHYS J, V270, P365, DOI 10.1086/161130; Randall L, 2002, SCIENCE, V296, P1422, DOI 10.1126/science.1072567; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; SHABHAZ T, 1994, MON NOT R ASTRON SOC, V271, pL10; Spergel DN, 2000, PHYS REV LETT, V84, P3760, DOI 10.1103/PhysRevLett.84.3760; Steinhardt PJ, 2002, SCIENCE, V296, P1436, DOI 10.1126/science.1070462; STEVENS D, 1993, PHYS REV LETT, V71, P20, DOI 10.1103/PhysRevLett.71.20; TEGMARK M, UNPUB; VILENKIN A, 1995, PHYS REV LETT, V74, P846, DOI 10.1103/PhysRevLett.74.846; WANG X, IN PRESS; White M, 2001, ASTROPHYS J, V560, P539, DOI 10.1086/323074; WILL CM, 1993, THEORY EXPT GRAVITAT; WITTEN E, 1984, PHYS REV D, V30, P272, DOI 10.1103/PhysRevD.30.272; Zwicky F., 1933, HELV PHYS ACTA, V6, P110, DOI [DOI 10.1007/S10714-008-0707-4, 10.1007/s10714-008-0707-4]; [No title captured]	43	24	25	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1427	1433		10.1126/science.1072184	http://dx.doi.org/10.1126/science.1072184			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029125	Green Submitted			2022-12-28	WOS:000175910300037
J	Verity, C; Nicoll, A				Verity, C; Nicoll, A			Education and debate - Consent, confidentiality, and the threat to public health surveillance	BRITISH MEDICAL JOURNAL			English	Article							NATIONAL SURVEILLANCE; MMR VACCINE; RUBELLA; UK		Addenbrookes Hosp, Child Dev Ctr, Cambridge CB2 2QQ, England; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Public Health England	Verity, C (corresponding author), Addenbrookes Hosp, Child Dev Ctr, Hills Rd, Cambridge CB2 2QQ, England.							Al-Shahi R, 2000, BMJ-BRIT MED J, V321, P1031, DOI 10.1136/bmj.321.7268.1031; Anderson R, 2001, BRIT MED J, V322, P442, DOI 10.1136/bmj.322.7284.442; Berridge V., 1996, AIDS UK MAKING POLIC; BOOY R, 1997, LANCET, V349, P197; *BRIT PAED SURV UN, 1998, 12 ROYAL COLL PAED C; *BRIT PAED SURV UN, 1998, 12 ROYAL COLL PAED C, P25; *BRIT PAED SURV UN, 1998, 12 ROYAL COLL PAED C, P31; *BRIT PAED SURV UN, 1997, 12 ROYAL COLL PAED C; *BRIT PAED SURV UN, 1998, 12 ROYAL COLL PAED C, P20; BURNETT SD, 1992, BRIT MED J, V305, P627, DOI 10.1136/bmj.305.6854.627; *COMM DIS SURV CTR, 2000, COMMON DIS REP CDR W, V10, P133; *COMM DIS SURV CTR, 1995, CDR REV, V5, pR189; *DEP HLTH, 2002, HSG965 DEP HLTH; *DEP HLTH, 2002, ETH REV MULT RES NHS; *DEP HLTH, 1999, 1999183 HSC NHS DEP; *DEP HLTH, ETH REV MULT RES NHS; DONALDSON L, 2001, REPORT CHIRF MED OFF; DWYER T, 1996, BRIT MED J, V313, P179; Elliman D, 2001, BMJ-BRIT MED J, V322, P183, DOI 10.1136/bmj.322.7280.183; FALCONER C, 2001, TIMES           0517; FRANCE E, 2001, TIMES           0522; *GEN MED COUNC, 2000, CONF PROT PROV INF; Hardie RM, 1996, ARCH DIS CHILD, V74, P400, DOI 10.1136/adc.74.5.400; Hewson B, 2000, BRIT MED J, V321, P780, DOI 10.1136/bmj.321.7264.780; Jacobsen SJ, 1999, MAYO CLIN PROC, V74, P330, DOI 10.4065/74.4.330; Killalea D, 1996, BMJ-BRIT MED J, V313, P1105, DOI 10.1136/bmj.313.7065.1105; LANGMUIR AD, 1963, NEW ENGL J MED, V268, P182, DOI 10.1056/NEJM196301242680405; McKiernan PJ, 2000, LANCET, V355, P25, DOI 10.1016/S0140-6736(99)03492-3; MILLER E, 1993, LANCET, V341, P979, DOI 10.1016/0140-6736(93)91069-X; Miller E, 1998, Dev Biol Stand, V95, P235; Miller E, 2001, ARCH DIS CHILD, V84, P227, DOI 10.1136/adc.84.3.227; *NHS EX, 1999, 1999012 NHS HSC; *NHS NAT SPEC COMM, 2000, GUID LIV SERV CHILDR; Nicoll A, 2000, J ROY SOC MED, V93, P580, DOI 10.1177/014107680009301107; Nicoll A, 1998, BRIT MED J, V316, P253, DOI 10.1136/bmj.316.7127.253; Paterson ICM, 2001, BRIT MED J, V322, P1130, DOI 10.1136/bmj.322.7294.1130; PATTISON J, 1999, FACULTY PUBLIC HLTH; Regan M, 1999, J EPIDEMIOL COMMUN H, V53, P517, DOI 10.1136/jech.53.9.517; *ROYAL COLL PAED C, 1998, INT WORK PART ENH VO; SINGLETON P, 2002, GAINING PATIENT CONS; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Tookey PA, 1999, BRIT MED J, V318, P769, DOI 10.1136/bmj.318.7186.769; Verity CM, 2000, LANCET, V356, P1224, DOI 10.1016/S0140-6736(00)02785-9; 1999, CURRENT PROBLEMS PHA, V25, P9; 1997, CDR WEEKLY, V7, P36; 2001, CDR WEEKLY, V11, P1; 1997, CDR WEEKLY, V7, P33	47	61	62	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1210	1213		10.1136/bmj.324.7347.1210	http://dx.doi.org/10.1136/bmj.324.7347.1210			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016192	Green Published			2022-12-28	WOS:000175763200027
J	Rubin, MA				Rubin, MA			Understanding disease cell by cell	SCIENCE			English	Article							REED-STERNBERG CELLS; GENE-EXPRESSION; CANCER; MUTATIONS		Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Rubin, MA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.			Rubin, Mark/0000-0002-8321-9950				BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cossman J, 1999, BLOOD, V94, P411, DOI 10.1182/blood.V94.2.411; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.3.CO;2-F; Messineo C, 1998, BLOOD, V91, P2443, DOI 10.1182/blood.V91.7.2443.2443_2443_2451; Nuland Sherwin B., 1988, DOCTORS BIOGRAPHY ME; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Phillips Jennifer, 1996, Methods (Orlando), V10, P283, DOI 10.1006/meth.1996.0104; Sgroi DC, 1999, CANCER RES, V59, P5656; Strausberg RL, 2001, J PATHOL, V195, P31, DOI 10.1002/1096-9896(200109)195:1<31::AID-PATH920>3.0.CO;2-W; TRUMPER LH, 1993, BLOOD, V81, P3097; Virchow R, 1858, CELLULARPATHOLOGIE I; Vocke CD, 1996, CANCER RES, V56, P2411; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901	16	24	26	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1329	1330		10.1126/science.296.5571.1329	http://dx.doi.org/10.1126/science.296.5571.1329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016318				2022-12-28	WOS:000175713000058
J	Reiber, GE; Smith, DG; Wallace, C; Sullivan, K; Hayes, S; Vath, C; Maciejewski, ML; Yu, OC; Heagerty, PJ; LeMaster, J				Reiber, GE; Smith, DG; Wallace, C; Sullivan, K; Hayes, S; Vath, C; Maciejewski, ML; Yu, OC; Heagerty, PJ; LeMaster, J			Effect of therapeutic footwear on foot reulceration in patients with diabetes - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEUROPATHY; PREVALENCE; POPULATION; PREVENTION; ULCERS; AMPUTATION; PATHWAYS; LESIONS; DISEASE	Context Many people with diabetes experience lower-limb ulcers. Footwear has been implicated as a primary cause of foot ulcers, yet research is limited on the efficacy of shoe and insert combinations to prevent reulceration. Objective To determine whether extra-depth and -width therapeutic shoes used with 2 types of inserts reduce reulceration in diabetic individuals with a history of foot ulcer. Design, Setting, and Participants Randomized clinical trial of 400 diabetes patients with history of foot ulcer in 2 Washington State health care organizations who did not require custom shoes for foot deformity and were enrolled between August 1997 and December 1998 and followed up for 2 years. Data collected at regular intervals documented physical, foot, and diabetes characteristics; footwear use; foot lesions; and ulcers. Interventions Participants were randomly assigned to receive 3 pairs of therapeutic shoes and 3 pairs of customized medium-density cork inserts with a neoprene closed-cell cover (n=121); to receive 3 pairs of therapeutic shoes and 3 pairs of prefabricated, tapered polyurethane inserts with a brushed nylon cover (n = 119); or to wear their usual footwear (controls; n = 160). Main Outcome Measure Foot reulceration, compared among the 3 groups. Results Two-year cumulative reulceration incidence across the 3 groups was low: 15% in the cork-insert group, 14% in the prefabricated-insert group, and 17% in controls. In the intent-to-treat analysis, patients assigned to therapeutic shoes did not have a significantly lower risk of reulceration compared with controls (risk ratio [RR] for the cork-insert group, 0.88; 95% confidence interval [CI], 0,51-1.52 and RR the for prefabricated-insert group, 0.85; 95% CI, 0.48-1.48). All ulcer episodes in patients assigned to therapeutic shoes and 88% wearing nonstudy shoes occurred in patients with foot insensitivity. Conclusions This study of persons without severe foot deformity does not provide evidence to support widespread dispensing of therapeutic shoes and inserts to diabetic patents with a history of foot ulcer. Study shoes and custom cork or preformed polyurethane inserts conferred no significant ulcer reduction compared with control footwear. This study suggests that careful attention to foot care by health care professionals may be more important than therapeutic footwear but does not negate the possibility that special footwear is beneficial in persons with diabetes who do not receive such close attention to foot care by their health care providers or in individuals with severe foot deformities.	Dept Vet Affairs, VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA; Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Orthopaed Surg, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Family Med, Seattle, WA 98195 USA; Swedish Med Ctr, Joslin Diabet Ctr, Seattle, WA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Joslin Diabetes Center, Inc.; Swedish Medical Center	Reiber, GE (corresponding author), Dept Vet Affairs, VA Puget Sound Hlth Care Syst, 152,1660 Columbian Way, Seattle, WA 98108 USA.							BORCHERS RE, 1995, J PROSTHET ORTHOT, V7, P29; BORSSEN B, 1990, DIABETIC MED, V7, P438, DOI 10.1111/j.1464-5491.1990.tb01420.x; BOULTON AJM, 1984, DIABETES CARE, V7, P42, DOI 10.2337/diacare.7.1.42; Boyko EJ, 1999, DIABETES CARE, V22, P1036, DOI 10.2337/diacare.22.7.1036; BRAND PW, 1983, DIABETES MELLITUS TH, V2, P829; BRODSKY JW, 1988, FOOT ANKLE, V9, P111, DOI 10.1177/107110078800900303; Campbell G J, 1984, J Rehabil Res Dev, V21, P57; CHANTELAU E, 1994, DIABETIC MED, V11, P114, DOI 10.1111/j.1464-5491.1994.tb00240.x; COLEMAN WC, 1993, DIABETIC FOOT, P531; CRAUSAZ FM, 1988, DIABETIC MED, V5, P771, DOI 10.1111/j.1464-5491.1988.tb01106.x; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; EASTMAN RC, 1995, NIH PUBLICATION, P339; EDMONDS ME, 1986, Q J MED, V60, P763; FRANKLIN GM, 1990, AM J EPIDEMIOL, V131, P633, DOI 10.1093/oxfordjournals.aje.a115547; Janisse D J, 1995, Clin Podiatr Med Surg, V12, P41; KREINES K, 1985, DIABETES CARE, V8, P235, DOI 10.2337/diacare.8.3.235; KUMAR S, 1994, DIABETIC MED, V11, P480, DOI 10.1111/j.1464-5491.1994.tb00310.x; Litzelman DK, 1997, DIABETES CARE, V20, P156, DOI 10.2337/diacare.20.2.156; MELTON LJ, 1980, DIABETES CARE, V3, P648; MOSS SE, 1992, ARCH INTERN MED, V152, P610, DOI 10.1001/archinte.152.3.610; PECORARO RE, 1990, DIABETES CARE, V13, P513, DOI 10.2337/diacare.13.5.513; PHILIPS JW, 1990, FUNCTIONAL FOOT ORTH; PRATT DJ, 1986, PROSTHET ORTHOT INT, V10, P43; Ramsey SD, 1999, DIABETES CARE, V22, P382, DOI 10.2337/diacare.22.3.382; Reiber GE, 1999, DIABETES CARE, V22, P157, DOI 10.2337/diacare.22.1.157; Reiber GE, 2002, DIABETIC FOOT: MEDICAL AND SURGICAL MANAGEMENT, P35; Reiber GE, 1997, J REHABIL RES DEV, V34, P1; Reiber GE, 1995, DIABETES AM, P409; *SAS I INC, 2000, SAS STAT SOFTW COMP; STAATS TB, 1989, J PROSTHET ORTHOT, V1, P182, DOI 10.1097/00008526-198904000-00012; UCCIOLI L, 1995, DIABETES CARE, V18, P1376, DOI 10.2337/diacare.18.10.1376; Wooldridge J, 1996, AM J PUBLIC HEALTH, V86, P935, DOI 10.2105/AJPH.86.7.935	32	137	146	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2552	2558		10.1001/jama.287.19.2552	http://dx.doi.org/10.1001/jama.287.19.2552			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020336	Bronze			2022-12-28	WOS:000175566200024
J	Simpson, JL; Gray, R; Perez, A; Mena, P; Queenan, J; Barbato, M; Pardo, F; Kambic, R; Jennings, V				Simpson, JL; Gray, R; Perez, A; Mena, P; Queenan, J; Barbato, M; Pardo, F; Kambic, R; Jennings, V			Fertilisation involving ageing gametes, major birth defects, and Down's syndrome	LANCET			English	Article							RISK	For many years, ageing of gametes as a result of prolonged retention In the female reproductive tract before fertilisation has been circumstantially associated with major birth defects. To assess this association, we studied pregnant women who had recorded the timing, with regard to presumed ovulation, of the coital event leading to conception. We found major anomalies In 11 l of 400 Infants born to women with optimally timed conceptions (on the day of or 1 day before ovulation), compared with 14 (2.5%) of 538 Infants of women with non-optimally timed conceptions (odds ratio 0.94, 95% CI 0.43-2.06). The numbers of Infants with Down's syndrome were two l of 400, and four (0.7%) of 538, respectively (1.48, 0.27-8.06). There is no association between ageing gametes and major birth defects, Including Down's syndrome.	Baylor Coll Med, Houston, TX 77030 USA; Johns Hopkins Univ, Baltimore, MD USA; Pontificia Univ Catolica Chile, Santiago, Chile; Univ Los Andes, Santiago, Chile; Georgetown Univ, Inst Reprod Hlth, Washington, DC USA; Ctr Ambrosiano Metodi Nat, Milan, Italy; Univ Javeriana, Bogota, Colombia	Baylor College of Medicine; Johns Hopkins University; Pontificia Universidad Catolica de Chile; Universidad de los Andes - Chile; Georgetown University; Pontificia Universidad Javeriana	Simpson, JL (corresponding author), Baylor Coll Med, 6650 Fannin, Houston, TX 77030 USA.							CASTILLA EE, 1995, AM J MED GENET, V59, P525, DOI 10.1002/ajmg.1320590424; GRAY RH, 1995, AM J OBSTET GYNECOL, V172, P1567, DOI 10.1016/0002-9378(95)90498-0; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; SIMPSON J L, 1988, Advances in Contraception, V4, P247, DOI 10.1007/BF01849266; Yoon PW, 1996, AM J HUM GENET, V58, P628	5	1	1	0	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1670	1671		10.1016/S0140-6736(02)08559-8	http://dx.doi.org/10.1016/S0140-6736(02)08559-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020531				2022-12-28	WOS:000175593300014
J	Steele, JPC; Timothy, R; Oliver, D				Steele, JPC; Timothy, R; Oliver, D			Testicular cancer: perils of very late presentation	LANCET			English	Editorial Material									St Bartholomews Hosp, Dept Med Oncol, London EC1A 7BE, England	University of London; Queen Mary University London	Steele, JPC (corresponding author), St Bartholomews Hosp, Dept Med Oncol, London EC1A 7BE, England.							Burnett A, 2001, BRIT MED J, V322, P544, DOI 10.1136/bmj.322.7285.544; EINHORN LH, 1977, ANN INTERN MED, V87, P293, DOI 10.7326/0003-4819-87-3-293; Mead GM, 1997, J CLIN ONCOL, V15, P594; OLIVER RT, 1996, BR J UROL, V79, P119; WOODHEAD D, 2000, HLTH WEILBEING ASYLU; 2002, AS SEEK HLTH BMA MED	6	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1632	1633		10.1016/S0140-6736(02)08544-6	http://dx.doi.org/10.1016/S0140-6736(02)08544-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020521				2022-12-28	WOS:000175593300004
J	Fenchel, T				Fenchel, T			Microbial behavior in a heterogeneous world	SCIENCE			English	Review							MARINE SNOW; OXYGEN GRADIENTS; BACTERIA; RESPONSES; O-2; THIOVULUM; MOTILITY; LIGHT; SEA	Most microorganisms are motile during at least part of their life cycle, because they need to find optimal conditions in a patchy world. The sheer volume of microorganisms in the biosphere means that their motile sensory behavior also contributes to the global transformation and cycling of matter. How microorganisms move and how they orient themselves using environmental cues are integral to understanding the complex structure and function of microbial communities, but although motility in response to external stimuli was first described more than 120 years ago, understanding of the cellular and molecular mechanisms involved has only been achieved more recently.	Univ Copenhagen, Marine Biol Lab, DK-3000 Helsingor, Denmark	University of Copenhagen	Fenchel, T (corresponding author), Univ Copenhagen, Marine Biol Lab, Strandpromenaden 5, DK-3000 Helsingor, Denmark.	tfenchel@zi.ku.dk	Fenchel, Tom/F-8979-2011; chen, qi/C-8585-2011	Fenchel, Tom/0000-0003-0023-2402; 				AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Armitage JP, 1997, ARCH MICROBIOL, V168, P249, DOI 10.1007/s002030050496; Armitage JP, 1990, BIOL CHEMOTACTIC RES; Artolozaga I, 1997, J PLANKTON RES, V19, P1429, DOI 10.1093/plankt/19.10.1429; Blackburn N, 1999, MAR ECOL PROG SER, V189, P1, DOI 10.3354/meps189001; Blackburn N, 1999, PROTIST, V150, P337, DOI 10.1016/S1434-4610(99)70034-9; BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245; Boudreau B.P., 2001, BENTHIC BOUNDARY LAY; BOWEN JD, 1992, J FLUID MECH, V236, P95, DOI 10.1017/S0022112092001356; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; Eberl L, 1996, MOL MICROBIOL, V20, P127, DOI 10.1111/j.1365-2958.1996.tb02495.x; Engelmann Th.W., 1883, PFLUGER ARCH, V30, P95, DOI [10.1007/BF01674325, DOI 10.1007/BF01674325]; Eschemann A, 1999, ENVIRON MICROBIOL, V1, P489, DOI 10.1046/j.1462-2920.1999.00057.x; Fenchel T, 1996, EUR J PROTISTOL, V32, P55, DOI 10.1016/S0932-4739(96)80039-3; Fenchel T, 1998, NATURE, V394, P367, DOI 10.1038/28609; Fenchel T, 2001, AQUAT MICROB ECOL, V24, P197, DOI 10.3354/ame024197; Fenchel T., 1987, ECOLOGY OF PROTOZOA, DOI [10.1007/978-3-662-06817-5, DOI 10.1007/978-3-662-06817-5, DOI 10.1007/978-3-662-25981-8]; FINLAY BJ, 1987, J PROTOZOOL, V34, P349, DOI 10.1111/j.1550-7408.1987.tb03189.x; Givskov M, 1997, FEMS MICROBIOL LETT, V148, P115, DOI 10.1016/S0378-1097(96)00530-7; Glud RN, 1996, MAR ECOL PROG SER, V140, P217, DOI 10.3354/meps140217; Glud RN, 2001, LIMNOL OCEANOGR, V46, P2073, DOI 10.4319/lo.2001.46.8.2073; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; HERNDL GJ, 1988, MAR ECOL PROG SER, V48, P265, DOI 10.3354/meps048265; JORGENSEN BB, 1983, APPL ENVIRON MICROB, V45, P1261; Kiorboe T, 2001, LIMNOL OCEANOGR, V46, P1309, DOI 10.4319/lo.2001.46.6.1309; Mann K.H., 1991, DYNAMICS MARINE ECOS, DOI 10.1002/9781118687901; MOLLER MM, 1985, APPL ENVIRON MICROB, V50, P373; Nielsen AT, 2000, ENVIRON MICROBIOL, V2, P59, DOI 10.1046/j.1462-2920.2000.00084.x; Overmann J, 2002, ARCH MICROBIOL, V177, P201, DOI 10.1007/s00203-001-0377-z; Paerl HW, 2000, ENVIRON MICROBIOL, V2, P11, DOI 10.1046/j.1462-2920.2000.00071.x; PFENNIG N, 1967, ANNU REV MICROBIOL, V21, P285, DOI 10.1146/annurev.mi.21.100167.001441; Ploug H, 1999, MAR ECOL PROG SER, V179, P1, DOI 10.3354/meps179001; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; Rath J, 1998, AQUAT MICROB ECOL, V14, P261, DOI 10.3354/ame014261; SCHINK B, 1991, PROKARYOTES; Schulz HN, 2001, ANNU REV MICROBIOL, V55, P105, DOI 10.1146/annurev.micro.55.1.105; Thar R, 2001, APPL ENVIRON MICROB, V67, P3299, DOI 10.1128/AEM.67.7.3299-3303.2001; Thar R, 2001, APPL ENVIRON MICROB, V67, P5410, DOI 10.1128/AEM.67.12.5410-5419.2001; Tolker-Nielsen T, 2000, MICROB ECOL, V40, P75	39	201	214	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1068	1071		10.1126/science.1070118	http://dx.doi.org/10.1126/science.1070118			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004118				2022-12-28	WOS:000175565000040
J	Finlay, BJ				Finlay, BJ			Global dispersal of free-living microbial eukaryote species	SCIENCE			English	Article							GEOGRAPHIC-DISTRIBUTION; POPULATION-DENSITY; MOLECULAR EVIDENCE; BODY-SIZE; DIVERSITY; PROTOZOA; BIODIVERSITY; GYMNAMOEBAE; ABUNDANCES; CILIOPHORA	The abundance of individuals in microbial species is so large that dispersal is rarely (if ever) restricted by geographical barriers. This "ubiquitous" dispersal requires an alternative view of the scale and dynamics of biodiversity at the microbial Level, wherein global species number is relatively low and Local species richness is always sufficient to drive ecosystem functions.	Ctr Ecol & Hydrol Windermere, Ambleside LA22 0LP, Cumbria, England	UK Centre for Ecology & Hydrology (UKCEH)	Finlay, BJ (corresponding author), Ctr Ecol & Hydrol Windermere, Ferry House, Ambleside LA22 0LP, Cumbria, England.	bjf@ceh.ac.uk						Anderson OR, 1997, J EUKARYOT MICROBIOL, V44, P393, DOI 10.1111/j.1550-7408.1997.tb05714.x; ANDERSON S, 1994, Q REV BIOL, V69, P451, DOI 10.1086/418743; Atkins MS, 2000, J EUKARYOT MICROBIOL, V47, P400, DOI 10.1111/j.1550-7408.2000.tb00067.x; Bell G, 2001, SCIENCE, V293, P2413, DOI 10.1126/science.293.5539.2413; BERNINGER UG, 1991, LIMNOL OCEANOGR, V36, P139, DOI 10.4319/lo.1991.36.1.0139; Bischoff PJ, 1998, ACTA PROTOZOOL, V37, P17; Bowers N, 1998, EUR J PROTISTOL, V34, P341, DOI 10.1016/S0932-4739(98)80001-1; COLEMAN AW, 1994, J PHYCOL, V30, P80, DOI 10.1111/j.0022-3646.1994.00080.x; CORLISS JO, 1999, NATURE HUMAN SOC QUE, P130; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darwin C., 1846, Q J GEOL SOC, V2, P26, DOI DOI 10.1144/GSL.JGS.1846.002.01-02.09; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; Esteban GF, 2001, J ZOOL, V255, P139, DOI 10.1017/S0952836901001200; Esteban GF, 2000, J NAT HIST, V34, P159, DOI 10.1080/002229300299598; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; FENCHEL T, 1994, PHILOS T ROY SOC B, V343, P51, DOI 10.1098/rstb.1994.0007; Fenchel T., 1986, Progress in Protistology, V1, P65; FENCHEL T, 1993, OIKOS, V68, P375, DOI 10.2307/3544855; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; FENCHEL T, COMMUNICATION; FINLAY BB, UNPUB; Finlay BJ, 1999, PROTIST, V150, P229, DOI 10.1016/S1434-4610(99)70025-8; Finlay BJ, 1998, PROTIST, V149, P29, DOI 10.1016/S1434-4610(98)70007-0; Finlay BJ, 1996, Q REV BIOL, V71, P221, DOI 10.1086/419370; Finlay BJ, 1997, OIKOS, V80, P209, DOI 10.2307/3546587; Finlay BJ, 2001, PROTIST, V152, P355, DOI 10.1078/1434-4610-00073; Finlay BJ, 1999, NATURE, V400, P828, DOI 10.1038/23616; Finlay BJ, 1999, ECOGRAPHY, V22, P138, DOI 10.1111/j.1600-0587.1999.tb00461.x; Finlay Bland J., 2001, P901, DOI 10.1006/rwbd.1999.0285; Foissner W, 1999, PROTIST, V150, P363, DOI 10.1016/S1434-4610(99)70037-4; GASTON KJ, 1992, FUNCT ECOL, V6, P243, DOI 10.2307/2389513; HAPPEYWOOD CM, 1988, HYDROBIOLOGIA, V161, P99, DOI 10.1007/BF00044104; Hubbell S.P., 2001, MG POP BIOL, V32; KRISTIANSEN J, 2001, NOVA HEDWIGIA, V122, P23; Kusch J, 1998, PROTIST, V149, P147, DOI 10.1016/S1434-4610(98)70019-7; Lawton JH, 1998, OIKOS, V81, P3, DOI 10.2307/3546461; Maskell WM, 1887, T P NZ I, V20, P3; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Nanney DL, 1999, SPECIES, P93; Noland L. E, 1967, RES PROTOZOOL, V2; PATTERSON DJ, 2000, FLAGELLATES UNITY DI, P269; Roberts MS, 1995, EVOLUTION, V49, P1081, DOI 10.1111/j.1558-5646.1995.tb04435.x; Schmid PE, 2000, SCIENCE, V289, P1557, DOI 10.1126/science.289.5484.1557; Stoeck T, 1998, EUR J PROTISTOL, V34, P348, DOI 10.1016/S0932-4739(98)80002-3; VANNIEL CB, 1983, MW BEIJERINCK HIS LI	46	1248	1315	11	355	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1061	1063		10.1126/science.1070710	http://dx.doi.org/10.1126/science.1070710			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004115				2022-12-28	WOS:000175565000037
J	Rulifson, EJ; Kim, SK; Nusse, R				Rulifson, EJ; Kim, SK; Nusse, R			Ablation of insulin-producing neurons in flies: Growth and diabetic phenotypes	SCIENCE			English	Article							DROSOPHILA; RECEPTOR; GENE; PEPTIDE	In the fruit fly Drosophila, four insulin genes are coexpressed in small clusters of cells [insulin-producing cells (IPCs)] in the brain. Here, we show that ablation of these IPCs causes developmental delay, growth retardation, and elevated carbohydrate levels in larval hemolymph. All of the defects were reversed by ectopic expression of a Drosophila insulin transgene. On the basis of these functional data and the observation that IPCs release insulin into the circulatory system, we conclude that brain IPCs are the main systemic supply of insulin during larval growth. We propose that IPCs and pancreatic islet beta cells are functionally analogous and may have evolved from a common ancestral insulin-producing neuron. Interestingly, the phenotype of flies lacking IPCs includes certain features of diabetes mellitus.	Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Beckman Ctr B300, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Rulifson, EJ (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.			Kim, Seung/0000-0001-6135-7810				Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; CLARKE DW, 1986, J NEUROCHEM, V47, P831; Duvillie B, 1997, P NATL ACAD SCI USA, V94, P5137, DOI 10.1073/pnas.94.10.5137; Joslin E.P., 1994, JOSLINS DIABETES MEL; Kondo H, 1996, J MOL BIOL, V259, P926, DOI 10.1006/jmbi.1996.0370; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; McRory JE, 1997, DNA CELL BIOL, V16, P939, DOI 10.1089/dna.1997.16.939; Nijhout H.F., 1994, INSECT HORMONES; NOYES BE, 1995, MOL CELL ENDOCRINOL, V109, P133, DOI 10.1016/0303-7207(95)03492-P; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; SMIT AB, 1988, NATURE, V331, P535, DOI 10.1038/331535a0; Vroemen SF, 1998, MOL CELL ENDOCRINOL, V141, P7, DOI 10.1016/S0303-7207(98)00079-3; WYATT GR, 1961, ANNU REV ENTOMOL, V6, P75, DOI 10.1146/annurev.en.06.010161.000451	15	794	819	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1118	1120		10.1126/science.1070058	http://dx.doi.org/10.1126/science.1070058			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004130				2022-12-28	WOS:000175565000053
J	Daly, JS; Shepard, JO; Mark, EJ				Daly, JS; Shepard, JO; Mark, EJ			A 51-year-old woman with recurrent hemoptysis. Broncholithiasis due to histoplasmosis, with superinfection by actinomyces.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLASTOMYCOSIS; WISCONSIN; FEATURES		UMass Mem Hlth Care, Infect Dis & Immunol, Worcester, MA 01655 USA; Univ Massachusetts, Sch Med, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Daly, JS (corresponding author), UMass Mem Hlth Care, Infect Dis & Immunol, Worcester, MA 01655 USA.							ADAM RD, 1986, MEDICINE, V65, P203, DOI 10.1097/00005792-198607000-00001; ARRIGONI MG, 1971, J THORAC CARDIOV SUR, V62, P231, DOI 10.1016/S0022-5223(19)42076-X; BAUMGARDNER DJ, 1992, CLIN INFECT DIS, V15, P629, DOI 10.1093/clind/15.4.629; BHAGAVAN BS, 1971, ARCH PATHOL, V91, P577; CHRISTIE A, 1945, AM J PUBLIC HEALTH, V35, P1131; Cox AJ, 1939, ARCH PATHOL, V27, P717; ELLIOT DL, 1985, CHEST, V87, P687, DOI 10.1378/chest.87.5.687; GOODWIN RA, 1980, MEDICINE, V59, P1, DOI 10.1097/00005792-198001000-00001; GOODWIN RA, 1981, MEDICINE, V60, P231, DOI 10.1097/00005792-198107000-00001; HEAD JR, 1949, AM REV TUBERC PULM, V60, P1; HIRSCHFIELD LS, 1989, CHEST, V96, P218, DOI 10.1378/chest.96.1.218; HOTCHI M, 1972, AM J CLIN PATHOL, V58, P654; IRWIN RS, 1999, IRWIN RIPPES INTENSI, V1, P672; JOHNSTON H, 1989, ARCH INTERN MED, V149, P1666, DOI 10.1001/archinte.149.7.1666; KAUFFMAN CA, 1981, J UROLOGY, V125, P434, DOI 10.1016/S0022-5347(17)55066-1; Kauffman CA, 1999, CLIN INFECT DIS, V29, P231, DOI 10.1086/520190; LEE JH, 1992, CHEST, V102, P990, DOI 10.1378/chest.102.4.990; LEE JH, 1993, CHEST, V103, P1640; MYERS JL, 1995, AM J SURG PATHOL, V19, P1300, DOI 10.1097/00000478-199511000-00011; Nollet AS, 1998, RESP MED, V92, P963, DOI 10.1016/S0954-6111(98)90197-4; NOPPEN M, 1995, EUR RESPIR J, V8, P477, DOI 10.1183/09031936.95.08030477; ORR WA, 1972, J UROLOGY, V107, P1047, DOI 10.1016/S0022-5347(17)61204-7; Puryear Douglas W., 1996, Comprehensive Therapy, V22, P649; ROSENTHAL J, 1983, ARTHRITIS RHEUM, V26, P1065, DOI 10.1002/art.1780260902; Sarosi G A, 1986, Semin Respir Infect, V1, P40; STARKEY GWB, 1978, NEW ENGL J MED, V298, P1353, DOI 10.1056/NEJM197806152982408; VAALER AK, 1990, AM J MED, V89, P470, DOI 10.1016/0002-9343(90)90378-Q; WAIN JC, 1991, NEW ENGL J MED, V324, P1049; WALKER JV, 1977, JAMA-J AM MED ASSOC, V237, P1350, DOI 10.1001/jama.237.13.1350; WHEAT LJ, 1981, ANN INTERN MED, V94, P331, DOI 10.7326/0003-4819-94-3-331	30	6	6	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1475	1482		10.1056/NEJMcpc020014	http://dx.doi.org/10.1056/NEJMcpc020014			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000819				2022-12-28	WOS:000175433200008
J	Altman, DG; Goodman, SN; Schroter, S				Altman, DG; Goodman, SN; Schroter, S			How statistical expertise is used in medical research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				CLINICAL-TRIALS; JOURNALS	Context Investigation of the nature and frequency of statistician involvement in medical research and its relation to the final editorial decision. Methods Authors of original research articles who submitted to BMJ and Annals of Internal Medicine from May through August 2001 were sent a short questionnaire at the time of manuscript submission. Authors were asked if they received assistance from a person with statistical expertise, the nature of any such contribution, and reasons why, if no statistical input was received. Results The response rate was 75% (704/943); methodological input was reported for 514 (73%) of these papers. In 435 papers (85%), such input was provided by biostatisticians or epidemiologists and, if deemed significant, was typically associated with authorship. A total of 33 of 122 methodologists (27%) whose main contribution started at the analysis stage received neither acknowledgment nor authorship. Research without methodological assistance was more likely to be rejected without review (71% vs 57%; chi(2) = 10.6; P=.001) and possibly less likely to be accepted for publication (7% vs 11%; chi(2)=2.37; P=.12). Conclusions Statistical input to medical research is widely recommended but inconsistently obtained. Individuals providing such expertise are often not involved until the analysis of data and many go unrecognized by either authorship or acknowledgment.	Ctr Stat Med, Oxford, England; BMJ, London, England; Johns Hopkins Sch Med, Baltimore, MD USA	University of Oxford; Johns Hopkins University; Johns Hopkins Medicine	Altman, DG (corresponding author), Canc Res Uk NHS Ctr Stat Med, Inst Hlth Sci, Old Rd, Oxford OX3 7LF, England.		Schroter, Sara/G-3427-2012	Schroter, Sara/0000-0002-8791-8564; Goodman, Steven/0000-0002-3872-5723				Altman D G, 1982, Stat Med, V1, P59, DOI 10.1002/sim.4780010109; ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; ALTMAN DG, 1994, JAMA-J AM MED ASSOC, V272, P129, DOI 10.1001/jama.272.2.129; Andersen B, 1990, METHODOLOGICAL ERROR; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; Delgado-Rodriguez M, 2001, J EPIDEMIOL COMMUN H, V55, P569, DOI 10.1136/jech.55.8.569; Goodman SN, 1998, J GEN INTERN MED, V13, P753, DOI 10.1046/j.1525-1497.1998.00227.x; LUYKX HMC, 1949, JAMA-J AM MED ASSOC, V141, P195, DOI 10.1001/jama.1949.62910030004007; Mullner M, 2002, ANN INTERN MED, V136, P122, DOI 10.7326/0003-4819-136-2-200201150-00009; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706	10	87	96	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2817	2820		10.1001/jama.287.21.2817	http://dx.doi.org/10.1001/jama.287.21.2817			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038922	Bronze			2022-12-28	WOS:000176002200019
J	Huwiler-Muntener, K; Juni, P; Junker, C; Egger, M				Huwiler-Muntener, K; Juni, P; Junker, C; Egger, M			Quality of reporting of randomized trials as a measure of methodologic quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				CONSORT STATEMENT; CLINICAL-TRIALS	Context The evaluation of the methodologic quality of randomized controlled trials (RCTs) is central to evidence-based health care. Important methodologic detail may, however, be omitted from published reports, and the quality of reporting is therefore often used as a proxy measure for methodologic quality. We examined the relationship between reporting quality and methodologic quality of published RCTs. Methods Study of 60 reports of placebo-controlled trials published in English-language journals from 1985 to 1997. Reporting quality was measured using a 25-item scale based on the 1996 issue of the Consolidated Standards of Reporting Trials (CONSORT). Concealment of allocation, appropriate blinding, and analysis according to the intention-to-treat principle were indicators of methodologic quality. Methodologic quality was compared between groups of trials defined by reporting quality scores of low, intermediate, and high. Reporting quality scores were compared between groups defined by high and low methodologic quality. Results Among 23 trials of low reporting quality (median score, 9 [range, 3.5-10.5]), allocation concealment was unclear for all but 1 trial, but there were 16 trials (70%) with adequate blinding and 9 trials (39%) that had been analyzed according to the intention-to-treat principle. Among 18 trials of high reporting quality (median score, 18 [range 16.5-22.0]), there were 8 trials (44%) with adequate allocation concealment, 16 trials (89%) with adequate blinding, and 13 trials (72%) analyzed according to the intention-to-treat principle. The median reporting score was 15.0 for the 33 trials that were analyzed according to intention-to-treat principle and 14.5 for the 14 trials with on-treatment analyses (P=.67). Conclusions Similar quality of reporting may hide important differences in methodologic quality, and well-conducted trials may be reported badly. A clear distinction should be made between these 2 dimensions of the quality of RCTs.	Univ Bern, Dept Social & Prevent Med, CH-3012 Bern, Switzerland; Univ Bern, Dept Rheumatol & Clin Immunol, Bern, Switzerland; Univ Bristol, Dept Social Med, MRC, Hlth Serv Res Collaborat, Bristol, Avon, England	University of Bern; University of Bern; University of Bristol	Huwiler-Muntener, K (corresponding author), Univ Bern, Dept Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	huwiler@ispm.unibe.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Egger, Matthias/0000-0001-7462-5132				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Egger E, 1997, LANCET, V350, P326, DOI 10.1016/S0140-6736(97)02419-7; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; HUWILERMUNTENER K, 2000, THESIS U BERN BERN S; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Junker CA, 1998, JAMA-J AM MED ASSOC, V280, P247, DOI 10.1001/jama.280.3.247; LIBERATI A, 1986, J CLIN ONCOL, V4, P942, DOI 10.1200/JCO.1986.4.6.942; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408	14	299	311	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2801	2804		10.1001/jama.287.21.2801	http://dx.doi.org/10.1001/jama.287.21.2801			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038917	Bronze			2022-12-28	WOS:000176002200014
J	Rochon, PA; Bero, LA; Bay, AM; Gold, JL; Dergal, JM; Binns, MA; Streiner, DL; Gurwitz, JH				Rochon, PA; Bero, LA; Bay, AM; Gold, JL; Dergal, JM; Binns, MA; Streiner, DL; Gurwitz, JH			Comparison of review articles published in peer-reviewed and throwaway journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				QUALITY; ANNALS	Context To compare the quality, presentation, readability, and clinical relevance of review articles published in peer-reviewed and "throwaway" journals. Methods We reviewed articles that focused on the diagnosis or treatment of a medical condition published between January 1 and December 31, 1998, in the 5 leading peer-reviewed general medical journals and high-circulation throwaway journals. Reviewers independently assessed the methodologic and reporting quality, and evaluated each article's presentation and readability. Clinical relevance was evaluated independently by 6 physicians. Results Of the 394 articles in our sample, 16 (4.1%) were peer-reviewed systematic reviews, 135 (34.3%) were peer-reviewed nonsystematic reviews, and 243 (61.7%) were nonsystematic reviews published in throwaway journals. The mean (SD) quality scores were highest for peer-reviewed articles (0.94 [0.09] for systematic reviews and 0.30 [0.19] for nonsystematic reviews) compared with throwaway journal articles (0.23 [0.03], F(2,391) =280.8, P<.001). Throwaway journal articles used more tables (P=.02), figures (P=.01), photographs (P<.001), color (P<.001), and larger font sizes (P<.001) compared with peer-reviewed articles. Readability scores were more often in the college or higher range for peer-reviewed journals compared with the throwaway journal articles (104 [77.0%] vs 156 [64.2%]; P=.01). Peer-reviewed article titles were judged less relevant to clinical practice than throwaway journal article titles (P<.001). Conclusions Although lower in methodologic and reporting quality, review articles published in throwaway journals have characteristics that appeal to physician readers.	Univ Toronto, Baycrest Ctr Geriatr Care, Dept Med, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; Univ Toronto, Baycrest Ctr Geriatr Care, Dept Med, Rotman Res Inst, Toronto, ON M6A 2E1, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Univ Calif San Francisco, Sch Pharm, Div Clin Pharm, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Univ Toronto, Dept Psychiat, Toronto, ON, Canada; Univ Massachusetts, Sch Med, Worcester, MA USA; Fallon Healthcare Syst, Meyers Primary Care Inst, Worcester, MA USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University of Massachusetts System; University of Massachusetts Worcester	Rochon, PA (corresponding author), Univ Toronto, Baycrest Ctr Geriatr Care, Dept Med, Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	paula.rochon@utoronto.ca	Rochon, Paula A/J-2918-2016; Binns, Malcolm/AAQ-9195-2020; Streiner, David/E-6563-2011	Rochon, Paula A/0000-0002-5973-4151; Binns, Malcolm/0000-0001-9998-6612; Streiner, David/0000-0003-0610-6271				Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; BOWKER RR, 1998, BOWKER INT SERIALS D; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Cook DJ, 1996, CRIT CARE MED, V24, P1757, DOI 10.1097/00003246-199610000-00026; Davidoff F, 1996, ANN INTERN MED, V124, P67, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00012; Delamothe T, 1996, BRIT MED J, V312, P232; FINKELSTEIN D, 1985, ARCH OPHTHALMOL-CHIC, V103, P1641, DOI 10.1001/archopht.1985.01050110035017; Flanagin A, 1999, JAMA-J AM MED ASSOC, V281, P85, DOI 10.1001/jama.281.1.85; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; GOODMAN NW, 1995, JAMA-J AM MED ASSOC, V273, P1087, DOI 10.1001/jama.1995.03520380023014; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Hunt DL, 1997, ANN INTERN MED, V126, P532, DOI 10.7326/0003-4819-126-7-199704010-00006; MULROW CD, 1987, ANN INTERN MED, V106, P485, DOI 10.7326/0003-4819-106-3-485; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P91, DOI 10.1016/0895-4356(91)90205-N; RENNIE D, 1990, CBE VIEWS, V13, P31; ROBERTS JC, 1994, JAMA-J AM MED ASSOC, V272, P119, DOI 10.1001/jama.272.2.119; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; SOFFER A, 1980, ARCH INTERN MED, V140, P1419, DOI 10.1001/archinte.1980.00330220007004	20	41	42	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2853	2856		10.1001/jama.287.21.2853	http://dx.doi.org/10.1001/jama.287.21.2853			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038932	Bronze			2022-12-28	WOS:000176002200029
J	Copeland, NG; Jenkins, NA; O'Brien, SJ				Copeland, NG; Jenkins, NA; O'Brien, SJ			Genomics: Mmu 16 - Comparative genomic highlights	SCIENCE			English	Editorial Material							MOUSE		NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; NCI, Lab Genome Divers, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Copeland, NG (corresponding author), NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA.	copeland@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; Eizirik E, 2001, J HERED, V92, P212, DOI 10.1093/jhered/92.2.212; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; MURPHY WJ, 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-6-REVIEWS0005; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Stanyon R, 1999, CYTOGENET CELL GENET, V84, P150, DOI 10.1159/000015244; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	10	12	12	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1617	1618		10.1126/science.1073127	http://dx.doi.org/10.1126/science.1073127			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040165				2022-12-28	WOS:000175976200028
J	Korn, D; Rich, RR; Garrison, HH; Golub, SH; Hendrix, MJC; Heinig, SJ; Masters, BS; Turman, RJ				Korn, D; Rich, RR; Garrison, HH; Golub, SH; Hendrix, MJC; Heinig, SJ; Masters, BS; Turman, RJ			Science policy - The NIH budget in the "postdoubting" era	SCIENCE			English	Article									Assoc Amer Med Coll, Washington, DC 20037 USA; Federat Amer Soc Expt Biol, Off Publ Affairs, Bethesda, MD 20814 USA; Federat Amer Soc Expt Biol, Sci Policy Comm, Bethesda, MD 20814 USA; Assoc Amer Univ, Washington, DC 20005 USA	Association of American Medical Colleges; American University	Korn, D (corresponding author), Assoc Amer Med Coll, Washington, DC 20037 USA.	dkorn@aamc.org		Garrison, Howard/0000-0001-9455-3527				*ASS AM MED COLL, 1998, MAX INV; Bray GA, 1999, DIABETES CARE, V22, P623; *GOV PRINT OFF, 2002, FY 2003 PRES BUDG HH, P44; HALEY S, 2000, WASHINGTON FAX  1130; Malakoff D, 2001, SCIENCE, V292, P1992, DOI 10.1126/science.292.5524.1992; MARKS PA, 1994, NIH INTRAUMURAL RES; *NAT CANC I, 2002, H TEM AW PROGR ANN P; *NIH, 2000, NIH GRANTS NEWS; *NIH, ALM APPR; *OFF MAN BUDG, 2002, PRES BUDG FY 2003	10	33	34	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1401	1402		10.1126/science.1072486	http://dx.doi.org/10.1126/science.1072486			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029114				2022-12-28	WOS:000175910300024
J	Husmann, A; Betts, JB; Boebinger, GS; Migliori, A; Rosenbaum, TF; Saboungi, ML				Husmann, A; Betts, JB; Boebinger, GS; Migliori, A; Rosenbaum, TF; Saboungi, ML			Megagauss sensors	NATURE			English	Article							LARGE MAGNETORESISTANCE; VIOLATION; RULE	Magnetic fields change the way that electrons move through solids. The nature of these changes reveals information about the electronic structure of a material and, in auspicious circumstances, can be harnessed for applications. The silver chalcogenides, Ag2Se and Ag2Te, are non-magnetic materials, but their electrical resistance can be made very sensitive to magnetic field by adding small amounts-just 1 part in 10, 000-of excess silver(1-4). Here we show that the resistance of Ag2Se displays a large, nearly linear increase with applied magnetic field without saturation to the highest fields available, 600,000 gauss, more than a million times the Earth's magnetic field. These characteristics of large (thousands of per cent) and near-linear response over a large letters to nature field range make the silver chalcogenides attractive as magnetic-field sensors, especially in physically tiny megagauss (10(6) G) pulsed magnets where large fields have been produced but accurate calibration has proved elusive. High-field studies at low temperatures reveal both oscillations in the magnetoresistance and a universal scaling form that point to a quantum origin(5,6) for this material's unprecedented behaviour.	Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Los Alamos Natl Lab, Natl High Magnet Field Lab, Los Alamos, NM 87545 USA; Argonne Natl Lab, Argonne, IL 60439 USA; CNRS, CRMD, Orleans 2, France	University of Chicago; University of Chicago; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Centre National de la Recherche Scientifique (CNRS)	Rosenbaum, TF (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.		Saboungi, Marie-Louise/C-5920-2013; Migliori, Albert/F-6961-2015	Saboungi, Marie-Louise/0000-0002-0607-4815; 				Abrikosov AA, 1998, PHYS REV B, V58, P2788, DOI 10.1103/PhysRevB.58.2788; Abrikosov AA, 2000, EUROPHYS LETT, V49, P789, DOI 10.1209/epl/i2000-00220-2; Aliev F. F., 1985, IAN SSSR NEORG MATER, V21, P1869; Boebinger GS, 2001, PHYSICA B, V294, P512, DOI 10.1016/S0921-4526(00)00712-2; Chuprakov IS, 1998, APPL PHYS LETT, V72, P2165, DOI 10.1063/1.121309; Drndic M, 1998, APPL PHYS LETT, V72, P2906, DOI 10.1063/1.121455; HARRIS JM, 1995, PHYS REV LETT, V75, P1391, DOI 10.1103/PhysRevLett.75.1391; HERRING C, 1960, J APPL PHYS, V31, P1939, DOI 10.1063/1.1735477; Kohler M, 1938, ANN PHYS-BERLIN, V32, P211; Mackay K, 2000, J APPL PHYS, V87, P1996, DOI 10.1063/1.372126; McKenzie RH, 1998, PHYS REV B, V57, P11854, DOI 10.1103/PhysRevB.57.11854; Ogorelec Z, 1999, EUROPHYS LETT, V46, P56, DOI 10.1209/epl/i1999-00562-1; Pippard A., 1989, MAGNETORESISTANCE ME; Schnyders HS, 2000, APPL PHYS LETT, V76, P1710, DOI 10.1063/1.126144; TRITTON DJ, 1977, PHYSICAL FLUID DYNAM; von Ortenberg M, 2001, PHYSICA B, V294, P568, DOI 10.1016/S0921-4526(00)00722-5; Xu R, 1997, NATURE, V390, P57, DOI 10.1038/36306	17	175	178	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					421	424		10.1038/417421a	http://dx.doi.org/10.1038/417421a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024208				2022-12-28	WOS:000175730900033
J	Tanda, S; Tsuneta, T; Okajima, Y; Inagaki, K; Yamaya, K; Hatakenaka, N				Tanda, S; Tsuneta, T; Okajima, Y; Inagaki, K; Yamaya, K; Hatakenaka, N			Crystal topology: A Mobius strip of single crystals - A crystalline ribbon of niobium and selenium can be coaxed into a novel topology.	NATURE			English	Article							CARBON; PHASE		Hokkaido Univ, Dept Appl Phys, Sapporo, Hokkaido 0608628, Japan; NTT Corp, Basic Res Labs, Kanagawa 2430198, Japan	Hokkaido University; Nippon Telegraph & Telephone Corporation	Tanda, S (corresponding author), Hokkaido Univ, Dept Appl Phys, Sapporo, Hokkaido 0608628, Japan.	tanda@ang.hokudai.ac.jp	Inagaki, Katsuhiko/AAF-6107-2019	Inagaki, Katsuhiko/0000-0001-6840-5643				Ando T, 1998, J PHYS SOC JPN, V67, P2857, DOI 10.1143/JPSJ.67.2857; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Hayashi M, 2001, J PHYS SOC JPN, V70, P3495, DOI 10.1143/JPSJ.70.3495; Hearmon R.F.S., 1961, INTRO APPL ANISOTROP; HYDE ST, 1993, PHYS CHEM MINER, V20, P190; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Kaneda K, 2001, PHYS REV LETT, V86, P2134, DOI 10.1103/PhysRevLett.86.2134; Mila F, 1998, PHYS REV B, V57, P1457, DOI 10.1103/PhysRevB.57.1457; Monceau P., 1985, ELECT PROPERTIES INO; TSUTSUMI K, 1977, PHYS REV LETT, V39, P1675, DOI 10.1103/PhysRevLett.39.1675; VOLOGODSKII AV, 1979, NATURE, V280, P294, DOI 10.1038/280294a0; WALBA DM, 1982, J AM CHEM SOC, V104, P3219, DOI 10.1021/ja00375a051; WHITE JH, 1969, AM J MATH, V91, P693, DOI 10.2307/2373348	13	192	195	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					397	398		10.1038/417397a	http://dx.doi.org/10.1038/417397a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024204				2022-12-28	WOS:000175730900027
J	Devlin, JP; Uras, N; Sadlej, J; Buch, V				Devlin, JP; Uras, N; Sadlej, J; Buch, V			Discrete stages in the solvation and ionization of hydrogen chloride adsorbed on ice particles	NATURE			English	Article							INFRARED-SPECTRA; ACID IONIZATION; WATER CLUSTERS; HCL; SURFACE; HCL(H2O)(N); ADSORPTION; MOLECULES; MECHANISM; MODEL	Ionization and dissociation reactions play a fundamental role in aqueous chemistry. A basic and well-understood example is the reaction between hydrogen chloride (HCl) and water to form chloride ions (Cl-) and hydrated protons (H3O+ or H5O2+). This acid ionization process also occurs in small water clusters(1-4) and on ice surfaces(5-17), and recent attention has focused on the mechanism of this reaction in confined-water media and the extent of solvation needed for it to proceed(1-4,9,15-17). In fact, the transformation of HCl adsorbed on ice surfaces from a predominantly molecular form to ionic species during heating from 50 to 140 K has been observed(8,13,14). But the molecular details of this process remain poorly understood. Here we report infrared transmission spectroscopic signatures of distinct stages in the solvation and ionization of HCl adsorbed on ice nanoparticles kept at progressively higher temperatures. By using Monte Carlo and ab initio simulations to interpret the spectra, we are able to identify slightly stretched HCl molecules, strongly stretched molecules on the verge of ionization, contact ion pairs comprising H3O+ and Cl-, and an ionic surface phase rich in Zundel ions, H5O2+.	Hebrew Univ Jerusalem, Fritz Haber Inst Mol Dynam, IL-91904 Jerusalem, Israel; Drug Inst, PL-00725 Warsaw, Poland; Univ Warsaw, Dept Chem, PL-02093 Warsaw, Poland; Oklahoma State Univ, Dept Chem, Stillwater, OK 74078 USA	Hebrew University of Jerusalem; Max Planck Society; University of Warsaw; Oklahoma State University System; Oklahoma State University - Stillwater	Buch, V (corresponding author), Hebrew Univ Jerusalem, Fritz Haber Inst Mol Dynam, IL-91904 Jerusalem, Israel.	viki@fh.huji.ac.il	Aytemiz, Nevin/B-2188-2017	Aytemiz, Nevin/0000-0001-5127-3568				AGMON N, 1995, CHEM PHYS LETT, V244, P456, DOI 10.1016/0009-2614(95)00905-J; Allouche A, 2000, J PHYS CHEM B, V104, P1497, DOI 10.1021/jp991370g; Ando K, 1997, J PHYS CHEM B, V101, P10464, DOI 10.1021/jp970173j; Bacelo DE, 1999, J PHYS CHEM A, V103, P4631, DOI 10.1021/jp9843003; Banham SF, 1995, FARADAY DISCUSS, V100, P321, DOI 10.1039/fd9950000321; Chaban GM, 2001, J PHYS CHEM A, V105, P8323, DOI 10.1021/jp011567k; CHU LT, 1993, J PHYS CHEM-US, V97, P7779, DOI 10.1021/j100131a057; DELZEIT L, 1993, J PHYS CHEM-US, V97, P10312, DOI 10.1021/j100142a009; Devlin JP, 2000, J PHYS CHEM A, V104, P1974, DOI 10.1021/jp994416e; DEVLIN JP, 1995, J PHYS CHEM-US, V99, P16534, DOI 10.1021/j100045a010; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Frisch M. J., 1998, GAUSSIAN 98; Gertner BJ, 1998, FARADAY DISCUSS, V110, P301, DOI 10.1039/a801721b; GRAHAM JD, 1995, GEOPHYS RES LETT, V22, P251, DOI 10.1029/94GL03022; HANSON DR, 1992, J PHYS CHEM-US, V96, P2682, DOI 10.1021/j100185a052; HORN AB, 1992, J CHEM SOC FARADAY T, V88, P1077, DOI 10.1039/ft9928801077; Isakson MJ, 1999, J PHYS CHEM A, V103, P2044, DOI 10.1021/jp984106g; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kang H, 2000, J AM CHEM SOC, V122, P9842, DOI 10.1021/ja000218l; LUNDGREN JO, 1967, ACTA CRYSTALLOGR, V23, P966, DOI 10.1107/S0365110X6700413X; Mantz YA, 2001, CHEM PHYS LETT, V348, P285, DOI 10.1016/S0009-2614(01)01103-4; PACKER MJ, 1995, J PHYS CHEM-US, V99, P14323, DOI 10.1021/j100039a020; Re S, 1998, J CHEM PHYS, V109, P973, DOI 10.1063/1.476640; Robertson SH, 1995, FARADAY DISCUSS, V100, P309, DOI 10.1039/fd9950000309; Svanberg M, 2000, J PHYS CHEM A, V104, P5787, DOI 10.1021/jp0012698; Uras N, 2000, J PHYS CHEM B, V104, P9203, DOI 10.1021/jp0017240; VOTAVA C, 1983, J CHEM PHYS, V78, P6841, DOI 10.1063/1.444630; Zundel G, 2000, ADV CHEM PHYS, V111, P1	28	171	171	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					269	271		10.1038/417269a	http://dx.doi.org/10.1038/417269a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015598				2022-12-28	WOS:000175592100042
J	Connor, J; Norton, R; Ameratunga, S; Robinson, E; Civil, I; Dunn, R; Bailey, J; Jackson, R				Connor, J; Norton, R; Ameratunga, S; Robinson, E; Civil, I; Dunn, R; Bailey, J; Jackson, R			Driver sleepiness and risk of serious injury to car occupants: population based case control study	BRITISH MEDICAL JOURNAL			English	Article							ATTRIBUTABLE RISK; WORK HOURS; ACCIDENTS; CRASHES; DEPRIVATION	Objectives To estimate the contribution of driver sleepiness to the causes of car crash injuries. Design Population based case control study. Setting Auckland region of New Zealand, April 1998 to July 1999. Participants 571 car drivers involved in crashes where at least one occupant was admitted to hospital or killed ("injury crash"); 588 car drivers recruited while driving on public roads (controls), representative of all time spent driving in the study region during the study period. Main outcome measures Relative risk for injury crash associated with driver characteristics related to sleep, and the population attributable risk for driver sleepiness. Results There was a strong association between measures of acute sleepiness and the risk of an injury crash. After adjustment for major confounders significantly increased risk was associated with drivers who identified themselves as sleepy (Stanford sleepiness score 4-7 v 1-3; odds ratio 8.2, 95% confidence interval 3.4 to 19.7); with drivers who reported five hours or less of sleep in the previous 24 hours compared with more than five hours (2.7, 1.4 to 5.4); and with driving between 2 am and 5 am compared with other times of day (5.6, 1.4 to 22.7 No increase in risk was associated with measures of chronic sleepiness. The population attributable risk for driving with one or more of the acute sleepiness risk factors was 19% (15% to 25%). Conclusions Acute sleepiness in car drivers significantly increases the risk of a crash in which a car occupant is injured or killed. Reductions in road traffic injuries may be achieved if fewer people drive when they are sleepy or have been deprived of sleep or drive between 2 am and 5 am.	Univ Auckland, Div Community Hlth, Auckland 1, New Zealand; Univ Sydney, Inst Int Hlth, Newtown, NSW, Australia; Auckland Hosp, Dept Surg, Auckland, New Zealand; Univ Auckland, Dept Civil & Environm Engn, Auckland 1, New Zealand; Bailey Partnership, Porirua 6006, New Zealand	University of Auckland; University of Sydney; Auckland City Hospital; University of Auckland	Connor, J (corresponding author), Univ Auckland, Div Community Hlth, Private Bag 92019, Auckland 1, New Zealand.			Civil, Ian/0000-0002-1371-1114; Jackson, Rod/0000-0001-5914-6934; Connor, Jennie/0000-0002-3209-8693; Ameratunga, Shanthi/0000-0001-8042-2251				Akerstedt T, 1995, J SLEEP RES, V4, P1, DOI 10.1111/j.1365-2869.1995.tb00219.x; Akerstedt T, 1995, J SLEEP RES, V4, P15, DOI 10.1111/j.1365-2869.1995.tb00221.x; BENICHOU J, 1991, STAT MED, V10, P1753, DOI 10.1002/sim.4780101113; BONNET MH, 2000, PRINCIPLES PRACTICE; CHERVIN R, 2000, PRINCIPLES PRACTICE; Connor J, 2001, SLEEP, V24, P688, DOI 10.1093/sleep/24.6.688; Connor J, 2001, ACCIDENT ANAL PREV, V33, P31, DOI 10.1016/S0001-4575(00)00013-0; COUGHLIN SS, 1994, EPIDEMIOL REV, V16, P51, DOI 10.1093/oxfordjournals.epirev.a036144; Cummings P, 2001, Inj Prev, V7, P194, DOI 10.1136/ip.7.3.194; DINGES DF, 1991, SLEEP SLEEPINESS PER, P98; *EXP PAN DRIV FAT, 1997, DROWES DRIV AUT CRAS; *EXP PAN DRIV FAT, 1997, DROWS DRIV AUT CRASH; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; JOHNS M, 1991, SLEEP, V14, P54; *LAND TRANSP SAF A, 1998, ACC INV SYST AIS 199; LEGER D, 1994, SLEEP, V17, P84, DOI 10.1093/sleep/17.1.84; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; MAYCOCK G, 1995, DRIVER SLEEPINESS FA, P39; Philip P, 2001, BRIT MED J, V322, P829, DOI 10.1136/bmj.322.7290.829; Philip P, 1999, SLEEP, V22, P475, DOI 10.1093/sleep/22.4.475; Pierce RJ, 1999, AUST NZ J MED, V29, P658, DOI 10.1111/j.1445-5994.1999.tb01613.x; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; ROEHRS T, 2000, PRINCIPLES PRACTICE; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104	25	461	480	0	39	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1125	1128A		10.1136/bmj.324.7346.1125	http://dx.doi.org/10.1136/bmj.324.7346.1125			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003884	Green Published, Bronze			2022-12-28	WOS:000175622800018
J	d'Oliveira, AFPL; Diniz, SG; Schraiber, LB				d'Oliveira, AFPL; Diniz, SG; Schraiber, LB			Violence against women in health-care institutions: an emerging problem	LANCET			English	Article							PHYSICIANS; SERVICES; RATES	Maternal morbidity and mortality in childbirth is a matter of utmost importance in public health. In this article, we argue that part of the problem lies in violence committed by health workers in childbearing or abortion services, which affects health-service access, compliance, quality, and effectiveness. We analysed rigorous research from the past decade and discuss four forms of violent abuse by doctors and nurses: neglect and verbal, physical, and sexual abuse. These forms of violence recur, are often deliberate, are a serious violation of human rights, and are related to poor quality and effectiveness of health-care services. This abuse is a means of controlling patients that is learnt during training and reinforced in health facilities. Abuse occurs mainly in situations in which the legitimacy of health services is questionable or can be the result of prejudice against certain population groups. We discuss ways to prevent violent abuse.	Univ Sao Paulo, Sch Med, Dept Prevent Med, Gender Violence & Hlth Res Grp, Sao Paulo, Brazil; Feminist Collect Sexual & Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo	Schraiber, LB (corresponding author), Univ Sao Paulo, Fac Med, Dept Prevent Med, Av Dr Arnaldo,455 2nd Andar, BR-01246903 Sao Paulo, SP, Brazil.	lilia@usp.br	d'Oliveira, Ana Flavia Pires Lucas/K-6813-2016; Diniz, Carmen S G/H-4129-2013; Schraiber, Lilia B/B-5708-2014					Ahmad K, 1999, LANCET, V354, P659, DOI 10.1016/S0140-6736(05)77648-0; ALVES MT, 2000, AVALIACAO QUALIDADE; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; BERQUO E, 1995, FECUNDIDADE SAUDE RE, V1; Campos T P, 2000, Cad Saude Publica, V16, P411, DOI 10.1590/S0102-311X2000000200011; CRUZ CR, 2000, DERECHOS MUJERES DER, P115; DEBRUYN M, 2001, VIOLENCE PREGNANCY A; Dehlendorf CE, 1998, JAMA-J AM MED ASSOC, V279, P1883, DOI 10.1001/jama.279.23.1883; DINIZ CSG, 2001, THESIS SAO PAULO U B; Diniz SG, 1998, INT J GYNECOL OBSTET, V63, pS33, DOI 10.1016/S0020-7292(98)00182-9; DOLIVEIRA AFP, 1999, QUESTOES SAUDE REPRO; FARY T, 1992, BRIT MED J, V304, P1519; FAYAD M, 2000, FEMALE GENITAL MUTIL; Frank MW, 1999, JAMA-J AM MED ASSOC, V282, P485, DOI 10.1001/jama.282.5.485; GILSON L, 1994, SOC SCI MED, V39, P767, DOI 10.1016/0277-9536(94)90038-8; GOMES MAS, 1995, ASPECTOS QUALIDADE A; JAFFRE Y, 1994, SOC SCI MED, V38, P1069, DOI 10.1016/0277-9536(94)90224-0; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Judd K., 1998, NEGOTIATING REPROD R; Kisa A, 1996, Health Serv Manage Res, V9, P243; KITZINGER A, 1997, CHILDBIRTH AUTHORITA, P209; *LACWHN UNFPA, 1998, SEX REPR HLTH MATT R; LAMONT JA, 1994, CAN MED ASSOC J, V150, P1433; *LAT AM CAR COMM D, 1998, SIL COMPL VIOL CONTR; *LAT AM CAR COMM D, 1999, NAD PERS REP DER HUM; MATHAI M, 1997, THESIS U CAPE TOWN; McPhedran Marilou, 1996, World Health Statistics Quarterly, V49, P154; Murray SF, 2000, BRIT MED J, V321, P1501, DOI 10.1136/bmj.321.7275.1501; NOGUEIRA MI, 1994, ASSISTENCIA PRENATAL; *PAN I, 2001, BIRTH RIGHTS NEW APP; PITTMAN P, 1995, REV MUJER SALUD, V3, P19; SARGENT C, 1992, SOC SCI MED, V35, P1225, DOI 10.1016/0277-9536(92)90176-Q; Schreier HJ, 1999, EXTREMOPHILES, V3, P11, DOI 10.1007/s007920050094; Shaikh M A, 2000, J Pak Med Assoc, V50, P130; Solo J, 2000, REPROD HEALTH MATTER, V8, P45, DOI 10.1016/S0968-8080(00)90005-3; SOUZA EM, 1992, SERIE TEXTOS, V7; Thomasson GO, 1999, JAMA-J AM MED ASSOC, V281, P419, DOI 10.1001/jama.281.5.419; Wood K, 1997, ADOLESCENT SEX CONTR; World Health Organization, 1998, WORLD HLTH DAY SAF M	39	163	181	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1681	1685		10.1016/S0140-6736(02)08592-6	http://dx.doi.org/10.1016/S0140-6736(02)08592-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551ZF	12020546				2022-12-28	WOS:000175593300029
J	Neutel, AM; Heesterbeek, JAP; de Ruiter, PC				Neutel, AM; Heesterbeek, JAP; de Ruiter, PC			Stability in real food webs: Weak links in long loops	SCIENCE			English	Article							ECOLOGY; FIELD	Increasing evidence that the strengths of interactions among populations in biological communities form patterns that are crucial for system stability requires clarification of the precise form of these patterns, how they come about, and why they influence stability. We show that in real food webs, interaction strengths are organized in trophic loops in such a way that long loops contain relatively many weak links. We show and explain mathematically that this patterning enhances stability, because it reduces maximum "loop weight" and thus reduces the amount of intraspecific interaction needed for matrix stability. The patterns are brought about by biomass pyramids, a feature common to most ecosystems. Incorporation of biomass pyramids in 104 food-web descriptions reveals that the tow weight of the tong loops stabilizes complex food webs. Loop-weight analysis could be a useful toot for exploring the structure and organization of complex communities.	Univ Utrecht, Dept Environm Sci, NL-3508 TC Utrecht, Netherlands; Univ Utrecht, Fac Vet Med, Quantitat Vet Epidemiol Grp, NL-3508 TD Utrecht, Netherlands	Utrecht University; Utrecht University	Neutel, AM (corresponding author), Univ Utrecht, Dept Environm Sci, POB 80115, NL-3508 TC Utrecht, Netherlands.	a.neutel@geog.uu.nl						Cohen J.E., 1990, COMMUNITY FOOD WEBS; de Ruiter PC, 1998, APPL SOIL ECOL, V10, P217, DOI 10.1016/S0929-1393(98)00121-8; DERUITER PC, 1993, PLANT SOIL, V157, P263, DOI 10.1007/BF00011055; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; Hall S. J., 1993, V24, P187; HOFBAUER J, 1988, THEORY EVOLUTION DYN, P193; HUNT HW, 1987, BIOL FERT SOILS, V3, P57, DOI 10.1007/BF00260580; KRASNOSELSKIJ J, 1989, POSITIVE LINEAR SYST, P169; LAWTON JH, 1992, NATURE, V355, P19, DOI 10.1038/355019a0; Levins R, 1977, LECT NOTES BIOMATH, V18, P153; LOGOFET DO, 1993, MATRICES GRAPHS STAB, P128; May R.M., 1973, STABILITY COMPLEXITY; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; MENGE BA, 1994, ECOL MONOGR, V64, P249, DOI 10.2307/2937163; Moore JC, 1996, ECOLOGY, V77, P694, DOI 10.2307/2265494; MOORE JC, 1988, ANNU REV ENTOMOL, V33, P419, DOI 10.1146/annurev.en.33.010188.002223; ODUM E P, 1971, P574; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; POLIS GA, 1994, AUST J ECOL, V19, P121; WOOTTON JT, 1994, ECOLOGY, V75, P151, DOI 10.2307/1939391; Yodzis P., 1989, INTRO THEORETICAL EC	23	510	528	3	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1120	1123		10.1126/science.1068326	http://dx.doi.org/10.1126/science.1068326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004131	Green Submitted			2022-12-28	WOS:000175565000054
J	Ganichev, SD; Ivchenko, EL; Bel'kov, VV; Tarasenko, SA; Sollinger, M; Weiss, D; Wegscheider, W; Prettl, W				Ganichev, SD; Ivchenko, EL; Bel'kov, VV; Tarasenko, SA; Sollinger, M; Weiss, D; Wegscheider, W; Prettl, W			Spin-galvanic effect	NATURE			English	Article							ELECTRON-GAS; RELAXATION; INJECTION; SEMICONDUCTORS; TRANSPORT	There is much recent interest in exploiting the spin of conduction electrons in semiconductor heterostructures together with their charge to realize new device concepts(1). Electrical currents are usually generated by electric or magnetic fields, or by gradients of, for example, carrier concentration or temperature. The electron spin in a spin-polarized electron gas can, in principle, also drive an electrical current, even at room temperature, if some general symmetry requirements are met. Here we demonstrate such a 'spin-galvanic' effect in semiconductor heterostructures, induced by a non-equilibrium, but uniform population of electron spins. The microscopic origin for this effect is that the two electronic sub-bands for spin-up and spin-down electrons are shifted in momentum space and, although the electron distribution in each sub-band is symmetric, there is an inherent asymmetry in the spin-flip scattering events between the two sub-bands. The resulting current flow has been detected by applying a magnetic field to rotate an optically oriented non-equilibrium spin polarization in the direction of the sample plane. In contrast to previous experiments, where spin-polarized currents were driven by electric fields in semiconductor(2,3),we have here the complementary situation where electron spins drive a current without the need of an external electric field.	Univ Regensburg, Fak Phys, D-93040 Regensburg, Germany; RAS, AF Ioffe Physicotech Inst, St Petersburg 194021, Russia; Tech Univ Munich, Walter Schottky Inst, D-85748 Garching, Germany	University of Regensburg; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Technical University of Munich	Ganichev, SD (corresponding author), Univ Regensburg, Fak Phys, D-93040 Regensburg, Germany.	sergey.ganichev@physik.uni-regensburg.de	Wegscheider, Werner H/D-1493-2010; Tarasenko, Sergey/E-6071-2014; Ivchenko, Eugeniyus Levovich/C-4320-2014; Weiss, Dieter/G-4883-2016; Bel'kov, Vasily V/E-4363-2014	Weiss, Dieter/0000-0002-9630-9787; 				ANDRIANOV AV, 1984, JETP LETT+, V40, P882; AVERKIEV NS, 1983, SOV PHYS SEMICOND+, V17, P393; AVERKIEV NS, 2002, CONDMAT0202437; DAMEN TC, 1991, PHYS REV LETT, V67, P3432, DOI 10.1103/PhysRevLett.67.3432; DYAKONOV MI, 1986, SOV PHYS SEMICOND+, V20, P110; Fiederling R, 1999, NATURE, V402, P787, DOI 10.1038/45502; Ganichev SD, 1999, PHYSICA B, V273-4, P737, DOI 10.1016/S0921-4526(99)00637-7; Ganichev SD, 2001, PHYS REV LETT, V86, P4358, DOI 10.1103/PhysRevLett.86.4358; Hagele D, 1998, APPL PHYS LETT, V73, P1580, DOI 10.1063/1.122210; Hammar PR, 2001, APPL PHYS LETT, V79, P2591, DOI 10.1063/1.1408270; Hanbicki AT, 2002, APPL PHYS LETT, V80, P1240, DOI 10.1063/1.1449530; Hanle W, 1924, Z PHYS, V30, P93, DOI 10.1007/BF01331827; Ivchenko E. L., 1990, Soviet Physics - JETP, V71, P550; Ivchenko EL, 1997, SOLID STATE COMMUN, V102, P375, DOI 10.1016/S0038-1098(97)00009-4; IVCHENKO EL, 1989, SOLID STATE COMMUN, V69, P663, DOI 10.1016/0038-1098(89)90057-4; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Kikkawa JM, 1999, NATURE, V397, P139, DOI 10.1038/16420; Kikkawa JM, 1997, SCIENCE, V277, P1284, DOI 10.1126/science.277.5330.1284; Koopmans B, 1998, PHYS STATUS SOLIDI B, V205, P419, DOI 10.1002/(SICI)1521-3951(199802)205:2<419::AID-PSSB419>3.0.CO;2-M; Marie X, 1999, PHYS REV B, V60, P5811, DOI 10.1103/PhysRevB.60.5811; MEIER F, 1984, OPTICAL ORIENTATION, P1; Sandhu JS, 2001, PHYS REV LETT, V86, P2150, DOI 10.1103/PhysRevLett.86.2150; TARASENKO SA, 2002, CONDMAT0202471; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Zhu HJ, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.016601; Zutic I, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.066603	27	397	401	8	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					153	156		10.1038/417153a	http://dx.doi.org/10.1038/417153a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000954				2022-12-28	WOS:000175460200037
J	Lelouard, H; Gatti, E; Cappello, F; Gresser, O; Camosseto, V; Pierre, P				Lelouard, H; Gatti, E; Cappello, F; Gresser, O; Camosseto, V; Pierre, P			Transient aggregation of ubiquitinated proteins during dendritic cell maturation	NATURE			English	Article							NEWLY SYNTHESIZED PROTEINS; PEPTIDE LIGANDS; IN-VIVO; PROTEASOME; ANTIGEN; DEGRADATION; AGGRESOMES; BIOLOGY	Dendritic cells (DCs) are antigen-presenting cells with the unique capacity to initiate primary immune responses(1). Dendritic cells have a remarkable pattern of differentiation (maturation) that exhibits highly specific mechanisms to control antigen presentation restricted by major histocompatibility complex (MHC)(2). MHC class I molecules present to CD8(+) cytotoxic T cells peptides that are derived mostly from cytosolic proteins, which are ubiquitinated and then degraded by the proteasome(3,4). Here we show that on inflammatory stimulation, DCs accumulate newly synthesized ubiquitinated proteins in large cytosolic structures. These structures are similar to, but distinct from, aggresomes and inclusion bodies observed in many amyloid diseases(5,6). Notably, these dendritic cell aggresome-like induced structures (DALIS) are transient, require continuous protein synthesis and do not affect the ubiquitin-proteasome pathway. Our observations suggest the existence of an organized prioritization of protein degradation in stimulated DCs, which is probably important for regulating MHC class I presentation during maturation.	Univ Med, CNRS, INSERM, Ctr Immunol Marseille Luminy, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pierre, P (corresponding author), Univ Med, CNRS, INSERM, Ctr Immunol Marseille Luminy, Campus Luminy,Case 906, F-13288 Marseille 09, France.		Gatti, Evelina/B-7941-2012; Lelouard, Hugues/R-7985-2019	Gatti, Evelina/0000-0002-0667-0799; Lelouard, Hugues/0000-0002-9205-5011; pierre, philippe/0000-0003-0863-8255				Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bogyo M, 1998, CHEM BIOL, V5, P307, DOI 10.1016/S1074-5521(98)90169-7; BRODSKY FM, 1982, J IMMUNOL, V128, P129; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Gatti E, 2000, J IMMUNOL, V164, P3600, DOI 10.4049/jimmunol.164.7.3600; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hirsch C, 2000, TRENDS CELL BIOL, V10, P268, DOI 10.1016/S0962-8924(00)01768-2; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; STAUFENBIEL M, 1984, J CELL BIOL, V98, P1886, DOI 10.1083/jcb.98.5.1886; Thery C, 2001, CURR OPIN IMMUNOL, V13, P45, DOI 10.1016/S0952-7915(00)00180-1; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Yewdell JW, 2001, CURR OPIN IMMUNOL, V13, P13, DOI 10.1016/S0952-7915(00)00175-8; Yewdell JW, 2001, J CELL SCI, V114, P845	29	148	152	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					177	182		10.1038/417177a	http://dx.doi.org/10.1038/417177a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000969				2022-12-28	WOS:000175460200044
J	Ben-Yehuda, S; Losick, R				Ben-Yehuda, S; Losick, R			Asymmetric cell division in B-subtilis involves a spiral-like intermediate of the cytokinetic protein FtsZ	CELL			English	Article							ESCHERICHIA-COLI-CELLS; BACILLUS-SUBTILIS; SPORULATION; TRANSCRIPTION; SPOIIE; LOCALIZATION; ACTIVATION; SEPTATION; MUTANTS; RING	A fundamental feature of development in the spore-forming bacterium Bacillus subtilis is the switch from medial to asymmetric division. The switch is brought about by a change in the location of the cytokinetic Z ring, which is composed of the tubulin-like protein FtsZ, from the cell middle to the poles during sporulation. We report that the medial Z ring is replaced by a spiral-like filament of FtsZ that grows along the long axis of the cell. We propose that the filament mediates the switch by redeploying FtsZ to the poles. Spiral formation and the switch to polar Z rings are largely caused by a sporulation-specific increase in transcription of the gene for FtsZ and activation of the gene for the FtsZ-assoclated protein SpollE.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Losick, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018568, R01GM018568] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 18568] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Addinall SG, 1996, J BACTERIOL, V178, P7167, DOI 10.1128/jb.178.24.7167-7172.1996; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Barak I, 1996, J BACTERIOL, V178, P4984, DOI 10.1128/jb.178.16.4984-4989.1996; Barak I, 1998, J BACTERIOL, V180, P5327; DUBNAU D, 1971, J MOL BIOL, V56, P209, DOI 10.1016/0022-2836(71)90460-8; DUNN G, 1976, J BACTERIOL, V125, P776, DOI 10.1128/JB.125.3.776-779.1976; Eichenberger P, 2001, MOL MICROBIOL, V42, P1147, DOI 10.1046/j.1365-2958.2001.02660.x; Erickson HP, 1998, TRENDS CELL BIOL, V8, P133, DOI 10.1016/S0962-8924(98)01237-9; Erickson HP, 2000, J CELL BIOL, V148, P1103, DOI 10.1083/jcb.148.6.1103; Erickson HP, 1997, TRENDS CELL BIOL, V7, P362, DOI 10.1016/S0962-8924(97)01108-2; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Flardh K, 2000, MOL MICROBIOL, V38, P737, DOI 10.1046/j.1365-2958.2000.02177.x; GHOLAMHOSEINIAN A, 1992, J BACTERIOL, V174, P4647, DOI 10.1128/JB.174.14.4647-4656.1992; GONZYTREBOUL G, 1992, J MOL BIOL, V224, P967, DOI 10.1016/0022-2836(92)90463-T; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hatt JK, 1998, J BACTERIOL, V180, P3584, DOI 10.1128/JB.180.14.3584-3591.1998; HORVITZ HR, 1992, CELL, V68, P237, DOI 10.1016/0092-8674(92)90468-R; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Kelly AJ, 1998, GENE DEV, V12, P880, DOI 10.1101/gad.12.6.880; Khvorova A, 1998, J BACTERIOL, V180, P1256, DOI 10.1128/JB.180.5.1256-1260.1998; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Kwak J, 2001, J BACTERIOL, V183, P5092, DOI 10.1128/JB.183.17.5092-5101.2001; Levin PA, 1999, P NATL ACAD SCI USA, V96, P9642, DOI 10.1073/pnas.96.17.9642; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; LEWIS PJ, 1994, P NATL ACAD SCI USA, V91, P3849, DOI 10.1073/pnas.91.9.3849; Lu C, 2001, BMC Microbiol, V1, P7, DOI 10.1186/1471-2180-1-7; Lu CL, 2000, J BACTERIOL, V182, P164, DOI 10.1128/JB.182.1.164-170.2000; Lucet I, 2000, EMBO J, V19, P1467, DOI 10.1093/emboj/19.7.1467; Lutkenhaus J, 1997, ANNU REV BIOCHEM, V66, P93, DOI 10.1146/annurev.biochem.66.1.93; Ma XL, 1997, J BACTERIOL, V179, P6788, DOI 10.1128/jb.179.21.6788-6797.1997; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 2000, FEMS MICROBIOL REV, V24, P531, DOI 10.1016/S0168-6445(00)00038-3; Mileykovskaya E, 1998, J BACTERIOL, V180, P4252, DOI 10.1128/JB.180.16.4252-4257.1998; Parker GF, 1996, MICROBIOL-UK, V142, P3445, DOI 10.1099/13500872-142-12-3445; PIGGOT PJ, 1976, BACTERIOL REV, V40, P908, DOI 10.1128/MMBR.40.4.908-962.1976; PIGGOT PJ, 2001, BACILLUS SUBTILIS IT, P483; Pogliano J, 1999, MOL MICROBIOL, V31, P1149, DOI 10.1046/j.1365-2958.1999.01255.x; Rudner DZ, 1999, P NATL ACAD SCI USA, V96, P14765, DOI 10.1073/pnas.96.26.14765; Sambrook J., 2002, MOL CLONING LAB MANU; Schwedock J, 1997, MOL MICROBIOL, V25, P847, DOI 10.1111/j.1365-2958.1997.mmi507.x; STERLINI JM, 1969, BIOCHEM J, V113, P29, DOI 10.1042/bj1130029; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; YOUNGMAN P, 1984, PLASMID, V12, P1, DOI 10.1016/0147-619X(84)90061-1	47	250	257	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					257	266		10.1016/S0092-8674(02)00698-0	http://dx.doi.org/10.1016/S0092-8674(02)00698-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007411	Bronze			2022-12-28	WOS:000175082600014
J	Altman, DG				Altman, DG			Poor-quality medical research - What can journals do?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RANDOMIZED CONTROLLED TRIALS; CLINICAL-TRIALS; STATISTICS; INTERVENTION; DEPRESSION; STATEMENT; REVIEWS; CANCER	The aim of medical research is to advance scientific knowledge and hence-directly or indirectly-lead to improvements in the treatment and prevention of disease. Each research project should continue systematically from previous research and feed into future research. Each project should contribute beneficially to a slowly evolving body of research. A study should not mislead; otherwise it could adversely affect clinical practice and future research. In 1994 1 observed that research papers commonly contain methodological errors, report results selectively, and draw unjustified conclusions. Here I revisit the topic and suggest how journal editors can help.	Canc Res UK NHS Ctr Stat Med, Inst Hlth Sci, Oxford OX3 7LF, England	Cancer Research UK; University of Oxford	Altman, DG (corresponding author), Canc Res UK NHS Ctr Stat Med, Inst Hlth Sci, Old Rd, Oxford OX3 7LF, England.	doug.altman@cancer.org.uk						ALTMAN DG, 1994, BRIT MED J, V308, P283, DOI 10.1136/bmj.308.6924.283; Altman DG, 2002, JAMA-J AM MED ASSOC, V287, P2817, DOI 10.1001/jama.287.21.2817; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; BLAND JM, 1987, BRIT MED J, V295, P979; Bland M, 2000, BRIT MED J, V320, P515; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919; Chalmers I, 1999, LANCET, V353, P490, DOI 10.1016/S0140-6736(98)07618-1; Chanter DO, 2002, BRIT MED J, V324, P169; Clarke M, 2002, JAMA-J AM MED ASSOC, V287, P2799, DOI 10.1001/jama.287.21.2799; DONNER A, 1990, INT J EPIDEMIOL, V19, P795, DOI 10.1093/ije/19.4.795; Egger M, 2001, SYSTEMATIC REV HLTH; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Gehlbach S. H., 1993, INTERPRETING MED LIT; Godlee F, 2001, BMC NEWS VIEWS, V2; Goodman SN, 1998, J GEN INTERN MED, V13, P753, DOI 10.1046/j.1525-1497.1998.00227.x; Guyatt G., 2015, USERS GUIDES MED LIT; Horton R, 1997, LANCET, V349, P6, DOI 10.1016/S0140-6736(05)62158-7; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Lawlor DA, 2001, BMJ-BRIT MED J, V322, P763, DOI 10.1136/bmj.322.7289.763; Mariani L, 2000, J CLIN ONCOL, V18, P429, DOI 10.1200/JCO.2000.18.2.429; MCGUIGAN SM, 1995, BRIT J PSYCHIAT, V167, P683, DOI 10.1192/bjp.167.5.683; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MOHER D, 2001, JAMA-J AM MED ASSOC, V285, P187; OLDHAM PD, 1962, J CHRON DIS, V15, P969, DOI 10.1016/0021-9681(62)90116-9; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Rennie D, 1998, JAMA-J AM MED ASSOC, V280, P300, DOI 10.1001/jama.280.3.300; ROTHMAN KJ, 1977, CANCER, V39, P1771, DOI 10.1002/1097-0142(197704)39:4+<1771::AID-CNCR2820390803>3.0.CO;2-2; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Schwarzer G, 2000, STAT MED, V19, P541, DOI 10.1002/(SICI)1097-0258(20000229)19:4<541::AID-SIM355>3.0.CO;2-V; Smith R, 2002, BRIT MED J, V324, P5, DOI 10.1136/bmj.324.7328.5; *STARD GROUP, 2002, STARD IN COMPL ACC R; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Welch GE, 1996, AM J OBSTET GYNECOL, V175, P1138, DOI 10.1016/S0002-9378(96)70018-2; WESTGARD JO, 1973, CLIN CHEM, V19, P49; *WORLD ASS MED ED, 2002, REP	36	188	199	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2765	2767		10.1001/jama.287.21.2765	http://dx.doi.org/10.1001/jama.287.21.2765			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038906				2022-12-28	WOS:000176002200003
J	Horton, R				Horton, R			The hidden research paper	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				TRIALS	Context To determine whether the views expressed in a research paper are accurate representations of contributors' opinions about the research being reported. Methods Purposive sampling of 10 research articles published in The Lancet; qualitative analysis of answers to 6 questions about the meaning of the study put to contributors who were listed on the byline of these articles. Fifty-four contributors listed on the bylines of the 10 articles were evaluated, and answers to questions were compared between contributors within research groups and against the published research report. Results A total of 36 (67%) of 54 contributors replied to this survey. Important weaknesses were often admitted on direct questioning but were not included in the published article. Contributors frequently disagreed about the importance of their findings, implications, and directions for future research. I could find no effort to study systematically past evidence relating to the investigators' own findings in either survey responses or the published article. Overall, the diversity of contributor opinion was commonly excluded from the published report. I found that discussion sections were haphazardly organized and did not deal systematically with important questions about the study. Conclusions A research paper rarely represents the opinions of those scientists whose work it reports. The findings described herein reveal evidence of (self-)censored criticism, obscured meanings, confused assessment of implications, and failures to indicate directions for future research. There is now empirical support for the introduction of structured discussion sections in research papers. Editors might also explore ways to recover the plurality of contributors' opinions.	The Lancet, London NW1 78Y, England		Horton, R (corresponding author), The Lancet, 32 Jamestown Rd, London NW1 78Y, England.							Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 1987, SCI ACTION; CANDELISE L, 1995, LANCET, V346, P1509; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Docherty M, 1999, BRIT MED J, V318, P1224; HORTON R, 1995, BRIT MED J, V310, P985, DOI 10.1136/bmj.310.6985.985; Horton R, 1997, J CLIN EPIDEMIOL, V50, P981, DOI 10.1016/S0895-4356(97)00156-X; Kontos J, 2000, Stud Health Technol Inform, V57, P260; Purcell GP, 1998, JAMA-J AM MED ASSOC, V280, P227, DOI 10.1001/jama.280.3.227; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; RENNIE D, 1991, JAMA-J AM MED ASSOC, V266, P3333, DOI 10.1001/jama.266.23.3333; SLATER PE, 1990, LANCET, V335, P1192, DOI 10.1016/0140-6736(90)92705-M; TOGNONI G, 1995, LANCET, V346, P1515, DOI 10.1016/S0140-6736(95)92050-1; Yank V, 1999, ANN INTERN MED, V130, P661, DOI 10.7326/0003-4819-130-8-199904200-00013	14	52	54	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2775	2778		10.1001/jama.287.21.2775	http://dx.doi.org/10.1001/jama.287.21.2775			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038909	Bronze			2022-12-28	WOS:000176002200006
J	Parrish, DM; Bruns, DE				Parrish, DM; Bruns, DE			US legal principles and confidentiality of the peer review process	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					When drawn into other parties' litigation or investigations, journals often receive requests or subpoenas for confidential peer review documents. We describe reasons for such requests and reasons that journals resist producing confidential documents, ways that journals respond, and steps that journals can take to minimize third-party breaches of journals' confidential processes. We discuss legal principles on which resistance may be based in the United States, including the journalist's privilege, the scholar's privilege, the burdensomeness of response, and the Federal Rules of Civil Procedure, which protect against attempts to obtain expert opinion testimony without compensation. Illustrative cases are described in which courts affirmed the confidentiality of peer review conducted by journals.	Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA; Univ Pittsburgh, Program Teaching Survival Skills & Eth Sci, Pittsburgh, PA USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bruns, DE (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Box 800214, Charlottesville, VA 22908 USA.							Cole LA, 1997, CLIN CHEM, V43, P2233; Cole LA, 1999, CLIN CHEM, V45, P313; *INT COMM MED J ED, 2002, UN REQ MAN SUBM BIOM	3	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2839	2841		10.1001/jama.287.21.2839	http://dx.doi.org/10.1001/jama.287.21.2839			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038928	Bronze			2022-12-28	WOS:000176002200025
J	Slovis, C; Jenkins, R				Slovis, C; Jenkins, R			ABC of clinical electrocardiography - Conditions not primarily affecting the heart	BRITISH MEDICAL JOURNAL			English	Article									Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN 37240 USA; No Gen Hosp, Sheffield S5 7AU, S Yorkshire, England	Vanderbilt University; Northern General Hospital	Slovis, C (corresponding author), Vanderbilt Univ, Med Ctr, Dept Emergency Med, Nashville, TN 37240 USA.								0	59	62	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1320	1323		10.1136/bmj.324.7349.1320	http://dx.doi.org/10.1136/bmj.324.7349.1320			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039829	Green Published			2022-12-28	WOS:000176041500022
J	Jernvall, J; Fortelius, M				Jernvall, J; Fortelius, M			Common mammals drive the evolutionary increase of hypsodonty in the Neogene	NATURE			English	Article							DIVERSIFICATION; ECOLOGY	During the past 20 million years, herbivorous mammals of numerous lineages have evolved hypsodont, or high-crowned, cheek teeth. Hypsodonty is informative ecologically because it is well developed in mammals eating fibrous and abrasive foods that are most abundant in open and generally or seasonally dry environments(1-5). Here we report that in the Neogene of Europe mammals with the greatest locality coverages showed an increase in hypsodonty. We used a data set of 209 localities to measure whether large mammals occurring in many fossil localities show a similar increase in hypsodonty to mammals occurring in single or few localities. Taxonomic and morphological groupings show a low average hypsodonty in the early Miocene epoch. From the middle Miocene onwards, only the hypsodonty of commonly found mammals shows a marked increase. Therefore, in the drying Europe of the late Miocene, only increasingly hypsodont mammals may have been able to expand their share of habitats and food resources. These results suggest that the relatively small number of species known from multiple localities are palaeoecologically informative by themselves, irrespective of the rest of the known species.	Univ Helsinki, Inst Biotechnol, Dev Biol Programme, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Systemat & Ecol, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Geol, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki	Jernvall, J (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Programme, POB 56, FIN-00014 Helsinki, Finland.	mikael.fortelius@helsinki.fi	Self, Casey J/B-6871-2011					Alroy J, 1996, PALAEOGEOGR PALAEOCL, V127, P285, DOI 10.1016/S0031-0182(96)00100-9; Alroy J, 2001, P NATL ACAD SCI USA, V98, P6261, DOI 10.1073/pnas.111144698; ALROY J, 1998, HIST GEOL, V38, P243; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Barnosky AD, 2001, J VERTEBR PALEONTOL, V21, P172, DOI 10.1671/0272-4634(2001)021[0172:DTEOTR]2.0.CO;2; Broccoli A.J., 1997, TECTONIC UPLIFT CLIM, P89; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; Fortelius M., 1996, P414; FORTELIUS M, 2001, PHYLOGENY NEOGNE HOM; Garces M, 1997, GEOLOGY, V25, P19, DOI 10.1130/0091-7613(1997)025<0019:OWFADO>2.3.CO;2; JANIS CM, 1988, BIOL REV, V63, P197, DOI 10.1111/j.1469-185X.1988.tb00630.x; JANIS CM, 1982, BIOL REV, V57, P216; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Jernvall J, 1996, SCIENCE, V274, P1489, DOI 10.1126/science.274.5292.1489; Jernvall Jukka, 1995, Acta Zoologica Fennica, V198, P1; MacFadden Bruce J., 2000, P223, DOI 10.1017/CBO9780511549717.009; Manly BFJ, 1997, RANDOMIZATION BOOTST; MEIN P, 1989, NATO ADV SCI I A-LIF, V180, P73; Meng J, 1998, NATURE, V394, P364, DOI 10.1038/28603; Perez-Barberia FJ, 2001, EVOL ECOL RES, V3, P221; Ruddiman W. F., 1997, TECTONIC UPLIFT CLIM; Simpson G.G., 1951, HORSES; Steininger F. F, 1996, EVOLUTION W EURASIAN, P7; VANVALEN L, 1960, EVOLUTION, V14, P531	24	128	136	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					538	540		10.1038/417538a	http://dx.doi.org/10.1038/417538a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037565				2022-12-28	WOS:000175860300039
J	Srinivasan, G; James, CM; Krzycki, JA				Srinivasan, G; James, CM; Krzycki, JA			Pyrrolysine encoded by UAG in Archaea: Charging of a UAG-decoding specialized tRNA	SCIENCE			English	Article							TRANSFER-RNA-SYNTHETASES; METHANOSARCINA-BARKERI; SEQUENCE; GENES; MONOMETHYLAMINE; RECOGNITION; DATABASE; BINDING; DOMAIN	Pyrrolysine is a lysine derivative encoded by the UAG codon in methylamine methyltransferase genes of Methanosarcina barkeri. Near a methyltransferase gene cluster is the pylT gene, which encodes an unusual transfer RNA (tRNA) with a CUA anticodon. The adjacent pylS gene encodes a class II aminoacyl-tRNA synthetase that charges the pylT-derived tRNA with lysine but is not closely related to known lysyl-tRNA synthetases. Homologs of pylS and pylT are found in a Gram-positive bacterium. Charging a tRNA(CUA) with lysine is a likely first step in translating UAG amber codons as pyrrolysine in certain methanogens. Our results indicate that pyrrolysine is the 22nd genetically encoded natural amino acid.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.							Alexander RW, 2001, PROG NUCLEIC ACID RE, V69, P317, DOI 10.1016/S0079-6603(01)69050-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; Desogus G, 2000, BIOCHEMISTRY-US, V39, P8418, DOI 10.1021/bi0006722; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; FERGUSON T, UNPUB; FREIST W, 1995, BIOL CHEM HOPPESEYLE, V276, P451; GALE AJ, 1995, BIOCHEMISTRY-US, V34, P8896, DOI 10.1021/bi00027a042; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741, DOI 10.1146/annurev.bi.65.070196.003521; GIEGE R, 1993, PROG NUCLEIC ACID RE, V45, P129, DOI 10.1016/S0079-6603(08)60869-7; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ibba M, 1999, P NATL ACAD SCI USA, V96, P418, DOI 10.1073/pnas.96.2.418; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MORAS D, 1992, TRENDS BIOCHEM SCI, V17, P159, DOI 10.1016/0968-0004(92)90326-5; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; SRINIVASAN G, UNPUB; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000	26	420	446	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1459	1462		10.1126/science.1069588	http://dx.doi.org/10.1126/science.1069588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029131				2022-12-28	WOS:000175910300046
J	Zhuang, XW; Kim, H; Pereira, MJB; Babcock, HP; Walter, NG; Chu, S				Zhuang, XW; Kim, H; Pereira, MJB; Babcock, HP; Walter, NG; Chu, S			Correlating structural dynamics and function in single ribozyme molecules	SCIENCE			English	Article							HAIRPIN RIBOZYME; CLEAVAGE MECHANISM; TERTIARY STRUCTURE; RNA; CATALYSIS; DOMAIN; LOOP	We have studied the correlation between structural dynamics and function of the hairpin ribozyme. The enzyme-substrate complex exists in either docked (active) or undocked (inactive) conformations. Using single-molecule fluorescence methods, we found complex structural dynamics with four docked states of distinct stabilities and a strong memory effect where each molecule rarely switches between different docked states. We also found substrate cleavage to be rate-Limited by a combination of conformational transitions and reversible chemistry equilibrium. The complex structural dynamics quantitatively explain the heterogeneous cleavage kinetics common to many catalytic RNAs. The intimate coupling of structural dynamics and function is likely a general phenomenon for RNA.	Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Michigan System; University of Michigan; Stanford University	Walter, NG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.		Walter, Nils/P-3163-2019; Walter, Nils G/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Walter, Nils G/0000-0002-7301-1275; Babcock, Hazen/0000-0003-4835-3692	NIGMS NIH HHS [GM62357] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062357] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins J.F, 1999, RNA WORLD; Butcher SE, 1999, NAT STRUCT BIOL, V6, P212; Cai ZP, 1996, BIOCHEMISTRY-US, V35, P6026, DOI 10.1021/bi952985g; Collins CA, 2000, NAT STRUCT BIOL, V7, P850; Doherty EA, 2000, ANNU REV BIOCHEM, V69, P597, DOI 10.1146/annurev.biochem.69.1.597; Earnshaw DJ, 1997, J MOL BIOL, V274, P197, DOI 10.1006/jmbi.1997.1405; Edman L, 2000, P NATL ACAD SCI USA, V97, P8266, DOI 10.1073/pnas.130589397; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Esteban JA, 1998, P NATL ACAD SCI USA, V95, P6091, DOI 10.1073/pnas.95.11.6091; Esteban JA, 1997, J BIOL CHEM, V272, P13629, DOI 10.1074/jbc.272.21.13629; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Nesbitt SM, 1999, J MOL BIOL, V286, P1009, DOI 10.1006/jmbi.1999.2543; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; Pinard R, 2001, EMBO J, V20, P6434, DOI 10.1093/emboj/20.22.6434; Pinard R, 2001, J MOL BIOL, V307, P51, DOI 10.1006/jmbi.2000.4472; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; Rupert PB, 2001, NATURE, V410, P780, DOI 10.1038/35071009; SANTALUCIA J, 1992, SCIENCE, V256, P217, DOI 10.1126/science.1373521; Schutz GJ, 1998, BIOPHYS J, V74, P2223, DOI 10.1016/S0006-3495(98)77931-7; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Walter NG, 1998, CURR OPIN CHEM BIOL, V2, P24, DOI 10.1016/S1367-5931(98)80032-X; Walter NG, 1998, EMBO J, V17, P2378, DOI 10.1093/emboj/17.8.2378; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	29	413	430	2	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1473	1476		10.1126/science.1069013	http://dx.doi.org/10.1126/science.1069013			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029135				2022-12-28	WOS:000175910300050
J	Zimmers, TA; Davies, MV; Koniaris, LG; Haynes, P; Esquela, AF; Tomkinson, KN; McPherron, AC; Wolfman, NM; Lee, SJ				Zimmers, TA; Davies, MV; Koniaris, LG; Haynes, P; Esquela, AF; Tomkinson, KN; McPherron, AC; Wolfman, NM; Lee, SJ			Induction of cachexia in mice by systemically administered myostatin	SCIENCE			English	Article							GROWTH-FACTOR-BETA; MOLECULAR-WEIGHT COMPLEX; INHIBIN-DEFICIENT MICE; SUPERFAMILY MEMBER; BINDING-PROTEIN; HUMAN-PLATELETS; MUSCLE GROWTH; CATTLE; GENE; MUTATIONS	Mice and cattle with genetic deficiencies in myostatin exhibit dramatic increases in skeletal muscle mass, suggesting that myostatin normally suppresses muscle growth. Whether this increased muscling results from prenatal or postnatal lack of myostatin activity is unknown. Here we show that myostatin circulates in the blood of adult mice in a latent form that can be activated by acid treatment Systemic overexpression of myostatin in adult mice was found to induce profound muscle and fat loss analogous to that seen in human cachexia syndromes. These data indicate that myostatin acts systemically in adult animals and may be a useful pharmacologic target in clinical settings such as cachexia, where muscle growth is desired.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Wyeth Pharmaceut Inc, Wyeth Res Div, Cambridge, MA 02140 USA	Johns Hopkins University; Pfizer	Lee, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, 725 N Wolfe St, Baltimore, MD 21205 USA.	sjlee@jhmi.edu	Zimmers, Teresa/AAD-5461-2019	Zimmers, Teresa/0000-0001-7872-0540; Haynes, Paul/0000-0003-1472-8249	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035887] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009139, R01CA088866] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA88866, 5 T32 CA09139] Funding Source: Medline; NICHD NIH HHS [R01 HD35887] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BLACK K, 1991, ENDOCRINOLOGY, V128, P2657, DOI 10.1210/endo-128-5-2657; Brownh PD, 1990, GROWTH FACTORS, V3, DOI 10.3109/08977199009037500; BULLOUGH WS, 1962, BIOL REV, V37, P307, DOI 10.1111/j.1469-185X.1962.tb01615.x; BULLOUGH WS, 1965, CANCER RES, V25, P1683; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; COSTA G, 1981, CANCER TREAT REP, V65, P3; GENTRY LE, 1990, BIOCHEMISTRY-US, V29, P6851, DOI 10.1021/bi00481a014; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Grobet L, 1997, NAT GENET, V17, P71, DOI 10.1038/ng0997-71; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; GROSVENOR M, 1989, CANCER, V63, P330, DOI 10.1002/1097-0142(19890115)63:2<330::AID-CNCR2820630221>3.0.CO;2-U; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; LAWRENCE D, 1985, BIOCHEM BIOPH RES CO, V133, P1026, DOI 10.1016/0006-291X(85)91239-2; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; MIYAZONO K, 1988, J BIOL CHEM, V263, P6407; OLIFF A, 1987, CELL, V50, P555, DOI 10.1016/0092-8674(87)90028-6; Sakuma K, 2000, BBA-MOL CELL RES, V1497, P77, DOI 10.1016/S0167-4889(00)00044-6; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Thies RS, 2001, GROWTH FACTORS, V18, P251; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Tisdale MJ, 1999, J NUTR, V129, p243S, DOI 10.1093/jn/129.1.243S; Tsuchida K, 2000, J BIOL CHEM, V275, P40788, DOI 10.1074/jbc.M006114200; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; WAKEFIELD LM, 1988, J BIOL CHEM, V263, P7646; ZIMMERS T, UNPUB	30	681	783	4	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1486	1488		10.1126/science.1069525	http://dx.doi.org/10.1126/science.1069525			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029139				2022-12-28	WOS:000175910300054
J	Berglund, GI; Carlsson, GH; Smith, AT; Szoke, H; Henriksen, A; Hajdu, J				Berglund, GI; Carlsson, GH; Smith, AT; Szoke, H; Henriksen, A; Hajdu, J			The catalytic pathway of horseradish peroxidase at high resolution	NATURE			English	Article							X-RAY; RADIATION-DAMAGE; ATOMIC-RESOLUTION; CRYSTAL-STRUCTURE; SYNCHROTRON-RADIATION; ANGSTROM RESOLUTION; PROTEIN CRYSTALS; ACTIVATION; REDUCTASE; ELECTRON	A molecular description of oxygen and peroxide activation in biological systems is difficult, because electrons liberated during X-ray data collection reduce the active centres of redox enzymes catalysing these reactions(1-5). Here we describe an effective strategy to obtain crystal structures for high-valency redox intermediates and present a three-dimensional movie of the X-ray-driven catalytic reduction of a bound dioxygen species in horseradish peroxidase (HRP). We also describe separate experiments in which high-resolution structures could be obtained for all five oxidation states of HRP, showing such structures with preserved redox states for the first time.	Univ Uppsala, Ctr Biomed, Dept Biochem, S-75123 Uppsala, Sweden; Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Copenhagen, Dept Chem, Prot Struct Grp, DK-2100 Copenhagen, Denmark	Uppsala University; University of Sussex; University of Copenhagen	Hajdu, J (corresponding author), Univ Uppsala, Ctr Biomed, Dept Biochem, Box 576, S-75123 Uppsala, Sweden.			Smith, Andrew/0000-0002-0926-1878; Henriksen, Anette/0000-0003-4051-5079				[Anonymous], MEM IST GEOL MIN U P; Burmeister WP, 2000, ACTA CRYSTALLOGR D, V56, P328, DOI 10.1107/S0907444999016261; CHANCE B, 1984, ARCH BIOCHEM BIOPHYS, V235, P596, DOI 10.1016/0003-9861(84)90234-0; CHANCE B, 1980, FEBS LETT, V112, P178, DOI 10.1016/0014-5793(80)80174-8; Cravens TE, 1997, GEOPHYS RES LETT, V24, P105, DOI 10.1029/96GL03780; Dunford H. B., 1999, HEME PEROXIDASES; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Gajhede M, 1997, NAT STRUCT BIOL, V4, P1032, DOI 10.1038/nsb1297-1032; GONZALEZ A, 1994, ACTA CRYSTALLOGR D, V50, P874, DOI 10.1107/S0907444994006311; Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Henriksen A, 1999, J BIOL CHEM, V274, P35005, DOI 10.1074/jbc.274.49.35005; Lancaster CRD, 1999, NATURE, V402, P377, DOI 10.1038/46483; Leiros HKS, 2001, ACTA CRYSTALLOGR D, V57, P488, DOI 10.1107/S0907444901000646; Logan DT, 1996, STRUCTURE, V4, P1053, DOI 10.1016/S0969-2126(96)00112-8; NAKAJIMA R, 1987, J BIOL CHEM, V262, P2576; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Persson P, 2001, PROTEIN SCI, V10, P2480, DOI 10.1110/ps.ps.26201; Planche L. A., 1810, B PHARM, V<bold>2</bold>, P578; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sjogren T, 2001, J BIOL CHEM, V276, P13072, DOI 10.1074/jbc.M011312200; SMITH AT, 1990, J BIOL CHEM, V265, P13335; Szoke A, 1998, ACTA CRYSTALLOGR A, V54, P543, DOI 10.1107/S0108767397019235; VANWART HE, 1985, J BIOL CHEM, V260, P8372; Veitch NC, 2001, ADV INORG CHEM, V51, P107; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Ziaja B, 2001, PHYS REV B, V64, DOI [10.1103/PhysRevLett.87.214104, 10.1103/PhysRevB.64.214104]	30	708	730	8	237	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					463	468		10.1038/417463a	http://dx.doi.org/10.1038/417463a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024218				2022-12-28	WOS:000175730900044
J	Thaler, DE; Lev, MH; Frosch, MP; Buonanno, FS				Thaler, DE; Lev, MH; Frosch, MP; Buonanno, FS			A 41-year-old woman with global headache and an intracranial mass - Cerebral venous thrombosis, resulting in hemorrhagic infarction of the posterior left temporal lobe.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; FACTOR-V-LEIDEN; INTRACEREBRAL HEMORRHAGE; GRANULOMATOUS-ANGIITIS; PROTHROMBIN-GENE; RISK FACTOR; MUTATION; COCCIDIOIDOMYCOSIS; ASPERGILLOSIS; ANTIBODIES		Tufts Univ New England Med Ctr, Tufts Comprehens Stroke Ctr, Boston, MA 02111 USA; Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts Medical Center; Tufts University	Thaler, DE (corresponding author), Tufts Univ New England Med Ctr, Tufts Comprehens Stroke Ctr, 750 Washington St, Boston, MA 02111 USA.		Frosch, Matthew P/ABD-7456-2021	Frosch, Matthew P/0000-0002-3940-9861				AMERI A, 1992, NEUROL CLIN, V10, P87, DOI 10.1016/S0733-8619(18)30235-4; ARTHUR G, 1977, ARCH PATHOL LAB MED, V101, P382; BIBERFELD G, 1971, CLIN EXP IMMUNOL, V8, P319; Biousse V, 1998, STROKE, V29, P1398, DOI 10.1161/01.STR.29.7.1398; Bousser M.-G., 1992, STROKE PATHOPHYSIOLO, P517; Bousser MG, 2000, J NEUROL, V247, P252, DOI 10.1007/s004150050579; BOUSSER MG, 1997, CEREBRAL VENOUS THRO; BOUZA E, 1981, MEDICINE, V60, P139, DOI 10.1097/00005792-198105000-00001; Bradsher R W, 1997, Semin Respir Infect, V12, P229; CANTU C, 1993, STROKE, V24, P1880, DOI 10.1161/01.STR.24.12.1880; CAPLAN L, 1983, NEUROLOGY, V33, P1130, DOI 10.1212/WNL.33.9.1130; COOK DJ, 1990, AM J MED, V88, P74, DOI 10.1016/0002-9343(90)90132-W; DAIF A, 1995, STROKE, V26, P1193, DOI 10.1161/01.STR.26.7.1193; de Bruijn SFTM, 1998, BRIT MED J, V316, P589, DOI 10.1136/bmj.316.7131.589; de Bruijn SFTM, 1998, BRIT MED J, V316, P822; DEFELICE R, 1982, AM REV RESPIR DIS, V125, P49; Deschiens MA, 1996, STROKE, V27, P1724, DOI 10.1161/01.STR.27.10.1724; DRURY I, 1984, NEUROLOGY, V34, P653, DOI 10.1212/WNL.34.5.653; Einhaupl KM, 1990, CEREBRAL SINUS THROM, P149, DOI 10.1007/978- 1-4684-8199-0_14; Friedman JA, 2000, MAYO CLIN PROC, V75, P403, DOI 10.4065/75.4.403; Hunn M, 1998, J NEUROL NEUROSUR PS, V65, P956, DOI 10.1136/jnnp.65.6.956; KASE CS, 1982, NEUROLOGY, V32, P1146, DOI 10.1212/WNL.32.10.1146; KASE CS, 1994, INTRACEREBRAL HEMORR, P363; KASE CS, 1995, INTRACEREBRAL HEMORR, P95; KASE CS, 1994, INTRACEREBRAL HEMORR, P263; KOLODNY EH, 1968, ARCH NEUROL-CHICAGO, V19, P510, DOI 10.1001/archneur.1968.00480050080008; KOSKINIEMI M, 1993, CLIN INFECT DIS, V17, pS52, DOI 10.1093/clinids/17.Supplement_1.S52; Lavrnic D V, 1992, Srp Arh Celok Lek, V120, P363; LOURIA DB, 1998, INFECT DIS, P605; Ludemann P, 1998, STROKE, V29, P2507, DOI 10.1161/01.STR.29.12.2507; Lundergan L. L., 1985, COCCIDIOIDOMYCOSIS, P47; Marrie TJ, 1996, AM J MED, V101, P508, DOI 10.1016/S0002-9343(96)00255-0; Martinelli I, 1996, THROMB HAEMOSTASIS, V75, P393; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; RODENBIKER HT, 1981, ARCH OPHTHALMOL-CHIC, V99, P71, DOI 10.1001/archopht.1981.03930010073005; SMEGO RA, 1987, REV INFECT DIS, V9, P855; SOBEL RA, 1984, HUM PATHOL, V15, P980, DOI 10.1016/S0046-8177(84)80128-8; TSAI FY, 1995, AM J NEURORADIOL, V16, P1021; TUHY JE, 1958, AM J MED, V25, P638, DOI 10.1016/0002-9343(58)90052-4; UEDA K, 1988, STROKE, V19, P48, DOI 10.1161/01.STR.19.1.48; VISUDHIPHAN P, 1973, J NEUROSURG, V38, P472, DOI 10.3171/jns.1973.38.4.0472; Weih M, 1998, J NEUROL, V245, P149, DOI 10.1007/s004150050195; WEISBERG LA, 1990, NEURORADIOLOGY, V32, P137, DOI 10.1007/BF00588563; WHEAT LJ, 1990, MEDICINE, V69, P244, DOI 10.1097/00005792-199007000-00006; Zuber M, 1996, STROKE, V27, P1721, DOI 10.1161/01.STR.27.10.1721	45	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1651	1658		10.1056/NEJMcpc020016	http://dx.doi.org/10.1056/NEJMcpc020016			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023999				2022-12-28	WOS:000175728600009
J	Greengold, NL				Greengold, NL			Value	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2621	2622		10.1001/jama.287.20.2621	http://dx.doi.org/10.1001/jama.287.20.2621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020282				2022-12-28	WOS:000175732400001
J	Fredrick, DR				Fredrick, DR			Myopia	BRITISH MEDICAL JOURNAL			English	Review							REFRACTIVE ERROR; EYE; PROGRESSION; CHILDREN; DESIGN; LOCUS; MAPS		Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Fredrick, DR (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, 10 Koret Way, San Francisco, CA 94143 USA.							CHOW Y C, 1990, SMJ Singapore Medical Journal, V31, P472; Crewther DP, 2000, PROG RETIN EYE RES, V19, P421, DOI 10.1016/S1350-9462(00)00004-5; Diether S, 2001, INVEST OPHTH VIS SCI, V42, P3072; DUNPHY EB, 1968, AM J OPHTHALMOL, V65, P518, DOI 10.1016/0002-9394(68)93865-8; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P1232; HOYT CS, 1981, AM J OPHTHALMOL, V91, P197, DOI 10.1016/0002-9394(81)90173-2; Hyman L, 2001, CONTROL CLIN TRIALS, V22, P573, DOI 10.1016/S0197-2456(01)00156-8; JAVITT JC, 1994, ARCH OPHTHALMOL-CHIC, V112, P526; Khoo C. Y., 1999, SMJ, V40, P230; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; Pararajasegaram R, 1999, AM J OPHTHALMOL, V128, P359; RAJAN U, 1995, P 5 INT C MYOP TOR O, P41; RAKASHIMA T, 2001, JPN J OPHTHALMOL, V45, P84; RAVIOLA E, 1985, NEW ENGL J MED, V312, P1609, DOI 10.1056/NEJM198506203122505; ROBB RM, 1977, AM J OPHTHALMOL, V83, P52, DOI 10.1016/0002-9394(77)90191-X; Saw SM, 2000, OPTOMETRY VISION SCI, V77, P549, DOI 10.1097/00006324-200010000-00009; Saw SM, 1996, EPIDEMIOL REV, V18, P175, DOI 10.1093/oxfordjournals.epirev.a017924; Siegwart JT, 1998, VISION RES, V38, P3505, DOI 10.1016/S0042-6989(98)00053-4; Tay M T, 1992, Ann Acad Med Singap, V21, P785; Teasdale T W, 1988, Acta Ophthalmol Suppl, V185, P41; TEIKARI J, 1980, OPTOMETRY VISION SCI, V66, P594; TEIKARI JM, 1991, HUM HERED, V41, P151, DOI 10.1159/000153994; Vongphanit J, 2002, OPHTHALMOLOGY, V109, P704, DOI 10.1016/S0161-6420(01)01024-7; Walline JJ, 2001, OPTOMETRY VISION SCI, V78, P223, DOI 10.1097/00006324-200104000-00011; WALLMAN J, 1978, SCIENCE, V201, P1249, DOI 10.1126/science.694514; Whatham AR, 2001, VISION RES, V41, P267, DOI 10.1016/S0042-6989(00)00250-9; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, pS324; YOUNG FA, 1969, AMER J OPT ARCH AM A, V46, P676; Young TL, 1998, AM J HUM GENET, V63, P109, DOI 10.1086/301907; Young TL, 1998, AM J HUM GENET, V63, P1419, DOI 10.1086/302111; ZADNIK K, 1994, JAMA-J AM MED ASSOC, V271, P1323, DOI 10.1001/jama.271.17.1323; Zadnik K, 2001, OPTOMETRY VISION SCI, V78, P179, DOI 10.1097/00006324-200104000-00001	32	128	134	1	23	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1195	1199		10.1136/bmj.324.7347.1195	http://dx.doi.org/10.1136/bmj.324.7347.1195			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016188	Green Published			2022-12-28	WOS:000175763200023
J	Harrigan, RA; Jones, K				Harrigan, RA; Jones, K			ABC of clinical electrocardiography - Conditions affecting the right side of the heart	BRITISH MEDICAL JOURNAL			English	Article									Temple Univ, Sch Med, Philadelphia, PA 19122 USA; Temple Univ Hosp & Med Sch, Div Emergency Med, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Harrigan, RA (corresponding author), Temple Univ, Sch Med, Philadelphia, PA 19122 USA.								0	40	42	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1201	1204		10.1136/bmj.324.7347.1201	http://dx.doi.org/10.1136/bmj.324.7347.1201			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016190	Green Published			2022-12-28	WOS:000175763200025
J	Gill, RA; Polley, HW; Johnson, HB; Anderson, LJ; Maherali, H; Jackson, RB				Gill, RA; Polley, HW; Johnson, HB; Anderson, LJ; Maherali, H; Jackson, RB			Nonlinear grassland responses to past and future atmospheric CO2	NATURE			English	Article							ELEVATED CO2; CARBON-DIOXIDE; WATER-USE; SOIL; NITROGEN; BIOMASS; DECOMPOSITION; FEEDBACK; LITTER	Carbon sequestration in soil organic matter may moderate increases in atmospheric CO2 concentrations (C-a) as C-a increases to more than 500 mumol mol(-1) this century from interglacial levels of less than 200 mumol mol(-1) (refs 1- 6). However, such carbon storage depends on feedbacks between plant responses to Ca and nutrient availability(7,8). Here we present evidence that soil carbon storage and nitrogen cycling in a grassland ecosystem are much more responsive to increases in past Ca than to those forecast for the coming century. Along a continuous gradient of 200 to 550 mumol mol(-1) (refs 9, 10), increased C-a promoted higher photosynthetic rates and altered plant tissue chemistry. Soil carbon was lost at subambient C-a, but was unchanged at elevated C-a where losses of old soil carbon offset increases in new carbon. Along the experimental gradient in C-a there was a nonlinear, threefold decrease in nitrogen availability. The differences in sensitivity of carbon storage to historical and future C-a and increased nutrient limitation suggest that the passive sequestration of carbon in soils may have been important historically, but the ability of soils to continue as sinks is limited.	Duke Univ, Nicholas Sch Environm & Earth Sci, Durham, NC 27708 USA; ARS, USDA, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; Univ Texas, Dept Bot, Austin, TX 78713 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University; United States Department of Agriculture (USDA); University of Texas System; University of Texas Austin; Duke University	Gill, RA (corresponding author), Washington State Univ, Program Environm Sci & Reg Planning, Pullman, WA 99164 USA.	rgill@wsu.edu	Gill, Richard/AAC-8137-2021	Gill, Richard/0000-0001-8981-0621; Polley, Herbert/0000-0002-1197-8800; Jackson, Robert/0000-0001-8846-7147				Anderson LJ, 2001, GLOBAL CHANGE BIOL, V7, P693, DOI 10.1046/j.1354-1013.2001.00438.x; Canadell JG, 1996, PLANT SOIL, V187, P391, DOI 10.1007/BF00017102; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; CHICHESTER FW, 1992, SOIL SCI, V153, P237, DOI 10.1097/00010694-199203000-00007; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Follett RF, 2001, POTENTIAL OF U.S. GRAZING LANDS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P401; Hattenschwiler S, 1996, OECOLOGIA, V106, P172, DOI 10.1007/BF00328596; HOOK PB, 1995, SOIL SCI SOC AM J, V59, P831, DOI 10.2136/sssaj1995.03615995005900030028x; Hu S, 2001, NATURE, V409, P188, DOI 10.1038/35051576; Hungate BA, 1997, NATURE, V388, P576, DOI 10.1038/41550; JACKSON RB, 1994, OECOLOGIA, V98, P257, DOI 10.1007/BF00324212; Johnson HB, 2000, FUNCT ECOL, V14, P388, DOI 10.1046/j.1365-2435.2000.00435.x; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; KORNER C, 1992, SCIENCE, V257, P1672, DOI 10.1126/science.257.5077.1672; Korner C, 2000, ECOL APPL, V10, P1590, DOI 10.2307/2641226; Morgan JA, 2001, GLOBAL CHANGE BIOL, V7, P451, DOI 10.1046/j.1365-2486.2001.00415.x; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; OECHEL WC, 1994, NATURE, V371, P500, DOI 10.1038/371500a0; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Owensby CE, 1999, GLOB CHANGE BIOL, V5, P497, DOI 10.1046/j.1365-2486.1999.00245.x; POLLEY HW, 1993, NATURE, V361, P61, DOI 10.1038/361061a0; Sage RF, 1999, CARBON DIOXIDE ENV S, P289; SCHINDEWOLF U, 1991, J PHYS IV, V1, P77, DOI 10.1051/jp4:1991509; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; Six J, 1998, SOIL SCI SOC AM J, V62, P1367, DOI 10.2136/sssaj1998.03615995006200050032x; Tans PP, 1998, SCIENCE, V281, P183, DOI 10.1126/science.281.5374.183; Van Kessel C, 2000, GLOBAL CHANGE BIOL, V6, P123, DOI 10.1046/j.1365-2486.2000.00287.x; ZAK DR, 1993, PLANT SOIL, V151, P105, DOI 10.1007/BF00010791; Zak DR, 2000, ECOL APPL, V10, P34, DOI 10.1890/1051-0761(2000)010[0034:ACSNAA]2.0.CO;2	29	252	287	5	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					279	282		10.1038/417279a	http://dx.doi.org/10.1038/417279a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015601				2022-12-28	WOS:000175592100045
J	Hoerger, TJ; Bethke, AD; Richter, A; Sorensen, SW; Engelgau, M; Thompson, T; Narayan, KMV; Williamson, DF; Gregg, E; Zhang, P; Eastman, RC; Fuller, J; Gibbons, CB; Haffner, S; Herman, WH; Howard, B; Ratner, R; Orchard, T				Hoerger, TJ; Bethke, AD; Richter, A; Sorensen, SW; Engelgau, M; Thompson, T; Narayan, KMV; Williamson, DF; Gregg, E; Zhang, P; Eastman, RC; Fuller, J; Gibbons, CB; Haffner, S; Herman, WH; Howard, B; Ratner, R; Orchard, T		CDC Diabet Cost-Effectiveness Grp	Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DIRECT MEDICAL COSTS; SECULAR TRENDS; COMPLICATIONS; MORTALITY; GLUCOSE; STROKE; HEALTH; PRAVASTATIN; MANAGEMENT	Context Several treatment interventions can reduce complications of type 2 diabetes, but their relative cost-effectiveness is not known. Objective To estimate the incremental cost-effectiveness of intensive glycemic control (relative to conventional control), intensified hypertension control, and reduction in serum cholesterol level for patients with type 2 diabetes. Design, Setting, and Patients Cost-effectiveness analysis of a hypothetical cohort of individuals living in the United States, aged 25 years or older, who were newly diagnosed as having type 2 diabetes. The results of the United Kingdom Prospective Diabetes Study (UKPDS) and other studies were used to create a model of disease progression and treatment patterns. Costs were based on those used in community practices in the United States. Interventions Insulin or sulfonylurea therapy for intensive glycemic control; angiotensin-converting enzyme inhibitor or beta-blocker for intensified hypertension control; and pravastatin for reduction of serum cholesterol level. Main Outcome Measures Cost per quality-adjusted life-year (QALY) gained, Costs (in 1997 US dollars) and QALYs were discounted at a 3% annual rate. Results The incremental cost-effectiveness ratio for intensive glycemic control is $41384 per QALY; this ratio increased with age at diagnosis from $9614 per QALY for patients aged 25 to 34 years to $2.1 million for patients aged 85 to 94 years. For intensified hypertension control the cost-effectiveness ratio is -$1959 per QALY. The cost-effectiveness ratio for reduction in serum cholesterol level is $51889 per QALY; this ratio varied by age at diagnosis and is lowest for patients diagnosed between the ages of 45 and 84 years. Conclusions Intensified hypertension control reduces costs and improves health outcomes relative to moderate hypertension control. Intensive glycemic control and reduction in serum cholesterol level increase costs and improve health outcomes. The cost-effectiveness ratios for these 2 interventions are comparable with those of several other frequently adopted health care interventions.	Res Triangle Inst, Res Triangle Pk, NC 27709 USA; Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA; Cygnus Inc, Redwood City, CA 94063 USA; UCL, London, England; Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; Univ Texas, Ctr Hlth, San Antonio, TX USA; Univ Michigan, Med Ctr, Ann Arbor, MI USA; MedStar Res Inst, Washington, DC USA; Univ Pittsburgh, Pittsburgh, PA USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA; University of London; University College London; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hoerger, TJ (corresponding author), Res Triangle Inst, 3040 Cornwallis Rd,POB 12194, Res Triangle Pk, NC 27709 USA.		Narayan, K.M. Venkat/J-9819-2012; Richter, Anke/I-9050-2012	Narayan, K.M. Venkat/0000-0001-8621-5405; Hoerger, Thomas/0000-0003-4154-7806; orchard, trevor/0000-0001-9552-3215; Gregg, Edward/0000-0003-2381-6822				ALBERTI KGM, 1995, INT TXB DIABETES MEL; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1995, DIABETES, V44, P968; [Anonymous], 1997, Am J Cardiol, V79, P756; [Anonymous], 1995, DIABETES AM; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; *CDCP, 1997, DIAB SURV; *CDCP, 1997, NAT DIAB FACT SHEET; Chapman RH, 2000, MED DECIS MAKING, V20, P451, DOI 10.1177/0272989X0002000409; Cowie CC, 1995, NIH PUBLICATION, V95-1468, P117; DONG F, 1997, EC EVALUATION APPROA; Eastman RC, 1997, DIABETES CARE, V20, P735, DOI 10.2337/diacare.20.5.735; Eastman RC, 1997, DIABETES CARE, V20, P725, DOI 10.2337/diacare.20.5.725; ECKMAN MH, 1995, JAMA-J AM MED ASSOC, V273, P712, DOI 10.1001/jama.273.9.712; Engelgau MM, 1998, JAMA-J AM MED ASSOC, V280, P1757; Gold MR, 1996, COST EFFECTIVENESS H; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gray A, 2000, BMJ-BRIT MED J, V320, P1373, DOI 10.1136/bmj.320.7246.1373; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; *HLTH CAR FIN ADM, 2002, DUR MED EQ REG CARR; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Kuller LH, 1995, NIH PUBLICATION, P449; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; *MED EC CO, 1997, RED BOOK; Nathan DM, 1996, JAMA-J AM MED ASSOC, V276, P1409; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; O'Brien JA, 1998, DIABETES CARE, V21, P1122, DOI 10.2337/diacare.21.7.1122; Ray NF, 1998, DIABETES CARE, V21, P296; RUBIN RJ, 1994, J CLIN ENDOCR METAB, V78, pA809, DOI 10.1210/jcem.78.4.8157701; Russell MW, 1998, AM J CARDIOL, V81, P1110, DOI 10.1016/S0002-9149(98)00136-2; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shin AY, 1997, STROKE, V28, P2395, DOI 10.1161/01.STR.28.12.2395; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; TURNER R, 1998, EUR ASS STUD DIAB M; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *US BUR CENS, 2002, NAT POP EST 1990; *US DEP HHS, 1994, DHHS PUBL 1; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wingard DL., 1995, DIABETES AM, P429; WOLF PA, 1992, STROKE, V23, P1551, DOI 10.1161/01.STR.23.11.1551; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001	46	387	392	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2542	2551						10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020335				2022-12-28	WOS:000175566200023
J	Helmke, B; Starz, H; Bachter, D; Balda, BR				Helmke, B; Starz, H; Bachter, D; Balda, BR			Metastasising porocarcinoma following exposure to poison gas	LANCET			English	Editorial Material									Klinikum Augsburg, Dept Dermatol & Allergol, D-86156 Augsburg, Germany	Klinikum Augsburg	Helmke, B (corresponding author), Klinikum Augsburg, Dept Dermatol & Allergol, Stenglinstr 2, D-86156 Augsburg, Germany.								0	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1685	1685		10.1016/S0140-6736(02)08593-8	http://dx.doi.org/10.1016/S0140-6736(02)08593-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020547				2022-12-28	WOS:000175593300030
J	Lill, JT; Marquis, RJ; Ricklefs, RE				Lill, JT; Marquis, RJ; Ricklefs, RE			Host plants influence parasitism of forest caterpillars	NATURE			English	Article							PHYTOPHAGOUS INSECTS; SPECIES RICHNESS; HERBIVORES; SPECIALIZATION; BUTTERFLIES; EVOLUTION; LARVAE	Patterns of association between herbivores and host plants have been thought to reflect the quality of plants as food resources(1,2) as influenced by plant nutrient composition(3), defences(4,5),and phenology(6). Host-plant-specific enemies, that is, the third trophic level, might also influence the distribution of herbivores across plant species(7-10). However, studies of the evolution of herbivore host range(11-15) have generally not examined the third trophic level, leaving unclear the importance of this factor in the evolution of plant-insect herbivore interactions(16). Analysis of parasitoid rearings by the Canadian Forest Insect Survey shows that parasitism of particular Lepidoptera species is strongly host-plant-dependent, that the pattern of host-plant dependence varies among species of caterpillars, and that some parasitoid species are themselves specialized with respect to tree species. Host-plant-dependent parasitism suggests the possibility of top-down influence on host plant use. Differences in parasitism among particular caterpillar-host plant combinations could select for specialization of host plant ranges within caterpillar communities. Such specialization would ultimately promote the species diversification of Lepidoptera in temperate forests with respect to escape from enemies.	Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Lill, JT (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.		Lill, John/A-7935-2009					Barbosa P, 2001, ECOLOGY, V82, P698, DOI 10.1890/0012-9658(2001)082[0698:DPOMHO]2.0.CO;2; Barbosa Pedro, 1998, P55, DOI 10.1016/B978-012078147-8/50050-5; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; BROWER LP, 1958, AM NAT, V864, P886; BUSH GL, 1975, ANNU REV ECOL SYST, V6, P339, DOI 10.1146/annurev.es.06.110175.002011; CATES RG, 1980, OECOLOGIA, V46, P22, DOI 10.1007/BF00346961; COURTNEY SP, 1981, OECOLOGIA, V51, P91, DOI 10.1007/BF00344658; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; ELZEN GW, 1983, ENVIRON ENTOMOL, V12, P1873; ENGELS W, 1988, STAT TESTS CATEGORIC; FEDER JL, 1988, NATURE, V336, P61, DOI 10.1038/336061a0; GOULD F, 1979, EVOLUTION, V33, P791, DOI [10.1111/j.1558-5646.1979.tb04735.x, 10.2307/2407646]; GREENBLATT JA, 1981, J APPL ECOL, V18, P1, DOI 10.2307/2402474; GROSS P, 1988, ECOLOGY, V69, P1506, DOI 10.2307/1941648; HAWKINS BA, 1987, NATURE, V326, P788, DOI 10.1038/326788a0; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Janzen D.H., 1985, Illinois Natural History Survey Bulletin, V33, P141; KARBAN R, 1983, ECOLOGY, V64, P636, DOI 10.2307/1937182; Le Corff J, 2000, ENVIRON ENTOMOL, V29, P181, DOI 10.1603/0046-225X(2000)029[0181:TASVIA]2.0.CO;2; MCGUGAN BM, 1958, P 10 INT C ENT, V4, P219; MUELLER TF, 1983, ENTOMOL EXP APPL, V34, P78, DOI 10.1007/BF00300903; OHSAKI N, 1994, ECOLOGY, V75, P59, DOI 10.2307/1939382; RAUSHER MD, 1985, J INSECT PHYSIOL, V31, P873, DOI 10.1016/0022-1910(85)90105-2; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Thompson JD., 1994, COEVOLUTIONARY PROCE; Weseloh Ronald M., 1993, P203; WOOD TK, 1990, EVOLUTION, V44, P619, DOI 10.1111/j.1558-5646.1990.tb05942.x	30	148	161	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					170	173		10.1038/417170a	http://dx.doi.org/10.1038/417170a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000959				2022-12-28	WOS:000175460200042
J	McLellan, JS; Marcos, S; Prieto, PM; Burns, SA				McLellan, JS; Marcos, S; Prieto, PM; Burns, SA			Imperfect optics may be the eye's defence against chromatic blur	NATURE			English	Article							ABERRATION	The optics of the eye cause different wavelengths of light to be differentially focused at the retina. This phenomenon is due to longitudinal chromatic aberration, a wavelength-dependent change in refractive power(1). Retinal image quality may consequently vary for the different classes of cone photoreceptors, cells tuned to absorb bands of different wavelengths. For instance, it has been assumed that when the eye is focused for mid-spectral wavelengths near the peak sensitivities of long- (L) and middle( M) wavelength-sensitive cones, short-wavelength (bluish) light is so blurred that it cannot contribute to and may even impair spatial vision(2,3). These optical effects have been proposed to explain the function of the macular pigment(4), which selectively absorbs short-wavelength light, and the sparsity of short-wavelength-sensitive (S) cones(5). However, such explanations have ignored the effect of monochromatic wave aberrations present in real eyes. Here we show that, when these effects are taken into account, short wavelengths are not as blurred as previously thought, that the potential image quality for S cones is comparable to that for L and M cones, and that macular pigment has no significant function in improving the retinal image.	Schepens Eye Res Inst, Boston, MA 02114 USA; CSIC, Inst Opt, E-28006 Madrid, Spain; Univ Murcia, Lab Opt, E-30071 Murcia, Spain	Harvard University; Schepens Eye Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes); University of Murcia	McLellan, JS (corresponding author), Schepens Eye Res Inst, 20 Staniford St, Boston, MA 02114 USA.	mclellan@vision.eri.harvard.edu	Burns, Stephen/AAN-3044-2021; Burns, Stephen A/D-9259-2011; Prieto, Pedro M/A-7346-2008; Marcos, Susana/A-7765-2008	Burns, Stephen A/0000-0001-5348-035X; Prieto, Pedro M/0000-0001-6192-4053; Marcos, Susana/0000-0001-5511-1697	NEI NIH HHS [R01 EY004395, R01 EY004395-22] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004395] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BEDFORD RE, 1957, J OPT SOC AM, V47, P564; Boynton R. M., 1979, HUMAN COLOR VISION; HAEGERSTROMPORTNOY G, 1988, J OPT SOC AM A, V5, P2140, DOI 10.1364/JOSAA.5.002140; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Marcos S, 1999, VISION RES, V39, P4309, DOI 10.1016/S0042-6989(99)00145-5; Marcos S, 2001, VISION RES, V41, P3861, DOI 10.1016/S0042-6989(01)00133-X; McLellan JS, 2001, INVEST OPHTH VIS SCI, V42, P1390; MOLLON JD, 1989, J EXP BIOL, V146, P21; Mollon JD, 1982, DOC OPHTHALMOL P SER, V33, P87; Porter J, 2001, J OPT SOC AM A, V18, P1793, DOI 10.1364/JOSAA.18.001793; READING VM, 1974, J OPT SOC AM, V64, P231, DOI 10.1364/JOSA.64.000231; RYNDERS M, 1995, J OPT SOC AM A, V12, P2348, DOI 10.1364/JOSAA.12.002348; SNODDERLY DM, 1995, AM J CLIN NUTR, V62, P1448; STOCKMAN A, 1993, J OPT SOC AM A, V10, P2491, DOI 10.1364/JOSAA.10.002491; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P548, DOI 10.1097/00006324-199707000-00024; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132; WYSECKI G, 1982, COLOR SCI CONCEPTS M	17	113	122	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					174	176		10.1038/417174a	http://dx.doi.org/10.1038/417174a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000960				2022-12-28	WOS:000175460200043
J	Ouriel, K				Ouriel, K			Abdominal aortic aneurysm.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Cleveland Clin Fdn, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Ouriel, K (corresponding author), Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA.								0	7	7	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1467	1467		10.1056/NEJMicm010523	http://dx.doi.org/10.1056/NEJMicm010523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000817				2022-12-28	WOS:000175433200006
J	Launay, P; Fleig, A; Perraud, AL; Scharenberg, AM; Penner, R; Kinet, JP				Launay, P; Fleig, A; Perraud, AL; Scharenberg, AM; Penner, R; Kinet, JP			TRPM4 is a Ca2+-activated nonselective cation channel mediating cell membrane depolarization	CELL			English	Article							COLLECTING DUCT CELLS; APICAL MEMBRANE; CALCIUM; ACTIVATION; PROTEIN; INFLUX; SYSTEM; LTRPC2; ENTRY; CA2+	Calcium-activated nonselective (CAN) cation channels are expressed in various excitable and nonexcitable cells supporting important cellular responses such as neuronal bursting activity, fluid secretion, and cardiac rhythmicity. We have cloned and characterized a second form of TRPM4, TRPM4b, a member of the TRP channel family, as a molecular candidate of a CAN channel. TRPM4b encodes a cation channel of 25 pS unitary conductance that is directly activated by [Ca2+]i with an apparent K-D of similar to400 nM. It conducts monovalent cations such as Na+ and K+ without significant permeation of Ca2+. TRPM4b is activated following receptor-mediated Ca2+ mobilization, representing a regulatory mechanism that controls the magnitude of Call influx by modulating the membrane potential and, with it, the driving force for Ca2+ entry through other Ca2+-permeable pathways.	Univ Hawaii, John A Burns Sch Med, Queens Med Ctr, Ctr Biomed Res,Lab Cell & Mol Signalling, Honolulu, HI 96813 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA	The Queen's Medical Center; University of Hawaii System; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of Washington; University of Washington Seattle	Penner, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Queens Med Ctr, Ctr Biomed Res,Lab Cell & Mol Signalling, Honolulu, HI 96813 USA.		Launay, Pierre/AAH-7076-2019	Penner, Reinhold/0000-0002-5366-1537; Fleig, Andrea/0000-0001-8396-7249	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050200, R01AI046734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040927] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI46734, R01 AI50200] Funding Source: Medline; NIGMS NIH HHS [R01 GM64091] Funding Source: Medline; NINDS NIH HHS [R01 NS40927] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen MK, 2001, J NEUROSCI, V21, P6512, DOI 10.1523/JNEUROSCI.21-17-06512.2001; Chiba T, 2000, J MEMBRANE BIOL, V174, P167, DOI 10.1007/s002320001041; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COLQUHOUN D, 1981, NATURE, V294, P752, DOI 10.1038/294752a0; EHARA T, 1988, J PHYSIOL-LONDON, V403, P117, DOI 10.1113/jphysiol.1988.sp017242; Elliott AC, 2001, CELL CALCIUM, V30, P73, DOI 10.1054/ceca.2001.0215; Floto RA, 1997, J BIOL CHEM, V272, P4753, DOI 10.1074/jbc.272.8.4753; Gao ZH, 1999, J BIOL CHEM, V274, P5972, DOI 10.1074/jbc.274.9.5972; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hofmann T, 2000, J MOL MED, V78, P14, DOI 10.1007/s001090050378; KORBMACHER C, 1995, J MEMBRANE BIOL, V146, P29; MARUYAMA Y, 1982, NATURE, V299, P159, DOI 10.1038/299159a0; MCKEMY DD, 2002, IN PRESS NATURE; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell C, 2002, MOL CELL, V9, P229, DOI 10.1016/S1097-2765(02)00448-3; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; NONAKA T, 1995, BBA-BIOMEMBRANES, V1233, P163, DOI 10.1016/0005-2736(94)00241-G; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; PARTRIDGE LD, 1994, BRAIN RES REV, V19, P319, DOI 10.1016/0165-0173(94)90017-5; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; RAZANIBOROUJERDI S, 1993, BRAIN RES, V623, P195, DOI 10.1016/0006-8993(93)91427-T; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Siemen D, 1993, EXS, V66, P3; Thorn P, 1993, EXS, V66, P185; VANDENABBEELE T, 1994, PFLUG ARCH EUR J PHY, V427, P56, DOI 10.1007/BF00585942; WANG Q, 1993, PFLUG ARCH EUR J PHY, V423, P28, DOI 10.1007/BF00374957; Xu XZS, 2001, P NATL ACAD SCI USA, V98, P10692, DOI 10.1073/pnas.191360198; YELLEN G, 1982, NATURE, V296, P357, DOI 10.1038/296357a0	30	512	559	3	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					397	407		10.1016/S0092-8674(02)00719-5	http://dx.doi.org/10.1016/S0092-8674(02)00719-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015988	Bronze			2022-12-28	WOS:000175412100014
J	Eddy, SR				Eddy, SR			Computational Genomics of noncoding RNA genes	CELL			English	Review							IDENTIFICATION	The number of known noncoding RNA genes is expanding rapidly. Computational analysis of genome sequences, which has been revolutionary for protein gene analysis, should also be able to address questions of the number and diversity of noncoding RNA genes. However, noncoding RNAs present computational genomics with a new set of challenges.	Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Eddy, SR (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, St Louis, MO 63110 USA.	eddy@genetics.wustl.edu		Eddy, Sean/0000-0001-6676-4706				ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Atkins J.F, 1999, RNA WORLD; Carter RJ, 2001, NUCLEIC ACIDS RES, V29, P3928, DOI 10.1093/nar/29.19.3928; DANDEKAR T, 1995, TRENDS GENET, V11, P45, DOI 10.1016/S0168-9525(00)88996-9; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Eliceiri GL, 1999, CELL MOL LIFE SCI, V56, P22, DOI 10.1007/s000180050003; Erdmann VA, 2001, NUCLEIC ACIDS RES, V29, P189, DOI 10.1093/nar/29.1.189; Galtier N, 1997, J MOL EVOL, V44, P632, DOI 10.1007/PL00006186; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kelley RL, 2000, CELL, V103, P9, DOI 10.1016/S0092-8674(00)00099-4; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Rivas E, 2001, CURR BIOL, V11, P1369, DOI 10.1016/S0960-9822(01)00401-8; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001	18	177	196	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					137	140		10.1016/S0092-8674(02)00727-4	http://dx.doi.org/10.1016/S0092-8674(02)00727-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007398	Bronze			2022-12-28	WOS:000175082600001
J	Marin, EC; Jefferis, GSXE; Komiyama, T; Zhu, HT; Luo, LQ				Marin, EC; Jefferis, GSXE; Komiyama, T; Zhu, HT; Luo, LQ			Representation of the glomerular olfactory map in the Drosophila brain	CELL			English	Article							RECEPTOR GENE-EXPRESSION; ANTENNAL LOBE; ODORANT RECEPTORS; SENSORY MAP; MELANOGASTER; BULB; ORGANIZATION; NEURONS; COMBINATORIAL; INFORMATION	We explored how the odor map in the Drosophila antennal lobe is represented in higher olfactory centers, the mushroom body and lateral horn. Systematic single-cell tracing of projection neurons (PNs) that send dendrites to specific glomeruli in the antennal lobe revealed their stereotypical axon branching patterns and terminal fields in the lateral horn. PNs with similar axon terminal fields tend to receive input from neighboring glomeruli. The glomerular classes of individual PNs could be accurately predicted based solely on their axon projection patterns. The sum of these patterns defines an "axon map" in higher olfactory centers reflecting which olfactory receptors provide input. This map is characterized by spatial convergence and divergence of PN axons, allowing integration of olfactory information.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Program Neurosci, Stanford, CA 94305 USA	Stanford University; Stanford University	Jefferis, GSXE (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	jefferis@stanford.edu; lluo@stanford.edu	Jefferis, Gregory/C-6386-2012	Luo, Liqun/0000-0001-5467-9264; Jefferis, Gregory/0000-0002-0587-9355; Komiyama, Takaki/0000-0001-9609-4600				AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HOMBERG U, 1988, CELL TISSUE RES, V254, P255; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; KNUDSEN EI, 1995, ANNU REV NEUROSCI, V18, P19, DOI 10.1146/annurev.ne.18.030195.000315; Laissue PP, 1999, J COMP NEUROL, V405, P543; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MALUN D, 1993, J COMP NEUROL, V329, P143, DOI 10.1002/cne.903290202; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; NIGHORN A, 1991, NEURON, V6, P455, DOI 10.1016/0896-6273(91)90253-V; Penfield W., 1950, CEREBRAL CORTEX MAN; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Tsuboi A, 1999, J NEUROSCI, V19, P8409; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Venables W.N., 2013, MODERN APPL STAT S; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	45	347	350	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					243	255		10.1016/S0092-8674(02)00700-6	http://dx.doi.org/10.1016/S0092-8674(02)00700-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007410	Bronze			2022-12-28	WOS:000175082600013
J	Kuo, YH				Kuo, YH			Extrapolation of correlation between 2 variables in 4 general medical journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				MONICA PROJECT POPULATIONS; STEM-CELL TRANSPLANTATION; BONE-MINERAL DENSITY; VIRAL-LOAD KINETICS; UNITED-STATES; INCOME INEQUALITY; HEART-DISEASE; EVENT RATES; MORTALITY; RISK	Context An estimated correlation between 2 variables is valid only within the range of observed data. Extrapolation is risky and should be performed with caution. Methods To assess the prevalence of problems with data extrapolation in the medical literature, all articles published from January through June 2000 in BMJ, JAMA, The Lancet, and The New England Journal of Medicine (NEJM) were reviewed manually. Articles containing at least 1 scatterplot with raw data and a corresponding fitted regression line were included in the analysis. Articles were considered to involve extrapolation if they contained at least I fitted line beyond the observed data in any scatter plot. Results A total of 178 articles presenting at least 1 scatterplot were identified. Among them, 37 articles (21%) (5 from BMJ, 7 from JAMA, 23 from The Lancet, and 2 from NEJM) were included. Twenty-two articles (59% [95% confidence interval, 42%-75%]) from all 4 journals involved extrapolation. None changed the line type to indicate extrapolation. Four articles (11%) contained a plot in which the fitted line reached unreasonable or meaningless values. Three articles (8%) stated explicit conclusions about values outside the range of the observed data. Conclusions A high proportion of the articles analyzed from all 4 weekly general medical journals involved extrapolation without indication. Researchers, reviewers, and editors should be aware of this problem and work to eliminate it.	Meridian Hlth Syst, Jersey Shore Med Ctr, Dept Res, Neptune, NJ 07753 USA	Jersey Shore University Medical Center	Kuo, YH (corresponding author), Meridian Hlth Syst, Jersey Shore Med Ctr, Dept Res, 1945 State Rte 33, Neptune, NJ 07753 USA.							Albers GW, 2000, JAMA-J AM MED ASSOC, V283, P1145, DOI 10.1001/jama.283.9.1145; Altman DG, 1998, BRIT MED J, V317, P409; Armitage P., 2001, STAT METHODS MED RES; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Copas JB, 2000, BRIT MED J, V320, P417, DOI 10.1136/bmj.320.7232.417; DANIEL WW, 1999, BIOSTATISTICS FDN AN; Diskin CJ, 2000, LANCET, V355, P901, DOI 10.1016/S0140-6736(00)01097-7; Donnelly R, 2000, BRIT MED J, V320, P1062, DOI 10.1136/bmj.320.7241.1062; Doty RL, 1997, NEW ENGL J MED, V336, P1918, DOI 10.1056/NEJM199706263362617; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Ebrahim SH, 2000, JAMA-J AM MED ASSOC, V283, P361, DOI 10.1001/jama.283.3.361; Emery VC, 2000, LANCET, V355, P2032, DOI 10.1016/S0140-6736(00)02350-3; Fukumoto M, 1999, LANCET, V354, P1790, DOI 10.1016/S0140-6736(99)03746-0; Gallagher RDP, 2000, JAMA-J AM MED ASSOC, V283, P2955, DOI 10.1001/jama.283.22.2955; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Green A, 2000, LANCET, V355, P873; Haber HP, 2000, LANCET, V355, P1239, DOI 10.1016/S0140-6736(00)02092-4; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hauben E, 2000, LANCET, V355, P286, DOI 10.1016/S0140-6736(99)05140-5; Hutter JC, 2000, JAMA-J AM MED ASSOC, V283, P2128, DOI 10.1001/jama.283.16.2128; Idle JR, 2000, LANCET, V355, P1824, DOI 10.1016/S0140-6736(05)73082-8; Jokeit H, 2000, LANCET, V355, P1018, DOI 10.1016/S0140-6736(05)74765-6; Karlsson MK, 2000, LANCET, V355, P469; Kuo YH, 2000, LANCET, V356, P1352, DOI 10.1016/S0140-6736(05)74259-8; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Laureys S, 2000, LANCET, V355, P1790, DOI 10.1016/S0140-6736(00)02271-6; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; Packham C, 2000, BMJ-BRIT MED J, V320, P1583, DOI 10.1136/bmj.320.7249.1583; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; Port S, 2000, LANCET, V355, P175, DOI 10.1016/S0140-6736(99)07051-8; Powers HJ, 2000, LANCET, V355, P64, DOI 10.1016/S0140-6736(99)00223-8; Ross NA, 2000, BRIT MED J, V320, P898, DOI 10.1136/bmj.320.7239.898; Rubinstein S, 2000, JAMA-J AM MED ASSOC, V283, P1569, DOI 10.1001/jama.283.12.1569; Schairer C, 2000, JAMA-J AM MED ASSOC, V283, P485, DOI 10.1001/jama.283.4.485; Smith JK, 1999, JAMA-J AM MED ASSOC, V281, P1722, DOI 10.1001/jama.281.18.1722; Spivak JL, 2000, LANCET, V355, P1707, DOI 10.1016/S0140-6736(00)02249-2; Stark J, 2000, LANCET, V355, P1004, DOI 10.1016/S0140-6736(00)90001-1; Tunstall-Pedoe H, 2000, LANCET, V355, P688, DOI 10.1016/S0140-6736(99)11181-4; van der Gaag MS, 2000, LANCET, V355, P1522, DOI 10.1016/S0140-6736(00)02172-3; von Dadelszen P, 2000, LANCET, V355, P87, DOI 10.1016/S0140-6736(98)08049-0; Wong CA, 2000, LANCET, V355, P1399, DOI 10.1016/S0140-6736(00)02138-3; Ylitalo N, 2000, LANCET, V355, P2194, DOI 10.1016/S0140-6736(00)02402-8; Yokota F, 2000, JAMA-J AM MED ASSOC, V283, P2716, DOI 10.1001/jama.283.20.2716	44	9	11	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2815	2817		10.1001/jama.287.21.2815	http://dx.doi.org/10.1001/jama.287.21.2815			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038921	Bronze			2022-12-28	WOS:000176002200018
J	Kadau, K; Germann, TC; Lomdahl, PS; Holian, BL				Kadau, K; Germann, TC; Lomdahl, PS; Holian, BL			Microscopic view of structural phase transitions induced by shock waves	SCIENCE			English	Article							SCALE MOLECULAR-DYNAMICS; SIMULATIONS; TRANSFORMATION; MARTENSITE; FRICTION; SILICON; IRON; FE	Multimillion-atom molecular-dynamics simulations are used to investigate the shock-induced phase transformation of solid iron. Above a critical shock strength, many small close-packed grains nucleate in the shock-compressed body-centered cubic crystal growing on a picosecond time scale to form larger, energetically favored grains. A split two-wave shock structure is observed immediately above this threshold, with an elastic precursor ahead of the lagging transformation wave. For even higher shock strengths, a single, overdriven wave is obtained. The dynamics and orientation of the developing close-packed grains depend on the shock strength and especially on the crystallographic shock direction. Orientational relations between the unshocked and shocked regions are similar to those found for the temperature-driven martensitic transformation in iron and its alloys.	Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; Univ Duisburg Gesamthsch, D-47048 Duisburg, Germany; Los Alamos Natl Lab, Div Appl Phys, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; University of Duisburg Essen; United States Department of Energy (DOE); Los Alamos National Laboratory	Kadau, K (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA.	kkadau@lanl.gov	Germann, Timothy C./ABF-5034-2021	Germann, Timothy C./0000-0002-6813-238X				BASKES MI, 1992, PHYS REV B, V46, P2727, DOI 10.1103/PhysRevB.46.2727; Beazley DM, 1997, COMPUT PHYS, V11, P230; Belonoshko AB, 1997, PHYS EARTH PLANET IN, V102, P171, DOI 10.1016/S0031-9201(97)00014-9; BHUSHAN B, 1995, NATURE, V374, P607, DOI 10.1038/374607a0; Brown JM, 2000, J APPL PHYS, V88, P5496, DOI 10.1063/1.1319320; CIEPLAK M, 1994, SCIENCE, V265, P1209, DOI 10.1126/science.265.5176.1209; Cohen RE, 1997, PHYS REV B, V56, P8575, DOI 10.1103/PhysRevB.56.8575; CZICHOS H, 1989, MARTENSITIC TRANSFOR, pCH1; DAW MS, 1993, MATER SCI REP, V9, P251, DOI 10.1016/0920-2307(93)90001-U; DELAEY L, 1991, MATERIALS SCI TECHNO, V5, P339; DUVAL GE, 1977, REV MOD PHYS, V49, P523, DOI 10.1103/RevModPhys.49.523; Entel P, 1998, PHASE TRANSIT, V65, P79, DOI 10.1080/01411599808209282; FOILES SM, 1988, PHYS REV B, V38, P12643, DOI 10.1103/PhysRevB.38.12643; Germann TC, 2000, PHYS REV LETT, V84, P5351, DOI 10.1103/PhysRevLett.84.5351; Gumbsch P, 1999, SCIENCE, V283, P965, DOI 10.1126/science.283.5404.965; HARRISON RJ, 1989, ATOMISTIC SIMULATION OF MATERIALS : BEYOND PAIR POTENTIALS, P219; Holian B. L., 1998, Journal of Computer-Aided Materials Design, V5, P207, DOI 10.1023/A:1008641217554; Holian BL, 1998, SCIENCE, V280, P2085, DOI 10.1126/science.280.5372.2085; Kadau K, 2001, J PHYS IV, V11, P17, DOI 10.1051/jp4:2001803; KUBLER J, 1994, ELECT STRUCTURE A 1, V3, pCH1; Lomdahl P. S., 1993, Proceedings SUPERCOMPUTING '93, P520, DOI 10.1145/169627.169794; Loveridge-Smith A, 2001, PHYS REV LETT, V86, P2349, DOI 10.1103/PhysRevLett.86.2349; Marder M, 1999, COMPUT SCI ENG, V1, P48, DOI 10.1109/5992.790587; Matsui M, 1997, PHYS EARTH PLANET IN, V103, P55, DOI 10.1016/S0031-9201(97)00020-4; McQueen R.G., 1970, HIGH VELOCITY IMPACT, P293; Meyer R, 1998, PHYS REV B, V57, P5140, DOI 10.1103/PhysRevB.57.5140; MEYERS MA, 1994, DYNAMIC BEHAV MAT, pCH8; Rapaport D., 2004, ART MOL DYNAMICS SIM; ROSE JH, 1984, PHYS REV B, V29, P2963, DOI 10.1103/PhysRevB.29.2963; RUBINI S, 1993, PHYS REV B, V48, P99, DOI 10.1103/PhysRevB.48.99; Shao Y, 1996, METALL MATER TRANS A, V27, P1477, DOI 10.1007/BF02649808; Shimojo F, 2000, PHYS REV LETT, V84, P3338, DOI 10.1103/PhysRevLett.84.3338; WARREN MS, 1998, P 1998 ACM IEEE SC98; WAYMAN CM, 1996, PHYSICAL METALLURGY, V2, pCH15; Zhou SJ, 1998, SCIENCE, V279, P1525, DOI 10.1126/science.279.5356.1525; Zhou SJ, 1997, PHYS REV LETT, V78, P479, DOI 10.1103/PhysRevLett.78.479	36	412	430	4	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1681	1684		10.1126/science.1070375	http://dx.doi.org/10.1126/science.1070375			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040192				2022-12-28	WOS:000175976200056
J	Moon, RT; Bowerman, B; Boutros, M; Perrimon, N				Moon, RT; Bowerman, B; Boutros, M; Perrimon, N			The promise and perils of Wnt signaling through beta-catenin	SCIENCE			English	Editorial Material							GLYCOGEN-SYNTHASE KINASE-3; CAENORHABDITIS-ELEGANS; XENOPUS EMBRYOS; C-ELEGANS; DROSOPHILA HOMOLOG; SPEMANN ORGANIZER; CELL POLARITY; GENE; PATHWAY; WINGLESS	Writ pathways are involved in the control of gene expression, cell behavior, cell adhesion, and cell polarity. In addition, they often operate in combination with other signaling pathways. The Wnt/beta-catenin pathway is the best studied of the Wnt pathways and is highly conserved through evolution. In this pathway, Wnt signaling inhibits the degradation of beta-catenin, which can regulate transcription of a number of genes. Some of the genes regulated are those associated with cancer and other diseases (for example, colorectal cancer and melanomas). As a result, components of the Wnt/beta-catenin pathway are promising targets in the search for therapeutic agents. Information about Writ pathways is available both in canonical terms and at the species level. In addition to the canonical Wnt/beta-catenin pathway, information is now available for Drosophila, Caenorhabditis elegans, and Xenopus. The STKE Connections Maps for these pathways provide an important toot in accessing this large body of complex information.	Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Ctr Dev Biol, Seattle, WA 98195 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oregon; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moon, RT (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA.		Moon, Randall T/B-1743-2014; Boutros, Michael/C-3566-2008; Moon, Randall/M-5605-2019	Moon, Randall T/0000-0002-9352-1408; Boutros, Michael/0000-0002-9458-817X; Moon, Randall/0000-0002-9352-1408; Perrimon, Norbert/0000-0001-7542-472X				Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; BOUTROS M, 2002, SCI STKE; BOWERMAN B, 2002, SCI STKE; CABRERA CV, 1987, CELL, V50, P659, DOI 10.1016/0092-8674(87)90039-0; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; GOLDSTEIN B, 1995, DEVELOPMENT, V121, P1227; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Heikkila M, 2001, J EXP ZOOL, V290, P616, DOI 10.1002/jez.1112; Herman MA, 2001, DEVELOPMENT, V128, P581; HINCK L, 1994, J CELL BIOL, V124, P729, DOI 10.1083/jcb.124.5.729; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Lee E, 2001, J CELL BIOL, V154, P983, DOI 10.1083/jcb.200102074; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Lin KM, 1997, P NATL ACAD SCI USA, V94, P11196, DOI 10.1073/pnas.94.21.11196; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Lucas FR, 1998, J CELL SCI, V111, P1351; Maloof JN, 1999, DEVELOPMENT, V126, P37; Martin G, 2001, BIOESSAYS, V23, P865, DOI 10.1002/bies.1126; Megason SG, 2002, DEVELOPMENT, V129, P2087; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; MOON R, 2002, SCI STKE; Morfini G, 2002, EMBO J, V21, P281, DOI 10.1093/emboj/21.3.281; Niehrs C, 1999, TRENDS GENET, V15, P314, DOI 10.1016/S0168-9525(99)01767-9; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Polakis P, 2000, GENE DEV, V14, P1837; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wright M, 1999, BIOCHEM BIOPH RES CO, V263, P384, DOI 10.1006/bbrc.1999.1344; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	46	844	930	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1644	1646		10.1126/science.1071549	http://dx.doi.org/10.1126/science.1071549			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040179				2022-12-28	WOS:000175976200042
J	Sheen, J				Sheen, J			Phosphorelay and transcription control in cytokinin signal transduction	SCIENCE			English	Editorial Material							HISTIDINE KINASE; ASP PHOSPHORELAY; ARABIDOPSIS; GENES; PLANTS; EXPRESSION; MOLECULE; RECEPTOR; FAMILY; ARR1	The past decade has seen substantial advances in knowledge of molecular mechanisms and actions of plant hormones, but only in the past few years has research on cytokinins begun to hit its stride. Cytokinins are master regulators of a large number of processes in plant development, which is known to be unusually plastic and adaptive, as well as resilient and perpetual. These characteristics allow plants to respond sensitively and quickly to their environments. Recent studies have demonstrated that cytokinin signaling involves a multistep two-component signaling pathway, resulting in the development of a canonical model of cytokinin signaling that is likely representative in plants. This Viewpoint outlines this genera[ model, focusing on the specific example of Arabidopsis, and introduces the STKE Connections Maps for both the canonical module and the specific Arabidopsis Cytokinin Signaling Pathway.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Sheen, J (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	sheen@molbio.mgh.harvard.edu						Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Davies Peter J., 1995, P1; Haberer G, 2002, PLANT PHYSIOL, V128, P354, DOI 10.1104/pp.010773; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; HWANG I, UNPUB; HWANG I, 2002, PLANT PHYSIOL, V29, P500; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Kakimoto T, 1996, SCIENCE, V274, P982, DOI 10.1126/science.274.5289.982; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; Lohrmann J, 2002, PLANT PHYSIOL, V128, P363, DOI 10.1104/pp.010907; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; ROLLAND F, UNPUB; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sakakibara H, 2000, PLANT MOL BIOL, V42, P273, DOI 10.1023/A:1006334926388; SHEEN J, 2002, SCI STKE; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Suzuki T, 2002, PLANT CELL PHYSIOL, V43, P123, DOI 10.1093/pcp/pcf007; Suzuki T, 2000, BIOSCI BIOTECH BIOCH, V64, P2486, DOI 10.1271/bbb.64.2486; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Ueguchi C, 2001, PLANT CELL PHYSIOL, V42, P231, DOI 10.1093/pcp/pce015; Urao T, 1998, FEBS LETT, V427, P175, DOI 10.1016/S0014-5793(98)00418-9; Urao T, 1999, PLANT CELL, V11, P1743, DOI 10.1105/tpc.11.9.1743; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Yamada H, 2001, PLANT CELL PHYSIOL, V42, P1017, DOI 10.1093/pcp/pce127; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	31	71	76	3	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1650	1652		10.1126/science.1071883	http://dx.doi.org/10.1126/science.1071883			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040183				2022-12-28	WOS:000175976200046
J	Shidara, M; Richmond, BJ				Shidara, M; Richmond, BJ			Anterior cingulate: Single neuronal signals related to degree of reward expectancy	SCIENCE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; RHESUS-MONKEY; SYMPTOM PROVOCATION; MOTOR AREAS; HUMAN BRAIN; CORTEX; ACTIVATION; BEHAVIOR; SELECTION; TOMOGRAPHY	As monkeys perform schedules containing several trials with a visual cue indicating reward proximity, their error rates decrease as the number of remaining trials decreases, suggesting that their motivation and/or reward expectancy increases as the reward approaches. About one-third of single neurons recorded in the anterior cingulate cortex of monkeys during these reward schedules had responses that progressively changed strength with reward expectancy, an effect that disappeared when the cue was random. Alterations of this progression could be the basis for the changes from normal that are reported in anterior cingulate population activity for obsessive-compulsive disorder and drug abuse, conditions characterized by disturbances in reward expectancy.	Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA	National Institute of Advanced Industrial Science & Technology (AIST); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Shidara, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	m.shidara@aist.go.jp			NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002619, Z01MH002032, ZIAMH002032, Z01MH002619] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adinoff R, 2001, AM J PSYCHIAT, V158, P390, DOI 10.1176/appi.ajp.158.3.390; Adler CM, 2000, J PSYCHIATR RES, V34, P317, DOI 10.1016/S0022-3956(00)00022-4; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexandrov YI, 2001, ACTA PHYSIOL SCAND, V171, P87, DOI 10.1046/j.1365-201x.2001.171001087.x; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; Busatto GF, 2000, PSYCHIAT RES-NEUROIM, V99, P15, DOI 10.1016/S0925-4927(00)00050-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Drexler K, 2000, AM J ADDICTION, V9, P331; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Ingvar M, 1998, J STUD ALCOHOL, V59, P258, DOI 10.15288/jsa.1998.59.258; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Liu Z, 2000, NAT NEUROSCI, V3, P1307, DOI 10.1038/81841; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Maas LC, 1998, AM J PSYCHIAT, V155, P124, DOI 10.1176/ajp.155.1.124; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MIALLEF J, 2001, CLIN NEUROPHARMACOL, V24, P191; MORECRAFT RJ, 1993, J COMP NEUROL, V337, P669, DOI 10.1002/cne.903370411; Neisewander JL, 2000, J NEUROSCI, V20, P798, DOI 10.1523/JNEUROSCI.20-02-00798.2000; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Nimchinsky EA, 1996, J COMP NEUROL, V374, P136; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; Parkinson JA, 2000, BEHAV NEUROSCI, V114, P42, DOI 10.1037/0735-7044.114.1.42; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Procyk E, 2000, NAT NEUROSCI, V3, P502, DOI 10.1038/74880; Rainville P, 1997, SCIENCE, V277, P968, DOI 10.1126/science.277.5328.968; RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62; SAUNDERS RC, 1990, EXP BRAIN RES, V81, P443; Shidara M, 1998, J NEUROSCI, V18, P2613; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P518; Takenouchi K, 1999, NEUROSCIENCE, V93, P1271, DOI 10.1016/S0306-4522(99)00216-X; Turken AU, 1999, NAT NEUROSCI, V2, P920, DOI 10.1038/13224; VOGT BA, 1987, J COMP NEUROL, V262, P271, DOI 10.1002/cne.902620208	39	385	391	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1709	1711		10.1126/science.1069504	http://dx.doi.org/10.1126/science.1069504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040201				2022-12-28	WOS:000175976200066
J	Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R				Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R			Crystal structure and mechanism of a calcium-gated potassium channel	NATURE			English	Article							CA-2+-ACTIVATED K+ CHANNELS; MAMMALIAN SKELETAL-MUSCLE; ION CHANNELS; BACTERIAL TRANSPORT; BINDING-PROTEIN; LIGAND-BINDING; BK CHANNEL; COMPLEX; CRYSTALLOGRAPHY; CHARYBDOTOXIN		Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BJORKMAN AJ, 1994, J BIOL CHEM, V269, P30206; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadene M, 2000, ANAL CHEM, V72, P5655, DOI 10.1021/ac000811l; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cohen SL, 2001, ANNU REV BIOPH BIOM, V30, P67, DOI 10.1146/annurev.biophys.30.1.67; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P750, DOI 10.1107/S0907444997016247; Cox DH, 1997, J GEN PHYSIOL, V109, P633, DOI 10.1085/jgp.109.5.633; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Finn JT, 1996, ANNU REV PHYSIOL, V58, P395, DOI 10.1146/annurev.ph.58.030196.002143; GOLOWASCH J, 1986, J EXP BIOL, V124, P5; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; MACKINNON R, 1989, SCIENCE, V245, P1382, DOI 10.1126/science.2476850; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; MILLER C, 1985, NATURE, V313, P316, DOI 10.1038/313316a0; MOCZYDLOWSKI E, 1983, J GEN PHYSIOL, V82, P511, DOI 10.1085/jgp.82.4.511; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SACK JS, 1989, J MOL BIOL, V206, P171, DOI 10.1016/0022-2836(89)90531-7; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VERGARA C, 1983, J GEN PHYSIOL, V82, P543, DOI 10.1085/jgp.82.4.543; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; ZOU JY, 1993, J MOL BIOL, V233, P739, DOI 10.1006/jmbi.1993.1549	41	1133	1184	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					515	522		10.1038/417515a	http://dx.doi.org/10.1038/417515a			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037559				2022-12-28	WOS:000175860300033
J	Trampert, J; van Heijst, HJ				Trampert, J; van Heijst, HJ			Global azimuthal anisotropy in the transition zone	SCIENCE			English	Article							SURFACE-WAVES; SEISMIC ANISOTROPY; BOUNDARY-LAYERS; UPPER-MANTLE; CONVECTION; EARTH; OVERTONE	Surface wave dispersion measurements for Love wave overtones carry evidence of azimuthal anisotropy in the transition zone of Earth's mantle (400 to 660 kilometers deep). A Backus-Gilbert inversion of anisotropic phase velocity maps, with resolution kernels mainly sensitive to the transition zone, shows a robust long-wavelength azimuthally anisotropic velocity structure. This observation puts new constraints on the mineralogy and dynamics of the transition zone because this anisotropy may result from aligned minerals, tilted laminated structures, or even organized pockets of fluid inclusions.	Univ Utrecht, Fac Earth Sci, NL-3508 TA Utrecht, Netherlands; Shell Int Explorat & Prod BV, NL-2280 AB Rijswijk, Netherlands	Utrecht University; Royal Dutch Shell	Trampert, J (corresponding author), Univ Utrecht, Fac Earth Sci, POB 80021, NL-3508 TA Utrecht, Netherlands.		Trampert, Jeannot/B-8090-2015; Trampert, Jeannot/N-3240-2019	Trampert, Jeannot/0000-0002-5868-9491; Trampert, Jeannot/0000-0002-5868-9491				BACKUS G, 1968, GEOPHYS J ROY ASTR S, V16, P169, DOI 10.1111/j.1365-246X.1968.tb00216.x; Boehler R, 1996, PHILOS T R SOC A, V354, P1265, DOI 10.1098/rsta.1996.0048; Davies G.F., 1999, DYNAMIC EARTH PLATES; Dawson PR, 2000, PHILOS MAG A, V80, P573, DOI 10.1080/01418610008212069; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Fouch MJ, 1996, J GEOPHYS RES-SOL EA, V101, P15987, DOI 10.1029/96JB00881; Jung H, 2001, SCIENCE, V293, P1460, DOI 10.1126/science.1062235; KARATO S, 1989, SEISMIC ANISOTROPY M, P393; Karato SI, 1998, PURE APPL GEOPHYS, V151, P565, DOI 10.1007/s000240050130; Kendall J., 2000, GEOPHYSICS MONOGRAPH, V117, P133; Larson EWF, 1998, GEOPHYS J INT, V132, P654, DOI 10.1046/j.1365-246X.1998.00452.x; Laske G, 1998, GEOPHYS J INT, V132, P508, DOI 10.1046/j.1365-246X.1998.00450.x; LOVE EH, 1927, TREATISE THEORY ELAS; Mainprice D., 2000, EARTHS DEEP INTERIOR, P237, DOI [10.1029/GM117p0237, DOI 10.1029/GM117P0237]; Montagner JP, 1996, GEOPHYS J INT, V125, P229, DOI 10.1111/j.1365-246X.1996.tb06548.x; Montagner JP, 1998, PURE APPL GEOPHYS, V151, P223, DOI 10.1007/s000240050113; MONTAGNER JP, 1994, REV GEOPHYS, V32, P115, DOI 10.1029/94RG00099; MONTAGNER JP, 1986, J GEOPHYS RES, V94, P295; Mooney WD, 1998, J GEOPHYS RES-SOL EA, V103, P727, DOI 10.1029/97JB02122; Park J, 1997, GEOPHYS J INT, V129, P399, DOI 10.1111/j.1365-246X.1997.tb01591.x; Ritsema J, 1999, SCIENCE, V286, P1925, DOI 10.1126/science.286.5446.1925; ROMANOWICZ B, 1988, GEOPHYS J INT, V93, P91, DOI 10.1111/j.1365-246X.1988.tb01389.x; SMITH ML, 1973, J GEOPHYS RES, V78, P3321, DOI 10.1029/JB078i017p03321; SMITH ML, 1975, J GEOPHYS RES, V80, P1923, DOI 10.1029/JB080i014p01923; Van Heijst HJ, 1999, GEOPHYS J INT, V137, P601, DOI 10.1046/j.1365-246x.1999.00825.x; vanHeijst HJ, 1997, GEOPHYS J INT, V131, P209, DOI 10.1111/j.1365-246X.1997.tb01217.x; Vinnik L, 1998, GEOPHYS RES LETT, V25, P1995, DOI 10.1029/98GL01418; Vinnik L, 1996, GEOPHYS RES LETT, V23, P2449, DOI 10.1029/96GL02263; Wookey J, 2002, NATURE, V415, P777, DOI 10.1038/415777a	30	110	114	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1297	1299		10.1126/science.1070264	http://dx.doi.org/10.1126/science.1070264			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016310				2022-12-28	WOS:000175713000048
J	Duman-Scheel, M; Weng, L; Xin, SJ; Du, W				Duman-Scheel, M; Weng, L; Xin, SJ; Du, W			Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E	NATURE			English	Article							DEPENDENT KINASE INHIBITOR; DROSOPHILA EMBRYOGENESIS; S-PHASE; PROGRESSION; PROTEINS; SIZE; WINGLESS; TARGETS; DACAPO; ARREST	Although mutations that activate the Hedgehog (Hh) signalling pathway have been linked to several types of cancer(1), the molecular and cellular basis of Hh's ability to induce tumour formation is not well understood. We identified a mutation in patched (ptc), an inhibitor of Hh signalling, in a genetic screen for regulators of the Retinoblastoma (Rb) pathway in Drosophila. Here we show that Hh signalling promotes transcription of Cyclin E and Cyclin D, two inhibitors of Rb-2, and principal regulators of the cell cycle during development in Drosophila. Upregulation of Cyclin E expression, accomplished through binding of Cubitus interruptus (Ci) to the Cyclin E promoter, mediates the ability of Hh to induce DNA replication. Upregulation of Cyclin D expression by Hh mediates the distinct ability of Hh to promote cellular growth. The discovery of a direct connection between Hh signalling and principal cell-cycle regulators provides insight into the mechanism by which deregulated Hh signalling promotes tumour formation.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA; Univ Chicago, Ctr Mol Oncol, Chicago, IL 60637 USA; Univ Chicago, Comm Canc Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Du, W (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.				NATIONAL CANCER INSTITUTE [R01CA080871] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA080871] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; BOSCH T, 1995, OPT REV, V2, P289, DOI 10.1007/s10043-995-0289-2; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Donnellan R, 1999, FASEB J, V13, P773, DOI 10.1096/fasebj.13.8.773; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Finley RL, 1996, P NATL ACAD SCI USA, V93, P3011, DOI 10.1073/pnas.93.7.3011; Huang Z, 1998, DEVELOPMENT, V125, P3753; Johnson RL, 1995, DEVELOPMENT, V121, P4161; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Jones L, 2000, DEVELOPMENT, V127, P4619; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Milenkovic L, 1999, DEVELOPMENT, V126, P4431; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; PATEL N, 1996, IN SITU HYBRIDIZATIO, P357; Secombe J, 1998, GENETICS, V149, P1867; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wolff Tanya, 1993, P1277; Xin SJ, 2002, DEVELOPMENT, V129, P1345; XU T, 1993, DEVELOPMENT, V117, P1223; ZARKOWER D, 1993, NUCLEIC ACIDS RES, V21, P3691, DOI 10.1093/nar/21.16.3691	30	337	362	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					299	304		10.1038/417299a	http://dx.doi.org/10.1038/417299a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015606				2022-12-28	WOS:000175592100050
J	Halman, SI; Chipman, M; Parkin, PC; Wright, JG				Halman, SI; Chipman, M; Parkin, PC; Wright, JG			Are seat belt restraints as effective in school age children as in adults? A prospective crash study	BRITISH MEDICAL JOURNAL			English	Article							MOTOR-VEHICLE CRASHES; INJURIES; EXPERIENCE	Objective To study effectiveness of seat belts for protecting school age children in road vehicle crashes. Design Crash examinations by trained investigators. Setting Ten Canadian university based crash investigation centres. Subjects 470 children aged 4-14 years, with 168 selected for detailed analysis, and 1301 adults. Main outcomes measures Use of seat belts by vehicle occupants; severity of injury adjusted for age and crash severity. Results Overall, 40% (189/470) of children were unbelted. Of the 335 children in cars driven by belted adults, 73 (22%) were unbelted. The odds of sustaining fatal or moderately severe injury (injury severity score greater than or equal to4) for children in the front passenger seat was more than nine times higher for unbelted children than for belted ones (odds ratio 9.8 (95% confidence interval 2.4 to 39.4)) and for those in the rear left seat was more than two times higher for unbelted than for belted children (2.6 (1.1 to 5.9)). The protection afforded by seat belts compared favourably with the results for adults in the same seat positions (odds ratios for unbelted v belted adults of 2.4 and 2.7 for front and rear seat passengers respectively). Conclusions Seat belts helped to protect school age children from injury in road vehicle crashes. However, 40% of children were unbelted. Despite standard seat belts being designed for adults, school age children were at least as well protected as adults.	Hosp Sick Children, Div Orthopaed Surg, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Div Pediat Med, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Wright, JG (corresponding author), Hosp Sick Children, Div Orthopaed Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.							AGRAN PF, 1992, ACCIDENT ANAL PREV, V24, P349, DOI 10.1016/0001-4575(92)90047-M; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Berg MD, 2000, PEDIATRICS, V105, P831, DOI 10.1542/peds.105.4.831; COOPER PJ, 1994, ACCIDENT ANAL PREV, V26, P263, DOI 10.1016/0001-4575(94)90096-5; Corneli HM, 2000, ANN EMERG MED, V36, P340, DOI 10.1067/mem.2000.109443; DALMOTAS DJ, 1995, J TRAUMA, V38, P476, DOI 10.1097/00005373-199504000-00002; DAY TD, 1987, OVERVIEW WAY ENDCRAS; DECKER MD, 1984, JAMA-J AM MED ASSOC, V252, P2571, DOI 10.1001/jama.252.18.2571; Eurenius K, 1996, GYNECOL OBSTET INVES, V42, P73, DOI 10.1159/000291894; GLASSMAN SD, 1992, J TRAUMA, V33, P882, DOI 10.1097/00005373-199212000-00015; HOY GA, 1993, INJURY, V24, P297, DOI 10.1016/0020-1383(93)90048-B; JOHNSON DL, 1990, NEUROSURGERY, V26, P434, DOI 10.1227/00006123-199003000-00010; JOHNSTON C, 1994, PEDIATRICS, V93, P960; KELLEHER BJ, 1983, EXPT STUDY EFFECTS C; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; LANE JC, 1994, ACCIDENT ANAL PREV, V26, P813, DOI 10.1016/0001-4575(94)90058-2; Linn Shai, 1995, Annals of Epidemiology, V5, P440, DOI 10.1016/1047-2797(95)00059-3; *NAT HIGHW TRAFF S, 1996, 3 NHTSA; OSBERG JS, 1992, AM J PUBLIC HEALTH, V82, P422, DOI 10.2105/AJPH.82.3.422; PLESS B, 1996, CAN MED ASSOC J, V40, P951; STRUBLE DE, 1987, GEN CRASH3 RECONSTRU; Tumbas NS, 1988, MEASURING PROTOCOL Q; WALLER JA, 1988, J TRAUMA, V28, P1632, DOI 10.1097/00005373-198812000-00003; 2000, MMWR MORB MORTAL WKL, V49, P135	24	18	19	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1123	1125		10.1136/bmj.324.7346.1123	http://dx.doi.org/10.1136/bmj.324.7346.1123			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552LX	12003883	Bronze, Green Published			2022-12-28	WOS:000175622800017
J	Davidson, AL				Davidson, AL			Structural biology - Not just another ABC transporter	SCIENCE			English	Editorial Material							ATP-BINDING CASSETTE; CRYSTAL-STRUCTURE; SUPERFAMILY; SUBUNIT		Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine	Davidson, AL (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.							Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Davidson AL, 2002, J BACTERIOL, V184, P1225, DOI 10.1128/JB.184.5.1225-1233.2002; Dean M, 2001, J LIPID RES, V42, P1007; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200	13	15	15	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1038	1040		10.1126/science.1072484	http://dx.doi.org/10.1126/science.1072484			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004108				2022-12-28	WOS:000175565000030
J	Bentley, SD; Chater, KF; Cerdeno-Tarraga, AM; Challis, GL; Thomson, NR; James, KD; Harris, DE; Quail, MA; Kieser, H; Harper, D; Bateman, A; Brown, S; Chandra, G; Chen, CW; Collins, M; Cronin, A; Fraser, A; Goble, A; Hidalgo, J; Hornsby, T; Howarth, S; Huang, CH; Kieser, T; Larke, L; Murphy, L; Oliver, K; O'Neil, S; Rabbinowitsch, E; Rajandream, MA; Rutherford, K; Rutter, S; Seeger, K; Saunders, D; Sharp, S; Squares, R; Squares, S; Taylor, K; Warren, T; Wietzorrek, A; Woodward, J; Barrell, BG; Parkhill, J; Hopwood, DA				Bentley, SD; Chater, KF; Cerdeno-Tarraga, AM; Challis, GL; Thomson, NR; James, KD; Harris, DE; Quail, MA; Kieser, H; Harper, D; Bateman, A; Brown, S; Chandra, G; Chen, CW; Collins, M; Cronin, A; Fraser, A; Goble, A; Hidalgo, J; Hornsby, T; Howarth, S; Huang, CH; Kieser, T; Larke, L; Murphy, L; Oliver, K; O'Neil, S; Rabbinowitsch, E; Rajandream, MA; Rutherford, K; Rutter, S; Seeger, K; Saunders, D; Sharp, S; Squares, R; Squares, S; Taylor, K; Warren, T; Wietzorrek, A; Woodward, J; Barrell, BG; Parkhill, J; Hopwood, DA			Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2)	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION; CHROMOSOME; IDENTIFICATION; BIOSYNTHESIS; METABOLISM; ALIGNMENT; STRESS; MAP	Streptomyces coelicolor is a representative of the group of soil-dwelling, filamentous bacteria responsible for producing most natural antibiotics used in human and veterinary medicine. Here we report the 8,667, 507 base pair linear chromosome of this organism, containing the largest number of genes so far discovered in a bacterium. The 7,825 predicted genes include more than 20 clusters coding for known or predicted secondary metabolites. The genome contains an unprecedented proportion of regulatory genes, predominantly those likely to be involved in responses to external stimuli and stresses, and many duplicated gene sets that may represent 'tissue-specific' isoforms operating in different phases of colonial development, a unique situation for a bacterium. An ancient synteny was revealed between the central 'core' of the chromosome and the whole chromosome of pathogens Mycobacterium tuberculosis and Corynebacterium diphtheriae. The genome sequence will greatly increase our understanding of microbial life in the soil as well as aiding the generation of new drug candidates by genetic engineering.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; Natl Yang Ming Univ, Inst Genet, Taipei 112, Taiwan	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Warwick; National Yang Ming Chiao Tung University	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	david.hopwood@bbsrc.ac.uk	Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Bateman, Alex/H-2861-2019; Rutherford, Kim/Y-7995-2018; Bateman, Alex/E-6518-2011; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Bateman, Alex/0000-0002-6982-4660; Rutherford, Kim/0000-0001-6277-726X; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Harper, David/0000-0002-8313-3516; Thomson, Nicholas/0000-0002-4432-8505; Murphy, Lee/0000-0001-6467-7449; Chandra, Govind/0000-0002-7882-6676; Challis, Gregory/0000-0001-5976-3545				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bao K, 2001, GENE DEV, V15, P1518, DOI 10.1101/gad.896201; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000; Challis GL, 2000, FEMS MICROBIOL LETT, V187, P111, DOI 10.1111/j.1574-6968.2000.tb09145.x; Challis GL, 2000, CHEM BIOL, V7, P211, DOI 10.1016/S1074-5521(00)00091-0; Chater K. F., 1997, BACTERIA MULTICELLUL, P149; Chong PP, 1998, MICROBIOL-UK, V144, P193, DOI 10.1099/00221287-144-1-193; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; DAVIS NK, 1990, MOL MICROBIOL, V4, P1679, DOI 10.1111/j.1365-2958.1990.tb00545.x; Eisen JA, 2000, GENOME BIOL, V1; FRIEND EJ, 1971, J GEN MICROBIOL, V68, P187, DOI 10.1099/00221287-68-2-187; Funa N, 1999, NATURE, V400, P897, DOI 10.1038/23748; Harris DE, 2001, METH MOL B, V175, P217; Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5; Hopwood D A, 1995, Biotechnology, V28, P65; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Hopwood DA, 1999, MICROBIOL-UK, V145, P2183, DOI 10.1099/00221287-145-9-2183; Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401; IMBERT M, 1995, CURR MICROBIOL, V31, P129, DOI 10.1007/BF00294289; Jacobs C, 1999, P NATL ACAD SCI USA, V96, P5891, DOI 10.1073/pnas.96.11.5891; Kaneko T, 2000, DNA RES, V7, P331, DOI 10.1093/dnares/7.6.331; Kelemen GH, 2001, MOL MICROBIOL, V40, P804, DOI 10.1046/j.1365-2958.2001.02417.x; Kim HJ, 2000, J BACTERIOL, V182, P1313, DOI 10.1128/JB.182.5.1313-1320.2000; Krugel H, 1999, BBA-MOL CELL BIOL L, V1439, P57, DOI 10.1016/S1388-1981(99)00075-X; Kwak J, 2001, J BACTERIOL, V183, P5092, DOI 10.1128/JB.183.17.5092-5101.2001; Li N, 1998, J BACTERIOL, V180, P2450, DOI 10.1128/JB.180.9.2450-2458.1998; Lin DCH, 1998, CELL, V92, P675, DOI 10.1016/S0092-8674(00)81135-6; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; MAZODIER P, 1990, MOL GEN GENET, V222, P431, DOI 10.1007/BF00633850; Messer W, 1997, MOL MICROBIOL, V24, P1, DOI 10.1046/j.1365-2958.1997.3171678.x; Offner S, 2000, J BACTERIOL, V182, P4328, DOI 10.1128/JB.182.15.4328-4336.2000; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; PAGET MSB, 2002, CONTROL BACTERIAL GE, P105; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Poralla K, 2000, FEMS MICROBIOL LETT, V189, P93, DOI 10.1111/j.1574-6968.2000.tb09212.x; Redenbach M, 1996, MOL MICROBIOL, V21, P77, DOI 10.1046/j.1365-2958.1996.6191336.x; Revill WP, 2001, J BACTERIOL, V183, P3526, DOI 10.1128/JB.183.11.3526-3530.2001; Rodriguez E, 2001, CURR OPIN MICROBIOL, V4, P526, DOI 10.1016/S1369-5274(00)00246-0; Sezonov G, 1998, J BACTERIOL, V180, P3056, DOI 10.1128/JB.180.12.3056-3061.1998; Stachelhaus T, 1999, CHEM BIOL, V6, P493, DOI 10.1016/S1074-5521(99)80082-9; Takeyama H, 1997, MICROBIOL-UK, V143, P2725, DOI 10.1099/00221287-143-8-2725; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000; Volff JN, 1998, MOL MICROBIOL, V27, P239, DOI 10.1046/j.1365-2958.1998.00652.x; Zakrzewska-Czerwinska J, 2000, ANTON LEEUW INT J G, V78, P211, DOI 10.1023/A:1010202411244	50	2452	3465	17	495	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					141	147		10.1038/417141a	http://dx.doi.org/10.1038/417141a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000953	Bronze			2022-12-28	WOS:000175460200034
J	Giraud, E; Fardoux, L; Fourrier, N; Hannibal, L; Genty, B; Bouyer, P; Dreyfus, B; Vermeglio, A				Giraud, E; Fardoux, L; Fourrier, N; Hannibal, L; Genty, B; Bouyer, P; Dreyfus, B; Vermeglio, A			Bacteriophytochrome controls photosystem synthesis in anoxygenic bacteria	NATURE			English	Article							PHYTOCHROME; CHROMOPHORE; LIGHT; PHOTOSYNTHESIS; EXPRESSION; SIMILARITY; PERCEPTION; SENSORS; OXYGEN; REDOX	Plants use a set of light sensors to control their growth and development in response to changes in ambient light. In particular, phytochromes exert their regulatory activity by switching between a biologically inactive red-light-absorbing form (Pr) and an active far-red-light absorbing form (Pfr)(1,2). Recently, biochemical and genetic studies have demonstrated the occurrence of phytochrome-like proteins in photosynthetic and non-photosynthetic bacteria(3-7)-but little is known about their functions. Here we report the discovery of a bacteriophytochrome located downstream from the photosynthesis gene cluster in a Bradyrhizobium strain symbiont of Aeschynomene. The synthesis of the complete photosynthetic apparatus is totally under the control of this bacteriophytochrome. A similar behaviour is observed for the closely related species Rhodopseudomonas palustris, but not for the more distant anoxygenic photosynthetic bacteria of the genus Rhodobacter, Rubrivivax or Rhodospirillum. Unlike other (bacterio) phytochromes, the carboxy-terminal domain of this bacteriophytochrome contains no histidine kinase features. This suggests a light signalling pathway involving direct protein-protein interaction with no phosphorelay cascade. This specific mechanism of regulation may represent an important ecological adaptation to optimize the plant-bacteria interaction.	Univ Mediterranee CEA1000, CEA Cadarache, DEVM Lab Bioenerget Cellulaire, CEA,CNRS,UMR 163, F-13108 St Paul Les Durance, France; CEA, DEVM Lab Ecophysiol Photosynth, CEA Cadarache, CEA,CNRS,UMR 163, F-13108 St Paul Les Durance, France; ENSAM, INRA, CIRAD,IRD,Lab Symbioses Trop & Mediterraneennes, LSTM TA 10,UMR 113, F-34398 Montpellier, France	CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Arts et Metiers Institute of Technology; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Vermeglio, A (corresponding author), Univ Mediterranee CEA1000, CEA Cadarache, DEVM Lab Bioenerget Cellulaire, CEA,CNRS,UMR 163, F-13108 St Paul Les Durance, France.		Giraud, Eric/GLS-1036-2022					Bhoo SH, 2001, NATURE, V414, P776, DOI 10.1038/414776a; BOIVIN C, 1990, PLANT CELL, V2, P1157, DOI 10.1105/tpc.2.12.1157; CLAYTON RK, 1960, BIOCHIM BIOPHYS ACTA, V37, P503, DOI 10.1016/0006-3002(60)90507-2; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Fleischman D, 1998, BBA-BIOENERGETICS, V1364, P17, DOI 10.1016/S0005-2728(98)00011-5; Giraud E, 2000, P NATL ACAD SCI USA, V97, P14795, DOI 10.1073/pnas.250484097; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; Hughes J, 1997, NATURE, V386, P663, DOI 10.1038/386663a0; Jiang ZY, 1999, SCIENCE, V285, P406, DOI 10.1126/science.285.5426.406; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KOKOTEK W, 1989, GENE, V84, P467, DOI 10.1016/0378-1119(89)90522-2; LI LM, 1992, J BIOL CHEM, V267, P19204; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; PONNAMPALAM SN, 1995, J BACTERIOL, V177, P2990, DOI 10.1128/jb.177.11.2990-2997.1995; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Yurkov V, 1998, PHOTOSYNTH RES, V57, P117, DOI 10.1023/A:1006097120530; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	22	167	180	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					202	205		10.1038/417202a	http://dx.doi.org/10.1038/417202a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000965				2022-12-28	WOS:000175460200049
J	Panda, S; Antoch, MP; Miller, BH; Su, AI; Schook, AB; Straume, M; Schultz, PG; Kay, SA; Takahashi, JS; Hogenesch, JB				Panda, S; Antoch, MP; Miller, BH; Su, AI; Schook, AB; Straume, M; Schultz, PG; Kay, SA; Takahashi, JS; Hogenesch, JB			Coordinated transcription of key pathways in the mouse by the circadian clock	CELL			English	Article							FRONTAL-LOBE EPILEPSY; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; ENDOPLASMIC-RETICULUM; HUMAN GENOME; PROTEIN; RECEPTOR; RHYTHMS; DROSOPHILA; RAT	In mammals, circadian control of physiology and behavior is driven by a master pacemaker located in the suprachiasmatic nuclei (SCN) of the hypothalamus. We have used gene expression profiling to identify cycling transcripts in the SCN and in the liver. Our analysis revealed similar to650 cycling transcripts and showed that the majority of these were specific to either the SCN or the liver. Genetic and genomic analysis suggests that a relatively small number of output genes are directly regulated by core oscillator components. Major processes regulated by the SCN and liver were found to be under circadian regulation. Importantly, rate-limiting steps in these various pathways were key sites of circadian control, highlighting the fundamental role that circadian clocks play in cellular and organismal physiology.	Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; Northwestern Univ, Dept Neurobiol & Physiol, Howard Hughes Med Inst, Evanston, IL 60208 USA; Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Virginia, Dept Stat, Charlottesville, VA 22904 USA	Novartis; Howard Hughes Medical Institute; Northwestern University; Scripps Research Institute; Scripps Research Institute; University of Virginia	Hogenesch, JB (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	hogenesch@gnf.org	Takahashi, Joseph S./Y-2781-2019; Panda, Satchidananda/J-6891-2012; Takahashi, Joseph S/E-8482-2012; Kay, Steve A/F-6025-2011	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Kay, Steve A/0000-0002-0402-2878; Su, Andrew I./0000-0002-9859-4104; Antoch, mantoch/0000-0003-3001-8511	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51573] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ARIAS IM, 2001, LIVER BIOL PATHOPHYS; BESSONE R, 1985, CELL TISSUE RES, V240, P393; BRAKS JAM, 1994, CELL, V78, P263, DOI 10.1016/0092-8674(94)90296-8; BURR WA, 1975, LANCET, V2, P1277; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; CASTELLO A, 1995, BIOCHEM J, V309, P271, DOI 10.1042/bj3090271; Claridge-Chang A, 2001, NEURON, V32, P657, DOI 10.1016/S0896-6273(01)00515-3; Cui Y, 1998, MOL CELL BIOL, V18, P1506, DOI 10.1128/MCB.18.3.1506; De Fusco M, 2000, NAT GENET, V26, P275; del Pozo JC, 2000, PLANT MOL BIOL, V44, P123, DOI 10.1023/A:1006413007456; Derrien A, 2001, J BIOL CHEM, V276, P48532, DOI 10.1074/jbc.M108862200; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; FOCAN C, 1995, PHARMACOL THERAPEUT, V67, P1, DOI 10.1016/0163-7258(95)00009-6; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hirst J, 1999, MOL BIOL CELL, V10, P2787, DOI 10.1091/mbc.10.8.2787; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ibata Y, 1999, FRONT NEUROENDOCRIN, V20, P241, DOI 10.1006/frne.1999.0180; Ioannou YA, 2001, NAT REV MOL CELL BIO, V2, P657, DOI 10.1038/35089558; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; KIMBALL SR, 1994, BIOCHIMIE, V76, P729, DOI 10.1016/0300-9084(94)90077-9; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Kornmann B, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.11.e51; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Kullak-Ublick GA, 2000, J HEPATOL, V32, P3, DOI 10.1016/S0168-8278(00)80411-0; la Fleur SE, 2001, DIABETES, V50, P1237, DOI 10.2337/diabetes.50.6.1237; LABRECQUE G, 1991, CHRONOBIOL INT, V8, P361, DOI 10.3109/07420529109059172; LAKE BG, 1976, CHEM-BIOL INTERACT, V12, P81, DOI 10.1016/0009-2797(76)90069-7; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lara J, 1999, J NEUROPHYSIOL, V82, P1317, DOI 10.1152/jn.1999.82.3.1317; LARSON DE, 1991, BIOCHEM CELL BIOL, V69, P5, DOI 10.1139/o91-002; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; LORENT K, 1994, DIFFERENTIATION, V55, P213, DOI 10.1046/j.1432-0436.1994.5530213.x; Lovell PV, 2001, J NEUROSCI, V21, P3429, DOI 10.1523/JNEUROSCI.21-10-03429.2001; MACKIN RB, 1991, ENDOCRINOLOGY, V129, P2263, DOI 10.1210/endo-129-4-2263; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Michal G, 1999, BIOCH PATHWAYS; NEWBY LM, 1993, GENETICS, V135, P1077; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phillips HA, 2001, AM J HUM GENET, V68, P225, DOI 10.1086/316946; Pruitt KD, 2000, TRENDS GENET, V16, P44, DOI 10.1016/S0168-9525(99)01882-X; Raden D, 1998, MOL BIOL CELL, V9, P117, DOI 10.1091/mbc.9.1.117; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rhoads DB, 1998, J BIOL CHEM, V273, P9510, DOI 10.1074/jbc.273.16.9510; Romisch K, 1999, J CELL SCI, V112, P4185; Salcini AE, 2001, NAT CELL BIOL, V3, P755, DOI 10.1038/35087075; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; Seaman MNJ, 1997, J CELL BIOL, V137, P79, DOI 10.1083/jcb.137.1.79; SEITE R, 1985, Chronobiology International, V2, P69, DOI 10.3109/07420528509055546; SHAPIRO DJ, 1969, BIOCHEM BIOPH RES CO, V37, P867, DOI 10.1016/0006-291X(69)90972-3; SHINOHARA K, 1991, NEUROSCI LETT, V129, P59, DOI 10.1016/0304-3940(91)90720-E; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Wang Y, 2001, BMC Dev Biol, V1, P9, DOI 10.1186/1471-213X-1-9; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Yoshimori T, 2000, MOL BIOL CELL, V11, P747, DOI 10.1091/mbc.11.2.747; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	73	1743	1800	8	184	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					307	320		10.1016/S0092-8674(02)00722-5	http://dx.doi.org/10.1016/S0092-8674(02)00722-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015981	Bronze			2022-12-28	WOS:000175412100007
J	Klappacher, GW; Lunyak, VV; Sykes, DB; Sawka-Verhelle, D; Sage, J; Brard, G; Ngo, SD; Gangadharan, D; Jacks, T; Kamps, MP; Rose, DW; Rosenfeld, MG; Glass, CK				Klappacher, GW; Lunyak, VV; Sykes, DB; Sawka-Verhelle, D; Sage, J; Brard, G; Ngo, SD; Gangadharan, D; Jacks, T; Kamps, MP; Rose, DW; Rosenfeld, MG; Glass, CK			An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation	CELL			English	Article							DEAD BOX PROTEIN; DNA-BINDING DOMAIN; TRANSCRIPTION FACTORS; COMBINATORIAL INTERACTIONS; INTERSTITIAL COLLAGENASE; TARGETED DISRUPTION; SIGNALING PATHWAYS; RAS; EXPRESSION; ACTIVATION	Defining the molecular mechanisms that coordinately regulate proliferation and differentiation is a central issue in development. Here, we describe a mechanism in which induction of the Ets repressor METS/PE1 links terminal differentiation to cell cycle arrest. Using macrophages as a model, we provide evidence that METS/PE1 blocks Ras-dependent proliferation without inhibiting Ras-dependent expression of cell type-specific genes by selectively replacing Ets activators on the promoters of cell cycle control genes. Antiproliferative effects of METS require its interaction with DP103, a DEAD box-containing protein that assembles a novel corepressor complex. Functional interactions between the METS/DP103 complex and E2F/pRB family proteins are also necessary for inhibition of cellular proliferation, suggesting a combinatorial code that directs permanent cell cycle exit during terminal differentiation.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Glass, CK (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021; lunyak, victoria/R-3765-2017	Glass, Christopher/0000-0003-4344-3592; lunyak, victoria/0000-0001-9093-2714	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aasland R, 1996, TRENDS BIOCHEM SCI, V21, P87, DOI 10.1016/S0968-0004(96)30009-1; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; BORLES JC, 1995, NATURE, V377, P635; Calvo KR, 2000, MOL CELL BIOL, V20, P3274, DOI 10.1128/MCB.20.9.3274-3285.2000; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Graves BJ, 1998, ADV CANCER RES, V75, P1, DOI 10.1016/S0065-230X(08)60738-1; Grundhoff AT, 1999, J BIOL CHEM, V274, P19136, DOI 10.1074/jbc.274.27.19136; Guidez F, 1998, MOL CELL BIOL, V18, P3851, DOI 10.1128/MCB.18.7.3851; Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7; Hecht A, 1999, METHOD ENZYMOL, V304, P399; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; JIANG J, 1993, EMBO J, V12, P3201, DOI 10.1002/j.1460-2075.1993.tb05989.x; JIN DI, 1995, MOL CELL BIOL, V15, P693; KIROV N, 1993, EMBO J, V12, P3193, DOI 10.1002/j.1460-2075.1993.tb05988.x; Kolch W, 1996, ONCOGENE, V13, P1305; LANGER SJ, 1992, MOL CELL BIOL, V12, P5355, DOI 10.1128/MCB.12.12.5355; Li AC, 1998, J BIOL CHEM, V273, P5389, DOI 10.1074/jbc.273.9.5389; Mavrothalassitis G, 2000, ONCOGENE, V19, P6524, DOI 10.1038/sj.onc.1204045; McCormick Frank, 1999, Trends in Cell Biology, V9, pM53, DOI 10.1016/S0962-8924(99)01668-2; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MOULTON KS, 1994, MOL CELL BIOL, V14, P4408, DOI 10.1128/MCB.14.7.4408; MUTHUSAMY N, 1995, NATURE, V377, P639, DOI 10.1038/377639a0; Olson MF, 2000, SEMIN IMMUNOL, V12, P63, DOI 10.1006/smim.2000.0208; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Ou QL, 2001, MOL ENDOCRINOL, V15, P69, DOI 10.1210/me.15.1.69; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; REDDY MA, 1992, MOL ENDOCRINOL, V6, P1051, DOI 10.1210/me.6.7.1051; ROSE DW, 1999, NUCL RECEPTORS PRACT, P199; ROUSSEL MF, 1994, ONCOGENE, V9, P405; SAARIALHOKERE UK, 1993, J BIOL CHEM, V268, P17354; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127; SGOURAS DN, 1995, EMBO J, V14, P4781, DOI 10.1002/j.1460-2075.1995.tb00160.x; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; STACEY DW, 1988, COLD SPRING HARB SYM, V53, P871, DOI 10.1101/SQB.1988.053.01.100; STACEY KJ, 1995, MOL CELL BIOL, V15, P3430; Sullivan J, 1997, J BIOL CHEM, V272, P1943, DOI 10.1074/jbc.272.3.1943; Sykes DB, 2001, BLOOD, V98, P2308, DOI 10.1182/blood.V98.8.2308; Takahashi Y, 2000, GENE DEV, V14, P804; Tan PBO, 1999, TRENDS GENET, V15, P145, DOI 10.1016/S0168-9525(99)01694-7; TREIER M, 1995, CELL, V83, P753, DOI 10.1016/0092-8674(95)90188-4; WASSARMAN DA, 1995, CURR OPIN GENET DEV, V5, P44, DOI 10.1016/S0959-437X(95)90052-7; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WASYLYK B, 1990, NATURE, V346, P191, DOI 10.1038/346191a0; WU H, 1994, MOL CELL BIOL, V14, P2129, DOI 10.1128/MCB.14.3.2129; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315	50	77	85	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					169	180		10.1016/S0092-8674(02)00714-6	http://dx.doi.org/10.1016/S0092-8674(02)00714-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007404	Bronze			2022-12-28	WOS:000175082600007
J	Bell, J				Bell, J			Planetary science: Tip of the martian iceberg?	SCIENCE			English	Editorial Material							MARS; WATER; ICE; CLIMATE		Cornell Univ, Dept Astron, Ithaca, NY 14853 USA	Cornell University	Bell, J (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.							BELL JF, 1993, ICARUS, V104, P2, DOI 10.1006/icar.1993.1078; BLASIUS RK, 1982, ICARUS, V50, P140; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Clancy RT, 1996, ICARUS, V122, P36, DOI 10.1006/icar.1996.0108; CLIFFORD SM, 1993, J GEOPHYS RES-PLANET, V98, P10973, DOI 10.1029/93JE00225; FANALE FP, 1986, ICARUS, V67, P1, DOI 10.1016/0019-1035(86)90170-3; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; HOUCK JR, 1973, ICARUS, V18, P470, DOI 10.1016/0019-1035(73)90156-5; Jakosky BM, 1997, ICARUS, V130, P87, DOI 10.1006/icar.1997.5799; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2000, SCIENCE, V288, P2330, DOI 10.1126/science.288.5475.2330; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; MURCHIE S, 1993, ICARUS, V105, P454, DOI 10.1006/icar.1993.1141; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; SODERBLOM LA, 1978, ICARUS, V34, P622, DOI 10.1016/0019-1035(78)90050-7; SQUYRES SW, 1989, ICARUS, V79, P229, DOI 10.1016/0019-1035(89)90078-X; TOUMA J, 1993, SCIENCE, V259, P1294, DOI 10.1126/science.259.5099.1294; ZUREK RW, 1993, J GEOPHYS RES-PLANET, V98, P3247, DOI 10.1029/92JE02936	20	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					60	61		10.1126/science.1074025	http://dx.doi.org/10.1126/science.1074025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040091				2022-12-28	WOS:000176711000026
J	Murzin, AG				Murzin, AG			Biochemistry: DNA building block reinvented	SCIENCE			English	Editorial Material									MRC, Ctr Prot Engn, Cambridge CB2 2QH, England	University of Cambridge	Murzin, AG (corresponding author), MRC, Ctr Prot Engn, Hills Rd, Cambridge CB2 2QH, England.							DELK AS, 1980, J BIOL CHEM, V255, P4387; DYNES JL, 1989, P NATL ACAD SCI USA, V86, P7966, DOI 10.1073/pnas.86.20.7966; Galperin MY, 2000, NAT BIOTECHNOL, V18, P609, DOI 10.1038/76443; HARDY LW, 1987, SCIENCE, V235, P448, DOI 10.1126/science.3099389; KUHN P, IN PRESS PROTEINS ST; Myllykallio H, 2002, SCIENCE, V297, P105, DOI 10.1126/science.1072113	6	14	14	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					61	62		10.1126/science.1073910	http://dx.doi.org/10.1126/science.1073910			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12029066				2022-12-28	WOS:000176711000027
J	Cummings, CA; Relman, DA				Cummings, CA; Relman, DA			Genomics and microbiology - Microbial forensics - "Cross-examining pathogens"	SCIENCE			English	Editorial Material							ENCEPHALITIS; ORIGIN		Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Relman, DA (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	relman@stanford.edu		Relman, David A./0000-0001-8331-1354				[Anonymous], COMMUNICATION; *CDCP, 1991, MMWR-MORBID MORTAL W, V21, P33; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P889; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fitzgerald JR, 2001, P NATL ACAD SCI USA, V98, P8821, DOI 10.1073/pnas.161098098; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Jia XY, 1999, LANCET, V354, P1971, DOI 10.1016/S0140-6736(99)05384-2; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Read TD, 2002, SCIENCE, V296, P2028, DOI 10.1126/science.1071837; Relman DA, 1999, SCIENCE, V284, P1308, DOI 10.1126/science.284.5418.1308; Weir BS, 1990, GENETIC DATA ANAL	13	53	58	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 14	2002	296	5575					1976	+		10.1126/science.1073125	http://dx.doi.org/10.1126/science.1073125			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563UD	12004075				2022-12-28	WOS:000176273300036
J	Chopra, KF; Grossman, ME				Chopra, KF; Grossman, ME			Finger-pad tophi	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											Chopra, KF (corresponding author), 9850 Genesee Ave, La Jolla, CA 92014 USA.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1714	1714		10.1056/NEJMicm990355	http://dx.doi.org/10.1056/NEJMicm990355			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037151				2022-12-28	WOS:000175834100006
J	Bernheim-Groswasser, A; Wiesner, S; Golsteyn, RM; Carlier, MF; Sykes, C				Bernheim-Groswasser, A; Wiesner, S; Golsteyn, RM; Carlier, MF; Sykes, C			The dynamics of actin-based motility depend on surface parameters	NATURE			English	Article							ARP2/3 COMPLEX; DENDRITIC ORGANIZATION; LISTERIA-MONOCYTOGENES; PROTEIN; POLYMERIZATION; FILAMENTS; NETWORKS; WASP; NUCLEATION; PROPULSION	In cells, actin polymerization at the plasma membrane is induced by the recruitment of proteins such as the Arp2/3 complex, and the zyxin/VASP complex(1-3). The physical mechanism of force generation by actin polymerization has been described theoretically using various approaches(4-6), but lacks support from experimental data. By the use of reconstituted motility medium 7,we find that the Wiskott-Aldrich syndrome protein(8,9) (WASP) subdomain, known as VCA, is sufficient to induce actin polymerization and movement when grafted on microspheres. Changes in the surface density of VCA protein or in the microsphere diameter markedly affect the velocity regime, shifting from a continuous to a jerky movement resembling that of the mutated 'hopping' Listeria(10). These results highlight how simple physical parameters such as surface geometry and protein density directly affect spatially controlled actin polymerization, and play a fundamental role in actin-dependent movement.	Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, F-75231 Paris 05, France; Lab Enzymol & Biochim Struct, CNRS, UPR A 9063, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Sykes, C (corresponding author), Inst Curie, Lab Physicochim Curie, CNRS, UMR 168, 11 Rue Pierre & Marie Curie, F-75231 Paris 05, France.	carlier@lebs.caps-gif.fr; cecile.sykes@curie.fr	Sykes, Cécile/B-1271-2016; Bernheim, Anne/AAM-5969-2020	Sykes, Cécile/0000-0003-3057-2600; Bernheim-Groswasser, Anne/0000-0003-3999-6098				Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Blanchoin L, 2000, NATURE, V404, P1007, DOI 10.1038/35010008; Cameron LA, 1999, P NATL ACAD SCI USA, V96, P4908, DOI 10.1073/pnas.96.9.4908; Cameron LA, 2001, CURR BIOL, V11, P130, DOI 10.1016/S0960-9822(01)00022-7; Carlsson AE, 2001, BIOPHYS J, V81, P1907, DOI 10.1016/S0006-3495(01)75842-0; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Fradelizi J, 2001, NAT CELL BIOL, V3, P699, DOI 10.1038/35087009; Gerbal F, 2000, BIOPHYS J, V79, P2259, DOI 10.1016/S0006-3495(00)76473-3; Gerbal F, 1999, PRAMANA-J PHYS, V53, P155, DOI 10.1007/s12043-999-0147-z; Giardini PA, 2001, BIOPHYS J, V81, P3193, DOI 10.1016/S0006-3495(01)75955-3; Kuo SC, 2000, NATURE, V407, P1026, DOI 10.1038/35039544; Lasa I, 1997, EMBO J, V16, P1531, DOI 10.1093/emboj/16.7.1531; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Noireaux V, 2000, BIOPHYS J, V78, P1643, DOI 10.1016/S0006-3495(00)76716-6; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pantaloni D, 2000, NAT CELL BIOL, V2, P385, DOI 10.1038/35017011; Renfranz PJ, 2002, CURR OPIN CELL BIOL, V14, P88, DOI 10.1016/S0955-0674(01)00299-X; Rutenberg AD, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.021904; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Takenawa T, 2001, J CELL SCI, V114, P1801; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; van Oudenaarden A, 1999, NAT CELL BIOL, V1, P493, DOI 10.1038/70281; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4	29	186	190	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					308	311		10.1038/417308a	http://dx.doi.org/10.1038/417308a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015607				2022-12-28	WOS:000175592100052
J	Soares, D				Soares, D			An ancient sensory organ in crocodilians - Waiting alligators can detect silent ripples in the water even in total darkness.	NATURE			English	Article									Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Soares, D (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.							Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; GREGORY JE, 1987, NATURE, V326, P386, DOI 10.1038/326386a0; Jackson K, 1996, J MORPHOL, V229, P315, DOI 10.1002/(SICI)1097-4687(199609)229:3<315::AID-JMOR6>3.0.CO;2-X; MOLENAAR GJ, 1974, BRAIN RES, V78, P340, DOI 10.1016/0006-8993(74)90560-5; von During M., 1973, Zeitschrift Anat Entwickl-Gesch, V143, P81	6	85	87	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					241	242		10.1038/417241a	http://dx.doi.org/10.1038/417241a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015589				2022-12-28	WOS:000175592100033
J	Webb, B				Webb, B			Robots in invertebrate neuroscience	NATURE			English	Review							CRICKET; MODEL; BEHAVIOR; WALKING; DISCRIMINATION; INTERNEURONS; NAVIGATION; NEURON		Univ Stirling, Dept Psychol, Ctr Cognit & Computat Neurosci, Stirling FK9 4LA, Scotland	University of Stirling	Webb, B (corresponding author), Univ Stirling, Dept Psychol, Ctr Cognit & Computat Neurosci, Stirling FK9 4LA, Scotland.	b.h.webb@stir.ac.uk						Blanchard M, 2000, ROBOT AUTON SYST, V30, P17, DOI 10.1016/S0921-8890(99)00063-9; BOHM H, 1991, J EXP BIOL, V159, P235; Braitenberg V., 1984, VEHICLES EXPT SYNTHE; CHAPMAN T, 2001, MORPHOLOGICAL NEURAL; CRUSE H, 1995, BIOL CYBERN, V72, P421, DOI 10.1007/BF00201417; Cruse H, 1998, NEURAL NETWORKS, V11, P1435, DOI 10.1016/S0893-6080(98)00067-7; Damper RI, 2000, ROBOT AUTON SYST, V31, P247, DOI 10.1016/S0921-8890(99)00122-0; Delcomyn F, 2000, ROBOT AUTON SYST, V30, P5, DOI 10.1016/S0921-8890(99)00062-7; Ezrachi FA, 1999, BIOL CYBERN, V81, P89, DOI 10.1007/s004220050546; FRANCESCHINI N, 1992, PHILOS T R SOC B, V337, P283, DOI 10.1098/rstb.1992.0106; FRANCESCHINI N, 1997, NEUROBIOLOGY MEMBRAN; Frantz MA, 1996, CYTOPATHOLOGY, V7, P38, DOI 10.1046/j.1365-2303.1996.36882368.x; Grasso F., 1996, From Animals to Animats 4. Proceedings of the Fourth International Conference on Simulation of Adaptive Behavior, P104; Grasso FW, 2000, ROBOT AUTON SYST, V30, P115, DOI 10.1016/S0921-8890(99)00068-8; Harrison RR, 1999, AUTON ROBOT, V7, P211, DOI 10.1023/A:1008916202887; Harrison RR, 1998, ADV NEUR IN, V10, P880; Harrison RR, 2000, NEURAL COMPUT, V12, P2291, DOI 10.1162/089976600300014944; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; HORRIDGE GA, 1992, PHILOS T R SOC B, V337, P271, DOI 10.1098/rstb.1992.0105; Hoshino K, 2000, J MICROELECTROMECH S, V9, P32, DOI 10.1109/84.825774; HUBER F, 1992, NATURWISSENSCHAFTEN, V79, P393, DOI 10.1007/BF01138570; HUBER F, 1985, SCI AM, V253, P60, DOI 10.1038/scientificamerican1285-60; KOHSTALLSCHNELL D, 1994, J EXP BIOL, V193, P157; KUWANA Y, 1995, IROS '95 - 1995 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS: HUMAN ROBOT INTERACTION AND COOPERATIVE ROBOTS, PROCEEDINGS, VOL 2, P530, DOI 10.1109/IROS.1995.526267; LABHART T, 1988, NATURE, V331, P435, DOI 10.1038/331435a0; Lambrinos D, 1997, ADAPT BEHAV, V6, P131, DOI 10.1177/105971239700600104; Lambrinos D, 2000, ROBOT AUTON SYST, V30, P39, DOI 10.1016/S0921-8890(99)00064-0; Lewis MA, 1998, ADV NEUR IN, V10, P822; Lund HH, 1998, ARTIF LIFE, V4, P95, DOI 10.1162/106454698568468; Lund HH, 1997, FROM ANIM ANIMAT, P246; Mead C.A., 1989, ANALOG VLSI NEURAL S; MICHELSEN A, 1994, J COMP PHYSIOL A, V175, P153, DOI 10.1007/BF00215111; Morse TM, 1998, ADAPT BEHAV, V6, P393, DOI 10.1177/105971239800600303; MURA F, 1996, INTELLIGENT VEHICLES, V2, P47; Paydar S, 1999, J NEUROSCI, V19, P1771; PICHON JM, 1989, MOBILE ROBOTS, V4, P44; Pollack GS, 1998, SPR HDB AUD, V10, P139; Quinn RD, 1998, CONNECT SCI, V10, P239, DOI 10.1080/095400998116422; Rind FC, 1997, J NEUROPHYSIOL, V77, P1029, DOI 10.1152/jn.1997.77.2.1029; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; SCHILDBERGER K, 1988, EXPERIENTIA, V44, P408, DOI 10.1007/BF01940535; SHIMOZAWA T, 1984, J COMP PHYSIOL, V155, P495, DOI 10.1007/BF00611914; Srinivasan M. V., 1997, LIVING EYES SEEING M; TAUBER E, 1995, J EXP BIOL, V198, P1895; Webb B, 2000, BIOL CYBERN, V82, P247, DOI 10.1007/s004220050024; Webb B, 1995, ROBOT AUTON SYST, V16, P117, DOI 10.1016/0921-8890(95)00044-5; Webb B, 2000, ANIM BEHAV, V60, P545, DOI 10.1006/anbe.2000.1514; WEBB B, 1994, COM ADAP SY, P45; WEBB B, 2000, P SPIE S SENS FUS DE, V3, P113; WEBB B, IN PRESS BEHAV BRAIN; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; WEHNER R, 1994, FORTS ZOOL, V39, P103; WENDLER G, 1990, ADV LIF SCI, P387; WOHLERS DW, 1982, J COMP PHYSIOL, V146, P161, DOI 10.1007/BF00610234	54	87	87	2	40	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					359	363		10.1038/417359a	http://dx.doi.org/10.1038/417359a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015617				2022-12-28	WOS:000175592100061
J	Aono, N; Sutani, T; Tomonaga, T; Mochida, S; Yanagida, M				Aono, N; Sutani, T; Tomonaga, T; Mochida, S; Yanagida, M			Cnd2 has dual roles in mitotic condensation and interphase	NATURE			English	Article							CHROMOSOME CONDENSATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; CDC2 PHOSPHORYLATION; TOPOISOMERASE-II; PROTEIN-KINASE; CHECKPOINT; MITOSIS; GENE	Chromosome condensation requires condensin(1-4), which comprises five subunits(5,6). Two of these subunits-both being structural maintenance of chromosome (SMC) proteins-are coiled-coils with globular terminal domains that interact with ATP and DNA. The remaining three, non-SMC subunits also have essential, albeit undefined, roles in condensation. Here we report that Cnd2 (ref. 6), a non-SMC subunit of fission yeast similar to Drosophila Barren 7 and the budding yeast protein Brn1 (refs 8, 9), is required for both interphase and mitotic condensation. In cnd2-1 mutants, ultraviolet-induced DNA damage is not repaired, and cells arrested by hydroxyurea do not recover. A definitive defect of interphase is abolishment of Cds1 (a checkpoint kinase) activation in the presence of hydroxyurea in both cnd2-1 mutant cells and in cells where other condensin subunits have been genetically disrupted. In the absence of hydroxyurea, a G2 checkpoint delay occurred in cnd2-1 mutants in a manner dependent on Cds1 and ATM-like Rad3, but not Chk1 (refs 10-13), before the mitotic condensation defect. Furthermore, cnd2-1 was synthetic-lethal with mutations of excision repair, RecQ helicase and DNA replication enzymes. These interphase and mitotic defects provide insight into the mechanistic role of non-SMC subunits that interact with the globular SMC domains in the heteropentameric holocomplex(14).	Kyoto Univ, Dept Gene Mech, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068582, Japan	Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Dept Gene Mech, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068582, Japan.			Sutani, Takashi/0000-0002-9959-9513				Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; CARR AM, 1993, NUCLEIC ACIDS RES, V21, P1345, DOI 10.1093/nar/21.6.1345; Christensen PU, 2000, P NATL ACAD SCI USA, V97, P2579, DOI 10.1073/pnas.97.6.2579; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Hutchins JRA, 2000, FEBS LETT, V466, P91, DOI 10.1016/S0014-5793(99)01763-9; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293, DOI 10.1091/mbc.11.4.1293; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Murray JM, 1997, MOL CELL BIOL, V17, P6868, DOI 10.1128/MCB.17.12.6868; Ouspenski II, 2000, MOL BIOL CELL, V11, P1305, DOI 10.1091/mbc.11.4.1305; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Sutani T, 1997, NATURE, V388, P798, DOI 10.1038/42062; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; YAJIMA H, 1995, EMBO J, V14, P2393, DOI 10.1002/j.1460-2075.1995.tb07234.x; Yamashita YM, 1999, GENES CELLS, V4, P445, DOI 10.1046/j.1365-2443.1999.00274.x; Yoshimura SH, 2002, CURR BIOL, V12, P508, DOI 10.1016/S0960-9822(02)00719-4	30	118	122	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					197	202		10.1038/417197a	http://dx.doi.org/10.1038/417197a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000964				2022-12-28	WOS:000175460200048
J	Lederle, FA; Wilson, SE; Johnson, GR; Reinke, DB; Littooy, FN; Acher, CW; Ballard, DJ; Messina, LM; Gordon, IL; Chute, EP; Krupski, WC; Bandyk, D				Lederle, FA; Wilson, SE; Johnson, GR; Reinke, DB; Littooy, FN; Acher, CW; Ballard, DJ; Messina, LM; Gordon, IL; Chute, EP; Krupski, WC; Bandyk, D		Aneurysm Detection Management Vet	Immediate repair compared with surveillance of small abdominal aortic aneurysms.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VASCULAR-SURGERY; EPIDEMIOLOGY; MANAGEMENT; VOLUME	Background: Whether elective surgical repair of small abdominal aortic aneurysms improves survival remains controversial. Methods: We randomly assigned patients 50 to 79 years old with abdominal aortic aneurysms of 4.0 to 5.4 cm in diameter who did not have high surgical risk to undergo immediate open surgical repair of the aneurysm or to undergo surveillance by means of ultrasonography or computed tomography every six months with repair reserved for aneurysms that became symptomatic or enlarged to 5.5 cm. Follow-up ranged from 3.5 to 8.0 years (mean, 4.9). Results: A total of 569 patients were randomly assigned to immediate repair and 567 to surveillance. By the end of the study, aneurysm repair had been performed in 92.6 percent of the patients in the immediate-repair group and 61.6 percent of those in the surveillance group. The rate of death from any cause, the primary outcome, was not significantly different in the two groups (relative risk in the immediate-repair group as compared with the surveillance group, 1.21; 95 percent confidence interval, 0.95 to 1.54). Trends in survival did not favor immediate repair in any of the prespecified subgroups defined by age or diameter of aneurysm at entry. These findings were obtained despite a low total operative mortality of 2.7 percent in the immediate-repair group. There was also no reduction in the rate of death related to abdominal aortic aneurysm in the immediate-repair group (3.0 percent) as compared with the surveillance group (2.6 percent). Eleven patients in the surveillance group had rupture of abdominal aortic aneurysms (0.6 percent per year), resulting in seven deaths. The rate of hospitalization related to abdominal aortic aneurysm was 39 percent lower in the surveillance group. Conclusions: Survival is not improved by elective repair of abdominal aortic aneurysms smaller than 5.5 cm, even when operative mortality is low.	Vet Affairs Med Ctr, Dept Med, Minneapolis, MN 55417 USA; Vet Affairs Med Ctr, Long Beach, CA USA; Vet Affairs Med Ctr, West Haven, CT USA; Vet Affairs Med Ctr, Hines, IL USA; Vet Affairs Med Ctr, Madison, WI USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Vet Affairs Med Ctr, Denver, CO USA; Vet Affairs Med Ctr, Tampa, FL USA; Vet Affairs Med Ctr, Cleveland, OH USA; Vet Affairs Med Ctr, Little Rock, AR USA; Vet Affairs Med Ctr, San Diego, CA 92161 USA; Vet Affairs Med Ctr, Ann Arbor, MI USA; Vet Affairs Med Ctr, Pittsburgh, PA USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Vet Affairs Med Ctr, Milwaukee, WI USA; Vet Affairs Med Ctr, Richmond, VA USA; Vet Affairs Med Ctr, Miami, FL 33125 USA; Vet Affairs Med Ctr, Los Angeles, CA USA; Baylor Hlth Care Syst, Dallas, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Hunter Holmes McGuire Veterinary Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor Health Care System	Lederle, FA (corresponding author), Vet Affairs Med Ctr, Dept Med, Minneapolis, MN 55417 USA.	frank.lederle@med.va.gov	Ballard, David J/H-1062-2018	Eton, Darwin/0000-0001-5937-1971				Ballard DJ, 1992, ABDOMINAL AORTIC ANE; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; CLAGETT GP, 1991, J VASC SURG, V13, P549, DOI 10.1016/0741-5214(91)90319-P; Collin J, 1990, Eur J Vasc Surg, V4, P113, DOI 10.1016/S0950-821X(05)80423-2; Cronenwett JL, 1999, J VASC SURG, V29, P191, DOI 10.1016/S0741-5214(99)70360-5; DARLING RC, 1977, CIRCULATION, V56, P161; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Glimaker H, 1991, Eur J Vasc Surg, V5, P125, DOI 10.1016/S0950-821X(05)80675-9; GREATOREX RA, 1988, BRIT MED J, V297, P284, DOI 10.1136/bmj.297.6643.284; HOLLIER LH, 1992, J VASC SURG, V15, P1046, DOI 10.1016/0741-5214(92)90462-H; Huber TS, 2001, J VASC SURG, V33, P304, DOI 10.1067/mva.2001.112703; Lawrence PF, 1999, J VASC SURG, V30, P632, DOI 10.1016/S0741-5214(99)70102-3; LEDERLE FA, 1995, J VASC SURG, V21, P945, DOI 10.1016/S0741-5214(95)70222-9; LEDERLE FA, 1994, J VASC SURG, V20, P296, DOI 10.1016/0741-5214(94)90019-1; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Manheim LM, 1998, J VASC SURG, V28, P45, DOI 10.1016/S0741-5214(98)70199-5; NEVITT MP, 1989, NEW ENGL J MED, V321, P1009, DOI 10.1056/NEJM198910123211504; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Pearce WH, 1999, J VASC SURG, V29, P768, DOI 10.1016/S0741-5214(99)70202-8; Pretre R, 1998, LANCET, V352, P1642, DOI 10.1016/S0140-6736(98)00069-5; SCOTT RAP, 1993, LANCET, V342, P1395, DOI 10.1016/0140-6736(93)92756-J; Semmens JB, 2000, BRIT J SURG, V87, P191, DOI 10.1046/j.1365-2168.2000.01346.x; TILSON MD, 1992, J VASC SURG, V15, P871, DOI 10.1016/0741-5214(92)90726-O; *UK SMALL AN TRIAL, 1998, LANCET, V352, P1642	26	803	843	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1437	1444		10.1056/NEJMoa012573	http://dx.doi.org/10.1056/NEJMoa012573			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000813				2022-12-28	WOS:000175433200002
J	Callaham, M; Wears, RL; Weber, E				Callaham, M; Wears, RL; Weber, E			Journal prestige, publication bias, and other characteristics associated with citation of published studies in peer-reviewed journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				METAANALYSIS; ABSTRACTS; QUALITY; HAZARDS; TRIALS	Context Citation by other authors is important in the dissemination of published science, but factors predicting it are little studied. Methods To identify characteristics of published research predicting citation in other journals, we searched the Science Citations Index database for a standardized 3.5 years for all citations of published articles originally submitted to a 1991 emergency medicine specialty meeting. Analysis was conducted by classification and regression trees, a nonparametric modeling technique of regression trees, to determine the impact of previously determined characteristics of the full articles on the outcome measures, We calculated the the number of times an article was cited each year and calculated the mean impact factor (citations per manuscript per year) in other citing journals. Results Of the 493 submitted manuscripts, 204 published articles met entry criteria. The mean citations per year was 2.04 (95% confidence interval, 1.6-2.4; range, 0-20.9) in 440 different journals. Nineteen articles (9.3%)were never cited. The ability to predict the citations per year was weak (pseudo R-2 = 0.14.). The strongest predictor of citations per year was the impact factor of the original publishing journal. The presence of a control group, the subjective newsworthiness score, and sample size predicted citation frequency (24.3%, 26.0%, and 26.5% as strongly, respectively). The ability to predict mean impact factor of the citing journals was even weaker (pseudo R-2 = 0.09). The impact factor of the publishing journal was the strongest predictor, followed by the newsworthiness score (89.9% as strongly) and a subjective quality score (61.5%). Positive outcome bias was not evident for either outcome measure. Conclusion In this cohort of published research, commonly used measures of study methodology and design did not predict the frequency of citations or the importance of citing journals. Positive outcome bias was not evident, The impact factor of the original publishing journal was more important than any other variable, suggesting that the journal in which a study is published may be as important as traditional measures of study quality in ensuring dissemination.	Univ Calif San Francisco, Div Emergency Med, San Francisco, CA 94143 USA; Univ Florida, Dept Emergency Med, Jacksonville, FL USA	University of California System; University of California San Francisco; State University System of Florida; University of Florida	Callaham, M (corresponding author), Univ Calif San Francisco, Div Emergency Med, Box 0208, San Francisco, CA 94143 USA.	mlc@medicine.ucsf.edu	Weber, Ellen/GRR-9967-2022; Wears, Robert/N-5959-2014	Weber, Ellen/0000-0002-0094-1973; Wears, Robert/0000-0001-9826-954X; Callaham, Michael/0000-0003-2284-256X				Berlin JA, 1999, JAMA-J AM MED ASSOC, V282, P1083, DOI 10.1001/jama.282.11.1083; Breiman L., 1984, CLASSIFICATION REGRE; BROWN P, 1993, NEW SCI, V15, P12; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; Davies D, 1996, CAN MED ASSOC J, V155, P877; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Garfield E, 1998, LIBRI, V48, P67, DOI 10.1515/libr.1998.48.2.67; Garfield E, 1996, BRIT MED J, V313, P411, DOI 10.1136/bmj.313.7054.411; GARFIELD E, 1997, COLL RES LIBR, V48, P19; GARFIELD E, 1996, SCI J CITATION REPOR; GOLDMAN L, 1980, NEW ENGL J MED, V303, P255, DOI 10.1056/NEJM198007313030504; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; KOREN G, 1989, LANCET, V2, P1440; MCCORMICK MC, 1985, AM J DIS CHILD, V139, P122, DOI 10.1001/archpedi.1985.02140040020017; MERANZE J, 1982, ANESTH ANALG, V61, P445; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Weber EJ, 1998, JAMA-J AM MED ASSOC, V280, P257, DOI 10.1001/jama.280.3.257	19	435	443	4	69	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2847	2850		10.1001/jama.287.21.2847	http://dx.doi.org/10.1001/jama.287.21.2847			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038930	Bronze			2022-12-28	WOS:000176002200027
J	Gulbrandsen, P; Schroeder, TV; Milerad, J; Nylenna, M				Gulbrandsen, P; Schroeder, TV; Milerad, J; Nylenna, M			Paper or screen, mother tongue or English: Which is better? A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				FUTURE	Context To compare family physicians' ability to retain information when reading a review article on paper vs on screen, and in their mother tongue vs in English. Methods Randomized trial of 114 Scandinavian family physicians who read a review article in October or November 2000 from the Journal of Trauma for 10 minutes either on paper and in English, on screen and in English, on paper in their mother tongue, or on screen in their mother tongue. To assess comprehension, they immediately completed a questionnaire with 6 open questions about 13 key facts from the review article. Sum score was on a scale from 0 (no correct answers) to 13 points (all questions answered correctly). Results There was no significant difference between readers of paper vs screen versions, with a median (interquartile range [IQR]) of 4 (2-6) vs 4 (2-5), respectively (P=.97). Physicians who read in their mother tongue scored significantly higher than those who read in English, with a median (IQR) of 4 (3-6) vs 3 (2-4) (P=.01). Conclusion The medium (paper vs screen) did not influence the ability of family physicians to retain medical information. They best retained medical information when reading in their mother tongue.	Journal Norwegian Med Assoc, Oslo, Norway; Journal Danish Med Assoc, Copenhagen, Denmark; Journal Swedish Med Assoc, Stockholm, Sweden		Gulbrandsen, P (corresponding author), Ctr Hlth Serv Res HELTEF, POB 55, NO-1474 Nordbyhagen, Norway.			Schroeder, Torben/0000-0002-9827-9438				Beller FK, 2000, GYNAKOL GEBURT RUNDS, V40, P50, DOI 10.1159/000022329; Delamothe T, 2001, BMJ-BRIT MED J, V322, P1, DOI 10.1136/bmj.322.7277.1; ESCANDON MAS, 2000, ARCH ESP UROL, V53, P93; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; McKinley NM, 1997, GENDER DIFFERENCES H, P30; NYLENNA M, 1999, PEER REV HLTH SCI; Richardson J. T. E., 1991, MENTAL IMAGES HUMAN, P271	7	23	24	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2851	2853		10.1001/jama.287.21.2851	http://dx.doi.org/10.1001/jama.287.21.2851			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038931				2022-12-28	WOS:000176002200028
J	Nuovo, J; Melnikow, J; Chang, D				Nuovo, J; Melnikow, J; Chang, D			Reporting number needed to treat and absolute risk reduction in randomized controlled trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				CONSORT STATEMENT; QUALITY; CONSEQUENCES	Context Ongoing efforts to improve the quality of reporting for randomized controlled trials (RCTs) include the Consolidated Standards of Reporting Trials (CONSORT) statement. We examined the frequency of explicit reporting of the number needed to treat (NNT) and the absolute risk reduction (ARR) in RCTs. Methods Five frequently cited journals were investigated: Annals of Internal Medicine, BMJ, JAMA, The Lancet, and the New England Journal of Medicine. For each journal, 4 years were evaluated: 1989, 1992, 1995, and 1998. All issues of each journal for each year were reviewed manually. Eligible articles were those in which an RCT was conducted on the use of a medication showing a significant treatment effect. Elements abstracted from each eligible article were the condition investigated, event being treated or prevented, intervention, study results, and reporting methods (relative risk reduction, NNT, and ARR). Results Of 359 eligible articles, NNT was reported in 8 articles. Six of the 8 studies were from 1998. Absolute risk reduction was reported in 18 articles, 10 of which were from 1998. Conclusions Despite CONSORT recommendations, few authors expressed their findings in terms of NNT or ARR. Consideration should be given to including these values in reports of RCTs.	Univ Calif Davis, Dept Family & Community Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Nuovo, J (corresponding author), Univ Calif Davis, Dept Family & Community Med, 4860 Y St, Sacramento, CA 95817 USA.							Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Chatellier G, 1996, BRIT MED J, V312, P426; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Elting LS, 1999, BRIT MED J, V318, P1527, DOI 10.1136/bmj.318.7197.1527; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Junker CA, 1998, JAMA-J AM MED ASSOC, V280, P247, DOI 10.1001/jama.280.3.247; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916	12	132	135	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2813	2814		10.1001/jama.287.21.2813	http://dx.doi.org/10.1001/jama.287.21.2813			2	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038920				2022-12-28	WOS:000176002200017
J	Pitkin, RM; Burmeister, LF				Pitkin, RM; Burmeister, LF			Prodding tardy reviewers - A randomized comparison of telephone, fax, and e-mail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context To compare telephone, fax, and e-mail methods of Prodding tardy reviewers. Methods Randomized trial conducted January 1998 through June 1999 at the main editorial office of Obstetrics & Gynecology. Reviewers who had failed to file reviews by 28 days after being sent manuscripts (7 days after deadline) were sent identical messages in oral (telephone) or written (fax and e-mail) form inquiring as to the status of review, asking for its completion as soon as possible, and requesting it be sent by fax or e-mail. Results Of 378 reviewers, proportions returning reviews within 7 days were essentially identical: telephone, 85 (68%) of 125; fax, 86 (67%) of 129; and e-mail, 84 (67%) of 124 (P=.59). In the two thirds who responded, the mean time to return reviews did not differ among the 3 groups. Conclusion Contacting tardy reviewers resulted in a review being received within 7 days in about two thirds of cases, and it made no difference if the contact was made by telephone, fax, or e-mail.	Obstet & Gynecol, Washington, DC USA; Univ Iowa, Coll Publ Hlth, Iowa City, IA USA	University of Iowa	Pitkin, RM (corresponding author), 78900 Rancho La Quinta Dr, La Quinta, CA 92253 USA.							BISHOP CT, 1984, HOW TO EDIT A SCI J, P92	1	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2794	2795		10.1001/jama.287.21.2794	http://dx.doi.org/10.1001/jama.287.21.2794			2	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038914	Bronze			2022-12-28	WOS:000176002200011
J	Crandall, CG; Vongpatanasin, W; Victor, RG				Crandall, CG; Vongpatanasin, W; Victor, RG			Mechanism of cocaine-induced hyperthermia in humans	ANNALS OF INTERNAL MEDICINE			English	Article							NEUROLEPTIC MALIGNANT SYNDROME; PHYSIOLOGICAL-RESPONSES; CUTANEOUS VASODILATION; AMBIENT-TEMPERATURE; CORE TEMPERATURE; SKELETAL-MUSCLE; OVERDOSE; EXERCISE; VARIANT; ABUSE	Background: The lethal effects of cocaine are unique among those of other illicit drugs because cocaine has the propensity to cause hyperthermia. The traditional view is that cocaine causes a hypermetabolic state with increased heat production. However, because cocaine-induced hyperthermia occurs primarily in hot weather, it is hypothesized that cocaine also impairs thermoregulatory adjustments that mediate heat dissipation. Objective: To test the effects of cocaine on body temperature regulation in humans. Design: Randomized, double-blind, placebo-controlled crossover trial. Setting: A cardiovascular physiology laboratory in Dallas, Texas. Participants: 7 healthy, cocaine-naive volunteers. Intervention: Progressive passive heat stress, during which each participant received intranasal cocaine (2 mg/kg of body weight) or placebo (lidocaine, 2 mg/kg). Measurements: Esophageal temperature, skin blood flow, sweat rate, and perceived thermal sensation. Results: Three major new findings were noted. First, cocaine substantially augmented the progressive increase in esophageal temperature during heat stress (P < 0.001). Second, this augmentation was explained by a rightward shift in the esophageal temperature threshold for the onset of both cutaneous vasodilation (37.37 +/- 0.09 degreesC for cocaine vs. 37.06 +/- 0.07 degreesC for lidocaine; P = 0.01) and sweating (37.38 +/- 0.09 degreesC for cocaine vs. 37.07 +/- 0.06 degreesC for lidocaine; P = 0.002). Third, cocaine paradoxically impaired the perception of heating by attenuating the progressive increase in thermal discomfort associated with heat stress. Conclusions: in humans, impaired heat dissipation is a major mechanism by which cocaine elevates body temperature. When healthy, cocaine-naive persons are subjected to passive heating, pretreatment with even a small dose of intranasal cocaine impairs sweating and cutaneous vasodilation (the major autonomic adjustments to thermal stress) and heat perception (the key trigger for behavioral adjustments).	Presbyterian Med Ctr, Inst Exercise & Environm Med, Dallas, TX 75231 USA; Univ Texas, SW Med Ctr, Dallas, TX USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Crandall, CG (corresponding author), Presbyterian Med Ctr, Inst Exercise & Environm Med, 7232 Greenville Ave, Dallas, TX 75231 USA.	CraigCrandall@texashealth.org		Vongpatanasin, Wanpen/0000-0002-7531-9388; Crandall, Craig/0000-0001-7792-9713	NHLBI NIH HHS [HL-61388] Funding Source: Medline; NIDA NIH HHS [R0-1 DA10064] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061388] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010064] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ansah TA, 1996, PHYSIOL BEHAV, V60, P1261, DOI 10.1016/S0031-9384(96)00250-8; ASTRUP A, 1985, AM J PHYSIOL, V248, pE507, DOI 10.1152/ajpendo.1985.248.5.E507; BAUWENS JE, 1989, WESTERN J MED, V150, P210; BRENGELMANN GL, 1981, AM J PHYSIOL, V240, pH571, DOI 10.1152/ajpheart.1981.240.4.H571; BRENGELMANN GL, 1994, J APPL PHYSIOL, V77, P1671, DOI 10.1152/jappl.1994.77.4.1671; BROWN JH, 2001, GOODMAN GILMANS PHAR, P162; CALLAWAY CW, 1994, ANN EMERG MED, V24, P68, DOI 10.1016/S0196-0644(94)70165-2; CATRAVAS JD, 1981, J PHARMACOL EXP THER, V217, P350; Chung L L, 1991, Proc West Pharmacol Soc, V34, P27; DARAS M, 1995, ACTA NEUROL SCAND, V92, P161; ESCOBEDO LG, 1991, ARCH PATHOL LAB MED, V115, P900; Gisolfi C V, 1984, Exerc Sport Sci Rev, V12, P339; JOHNS ME, 1977, T AM ACAD OPHTHALMOL, V84, P969; JUUL A, 1995, J CLIN ENDOCR METAB, V80, P3335, DOI 10.1210/jc.80.11.3335; KELLOGG DL, 1995, CIRC RES, V77, P1222, DOI 10.1161/01.RES.77.6.1222; KOSTEN TR, 1988, AM J DRUG ALCOHOL AB, V14, P335, DOI 10.3109/00952998809001555; Lange RA, 2001, NEW ENGL J MED, V345, P351, DOI 10.1056/NEJM200108023450507; Lenhardt R, 1996, Acta Anaesthesiol Scand Suppl, V109, P34; LOMAX P, 1990, PHARMACOLOGY, V40, P103, DOI 10.1159/000138648; Makisumi T, 1998, EUR J PHARMACOL, V363, P107, DOI 10.1016/S0014-2999(98)00758-4; Marzuk PM, 1998, JAMA-J AM MED ASSOC, V279, P1795, DOI 10.1001/jama.279.22.1795; ROWELL LB, 1993, HUMAN CARDIOVASCULAR, P220; Sessler D I, 1996, Acta Anaesthesiol Scand Suppl, V109, P25; Sessler DI, 1997, NEW ENGL J MED, V336, P1730, DOI 10.1056/NEJM199706123362407; TAYLOR WF, 1984, J APPL PHYSIOL, V57, P191, DOI 10.1152/jappl.1984.57.1.191; TONER MM, 1986, PERCEPT MOTOR SKILL, V62, P211, DOI 10.2466/pms.1986.62.1.211; TOTEL GL, 1974, J APPL PHYSIOL, V37, P346, DOI 10.1152/jappl.1974.37.3.346; Vongpatanasin W, 1999, CIRCULATION, V100, P497, DOI 10.1161/01.CIR.100.5.497	28	63	66	1	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 4	2002	136	11					785	791		10.7326/0003-4819-136-11-200206040-00006	http://dx.doi.org/10.7326/0003-4819-136-11-200206040-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558KG	12044126				2022-12-28	WOS:000175964500001
J	Fedo, CM; Whitehouse, MJ				Fedo, CM; Whitehouse, MJ			Metasomatic origin of quartz-pyroxene rock, Akilia, Greenland, and implications for Earth's earliest life	SCIENCE			English	Article							FISCHER-TROPSCH SYNTHESIS; COMBINED ION-MICROPROBE; EARLY ARCHEAN ROCKS; PB ZIRCON DATA; WEST GREENLAND; CRUSTAL EVOLUTION; SEDIMENTARY-ROCKS; AGE SIGNIFICANCE; ELEMENTS; FRACTIONATION	A quartz-pyroxene rock interpreted as a banded iron formation (BIF) from the island of Akilia, southwest Greenland, contains C-13-depleted graphite that has been claimed as evidence for the oldest (>3850 million years ago) life on Earth. Field relationships on Akilia document multiple intense deformation events that have resulted in parallel transposition of Early Archean rocks and significant boudinage, the tails of which commonly form the banding in the quartz-pyroxene rock. Geochemical data possess distinct characteristics consistent with an ultramafic igneous, not BIF, protolith for this lithology and the adjacent schists. Later metasomatic silica and iron introduction have merely resulted in a rock that superficially resembles a BIF. An ultramafic igneous origin invalidates claims that the carbon isotopic composition of graphite inclusions represents evidence for life at the time of crystallization.	George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA; Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden	George Washington University; Swedish Museum of Natural History	Fedo, CM (corresponding author), George Washington Univ, Dept Earth & Environm Sci, Washington, DC 20052 USA.	cfedo@gwu.edu	Whitehouse, Martin J/E-1425-2013	Whitehouse, Martin J/0000-0003-2227-577X				ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Arrhenius G, 2000, CHEM GEOL, V169, P69, DOI 10.1016/S0009-2541(00)00333-8; Bau M, 1996, PRECAMBRIAN RES, V79, P37, DOI 10.1016/0301-9268(95)00087-9; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; CHYBA CF, 1993, GEOCHIM COSMOCHIM AC, V57, P3351, DOI 10.1016/0016-7037(93)90543-6; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; DYMEK RF, 1988, PRECAMBRIAN RES, V39, P247, DOI 10.1016/0301-9268(88)90022-8; Eiler JM, 1997, NATURE, V386, P665, DOI 10.1038/386665a0; GRIFFIN WL, 1980, EARTH PLANET SC LETT, V50, P59, DOI 10.1016/0012-821X(80)90119-3; Hobbs BE., 1976, OUTLINE STRUCTURAL G; Holm NG, 2001, EARTH PLANET SC LETT, V191, P1, DOI 10.1016/S0012-821X(01)00397-1; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; Kamber BS, 1998, CHEM GEOL, V150, P19, DOI 10.1016/S0009-2541(98)00059-X; Kamber BS, 2001, GEOCHIM COSMOCHIM AC, V65, P2509, DOI 10.1016/S0016-7037(01)00613-5; Klein C., 1992, PROTEROZOIC BIOSPHER, P139, DOI DOI 10.1017/CB09780511601064; LANCET MS, 1970, SCIENCE, V170, P980, DOI 10.1126/science.170.3961.980; LEPLAND A, 2001, EOS, V82; MAHER KA, 1988, NATURE, V331, P612, DOI 10.1038/331612a0; MCGREGOR VR, 1977, AM MINERAL, V62, P887; MCLENNAN SM, 1989, REV MINERAL, V21, P169; Mojzsis SJ, 1996, NATURE, V384, P55, DOI 10.1038/384055a0; Mojzsis SJ, 1999, NATURE, V400, P127, DOI 10.1038/22035; Mojzsis SJ, 2000, GSA TODAY, V10, P1; Myers JS, 2001, PRECAMBRIAN RES, V105, P129, DOI 10.1016/S0301-9268(00)00108-X; Myers JS, 2000, PRECAMBRIAN RES, V103, P101, DOI 10.1016/S0301-9268(00)00089-9; Nutman A.P., 1986, GRONLANDS GEOLOGISKE, V154, P80, DOI DOI 10.34194/BULLGGU.V154.6696; Nutman AP, 1997, GEOCHIM COSMOCHIM AC, V61, P2475, DOI 10.1016/S0016-7037(97)00097-5; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; PERRY EC, 1977, EARTH PLANET SC LETT, V36, P280, DOI 10.1016/0012-821X(77)90210-2; Rose NM, 1996, AM J SCI, V296, P1004, DOI 10.2475/ajs.296.9.1004; Rosing MT, 1999, SCIENCE, V283, P674, DOI 10.1126/science.283.5402.674; Rosing MT, 1996, GEOLOGY, V24, P43, DOI 10.1130/0091-7613(1996)024<0043:EPOESS>2.3.CO;2; Sano Y, 1999, NATURE, V400, P127, DOI 10.1038/22032; SCHOPF JW, 1993, SCIENCE, V260, P640, DOI 10.1126/science.260.5108.640; SZATMARI P, 1989, AAPG BULL, V73, P989; VENNEMANN TW, 1999, AM SPEC PAP, V329, P133; Whitehouse MJ, 1999, CHEM GEOL, V160, P201, DOI 10.1016/S0009-2541(99)00066-2; Whitehouse MJ, 2001, CHEM GEOL, V175, P201, DOI 10.1016/S0009-2541(00)00301-6	38	139	144	5	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1448	1452		10.1126/science.1070336	http://dx.doi.org/10.1126/science.1070336			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029129				2022-12-28	WOS:000175910300043
J	Wigler, M; Mishra, B				Wigler, M; Mishra, B			Genetics - Wild by nature	SCIENCE			English	Editorial Material									Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NYU, Courant Inst Math Sci, New York, NY 10012 USA	Cold Spring Harbor Laboratory; New York University	Wigler, M (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Wigler, Michael/0000-0003-4396-1971				Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407	1	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1407	1408		10.1126/science.1072445	http://dx.doi.org/10.1126/science.1072445			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029116				2022-12-28	WOS:000175910300028
J	Fares, MA; Ruiz-Gonzalez, MX; Moya, A; Elena, SF; Barrio, E				Fares, MA; Ruiz-Gonzalez, MX; Moya, A; Elena, SF; Barrio, E			Endosymbiotic bacteria - GroEL buffers against deleterious mutations	NATURE			English	Article							ESCHERICHIA-COLI; EVOLUTION; EXPRESSION; SYMBIONT		Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia 46071, Spain; Univ Valencia, Dept Genet, Valencia 46071, Spain	University of Valencia; University of Valencia	Barrio, E (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, POB 22085, Valencia 46071, Spain.		Moya, Andrés/A-8190-2008; Barrio, Eladio/G-8969-2015; Ruiz-González, Mario X./M-4450-2019; Ruiz-González, Mario X./B-4009-2017; Elena, Santiago F./A-4191-2011; Fares, Mario/L-7100-2016	Moya, Andrés/0000-0002-2867-1119; Barrio, Eladio/0000-0003-1024-954X; Ruiz-González, Mario X./0000-0003-3654-773X; Elena, Santiago F./0000-0001-8249-5593; Fares, Mario/0000-0002-4345-3013				AKSOY S, 1995, INSECT MOL BIOL, V4, P2; Charles H, 1997, BIOCHEM BIOPH RES CO, V239, P769, DOI 10.1006/bbrc.1997.7552; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Funk DJ, 2001, GENETICS, V157, P477; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2000, TRENDS ECOL EVOL, V15, P321, DOI 10.1016/S0169-5347(00)01902-9; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sato S, 1997, J BACTERIOL, V179, P2300, DOI 10.1128/jb.179.7.2300-2304.1997; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; ZYSKIND J, 1989, RECOMBINANT DNA LAB	13	194	196	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					398	398		10.1038/417398a	http://dx.doi.org/10.1038/417398a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024205	Bronze			2022-12-28	WOS:000175730900028
J	Aird, WC; Mark, EJ; Escobar, B				Aird, WC; Mark, EJ; Escobar, B			A 53-year-old man with a myocardial infarct and thromboses after coronary-artery bypass grafting - Heparin-induced thrombocytopenia associated with extensive thrombosis (white-clot syndrome)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MOLECULAR-WEIGHT HEPARIN; CARDIOPULMONARY BYPASS; UNFRACTIONATED HEPARIN; PLATELET FACTOR-4; ANTIBODIES; COMPLICATIONS; ANTICOAGULATION; RISK		Beth Israel Deaconess Med Ctr, Hematol Serv, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Aird, WC (corresponding author), Beth Israel Deaconess Med Ctr, Hematol Serv, Boston, MA 02215 USA.							Dupont PJ, 2000, BMJ-BRIT MED J, V321, P1065, DOI 10.1136/bmj.321.7268.1065; Greinacher A, 2000, BLOOD, V96, P846, DOI 10.1182/blood.V96.3.846.015k09_846_851; Greinacher A, 1999, CIRCULATION, V99, P73, DOI 10.1161/01.CIR.99.1.73; Harenberg J, 2001, AM J CLIN PATHOL, V115, P432, DOI 10.1309/ET2W-5J8E-MFVU-QYAH; KELTON JG, 1994, BLOOD, V83, P3232; Lewis BE, 1997, SEMIN THROMB HEMOST, V23, P197, DOI 10.1055/s-2007-996091; Nand S, 1998, AM J HEMATOL, V58, P253, DOI 10.1002/(SICI)1096-8652(199807)58:3<253::AID-AJH25>3.0.CO;2-9; Nand S, 1997, AM J HEMATOL, V56, P12, DOI 10.1002/(SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO;2-5; Ortel TL, 1998, SEMIN HEMATOL, V35, P26; Pouplard C, 1999, CIRCULATION, V99, P2530, DOI 10.1161/01.CIR.99.19.2530; Rosenberg RD, 1999, NEW ENGL J MED, V340, P1555, DOI 10.1056/NEJM199905203402007; Sirbu H, 2000, CARDIOVASC SURG, V8, P66, DOI 10.1016/S0967-2109(99)00087-3; Thomas DP, 1997, ANN INTERN MED, V126, P638, DOI 10.7326/0003-4819-126-8-199704150-00009; Trossaert M, 1998, BRIT J HAEMATOL, V101, P653, DOI 10.1046/j.1365-2141.1998.00750.x; Vignon P, 1996, J Am Soc Echocardiogr, V9, P344, DOI 10.1016/S0894-7317(96)90150-9; VISENTIN GP, 1994, J CLIN INVEST, V93, P81, DOI 10.1172/JCI116987; Vonderheide RH, 1998, AM J MED, V105, P27, DOI 10.1016/S0002-9343(98)00128-4; Wallis DE, 1999, AM J MED, V106, P629, DOI 10.1016/S0002-9343(99)00124-2; Warkentin TE, 2000, BLOOD, V96, P1703, DOI 10.1182/blood.V96.5.1703.h8001703_1703_1708; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Warkentin TE, 2001, NEW ENGL J MED, V344, P1286, DOI 10.1056/NEJM200104263441704; Warkentin TE, 1999, ANNU REV MED, V50, P129; Warkentin TE, 1998, SEMIN HEMATOL, V35, P9; WARKENTIN TE, 1994, BLOOD, V84, P3691, DOI 10.1182/blood.V84.11.3691.bloodjournal84113691; Warkentin TE, 1996, TRANSFUS MED REV, V10, P249, DOI 10.1016/S0887-7963(96)80001-0; Warkentin TE, 1996, AM J MED, V101, P502, DOI 10.1016/S0002-9343(96)00258-6; WARKENTIN TE, 2001, HEPARIN INDUCED THRO, P1	27	11	13	0	11	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1562	1570		10.1056/NEJMcpc020015	http://dx.doi.org/10.1056/NEJMcpc020015			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015397				2022-12-28	WOS:000175563900009
J	Duperrex, O; Bunn, F; Roberts, I				Duperrex, O; Bunn, F; Roberts, I			Safety education of pedestrians for injury prevention: a systematic review of randomised controlled trials	BRITISH MEDICAL JOURNAL			English	Review							CHILDREN; ROAD; KINDERGARTEN; PROGRAM; ROUTES; CROSS	Objectives To quantify the effectiveness of safety education of pedestrians. Design Systematic review of randomised controlled trials of safety education programmes for pedestrians of all ages. Main outcome measures Effect of safety education on pedestrians' injuries, behaviour, attitude, and knowledge and on pedestrian-motor vehicle collisions. Quality of trials: methods of randomisation; and numbers lost to follow up Results We identified 15 randomised controlled trials of safety education programmes for pedestrians. Fourteen trials targeted children, and one targeted institutionalised adults. None assessed the effect of safety education on the occurrence of pedestrian injury, but six trials assessed its effect on behaviour. The effect of pedestrian education on behaviour varied considerably across studies and outcomes. Conclusions Pedestrian safety education can change observed road crossing behaviour, but whether this reduces the risk of pedestrian injury in road traffic crashes is unknown. There is a lack of good evidence of effectiveness of safety education for adult pedestrians, specially elderly people. None of the trials was conducted in low or middle income countries.	CMU, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland; London Sch Hyg & Trop Med, Publ Hlth Intervent Res Unit, London, England	University of Geneva; University of London; London School of Hygiene & Tropical Medicine	Duperrex, O (corresponding author), CMU, Inst Social & Prevent Med, CH-1211 Geneva 4, Switzerland.		Bunn, Frances/I-8108-2015	Bunn, Frances/0000-0002-5885-918X				AMPOFOBOATENG K, 1993, BRIT J DEV PSYCHOL, V11, P31, DOI 10.1111/j.2044-835X.1993.tb00586.x; BARSS P, 1998, INJURY PREVENTION IN; BOUCK LH, 1992, THESIS TEXAS A M U C; CROSS RT, 1988, INT J SCI EDUC, V10, P531, DOI 10.1080/0950069880100506; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; DOWNING CS, 1981, 992 TRRL LR, P1; FOLLMANN D, 1992, J CLIN EPIDEMIOL, V45, P769, DOI 10.1016/0895-4356(92)90054-Q; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; LIMBOURG M, 1981, ACCIDENT ANAL PREV, V13, P255, DOI 10.1016/0001-4575(81)90008-7; Luria JW, 2000, ARCH PEDIAT ADOL MED, V154, P227, DOI 10.1001/archpedi.154.3.227; MATSON JL, 1980, BEHAV RES THER, V18, P99, DOI 10.1016/0005-7967(80)90103-5; Miller D, 1982, J TRAFFIC SAFETY ED, V30, P13; MULROW CD, 1997, COCHRANE COLLABORATI; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Nishioka N., 1991, IATSS RES, V15, P39; RENAUD L, 1989, AM J PUBLIC HEALTH, V79, P307, DOI 10.2105/AJPH.79.3.307; RIVARA FP, 1990, AM J DIS CHILD, V144, P692, DOI 10.1001/archpedi.1990.02150300090023; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SINGH A, 1979, TRAFFIC ED, V4, P8; Thomson JA, 1998, BRIT J EDUC PSYCHOL, V68, P475, DOI 10.1111/j.2044-8279.1998.tb01306.x; THOMSON JA, 1992, BRIT J EDUC PSYCHOL, V62, P173, DOI 10.1111/j.2044-8279.1992.tb01011.x; Thomson JA, 1997, ROAD SAFETY RES REP, V3, P1; *WORLD BANK GROUP, 2001, ROAD SAF	23	130	137	0	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1129	1131		10.1136/bmj.324.7346.1129	http://dx.doi.org/10.1136/bmj.324.7346.1129			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552LX	12003885	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-28	WOS:000175622800019
J	Remuzzi, G; Ruggenenti, P; Codazzi, D; Noris, M; Caprioli, J; Locatelli, G; Gridelli, B				Remuzzi, G; Ruggenenti, P; Codazzi, D; Noris, M; Caprioli, J; Locatelli, G; Gridelli, B			Combined kidney and liver transplantation for familial haemolytic uraemic syndrome	LANCET			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR-H	Recurrent haemolytic uraemic syndrome (HUS) is a genetic form of thrombotic microangiopathy that is mostly associated with low activity of complement factor H. The disorder usually develops in families, leads to end stage renal disease, and invariably recurs after kidney transplantation. We did a simultaneous kidney and liver transplantation in a 2-year-old child with HUS and a mutation in complement factor H to restore the defective factor H, with no recurrence of the disease. The operation was successful, and at discharge, the child had healthy kidney and liver function, with no sign of haemolysis.	Osped Riuniti Bergamo, I-24100 Bergamo, Italy; Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy	Ospedali Riuniti di Bergamo; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Remuzzi, G (corresponding author), Osped Riuniti Bergamo, I-24100 Bergamo, Italy.		NORIS, MARINA/ABG-2219-2020; Codazzi, Daniela/M-6567-2017; Remuzzi, Giuseppe/V-9766-2017	NORIS, MARINA/0000-0001-7651-5033; Codazzi, Daniela/0000-0002-4495-0329; Remuzzi, Giuseppe/0000-0002-6194-3446				Caprioli J, 2001, J AM SOC NEPHROL, V12, P297, DOI 10.1681/ASN.V122297; DIENSTAG J, 1994, HARRISONS PRINCIPLES, P1501; Manuelian T, 2001, MOL IMMUNOL, V38, P109; Taylor CM, 2001, LANCET, V358, P1200, DOI 10.1016/S0140-6736(01)06339-5; Zipfel PF, 2001, TRENDS IMMUNOL, V22, P345, DOI 10.1016/S1471-4906(01)01972-X	5	122	128	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1671	1672		10.1016/S0140-6736(02)08560-4	http://dx.doi.org/10.1016/S0140-6736(02)08560-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020532				2022-12-28	WOS:000175593300015
J	Wiseman, BS; Werb, Z				Wiseman, BS; Werb, Z			Development - Stromal effects on mammary gland development and breast cancer	SCIENCE			English	Review							HORMONE-RELATED PROTEIN; COLONY-STIMULATING FACTOR-1; DUCTAL MORPHOGENESIS; TRANSGENIC MICE; GROWTH-HORMONE; IGF-I; MOUSE; INVOLUTION; DIFFERENTIATION; PROGESTERONE	Breast cancer manifests Itself in the mammary epithelium, yet there is a growing recognition that mammary stromal cells also play an important role in tumorigenesis. During Its developmental cycle, the mammary gland displays many of the properties associated with breast cancer, and many of the stromal, factors necessary for mammary development also promote or protect against breast cancer. Here we review our present knowledge of the specific factors and cell types that contribute to epithelial-stromal crosstalk during mammary development. To find cures for diseases like breast cancer that rely on epithelial-stromal crosstalk, we must understand how these different cell types communicate with each other.	Univ Calif San Francisco, Dept Astron, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Astron, 513 Parnassus Ave, San Francisco, CA 94143 USA.				NCI NIH HHS [R01 CA057621-07, R01 CA057621, CA57621] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057621] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Bahary N, 2001, SCIENCE, V294, P530, DOI 10.1126/science.1066282; Bonnette SG, 2001, ENDOCRINOLOGY, V142, P4937, DOI 10.1210/en.142.11.4937; Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076; Brisken C, 2000, GENE DEV, V14, P650; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chapman RS, 2000, ONCOGENE, V19, P6386, DOI 10.1038/sj.onc.1204016; Crowley MR, 2000, DEV BIOL, V225, P407, DOI 10.1006/dbio.2000.9844; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Djonov V, 2001, MICROSC RES TECHNIQ, V52, P182, DOI 10.1002/1097-0029(20010115)52:2<182::AID-JEMT1004>3.3.CO;2-D; Dunbar ME, 1998, DEV BIOL, V203, P75, DOI 10.1006/dbio.1998.9029; ELLIOTT BE, 1992, INT J CANCER, V51, P416, DOI 10.1002/ijc.2910510314; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Foley J, 2001, DEVELOPMENT, V128, P513; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; Ha HY, 2001, CANCER RES, V61, P984; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Humphreys RC, 1999, CELL GROWTH DIFFER, V10, P685; Kleinberg DL, 2000, J MAMMARY GLAND BIOL, V5, P7, DOI 10.1023/A:1009507030633; Klinowska TCM, 1999, DEV BIOL, V215, P13, DOI 10.1006/dbio.1999.9435; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Lewis MT, 2001, DEV BIOL, V238, P133, DOI 10.1006/dbio.2001.0410; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lund LR, 2000, DEVELOPMENT, V127, P4481; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen AV, 2000, DEVELOPMENT, V127, P3107; POLLARD JW, 1994, P NATL ACAD SCI USA, V91, P9312, DOI 10.1073/pnas.91.20.9312; Radice GL, 1997, J CELL BIOL, V139, P1025, DOI 10.1083/jcb.139.4.1025; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; Shieh DB, 1999, CANCER-AM CANCER SOC, V85, P47, DOI 10.1002/(SICI)1097-0142(19990101)85:1<47::AID-CNCR7>3.0.CO;2-L; Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P; Sternlicht MD, 1999, CELL, V98, P137, DOI 10.1016/S0092-8674(00)81009-0; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Walden PD, 1998, ENDOCRINOLOGY, V139, P659, DOI 10.1210/en.139.2.659; WISEMAN BS, UNPUB; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285	42	584	602	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1046	1049		10.1126/science.1067431	http://dx.doi.org/10.1126/science.1067431			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004111	Green Accepted			2022-12-28	WOS:000175565000033
J	Brady, AR; Brown, LC; Fowkes, EGR; Greenhalgh, RM; Powell, JT; Ruckley, CV; Thompson, SG				Brady, AR; Brown, LC; Fowkes, EGR; Greenhalgh, RM; Powell, JT; Ruckley, CV; Thompson, SG		United Kingdom Small Aneurysm Tria	Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMOKING-CESSATION; MORTALITY; WOMEN; RISK	Background: Two clinical trials, one British and one American, have shown that early, prophylactic elective surgery does not improve five-year survival among patients with small abdominal aortic aneurysms. We report long-term outcomes in the United Kingdom Small Aneurysm Trial. Methods: We randomly assigned 1090 patients, 60 to 76 years of age, with small abdominal aortic aneurysms (diameter, 4.0 to 5.5 cm) to one of two groups: 563 were assigned to undergo early elective surgery, and 527 were assigned to undergo surveillance by ultrasonography. Patients were followed in the trial until June 1998 and thereafter until August 2001; the mean duration of follow-up was 8 years (range, 6 to 10). Results: The mean duration of survival was 6.5 years among patients in the surveillance group, as compared with 6.7 years among patients in the early-surgery group (P=0.29). The adjusted hazard ratio for death from any cause in the early-surgery group as compared with the surveillance group was 0.83 (95 percent confidence interval, 0.69 to 1.00; P=0.05). The 30-day operative mortality in the early-surgery group (5.5 percent) led to an early disadvantage in terms of survival. The survival curves crossed at three years, and at eight years, mortality in the early-surgery group was 7.2 percentage points lower than that in the surveillance group (P=0.03). There was no evidence that age, sex, or the initial size of the aneurysm modified the hazard ratio or that delayed surgery in the surveillance group increased 30-day postoperative mortality. Death was attributable to a ruptured aneurysm in 19 of the 411 men who died (5 percent) and in 12 of the 85 women who died (14 percent) (P=0.001). The rate of early cessation of smoking was higher in the early-surgery group than in the surveillance group. Conclusions: Among patients with a small abdominal aortic aneurysm, we found no long-term difference in mean survival between the early-surgery and surveillance groups, although after eight years, total mortality was lower in the early-surgery group. This difference may be attributed in part to beneficial changes in lifestyle adopted by members of the early-surgery group.	Univ Hosp Coventry & Warwickshire, Coventry CV2 2DX, W Midlands, England	University of Warwick	Powell, JT (corresponding author), Univ Hosp Coventry & Warwickshire, Clifford Bridge Rd, Coventry CV2 2DX, W Midlands, England.		Powell, Janet/AAW-8669-2021	Powell, Janet/0000-0002-3905-1468; Wyatt, Michael G/0000-0002-9144-4437; Brady, Tony/0000-0003-4751-7616; Lane, Rodney/0000-0002-0782-2491				ALLEN RC, 1993, J VASC SURG, V18, P424, DOI 10.1016/0741-5214(93)90260-S; [Anonymous], 1995, Eur J Vasc Endovasc Surg, V9, P42; Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999; Brady AR, 2000, BRIT J SURG, V87, P742, DOI 10.1046/j.1365-2168.2000.01410.x; CURL GR, 1992, J VASC SURG, V16, P855; Forbes JF, 1998, LANCET, V352, P1656; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Jones KG, 2001, CIRCULATION, V103, P2260; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAWACHI I, 1993, ANN INTERN MED, V119, P992, DOI 10.7326/0003-4819-119-10-199311150-00005; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Pelkonen M, 2000, THORAX, V55, P746, DOI 10.1136/thorax.55.9.746; Powell JT, 1998, LANCET, V352, P1649; POWELL JT, 1990, ACTA CHIR SCAND, P99; TVERDAL A, 1993, J CLIN EPIDEMIOL, V46, P475, DOI 10.1016/0895-4356(93)90025-V	15	449	457	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1445	1452						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000814				2022-12-28	WOS:000175433200003
J	Stone, EG; Morton, SC; Hulscher, ME; Maglione, MA; Roth, EA; Grimshaw, JM; Mittman, BS; Rubenstein, LV; Rubenstein, LZ; Shekelle, PG				Stone, EG; Morton, SC; Hulscher, ME; Maglione, MA; Roth, EA; Grimshaw, JM; Mittman, BS; Rubenstein, LV; Rubenstein, LZ; Shekelle, PG			Interventions that increase use of adult immunization and cancer screening services: A meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; INFLUENZA VACCINATION RATES; FECAL OCCULT BLOOD; INNER-CITY WOMEN; COLORECTAL-CANCER; CERVICAL-CANCER; GENERAL-PRACTICE; PREVENTIVE CARE; BREAST-CANCER; MAMMOGRAPHY UTILIZATION	Purpose: The relative effectiveness of the diverse approaches used to promote preventive care activities, such as cancer screening and adult immunization, is unknown. Despite many high-quality published studies, practices and policymakers attempting to improve preventive care have little definitive information on which to base decisions. Thus, we quantitatively assessed the relative effectiveness of previously studied approaches for improving adherence to adult immunization and cancer screening guidelines. Data Sources: MEDLINE, the Cochrane Effective Practice and Organization of Care Review Group register, previous systematic reviews, and the Medicare Health Care Quality Improvement Project database. Study Selection: Controlled clinical trials that assessed interventions to increase use of immunizations for influenza and pneumococcal pneumonia and screening for colon, breast, and cervical cancer in adults. Data Extraction: Two reviewers independently extracted data on characteristics and outcomes from unmasked articles. Intervention components to increase use of services were classified as reminder, feedback, education, financial incentive, legislative action, organizational change, or mass media campaign. \ Data Synthesis: Of 552 abstracts and articles, 108 met the inclusion criteria. To assess the effect of intervention components, meta-regression models were developed for immunizations and each cancer screening service by using 81 studies with a usual care or control group. The most potent intervention types involved organizational change (the adjusted odds ratios for increased use of services from organizational change ranged from 2.47 to 17.6). Organizational change interventions included the use of separate clinics devoted to prevention, use of a planned care visit for prevention, or designation of nonphysician staff to do specific prevention activities. The next most effective intervention components were patient financial incentives (adjusted odds ratios, 1.82 to 3.42) and patient reminders (adjusted odds ratios, 1.74 to 2.75); the adjusted odds ratios ranged from 1.29 to 1.53 for patient education and from 1.10 to 1.76 for feedback. Conclusions: Rates of adult immunization and cancer screening are most likely to improve when a health care organization supports performance of these activities through organizational changes in staffing and clinical procedures. Involving patients in self-management through patient financial incentives and reminders is also likely to positively affect performance.	RAND Corp, So Calif Evidence Based Practice Ctr, Hlth Div, Santa Monica, CA 90407 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Greater Los Angeles Vet Adm Hlth Care Syst, Los Angeles, CA 90048 USA; Ctr Study Hlth Care Provider Behav, Sepulveda, CA USA; Univ Nijmegen, Ctr Qual Care Res, Nijmegen, Netherlands; Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland	RAND Corporation; Cedars Sinai Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Radboud University Nijmegen; University of Aberdeen	Shekelle, PG (corresponding author), RAND Corp, So Calif Evidence Based Practice Ctr, Hlth Div, 1700 Main St,POB 2138, Santa Monica, CA 90407 USA.	shekelle@rand.org	Hulscher, Marlies/B-1229-2014; Young, Alexander/A-1523-2009; Grimshaw, Jeremy/D-8726-2013; Greiver, Michelle/N-8764-2015	Hulscher, Marlies/0000-0002-2160-4810; Young, Alexander/0000-0002-9367-9213; Greiver, Michelle/0000-0001-8957-0285; Rubenstein, Laurence/0000-0001-5910-0266; Grimshaw, Jeremy/0000-0001-8015-8243				AIKEN LS, 1994, HEALTH PSYCHOL, V13, P526, DOI 10.1037/0278-6133.13.6.526; *AM COLL PHYS, 1994, TASK FORC AD IMM INF; ANDERSON GH, 1988, BMJ-BRIT MED J, V296, P975, DOI 10.1136/bmj.296.6627.975; Atri J, 1997, BRIT MED J, V315, P1356, DOI 10.1136/bmj.315.7119.1356; AUSTIN SM, 1994, J AM MED INFORM ASSN, P121; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; BECKER DM, 1989, AM J PREV MED, V5, P353, DOI 10.1016/S0749-3797(18)31056-0; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BELCHER DW, 1990, ARCH INTERN MED, V150, P2533, DOI 10.1001/archinte.150.12.2533; BENEDET JL, 1992, AM J OBSTET GYNECOL, V166, P1254, DOI 10.1016/S0002-9378(11)90618-8; Binstock MA, 1997, AM J PREV MED, V13, P425, DOI 10.1016/S0749-3797(18)30135-1; BLOOM HG, 1988, J AM GERIATR SOC, V36, P897, DOI 10.1111/j.1532-5415.1988.tb05782.x; Boon M E, 1990, Cytopathology, V1, P201, DOI 10.1111/j.1365-2303.1990.tb00348.x; BRIMBERRY R, 1988, J FAM PRACTICE, V26, P397; Briss PA, 2000, AM J PREV MED, V18, P97, DOI 10.1016/S0749-3797(99)00118-X; BUNTINX F, 1993, FAM PRACT, V10, P219, DOI 10.1093/fampra/10.2.219; CARGILL VA, 1991, MED CARE, V29, P1, DOI 10.1097/00005650-199101000-00001; CHAMPION VL, 1994, MED CARE, V32, P118, DOI 10.1097/00005650-199402000-00003; COSTA MJ, 1991, ACTA CYTOL, V35, P51; CRAMER DW, 1974, CANCER, V34, P2018, DOI 10.1002/1097-0142(197412)34:6<2018::AID-CNCR2820340621>3.0.CO;2-B; CURRY SJ, 1993, PREV MED, V22, P350, DOI 10.1006/pmed.1993.1029; Davis NA, 1997, AM J PREV MED, V13, P298, DOI 10.1016/S0749-3797(18)30179-X; Davis TC, 1998, J GEN INTERN MED, V13, P230, DOI 10.1046/j.1525-1497.1998.00072.x; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FEDSON DS, 1993, JAMA-J AM MED ASSOC, V270, P1956, DOI 10.1001/jama.270.16.1956; GONZALEZ JJ, 1989, SOUTHERN MED J, V82, P342, DOI 10.1097/00007611-198903000-00016; GRILLI R, 2000, COCHRANE DATABASE SY; GYORKOS TW, 1994, CAN J PUBLIC HEALTH, V85, pS14; HARDCASTLE JD, 1983, LANCET, V2, P1; HERMAN CJ, 1994, J AM GERIATR SOC, V42, P1154, DOI 10.1111/j.1532-5415.1994.tb06981.x; HERMAN CJ, 1995, ARCH INTERN MED, V155, P717, DOI 10.1001/archinte.155.7.717; Hogg WE, 1998, CAN FAM PHYSICIAN, V44, P81; Hulscher MEJL, 1999, AM J PUBLIC HEALTH, V89, P737, DOI 10.2105/AJPH.89.5.737; IVES DG, 1994, PREV MED, V23, P134, DOI 10.1006/pmed.1994.1019; Janz NK, 1997, AM J PUBLIC HEALTH, V87, P1683, DOI 10.2105/AJPH.87.10.1683; JOHANNESSON G, 1978, INT J CANCER, V21, P418, DOI 10.1002/ijc.2910210404; KARUZA J, 1995, ARCH INTERN MED, V155, P625, DOI 10.1001/archinte.155.6.625; LAARA E, 1987, LANCET, V1, P1247; Landis S E, 1992, N C Med J, V53, P575; LANTZ PM, 1995, AM J PUBLIC HEALTH, V85, P834, DOI 10.2105/AJPH.85.6.834; LARSON EB, 1982, MED CARE, V20, P639, DOI 10.1097/00005650-198206000-00010; MAGLIONE MA, 2002, IN PRESS AM J PR JUL; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANDELBLATT J, 1995, J FAM PRACTICE, V40, P162; Manfredi C, 1998, ARCH FAM MED, V7, P329, DOI 10.1001/archfami.7.4.329; MANT D, 1992, BRIT J GEN PRACT, V42, P18; MCAVOY BR, 1991, BMJ-BRIT MED J, V302, P833, DOI 10.1136/bmj.302.6780.833; MCDOWELL I, 1989, J FAM PRACTICE, V28, P420; MCDOWELL I, 1986, CAN MED ASSOC J, V135, P991; MILLER AB, 1976, INT J CANCER, V17, P602, DOI 10.1002/ijc.2910170508; MILLER MF, 1993, AM J MED SCI, V306, P98, DOI 10.1097/00000441-199308000-00006; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; MORRISSEY JP, 1995, MED CARE, V33, P315, DOI 10.1097/00005650-199504000-00001; MYERS RE, 1994, PREV MED, V23, P142, DOI 10.1006/pmed.1994.1020; MYERS RE, 1991, MED CARE, V29, P1039, DOI 10.1097/00005650-199110000-00009; NATTINGER AB, 1989, ARCH INTERN MED, V149, P2087, DOI 10.1001/archinte.149.9.2087; Nexoe J, 1997, SCAND J PRIM HEALTH, V15, P109, DOI 10.3109/02813439709018497; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; NICHOLS S, 1986, BRIT MED J, V293, P107, DOI 10.1136/bmj.293.6539.107; PELSEK PE, 1989, JURAN I QUALITY IMPR; PIERCE M, 1989, BMJ-BRIT MED J, V299, P160, DOI 10.1136/bmj.299.6692.160; PLASKON PP, 1995, SOC WORK HEALTH CARE, V21, P59, DOI 10.1300/J010v21n04_04; PRITCHARD DA, 1995, AUST J PUBLIC HEALTH, V19, P167; PYE G, 1988, J EPIDEMIOL COMMUN H, V42, P66, DOI 10.1136/jech.42.1.66; ROBSON J, 1989, BMJ-BRIT MED J, V298, P433, DOI 10.1136/bmj.298.6671.433; Rubenstein LV, 2000, MED CARE, V38, pS129; Ruchlin HS, 1997, OBSTET GYNECOL, V90, P16, DOI 10.1016/S0029-7844(97)00220-2; *SAS I, 1989, SAS STAT US GUID VER; Satterthwaite P, 1997, NEW ZEAL MED J, V110, P58; Sharp DJ, 1996, J EPIDEMIOL COMMUN H, V50, P72, DOI 10.1136/jech.50.1.72; Shea S, 1996, J AM MED INFORM ASSN, V3, P399, DOI 10.1136/jamia.1996.97084513; SHEKELLE PG, 1999, EVIDENCE REPORT TECH; SIEBERS MJ, 1985, J AM GERIATR SOC, V33, P175, DOI 10.1111/j.1532-5415.1985.tb04888.x; SIGURDSSON K, 1993, INT J CANCER, V54, P563, DOI 10.1002/ijc.2910540408; Snell JL, 1996, PREV MED, V25, P702, DOI 10.1006/pmed.1996.0109; STUCK AE, 1993, LANCET, V342, P1032, DOI 10.1016/0140-6736(93)92884-V; Sung JFC, 1997, AM J PREV MED, V13, P51, DOI 10.1016/S0749-3797(18)30225-3; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; Tape T. G., 1988, Proceedings. The Twelfth Annual Symposium on Computer Applications in Medical Care (IEEE Cat. No.88CH2616-1), P749; TAPLIN SH, 1994, AM J PUBLIC HEALTH, V84, P571, DOI 10.2105/AJPH.84.4.571; Taylor V, 1999, J GEN INTERN MED, V14, P104, DOI 10.1046/j.1525-1497.1999.00295.x; THOMPSON RS, 1986, MED CARE, V24, P904, DOI 10.1097/00005650-198610000-00004; TIERNEY WM, 1986, MED CARE, V24, P659, DOI 10.1097/00005650-198608000-00001; Turner K M, 1994, J Med Screen, V1, P199; TURNER RC, 1990, ARCH INTERN MED, V150, P645, DOI 10.1001/archinte.150.3.645; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Vernon SW, 1997, JNCI-J NATL CANCER I, V89, P1406, DOI 10.1093/jnci/89.19.1406; 1995, MMWR MORB MORTAL WKL, V44, P506; 1997, MMWR MORB MORTAL WKL, V46, P919; 1995, MMWR MORB MORTAL WKL, V44, P513	91	460	465	1	37	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					641	651		10.7326/0003-4819-136-9-200205070-00006	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00006			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	547XK	11992299				2022-12-28	WOS:000175357900001
J	Iben, S; Tschochner, H; Bier, M; Hoogstraten, D; Hozak, P; Egly, JM; Grummt, I				Iben, S; Tschochner, H; Bier, M; Hoogstraten, D; Hozak, P; Egly, JM; Grummt, I			TFIIH plays an essential role in RNA polymerase I transcription	CELL			English	Article							TERMINAL DOMAIN KINASE; TATA-BINDING PROTEIN; DNA-REPAIR; SACCHAROMYCES-CEREVISIAE; MULTIPROTEIN COMPLEX; GENE-TRANSCRIPTION; COILED BODIES; RIBOSOMAL-RNA; FACTOR-IIH; INITIATION	TFIIH is a multisubunit protein complex that plays an essential role in nucleotide excision repair and transcription of protein-coding genes. Here, we report that TFIIH is also required for ribosomal RNA synthesis in vivo and in vitro. In yeast, pre-rRNA synthesis is impaired in TFIIH ts strains. In a mouse, part of cellular TFIIH is localized within the nucleolus and is associated with subpopulations of both RNA polymerase I and the basal factor TIF-IB. Transcription systems lacking TFIIH are inactive and exogenous TFIIH restores transcriptional activity. TFIIH is required for productive but not abortive rDNA transcription, implying a postinitiation role in transcription. The results provide a molecular link between RNA polymerase I transcription and transcription-coupled repair of active ribosomal RNA genes.	German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany; Biochem Zentrum Heidelberg, D-69120 Heidelberg, Germany; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 Rotterdam, Netherlands; Acad Sci Czech Republ, Inst Expt Med, Dept Cell Ultrastruct & Mol Biol, Prague 14220 4, Czech Republic; Charles Univ Prague, Fac Med 3, Dept Cell & Mol Biol, Prague 10034, Czech Republic; Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Erasmus University Rotterdam; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Grummt, I (corresponding author), German Canc Res Ctr, Div Mol Biol Cell 2, D-69120 Heidelberg, Germany.	j.grummt@dkfz-heidelberg.de	Hozak, Pavel/AAB-5359-2021; Hozak, Pavel/J-4182-2014	Hozak, Pavel/0000-0003-1901-1394; Hozak, Pavel/0000-0003-1901-1394				Albert AC, 1999, MOL CELL BIOL, V19, P796; Balajee AS, 1999, NUCLEIC ACIDS RES, V27, P2511, DOI 10.1093/nar/27.12.2511; BOHMANN K, 1995, J CELL BIOL, V131, P817, DOI 10.1083/jcb.131.4.817; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Coin F, 1998, COLD SPRING HARB SYM, V63, P105, DOI 10.1101/sqb.1998.63.105; Coin F, 1999, EMBO J, V18, P1357, DOI 10.1093/emboj/18.5.1357; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Conconi A, 2002, P NATL ACAD SCI USA, V99, P649, DOI 10.1073/pnas.022373099; Dvir A, 1996, J BIOL CHEM, V271, P23352, DOI 10.1074/jbc.271.38.23352; Dvir A, 1997, J BIOL CHEM, V272, P28175, DOI 10.1074/jbc.272.45.28175; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; Gall JG, 2000, ANNU REV CELL DEV BI, V16, P273, DOI 10.1146/annurev.cellbio.16.1.273; GOODRICH JA, 1994, CELL, V77, P145, DOI 10.1016/0092-8674(94)90242-9; Grande MA, 1997, J CELL SCI, V110, P1781; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; Hannan RD, 1999, NUCLEIC ACIDS RES, V27, P3720, DOI 10.1093/nar/27.18.3720; Holstege FCP, 1997, EMBO J, V16, P7468, DOI 10.1093/emboj/16.24.7468; HOZAK P, 1994, J CELL SCI, V107, P639; JIANG Y, 1995, J BIOL CHEM, V270, P1277, DOI 10.1074/jbc.270.3.1277; Jordan P, 1997, MOL BIOL CELL, V8, P1207, DOI 10.1091/mbc.8.7.1207; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Kumar KP, 1998, P NATL ACAD SCI USA, V95, P9767, DOI 10.1073/pnas.95.17.9767; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LOFQUIST AK, 1993, NUCLEIC ACIDS RES, V21, P3233; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; Lyon CE, 1997, EXP CELL RES, V230, P84, DOI 10.1006/excr.1996.3380; MALATESTA M, 1994, EXP CELL RES, V211, P415, DOI 10.1006/excr.1994.1106; MATSUI P, 1995, NUCLEIC ACIDS RES, V23, P767, DOI 10.1093/nar/23.5.767; MCCLURE WR, 1978, J BIOL CHEM, V253, P8941; MEIER UT, 1992, CELL, V70, P127; NONET M, 1987, MOL CELL BIOL, V7, P1602, DOI 10.1128/MCB.7.5.1602; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; RASKA I, 1990, J STRUCT BIOL, V104, P120, DOI 10.1016/1047-8477(90)90066-L; SaezVasquez J, 1997, P NATL ACAD SCI USA, V94, P11869, DOI 10.1073/pnas.94.22.11869; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Schnapp A, 1996, METHOD ENZYMOL, V273, P233; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; SCHNAPP G, 1994, EMBO J, V13, P4028, DOI 10.1002/j.1460-2075.1994.tb06719.x; Seither P, 1998, J MOL BIOL, V275, P43, DOI 10.1006/jmbi.1997.1434; SERIZAWA H, 1993, J BIOL CHEM, V268, P17300; TIMMERS HTM, 1994, EMBO J, V13, P391, DOI 10.1002/j.1460-2075.1994.tb06273.x; VONHIPPEL PH, 1984, ANNU REV BIOCHEM, V53, P389, DOI 10.1146/annurev.bi.53.070184.002133	47	117	122	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2002	109	3					297	306		10.1016/S0092-8674(02)00729-8	http://dx.doi.org/10.1016/S0092-8674(02)00729-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015980	Bronze			2022-12-28	WOS:000175412100006
J	Feldman, WC; Boynton, WV; Tokar, RL; Prettyman, TH; Gasnault, O; Squyres, SW; Elphic, RC; Lawrence, DJ; Lawson, SL; Maurice, S; McKinney, GW; Moore, KR; Reedy, RC				Feldman, WC; Boynton, WV; Tokar, RL; Prettyman, TH; Gasnault, O; Squyres, SW; Elphic, RC; Lawrence, DJ; Lawson, SL; Maurice, S; McKinney, GW; Moore, KR; Reedy, RC			Global distribution of neutrons from Mars: Results from Mars Odyssey	SCIENCE			English	Article							GROUND ICE; EPITHERMAL NEUTRONS; LUNAR PROSPECTOR; TEMPERATURES; STABILITY; SURFACE; MOON	Global distributions of thermal, epithermal, and fast neutron fluxes have been mapped during late southern summer/northern winter using the Mars Odyssey Neutron Spectrometer. These fluxes are selectively sensitive to the vertical and lateral spatial distributions of H and CO2 in the uppermost meter of the martian surface. Poleward of +/-60degrees latitude is terrain rich in hydrogen, probably H2O ice buried beneath tens of centimeter-thick hydrogen-poor soil. The central portion of the north polar cap is covered by a thick CO2 layer, as is the residual south polar cap. Portions of the low to middle latitudes indicate subsurface deposits of chemically and/or physically bound H2O and/or OH.	Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Univ Arizona, Lunar Planetary Lab, Tucson, AZ 85721 USA; Observ Midi Pyrenees, F-31400 Toulouse, France	United States Department of Energy (DOE); Los Alamos National Laboratory; Cornell University; University of Arizona; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Feldman, WC (corresponding author), Los Alamos Natl Lab, POB 1663, Los Alamos, NM 87545 USA.		Gasnault, Olivier/F-4327-2010; Lawrence, David J/E-7463-2015	Gasnault, Olivier/0000-0002-6979-9012; Lawrence, David J/0000-0002-7696-6667; Prettyman, Thomas/0000-0003-0072-2831; Reedy, Robert/0000-0002-2189-1303				Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; BOYNTON WV, UNPUB SPACE SCI REV; FARMER CB, 1979, J GEOPHYS RES, V84, P2881, DOI 10.1029/JB084iB06p02881; Feldman WC, 1998, SCIENCE, V281, P1489, DOI 10.1126/science.281.5382.1489; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; FELDMAN WC, 1986, NUCL INSTRUM METH A, V245, P182, DOI 10.1016/0168-9002(86)90274-3; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P20347, DOI 10.1029/1999JE001183; FELDMAN WC, IN PRESS J GEOPHYS R; Gasnault O, 2001, GEOPHYS RES LETT, V28, P3797, DOI 10.1029/2001GL013072; GENETAY I, UNPUB PLANET SPACE S; James PB, 2001, ICARUS, V154, P131, DOI 10.1006/icar.2001.6653; JAMES PB, 1992, MARS, P934; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; LINGENFELTER R, 1961, J GEOPHYS RES, V66, P2665, DOI 10.1029/JZ066i009p02665; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; NEUGEBAUER G, 1971, ASTRON J, V76, P719, DOI 10.1086/111189; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; SODERBLOM L. A., 1992, MARS, P557; Thomas P., 1992, MARS, P767	23	412	420	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 5	2002	297	5578					75	78		10.1126/science.1073541	http://dx.doi.org/10.1126/science.1073541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	571HB	12040088				2022-12-28	WOS:000176711000034
J	Pitkin, RM; Burmeister, LF				Pitkin, RM; Burmeister, LF			Identifying manuscript reviewers - Randomized comparison of asking first or just sending	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context Some journals routinely query potential referees before sending manuscripts ("askfirst"), whereas others just send manuscripts and allow referees to opt out ("justsend"). It is not known which protocol results in more completed reviews or shorter review time. Methods Trial to assess proportion of referee turndowns and length of review process, conducted at editorial office of Obstetrics & Gynecology and involving 283 consecutive qualifying manuscripts. For each, a referee was randomly assigned to askfirst (manuscript sent only after affirmative response within 3 days) and another to just-send (manuscript sent with request to review; could opt out). Results Only 64% of askfirst referees assented initially (15% declined [vs 8% for justsend, P=.008] and 21% failed to respond within 3 working days, necessitating a replacement). But once manuscript was mailed, mean time to file a review was significantly shorter for askfirst (21.0 vs 25.0 days, P<.001); thus, overall time to receipt of review did not differ significantly (24.7 vs 25.9 days, P=.19), nor did review quality (P=39). Conclusion Askfirst led to a higher rate of referee turndown than did justsend, but assenting askfirst referees completed reviews faster. The overall time for the review process did not differ between the 2 protocols.	Obstet & Gynecol, Washington, DC USA		Pitkin, RM (corresponding author), 78900 Rancho La Quinta Dr, La Quinta, CA 92253 USA.							BISHOP CT, 1984, HOW TO EDIT A SCI J, P53	1	20	20	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2795	2796		10.1001/jama.287.21.2795	http://dx.doi.org/10.1001/jama.287.21.2795			2	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038915	Bronze			2022-12-28	WOS:000176002200012
J	Rankin, CH				Rankin, CH			Neuroscience: A bite to remember	SCIENCE			English	Editorial Material							IN-VITRO ANALOG; FUNCTIONAL DYNAMICS; IDENTIFIED NEURON; APLYSIA		Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Rankin, CH (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.			Rankin, Catharine/0000-0002-1781-0654				AHN S, 1999, J NEUROSCI, V19; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Brembs B, 2002, SCIENCE, V296, P1706, DOI 10.1126/science.1069434; Coleman J. E., 1979, ADV INORG BIOCHEM, V1, P1; Domjan M., 1998, PRINCIPLES LEARNING; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Murphy GG, 1999, J NEUROSCI, V19, P10595; Nargeot R, 1999, J NEUROSCI, V19, P2261; Nargeot R, 1999, J NEUROSCI, V19, P2247; RESCORLA RA, 1991, Q J EXP PSYCHOL-B, V43, P1	11	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1624	1625		10.1126/science.1072683	http://dx.doi.org/10.1126/science.1072683			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	558PR	12040169				2022-12-28	WOS:000175976200032
J	Nosil, P; Crespi, BJ; Sandoval, CP				Nosil, P; Crespi, BJ; Sandoval, CP			Host-plant adaptation drives the parallel evolution of reproductive isolation	NATURE			English	Article							NATURAL-SELECTION; PHYLOGENETIC INFERENCE; SEXUAL ISOLATION; SPECIATION; FREQUENCIES	Parallel evolution of similar traits in independent populations that inhabit ecologically similar environments strongly implicates natural selection as the cause of evolution(1). Parallel speciation is a special form of parallel evolution where traits that determine reproductive isolation evolve repeatedly, in closely related populations, as by-products of adaptation to ecological conditions(1,2). The outcome of such parallel evolution is that ecologically divergent pairs of populations exhibit greater levels of reproductive isolation than ecologically similar pairs of populations of a similar or younger age(2-4). The parallel evolution of reproductive isolation provides strong evidence for natural selection in the process of speciation(1), but only one conclusive example from nature is known(2). Populations of the walking-stick insect Timema cristinae that use different host-plant species have diverged in body size and shape, host preference, behaviour and the relative frequency of two highly cryptic colour-pattern morphs(5,6). Here we report that divergent selection for host adaptation, and not genetic drift, has promoted the parallel evolution of sexual isolation in this species. Our findings represent a clear demonstration that host-plant adaptation can play a crucial and repeatable role in the early stages of speciation.	Simon Fraser Univ, Dept Biosci, Behav Ecol Res Grp, Burnaby, BC V5A 1S6, Canada; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93206 USA	Simon Fraser University; University of California System; University of California Santa Barbara	Nosil, P (corresponding author), Simon Fraser Univ, Dept Biosci, Behav Ecol Res Grp, Burnaby, BC V5A 1S6, Canada.							Crespi BJ, 2000, J EVOLUTION BIOL, V13, P249, DOI 10.1046/j.1420-9101.2000.00164.x; Funk DJ, 1998, EVOLUTION, V52, P1744, DOI [10.2307/2411347, 10.1111/j.1558-5646.1998.tb02254.x]; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Manly BFJ, 1997, RANDOMIZATION BOOTST; McPeek MA, 1998, LIMNOL OCEANOGR, V43, P1162, DOI 10.4319/lo.1998.43.6.1162; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rolan-Alvarez E, 2000, EVOLUTION, V54, P30, DOI 10.1554/0014-3820(2000)054[0030:ESSASI]2.0.CO;2; Rundle HD, 2000, SCIENCE, V287, P306, DOI 10.1126/science.287.5451.306; SANDOVAL CP, 1994, BIOL J LINN SOC, V52, P341; SANDOVAL CP, 1994, EVOLUTION, V48, P1866, DOI 10.1111/j.1558-5646.1994.tb02220.x; Sandoval CP, 1993, THESIS U CALIFORNIA; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SWOFFORD DL, 2001, PAUP STAR PHYLOGENET; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x	16	346	360	1	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					440	443		10.1038/417440a	http://dx.doi.org/10.1038/417440a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024213				2022-12-28	WOS:000175730900038
J	Lebedev, S; Chevrot, S; van der Hilst, RD				Lebedev, S; Chevrot, S; van der Hilst, RD			Seismic evidence for olivine phase changes at the 410-and 660-kilometer discontinuities	SCIENCE			English	Article							MANTLE; TOMOGRAPHY; BOUNDARY; MG2SIO4; SPINEL; ZONE	The view that the seismic discontinuities bounding the mantle transition zone at 410- and 660-kilometer depths are caused by isochemical phase transformations of the olivine structure is debated. Combining converted-wave measurements in East Asia and Australia with seismic velocities from regional tomography studies, we observe a correlation of the thickness of, and wavespeed variations within, the transition zone that is consistent with olivine structural transformations. Moreover, the seismologically inferred Clapeyron slopes are in agreement with the mineralogical Clapeyron slopes of the (Mg,Fe)(2)SiO4 spinel. and postspinel transformations.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Observ Midi Pyrenees, F-31400 Toulouse, France	Massachusetts Institute of Technology (MIT); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lebedev, S (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Room 54-512, Cambridge, MA 02139 USA.		Lebedev, Sergei/E-5892-2011; Chevrot, Sebastien/W-7892-2019; Chevrot, Sebastien/D-8442-2011	Chevrot, Sebastien/0000-0002-6508-2524				ANDERSON DL, 1967, SCIENCE, V157, P1165, DOI 10.1126/science.157.3793.1165; BECKER TW, 2002, GEOCHEM GEOPHYS GEOS, V3; Bernal J.D., 1936, OBSERVATORY, V59, P265; Bina CR, 1998, NATURE, V392, P650, DOI 10.1038/33531; BINA CR, 1994, J GEOPHYS RES-SOL EA, V99, P15853, DOI 10.1029/94JB00462; Chevrot S, 1999, J GEOPHYS RES-SOL EA, V104, P20203, DOI 10.1029/1999JB900087; Chudinovskikh L, 2001, NATURE, V411, P574, DOI 10.1038/35079060; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Flanagan MP, 1998, J GEOPHYS RES-SOL EA, V103, P2673, DOI 10.1029/97JB03212; Hirose K, 2001, EARTH PLANET SC LETT, V184, P567, DOI 10.1016/S0012-821X(00)00354-X; Irifune T, 1998, NATURE, V392, P702, DOI 10.1038/33663; Irifune T, 1998, SCIENCE, V279, P1698, DOI 10.1126/science.279.5357.1698; ITO E, 1989, J GEOPHYS RES, V94, P10673; KARATO S, 1993, GEOPHYS RES LETT, V20, P1623, DOI 10.1029/93GL01767; KATSURA T, 1989, J GEOPHYS RES-SOLID, V94, P15663, DOI 10.1029/JB094iB11p15663; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; LEBEDEV S, UNPUB; NOLET G, 1990, J GEOPHYS RES-SOLID, V95, P8499, DOI 10.1029/JB095iB06p08499; Press W., 1992, NUMERICAL RECIPES FO; RINGWOOD AE, 1969, EARTH PLANET SC LETT, V5, P401; Shearer PM, 2000, GEOPHYS MONOGR SER, V117, P115, DOI DOI 10.1029/GM117P0115; Shim SH, 2001, NATURE, V411, P571, DOI 10.1038/35079053; Simons FJ, 1999, LITHOS, V48, P17, DOI 10.1016/S0024-4937(99)00041-9; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P14835, DOI 10.1029/97JB00550; VIDALE JE, 1992, NATURE, V356, P678, DOI 10.1038/356678a0; VINNIK LP, 1977, PHYS EARTH PLANET IN, V15, P39, DOI 10.1016/0031-9201(77)90008-5; Weidner DJ., 2000, EARTHS DEEP INTERIOR, P215, DOI [10.1029/gm117p0215, DOI 10.1029/GM117P0215]; WICKS CW, 1993, SCIENCE, V261, P1424, DOI 10.1126/science.261.5127.1424	29	74	79	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1300	1302		10.1126/science.1069407	http://dx.doi.org/10.1126/science.1069407			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016311	Green Submitted			2022-12-28	WOS:000175713000049
J	Budd, GE				Budd, GE			A palaeontological solution to the arthropod head problem	NATURE			English	Article							BURGESS SHALE; MORPHOLOGY; CHELICERATE; EXPRESSION; CRUSTACEA; EVOLUTION; POSITION; BEARING; ORIGIN	The composition of the arthropod head has been one of the most controversial topics in zoology, with a large number of theories being proposed to account for it over the last century(1). Although fossils have been recognized as being of potential importance in resolving the issue(2,3), a lack of consensus over their systematics(4,5) has obscured their contribution. Here, I show that a group of previously problematic Cambrian arthropods from the Burgess Shale and Chengjiang faunas form a clade close to crown- group euarthropods, the group containing myriapods, chelicerates, insects and crustaceans(6). They are characterized by modified or even absent endopods, and two pre- oral appendages. Comparison with reconstructions of the crown- group euarthropod ground plan(6) and recent investigations into onychophorans(7,8) demonstrates that these two appendages are the first antenna (of extant crustaceans) and a more anterior appendage associated with an ocular segment. The latter appendage has been reduced in all crown- group euarthropods. Its most likely relic is as a component of the labrum(9). These fossils thus tie together results from disparate living groups (onychophorans and euarthropods).	Uppsala Univ, Dept Earth Sci Hist Geol & Paleontol, SE-75236 Uppsala, Sweden	Uppsala University	Budd, GE (corresponding author), Uppsala Univ, Dept Earth Sci Hist Geol & Paleontol, Norbyvagen 22, SE-75236 Uppsala, Sweden.	graham.budd@pal.uu.se		Budd, Graham/0000-0001-9007-4369				Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Bousfield E.L., 1995, Amphipacifica, V2, P3; BRIGGS DEG, 1978, PHILOS T ROY SOC B, V281, P439, DOI 10.1098/rstb.1978.0005; BRIGGS DEG, 1988, PALAEONTOLOGY, V31, P779; BRUTON DL, 1983, PHILOS T R SOC B, V300, P553, DOI 10.1098/rstb.1983.0020; Budd G. E., 1997, ARTHROPOD RELATIONSH, V55, P125; Budd GE, 1999, T ROY SOC EDIN-EARTH, V89, P249, DOI 10.1017/S0263593300002418; CHEN JY, 1995, SCIENCE, V268, P1339, DOI 10.1126/science.268.5215.1339; Dewel R. A., 1997, ARTHROPOD RELATIONSH, V55, P109; Dewel RA, 1999, ZOOL ANZ, V238, P191; Edgecombe GD, 1999, J PALEONTOL, V73, P263, DOI 10.1017/S0022336000027761; Eriksson BJ, 2000, ARTHROPOD STRUCT DEV, V29, P197, DOI 10.1016/S1467-8039(00)00027-X; ERIKSSON BJ, IN PRESS J MORPHOL; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Haas MS, 2001, DEV GENES EVOL, V211, P89, DOI 10.1007/s004270000128; Hou XG, 1999, J PALEONTOL, V73, P102; HOU XG, 1995, GFF, V117, P163, DOI 10.1080/11035899509546213; Hou Xianguang, 1997, Fossils and Strata, V45, P1; REMPEL J G, 1975, Quaestiones Entomologicae, V11, P7; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Scholtz G, 2001, ZOOL-ANAL COMPLEX SY, V103, P99; SIMONETTA AM, 1991, EARLY EVOLUTION META, P189; Swofford D., 1998, PAUP PHYLOGENETIC AN; Telford MJ, 1998, P NATL ACAD SCI USA, V95, P10671, DOI 10.1073/pnas.95.18.10671; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Walossek Dieter, 1999, P3; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Whittington HB., 1979, ORIGIN MAJOR INVERTE, P253; Wills Matthew A., 1995, Verhandlungen der Deutschen Zoologischen Gesellschaft, V88, P203; WINTER G, 1980, Z ZOOL SYST EVOL, V18, P27	31	195	199	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					271	275		10.1038/417271a	http://dx.doi.org/10.1038/417271a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015599				2022-12-28	WOS:000175592100043
J	Rosenkranz, JA; Grace, AA				Rosenkranz, JA; Grace, AA			Dopamine-mediated modulation of odour-evoked amygdala potentials during pavlovian conditioning	NATURE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; LATERAL AMYGDALA; FEAR; INHIBITION; ANESTHESIA; RESPONSES; NEURONS	Pavlovian conditioning results when an innocuous stimulus, such as an odour, is paired with a behaviourally relevant stimulus, such as a foot-shock, so that eventually the former stimulus alone will elicit the behavioural response of the latter. The lateral nucleus of the amygdala (LAT) is necessary for the emotional memory formation in this paradigm(1-4). Enhanced neuronal firing in LAT to conditioned stimuli emerge in parallel with the behavioural changes(5-11) and are dependent on local dopamine(12-15). To study the changes in neuronal excitability and synaptic drive that contribute to the pavlovian conditioning process, here we used in vivo intracellular recordings to examine LAT neurons during pavlovian conditioning in rats. We found that repeated pairings of an odour with a foot-shock resulted in enhanced post-synaptic potential (PSP) responses to the odour and increased neuronal excitability. However, a non-paired odour displayed PSP decrement. The dopamine antagonist haloperidol blocked the PSP enhancement and associated increased neuronal excitability, without reversing previous conditioning. These results demonstrate that conditioning and habituation processes produce opposite effects on LAT neurons and that dopamine is important in these events, consistent with its role in emotional memory formation.	Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rosenkranz, JA (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	rosenk@bns.pitt.edu		Grace, Anthony/0000-0003-1864-5504				ANDREASEN NC, 1994, ACTA PSYCHIAT SCAND, V90, P51, DOI 10.1111/j.1600-0447.1994.tb05891.x; BENARI Y, 1972, ELECTROEN CLIN NEURO, V32, P667, DOI 10.1016/0013-4694(72)90103-4; Collins DR, 2000, LEARN MEMORY, V7, P97, DOI 10.1101/lm.7.2.97; Cousens G, 1998, BEHAV NEUROSCI, V112, P1092, DOI 10.1037/0735-7044.112.5.1092; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; Dutton RC, 2001, ANESTHESIOLOGY, V94, P514, DOI 10.1097/00000542-200103000-00024; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Ghoneim MM, 1997, ANESTHESIOLOGY, V87, P387, DOI 10.1097/00000542-199708000-00027; GOLD PE, 1985, BEHAV NEUROSCI, V99, P1019, DOI 10.1037/0735-7044.99.5.1019; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Greba Q, 2000, BEHAV NEUROSCI, V114, P262, DOI 10.1037//0735-7044.114.2.262; Grossberg S, 2000, BIOL PSYCHIAT, V48, P81, DOI 10.1016/S0006-3223(00)00903-3; Guarraci FA, 1999, BRAIN RES, V827, P28, DOI 10.1016/S0006-8993(99)01291-3; Guarraci FA, 2000, BEHAV NEUROSCI, V114, P647, DOI 10.1037/0735-7044.114.3.647; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; MAREN S, 1991, BRAIN RES, V549, P311, DOI 10.1016/0006-8993(91)90473-9; McGough JJ, 2000, CURR OPIN PEDIATR, V12, P319, DOI 10.1097/00008480-200008000-00006; MORRISON RL, 1988, SCHIZOPHRENIA BULL, V14, P67, DOI 10.1093/schbul/14.1.67; Nigg JT, 2001, PSYCHOL BULL, V127, P571, DOI 10.1037//0033-2909.127.5.571; Nishijo H, 1998, J NEUROPHYSIOL, V79, P21, DOI 10.1152/jn.1998.79.1.21; Pare D, 2000, J NEUROSCI, V20, P2701; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; RESCORLA RA, 1967, PSYCHOL REV, V74, P71, DOI 10.1037/h0024109; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Sacchetti B, 1999, J NEUROSCI, V19, P9570; WEINBERGER NM, 1984, SCIENCE, V223, P605, DOI 10.1126/science.6695173	27	272	275	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					282	287		10.1038/417282a	http://dx.doi.org/10.1038/417282a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	551YT	12015602				2022-12-28	WOS:000175592100046
J	Karter, AJ; Ferrara, A; Liu, JY; Moffet, HH; Ackerson, LM; Selby, JV				Karter, AJ; Ferrara, A; Liu, JY; Moffet, HH; Ackerson, LM; Selby, JV			Ethnic disparities in diabetic complications in an insured population	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STAGE RENAL-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; LOWER-EXTREMITY AMPUTATION; MANAGED CARE POPULATION; RISK-FACTORS; SOCIOECONOMIC-STATUS; MEDICAL-CARE; MEXICAN-AMERICANS; GLYCEMIC CONTROL; RACIAL-DIFFERENCES	Context Higher rates of microvascular complications have been reported for minorities. Disparate access to quality health care is a common explanation for ethnic disparities in diabetic complication rates in the US population. Examining an ethnically diverse population with uniform health care coverage may be useful. Objective To assess ethnic disparities in the incidence of diabetic complications within a nonprofit prepaid health care organization. Design and Setting Longitudinal observational study conducted January 1, 1995, through December 31, 1998, at Kaiser Permanente Medical Care Program in northern California. Participants A total of 62432 diabetic patients including Asians (12%), blacks (14%), Latinos (10%), and whites (64%). Main Outcome Measures Incident myocardial infarction (MI), stroke, congestive heart failure (CHF), and nontraumatic lower extremity amputation (LEA), defined by primary hospitalization discharge diagnosis, procedures, or underlying cause of death; and end-stage renal disease (ESRD), defined as renal insufficiency requiring renal replacement therapy or transplantation for survival or by underlying cause of death. Results Patterns of ethnic differences were not consistent across complications and frequently persisted despite adjustment for a wide range of demographic, socioeconomic, behavioral, and clinical factors. Adjusted hazard ratios (relative to that of whites) were 0.56, 0.68, and 0.68 for blacks, Asians, and Latinos, respectively (P<.001), for MI; 0.76 and 0.72 for Asians and Latinos, respectively (P<.01), for stroke; 0.70 and 0.61 for Asians and Latinos, respectively (P<.01), for CHF; 0.40 for Asians (P<.001) for LEA and 2.03, 1.85, and 1.46 for blacks, Asians, and Latinos, respectively (P<.01), for ESRD. There were no statistically significant black-white differences for stroke, CHF, or LEA and no Latino-white differences for LEA. Conclusions This study confirms previous reports of elevated incidence of ESRD among ethnic minorities, despite uniform medical care coverage, and provides new evidence that rates of other complications are similar or lower relative to those of whites. The persistence of ethnic disparities after adjustment suggests a possible genetic origin, the contribution of unmeasured environmental factors, or a combination of these factors.	Kaiser Permanente, Div Res, Oakland, CA 94612 USA	Kaiser Permanente	Karter, AJ (corresponding author), Kaiser Permanente, Div Res, 2000 Broadway, Oakland, CA 94612 USA.			Ferrara, Assiamira/0000-0002-7505-4826				Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Ayanian JZ, 1999, NEW ENGL J MED, V341, P1661, DOI 10.1056/NEJM199911253412206; AYANIAN JZ, 1994, JAMA-J AM MED ASSOC, V271, P1207, DOI 10.1001/jama.271.15.1207; Backlund E, 1999, SOC SCI MED, V49, P1373, DOI 10.1016/S0277-9536(99)00209-9; Bruno G, 1999, J CLIN EPIDEMIOL, V52, P413, DOI 10.1016/S0895-4356(99)00002-5; BURDEN AC, 1992, DIABETIC MED, V9, P641, DOI 10.1111/j.1464-5491.1992.tb01860.x; Burge MR, 2000, DIABETES OBES METAB, V2, P351, DOI 10.1046/j.1463-1326.2000.00105.x; *CDCP, 1997, DIAB SURV 1997; Chaturvedi N, 1996, DIABETES CARE, V19, P423, DOI 10.2337/diacare.19.5.423; Chaturvedi N, 1998, BMJ-BRIT MED J, V316, P100; Christen WG, 1999, AM J EPIDEMIOL, V150, P1142; Conigliaro J, 2000, ARCH INTERN MED, V160, P1329, DOI 10.1001/archinte.160.9.1329; Connolly VM, 1996, DIABETES CARE, V19, P419, DOI 10.2337/diacare.19.5.419; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Curb JD, 2002, DIABETES CARE, V25, P386; Destefano Frank, 1993, Ethnicity and Disease, V3, P145; FERGUSON R, 1988, J CLIN EPIDEMIOL, V41, P1189, DOI 10.1016/0895-4356(88)90023-6; Ferrara A, 2001, DIABETES CARE, V24, P1144, DOI 10.2337/diacare.24.7.1144; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P710, DOI 10.1016/0272-6386(95)90546-4; Freeman HP, 2000, NEW ENGL J MED, V342, P1045, DOI 10.1056/NEJM200004063421411; Gordon N P, 1991, Adv Health Econ Health Serv Res, V12, P19; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; GUJRAL JS, 1993, DIABETIC MED, V10, P271, DOI 10.1111/j.1464-5491.1993.tb00057.x; HAFFNER SM, 1991, DIABETES CARE, V14, P665, DOI 10.2337/diacare.14.7.665; Harris MI, 1999, DIABETES CARE, V22, P1679, DOI 10.2337/diacare.22.10.1679; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HIATT RA, 1982, AM J PUBLIC HEALTH, V72, P829, DOI 10.2105/AJPH.72.8.829; Iribarren C, 2001, CIRCULATION, V103, P2668; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; Karter AJ, 1999, DIABETES CARE, V22, P938, DOI 10.2337/diacare.22.6.938; Karter AJ, 2001, AM J MED, V111, P1, DOI 10.1016/S0002-9343(01)00742-2; Karter AJ, 2000, DIABETES CARE, V23, P477, DOI 10.2337/diacare.23.4.477; Karter AJ, 1998, J REGISTRY MANAGEMEN, V25, P7; Krieger N, 1998, AM J PUBLIC HEALTH, V88, P1308, DOI 10.2105/AJPH.88.9.1308; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lavery LA, 1996, DIABETES CARE, V19, P48, DOI 10.2337/diacare.19.1.48; Leggetter S, 2002, ARCH INTERN MED, V162, P73, DOI 10.1001/archinte.162.1.73; MARTIN TL, 1995, DIABETES CARE, V18, P1124, DOI 10.2337/diacare.18.8.1124; Mayberry RM, 2000, MED CARE RES REV, V57, P108, DOI 10.1177/107755800773743628; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Miller A D, 1985, J Med Soc N J, V82, P723; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; MOST RS, 1983, DIABETES CARE, V6, P87, DOI 10.2337/diacare.6.1.87; National Diabetes Data Group (U.S.) National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) National Institutes of Health (U.S.). Diabetes in America, 1995, DIAB AM; Nelson AR, 2002, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; PISUNYER X, 1998, CLIN GUIDELINES IDEN; PUGH JA, 1995, DIABETES, V44, P1375, DOI 10.2337/diabetes.44.12.1375; PUGH JA, 1988, AM J EPIDEMIOL, V127, P135, DOI 10.1093/oxfordjournals.aje.a114773; Pugh Jacqueline A., 1992, Journal of Diabetes and its Complications, V6, P236, DOI 10.1016/1056-8727(92)90058-S; REIBER GE, 1992, ANN INTERN MED, V117, P97, DOI 10.7326/0003-4819-117-2-97; REWERS M, 1992, AM J EPIDEMIOL, V135, P1321, DOI 10.1093/oxfordjournals.aje.a116243; RISCH N, IN PRESS GENOME BIOL; Robbins JM, 2000, J EPIDEMIOL COMMUN H, V54, P839, DOI 10.1136/jech.54.11.839; ROSEN AB, 2002, SOC GEN INT MED MAY; ROSTAND SG, 1982, NEW ENGL J MED, V306, P1276, DOI 10.1056/NEJM198205273062106; Schneeweiss S, 2001, HEALTH POLICY, V55, P97, DOI 10.1016/S0168-8510(00)00120-2; Schneider EC, 2002, JAMA-J AM MED ASSOC, V287, P1288, DOI 10.1001/jama.287.10.1288; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; Selby JV, 1997, ANN INTERN MED, V127, P719, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00056; Selby JV, 1999, DIABETES CARE, V22, P38, DOI 10.2337/diacare.22.1.38; SELBY JV, 1995, DIABETES CARE, V18, P509, DOI 10.2337/diacare.18.4.509; SLOAN NR, 1963, JAMA-J AM MED ASSOC, V183, P419, DOI 10.1001/jama.1963.03700060061008; SOUMERAI SB, 1991, NEW ENGL J MED, V325, P1072, DOI 10.1056/NEJM199110103251505; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; *US DEP HHS, 2002, PRES RAC HLTH DISP I; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; van Ryn M, 2000, SOC SCI MED, V50, P813, DOI 10.1016/S0277-9536(99)00338-X; Wagstaff A, 2000, ANNU REV PUBL HEALTH, V21, P543, DOI 10.1146/annurev.publhealth.21.1.543; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; 1992, MMWR MORB MORTAL WKL, V41, P845; [No title captured]	75	654	659	0	20	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2519	2527		10.1001/jama.287.19.2519	http://dx.doi.org/10.1001/jama.287.19.2519			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551MV	12020332	Bronze			2022-12-28	WOS:000175566200020
J	Hugel, T; Holland, NB; Cattani, A; Moroder, L; Seitz, M; Gaub, HE				Hugel, T; Holland, NB; Cattani, A; Moroder, L; Seitz, M; Gaub, HE			Single-molecule optomechanical cycle	SCIENCE			English	Article							FORCE SPECTROSCOPY; PHOTOMODULATION; PHOTOISOMERIZATION; PHOTOREGULATION; ISOMERIZATION; PEPTIDES	Light-powered molecular machines are conjectured to be essential constituents of future nanoscale devices. As a model for such systems, we have synthesized a polymer of bistable photosensitive azobenzenes. Individual polymers were investigated by single-molecule force spectroscopy in combination with optical excitation in total internal reflection. We were able to optically lengthen and contract individual polymers by switching the azo groups between their trans and cis configurations. The polymer was found to contract against an external force acting along the polymer backbone, thus delivering mechanical work. As a proof of principle, the polymer was operated in a periodic mode, demonstrating for the first time optomechanical energy conversion in a single-molecule device.	Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; Univ Munich, Ctr Nanosci, D-80799 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Munich; University of Munich; Max Planck Society	Gaub, HE (corresponding author), Univ Munich, Lehrstuhl Angew Phys, Amalienstr 54, D-80799 Munich, Germany.		Holland, Nolan B./F-6933-2011; Cattani-Scholz, Anna/G-5150-2016	Holland, Nolan B./0000-0002-0752-6887; Moroder, Luis/0000-0001-9570-5713; Hugel, Thorsten/0000-0003-3292-4569				Archut A, 1998, J AM CHEM SOC, V120, P12187, DOI 10.1021/ja9822409; Asanuma H, 1999, ANGEW CHEM INT EDIT, V38, P2393, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2393::AID-ANIE2393>3.0.CO;2-7; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Balzani V, 2000, ANGEW CHEM INT EDIT, V39, P3348, DOI 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X; Behrendt R, 1999, ANGEW CHEM INT EDIT, V38, P2771, DOI 10.1002/(SICI)1521-3773(19990917)38:18<2771::AID-ANIE2771>3.0.CO;2-W; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BLAIR HS, 1980, POLYMER, V21, P1195, DOI 10.1016/0032-3861(80)90087-7; Clausen-Schaumann H, 1998, ADV MATER, V10, P949, DOI 10.1002/(SICI)1521-4095(199808)10:12<949::AID-ADMA949>3.3.CO;2-S; Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5; Collin JP, 1998, EUR J INORG CHEM, P1; EISENBACH CD, 1980, POLYMER, V21, P1175, DOI 10.1016/0032-3861(80)90083-X; Feringa BL, 2000, CHEM REV, V100, P1789, DOI 10.1021/cr9900228; FERINGA BL, 1993, TETRAHEDRON, V49, P8267, DOI 10.1016/S0040-4020(01)81913-X; Finkelmann H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015501; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Hartley GS, 1937, NATURE, V140, P281, DOI 10.1038/140281a0; Hugel T, 2001, MACROMOL RAPID COMM, V22, P989, DOI 10.1002/1521-3927(20010901)22:13<989::AID-MARC989>3.0.CO;2-D; IRIE M, 1981, MACROMOLECULES, V14, P262, DOI 10.1021/ma50003a007; IRIE M, 1990, ADV POLYM SCI, V94, P27; Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213; KUMAR GS, 1989, CHEM REV, V89, P1915, DOI 10.1021/cr00098a012; Labarthet FL, 2000, PHYS CHEM CHEM PHYS, V2, P5154; LEE GU, 1994, LANGMUIR, V10, P354, DOI 10.1021/la00014a003; Lehn J.-M., 1995, SUPRAMOLECULAR CHEM; MONTI S, 1982, CHEM PHYS, V71, P87, DOI 10.1016/0301-0104(82)87008-0; MOY VT, 1994, COLLOID SURFACE A, V93, P343, DOI 10.1016/0927-7757(94)02933-4; Nagele T, 1997, CHEM PHYS LETT, V272, P489, DOI 10.1016/S0009-2614(97)00531-9; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143; RAU H, 1984, J PHOTOCHEM, V26, P221, DOI 10.1016/0047-2670(84)80041-6; Rau H, 1990, PHOTOCHROMISM MOL SY; Renner C, 2000, BIOPOLYMERS, V54, P501, DOI 10.1002/1097-0282(200012)54:7<501::AID-BIP30>3.0.CO;2-8; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Robertson JM, 1939, J CHEM SOC, P232, DOI 10.1039/jr9390000232; SHINKAI S, 1984, TOP CURR CHEM, V121, P67; Smith BL, 1999, NATURE, V399, P761, DOI 10.1038/21607; STRZEGOWSKI LA, 1994, J AM CHEM SOC, V116, P813, DOI 10.1021/ja00081a070; Tamai N, 2000, CHEM REV, V100, P1875, DOI 10.1021/cr9800816; ULYSSE L, 1995, J AM CHEM SOC, V117, P8466, DOI 10.1021/ja00137a023; VOGTLE F, 1991, SUPRAMOLECULAR CHEM; Willner I, 1997, ACCOUNTS CHEM RES, V30, P347, DOI 10.1021/ar9700062; Wong SS, 1998, NATURE, V394, P52, DOI 10.1038/27873; WURTHNER F, 1995, J CHEM SOC PERK T 2, P1727, DOI 10.1039/p29950001727	44	689	713	7	262	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1103	1106		10.1126/science.1069856	http://dx.doi.org/10.1126/science.1069856			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004125				2022-12-28	WOS:000175565000048
J	Woodside, MT; McEuen, PL				Woodside, MT; McEuen, PL			Scanned probe imaging of single-electron charge states in nanotube quantum dots	SCIENCE			English	Article							CARBON NANOTUBES; MICROSCOPY; TRANSPORT	An atomic force microscope was used to study single-electron motion in nanotube quantum dots. By applying a voltage to the microscope tip, the number of electrons occupying the quantum dot could be changed, causing Coulomb oscillations in the nanotube conductance. Spatial maps of these oscillations were used to locate individual dots and to study the electrostatic coupling between the dot and the tip. The electrostatic forces associated with single electrons hopping on and off the quantum dot were also measured. These forces changed the amplitude, frequency, and quality factor of the cantilever oscillation, demonstrating how single-electron motion can interact with a mechanical oscillator.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA	University of California System; University of California Berkeley; Cornell University	Woodside, MT (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.							Bachtold A, 2000, PHYS REV LETT, V84, P6082, DOI 10.1103/PhysRevLett.84.6082; Bockrath M, 2001, SCIENCE, V291, P283, DOI 10.1126/science.291.5502.283; Bockrath M, 1997, SCIENCE, V275, P1922, DOI 10.1126/science.275.5308.1922; Crook R, 2000, J PHYS-CONDENS MAT, V12, pL167, DOI 10.1088/0953-8984/12/8/102; Finkelstein G, 2000, SCIENCE, V289, P90, DOI 10.1126/science.289.5476.90; GRABERT H, 1992, SINGLE CHARGE TUNNEL; Kong J, 1998, NATURE, V395, P878, DOI 10.1038/27632; KOUWENHOVEN LP, 1997, MESOSCOPIC ELECT TRA; McCormick KL, 1999, PHYS REV B, V59, P4654, DOI 10.1103/PhysRevB.59.4654; Sarid D, 1994, SCANNING FORCE MICRO; SCHONENBERGER C, 1990, PHYS REV LETT, V65, P3162, DOI 10.1103/PhysRevLett.65.3162; Tans SJ, 2000, NATURE, V404, P834, DOI 10.1038/35009026; Tans SJ, 1997, NATURE, V386, P474, DOI 10.1038/386474a0; Tessmer SH, 1998, NATURE, V392, P51, DOI 10.1038/32112; Topinka MA, 2000, SCIENCE, V289, P2323, DOI 10.1126/science.289.5488.2323; Woodside MT, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.041310; Yoo MJ, 1997, SCIENCE, V276, P579, DOI 10.1126/science.276.5312.579; Zhitenev NB, 2000, NATURE, V404, P473, DOI 10.1038/35006591	18	221	225	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1098	1101		10.1126/science.1069923	http://dx.doi.org/10.1126/science.1069923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004123				2022-12-28	WOS:000175565000046
J	Jefferson, T; Demicheli, V; Vale, L				Jefferson, T; Demicheli, V; Vale, L			Quality of systematic reviews of economic evaluations in health care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				COST-UTILITY ANALYSES; PHARMACOECONOMIC ANALYSES; RECOMMENDATIONS; SUBMISSIONS; VACCINATION; GUIDELINES; VALUATION; BENEFIT	Context Reviews performed almost a decade ago showed considerable gaps in the quality of reporting and methods applied to economic evaluations of health care interventions. Measures taken by the research community to address the issue included the promulgation of guidelines and the publicizing of good practice in economic evaluation. Methods To assess the quality of methods of systematic reviews, economic evaluations in health care, and reporting methods, we conducted full-text searches of private and public databases for the period 1990 through March 2001 and corresponded with researchers active in the field. A total of 102 reports were identified, but only 39 were included. Quality of systematic reviews was assessed by a 6-item checklist. Results Quality of review methods was reasonable, but more attention needs to be paid to search methods and standardization of evaluation instruments. The reviews found consistent evidence of serious methodological flaws in a significant number of economic evaluations. Lack of clear descriptions of methods, lack of explanation and justification for the framework and approach used, and low-quality estimates of effectiveness for the interventions evaluated were the most frequent flaws. Modest improvements in quality of conducting and reporting economic evaluations appear to have taken place in the last decade. Conclusions Proper allocation of resources on the basis of economic evaluations remains uncertain. Editorial teams and regulatory bodies should perform quality assurance based on a single widely accepted and validated standard instrument.	Cochrane Hlth Econ Methods Grp, Rome, Italy; Hlth Reviews Ltd, Rome, Italy; Azienda Sanit Locale 20, Alessandria, Italy; Hlth Serv Res Unit, Aberdeen, Scotland; Hlth Econ Res Unit, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Jefferson, T (corresponding author), Ist Super Sanita, Reparto Epidemiol Clin, Viale Regina Elena 299, I-00161 Rome, Italy.	tjefferson@cochrane.co.uk		Vale, Luke/0000-0001-8574-8429				ADAMS ME, 1992, MED CARE, V30, P231, DOI 10.1097/00005650-199203000-00005; BADIA X, 1994, PHARMACOECONOMICS, V5, P123, DOI 10.2165/00019053-199405020-00006; Barber JA, 1998, BRIT MED J, V317, P1195, DOI 10.1136/bmj.317.7167.1195; Boynton J, 1998, J INFORM SCI, V24, P137, DOI 10.1177/016555159802400301; Brazier J., 1999, HEALTH TECHNOL ASSES, V4, P174, DOI [10.1177/135581969900400310, DOI 10.1177/135581969900400310, DOI 10.3310/hta3090]; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Brown J, 1999, PHARMACOECONOMICS, V16, P17, DOI 10.2165/00019053-199916010-00003; Chang WY, 1999, NURS RES, V48, P94, DOI 10.1097/00006199-199903000-00008; DEMICHELI V, 1999, PEER REV HLTH SCI, P172; DEMICHELI V, 1997, EC ASPECT BIOTECHNOL; Deverill M, 1998, PHARMACOECONOMICS, V13, P411, DOI 10.2165/00019053-199813040-00004; Diener A, 1998, HEALTH ECON, V7, P313, DOI 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.3.CO;2-2; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF, 2015, METHODS EC EVALUATIO; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; ELIXHAUSER A, 1993, MED CARE, V31, pJS1, DOI 10.1097/00005650-199307001-00001; Evers SMAA, 2000, STROKE, V31, P1046, DOI 10.1161/01.STR.31.5.1046; Evers SMAA, 1997, HEALTH ECON, V6, P161, DOI 10.1002/(SICI)1099-1050(199703)6:2<161::AID-HEC258>3.0.CO;2-I; Fergusson D, 1999, TRANSFUS MED REV, V13, P106, DOI 10.1016/S0887-7963(99)80005-4; Gambhir SS, 2000, Q J NUCL MED, V44, P121; Garcia-Altes A, 2001, HEALTH ECON, V10, P715, DOI 10.1002/hec.608; Gerard K, 2000, INT J TECHNOL ASSESS, V16, P100, DOI 10.1017/S0266462300016196; GERARD K, 1992, HEALTH POLICY, V21, P249, DOI 10.1016/0168-8510(92)90022-4; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; Holloway RG, 1999, STROKE, V30, P1340, DOI 10.1161/01.STR.30.7.1340; Hutton J, 1999, DRUG AGING, V15, P31, DOI 10.2165/00002512-199915001-00004; Jacobs P, 1998, INT J TECHNOL ASSESS, V14, P799, DOI 10.1017/S0266462300012095; JEFFERSON T, 1994, HEALTH ECON, V3, P25, DOI 10.1002/hec.4730030105; Jefferson T, 1996, PHARMACOECONOMICS, V9, P67, DOI 10.2165/00019053-199600093-00015; JEFFERSON T, 1995, HEALTH ECON, V4, P383, DOI 10.1002/hec.4730040504; Lord J, 1999, J EPIDEMIOL COMMUN H, V53, P179, DOI 10.1136/jech.53.3.179; MULROW CD, 1998, SYSTEMATIC REV SYNTH, P17; Neumann PJ, 2000, ANN INTERN MED, V132, P964, DOI 10.7326/0003-4819-132-12-200006200-00007; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Petrou S, 2000, J MED SCREEN, V7, P59, DOI 10.1136/jms.7.2.59; Rennie D, 2000, JAMA-J AM MED ASSOC, V283, P2158, DOI 10.1001/jama.283.16.2158; Saleh KJ, 1999, J ARTHROPLASTY, V14, P527, DOI 10.1016/S0883-5403(99)90072-4; Sassi F, 2001, Health Technol Assess, V5, P1; SASSI F, 2000, THESIS U LONDON; Schrappe M, 1998, AIDS, V12 Suppl A, pS231; SEIGEL J, 1996, COST EFFECTIVENESS H; Shackley P, 1999, J VASC SURG, V30, P668, DOI 10.1016/S0741-5214(99)70106-0; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Spath HM, 1999, HEALTH POLICY, V49, P161, DOI 10.1016/S0168-8510(99)00057-3; Stone PW, 2000, INT J TECHNOL ASSESS, V16, P111, DOI 10.1017/S0266462300161100; UDVARHELYI IS, 1992, ANN INTERN MED, V116, P238, DOI 10.7326/0003-4819-116-3-238; van der Weijden T, 1998, J EPIDEMIOL COMMUN H, V52, P586, DOI 10.1136/jech.52.9.586; Walker D, 2000, TROP MED INT HEALTH, V5, P237, DOI 10.1046/j.1365-3156.2000.00546.x; WALKER D, 2000, HEALTH ECON, V9, P699; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253	52	86	91	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2809	2812		10.1001/jama.287.21.2809	http://dx.doi.org/10.1001/jama.287.21.2809			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038919				2022-12-28	WOS:000176002200016
J	Woloshin, S; Schwartz, LM				Woloshin, S; Schwartz, LM			Press releases - Translating research into news	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context While medical journals strive to ensure accuracy and the acknowledgment of limitations in articles, press releases may not reflect these efforts. Methods Telephone interviews conducted in January 2001 with press officers at 9 prominent medical journals and analysis of press releases (n= 127) about research articles for the 6 issues of each journal preceding the interviews. Results Seven of the 9 journals routinely issue releases; in each case, the editor with the press office selects articles based on perceived newsworthiness and releases are written by press officers trained in communications. Journals have general guidelines (eg, length) but no standards for acknowledging limitations or for data presentation. Editorial input varies from none to intense. Of the 127 releases analyzed, 29 (23%) noted study limitations and 83 (65%) reported main effects using numbers; 58 reported differences between study groups and of these, 26 (55%) provided the corresponding base rate, the format least prone to exaggeration. Industry funding was noted in only 22% of 23 studies receiving such funding. Conclusions Press releases do not routinely highlight study limitations or the role of industry funding. Data are often presented using formats that may exaggerate the perceived importance of findings.	Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA; Dartmouth Coll Sch Med, Ctr Evaluat Clin Sci, Hanover, NH USA; Norris Cotton Canc Ctr, Lebanon, NH USA	VA Outcomes Group; Dartmouth College; Norris Cotton Cancer Center	Schwartz, LM (corresponding author), Dept Vet Affairs Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA.				NATIONAL CANCER INSTITUTE [R18CA091052] Funding Source: NIH RePORTER; NCI NIH HHS [CA91052-01] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BURNS RB, 1995, J GEN INTERN MED, V10, P19, DOI 10.1007/BF02599571; de Semir V, 1998, JAMA-J AM MED ASSOC, V280, P294, DOI 10.1001/jama.280.3.294; ENTWISTLE V, 1995, BRIT MED J, V310, P920, DOI 10.1136/bmj.310.6984.920; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; PHILLIPS DP, 1991, NEW ENGL J MED, V325, P1180, DOI 10.1056/NEJM199110173251620; Ransohoff D F, 2001, Eff Clin Pract, V4, P185; Schwartz LM, 1999, NEW ENGL J MED, V341, P279, DOI 10.1056/NEJM199907223410411; 2002, ISI J CITATION REPOR	10	111	115	2	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2856	2858		10.1001/jama.287.21.2856	http://dx.doi.org/10.1001/jama.287.21.2856			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038933	Bronze			2022-12-28	WOS:000176002200030
J	Schirm, E; Tobi, H; de Jong-van den Berg, LTW				Schirm, E; Tobi, H; de Jong-van den Berg, LTW			Unlicensed and off label drug use by children in the community: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article									Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacotherapy & Pharmacoepide, Groningen, Netherlands	University of Groningen	de Jong-van den Berg, LTW (corresponding author), Univ Groningen, Inst Drug Explorat, Dept Social Pharm Pharmacotherapy & Pharmacoepide, Groningen, Netherlands.		Tobi, Hilde/A-1512-2013	Tobi, Hilde/0000-0002-8804-0298				Chalumeau M, 2000, ARCH DIS CHILD, V83, P502, DOI 10.1136/adc.83.6.502; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; McIntyre J, 2000, ARCH DIS CHILD, V83, P498, DOI 10.1136/adc.83.6.498; 'T Jong GW, 2000, NEW ENGL J MED, V343, P1125, DOI 10.1056/NEJM200010123431515; Turner S, 1998, BRIT MED J, V316, P343, DOI 10.1136/bmj.316.7128.343	5	59	63	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1312	1313		10.1136/bmj.324.7349.1312	http://dx.doi.org/10.1136/bmj.324.7349.1312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039826	Bronze, Green Published			2022-12-28	WOS:000176041500019
J	Cantley, LC				Cantley, LC			The phosphoinositide 3-kinase pathway	SCIENCE			English	Editorial Material							SURVIVAL	Phosphorylated lipids are produced at cellular membranes during signaling events and contribute to the recruitment and activation of various signaling components. The role of phosphoinositide 3-kinase (PI3K), which catalyzes the production of phosphatidytinositol-3,4,5-trisphosphate, in cell survival pathways; the regulation of gene expression and cell metabolism; and cytoskeletal rearrangements are highlighted. The PI3K pathway is implicated in human diseases including diabetes and cancer, and understanding the intricacies of this pathway may provide new avenues for therapuetic intervention.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Cantley, LC (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	cantley@helix.mgh.harvard.edu	Cantley, Lewis C/D-1800-2014; Ioannidis, John P. A./G-9836-2011	Cantley, Lewis C/0000-0002-1298-7653; 	NIGMS NIH HHS [R01 GM041890] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; CANTLEY LC, 2002, SCI STKE; Clement S, 2001, NATURE, V409, P92, DOI 10.1038/35051094; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Lawlor MA, 2001, J CELL SCI, V114, P2903; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	8	4361	4735	16	556	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1655	1657		10.1126/science.296.5573.1655	http://dx.doi.org/10.1126/science.296.5573.1655			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040186				2022-12-28	WOS:000175976200049
J	Mural, RJ; Adams, MD; Myers, EW; Smith, HO; Miklos, GLG; Wides, R; Halpern, A; Li, PW; Sutton, GG; Nadeau, J; Salzberg, SL; Holt, RA; Kodira, CD; Lu, F; Chen, L; Deng, ZM; Evangelista, CC; Gan, WN; Heiman, TJ; Li, JY; Li, ZY; Merkulov, GV; Milshina, NV; Naik, AK; Qi, R; Shue, BC; Wang, AH; Wang, J; Wang, X; Yan, XH; Ye, JN; Yooseph, S; Zhao, Q; Zheng, LS; Zhu, SPC; Biddick, K; Bolanos, R; Delcher, AL; Dew, IM; Fasulo, D; Flanigan, MJ; Huson, DH; Kravitz, SA; Miller, JR; Mobarry, CM; Reinert, K; Remington, KA; Zhang, Q; Zheng, XQH; Nusskern, DR; Lai, ZW; Lei, YD; Zhong, WY; Yao, A; Guan, P; Ji, RR; Gu, ZP; Wang, ZY; Zhong, F; Xiao, CL; Chiang, CC; Yandell, M; Wortman, JR; Amanatides, PG; Hladun, SL; Pratts, EC; Johnson, JE; Dodson, KL; Woodford, KJ; Evans, CA; Gropman, B; Rusch, DB; Venter, E; Wang, V; Smith, TJ; Houck, JT; Tompkins, DE; Haynes, C; Jacob, D; Chin, SH; Allen, DR; Dahlke, CE; Sanders, R; Li, K; Liu, XJ; Levitsky, AA; Majoros, WH; Chen, Q; Xia, AC; Lopez, JR; Donnelly, MT; Newman, MH; Glodek, A; Kraft, CL; Nodell, M; Ali, F; An, HJ; Baldwin-Pitts, D; Beeson, KY; Cai, S; Carnes, M; Carver, A; Caulk, PM; Center, A; Chen, YH; Cheng, ML; Coyne, MD; Crowder, M; Danaher, S; Davenport, LB; Desilets, R; Dietz, SM; Doup, L; Dullaghan, P; Ferriera, S; Fosler, CR; Gire, HC; Gluecksmann, A; Gocayne, JD; Gray, J; Hart, B; Haynes, J; Hoover, J; Howland, T; Ibegwam, C; Jalali, M; Johns, D; Kline, L; Ma, DS; MacCawley, S; Magoon, A; Mann, F; May, D; McIntosh, TC; Mehta, S; Moy, L; Moy, MC; Murphy, BJ; Murphy, SD; Nelson, KA; Nuri, Z; Parker, KA; Prudhomme, AC; Puri, VN; Qureshi, H; Raley, JC; Reardon, MS; Regier, MA; Rogers, YHC; Romblad, DL; Schutz, J; Scott, JL; Scott, R; Sitter, CD; Smallwood, M; Sprague, AC; Stewart, E; Strong, RV; Suh, E; Sylvester, K; Thomas, R; Tint, NN; Tsonis, C; Wang, G; Wang, G; Williams, MS; Williams, SM; Windsor, SM; Wolfe, K; Wu, MM; Zaveri, J; Chaturvedi, K; Gabrielian, AE; Ke, ZX; Sun, JT; Subramanian, G; Venter, JC				Mural, RJ; Adams, MD; Myers, EW; Smith, HO; Miklos, GLG; Wides, R; Halpern, A; Li, PW; Sutton, GG; Nadeau, J; Salzberg, SL; Holt, RA; Kodira, CD; Lu, F; Chen, L; Deng, ZM; Evangelista, CC; Gan, WN; Heiman, TJ; Li, JY; Li, ZY; Merkulov, GV; Milshina, NV; Naik, AK; Qi, R; Shue, BC; Wang, AH; Wang, J; Wang, X; Yan, XH; Ye, JN; Yooseph, S; Zhao, Q; Zheng, LS; Zhu, SPC; Biddick, K; Bolanos, R; Delcher, AL; Dew, IM; Fasulo, D; Flanigan, MJ; Huson, DH; Kravitz, SA; Miller, JR; Mobarry, CM; Reinert, K; Remington, KA; Zhang, Q; Zheng, XQH; Nusskern, DR; Lai, ZW; Lei, YD; Zhong, WY; Yao, A; Guan, P; Ji, RR; Gu, ZP; Wang, ZY; Zhong, F; Xiao, CL; Chiang, CC; Yandell, M; Wortman, JR; Amanatides, PG; Hladun, SL; Pratts, EC; Johnson, JE; Dodson, KL; Woodford, KJ; Evans, CA; Gropman, B; Rusch, DB; Venter, E; Wang, V; Smith, TJ; Houck, JT; Tompkins, DE; Haynes, C; Jacob, D; Chin, SH; Allen, DR; Dahlke, CE; Sanders, R; Li, K; Liu, XJ; Levitsky, AA; Majoros, WH; Chen, Q; Xia, AC; Lopez, JR; Donnelly, MT; Newman, MH; Glodek, A; Kraft, CL; Nodell, M; Ali, F; An, HJ; Baldwin-Pitts, D; Beeson, KY; Cai, S; Carnes, M; Carver, A; Caulk, PM; Center, A; Chen, YH; Cheng, ML; Coyne, MD; Crowder, M; Danaher, S; Davenport, LB; Desilets, R; Dietz, SM; Doup, L; Dullaghan, P; Ferriera, S; Fosler, CR; Gire, HC; Gluecksmann, A; Gocayne, JD; Gray, J; Hart, B; Haynes, J; Hoover, J; Howland, T; Ibegwam, C; Jalali, M; Johns, D; Kline, L; Ma, DS; MacCawley, S; Magoon, A; Mann, F; May, D; McIntosh, TC; Mehta, S; Moy, L; Moy, MC; Murphy, BJ; Murphy, SD; Nelson, KA; Nuri, Z; Parker, KA; Prudhomme, AC; Puri, VN; Qureshi, H; Raley, JC; Reardon, MS; Regier, MA; Rogers, YHC; Romblad, DL; Schutz, J; Scott, JL; Scott, R; Sitter, CD; Smallwood, M; Sprague, AC; Stewart, E; Strong, RV; Suh, E; Sylvester, K; Thomas, R; Tint, NN; Tsonis, C; Wang, G; Wang, G; Williams, MS; Williams, SM; Windsor, SM; Wolfe, K; Wu, MM; Zaveri, J; Chaturvedi, K; Gabrielian, AE; Ke, ZX; Sun, JT; Subramanian, G; Venter, JC			A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome	SCIENCE			English	Article							MOUSE-CHROMOSOME 16; VELOCARDIOFACIAL SYNDROME REGION; CONSERVED SYNTENY; DNA-SEQUENCE; DOWN-SYNDROME; MAPS; MICE; MODEL; DROSOPHILA; EVOLUTION	The high degree of similarity between the mouse and human genomes is demonstrated through analysis of the sequence of mouse chromosome 16 (Mmu 16), which was obtained as part of a whole-genome shotgun assembly of the mouse genome. The mouse genome is about 10% smaller than the human genome, owing to a lower repetitive DNA content. Comparison of the structure and protein-coding potential of Mmu 16 with that of the homologous segments of the human genome identifies regions of conserved synteny with human chromosomes (Hsa) 3, 8, 12, 16, 21, and 22. Gene content and order are highly conserved between Mmu 16 and the syntenic blocks of the human genome. Of the 731 predicted genes on Mmu 16, 509 align with orthologs on the corresponding portions of the human genome, 44 are likely paralogous to these genes, and 164 genes have homologs elsewhere in the human genome; there are 14 genes for which we could find no human counterpart.	Celera Genom, Rockville, MD 20850 USA; GenetixXpress, Sydney, NSW 2108, Australia; Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Bar Ilan University; Case Western Reserve University; University Hospitals of Cleveland	Mural, RJ (corresponding author), Celera Genom, 45 W Gude Dr, Rockville, MD 20850 USA.	richard.mural@celera.com	Huson, Daniel H./AAC-5494-2019; Salzberg, Steven L/F-6162-2011; Ji, Ru-Rong/L-7070-2017; Hart, Brit/G-6205-2015; Moy, Linda/U-8018-2019; Salzberg, Steven/Q-6514-2019; Reinert, Knut/V-3327-2019; Holt, Robert A/C-3303-2009; Scott, Rodney/B-2827-2013	Salzberg, Steven L/0000-0002-8859-7432; Ji, Ru-Rong/0000-0002-9355-3688; Hart, Brit/0000-0002-9389-2786; Moy, Linda/0000-0001-9564-9360; Salzberg, Steven/0000-0002-8859-7432; Reinert, Knut/0000-0003-3078-8129; Holt, Robert A/0000-0002-7259-1247; Wortman, Jennifer/0000-0002-8713-1227; Chiang, Chia-Chien/0000-0002-2110-8278; Zheng Bradley, Xiangqun/0000-0002-9324-2708; Scott, Rodney/0000-0001-7724-3404; Yooseph, Shibu/0000-0001-5581-5002; Miller, Jason/0000-0002-6912-2925				Abril JF, 2000, BIOINFORMATICS, V16, P743, DOI 10.1093/bioinformatics/16.8.743; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Antona V, 1998, CYTOGENET CELL GENET, V83, P90, DOI 10.1159/000015138; Auffray JC, 2001, J HERED, V92, P23, DOI 10.1093/jhered/92.1.23; Bernard J., 1988, EUKARYOTE GENOME DEV, DOI [10.1007/978-94-011-5991-3, DOI 10.1007/978-94-011-5991-3]; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Dehal P, 2001, SCIENCE, V293, P104, DOI 10.1126/science.1060310; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; DENG ZM, 1993, GENOMICS, V18, P156, DOI 10.1006/geno.1993.1443; Doyle JL, 2000, CYTOGENET CELL GENET, V90, P285, DOI 10.1159/000056790; Festing MF, 1996, GENETIC VARIANTS STR, P1537; Festing MFW, 1999, MAMM GENOME, V10, P836, DOI 10.1007/s003359901099; Footz TK, 2001, GENOME RES, V11, P1053, DOI 10.1101/gr.154901; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Griffiths DJ, 2001, GENOME BIOL, V2; Gurwitz D, 2001, DRUG DISCOV TODAY, V6, P766, DOI 10.1016/S1359-6446(01)01874-8; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; KOOP BF, 1995, TRENDS GENET, V11, P367, DOI 10.1016/S0168-9525(00)89108-8; Krivan W, 2001, GENOME RES, V11, P1559, DOI 10.1101/gr.180601; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LENGELING A, 1995, GENET RES, V66, P175, DOI 10.1017/S0016672300034522; Lindblad-Toh Kerstin, 2001, Genesis The Journal of Genetics and Development, V31, P137, DOI 10.1002/gene.10016; Lund J, 1999, MAMM GENOME, V10, P438, DOI 10.1007/s003359901019; Lund J, 2000, GENOMICS, V63, P374, DOI 10.1006/geno.1999.6044; Maglott DR, 2000, NUCLEIC ACIDS RES, V28, P126, DOI 10.1093/nar/28.1.126; Makalowski W, 1998, P NATL ACAD SCI USA, V95, P9407, DOI 10.1073/pnas.95.16.9407; Mallon AM, 2000, GENOME RES, V10, P758, DOI 10.1101/gr.10.6.758; Morse H. C., 1978, ORIGINS INBRED MICE, P3; MORSE HC, 1981, MOUSE BIOMEDICAL RES, V1, P1; Mural RJ, 1999, METHOD ENZYMOL, V303, P77; MURAL RJ, UNPUB; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; Nadeau JH, 1997, NAT GENET, V15, P6, DOI 10.1038/ng0197-6; O'Brien SJ, 1999, SCIENCE, V286, P458, DOI 10.1126/science.286.5439.458; Pletcher MT, 2001, GENOMICS, V74, P45, DOI 10.1006/geno.2001.6533; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reeves RH, 1998, GENOMICS, V49, P156, DOI 10.1006/geno.1998.5215; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Sierra DA, 2002, GENOMICS, V79, P177, DOI 10.1006/geno.2002.6693; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; SORIANO P, 1981, EUR J BIOCHEM, V115, P235, DOI 10.1111/j.1432-1033.1981.tb05228.x; Threadgill DW, 1997, MAMM GENOME, V8, P390, DOI 10.1007/s003359900453; Uberbacher EC, 1996, METHOD ENZYMOL, V266, P259; Van Etten WJ, 1999, NAT GENET, V22, P384, DOI 10.1038/11962; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wasserman WW, 2000, NAT GENET, V26, P225, DOI 10.1038/79965; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zoubak S, 1996, GENE, V174, P95, DOI 10.1016/0378-1119(96)00393-9	56	273	293	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1661	1671		10.1126/science.1069193	http://dx.doi.org/10.1126/science.1069193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040188				2022-12-28	WOS:000175976200051
J	Seltzer, GO; Rodbell, DT; Baker, PA; Fritz, SC; Tapia, PM; Rowe, HD; Dunbar, RB				Seltzer, GO; Rodbell, DT; Baker, PA; Fritz, SC; Tapia, PM; Rowe, HD; Dunbar, RB			Early warming of tropical South America at the Last Glacial-interglacial transition	SCIENCE			English	Article							LATE QUATERNARY GLACIATION; CLIMATE-CHANGE; BOLIVIAN ALTIPLANO; SIERRA-NEVADA; OWENS LAKE; PERU; RECORD; ANDES; CALIFORNIA; ATLANTIC	Glaciation in the humid tropical Andes is a sensitive indicator of mean annual temperature. Here, we present sedimentological data from takes beyond the glacial limit in the tropical Andes indicating that deglaciation from the Last Glacial Maximum led substantial warming at high northern latitudes. Deglaciation from glacial maximum positions at Lake Titicaca, Peru/Bolivia (16degreesS), and Lake Junin, Peru (11 degreesS), occurred 22,000 to 19,500 calendar years before the present, several thousand years before the Bolling-Allerod warming of the Northern Hemisphere and deglaciation of the Sierra Nevada, United States (36.5- to 38degreesN). The tropical Andes deglaciated while climatic conditions remained regionally wet, which reflects the dominant control of mean annual temperature on tropical glaciation.	Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA; Union Coll, Dept Geol, Schenectady, NY 12308 USA; Duke Univ, Div Earth & Ocean Sci, Durham, NC 27708 USA; Univ Nebraska, Dept Geosci, Lincoln, NE 68588 USA; Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; Stanford Univ, Stanford, CA 94305 USA	Syracuse University; Union College; Duke University; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Stanford University	Seltzer, GO (corresponding author), Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 204, Syracuse, NY 13244 USA.		Tapia, Pedro/GYR-1147-2022	Tapia, Pedro M/0000-0002-0708-4468; Dunbar, Robert/0000-0002-9728-5609; Rowe, Harry/0000-0002-1665-6261				Abbott MB, 1997, QUATERNARY RES, V47, P169, DOI 10.1006/qres.1997.1881; [Anonymous], [No title captured]; Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; Benson L, 1999, GEOPH MONOG SERIES, V112, P203; Benson LV, 1996, SCIENCE, V274, P746, DOI 10.1126/science.274.5288.746; BERGER AL, 1978, QUATERNARY RES, V9, P139, DOI 10.1016/0033-5894(78)90064-9; Bischoff JL, 2001, QUATERNARY RES, V55, P14, DOI 10.1006/qres.2000.2183; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Clayton JD, 1997, J QUATERNARY SCI, V12, P169, DOI 10.1002/(SICI)1099-1417(199705/06)12:3<169::AID-JQS304>3.3.CO;2-J; Goodman AY, 2001, QUATERNARY RES, V56, P31, DOI 10.1006/qres.2001.2221; Grootes PM, 2001, QUATERNARY RES, V56, P289, DOI 10.1006/qres.2001.2276; GROVE MJ, 2000, THESIS DUKE U; Hostetler SW, 2000, SCIENCE, V290, P1747, DOI 10.1126/science.290.5497.1747; Klein AG, 1999, QUATERNARY SCI REV, V18, P63, DOI 10.1016/S0277-3791(98)00095-X; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; MERCER JH, 1977, GEOLOGY, V5, P600, DOI 10.1130/0091-7613(1977)5<600:RDOTLG>2.0.CO;2; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Porter SC, 2001, QUATERNARY SCI REV, V20, P1067, DOI 10.1016/S0277-3791(00)00178-5; Rodbell DT, 2000, QUATERNARY RES, V54, P328, DOI 10.1006/qres.2000.2177; Seltzer G, 2000, GEOLOGY, V28, P35; SELTZER GO, 1994, BOREAS, V23, P105; SELTZER GO, 1992, J QUATERNARY SCI, V7, P87, DOI 10.1002/jqs.3390070202; Seltzer GO, 2001, QUATERNARY SCI REV, V20, P1063, DOI 10.1016/S0277-3791(00)00179-7; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Stocker TF, 1998, SCIENCE, V282, P61, DOI 10.1126/science.282.5386.61; Thompson LG, 1998, SCIENCE, V282, P1858, DOI 10.1126/science.282.5395.1858; THOMPSON LG, 1995, SCIENCE, V269, P46, DOI 10.1126/science.269.5220.46; WRIGHT HE, 1983, GEOGR ANN A, V65, P35, DOI 10.2307/520719	30	128	130	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1685	1686		10.1126/science.1070136	http://dx.doi.org/10.1126/science.1070136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040193	Green Submitted			2022-12-28	WOS:000175976200057
J	Lok, ASF				Lok, ASF			Perspective: Chronic hepatitis B	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lok, ASF (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.		Lok, Anna/B-8292-2009; Franzeck, Fabian C/B-5055-2011	Yang, Shuman/0000-0002-9638-0890					0	341	364	0	7	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1682	1683		10.1056/NEJM200205303462202	http://dx.doi.org/10.1056/NEJM200205303462202			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037146				2022-12-28	WOS:000175834100001
J	Bennewith, O; Stocks, N; Gunnell, D; Peters, TJ; Evans, MO; Sharp, DJ				Bennewith, O; Stocks, N; Gunnell, D; Peters, TJ; Evans, MO; Sharp, DJ			General practice based intervention to prevent repeat episodes of deliberate self harm: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							CONSULTATION; REPETITION; SUICIDE; PATTERNS; TRENDS; OXFORD; CARE	Objectives To evaluate the impact of an intervention based in general practice on the incidence of repeat episodes of deliberate self harm. Design Cluster randomised controlled trial in which 98 general practices were assigned in equal numbers to an intervention or a control group. The intervention comprised a letter from die general practitioner inviting the patient to consult, and guidelines on assessment and management of deliberate self harm for the general practitioner to use in consultations. Control patients received usual general practitioner care. Setting General practices within Avon, Wiltshire, and Somerset Health Authorities, whose patients lived within the catchment area of four general hospitals in Bristol and Bath. Participants 1932 patients registered with the study practices who had attended accident and emergency departments at one of the four hospitals after an episode of deliberate self harm. Main outcome measures Primary outcome was occurrence of a repeat episode of deliberate self harm in the 12 months after the index episode. Secondary outcomes were number of repeat episodes and time to first repeat. Results The incidence of repeat episodes of deliberate self harm was not significantly different for patients in the intervention group compared with the control group (odds ratio 1.2, 95% confidence interval 0.9 to 1.5). Similar findings were obtained for the number of repeat episodes and time to first repeat. Subgroup analyses indicated that there was no differential effect of the intervention according to patient's sex (P = 0.51) or method used to cause deliberate self harm (P = 0.64). The treatment seemed to be beneficial fur people with a history of deliberate self harm, but it was associated with an adverse effect, in people for whom the index episode was their first episode (interaction P = 0.017). Conclusions An invitation to consults sent by the general practitioner of patients who have deliberately harmed themselves, and the use of management guidelines during any subsequent consultation did not reduce the incidence of repeat self harm. A subgroup analysis that indicated that patients who had previously harmed themselves benefited front the intervention was inconsistent with previous evidence and should be treated with caution. More research is needed on how to manage patients who deliberately harm themselves, to reduce the incidence of repeat episodes.	Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Univ Bristol, Dept Social Med, Bristol BS6 6JL, Avon, England; Univ Bristol, Div Psychiat, Bristol BS6 6JL, Avon, England	University of Bristol; University of Bristol; University of Bristol	Sharp, DJ (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.		Gunnell, David/ABE-6653-2020; Stocks, Nigel P/I-1083-2012	Gunnell, David/0000-0002-0829-6470; Stocks, Nigel/0000-0002-9018-0361; Peters, Tim/0000-0003-2881-4180				[Anonymous], 1999, EFFECTIVE HLTH CARE, V5; CORNFIELD J, 1978, AM J EPIDEMIOL, V108, P100, DOI 10.1093/oxfordjournals.aje.a112592; CRAWFORD M, 1998, HLTH TRENDS, V30, P66; CROCKETT AWB, 1987, BRIT MED J, V295, P476, DOI 10.1136/bmj.295.6596.476; Evans MO, 1999, BRIT J PSYCHIAT, V175, P23, DOI 10.1192/bjp.175.1.23; Gilbody S, 1997, J ROY COLL PHYS LOND, V31, P171; GORMAN D, 1990, BRIT J GEN PRACT, V40, P102; GUNNELL D, 1994, BMJ-BRIT MED J, V308, P1227, DOI 10.1136/bmj.308.6938.1227; Hawton K, 1998, BRIT MED J, V317, P441; HAWTON K, 1992, BRIT MED J, V304, P1409, DOI 10.1136/bmj.304.6839.1409; Hawton K, 1997, BRIT J PSYCHIAT, V171, P556, DOI 10.1192/bjp.171.6.556; HAWTON K., 1999, DELIBERATE SELF HARM; SHARP DJ, IN PRESS PRIM HLTH C; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Townsend PP., 1988, HLTH DEPRIVATION INE; VanderSande R, 1997, BRIT J PSYCHIAT, V171, P35, DOI 10.1192/bjp.171.1.35	16	71	73	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1254	+		10.1136/bmj.324.7348.1254	http://dx.doi.org/10.1136/bmj.324.7348.1254			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028981	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000175894900022
J	Macleod, J; Smith, GD; Heslop, PF; Metcalfe, C; Carroll, D; Hart, C				Macleod, J; Smith, GD; Heslop, PF; Metcalfe, C; Carroll, D; Hart, C			Psychological stress and cardiovascular disease: empirical demonstration of bias in a prospective observational study of Scottish men	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; PSYCHOSOCIAL FACTORS; RISK-FACTORS; FRAMINGHAM; MORTALITY; HEALTH; EDUCATION; PROGNOSIS; EVENTS; WORK	Objectives To examine the association between self perceived psychological stress mid cardiovascular disease in a population where stress was not associated with social disadvantage. Design Prospective observational study with follow up of 21 years and repeat screening of half the cohort 5 years from baseline. Measures included perceived psychological stress, coronary risk factors, self reported angina, and ischaemia detected by electrocardiography. Setting 27 workplaces in Scotland. Participants 5606 men (mean age 48 years) at first screening and 2623 men at second screening with complete data on all measures. Main outcome measures Prevalence of angina and ischaemia at baseline, odds ratio for incident angina and ischaemia at second screening, rate ratios for cause specific hospital admission, and hazard ratios for cause specific mortality, Results Both prevalence and incidence of angina increased with increasing perceived stress (fully adjusted odds ratio for incident angina high versus low stress 2.66, 95% confidence interval 1.61 to 4.41; P for trend < 0.001). Prevalence mid incidence of ischaemia showed weak trends in tire opposite direction. High stress was associated with a higher rate of admissions to hospital generally and for admissions related to cardiovascular disease and psychiatric disorders (fully adjusted rate ratios for any general hospital admission 1.13, 1.01 to 1.27, cardiovascular disease 1.20, 1.00 to 1.45, and psychiatric disorders 2.34, 1.41 to 3.91). High stress was not associated with increased admission for coronary heart disease (1.00, 0.76-1.32) and showed an inverse relation with all cause mortality, mortality from cardiovascular disease, and mortality from coronary heart disease, that was attenuated by adjustment for occupational class (fully, adjusted hazard ratio for all cause mortality 0.94, 0.81 to 1.11, cardiovascular mortality 0.91, 0.78 to 1.06, and mortality from coronary heart disease 0.98, 0.75 to 1.27). Conclusions The relation between higher stress, angina, and some categories of hospital admissions probably resulted from the tendency of participants reporting higher stress to also report more symptoms. The lack of a corresponding relation with objective indices of heart disease suggests that these symptoms did not reflect physical disease. The data suggest that associations between psychosocial measures and disease outcomes reported from some other studies may be spurious.	Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Birmingham, Sch Sport & Exercise Sci, Birmingham B15 2TT, W Midlands, England; Univ Glasgow, Dept Publ Hlth, Glasgow G12 8RZ, Lanark, Scotland	University of Birmingham; University of Bristol; University of Birmingham; University of Glasgow	Macleod, J (corresponding author), Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England.	j.a.macleod@bham.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; Macleod, John/0000-0001-8202-1144; Metcalfe, Chris/0000-0001-8318-8907	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; CHAPMAN JM, 1966, AM J EPIDEMIOL, V83, P537, DOI 10.1093/oxfordjournals.aje.a120605; DAVEYSMITH G, 1997, LANCET, V350, P1369; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; Glynn RJ, 1996, BMJ-BRIT MED J, V312, P364; Greenwood DC, 1996, J PUBLIC HEALTH MED, V18, P221, DOI 10.1093/oxfordjournals.pubmed.a024483; HAGMAN M, 1987, J CHRON DIS, V40, P265, DOI 10.1016/0021-9681(87)90163-9; Haines H, 2001, HEART, V85, P385, DOI 10.1136/heart.85.4.385; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P362, DOI 10.1093/oxfordjournals.aje.a112556; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P384, DOI 10.1093/oxfordjournals.aje.a112557; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; Heslop P, 2001, BRIT J HEALTH PSYCH, V6, P167, DOI 10.1348/135910701169133; HOLLIS JF, 1990, J BEHAV MED, V13, P263, DOI 10.1007/BF00846834; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; Macleod J., 2002, Journal of Epidemiology and Community Health, V56, P76, DOI 10.1136/jech.56.1.76; MACLEOD J, 2002, J EPIDEMIOL COMMUNIT, V56, P75; Marmot MG, 1997, LANCET, V350, P235, DOI 10.1016/S0140-6736(97)04244-X; Orth-Gomer K, 2000, JAMA-J AM MED ASSOC, V284, P3008, DOI 10.1001/jama.284.23.3008; REEDER LG, 1973, SOC SCI MED, V7, P573, DOI 10.1016/0037-7856(73)90026-7; Reeder LG., 1968, P EXCERPTA MED INT C, V182, P226, DOI 10.1093/oxfordjournals.aje.a120605; Rose G, 1982, CARDIOVASCULAR SURVE; ROSENGREN A, 1991, AM J CARDIOL, V68, P1171, DOI 10.1016/0002-9149(91)90189-R; SACKETT DL, 1978, CLIN INVEST MED, V1, P37; SCHACHTER S, 1977, J EXP PSYCHOL GEN, V106, P24, DOI 10.1037/0096-3445.106.1.24; Smith GD, 1997, LANCET, V350, P1369, DOI 10.1016/S0140-6736(05)65141-0; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P153; Wainwright D, 2000, EUR J PUBLIC HEALTH, V10, P231, DOI 10.1093/eurpub/10.3.231; WATSON D, 1984, PSYCHOL BULL, V96, P465, DOI 10.1037/0033-2909.96.3.465	29	205	206	2	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2002	324	7348					1247	1251		10.1136/bmj.324.7348.1247	http://dx.doi.org/10.1136/bmj.324.7348.1247			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	557EJ	12028978	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000175894900018
J	Thakar, R; Stanton, S				Thakar, R; Stanton, S			Management of genital prolapse	BRITISH MEDICAL JOURNAL			English	Review							VAULT PROLAPSE; EPIDEMIOLOGY; RECTOCELE; REPAIR; FASCIA; WOMEN; MESH		Univ London St Georges Hosp, Dept Urogynaecol, London, England	St Georges University London	Thakar, R (corresponding author), Mayday Univ Hosp, Dept Obstet & Gynaecol, Croydon CR7 7YE, England.							ALTRINGER WE, 1995, DIS COLON RECTUM, V38, P695, DOI 10.1007/BF02048024; Beck R, 1983, PRINCIPLES PRACTICE, P677; BUMP RC, 2000, CLIN UROGYNAECOLOGY; CARDOZO L, 1995, DEWHEASTS TXB OBSTET, V6, P42; Cundiff GW, 2000, OBSTET GYNECOL, V95, P931, DOI 10.1016/S0029-7844(00)00788-2; Davila GW, 1996, POSTGRAD MED, V99, P171, DOI 10.1080/00325481.1996.11946106; DAVILA GW, 1995, INT UROGYNECOL J, V6, P187; Fox AD, 2000, BRIT J OBSTET GYNAEC, V107, P1371; Jackson S, 1997, BRIT MED J, V314, P875; JEFFCOATE TNA, 1959, AM J OBSTET GYNECOL, V77, P490, DOI 10.1016/S0002-9378(16)36718-7; Kahn MA, 1997, BRIT J OBSTET GYNAEC, V104, P82, DOI 10.1111/j.1471-0528.1997.tb10654.x; Kenton K, 1999, AM J OBSTET GYNECOL, V181, P1360, DOI 10.1016/S0002-9378(99)70406-0; Leron E, 2001, BRIT J OBSTET GYNAEC, V108, P629, DOI 10.1111/j.1471-0528.2001.00138.x; Loret de Mola J R, 1996, Obstet Gynecol Surv, V51, P253, DOI 10.1097/00006254-199604000-00022; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Nager CW, 1997, LANCET, V350, P1751, DOI 10.1016/S0140-6736(05)63575-1; NICHOLS DH, 1970, OBSTET GYNECOL, V36, P251; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Pott-Grinstein E, 2001, J REPROD MED, V46, P205; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; SHULL BL, 1993, AM J OBSTET GYNECOL, V168, P1669, DOI 10.1016/0002-9378(93)90676-A; TIMMONS MC, 1992, J REPROD MED, V37, P323; TIMMONS MC, 1997, J PELVIC SURG, V3, P75; WEBBER AW, 2000, UROGYNECOLOGY RECONS, P211; WISKIND AK, 1992, AM J OBSTET GYNECOL, V167, P395	25	84	88	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 25	2002	324	7348					1258	1262		10.1136/bmj.324.7348.1258	http://dx.doi.org/10.1136/bmj.324.7348.1258			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	557EJ	12028982	Green Published			2022-12-28	WOS:000175894900024
J	Herrine, SK				Herrine, SK			Approach to the patient with chronic hepatitis C virus infection	ANNALS OF INTERNAL MEDICINE			English	Review							TRANSFUSION-ASSOCIATED HEPATITIS; COST-EFFECTIVENESS; RISK-FACTORS; INITIAL TREATMENT; BLOOD-DONORS; POSTTRANSFUSION HEPATITIS; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2A; HUMAN-IMMUNODEFICIENCY; PROTEASE INHIBITORS	Chronic hepatitis C virus (HCV) infection is common and often asymptomatic. Antibodies against HCV are a highly sensitive marker of infection. Molecular testing for HCV is used to confirm a positive result on antibody testing and to provide prognostic information for treatment; however, quantitative HCV RNA does not correlate with disease severity or risk for progression. Chronic HCV infection is most frequently associated with remote or current intravenous drug use and blood transfusion before 1992, although as many as 20% of infected patients have no identifiable risk factor. In an estimated 15% to 20% of persons infected with HCV, the infection progresses to cirrhosis; alcohol intake is an important cofactor in this progression. Most specialists prefer to include an examination of liver histology in the management of patients with chronic HCV infection to aid prognostic and treatment decisions. The current standard of pharmacologic treatment of chronic HCV is weekly subcutaneous peginterferon in combination with daily oral ribavirin, which results in sustained virologic response in approximately 55% of chronically infected patients. Side effects of interferon therapy include myalgias, fever, nausea, irritability, and depression. The cost-effectiveness of interferon therapy is similar to that of many commonly accepted medical interventions. The primary care physician serves a vital role in identifying patients with chronic HCV infection, educating patients about risk factors for transmission, advising patients about the avoidance of alcohol, and aiding patients in making treatment decisions.	Thomas Jefferson Univ, Div Gastroenterol & Hepatol, Philadelphia, PA 19107 USA	Jefferson University	Herrine, SK (corresponding author), Thomas Jefferson Univ, Div Gastroenterol & Hepatol, 132 South 10th St Suite 480, Philadelphia, PA 19107 USA.			Herrine, Steven/0000-0001-5763-1821				Al-Faleh FZ, 2000, J VIRAL HEPATITIS, V7, P287; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691; Alter M J, 1997, Clin Liver Dis, V1, P559, DOI 10.1016/S1089-3261(05)70321-4; ALTER MJ, 1995, INFECT DIS TESTING B, P23; *AM ASS BLOOD BANK, 2000, STAND BLOOD BANKS TR; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; [Anonymous], 1999, INT J GYNECOL OBSTET, V66, P307; [Anonymous], 1997, HEPATOLOGY, V26, pS2; ATRAH HI, 1995, J MED VIROL, V46, P329, DOI 10.1002/jmv.1890460407; Byron C, 1999, HEPATOLOGY, V30, p191A; Cassani F, 1997, HEPATOLOGY, V26, P561, DOI 10.1002/hep.510260305; Cheng SJ, 2001, HEPATOLOGY, V33, P231, DOI 10.1053/jhep.2001.20675; Cheung RC, 2000, AM J GASTROENTEROL, V95, P740, DOI 10.1111/j.1572-0241.2000.01854.x; Chiaramonte M, 1996, J HEPATOL, V24, P129, DOI 10.1016/S0168-8278(96)80020-1; CLIFFORD BD, 1995, HEPATOLOGY, V21, P613, DOI 10.1016/0270-9139(95)90507-3; ConryCantilena C, 1996, NEW ENGL J MED, V334, P1691, DOI 10.1056/NEJM199606273342602; Conte D, 2000, HEPATOLOGY, V31, P751, DOI 10.1002/hep.510310328; CORRAO G, 1995, AM J EPIDEMIOL, V142, P1136, DOI 10.1093/oxfordjournals.aje.a117572; Davis GL, 1998, NEW ENGL J MED, V339, P1493, DOI 10.1056/NEJM199811193392102; DAVIS GL, 1997, HEPATOLOGY S1, V26, P122; DONAHUE JG, 1991, AM J EPIDEMIOL, V134, P1206, DOI 10.1093/oxfordjournals.aje.a116023; Elzouki AN, 1997, J HEPATOL, V27, P42, DOI 10.1016/S0168-8278(97)80278-4; ESTEBAN JI, 1991, ANN INTERN MED, V115, P443, DOI 10.7326/0003-4819-115-6-443; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; FERENCI P, 1989, J HEPATOL, V9, P105, DOI 10.1016/0168-8278(89)90083-4; FRIED MW, 1993, DIGEST DIS SCI, V38, P631, DOI 10.1007/BF01316792; Gabriel C, 1996, LANCET, V347, P541, DOI 10.1016/S0140-6736(96)91171-X; Gambarin-Gelwan M, 2000, AM J GASTROENTEROL, V95, P1535; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; Glue P, 1999, HEPATOLOGY, V30, p303A; GOCKE DJ, 1972, J AMER MED ASSOC, V219, P1165, DOI 10.1001/jama.219.9.1165; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Herrine SK, 1999, INFECT MED, V16, P111; HOOFNAGLE JH, 1986, NEW ENGL J MED, V315, P1575, DOI 10.1056/NEJM198612183152503; Hsu H H, 1999, Clin Liver Dis, V3, P901, DOI 10.1016/S1089-3261(05)70246-4; Huang CC, 1997, J GASTROEN HEPATOL, V12, pS236, DOI 10.1111/j.1440-1746.1997.tb00506.x; HURAIB S, 1995, NEPHROL DIAL TRANSPL, V10, P470, DOI 10.1093/ndt/10.4.470; Kao JH, 1996, DIGEST DIS SCI, V41, P161, DOI 10.1007/BF02208599; Keeffe EB, 1998, HEPATOLOGY, V27, P881, DOI 10.1002/hep.510270336; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; KLEIN RS, 1991, LANCET, V338, P1539, DOI 10.1016/0140-6736(91)92369-D; KO YC, 1992, J MED VIROL, V38, P288, DOI 10.1002/jmv.1890380411; Kumar RM, 1998, J HEPATOL, V29, P191, DOI 10.1016/S0168-8278(98)80003-2; Lee JH, 2000, J MED VIROL, V60, P264, DOI 10.1002/(SICI)1096-9071(200003)60:3&lt;264::AID-JMV3&gt;3.0.CO;2-J; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Lindsay KL, 1996, HEPATOLOGY, V24, P1034; Mahmoud IM, 1999, AM J NEPHROL, V19, P576, DOI 10.1159/000013523; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mathurin P, 1998, HEPATOLOGY, V27, P868, DOI 10.1002/hep.510270333; McHutchinson J.G., 2000, HEPATITIS C, P203; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2000, HEPATOLOGY, V32, p223A; Morishima C, 1999, Clin Liver Dis, V3, P717, DOI 10.1016/S1089-3261(05)70235-X; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; Myers RP, 2000, HEPATOLOGY, V31, P834, DOI 10.1053/he.2000.5719; O'Connor JB, 1999, HEPATOLOGY, V30, P1077, DOI 10.1002/hep.510300422; OKAZAKI T, 1994, SCAND J GASTROENTERO, V29, P1039, DOI 10.3109/00365529409094883; Patrick L, 1999, Altern Med Rev, V4, P220; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; Piton A, 1998, HEPATOLOGY, V27, P1213, DOI 10.1002/hep.510270505; POLISH LB, 1993, AM J INFECT CONTROL, V21, P196, DOI 10.1016/0196-6553(93)90031-X; Pollard Richard B., 1999, American Journal of Medicine, V107, p41S; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 1996, HEPATOLOGY, V24, P778; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Reddy KR, 2001, HEPATOLOGY, V33, P433, DOI 10.1053/jhep.2001.21747; Rooney G, 1998, SEX TRANSM INFECT, V74, P399, DOI 10.1136/sti.74.6.399; Rutschmann OT, 1998, J INFECT DIS, V177, P783, DOI 10.1086/517808; Saadeh S, 2001, HEPATOLOGY, V33, P196, DOI 10.1053/jhep.2001.20534; Sarasin FP, 1996, AM J MED, V101, P422, DOI 10.1016/S0002-9343(96)00197-0; SARTORI M, 1993, SCAND J INFECT DIS, V25, P270, DOI 10.3109/00365549309008497; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; SIMMONDS P, 1995, HEPATOLOGY, V21, P570, DOI 10.1002/hep.1840210243; Soresi M, 1998, J HEPATOL, V28, P544, DOI 10.1016/S0168-8278(98)80276-6; Stern E, 1997, J Altern Complement Med, V3, P77, DOI 10.1089/acm.1997.3.77; Sun DX, 1996, LANCET, V347, P541, DOI 10.1016/S0140-6736(96)91172-1; TAKAHASHI M, 1993, AM J GASTROENTEROL, V88, P240; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; VRIELINK H, 1995, VOX SANG, V69, P14, DOI 10.1111/j.1423-0410.1995.tb00341.x; Welch PJ, 1998, CLIN DIAGN VIROL, V10, P163, DOI 10.1016/S0928-0197(98)00029-4; Werman HA, 1997, AM J EMERG MED, V15, P248, DOI 10.1016/S0735-6757(97)90006-1; Wiley TE, 1998, HEPATOLOGY, V28, P805, DOI 10.1002/hep.510280330; WILLIAMS I, 1999, AM J MED S, V107, P2, DOI DOI 10.1016/S0002-9343(99)00373-3; Wong JB, 2000, ANN INTERN MED, V133, P665, DOI 10.7326/0003-4819-133-9-200011070-00008; Wong JB, 2000, AM J GASTROENTEROL, V95, P1524; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zeuzem S, 1996, HEPATOLOGY, V24, P1003; 1996, MMWR MORB MORTAL WKL, V45, P1; 2000, RISK ACQUIRING HEPAT; 1991, MMWR MORB MORTAL WKL, V40, P117; 2002, PREVENTION HEPATITIS; 1997, MMWR MORB MORTAL WKL, V46, P597	98	34	38	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					747	757		10.7326/0003-4819-136-10-200205210-00010	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00010			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020143				2022-12-28	WOS:000175664600005
J	Ashworth, M; Golding, S; Shephard, L; Majeed, A				Ashworth, M; Golding, S; Shephard, L; Majeed, A			Prescribing incentive schemes in two NHS regions: cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE		Guys Kings Coll, London SE11 6SP, England; St Thomass Sch Med, Dept Gen Practice & Primary Care, London SE11 6SP, England; N Lambeth Primary Care Grp, London SE1 8RG, England; UCL, Sch Publ Policy, London WC1H 9EZ, England	University of London; King's College London; University of London; King's College London; University of London; University College London	Ashworth, M (corresponding author), Guys Kings Coll, London SE11 6SP, England.	mark.ashworth@kcl.ac.uk		Majeed, Azeem/0000-0002-2357-9858; Ashworth, Mark/0000-0001-6514-9904				Majeed A, 1997, BRIT MED J, V315, P1515, DOI 10.1136/bmj.315.7121.1515; OXMAN AD, 1995, CAN MED ASSOC J, V153, P1423; STEWARTBROWN S, 1995, BRIT MED J, V311, P1543, DOI 10.1136/bmj.311.7019.1543; WILKIN D, 1999, PROGR CHALLENGES 199	4	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1187	1188		10.1136/bmj.324.7347.1187	http://dx.doi.org/10.1136/bmj.324.7347.1187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016183	Green Published, Bronze			2022-12-28	WOS:000175763200017
J	Khaykovich, L; Schreck, F; Ferrari, G; Bourdel, T; Cubizolles, J; Carr, LD; Castin, Y; Salomon, C				Khaykovich, L; Schreck, F; Ferrari, G; Bourdel, T; Cubizolles, J; Carr, LD; Castin, Y; Salomon, C			Formation of a matter-wave bright soliton	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATE; NEUTRAL ATOMS; COLLISIONS; RESONANCE; COLLAPSE; LITHIUM; TRAPS	We report the production of matter-wave solitons in an ultracold lithium-7 gas. The effective interaction between atoms In a Bose-Einstein condensate is tuned with a Feshbach resonance from repulsive to attractive before release in a one-dimensional optical waveguide. Propagation of the soliton without dispersion over a macroscopic distance of 1.1 millimeter is observed. A simple theoretical model explains the stability region of the soliton. These matter-wave solitons open possibilities for future applications in coherent atom optics, atom interferometry, and atom transport.	Ecole Normale Super, Lab Kastler Brossel, F-75231 Paris 05, France; Ist Nazl Fis Mat, European Lab Nonlinear Spect, I-50125 Florence, Italy	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR)	Salomon, C (corresponding author), Ecole Normale Super, Lab Kastler Brossel, 24 Rue Lhomond, F-75231 Paris 05, France.	salomon@lkb.ens.fr	Schreck, Florian/C-9206-2009; Carr, Lincoln/E-3819-2016; Ferrari, Gabriele/E-3755-2010; Ferrari, Gabriele/AAK-3657-2020; Salomon, Carlos F/L-2167-2013	Schreck, Florian/0000-0001-8225-8803; Carr, Lincoln/0000-0002-4848-7941; Ferrari, Gabriele/0000-0003-1827-5048; Ferrari, Gabriele/0000-0003-1827-5048; Salomon, Carlos F/0000-0003-4474-0046				Barrett MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.010404; Bradley CC, 1997, PHYS REV LETT, V78, P985, DOI 10.1103/PhysRevLett.78.985; Burger S, 1999, PHYS REV LETT, V83, P5198, DOI 10.1103/PhysRevLett.83.5198; Carr LD, 2000, J PHYS B-AT MOL OPT, V33, P3983, DOI 10.1088/0953-4075/33/19/312; CARR LD, UNPUB; Denschlag J, 2000, SCIENCE, V287, P97, DOI 10.1126/science.287.5450.97; Grimm R, 2000, ADV ATOM MOL OPT PHY, V42, P95, DOI 10.1016/S1049-250X(08)60186-X; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Kagan Y, 1998, PHYS REV LETT, V81, P933, DOI 10.1103/PhysRevLett.81.933; Mewes MO, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.011403; Perez-Garcia VM, 1998, PHYS REV A, V57, P3837, DOI 10.1103/PhysRevA.57.3837; Roberts JL, 2000, PHYS REV LETT, V85, P728, DOI 10.1103/PhysRevLett.85.728; Roberts JL, 2001, PHYS REV LETT, V86, P4211, DOI 10.1103/PhysRevLett.86.4211; RUPRECHT PA, 1995, PHYS REV A, V51, P4704, DOI 10.1103/PhysRevA.51.4704; Schreck F, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.080403; Schreck F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.011402; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; VENTURI V, COMMUNICATION; ZAKHAROV VE, 1972, SOV PHYS JETP-USSR, V34, P62; 2000, CHAOS, V10, P471	20	1343	1361	3	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1290	1293		10.1126/science.1071021	http://dx.doi.org/10.1126/science.1071021			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016308	Green Submitted			2022-12-28	WOS:000175713000046
J	Watts, DJ; Dodds, PS; Newman, MEJ				Watts, DJ; Dodds, PS; Newman, MEJ			Identity and search in social networks	SCIENCE			English	Article							SMALL-WORLD	Social networks have the surprising property of being "searchable": Ordinary people are capable of directing messages through their network of acquaintances to reach a specific but distant target person in only a few steps. We present a model that offers an explanation of social network searchability in terms of recognizable personal identities: sets of characteristics measured along a number of social dimensions. Our model defines a class of searchable networks and a method for searching them that may be applicable to many network search problems, including the location of data files in peer-to-peer networks, pages on the World Wide Web, and information in distributed databases.	Columbia Univ, Dept Sociol, New York, NY 10027 USA; Columbia Univ, Columbia Earth Inst, New York, NY 10027 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Columbia University; Columbia University; The Santa Fe Institute	Watts, DJ (corresponding author), Columbia Univ, Dept Sociol, New York, NY 10027 USA.		Dodds, Peter S/C-9119-2014; Watts, Duncan J/J-6483-2012	Dodds, Peter S/0000-0003-1973-8614; 				Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BERNARD HR, 1988, ETHNOLOGY, V27, P155, DOI 10.2307/3773626; Bollobas B., 1985, RANDOM GRAPHS; BREIGER RL, 1974, SOC FORCES, V53, P181, DOI 10.2307/2576011; KILLWORTH PD, 1978, SOC NETWORKS, V1, P159, DOI 10.1016/0378-8733(78)90018-7; Kim BJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.027103; KLEINBERG J, 2000, P 32 ACM S THEOR COM; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; MANNEVILLE B, 1999, BIOL BUSINESS DECODI, pCH5; Nadel Fred., 1957, THEORY SOCIAL STRUCT; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Simmel G, 1902, AM J SOCIOL, V8, P1, DOI 10.1086/211115; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; White, 1992, IDENTITY AND CONTROL; WHITE HC, 1970, SOC FORCES, V49, P259, DOI 10.2307/2576525	18	543	570	4	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1302	1305		10.1126/science.1070120	http://dx.doi.org/10.1126/science.1070120			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554BL	12016312	Green Submitted			2022-12-28	WOS:000175713000050
J	Ostrowsky, BE; Whitener, C; Bredenberg, HK; Carson, LA; Holt, S; Hutwagner, L; Arduino, MJ; Jarvis, WR				Ostrowsky, BE; Whitener, C; Bredenberg, HK; Carson, LA; Holt, S; Hutwagner, L; Arduino, MJ; Jarvis, WR			Serratia marcescens bacteremia traced to an infused narcotic	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; FENTANYL; OUTBREAK; EPIDEMIC; RISK	Background: From June 30, 1998, through March 21, 1999, several patients in the surgical intensive care unit of a hospital acquired Serratia marcescens bacteremia. We investigated this outbreak. Methods: A case was defined as the occurrence of S. marcescens bacteremia in any patient in the surgical intensive care unit during the period of the epidemic. To identify risk factors, we compared patients with S. marcescens bacteremia with randomly selected controls. Isolates from patients and from medications were evaluated by pulsed-field gel electrophoresis. The hair of one employee was tested for fentanyl. Results: Twenty-six patients with S. marcescens bacteremia were identified; eight (31 percent) had polymicrobial bacteremia, and seven of these had Enterobacter cloacae and S. marcescens in the same culture. According to univariate analysis, patients with S. marcescens bacteremia stayed in the surgical intensive care unit longer than controls (13.5 vs. 4.0 days, P<0.001), were more likely to have received fentanyl in the surgical intensive care unit (odds ratio, 31; P<0.001), and were more likely to have been exposed to two particular respiratory therapists (odds ratios, 13.1 and 5.1; P<0.001 for both comparisons). In a multivariate analysis, receipt of fentanyl and exposure to the two respiratory therapists (adjusted odds ratio for one therapist, 6.7; P=0.002; adjusted odds ratio for the other therapist, 9.5; P=0.02) remained significant. One respiratory therapist had been reported for tampering with fentanyl; his hair sample tested positive for fentanyl. Cultures of fentanyl infusions from two case patients yielded S. marcescens and E. cloacae. The isolates from the case patients and from the fentanyl infusions had similar patterns on pulsed-field gel electrophoresis. After removal of the implicated respiratory therapist, no further cases occurred. Conclusions: An outbreak of S. marcescens and E. cloacae bacteremia in a surgical intensive care unit was traced to extrinsic contamination of the parenteral narcotic fentanyl by a health care worker. Our findings underscore the risk of complications in patients that is associated with illicit narcotic use by health care workers.	Ctr Dis Control & Prevent, Epidemiol Program Off, Natl Ctr Infect Dis, Div Healthcare Qual Promot, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Div Appl Publ Hlth Training, Epidem Intelligence Serv, Atlanta, GA USA; Ctr Dis Control & Prevent, Epidemiol Program Off, Div Publ Hlth Surveillance & Informat, Atlanta, GA USA; Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Hershey, PA 17033 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ostrowsky, BE (corresponding author), Virginia Commonwealth Univ, Med Coll Virginia, Dept Epidemiol & Infect Control, POB 980019, Richmond, VA 23298 USA.		Arduino, Matthew/C-1461-2012	Arduino, Matthew/0000-0001-7072-538X				American Public Health Association, 1998, STAND METH EX WAT WA; Archibald LK, 1997, PEDIATR INFECT DIS J, V16, P1045, DOI 10.1097/00006454-199711000-00008; Archibald LK, 1997, INFECT CONT HOSP EP, V18, P704; Berens AIL, 1996, LANCET, V347, P1334, DOI 10.1016/S0140-6736(96)90981-2; CLEARY TJ, 1981, AM J INFECT CONTROL, V9, P107, DOI 10.1016/S0196-6553(81)80090-9; DONOWITZ LG, 1979, JAMA-J AM MED ASSOC, V242, P1749, DOI 10.1001/jama.242.16.1749; EHRENKRANZ NJ, 1980, LANCET, V2, P1289; GOLDSTEIN A, 2000, WASHINGTON POST 0414, pB1; GOLDSTEIN A, 2000, WASHINGTON POST 0301, pB4; HAYS LR, 1992, ANESTHESIOLOGY, V77, P819, DOI 10.1097/00000542-199210000-00029; HIBBS J, 1991, JAMA-J AM MED ASSOC, V265, P1011, DOI 10.1001/jama.265.8.1011; HOFFMAN JP, 1996, DHHS SMA PUBLICATION; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LAI E, 1989, BIOTECHNIQUES, V7, P34; MAKI DG, 1991, JAMA-J AM MED ASSOC, V265, P981, DOI 10.1001/jama.265.8.981; MIECZKOWSKI T, 1995, HAIR ANAL DRUG DETEC, P1; Passaro DJ, 1997, J INFECT DIS, V175, P992, DOI 10.1086/514008; PETERSEN NJ, 1973, HEALTH LAB SCI, V10, P18; Sachs H, 1998, J CHROMATOGR B, V713, P147, DOI 10.1016/S0378-4347(98)00168-6; SMIALEK JE, 1994, J FORENSIC SCI, V39, P159; STANLEY TH, 1989, ANESTH ANALG, V69, P21; VILLARINO ME, 1989, J CLIN MICROBIOL, V27, P2433, DOI 10.1128/JCM.27.11.2433-2436.1989; WARD CF, 1983, JAMA-J AM MED ASSOC, V250, P922, DOI 10.1001/jama.250.7.922; WEBB SF, 1975, CHEST, V68, P703, DOI 10.1378/chest.68.5.703; YU VL, 1979, NEW ENGL J MED, V300, P887, DOI 10.1056/NEJM197904193001604	25	51	52	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1529	1537		10.1056/NEJMoa012370	http://dx.doi.org/10.1056/NEJMoa012370			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015392	Green Published			2022-12-28	WOS:000175563900004
J	Palmer, SM; Driscoll, CT				Palmer, SM; Driscoll, CT			Acidic deposition - Decline in mobilization of toxic aluminium	NATURE			English	Article							BROOK EXPERIMENTAL FOREST; HUBBARD-BROOK; NEW-HAMPSHIRE; CHEMISTRY; RECOVERY; CALCIUM; RAIN		Syracuse Univ, Dept Civil & Environm Engn, Syracuse, NY 13244 USA	Syracuse University	Palmer, SM (corresponding author), Syracuse Univ, Dept Civil & Environm Engn, 220 Hinds Hall, Syracuse, NY 13244 USA.		Driscoll, Charles/F-9832-2014	Driscoll, Charles/0000-0003-2692-2890				BULGER AJ, 1993, CAN J FISH AQUAT SCI, V50, P575, DOI 10.1139/f93-066; CRONAN CS, 1995, J ENVIRON QUAL, V24, P209, DOI 10.2134/jeq1995.00472425002400020002x; DRISCOLL CT, 1985, SOIL SCI SOC AM J, V49, P437, DOI 10.2136/sssaj1985.03615995004900020033x; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Driscoll CT., 1996, ENV CHEM ALUMINUM, P363; JOHNSON NM, 1981, GEOCHIM COSMOCHIM AC, V45, P1421, DOI 10.1016/0016-7037(81)90276-3; LAWRENCE GB, 1986, BIOGEOCHEMISTRY, V2, P115, DOI 10.1007/BF02180190; Likens GE, 1998, BIOGEOCHEMISTRY, V41, P89, DOI 10.1023/A:1005984620681; Likens GE, 1996, SCIENCE, V272, P244, DOI 10.1126/science.272.5259.244; Stoddard JL, 1999, NATURE, V401, P575, DOI 10.1038/44114	10	26	28	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					242	243		10.1038/417242a	http://dx.doi.org/10.1038/417242a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015590				2022-12-28	WOS:000175592100034
J	Percec, I; Plenge, RM; Nadeau, JH; Bartolomei, MS; Willard, HF				Percec, I; Plenge, RM; Nadeau, JH; Bartolomei, MS; Willard, HF			Autosomal, dominant mutations affecting X inactivation choice in the mouse	SCIENCE			English	Article							CHROMOSOME INACTIVATION; CONTROLLING ELEMENTS; EMBRYOS; GENE; DIFFERENTIATION; TRANSLOCATION; METHYLATION; REGION; TSIX	X chromosome inactivation is the silencing mechanism eutherian mammals use to equalize the expression of X-linked genes between mates and females early in embryonic development In the mouse, genetic control of inactivation requires elements within the X inactivation center (Xic) on the X chromosome that influence the choice of which X chromosome is to be inactivated in individual cells. It has long been posited that unidentified autosomal factors are essential to the process. We have used chemical mutagenesis in the mouse to identify specific factors involved in X inactivation and report two genetically distinct autosomal mutations with dominant effects on X chromosome choice early in embryogenesis.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Hosp Cleveland, Res Inst, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania; University Hospitals of Cleveland; University Hospitals of Cleveland	Bartolomei, MS (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA.	bartolom@mail.med.upenn.edu; willard@uhri.org			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM45441] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Boumil RM, 2001, HUM MOL GENET, V10, P2225; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; CATTANACH BM, 1981, HEREDITAS, V94, P5; CATTANACH BM, 1972, GENET RES, V19, P229, DOI 10.1017/S001667230001449X; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; Cattanach BM, 1994, MOUSE GENOME, V92, P114; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; COURTIER B, 1995, P NATL ACAD SCI USA, V92, P3531, DOI 10.1073/pnas.92.8.3531; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; LYON MF, 1971, NATURE-NEW BIOL, V232, P229, DOI 10.1038/newbio232229a0; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MCMAHON A, 1983, GENET RES, V41, P69, DOI 10.1017/S0016672300021078; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; NESBITT MN, 1971, DEV BIOL, V26, P252, DOI 10.1016/0012-1606(71)90125-4; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Percec I, 2002, SCIENCE, V295, P287, DOI 10.1126/science.1068663; PERCEC I, UNPUB; Plenge RM, 2000, MAMM GENOME, V11, P405, DOI 10.1007/s003350010077; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; Russell L B, 1978, Basic Life Sci, V12, P393; Stavropoulos N, 2001, P NATL ACAD SCI USA, V98, P10232, DOI 10.1073/pnas.171243598; TAKAGI N, 1974, EXP CELL RES, V86, P127, DOI 10.1016/0014-4827(74)90657-0; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S	32	53	54	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1136	1139		10.1126/science.1070087	http://dx.doi.org/10.1126/science.1070087			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004136				2022-12-28	WOS:000175565000059
J	Zhou, WH; Kuebler, SM; Braun, KL; Yu, TY; Cammack, JK; Ober, CK; Perry, JW; Marder, SR				Zhou, WH; Kuebler, SM; Braun, KL; Yu, TY; Cammack, JK; Ober, CK; Perry, JW; Marder, SR			An efficient two-photon-generated photoacid applied to positive-tone 3D microfabrication	SCIENCE			English	Article							OPTICAL-DATA STORAGE; IMAGING-SYSTEMS; 2-PHOTON; POLYMERIZATION; MICROSCOPY; RESOLUTION; DESIGN	A two-photon-activatable photoacid generator, based on a bis[(diarylamino) styryl] benzene core with covalently attached sulfonium moieties, has been synthesized. The photoacid generator has both a large two-photon absorption cross section (delta=690 X 10(-50) centimeter(4) second per photon) and a high quantum yield for the photochemical generation of acid (phi(H)(+) = 0.5). Under near-infrared Laser irradiation, the molecule produces acid after two-photon excitation and initiates the polymerization of epoxides at an incident Intensity that is one to two orders of magnitude lower than that needed for conventional ultraviolet-sensitive initiators. This photoacid generator was used in conjunction with a positive-tone chemically amplified resist for the fabrication of a three-dimensional (3D) microchannel structure.	Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA; Univ Arizona, Ctr Opt Sci, Dept Chem, Tucson, AZ 85721 USA	Cornell University; University of Arizona	Ober, CK (corresponding author), Cornell Univ, Dept Mat Sci & Engn, Ithaca, NY 14853 USA.	cober@ccmr.comell.edu; jwperry@u.arizona.edu; smarder@u.arizona.edu	Perry, Joseph W/B-7191-2011; Marder, Seth/GRR-9990-2022; Ober, Christopher/AAI-1568-2019	Perry, Joseph W/0000-0003-1101-7337; Ober, Christopher/0000-0002-3805-3314; Braun, Kevin/0000-0001-9930-7966				Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; ANGELO RW, 1991, Patent No. 5047568; ANGELO RW, 1992, Patent No. 5102772; Belfield KD, 2000, J PHYS ORG CHEM, V13, P837, DOI 10.1002/1099-1395(200012)13:12<837::AID-POC315>3.0.CO;2-5; Boiko Y, 2001, OPT EXPRESS, V8, P571, DOI 10.1364/OE.8.000571; Cumpston BH, 1999, NATURE, V398, P51, DOI 10.1038/17989; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; FRECHET JMJ, 1986, J IMAGING SCI, V30, P59; FRECHET JMJ, 1989, FUNCTIONAL POLYM, P193; Jager C, 1999, J NON-CRYST SOLIDS, V258, P161, DOI 10.1016/S0022-3093(99)00436-6; Kawata S, 2001, NATURE, V412, P697, DOI 10.1038/35089130; Kuebler S. M., 2001, Journal of Photopolymer Science and Technology, V14, P657, DOI 10.2494/photopolymer.14.657; Maruo S, 1997, OPT LETT, V22, P132, DOI 10.1364/OL.22.000132; Maruo S, 2000, PROC SPIE, V3937, P106, DOI 10.1117/12.382800; Pohlers G, 1997, CHEM MATER, V9, P3222, DOI 10.1021/cm970587p; Pudavar HE, 1999, APPL PHYS LETT, V74, P1338, DOI 10.1063/1.123543; Rumi M, 2000, J AM CHEM SOC, V122, P9500, DOI 10.1021/ja994497s; SAEVA FD, 1989, J AM CHEM SOC, V111, P1328, DOI 10.1021/ja00186a027; SAEVA FD, 1994, ADV ELECT T, V4, P1; Shirai M, 1996, PROG POLYM SCI, V21, P1, DOI 10.1016/0079-6700(95)00014-3; WILLIAMS RM, 1994, FASEB J, V8, P804, DOI 10.1096/fasebj.8.11.8070629; WILLSON CG, 1986, J ELECTROCHEM SOC, V133, P181, DOI 10.1149/1.2108519; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Zhou WH, 2002, J AM CHEM SOC, V124, P1897, DOI 10.1021/ja011186k	24	666	740	7	346	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1106	1109		10.1126/science.296.5570.1106	http://dx.doi.org/10.1126/science.296.5570.1106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004126				2022-12-28	WOS:000175565000049
J	Livio, M				Livio, M			The jet set	NATURE			English	Editorial Material									Space Telescope Sci Inst, Baltimore, MD 21218 USA	Space Telescope Science Institute	Livio, M (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.							Celotti A, 2001, ESO ASTROPHY SYMP, P206, DOI 10.1007/10720995_43; Livio M, 2001, ASTR SOC P, V224, P225; Mirabel IF, 1998, NATURE, V392, P673, DOI 10.1038/33603; Wilms J, 2001, MON NOT R ASTRON SOC, V328, pL27, DOI 10.1046/j.1365-8711.2001.05066.x	4	25	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					125	125		10.1038/417125a	http://dx.doi.org/10.1038/417125a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000939	Bronze			2022-12-28	WOS:000175460200022
J	Tsai, WL; Hsu, PC; Hwu, Y; Chen, CH; Chang, LW; Je, JH; Lin, HM; Groso, A; Margaritondo, G				Tsai, WL; Hsu, PC; Hwu, Y; Chen, CH; Chang, LW; Je, JH; Lin, HM; Groso, A; Margaritondo, G			Electrochemistry - Building on bubbles in metal electrodeposition	NATURE			English	Article							DIFFRACTION		Acad Sinica, Inst Phys, Taipei 11529, Taiwan; China Steel Corp, Kaohsiung 81233, Taiwan; Pohang Univ Sci & Technol, Dept Mat Sci, Pohang 790784, South Korea; Tatung Univ, Dept Mat Engn, Taipei 10452, Taiwan; Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland	Academia Sinica - Taiwan; China Steel Corporation; Pohang University of Science & Technology (POSTECH); Tatung University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Tsai, WL (corresponding author), Acad Sinica, Inst Phys, Taipei 11529, Taiwan.		Margaritondo, Giorgio/B-1367-2008; Chang, Liuwen/C-3526-2016; Hwu, Yeukuang/ABH-5311-2020; Hwu, Yeukuang/AAH-9947-2020	Chang, Liuwen/0000-0002-1874-1566; 				Brenner A., 1963, ELECTRODEPOSITION AL; CHEN JM, 1992, PLAT SURF FINISH, V10, P74; Coleman DH, 1998, J APPL ELECTROCHEM, V28, P889; Elkhatabi F, 1996, J ELECTROANAL CHEM, V404, P45, DOI 10.1016/0022-0728(95)04359-4; Hwu Y, 1999, J APPL PHYS, V86, P4613, DOI 10.1063/1.371411; Jayashree RS, 2001, J POWER SOURCES, V93, P273, DOI 10.1016/S0378-7753(00)00568-1; Manso M, 2000, BIOMATERIALS, V21, P1755, DOI 10.1016/S0142-9612(00)00061-2; Margaritondo G, 1999, J APPL PHYS, V85, P3406, DOI 10.1063/1.369697; Monev M, 1998, J APPL ELECTROCHEM, V28, P1107, DOI 10.1023/A:1003443219874; Velichenko AB, 2000, ELECTROCHIM ACTA, V46, P407, DOI 10.1016/S0013-4686(00)00599-5; Younan MM, 2000, J APPL ELECTROCHEM, V30, P55, DOI 10.1023/A:1003840519591; YUMOTO H, 1996, J SURFACE SCI SOC JP, V17, P43; ZAMANZADEH M, 1982, J ELECTROCHEM SOC, V129, P285	13	147	154	6	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 9	2002	417	6885					139	139		10.1038/417139a	http://dx.doi.org/10.1038/417139a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000951	Bronze			2022-12-28	WOS:000175460200032
J	Goldhaber, SZ				Goldhaber, SZ			Echocardiography in the management of pulmonary embolism	ANNALS OF INTERNAL MEDICINE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; PATENT FORAMEN OVALE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; MULTICENTER REGISTRY; CARDIAC-ARREST; RIGHT HEART; PERFUSION; THROMBOLYSIS; ULTRASOUND; DIAGNOSIS	Echocardiography is not recommended as a routine imaging test to diagnose suspected pulmonary embolism. However, it is useful for identifying patients with pulmonary embolism who may have a poor prognosis. It can be used for rapid and accurate risk assessment. Moderate or severe right ventricular hypokinesis, persistent pulmonary hypertension, a patent foramen ovale, and free-floating right-heart thrombus are echocardiographic markers that identify patients at risk for death or recurrent thromboembolism. Such patients warrant consideration for thrombolysis or embolectomy. Serial imaging of right ventricular function can help physicians monitor the effect of treatment and judge whether the selected management strategy is successful. Further research will clarify and define more precisely the utility and limitations of echocardiography in the management of pulmonary embolism.	Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Goldhaber, SZ (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	sgoldhaber@partners.org						Aklog L, 2002, CIRCULATION, V105, P1416, DOI 10.1161/01.CIR.0000012526.21603.25; Chartier L, 1999, CIRCULATION, V99, P2779, DOI 10.1161/01.CIR.99.21.2779; COME PC, 1992, CHEST, V101, pS151, DOI 10.1378/chest.101.4_Supplement.151S; Comess KA, 2000, AM J MED, V109, P351, DOI 10.1016/S0002-9343(00)00511-8; DABESTANI A, 1987, AM J CARDIOL, V59, P662, DOI 10.1016/0002-9149(87)91189-1; Ferrari E, 1997, CHEST, V111, P537, DOI 10.1378/chest.111.3.537; Giannitsis E, 2000, CIRCULATION, V102, P211, DOI 10.1161/01.CIR.102.2.211; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; Goldhaber SZ, 1998, CHEST, V114, P1237, DOI 10.1378/chest.114.5.1237; Greco F, 1999, CHEST, V116, P78, DOI 10.1378/chest.116.1.78; Grifoni S, 2000, CIRCULATION, V101, P2817, DOI 10.1161/01.CIR.101.24.2817; Jardin F, 1997, CHEST, V111, P209, DOI 10.1378/chest.111.1.209; Kasper W, 1997, J AM COLL CARDIOL, V30, P1165, DOI 10.1016/S0735-1097(97)00319-7; Konstantinides S, 1998, CIRCULATION, V97, P1946, DOI 10.1161/01.CIR.97.19.1946; Konstantinides S, 1997, CIRCULATION, V96, P882; Kurkciyan I, 2000, ARCH INTERN MED, V160, P1529, DOI 10.1001/archinte.160.10.1529; McConnell MV, 1996, AM J CARDIOL, V78, P469, DOI 10.1016/S0002-9149(96)00339-6; Meyer T, 2000, J AM COLL CARDIOL, V36, P1632, DOI 10.1016/S0735-1097(00)00905-0; Nass N, 1999, AM J CARDIOL, V83, P804, DOI 10.1016/S0002-9149(98)01000-5; PARKER JA, 1988, RADIOLOGY, V166, P441, DOI 10.1148/radiology.166.2.3122266; Pruszczyk P, 1997, CHEST, V112, P722, DOI 10.1378/chest.112.3.722; PRUSZCZYK P, 1995, EUR HEART J, V16, P534, DOI 10.1093/oxfordjournals.eurheartj.a060947; Ribeiro A, 1997, AM HEART J, V134, P479, DOI 10.1016/S0002-8703(97)70085-1; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; Ribeiro A, 1998, AM HEART J, V135, P868, DOI 10.1016/S0002-8703(98)70048-1; Rosenschein U, 2000, CIRCULATION, V102, P238, DOI 10.1161/01.CIR.102.2.238; Schuchlenz HW, 2000, AM J MED, V109, P456, DOI 10.1016/S0002-9343(00)00530-1; Siegel RJ, 2000, CIRCULATION, V101, P2026, DOI 10.1161/01.CIR.101.17.2026; Suchkova VN, 2000, CIRCULATION, V101, P2296, DOI 10.1161/01.CIR.101.19.2296; WOLFE MW, 1994, AM HEART J, V127, P1371, DOI 10.1016/0002-8703(94)90058-2	31	298	318	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 7	2002	136	9					691	700		10.7326/0003-4819-136-9-200205070-00012	http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	547XK	11992305				2022-12-28	WOS:000175357900007
J	Motson, RW				Motson, RW			Why does NICE not recommend laparoscopic herniorraphy?	BRITISH MEDICAL JOURNAL			English	Article							INGUINAL-HERNIA REPAIR; TRIAL; COST		Colchester Gen Hosp, Colchester CO4 5JL, Essex, England		Motson, RW (corresponding author), Colchester Gen Hosp, Colchester CO4 5JL, Essex, England.							Amid PK, 1996, EUR J SURG, V162, P447; Crawford DL, 1998, AM SURGEON, V64, P976; Grant A, 2000, BRIT J SURG, V87, P860, DOI 10.1046/j.1365-2168.2000.01540.x; LICHTENSTEIN IL, 1989, AM J SURG, V157, P188, DOI 10.1016/0002-9610(89)90526-6; Liem MSL, 1997, ANN SURG, V226, P668, DOI 10.1097/00000658-199712000-00004; National Institute for Clinical Excellence, 2001, GUID US LAP SURG ING; O'Dwyer P, 1999, LANCET, V354, P185; STOKER D, 1994, LANCET, V343, P1243, DOI 10.1016/S0140-6736(94)92148-2; STOPPA RE, 1995, HERNIA, V118, P210; Thumbe VK, 2001, SURG ENDOSC-ULTRAS, V15, P47, DOI 10.1007/s004640000254; Wellwood J, 1998, BRIT MED J, V317, P103, DOI 10.1136/bmj.317.7151.103	11	26	27	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2002	324	7345					1092	1094		10.1136/bmj.324.7345.1092	http://dx.doi.org/10.1136/bmj.324.7345.1092			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YY	11991919	Green Published			2022-12-28	WOS:000175476500028
J	Huse, M; Kuriyan, J				Huse, M; Kuriyan, J			The conformational plasticity of protein kinases	CELL			English	Review							TGF-BETA RECEPTOR; ALDRICH-SYNDROME PROTEIN; TYROSINE KINASE; CRYSTAL-STRUCTURE; CATALYTIC SUBUNIT; C-SRC; INSULIN-RECEPTOR; BINDING DOMAIN; ACTIVATION; COMPLEX	Protein kinases operate in a large number of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms. The catalytic domains of different kinases adopt strikingly similar structures when they are active. By contrast, crystal structures of inactive kinases have revealed a remarkable plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Stanford Univ, Dept Biol Sci, Palo Alto, CA 94305 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.							Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; Goldberg J, 1996, CELL, V84, P875, DOI 10.1016/S0092-8674(00)81066-1; Gonfloni S, 2000, NAT STRUCT BIOL, V7, P281; HU SH, 1994, NATURE, V369, P581, DOI 10.1038/369581a0; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; KEMP BE, 1987, J BIOL CHEM, V262, P2542; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kobe B, 1999, NATURE, V402, P373, DOI 10.1038/46478; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; LEVINSON AD, 1978, CELL, V15, P561, DOI 10.1016/0092-8674(78)90024-7; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Porter M, 2000, J BIOL CHEM, V275, P2721, DOI 10.1074/jbc.275.4.2721; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; ZHANG FM, 1994, NATURE, V367, P704, DOI 10.1038/367704a0; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4	48	1290	1358	3	121	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					275	282		10.1016/S0092-8674(02)00741-9	http://dx.doi.org/10.1016/S0092-8674(02)00741-9			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015977	Bronze			2022-12-28	WOS:000175412100003
J	Price, SR; Garcia, NVD; Ranscht, B; Jessell, TM				Price, SR; Garcia, NVD; Ranscht, B; Jessell, TM			Regulation of motor neuron pool sorting by differential expression of type II cadherins	CELL			English	Article							N-CADHERIN; CLASSIC CADHERINS; SUBTYPE IDENTITY; CELL ADHESION; ORGANIZATION; IDENTIFICATION; CONNECTIONS; DISRUPTION; PATTERNS; REGIONS	During spinal cord development, motor neurons with common targets and afferent inputs cluster into discrete nuclei, termed motor pools. Motor pools can be delineated by transcription factor expression, but cell surface proteins that distinguish motor pools in a systematic manner have not been identified. We show that the developmentally regulated expression of type II cadherins defines specific motor pools. Expression of one type II cadherin, MN-cadherin, regulates the segregation of motor pools that are normally distinguished by expression of this protein. Type II cadherins are also expressed by proprioceptive sensory neurons, raising the possibility that cadherins regulate additional steps in the development of sensory-motor circuits.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA	Columbia University; Howard Hughes Medical Institute; Sanford Burnham Prebys Medical Discovery Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu		Price, Stephen/0000-0001-7804-9849	NICHD NIH HHS [HD 25938] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Arndt K, 1998, MOL CELL NEUROSCI, V10, P211, DOI 10.1006/mcne.1998.0665; BRENOWITZ GL, 1983, BRAIN RES, V274, P371, DOI 10.1016/0006-8993(83)90721-7; Cajal S.R.y., 1894, P R SOC LOND, V55, P444; CAJAL SRY, 1911, HISTOLOGIE SYSTEM NE, V1; CAJAL SRY, 1911, HISTOLOGIE SYSTEM NE, V2; Chang Q, 2000, BRAIN RES REV, V32, P242, DOI 10.1016/S0165-0173(99)00085-5; DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; ECCLES J. C., 1930, PROC ROY SOC [LONDON] B, V106, P326, DOI 10.1098/rspb.1930.0032; Elliott HC, 1942, AM J ANAT, V70, P95, DOI 10.1002/aja.1000700105; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; Frank E, 1988, MESSAGE MIND, P180; FREDETTE BJ, 1994, J NEUROSCI, V14, P7331; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; HAMBURGER V, 1975, J COMP NEUROL, V160, P535, DOI 10.1002/cne.901600408; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Inoue T, 2001, DEVELOPMENT, V128, P561; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; LEE MT, 1988, J NEUROSCI, V8, P2530; LEVINE E, 1994, DEVELOPMENT, V120, P901; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Luo Y, 2001, DEVELOPMENT, V128, P459; Milner LD, 1999, J NEUROSCI, V19, P3007; Nakagawa S, 1998, DEVELOPMENT, V125, P2963; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Ozawa M, 1998, J CELL BIOL, V142, P1605, DOI 10.1083/jcb.142.6.1605; Rafuse VF, 1996, J NEUROSCI, V16, P6864; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; REXED B, 1952, J COMP NEUROL, V96, P415, DOI 10.1002/cne.900960303; Ritter A, 1999, J NEUROSCI, V19, P3457; ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93; ROMANES GJ, 1942, J ANAT, V76, P112; Ross ME, 2001, ANNU REV NEUROSCI, V24, P1041, DOI 10.1146/annurev.neuro.24.1.1041; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shapiro L, 1998, CURR OPIN NEUROBIOL, V8, P593, DOI 10.1016/S0959-4388(98)80086-X; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Yoon MS, 2000, J COMP NEUROL, V421, P461, DOI 10.1002/(SICI)1096-9861(20000612)421:4<461::AID-CNE2>3.0.CO;2-M	52	235	238	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					205	216		10.1016/S0092-8674(02)00695-5	http://dx.doi.org/10.1016/S0092-8674(02)00695-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007407	Bronze			2022-12-28	WOS:000175082600010
J	Gabriel, SB; Schaffner, SF; Nguyen, H; Moore, JM; Roy, J; Blumenstiel, B; Higgins, J; DeFelice, M; Lochner, A; Faggart, M; Liu-Cordero, SN; Rotimi, C; Adeyemo, A; Cooper, R; Ward, R; Lander, ES; Daly, MJ; Altshuler, D				Gabriel, SB; Schaffner, SF; Nguyen, H; Moore, JM; Roy, J; Blumenstiel, B; Higgins, J; DeFelice, M; Lochner, A; Faggart, M; Liu-Cordero, SN; Rotimi, C; Adeyemo, A; Cooper, R; Ward, R; Lander, ES; Daly, MJ; Altshuler, D			The structure of haplotype blocks in the human genome	SCIENCE			English	Article							HUMAN LIPOPROTEIN-LIPASE; MODERN HUMAN ORIGINS; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; CROHNS-DISEASE; GENE; SUSCEPTIBILITY; COMPLEX; IDENTIFICATION; MUTATION	Haplotype-based methods offer a powerful approach to disease gene mapping, based on the association between causal mutations and the ancestral haplotypes on which they arose. As part of The SNP Consortium Allele Frequency Projects, we characterized haplotype patterns across 51 autosomal regions (spanning 13 megabases of the human genome) in samples from Africa, Europe, and Asia. We show that the human genome can be parsed objectively into haplotype blocks: sizable regions over which there is little evidence for historical recombination and within which only a few common haplotypes are observed. The boundaries of blocks and specific haplotypes they contain are highly correlated across populations. We demonstrate that such haplotype frameworks provide substantial statistical power in association studies of common genetic variation across each region. Our results provide a foundation for the construction of a haplotype map of the human genome, facilitating comprehensive genetic association studies of human disease.	Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Howard Univ, Natl Human Genome Ctr, Washington, DC 20059 USA; Univ Ibadan, Coll Med, Dept Pediat, Ibadan, Nigeria; Loyola Univ, Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60143 USA; Univ Oxford, Inst Biol Anthropol, Oxford OX2 6QS, England; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard University; University of Ibadan; Loyola University Chicago; University of Oxford; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), Whitehead MIT Ctr Genome Res, Cambridge, MA 02139 USA.		Ganesh, Dunna Sai/AGX-5170-2022; ravegnini, gloria/K-1330-2016; Schaffner, Stephen F/D-1189-2011; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017	ravegnini, gloria/0000-0002-7774-402X; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Adeyemo, Adebowale/0000-0002-3105-3231; Schaffner, Stephen/0000-0001-6699-3568				Boehnke M, 2000, NAT GENET, V25, P246, DOI 10.1038/76980; CANN RL, 1984, GENETICS, V106, P479; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Clark AG, 1998, AM J HUM GENET, V63, P595, DOI 10.1086/301977; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Jorde LB, 2000, GENOME RES, V10, P1435, DOI 10.1101/gr.144500; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; LEWONTIN RC, 1964, GENETICS, V49, P49; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040	32	4489	4676	4	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 21	2002	296	5576					2225	2229		10.1126/science.1069424	http://dx.doi.org/10.1126/science.1069424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	565PQ	12029063				2022-12-28	WOS:000176379000060
J	't Jong, GW; Eland, IA; Sturkenboom, MCJM; van den Anker, JN; Stricker, BHC				't Jong, GW; Eland, IA; Sturkenboom, MCJM; van den Anker, JN; Stricker, BHC			Unlicensed and off label prescription of drugs to children: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							OFF-LABEL		Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat, Pharmacoepidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr Rotterdam, Sophia Childrens Hosp, Dept Paediat, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr Rotterdam, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr Rotterdam, Dept Med Informat, NL-3000 DR Rotterdam, Netherlands; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University System of Ohio; Ohio State University	Stricker, BHC (corresponding author), Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat, Pharmacoepidemiol Unit, POB 1738, NL-3000 DR Rotterdam, Netherlands.							Allen DB, 1998, RESP MED, V92, P37, DOI 10.1016/S0954-6111(98)90438-3; Stricker B H, 1992, Ned Tijdschr Geneeskd, V136, P1362; 't Jong GW, 2001, PEDIATRICS, V108, P1089, DOI 10.1542/peds.108.5.1089; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469; Vlug AE, 1999, METHOD INFORM MED, V38, P339	5	61	63	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1313	1314		10.1136/bmj.324.7349.1313	http://dx.doi.org/10.1136/bmj.324.7349.1313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039827	Green Published, Bronze			2022-12-28	WOS:000176041500020
J	Neves, SR; Ram, PT; Iyengar, R				Neves, SR; Ram, PT; Iyengar, R			G protein pathways	SCIENCE			English	Editorial Material							TRANSDUCTION; CYCLASE	The heterotrimeric guanine nucleotide-binding proteins (G proteins) are signal transducers that communicate signals from many hormones, neurotransmitters, chemokines, and autocrine and paracrine factors. The extracellular signals are received by members of a large superfamily of receptors with seven membrane-spanning regions that activate the G proteins, which route the signals to several distinct intracellular signaling pathways. These pathways interact with one another to form a network that regulates metabolic enzymes, ion channels, transporters, and other components of the cellular machinery controlling a broad range of cellular processes, including transcription, motility, contractility, and secretion. These cellular processes in turn regulate systemic functions such as embryonic development, gonadal development, learning and memory, and organismal homeostasis.	Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA.	ravi.iyengar@mssm.edu	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Ram, Prahlad/0000-0003-4739-3166	NCI NIH HHS [CA-81050] Funding Source: Medline; NIDDK NIH HHS [DK-38761] Funding Source: Medline; NIGMS NIH HHS [GM-54508, F31GM65065] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM065065, R01GM054508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BIRNBAUMER L, 1990, BIOCHIM BIOPHYS ACTA, V1031, P163, DOI 10.1016/0304-4157(90)90007-Y; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; CHAN AML, 1993, MOL CELL BIOL, V13, P762, DOI 10.1128/MCB.13.2.762; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; IYENGAR R, 1990, G PROTEINS; IYENGAR R, 2002, SCI STKE; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; KREBS EG, 1956, J BIOL CHEM, V218, P483; NEER EJ, 1988, NATURE, V333, P129, DOI 10.1038/333129a0; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; NEVES S, 2002, SCI STKE; RAM P, SCI STKE; RODBELL M, 1971, J BIOL CHEM, V246, P1877; RODBELL M, 1980, NATURE, V284, P17, DOI 10.1038/284017a0; ROSS EM, 1980, ANNU REV BIOCHEM, V49, P553, DOI 10.1146/annurev.bi.49.070180.002533; ROSS EM, 1977, J BIOL CHEM, V252, P6966; Schmitt JM, 2002, MOL CELL, V9, P85, DOI 10.1016/S1097-2765(01)00432-4; Shi CS, 2001, J BIOL CHEM, V276, P31845, DOI 10.1074/jbc.M101043200; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SUTHERLAND EW, 1955, NATURE, V175, P169, DOI 10.1038/175169a0; Xie Z, 2002, J BIOL CHEM, V277, P11979, DOI 10.1074/jbc.M109751200; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	23	920	951	5	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 31	2002	296	5573					1636	1639		10.1126/science.1071550	http://dx.doi.org/10.1126/science.1071550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040175				2022-12-28	WOS:000175976200038
J	Ray, LB; Gough, NR				Ray, LB; Gough, NR			Orienteering strategies for a signaling maze - Introduction	SCIENCE			English	Editorial Material													Gough, Nancy R./M-1360-2019	Gough, Nancy R./0000-0001-5179-8890					0	9	9	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1632	1633		10.1126/science.296.5573.1632	http://dx.doi.org/10.1126/science.296.5573.1632			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040172				2022-12-28	WOS:000175976200035
J	Moore, CB; John, M; James, IR; Christiansen, FT; Witt, CS; Mallal, SA				Moore, CB; John, M; James, IR; Christiansen, FT; Witt, CS; Mallal, SA			Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level	SCIENCE			English	Article							CYTOTOXIC T-LYMPHOCYTES; HUMAN-IMMUNODEFICIENCY-VIRUS; REVERSE-TRANSCRIPTASE; INFECTION; SUSCEPTIBILITY; PROSTITUTES; INDIVIDUALS; NAIROBI; EPITOPE; SELECT	Antigen-specific T cell immunity is HLA-restricted. Human immunodeficiency virus-type 1 (HIV-1) mutations that allow escape from host immune responses may therefore be HLA allele-specific. We analyzed HIV-1 reverse transcriptase sequences from a large HLA-diverse population of HIV-1-infected individuals. Polymorphisms in HIV-1 were most evident at sites of least functional or structural constraint and frequently were associated with particular host HLA class I alleles. Absence of polymorphism was also HLA allele-specific. At a population Level, the degree of HLA-associated selection in viral sequence was predictive of viral load. These results support a fundamental role for HLA-restricted immune responses in driving and shaping HIV-1 evolution in vivo.	Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Perth, WA 6000, Australia; Murdoch Univ, Royal Perth Hosp, Perth, WA 6000, Australia; Royal Perth Hosp, Dept Clin Immunol & Biochem Genet, Perth, WA, Australia; Univ Western Australia, Dept Pathol, Nedlands, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; Murdoch University; Royal Perth Hospital; University of Western Australia; Royal Perth Hospital; University of Western Australia; University of Western Australia	Mallal, SA (corresponding author), Royal Perth Hosp, Ctr Clin Immunol & Biomed Stat, Level 2 N Block,Wellington St, Perth, WA 6000, Australia.	mallal@prodigal.murdoch.edu.au	Mallal, Simon Alexander/HDM-9561-2022	Mallal, Simon Alexander/0000-0002-7036-1309				Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Brander C, 1998, J CLIN INVEST, V101, P2559, DOI 10.1172/JCI2405; CAMPOSLIMA P, 1993, SCIENCE, V260, P98; deCamposLima PO, 1997, J EXP MED, V186, P83, DOI 10.1084/jem.186.1.83; DeGroot AS, 1997, AIDS RES HUM RETROV, V13, P529, DOI 10.1089/aid.1997.13.529; DEL VM, 1991, CELL, V66, P1145; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; FABIO G, 1992, CLIN EXP IMMUNOL, V87, P20, DOI 10.1111/j.1365-2249.1992.tb06407.x; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Hay CM, 1999, J VIROL, V73, P5509, DOI 10.1128/JVI.73.7.5509-5519.1999; HOSMALIN A, 1990, P NATL ACAD SCI USA, V87, P2344, DOI 10.1073/pnas.87.6.2344; Korber B, 1999, HIV MOL IMMUNOLOGY D; Kuttler C, 2000, J MOL BIOL, V298, P417, DOI 10.1006/jmbi.2000.3683; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; MALLAL SA, 1998, AIDS HUM RETROVIROL, V17, pS23; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; RAMSEY FL, 1997, STAT SLEUTH COURSE M, P10; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; Rowland-Jones SL, 1998, J CLIN INVEST, V102, P1758, DOI 10.1172/JCI4314; Rowland-Jones SL, 1999, IMMUNOL LETT, V66, P9, DOI 10.1016/S0165-2478(98)00179-5; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Schmitt M, 2000, AIDS, V14, P653, DOI 10.1097/00002030-200004140-00004; Shankar P, 1998, J ACQ IMMUN DEF SYND, V19, P111, DOI 10.1097/00042560-199810010-00002; Sipsas NV, 1997, J CLIN INVEST, V99, P752, DOI 10.1172/JCI119221; Wagner L, 1998, NATURE, V391, P908, DOI 10.1038/36129; WALKER BD, 1988, SCIENCE, V240, P64, DOI 10.1126/science.2451288; Wrobel JA, 1998, P NATL ACAD SCI USA, V95, P638, DOI 10.1073/pnas.95.2.638	30	601	625	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1439	1443		10.1126/science.1069660	http://dx.doi.org/10.1126/science.1069660			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029127	Green Submitted			2022-12-28	WOS:000175910300040
J	da Silva, ACR; Ferro, JA; Reinach, FC; Farah, CS; Furlan, LR; Quaggio, RB; Monteiro-Vitorello, CB; Van Sluys, MA; Almeida, NF; Alves, LMC; do Amaral, AM; Bertolini, MC; Camargo, LEA; Camarotte, G; Cannavan, F; Cardozo, J; Chambergo, F; Clapina, LP; Cicarelli, RMB; Coutinho, LL; Cursino-Santos, JR; El-Dorry, H; Faria, JB; Ferreira, AJS; Ferreira, RCC; Ferro, MIT; Formighieri, EF; Franco, MC; Greggio, CC; Gruber, A; Katsuyama, AM; Kishi, LT; Leite, RP; Lemos, EGM; Lemos, MVF; Locali, EC; Machado, MA; Madeira, AMBN; Martinez-Rossi, NM; Martins, EC; Meidanis, J; Menck, CFM; Miyaki, CY; Moon, DH; Moreira, LM; Novo, MTM; Okura, VK; Oliveira, MC; Oliveira, VR; Pereira, HA; Rossi, A; Sena, JAD; Silva, C; de Souza, RF; Spinola, LAF; Takita, MA; Tamura, RE; Teixeira, EC; Tezza, RID; dos Santos, MT; Truffi, D; Tsai, SM; White, FF; Setubal, JC; Kitajima, JP				da Silva, ACR; Ferro, JA; Reinach, FC; Farah, CS; Furlan, LR; Quaggio, RB; Monteiro-Vitorello, CB; Van Sluys, MA; Almeida, NF; Alves, LMC; do Amaral, AM; Bertolini, MC; Camargo, LEA; Camarotte, G; Cannavan, F; Cardozo, J; Chambergo, F; Clapina, LP; Cicarelli, RMB; Coutinho, LL; Cursino-Santos, JR; El-Dorry, H; Faria, JB; Ferreira, AJS; Ferreira, RCC; Ferro, MIT; Formighieri, EF; Franco, MC; Greggio, CC; Gruber, A; Katsuyama, AM; Kishi, LT; Leite, RP; Lemos, EGM; Lemos, MVF; Locali, EC; Machado, MA; Madeira, AMBN; Martinez-Rossi, NM; Martins, EC; Meidanis, J; Menck, CFM; Miyaki, CY; Moon, DH; Moreira, LM; Novo, MTM; Okura, VK; Oliveira, MC; Oliveira, VR; Pereira, HA; Rossi, A; Sena, JAD; Silva, C; de Souza, RF; Spinola, LAF; Takita, MA; Tamura, RE; Teixeira, EC; Tezza, RID; dos Santos, MT; Truffi, D; Tsai, SM; White, FF; Setubal, JC; Kitajima, JP			Comparison of the genomes of two Xanthomonas pathogens with differing host specificities	NATURE			English	Article							CAMPESTRIS PV VESICATORIA; GENE-CLUSTER; BIOSYNTHESIS; EXPRESSION; SEQUENCE; HRP; PROTEINS; OPERON	The genus Xanthomonas is a diverse and economically important group of bacterial phytopathogens, belonging to the gamma-subdivision of the Proteobacteria. Xanthomonas axonopodis pv. citri (Xac) causes citrus canker, which affects most commercial citrus cultivars, resulting in significant losses worldwide. Symptoms include canker lesions, leading to abscission of fruit and leaves and general tree decline(1). Xanthomonas campestris pv. campestris (Xcc) causes black rot, which affects crucifers such as Brassica and Arabidopsis. Symptoms include marginal leaf chlorosis and darkening of vascular tissue, accompanied by extensive wilting and necrosis(2). Xanthomonas campestris pv. campestris is grown commercially to produce the exopolysaccharide xanthan gum, which is used as a viscosifying and stabilizing agent in many industries(3). Here we report and compare the complete genome sequences of Xac and Xcc. Their distinct disease phenotypes and host ranges belie a high degree of similarity at the genomic level. More than 80% of genes are shared, and gene order is conserved along most of their respective chromosomes. We identified several groups of strain-specific genes, and on the basis of these groups we propose mechanisms that may explain the differing host specificities and pathogenic processes.	Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Bot, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-05508900 Sao Paulo, Brazil; Univ Estadual Paulista, Fac Ciencias Agrarias & Vet, Dept Tecnol, BR-14884900 Jaboticabal, SP, Brazil; Univ Estadual Paulista, Fac Ciencias Agrarias & Vet, Dept Biol Aplicada Agropecuaria, BR-14884900 Jaboticabal, SP, Brazil; Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Melhoramento & Nutr Anim, BR-18600000 Botucatu, SP, Brazil; Univ Sao Paulo, Escola Super Agr Luiz Queiroz, Piracicaba, SP, Brazil; Univ Fed Mato Grosso do Sul, Dept Computacao & Estatist, BR-79070900 Campo Grande, MS, Brazil; IAC, Ctr Citricultura Sylvio Moreira, BR-13490970 Cordeiropolis, SP, Brazil; Univ Estadual Paulista, Inst Quim, Dept Bioquim & Tecnol Quim, BR-14801970 Araraquara, SP, Brazil; Ctr Energia Nucl Agr, BR-13400970 Piracicaba, SP, Brazil; Univ Estadual Paulista, Fac Ciencias Farmaceut, Dept Ciencias Biol, BR-14801902 Araraquara, SP, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; IAPAR, Inst Tecnol Parana, BR-86001970 Londrina, PR, Brazil; Univ Estadual Campinas, Inst Computacao, Ctr Biol Mol & Engn Genet, BR-13084971 Campinas, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Federal de Mato Grosso do Sul; Instituto Agronomico de Campinas (IAC); Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	da Silva, ACR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, Brazil.	acrasera@iq.usp.br	Menck, Carlos FM/G-6321-2011; tamura, rodrigo/C-3085-2012; Martinez-Rossi, Nilce Maria/AAL-2964-2021; Martinez-Rossi, Nilce M/C-2234-2013; Gruber, Arthur/B-4711-2011; Madeira, AMBN/E-7971-2012; Setubal, Joao Carlos/C-7305-2012; Tsai, Siu Mui/C-2793-2012; tamura, rodrigo e/O-9846-2014; Camargo, Luis Eduardo Aranha/Y-9954-2019; Formighieri, Eduardo F/F-2993-2012; Cannavan, Fabiana S/F-4952-2012; Kishi, Luciano T/O-3982-2014; Almeida, Nalvo/B-5856-2012; de Souza, RF/G-9716-2011; Martins, Elaine/AAC-6158-2019; Farah, Chuck Shaker/G-5565-2012; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Okura, Vagner/J-9180-2016; Coutinho, Luiz L/C-8455-2012; Ferreira, Rita/AFO-9971-2022; Meidanis, Joao/P-8140-2015; Alves, Lucia/D-2270-2012; Desiderio, Janete Apparecida/R-4864-2019; Mansur, Maria Teresa Marques Novo/G-4779-2012; Takita, Marco A/C-3430-2013; LEMOS, ELIANA GM/A-3604-2008; Apparecida Desidério, Janete/F-5848-2012; Barretto Cicarelli, Regina Maria/K-8899-2012; alves, lucia maria carareto/AAH-6555-2020; Van Sluys, Marie-Anne/A-8483-2012; Machado, Marcos/G-3582-2012; Camargo, Luis Eduardo A/C-2735-2012; Rossi, Antonio/I-1388-2013; Chambergo, Felipe S/B-8599-2012; Miyaki, Cristina Y/J-2431-2015; Locali, Eliane/AAP-3851-2020; Coutinho, Luiz/P-5233-2019; de Oliveira, Mariana Cabral/G-2512-2012; Bertolini, Maria Celia/D-3654-2012; Monteiro-Vitorello, Claudia B/F-2436-2012; FERRO, MARIA INÊS TIRABOSCHI/D-3634-2012; Ferreira, Ari J S/C-2266-2015; Formighieri, Eduardo/W-9242-2019; Ferro, Jesus Aparecido A/C-8251-2013	Menck, Carlos FM/0000-0003-1941-0694; Martinez-Rossi, Nilce Maria/0000-0002-5723-4276; Gruber, Arthur/0000-0001-8093-2278; Madeira, AMBN/0000-0002-3917-1849; Setubal, Joao Carlos/0000-0001-9174-2816; Tsai, Siu Mui/0000-0002-3733-6312; tamura, rodrigo e/0000-0001-7767-0887; Camargo, Luis Eduardo Aranha/0000-0002-5650-5695; Kishi, Luciano T/0000-0003-0449-4274; de Souza, RF/0000-0002-5284-4630; Martins, Elaine/0000-0001-5448-7713; Farah, Chuck Shaker/0000-0003-3110-6302; de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Okura, Vagner/0000-0002-3591-4051; Coutinho, Luiz L/0000-0002-7266-8881; Alves, Lucia/0000-0002-9328-2726; Desiderio, Janete Apparecida/0000-0001-7723-3070; Mansur, Maria Teresa Marques Novo/0000-0003-0308-6287; Takita, Marco A/0000-0003-3935-1361; LEMOS, ELIANA GM/0000-0002-1119-7748; Apparecida Desidério, Janete/0000-0001-7723-3070; Van Sluys, Marie-Anne/0000-0002-6506-2734; Machado, Marcos/0000-0001-9780-3990; Camargo, Luis Eduardo A/0000-0002-5650-5695; Chambergo, Felipe S/0000-0001-7567-0656; Miyaki, Cristina Y/0000-0002-9708-9202; Coutinho, Luiz/0000-0002-7266-8881; de Oliveira, Mariana Cabral/0000-0001-8495-2962; Bertolini, Maria Celia/0000-0001-5319-2710; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; FERRO, MARIA INÊS TIRABOSCHI/0000-0003-3389-9131; Ferreira, Ari J S/0000-0002-7526-5543; Ferro, Jesus Aparecido A/0000-0002-3966-1303; Locali, Eliane/0000-0002-2404-3211; Prioli Ciapina, Luciane/0000-0003-1894-3923; Almeida, Nalvo/0000-0001-5615-1746; Rossi, Antonio/0000-0003-1951-4741				Becker A, 1998, APPL MICROBIOL BIOT, V50, P145, DOI 10.1007/s002530051269; Beyer S, 1996, MOL GEN GENET, V250, P775, DOI 10.1007/BF02172990; Bhat TK, 1998, BIODEGRADATION, V9, P343, DOI 10.1023/A:1008397506963; BONAS U, 1991, MOL PLANT MICROBE IN, V4, P81, DOI 10.1094/MPMI-4-081; BREEDVELD MW, 1995, J BACTERIOL, V177, P6346, DOI 10.1128/jb.177.22.6346-6351.1995; Burns DL, 1999, CURR OPIN MICROBIOL, V2, P25, DOI 10.1016/S1369-5274(99)80004-6; Cao H, 2001, ANNU REV PHYTOPATHOL, V39, P259, DOI 10.1146/annurev.phyto.39.1.259; Chang KH, 1998, BIOCHEM BIOPH RES CO, V245, P313, DOI 10.1006/bbrc.1998.8432; Chen JH, 1999, J BACTERIOL, V181, P1220, DOI 10.1128/JB.181.4.1220-1228.1999; Dow JM, 2000, MICROBIOL-SGM, V146, P885, DOI 10.1099/00221287-146-4-885; Dow JM, 2000, YEAST, V17, P263, DOI 10.1002/1097-0061(200012)17:4&lt;263::AID-YEA44&gt;3.0.CO;2-G; DOW JM, 1995, MOL PLANT MICROBE IN, V8, P768, DOI 10.1094/MPMI-8-0768; DUMS F, 1991, MOL GEN GENET, V229, P357, DOI 10.1007/BF00267456; Fenselau S, 1995, MOL PLANT MICROBE IN, V8, P845, DOI 10.1094/MPMI-8-0845; GOTTFERT M, 1990, P NATL ACAD SCI USA, V87, P2680, DOI 10.1073/pnas.87.7.2680; Gottwald TR., 2000, COMPENDIUM CITRUS DI, P5; Gueneron M, 2000, MOL MICROBIOL, V36, P261, DOI 10.1046/j.1365-2958.2000.01870.x; Hayward A. C., 1993, XANTHOMONAS, P51; Lahaye T, 2001, TRENDS PLANT SCI, V6, P479, DOI 10.1016/S1360-1385(01)02083-0; LIN JT, 1994, J BACTERIOL, V176, P2551, DOI 10.1128/JB.176.9.2551-2559.1994; MENESTRINA G, 1999, COMPREHENSIVE SOURCE, P287; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Ronald P C, 1988, Mol Plant Microbe Interact, V1, P191, DOI 10.1094/MPMI-1-191; Rudolph K., 1993, Xanthomonas., P193; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Vorholter FJ, 2001, MOL GENET GENOMICS, V266, P79, DOI 10.1007/s004380100521; Wengelnik K, 1996, J BACTERIOL, V178, P3462, DOI 10.1128/jb.178.12.3462-3469.1996; YANG YO, 1995, J BACTERIOL, V177, P4963, DOI 10.1128/jb.177.17.4963-4968.1995; Young ND, 2000, CURR OPIN PLANT BIOL, V3, P285, DOI 10.1016/S1369-5266(00)00081-9	30	907	2117	6	198	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					459	463		10.1038/417459a	http://dx.doi.org/10.1038/417459a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024217				2022-12-28	WOS:000175730900043
J	Domanski, M; Mitchell, G; Pfeffer, M; Neaton, JD; Norman, J; Svendsen, K; Grimm, R; Cohen, J; Stamler, J				Domanski, M; Mitchell, G; Pfeffer, M; Neaton, JD; Norman, J; Svendsen, K; Grimm, R; Cohen, J; Stamler, J		MRFIT Res Grp	Pulse pressure and cardiovascular disease-related mortality - Follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ISOLATED SYSTOLIC HYPERTENSION; CORONARY-HEART-DISEASE; MIDDLE-AGED MEN; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; PREDICTOR; DEATH	Context The sixth Joint National Committee (JNC-VI) classification system of blood pressure emphasizes both systolic blood pressure (SBP) and diastolic blood pressure (DBP) for cardiovascular disease risk assessment. Pulse pressure may also be a valuable risk assessment tool. Objective To compare relationships of SBP, DBP, and pulse pressure, separately and jointly, with cardiovascular disease-related mortality in men. Design and Setting Data from the Multiple Risk Factor Intervention Trial (MRFIT), which screened men aged 35 to 57 years from 1973 through 1975 at 22 US centers, was used to assess cardiovascular disease-related mortality through 1996. Participants A total of 342815 men without diabetes or a history of myocardial infarction were divided into 2 groups based on their age at MRFIT screening (35- to 44-year-olds and 45- to 57-year olds). Participant blood pressure levels were classified into a JNC-VI blood pressure category based on SBP and DBP (optimal, normal but not optimal, high normal, stage 1 hypertension, stage 2-3 hypertension), and pulse pressure was calculated. Main Outcome Measure Cardiovascular disease-related mortality. Results There were 25721 cardiovascular disease-related deaths. Levels of SBP and DBP were more strongly related to cardiovascular disease than pulse pressure. Relationships of SBP, DBP, and pulse pressure to cardiovascular disease-related mortality varied within JNC-VI category. Concordant elevations of SBP and DBP were associated with a greater risk of cardiovascular disease-related mortality for both age groups of men, Among men aged 45 to 57 years, higher SBP and lower DBP (discordant elevations) also yielded a greater risk of cardiovascular disease-related mortality. Conclusion In both age groups, cardiovascular disease risk assessment was improved by considering both SBP and DBP, not just SBP, DBP, or pulse pressure separately.	Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55414 USA; NHLBI, Clin Trials Grp, Bethesda, MD 20892 USA; NHLBI, Off Biostat Res, Bethesda, MD 20892 USA; Cardiovasc Engn Inc, Holliston, MA USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; Univ Minnesota, Hennepin Cty Med Ctr, Berman Ctr Outcomes & Clin Res, Minneapolis, MN 55415 USA; St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO USA; Northwestern Univ, Sch Med, Dept Prevent Med, Chicago, IL USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Cardiovascular Engineering; Harvard University; Brigham & Women's Hospital; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities; Saint Louis University; Northwestern University	Neaton, JD (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, 2221 Univ Ave SE,Room 200, Minneapolis, MN 55414 USA.	jim@ccbr.umn.edu			NHLBI NIH HHS [R01-HL68140-02] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068140] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERNETHY J, 1986, American Journal of Preventive Medicine, V2, P123; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1992, INT CLASS DIS; Antikainen RL, 2000, J HYPERTENS, V18, P417, DOI 10.1097/00004872-200018040-00010; Benetos A, 1998, HYPERTENSION, V32, P560, DOI 10.1161/01.HYP.32.3.560; Benetos A, 2001, J AM COLL CARDIOL, V37, P163, DOI 10.1016/S0735-1097(00)01092-5; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; COX DR, 1972, J R STAT SOC B, V34, P187; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; DISCHINGER P, 1986, CONTROL CLIN TRIALS, V7, pS137; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Domanski MJ, 1999, HYPERTENSION, V34, P375, DOI 10.1161/01.HYP.34.3.375; DYER AR, 1982, J CHRON DIS, V35, P283, DOI 10.1016/0021-9681(82)90084-4; Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.213.7.1143; FANG J, 1995, J HYPERTENS, V13, P413; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; Glynn RJ, 2000, ARCH INTERN MED, V160, P2765, DOI 10.1001/archinte.160.18.2765; Lee MLT, 1999, ANN EPIDEMIOL, V9, P101, DOI 10.1016/S1047-2797(98)00034-9; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; Mitchell GF, 1997, CIRCULATION, V96, P4254; Miura K, 2001, J HUM HYPERTENS, V15, P1, DOI 10.1038/sj.jhh.1001142; NEATON JD, 1995, HYPERTENSION PATHOPH; *NIH, 1997, NIH PUBL, V4080; Psaty BM, 2001, ARCH INTERN MED, V161, P1183, DOI 10.1001/archinte.161.9.1183; RUTAN GH, 1988, CIRCULATION, V77, P504, DOI 10.1161/01.CIR.77.3.504; STAMLER J, 1993, ARCH INTERN MED, V153, P598, DOI 10.1001/archinte.153.5.598; STAMLER J, 1991, HYPERTENSION, V18, P95, DOI 10.1161/01.HYP.18.3_Suppl.I95; STAMLER J, 1973, DHEW PUBL; US Dept of Health and Human Services . International Classification of Diseases, 1988, INT CLASS DIS; WENTWORTH DN, 1983, AM J PUBLIC HEALTH, V73, P1270, DOI 10.2105/AJPH.73.11.1270; WHELTON PK, 1993, ARCH INTERN MED, V153, P186, DOI 10.1001/archinte.153.2.186	34	224	231	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2677	2683		10.1001/jama.287.20.2677	http://dx.doi.org/10.1001/jama.287.20.2677			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020303	Bronze			2022-12-28	WOS:000175732400027
J	Eysenbach, G; Powell, J; Kuss, O; Sa, ER				Eysenbach, G; Powell, J; Kuss, O; Sa, ER			Empirical studies assessing the quality of health information for consumers on the World Wide Web - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PATIENT INFORMATION; MEDICAL INFORMATION; SURGICAL DEPARTMENTS; INTERNET INFORMATION; SURGERY INFORMATION; CANCER INFORMATION; READABILITY LEVELS; PEDIATRIC-SURGERY; ANATOMY SITES; EDUCATION	Context The quality of consumer health information on the World Wide Web is an important issue for medicine, but to date no systematic and comprehensive synthesis or the methods and evidence has been performed. Objectives To establish a methodological framework on how quality on the Web is evaluated in practice, to determine the heterogeneity of the results and conclusions, and to compare the methodological rigor of these studies, to determine to what extent the conclusions depend on the methodology used, and to suggest future directions for research. Data Sources We searched MEDLINE and PREMEDLINE (1966 through September 2001), Science Citation Index (1997 through September 2001), Social Sciences Citation Index (1997 through September 2001), Arts and Humanities Citation Index (1997 through September 2001), LISA (1969 through July 2001), CINAHL (1982 through July 2001), PsychINFO (1988 through September 2001), EMBASE (1988 through June 2001), and SIGLE (1980 through June 2001). We also conducted hand searches, general Internet searches, and a personal bibliographic database search. Study Selection We included published and unpublished empirical studies in any language in which investigators searched the Web systematically for specific health information, evaluated the quality of Web sites or pages, and reported quantitative results. We screened 7830 citations and retrieved 170 potentially eligible full articles. A total of 79 distinct studies met the inclusion criteria, evaluating 5941 health Web sites and 1329 Web pages, and reporting 408 evaluation results for 86 different quality criteria. Data Extraction Two reviewers independently extracted study characteristics, medical domains, search strategies used, methods and criteria of quality assessment, results (percentage of sites or pages rated as inadequate pertaining to a quality criterion), and quality and rigor of study methods and reporting. Data Synthesis Most frequently used quality criteria used include accuracy, completeness, readability, design, disclosures, and references provided. Fifty-five studies (70%) concluded that quality is a problem on the Web, 17 (22%) remained neutral, and 7 studies (9%) came to a positive conclusion. Positive studies scored significantly lower in search (P=.02) and evaluation (P=.04) methods. Conclusions Due to differences in study methods and rigor, quality criteria, study population, and topic chosen, study results and conclusions on health-related Web sites vary widely. Operational definitions of quality criteria are needed.	Heidelberg Univ, Dept Clin Social Med, Unit Cybermed & E Hlth, Heidelberg, Germany; London Sch Hyg & Trop Med, Hlth Serv Res Unit, London WC1, England; Univ Halle Wittenberg, Dept Med Epidemiol Biometry & Informat, Halle An Der Saale, Germany; Univ Pittsburgh, Dept Epidemiol, Global Hlth Network Grp, Pittsburgh, PA 15261 USA	Ruprecht Karls University Heidelberg; University of London; London School of Hygiene & Tropical Medicine; Martin Luther University Halle Wittenberg; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Eysenbach, G (corresponding author), Toronto Gen Hosp, Ctr Global eHealth Innovat, 190 Elizabeth St, Toronto, ON M5G 2C4, Canada.	ey@yi.com	Eysenbach, Gunther/AAJ-7158-2020	Eysenbach, Gunther/0000-0001-6479-5330; Kuss, Oliver/0000-0003-3301-5869; Powell, John/0000-0002-1456-4857				Abbott VP, 2000, J PUBLIC HEALTH MED, V22, P191, DOI 10.1093/pubmed/22.2.191; Allen ES, 1999, NATURE, V402, P722, DOI 10.1038/45370; Armstrong K, 1999, NEW ENGL J MED, V341, P1389, DOI 10.1056/NEJM199910283411810; Beredjiklian PK, 2000, J BONE JOINT SURG AM, V82A, P1540, DOI 10.2106/00004623-200011000-00004; BERLAND G, 2001, EVALUATION ENGLISH S; Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Biermann JS, 1999, CANCER, V86, P381, DOI 10.1002/(SICI)1097-0142(19990801)86:3<381::AID-CNCR4>3.3.CO;2-7; Bloom BS, 1999, ANN INTERN MED, V131, P830, DOI 10.7326/0003-4819-131-11-199912070-00005; Bogenschutz MP, 2000, J PSYCHOACTIVE DRUGS, V32, P249, DOI 10.1080/02791072.2000.10400447; BOHNING D, IN PRESS NEW DEV APP; Boyer C, 1998, COMPUT BIOL MED, V28, P603, DOI 10.1016/S0010-4825(98)00037-7; Boyer EW, 2001, NEW ENGL J MED, V345, P469, DOI 10.1056/NEJM200108093450619; Breul H, 1999, SEM HOP PARIS, V75, P257; Butzke I, 2000, Z ORTHOP GRENZGEB, V138, P413, DOI 10.1055/s-2000-10170; Bykowski JL, 2000, J AM ACAD DERMATOL, V42, P784, DOI 10.1067/mjd.2000.103044; Canto MT, 1998, J PUBLIC HEALTH DENT, V58, P241, DOI 10.1111/j.1752-7325.1998.tb03000.x; Charnock D, 1999, J EPIDEMIOL COMMUN H, V53, P105, DOI 10.1136/jech.53.2.105; Chen LE, 2000, J PEDIATR SURG, V35, P1179, DOI 10.1053/jpsu.2000.8723; Coiera E, 1998, BRIT MED J, V317, P1469, DOI 10.1136/bmj.317.7171.1469; Corpron CA, 2001, J PEDIATR SURG, V36, P1187, DOI 10.1053/jpsu.2001.25751; Coulter A, 1999, BRIT MED J, V318, P318, DOI 10.1136/bmj.318.7179.318; D'Alessandro DM, 2001, ARCH PEDIAT ADOL MED, V155, P807, DOI 10.1001/archpedi.155.7.807; DALTON L, 1981, B MED LIBR ASSOC, V69, P322; Davison K, 1996, J CAN DIET ASSOC, V57, P137; Davison K, 1997, Clin Perform Qual Health Care, V5, P64; Delamothe T, 2000, BRIT MED J, V321, P843, DOI 10.1136/bmj.321.7265.843; Diering C L, 2001, J Wound Ostomy Continence Nurs, V28, P55, DOI 10.1067/mjw.2001.110622; Doupi P, 1999, MED INFORM INTERNET, V24, P171, DOI 10.1080/146392399298375; Dracos A., 1998, Tudomanyos es Muszaki Tajekoztatas, V45, P118; e-Health Ethics Initiative, 2000, J Med Internet Res, V2, pE9; Ellamushi H, 2001, ANN ROY COLL SURG, V83, P292; Estrada CA, 2000, STROKE, V31, P2966, DOI 10.1161/01.STR.31.12.2966; Eysenbach G, 1999, METHOD INFORM MED, V38, P80; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Eysenbach G, 1998, BRIT MED J, V317, P1496, DOI 10.1136/bmj.317.7171.1496; Eysenbach G, 2001, STUD HEALTH TECHNOL, V84, P1450; Eysenbach G, 2001, J AM MED INFORM ASSN, P169; Eysenbach G, 2001, BRIT MED J, V323, P1103, DOI 10.1136/bmj.323.7321.1103; Eysenbach G, 2000, BMJ-BRIT MED J, V320, P1713, DOI 10.1136/bmj.320.7251.1713; Eysenbach G, 1999, J MED INTERNET RES, V1, DOI 10.2196/jmir.1.2.e10; Eysenbach G, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.4.e34; Fitzmaurice DA, 2000, J HUM HYPERTENS, V14, P259, DOI 10.1038/sj.jhh.1001003; Frasca D, 2000, SURG RADIOL ANAT, V22, P107, DOI 10.1007/s00276-000-0107-2; FRAZIER PJ, 1974, J PUBLIC HEALTH DENT, V34, P244, DOI 10.1111/j.1752-7325.1974.tb04018.x; Galimberti A, 2000, J Obstet Gynaecol, V20, P297; Gillies M, 2000, BRIT MED J, V321, P47, DOI 10.1136/bmj.321.7252.47/a; Gillois P, 1999, J AM MED INFORM ASSN, P775; Graber MA, 1999, J FAM PRACTICE, V48, P58; Griffiths KM, 2000, BMJ-BRIT MED J, V321, P1511, DOI 10.1136/bmj.321.7275.1511; Groot D, 2001, INJURY, V32, P473, DOI 10.1016/S0020-1383(01)00019-5; Harmon D, 2000, ANAESTHESIA, V55, P728, DOI 10.1046/j.1365-2044.2000.01557-58x./; Hatfield CL, 1999, AM J HEALTH-SYST PH, V56, P2308, DOI 10.1093/ajhp/56.22.2308; Hellawell GO, 2000, BJU INT, V86, P191, DOI 10.1046/j.1464-410x.2000.00831.x; Hernandez-Borges AA, 1999, J MED INTERNET RES, V1, DOI 10.2196/jmir.1.1.e1; Hersh WR, 1998, JAMA-J AM MED ASSOC, V280, P1307, DOI 10.1001/jama.280.15.1307; *HI ETH GROUP, 2000, HLTH INT ETH ETH PRI; Hoffman-Goetz L, 2000, CAN J PUBLIC HEALTH, V91, P281, DOI 10.1007/BF03404290; Impicciatore P, 1997, BMJ-BRIT MED J, V314, P1875, DOI 10.1136/bmj.314.7098.1875; IMPICCIATORE P, 1997, RICERCA PRATICA, V13, P67; Jadad AR, 1998, JAMA-J AM MED ASSOC, V279, P611, DOI 10.1001/jama.279.8.611; Jiang YL, 2000, AM J ORTHOD DENTOFAC, V118, P4, DOI 10.1067/mod.2000.104492; Kihlstrom L C, 2001, Manag Care Interface, V14, P64; Kim P, 1999, BMJ-BRIT MED J, V318, P647, DOI 10.1136/bmj.318.7184.647; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Latthe M, 2000, BRIT J FAM PLAN, V26, P39; Latthe P. M., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P167; Latthe PM, 2000, BRIT J OBSTET GYNAEC, V107, P39, DOI 10.1111/j.1471-0528.2000.tb11577.x; Lawrence S, 1999, NATURE, V400, P107, DOI 10.1038/21987; Li L, 2001, SPINE, V26, P545, DOI 10.1097/00007632-200103010-00020; Libertiny G, 2000, EUR J VASC ENDOVASC, V20, P386, DOI 10.1053/ejvs.2000.1179; Lissman TL, 2001, PSYCHIAT SERV, V52, P1046, DOI 10.1176/appi.ps.52.8.1046; Mallory C, 1997, Health Care Women Int, V18, P315; MARTINEZLOPEZ JF, 1998, REV ORTOPEDIA TRAUMA, V42, P469; Matthews MS, 2001, PLAST RECONSTR SURG, V107, P171, DOI 10.1097/00006534-200101000-00028; Maugans TA, 1998, PEDIATR NEUROSURG, V28, P186, DOI 10.1159/000028647; McClung HJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e2; Miles J, 2000, J ROY SOC MED, V93, P254, DOI 10.1177/014107680009300510; Molnar FJ, 1999, CAN MED ASSOC J, V161, P393; Murphy P W, 2001, J Neurosci Nurs, V33, P99; Neugebauer S, 2001, Schweiz Monatsschr Zahnmed, V111, P298; Nielsen J., 1993, USABILITY ENG; O'Mahony B, 1999, IRISH MED J, V92, P334; Oermann MH, 2000, J NURS CARE QUAL, V14, P45, DOI 10.1097/00001786-200007000-00008; OGUSHI Y, 2000, RES ANAL CURRENT STA; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Pandolfini C, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e1; PASKOFF BM, 1991, B MED LIBR ASSOC, V79, P182; PAYNE C, 2000, AUSTRALAS J PODIATR, V34, P63; Peroutka SJ, 2001, CEPHALALGIA, V21, P20, DOI 10.1046/j.1468-2982.2001.00137.x; Risk A, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.4.e28; Roberts JR, 1997, ARCH PEDIAT ADOL MED, V151, P592, DOI 10.1001/archpedi.1997.02170430058012; Sacchetti P, 1999, UROLOGY, V53, P1117, DOI 10.1016/S0090-4295(98)00662-1; Sandvik H, 1999, BRIT MED J, V319, P29, DOI 10.1136/bmj.319.7201.29; Seaboldt JA, 1997, AM J HEALTH-SYST PH, V54, P1732, DOI 10.1093/ajhp/54.15.1732; Shon J, 1999, J AM MED INFORM ASSN, P945; Silberg WM, 1997, JAMA-J AM MED ASSOC, V277, P1244, DOI 10.1001/jama.277.15.1244; Sing A, 2001, J TRAVEL MED, V8, P109; SMITH FA, 1972, NEW ENGL J MED, V286, P516, DOI 10.1056/NEJM197203092861005; Smith M, 2000, HEALTH EDUC BEHAV, V27, P684, DOI 10.1177/109019810002700603; Soot LC, 1999, J VASC SURG, V30, P84, DOI 10.1016/S0741-5214(99)70179-5; Stausberg J, 2000, CHIRURG, V71, P472, DOI 10.1007/s001040050841; Stausberg J, 2001, MED INFORM INTERNET, V26, P17, DOI 10.1080/14639230010024348; Stone TW, 2001, SOUTHERN MED J, V94, P22; Suarez-Almazor ME, 2001, J RHEUMATOL, V28, P185; Tamm EP, 2000, ACAD RADIOL, V7, P137, DOI 10.1016/S1076-6332(00)80113-0; Tatsumi H, 2001, J MED INTERNET RES, V3, DOI 10.2196/jmir.3.1.e12; Thompson J M, 2000, Manag Care Q, V8, P33; Tu F, 2000, INT INF LIBR REV, V32, P325, DOI 10.1006/iilr.2000.0135; Turp J C, 2001, Z Arztl Fortbild Qualitatssich, V95, P539; *U WIEN I ERN, 1998, OST ERN; *US DEP HHS, 2000, PUBL US DEP HLTH HUM; Veronin MA, 2000, AM J HEALTH PROMOT, V15, P21, DOI 10.4278/0890-1171-15.1.21; Voiglio EJ, 1999, SURG RADIOL ANAT, V21, P65, DOI 10.1007/BF01635056; VONDANWITZ F, 1999, VERBREITUNG GESTALTU; WILLEMS M, 2001, MED CONTACT, V56, P673; WILLEMS M, 2001, PHARM WEEKBLAD, V136, P607; Wilson F L, 2000, Oncol Nurs Forum, V27, P1403; Winker MA, 2000, JAMA-J AM MED ASSOC, V283, P1600, DOI 10.1001/jama.283.12.1600; Wright B, 1999, IRISH J PSYCHOL MED, V16, P67, DOI 10.1017/S0790966700005218; Wyatt JC, 1997, BRIT MED J, V314, P1879, DOI 10.1136/bmj.314.7098.1879; 1999, CNN             0729	121	1115	1139	11	273	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2691	2700		10.1001/jama.287.20.2691	http://dx.doi.org/10.1001/jama.287.20.2691			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554JQ	12020305	Green Accepted			2022-12-28	WOS:000175732400029
J	Ahlquist, P				Ahlquist, P			RNA-dependent RNA polymerases, viruses, and RNA silencing	SCIENCE			English	Review							CRYSTAL-STRUCTURE; GENE-EXPRESSION; INTERFERENCE; PROTEIN; PLANTS; REPLICATION; TRANSGENE; REQUIREMENTS; PURIFICATION; SUPPRESSION	Most viruses have RNA genomes that are replicated and transcribed into messenger RNA by viral RNA-dependent RNA polymerases (RdRps), usually in concert with other viral and host factors. Many, if not most, eukaryotes also encode putative RdRps that have been implicated in sequence-specific, RNA-triggered gene silencing. Although the viral and cellular RdRps have no sequence homology, they share functional similarities such as copying messenger RNA templates and intercellular spread of the amplified sequences. Better understanding of viral and host RdRps will improve our ability to control viruses and to use RNA silencing and viruses as tools for research, biotechnology, and medicine.	Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ahlquist, P (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	ahlquist@facstaff.wisc.edu			NIGMS NIH HHS [GM35072] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035072, R01GM035072] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bernstein E, 2001, RNA, V7, P1509; Bitko V, 2001, BMC Microbiol, V1, P34, DOI 10.1186/1471-2180-1-34; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Carrington JC, 2001, VIROLOGY, V281, P1, DOI 10.1006/viro.2000.0812; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Diez J, 2000, P NATL ACAD SCI USA, V97, P3913, DOI 10.1073/pnas.080072997; DORSSERS L, 1982, VIROLOGY, V116, P236, DOI 10.1016/0042-6822(82)90416-0; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gamarnik AV, 1998, GENE DEV, V12, P2293, DOI 10.1101/gad.12.15.2293; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; Keck JL, 2000, SCIENCE, V287, P2482, DOI 10.1126/science.287.5462.2482; Klumpp K, 1997, EMBO J, V16, P1248, DOI 10.1093/emboj/16.6.1248; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Macnaughton TB, 2002, J VIROL, V76, P3920, DOI 10.1128/JVI.76.8.3920-3927.2002; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Moraleda G, 2001, J VIROL, V75, P10161, DOI 10.1128/JVI.75.21.10161-10169.2001; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Ng KKS, 2002, J BIOL CHEM, V277, P1381, DOI 10.1074/jbc.M109261200; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; O'Reilly EK, 1998, VIROLOGY, V252, P287, DOI 10.1006/viro.1998.9463; Ogawa T, 1996, NAT BIOTECHNOL, V14, P1566, DOI 10.1038/nbt1196-1566; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Poranen MM, 2001, MOL CELL, V7, P845, DOI 10.1016/S1097-2765(01)00228-3; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Ruvkun G, 2001, SCIENCE, V294, P797, DOI 10.1126/science.1066315; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Sharp PA, 2001, GENE DEV, V15, P485, DOI 10.1101/gad.880001; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; TAKANAMI Y, 1982, BIOCHEMISTRY-US, V21, P3161, DOI 10.1021/bi00256a020; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998	52	320	365	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1270	1273		10.1126/science.1069132	http://dx.doi.org/10.1126/science.1069132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016304				2022-12-28	WOS:000175713000041
J	Yu, N; Kruskall, MS; Yunis, JJ; Knoll, JHM; Uhl, L; Alosco, S; Ohashi, M; Clavijo, O; Husain, Z; Yunis, EJ; Yunis, JJ; Yunis, EJ				Yu, N; Kruskall, MS; Yunis, JJ; Knoll, JHM; Uhl, L; Alosco, S; Ohashi, M; Clavijo, O; Husain, Z; Yunis, EJ; Yunis, JJ; Yunis, EJ			Disputed maternity leading to identification of tetragametic chimerism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEQUENCE-SPECIFIC PRIMERS; TANDEM REPEAT LOCI; TRUE HERMAPHRODITE; CAUCASIAN-MESTIZOS; HUMAN CHROMOSOMES; POPULATION-DATA; HLA-B; FERTILIZATION; 46,XX/46,XY; COLOMBIA		Beth Israel Deaconess Med Ctr, Div Lab & Transfus Med, Boston, MA 02215 USA; Amer Red Cross, Blood Serv, New England Reg, Dedham, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Serv Medicos Yunis Turbay, Bogota, Colombia; Univ Nacl Colombia, Fac Med & Inst Genet, Dept Patol, Bogota, Colombia; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; American Red Cross; Harvard University; Harvard Medical School; Universidad Nacional de Colombia; Harvard University; Dana-Farber Cancer Institute	Kruskall, MS (corresponding author), Beth Israel Deaconess Med Ctr, Div Lab & Transfus Med, Yamins 309,330 Brookline Ave, Boston, MA 02215 USA.	mkruskal@caregroup.harvard.edu		Knoll, Joan/0000-0001-6691-1710; Yunis, Juan J./0000-0001-7688-9094	NHLBI NIH HHS [HL-29583, HL-59838] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029583, R01HL059838] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBRIGHT LM, 1994, CURRENT PROTOCOLS HU, V1; Alexander SI, 1998, TRANSPLANTATION, V65, P318; ARMSTRONG JP, 1994, FOREST PROD J, V44, P54; BAR W, 1995, VOX SANG, V69, P70; BENRAFAEL Z, 1987, FERTIL STERIL, V47, P707; BORDENAVE GR, 1984, MOL IMMUNOL, V21, P353, DOI 10.1016/0161-5890(84)90031-2; BROMILOW IM, 1989, VOX SANG, V57, P147, DOI 10.1111/j.1423-0410.1989.tb01153.x; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Cao K, 1999, Rev Immunogenet, V1, P177; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FIRESTONE WM, 1990, J INVEST DERMATOL, V94, P657, DOI 10.1111/1523-1747.ep12876228; GREEN AJ, 1994, J MED GENET, V31, P816, DOI 10.1136/jmg.31.10.816; KNOLL JHM, 1994, CURRENT PROTOCOLS HU, V1; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Kruskall MS, 2001, BLOOD, V98, P272, DOI 10.1182/blood.V98.2.272; MAYR WR, 1981, REV FR TRANSFUS IMMU, V24, P19, DOI 10.1016/S0338-4535(81)80024-4; MAYR WR, 1979, LANCET, V277, P210; MINTZ B, 1969, J EXP MED, V129, P1013, DOI 10.1084/jem.129.5.1013; Repas-Humpe LM, 1999, ANN HEMATOL, V78, P431, DOI 10.1007/s002770050543; SADLER AM, 1994, TISSUE ANTIGENS, V44, P148, DOI 10.1111/j.1399-0039.1994.tb02372.x; SCHOENLE E, 1983, HUM GENET, V64, P86, DOI 10.1007/BF00289485; SEABRIGH.M, 1971, LANCET, V2, P971; Starzl TE, 1998, THEOR MED BIOETH, V19, P441, DOI 10.1023/A:1009924907775; Strain L, 1998, NEW ENGL J MED, V338, P166, DOI 10.1056/NEJM199801153380305; STRAIN L, 1995, NAT GENET, V11, P164, DOI 10.1038/ng1095-164; Sumantri C, 1997, ANIM REPROD SCI, V46, P35, DOI 10.1016/S0378-4320(96)01619-3; SYBERT VP, 1994, J INVEST DERMATOL, V103, pS141; THOMPSON JD, 1992, BLOOD, V79, P1629; TIPPETT P, 1983, VOX SANG, V44, P333, DOI 10.1111/j.1423-0410.1983.tb03657.x; TUCKER EM, 1978, J REPROD FERTIL, V54, P77, DOI 10.1530/jrf.0.0540077; UEHARA S, 1995, FERTIL STERIL, V63, P189, DOI 10.1016/S0015-0282(16)57317-8; VENGELENTYLER V, 1999, TECHNICAL MANUAL; VERP MS, 1992, FERTIL STERIL, V57, P346; WATKINS WM, 1981, J IMMUNOGENET, V8, P113; Yu N, 1998, TISSUE ANTIGENS, V52, P302; Yu N, 1997, TISSUE ANTIGENS, V50, P380, DOI 10.1111/j.1399-0039.1997.tb02891.x; Yunis JJ, 2001, FORENSIC SCI INT, V115, P117, DOI 10.1016/S0379-0738(00)00316-9; Yunis JJ, 2000, INT J LEGAL MED, V113, P175, DOI 10.1007/s004140050293; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746; Yunis JJ, 2000, J FORENSIC SCI, V45, P429; ZEILMAKER GH, 1983, FERTIL STERIL, V40, P841	41	85	90	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1545	1552		10.1056/NEJMoa013452	http://dx.doi.org/10.1056/NEJMoa013452			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015394				2022-12-28	WOS:000175563900006
J	Wilde, GJS				Wilde, GJS			For and against - Does risk homoeostasis theory have implications for road safety	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Wilde, GJS (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.								0	44	44	1	23	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1149	1149		10.1136/bmj.324.7346.1149	http://dx.doi.org/10.1136/bmj.324.7346.1149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	552LX	12003891				2022-12-28	WOS:000175622800029
J	Cravens, TE				Cravens, TE			Planetary science - X-ray emission from comets	SCIENCE			English	Review							SOLAR-WIND; CHARGE-TRANSFER; ELECTRON-CAPTURE; TEMPORAL VARIATIONS; CROSS-SECTIONS; COLLISIONS; EXCHANGE; IONIZATION; SEARCH; IMPACT	The discovery of x-ray emission from comet Hyakutake was surprising given that comets are known to be cold. observations by x-ray satellites such as the Rontgen Satellite (ROSAT) indicate that x-rays are produced by almost all comets. Theoretical and observational work has demonstrated that charge-exchange collisions of highly charged solar wind ions with cometary neutral species can explain this emission. X-ray observations of comets and other solar system objects may be used to determine the structure and dynamics of the solar wind.	Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA	University of Kansas	Cravens, TE (corresponding author), Univ Kansas, Dept Phys & Astron, Malott Hall, Lawrence, KS 66045 USA.	cravens@ukans.edu						BAME SJ, 1972, NASA308 SPEC PUBL, P535; Beiersdorfer P, 2000, PHYS REV LETT, V85, P5090, DOI 10.1103/PhysRevLett.85.5090; Beiersdorfer P, 2001, ASTROPHYS J, V549, pL147, DOI 10.1086/319143; Bingham R, 1997, SCIENCE, V275, P49, DOI 10.1126/science.275.5296.49; BRANDT JC, 1982, COMETS, P519; Breitschwerdt D., 1998, LECT NOTE PHYS, V506, P121; CHUTJIAN A, IN PRESS; CIOFFI DF, 1990, NATO ADV SCI I C-MAT, V305, P1; CRAVENS TE, 1991, ASTROPHYS SPACE SC L, V167, P1211; Cravens TE, 1997, GEOPHYS RES LETT, V24, P105, DOI 10.1029/96GL03780; Cravens TE, 2000, ASTROPHYS J, V532, pL153, DOI 10.1086/312574; CRAVENS TE, 1987, J GEOPHYS RES, V92, P7341, DOI 10.1029/JA092iA07p07341; Cravens TE, 2001, J GEOPHYS RES-SPACE, V106, P24883, DOI 10.1029/2000JA000461; Cravens TE, 2001, GEOPHYS RES LETT, V28, P3043, DOI 10.1029/2001GL013021; Cravens TE, 2000, ADV SPACE RES-SERIES, V26, P1443, DOI 10.1016/S0273-1177(00)00100-9; CRAVENS TE, 1997, PHYSICS SOLAR SYSTEM; Dawson JM, 1997, PLASMA PHYS CONTR F, V39, P185, DOI 10.1088/0741-3335/39/5A/019; DELSEMME AH, 1991, ASTROPHYS SPACE SC L, V167, P377; Dennerl K, 1997, SCIENCE, V277, P1625, DOI 10.1126/science.277.5332.1625; Dennerl K, 1999, AIP CONF PROC, V477, P361; DIJKKAMP D, 1985, J PHYS B-AT MOL OPT, V18, P737, DOI 10.1088/0022-3700/18/4/018; FLAMMER KR, 1991, ASTROPHYS SPACE SC L, V167, P1125; FOUKAL PV, 1990, SOLAR ASTROPHYSICS; Freyberg M. J., 1998, Local Bubble and Beyond. Lyman-Spitzer-Colloquium. Proceedings of the IAU Colloquium No.166, P113; GALEEV AA, 1991, ASTROPHYS SPACE SC L, V167, P1145; GILBODY HB, 1986, ADV ATOM MOL PHYS, V22, P143, DOI 10.1016/S0065-2199(08)60336-X; GOMBOSI TI, 1991, ASTROPHYS SPACE SC L, V167, P991; Greenwood JB, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.062707; Greenwood JB, 2000, ASTROPHYS J, V533, pL175, DOI 10.1086/312615; Haberli RM, 1997, SCIENCE, V276, P939, DOI 10.1126/science.276.5314.939; Hasan AA, 2001, ASTROPHYS J, V560, pL201, DOI 10.1086/324058; Holmstrom M, 2001, GEOPHYS RES LETT, V28, P1287, DOI 10.1029/2000GL012381; HUDSON HS, 1981, PLANET SPACE SCI, V29, P1373, DOI 10.1016/0032-0633(81)90104-5; HUNDHAUSEN AJ, 1968, J GEOPHYS RES, V73, P5485, DOI 10.1029/JA073i017p05485; Ip WH, 1997, ICARUS, V130, P217, DOI 10.1006/icar.1997.5805; Kharchenko V, 2001, ASTROPHYS J, V554, pL99, DOI 10.1086/320929; Kharchenko V, 2000, J GEOPHYS RES-SPACE, V105, P18351, DOI 10.1029/1999JA000203; KRANKOWSKY D, 1986, NATURE, V321, P326, DOI 10.1038/321326a0; Krasnopolsky V, 1997, ICARUS, V128, P368, DOI 10.1006/icar.1997.5722; Krasnopolsky V, 2000, ICARUS, V148, P597, DOI 10.1006/icar.2000.6534; KRASNOPOLSKY V, IN PRESS; Krasnopolsky VA, 1997, SCIENCE, V277, P1488, DOI 10.1126/science.277.5331.1488; Krasnopolsky VA, 2001, ASTROPHYS J, V549, P629, DOI 10.1086/319064; Krasnopolsky VA, 2000, ICARUS, V146, P152, DOI 10.1006/icar.2000.6387; Lisse CM, 1997, EARTH MOON PLANETS, V77, P283, DOI 10.1023/A:1006274812124; Lisse CM, 1999, ICARUS, V141, P316, DOI 10.1006/icar.1999.6176; Lisse CM, 1996, SCIENCE, V274, P205, DOI 10.1126/science.274.5285.205; Lisse CM, 2001, SCIENCE, V292, P1343, DOI 10.1126/science.292.5520.1343; MANN R, 1981, J PHYS B-AT MOL OPT, V14, P1161, DOI 10.1088/0022-3700/14/7/012; MCCAMMON D, 1990, ANNU REV ASTRON ASTR, V28, P657; Mumma MJ, 1997, ASTROPHYS J, V491, pL125, DOI 10.1086/311071; Neugebauer M, 2000, J GEOPHYS RES-SPACE, V105, P20949, DOI 10.1029/1999JA000299; NEWBURN RL, 1991, COMETS POST HALLEY E; Northrop TG, 1997, ICARUS, V127, P246, DOI 10.1006/icar.1997.5694; Northrop TG, 1997, ICARUS, V128, P480, DOI 10.1006/icar.1997.5762; Owens A, 1998, ASTROPHYS J, V493, pL47, DOI 10.1086/311119; Parker E.N., 1963, ASTROPHYS J SUPPL S, DOI DOI 10.1086/190087; PHANEUF RA, 1982, PHYS REV A, V26, P1892, DOI 10.1103/PhysRevA.26.1892; Robertson IP, 2001, SPACE SCI REV, V97, P401, DOI 10.1023/A:1011822327202; RYUFUKU H, 1980, PHYS REV A, V21, P745, DOI 10.1103/PhysRevA.21.745; Schwadron NA, 2000, ASTROPHYS J, V544, P558, DOI 10.1086/317176; SEKANINA Z, 1991, ASTROPHYS SPACE SC L, V167, P769; Shapiro VD, 1999, J GEOPHYS RES-SPACE, V104, P2537, DOI 10.1029/1998JA900047; SUESS ST, 1990, REV GEOPHYS, V28, P97, DOI 10.1029/RG028i001p00097; Uchida M, 1998, ASTROPHYS J, V498, P863, DOI 10.1086/305566; Wargelin BJ, 2001, ASTROPHYS J, V546, pL57, DOI 10.1086/318066; Wegmann R, 1998, PLANET SPACE SCI, V46, P603, DOI 10.1016/S0032-0633(97)00196-7; WHIPPLE FL, 1950, ASTROPHYS J, V111, P375, DOI 10.1086/145272; Wickramasinghe NC, 1996, ASTROPHYS SPACE SCI, V239, P121, DOI 10.1007/BF00653772	69	188	188	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1042	1045		10.1126/science.1070001	http://dx.doi.org/10.1126/science.1070001			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004110				2022-12-28	WOS:000175565000032
J	Horton, R				Horton, R			Postpublication criticism and the shaping of clinical knowledge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				RANDOMIZED TRIAL; HYPERTENSION; MANAGEMENT; MORBIDITY; MORTALITY; INTERNET	Context Letters to the editor are an important means for ensuring accountability of authors and editors. They form a part of the postpublication peer review process. I studied the critical footprint made in the medical literature by 3 randomized trials (Hypertension Optimal Treatment [HOT], Captopril Prevention Project [CAPPP], and Swedish Trial in Old Patients with Hypertension 2 [STOP-2]) published in The Lancet and investigated the extent to which that footprint was preserved in shaping clinical knowledge. Methods Qualitative appraisal of the criticism of each trial, taken from published letters. Agreed weaknesses and unanswered criticisms were identified from the authors' reply, I searched MEDLINE for practice guidelines published after the trial report and sought evidence for incorporation of criticism into these guidelines. Results From the time of publication to October 2000, HOT was cited in 9 of 36 practice guidelines; CAPPP, in 6 of 36; and STOP-2, not at all. HOT received 14 published criticisms, 5 comments, and 3 questions, of which 15 were responded to. only I criticism, lack of power, was referred to in 1 guideline. CAPPP received 14 criticisms, 9 comments, and 3 questions, of which 8 were responded to. Only 1 criticism, imbalances between groups, was referred to in 1 guideline. STOP-2 received 12 criticisms, 9 comments, and 3 questions, of which only 6 were responded to. Conclusions More than half of all criticism made in correspondence went unanswered by authors. important weaknesses in trials were ignored in subsequently published practice guidelines. Failure to recognize the critical footprint of primary research weakens the validity of guidelines and distorts clinical knowledge.	Lancet, London NW1 7BY, England		Horton, R (corresponding author), Lancet, 32 Jamestown Rd, London NW1 7BY, England.	richard.horton@lancet.com						BHOPAL RS, 1994, BRIT MED J, V308, P1582, DOI 10.1136/bmj.308.6944.1582; Bingham C, 1998, LANCET, V351, P10; Bingham CM, 1998, LANCET, V352, P441, DOI 10.1016/S0140-6736(97)11510-0; Brown CJ, 1997, CAN MED ASSOC J, V157, P792; CASWELL A, 1992, MED J AUSTRALIA, V157, P63; Chalmers J, 1999, CLIN EXP HYPERTENS, V21, P1009; Edwards R, 2001, MED EDUC, V35, P691, DOI 10.1046/j.1365-2923.2001.00972.x; Fuchs FD, 2000, LANCET, V355, P651, DOI 10.1016/S0140-6736(00)00027-1; Goodman NW, 2001, HOSP MED, V62, P426, DOI 10.12968/hosp.2001.62.7.2396; Grant JM, 1999, LANCET, V353, P1190, DOI 10.1016/S0140-6736(05)74417-2; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1293; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; *INT COMM MED J ED, 2002, UN REQ MAN SUBM BIOM; McConnell J, 1999, LANCET, V354, P2, DOI 10.1016/S0140-6736(99)00226-3; Mill J.S., 1806, GBWW, V40, P274; Popper, 1983, REALISM AIM SCI POST; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Rothwell PM, 2000, BRAIN, V123, P1964, DOI 10.1093/brain/123.9.1964; Scheen AJ, 1999, LANCET, V353, P1793, DOI 10.1016/S0140-6736(99)00091-4; Simon A, 1998, LANCET, V352, P571, DOI 10.1016/S0140-6736(98)26033-8; Smith R, 2001, BRIT MED J, V322, P627, DOI 10.1136/bmj.322.7287.627; Winker MA, 1999, JAMA-J AM MED ASSOC, V281, P1543, DOI 10.1001/jama.281.16.1543	25	49	51	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2843	2847		10.1001/jama.287.21.2843	http://dx.doi.org/10.1001/jama.287.21.2843			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038929	Bronze			2022-12-28	WOS:000176002200026
J	Berger, A				Berger, A			Science commentary: Why is it important to reduce the need for blood transfusion, and how can it be done?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; PARKER MJ, 2001, COCHRANE DATABASE SY, V4; Tang RP, 2001, ANN SURG, V234, P181, DOI 10.1097/00000658-200108000-00007; Wiliamson L, 2000, VOX SANG, V78, P291	4	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1302	1303		10.1136/bmj.324.7349.1302	http://dx.doi.org/10.1136/bmj.324.7349.1302			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039821	Green Published, Bronze			2022-12-28	WOS:000176041500014
J	Marks, D; Wonderling, D; Thorogood, M; Lambert, H; Humphries, SE; Neil, HAW				Marks, D; Wonderling, D; Thorogood, M; Lambert, H; Humphries, SE; Neil, HAW			Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; HEART-DISEASE; PRIMARY-CARE; PRAVASTATIN	Objectives To assess the cost effectiveness of strategies to screen for and treat familial hypercholesterolaemia. Design Cost effectiveness analysis. A care pathway for each patient was delineated and the associated probabilities, benefits, and costs were calculated. Participants Simulated population aged 16-54 years in England and Wales. Interventions Identification and treatment of patients with familial hypercholesterolaemia by universal screening, opportunistic screening in primary care, screening of people admitted to hospital with premature myocardial infarction, or tracing family members of affected patients. Main outcome measure Cost effectiveness calculated as cost per life year gained (extension of life expectancy resulting from intervention) including estimated costs of screening and treatment. Results Tracing of family members was die most cost effective strategy (pound3097 ((sic)5066, $4479) per life year gained) as 2.6 individuals need to be screened to identify one case at a cost of pound133 per case detected. If the genetic mutation was known within the family their the cost per life year gained (pound4914) was only slightly increased by genetic confirmation of tire diagnosis. Universal population screening was least cost effective (pound13029 pet, life year gained) as 1365 individuals need to be screened at a cost of pound9754 per case detected. For each strategy it was more cost effective to screen younger people and women. Targeted strategies were more expensive per person screened, but the cost per case detected was lower. Population screening of 16 year olds only was as cost effective as family tracing (pound2777 with a clinical confirmation). Conclusions Screening family members of people with familial hypercholesterolaemia is the most cost effective option for detecting cases across the whole Population.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; UCL, Sch Med, Ctr Cardiovasc Genet, London WC1E 6JF, England; Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX2 6HE, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol; University of London; University College London; UCL Medical School; Radcliffe Infirmary; University of Oxford	Thorogood, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	Margaret.Thorogood@lshtm.ac.uk	Humphries, Stephen E/C-5075-2008	Humphries, Stephen E/0000-0002-8221-6547; Marks, Dalya/0000-0003-2475-3122; Wonderling, David/0000-0003-0315-6273				[Anonymous], 1991, BMJ, V303, P893; Becker DM, 1998, ARCH INTERN MED, V158, P1533, DOI 10.1001/archinte.158.14.1533; Bhatnagar D, 2000, BRIT MED J, V321, P1497, DOI 10.1136/bmj.321.7275.1497; *DEP HLTH, 1998, HLTH SURV ENGL 1996; GOLDMAN L, 1993, AM J CARDIOL, V72, pD75, DOI 10.1016/0002-9149(93)90015-5; Goldstein JL, 1995, METABOLIC BASIS INHE, P1215; Heath KE, 1999, ATHEROSCLEROSIS, V143, P41, DOI 10.1016/S0021-9150(98)00274-3; *HM TREAS, 1997, APPR EV CENTR GOV GR; *HM TREAS, 1997, APPR EV CENTR GOVT G; Humphries SE, 1997, QJM-INT J MED, V90, P169, DOI 10.1093/qjmed/90.3.169; Langham S, 1996, BRIT MED J, V312, P1265, DOI 10.1136/bmj.312.7041.1265; *LONG TERM INT PRA, 1998, LANCET, V339, P1349; Marks D, 2000, HEALTH TECHNOL ASSES, V4, P1, DOI [10.3310/hta4290, DOI 10.3310/HTA4290]; NEIL HAW, 1995, BMJ-BRIT MED J, V310, P569, DOI 10.1136/bmj.310.6979.569; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; NEIL HAW, 1996, PREVENTION CARDIOVAS; Netten A, 1998, UNIT COSTS HLTH SOCI; PATTERSON D, 1972, LANCET, V1, P393; PEDERSEN TR, 1994, LANCET, V344, P1383; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; SLACK J, 1969, LANCET, V2, P1380; STEVENS W, 1999, COST CIID N THAMES R; STEVENS W, 1999, COST CHD N THAMES RE; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; THOMPSON GR, 1995, LANCET, V345, P811, DOI 10.1016/S0140-6736(95)92961-4; Umans-Eckenhausen MAW, 2001, LANCET, V357, P165, DOI 10.1016/S0140-6736(00)03587-X; *WHO HUM GEN PROGR, 1997, FAM HYP REP WHO CONS; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6; WILSON J, 1968, WHO34 PUBL HLTH; Wilson JMB, 1968, 34 WHO; 1998, LANCET, V339, P1349	34	166	166	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1303	1306		10.1136/bmj.324.7349.1303	http://dx.doi.org/10.1136/bmj.324.7349.1303			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039822	Green Submitted, Bronze, Green Accepted, Green Published			2022-12-28	WOS:000176041500015
J	Kern, B; Martin, C				Kern, B; Martin, C			Optical pulsations from the anomalous X-ray pulsar 4U0142+61	NATURE			English	Article							NEUTRON-STARS; WHITE-DWARF; MAGNETIC-FIELD; COUNTERPART; 4U-0142+61; B0540-69; NEBULA	Anomalous X-ray pulsars(1) (AXPs) differ from ordinary radio pulsars in that their X-ray luminosity is orders of magnitude greater than their rate of rotational energy loss, and so they require an additional energy source. One possibility is that AXPs are highly magnetized neuron stars(2)-or 'magnetars'-having surface magnetic fields greater than 10(14) G. This would make them similar to the soft gamma-ray repeaters (SGRs)(3), but alternative models that do not require extreme magnetic fields also exist. An optical counterpart to the AXP 4U0142+61 was recently discovered(4), consistent with emission from a magnetar, but also from a magnetized hot white dwarf(5), or an accreting isolated(6) neutron star(7). Here we report the detection of optical pulsations from 4U0142+61. The pulsed fraction of optical light (27 per cent) is five to ten times greater than that of soft X-rays, from which we conclude that 4U0142+61 is a magnetar. Although this establishes a direct relationship between AXPs and the soft gamma-ray repeaters, the evolutionary connection between AXPs, SGRs and radio pulsars remains controversial.	CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA	California Institute of Technology	Kern, B (corresponding author), CALTECH, Div Phys Math & Astron, MS 405-47, Pasadena, CA 91125 USA.							ACHILLEOS N, 1992, ASTROPHYS J, V396, P273, DOI 10.1086/171715; Baring MG, 2001, ASTROPHYS J, V547, P929, DOI 10.1086/318390; BARSTOW MA, 1995, MON NOT R ASTRON SOC, V277, P971, DOI 10.1093/mnras/277.3.971; BOYD PT, 1995, ASTROPHYS J, V448, P365, DOI 10.1086/175967; CHESTER TJ, 1979, ASTROPHYS J, V227, P569, DOI 10.1086/156767; Coe MJ, 1998, MON NOT R ASTRON SOC, V299, P223, DOI 10.1046/j.1365-8711.1998.01764.x; DUNCAN RC, 1992, ASTROPHYS J, V392, pL9, DOI 10.1086/186413; Ferrario L, 1997, MON NOT R ASTRON SOC, V292, P205, DOI 10.1093/mnras/292.2.205; Gavriil FP, 2002, ASTROPHYS J, V567, P1067, DOI 10.1086/338698; Gotthelf EV, 2000, ASTROPHYS J, V532, pL117, DOI 10.1086/312568; HEISE J, 1994, ASTRON ASTROPHYS, V288, P45; Helfand DJ, 2001, ASTROPHYS J, V556, P380, DOI 10.1086/321533; Hulleman F, 2000, ASTRON ASTROPHYS, V358, P605; Hulleman F, 2000, NATURE, V408, P689, DOI 10.1038/35047024; Kouveliotou C, 1998, NATURE, V393, P235, DOI 10.1038/30410; MANCHESTER RN, 1980, MON NOT R ASTRON SOC, V190, pP9, DOI 10.1093/mnras/190.1.9P; Marsden D, 2001, ASTROPHYS J, V550, P397, DOI 10.1086/319701; MEREGHETTI S, 1999, NEUTRON STAR BLACK H, P351; PACZYNSKI B, 1990, ASTROPHYS J, V365, pL9, DOI 10.1086/185876; PECHENICK KR, 1983, ASTROPHYS J, V274, P846, DOI 10.1086/161498; PEDERSEN H, 1982, ASTROPHYS J, V263, P325, DOI 10.1086/160507; Perna R, 2000, ASTROPHYS J, V544, pL57, DOI 10.1086/317300; PIIROLA V, 1992, ASTRON ASTROPHYS, V259, P143; RAUCH T, 1996, SUPERSOFT XRAY SOURC, P139; REID CA, 1980, ASTRON J, V85, P1062, DOI 10.1086/112768; Romani RW, 2001, ASTROPHYS J, V563, P221, DOI 10.1086/323874; Shaviv NJ, 1999, MON NOT R ASTRON SOC, V306, P333, DOI 10.1046/j.1365-8711.1999.02509.x; Tennant AF, 2001, ASTROPHYS J, V554, pL173, DOI 10.1086/321718; White NE, 1996, ASTROPHYS J, V463, pL83, DOI 10.1086/310065; Wilson CA, 1999, ASTROPHYS J, V513, P464, DOI 10.1086/306839	30	89	90	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					527	529		10.1038/417527a	http://dx.doi.org/10.1038/417527a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037561				2022-12-28	WOS:000175860300035
J	Thomas, JA; Knapp, JJ; Akino, T; Gerty, S; Wakamura, S; Simcox, DJ; Wardlaw, JC; Elmes, GW				Thomas, JA; Knapp, JJ; Akino, T; Gerty, S; Wakamura, S; Simcox, DJ; Wardlaw, JC; Elmes, GW			Insect communication: Parasitoid secretions provoke ant warfare - Subterfuge used by a rare wasp may be the key to an alternative type of pest control.	NATURE			English	Article							BUTTERFLY MACULINEA-REBELI; CHEMICAL MIMICRY; HOST-SPECIFICITY; SOCIAL PARASITE		Winfrith Technol Ctr, NERC, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan	UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Southampton; National Institute of Agrobiological Sciences - Japan	Thomas, JA (corresponding author), Winfrith Technol Ctr, NERC, Ctr Ecol & Hydrol, Dorchester DT2 8ZD, Dorset, England.	jat@ceh.ac.uk	Thomas, Jeremy/A-9619-2013					Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; BILLEN I, 1998, PHEROMONE COMMUNICAT, P3; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Elmes GW, 1999, P ROY SOC B-BIOL SCI, V266, P447, DOI 10.1098/rspb.1999.0658; GODFRAY HCJ, 1994, PARASITOIDS; Holldobler B., 1990, pi; Klotz JH, 1997, J AGR ENTOMOL, V14, P249; Lawton JH, 2001, ECOL ENTOMOL, V26, P225, DOI 10.1046/j.1365-2311.2001.00351.x; Sledge MF, 2000, J INSECT PHYSIOL, V46, P753, DOI 10.1016/S0022-1910(99)00164-X; THOMAS JA, 1993, ANIM BEHAV, V45, P593, DOI 10.1006/anbe.1993.1069; WILSON EO, 1963, RECENT PROG HORM RES, V19, P673	11	38	41	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					505	506		10.1038/417505a	http://dx.doi.org/10.1038/417505a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037556				2022-12-28	WOS:000175860300030
J	Hubbert, C; Guardiola, A; Shao, R; Kawaguchi, Y; Ito, A; Nixon, A; Yoshida, M; Wang, XF; Yao, TP				Hubbert, C; Guardiola, A; Shao, R; Kawaguchi, Y; Ito, A; Nixon, A; Yoshida, M; Wang, XF; Yao, TP			HDAC6 is a microtubule-associated deacetylase	NATURE			English	Article							HISTONE-DEACETYLASE; ALPHA-TUBULIN; ACETYLATION; MUSCLE; CELLS; PROTEINS; DYNAMICS; GROWTH	Reversible acetylation of alpha-tubulin has been implicated in regulating microtubule stability and function(1). The distribution of acetylated alpha-tubulin is tightly controlled and stereotypic. Acetylated alpha-tubulin is most abundant in stable microtubules but is absent from dynamic cellular structures such as neuronal growth cones and the leading edges of fibroblasts(1,2). However, the enzymes responsible for regulating tubulin acetylation and deacetylation are not known. Here we report that a member of the histone deacetylase family, HDAC6, functions as a tubulin deacetylase. HDAC6 is localized exclusively in the cytoplasm, where it associates with microtubules and localizes with the microtubule motor complex containing p150(glued) (ref. 3). In vivo, the overexpression of HDAC6 leads to a global deacetylation of alpha-tubulin, whereas a decrease in HDAC6 increases alpha-tubulin acetylation. In vitro, purified HDAC6 potently deacetylates alpha-tubulin in assembled microtubules. Furthermore, overexpression of HDAC6 promotes chemotactic cell movement, supporting the idea that HDAC6-mediated deacetylation regulates microtubule-dependent cell motility. Our results show that HDAC6 is the tubulin deacetylase, and provide evidence that reversible acetylation regulates important biological processes beyond histone metabolism and gene transcription.	Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Japan Sci & Technol Corp, CREST Res Project, Saitama 3320012, Japan	Duke University; University of Tokyo; Japan Science & Technology Agency (JST)	Yao, TP (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.		Ito, Akihiro/A-6100-2015; Yoshida, Minoru/C-8049-2014; Nixon, Andrew/AAJ-4712-2020	Yoshida, Minoru/0000-0002-4376-5674; Nixon, Andrew/0000-0003-3971-2964				Barlow AL, 2001, EXP CELL RES, V265, P90, DOI 10.1006/excr.2001.5162; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; Furumai R, 2001, P NATL ACAD SCI USA, V98, P87, DOI 10.1073/pnas.011405598; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Guardiola AR, 2002, J BIOL CHEM, V277, P3350, DOI 10.1074/jbc.M109861200; Hicke L, 2001, CELL, V106, P527, DOI 10.1016/S0092-8674(01)00485-8; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Malinda KM, 1999, EXP CELL RES, V250, P168, DOI 10.1006/excr.1999.4511; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; ROBSON SJ, 1989, CELL MOTIL CYTOSKEL, V12, P273, DOI 10.1002/cm.970120408; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Verdel A, 2000, CURR BIOL, V10, P747, DOI 10.1016/S0960-9822(00)00542-X; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Wadsworth P, 1999, CELL MOTIL CYTOSKEL, V42, P48, DOI 10.1002/(SICI)1097-0169(1999)42:1<48::AID-CM5>3.3.CO;2-#; Waterman-Storer CM, 1999, CURR OPIN CELL BIOL, V11, P61, DOI 10.1016/S0955-0674(99)80008-8	21	1702	1773	4	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 23	2002	417	6887					455	458		10.1038/417455a	http://dx.doi.org/10.1038/417455a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024216				2022-12-28	WOS:000175730900042
J	Nowak, AP; Breedveld, V; Pakstis, L; Ozbas, B; Pine, DJ; Pochan, D; Deming, TJ				Nowak, AP; Breedveld, V; Pakstis, L; Ozbas, B; Pine, DJ; Pochan, D; Deming, TJ			Rapidly recovering hydrogel scaffolds from self-assembling diblock copolypeptide amphiphiles	NATURE			English	Article							BLOCK; MICELLES	Protein-based hydrogels are used for many applications, ranging from food and cosmetic thickeners to support matrices for drug delivery and tissue replacement(1-3). These materials are usually prepared using proteins extracted from natural sources, which can give rise to inconsistent properties unsuitable for medical applications(4). Recent developments have utilized recombinant DNA methods to prepare artificial protein hydrogels with specific association mechanisms and responsiveness to various stimuli(5,6). Here we synthesize diblock copolypeptide amphiphiles containing charged and hydrophobic segments. Dilute solutions of these copolypeptides would be expected to form micelles; instead, they form hydrogels that retain their mechanical strength up to temperatures of about 90 degreesC and recover rapidly after stress. The use of synthetic materials permits adjustment of copolymer chain length and composition, which we varied to study their effect on hydrogel formation and properties. We find that gelation depends not only on the amphiphilic nature of the polypeptides, but also on chain conformations-alpha-helix, beta-strand or random coil. Indeed, shape-specific supramolecular assembly is integral to the gelation process, and provides a new class of peptide-based hydrogels with potential for applications in biotechnology.	Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Delaware, Dept Mat Sci & Engn, Newark, DE 19716 USA; Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Delaware; University of Delaware	Deming, TJ (corresponding author), Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA.	tdeming@mrl.ucsb.edu	Deming, Timothy/I-5411-2013; Pine, David J/B-7740-2016; Breedveld, Victor/AAJ-5123-2020; Breedveld, Victor/A-6822-2009	Pine, David J/0000-0002-3304-6684; Deming, Timothy/0000-0002-0594-5025				Adler A J, 1973, Methods Enzymol, V27, P675; Buitenhuis J, 1997, J CHEM PHYS, V107, P262, DOI 10.1063/1.474346; Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038; CLARK AH, 1987, ADV POLYM SCI, V83, P57; Crocker JC, 2000, PHYS REV LETT, V85, P888, DOI 10.1103/PhysRevLett.85.888; DAGANI R, 1997, CHEM ENG NEWS, V23, P26; Deming TJ, 1999, MACROMOLECULES, V32, P4500, DOI 10.1021/ma9902899; Deming TJ, 1997, NATURE, V390, P386, DOI 10.1038/37084; Falini G, 2000, J CHEM SOC DALTON, P3983, DOI 10.1039/b003334k; Guenoun P, 2000, LANGMUIR, V16, P4436, DOI 10.1021/la991036b; Hamley IW, 2000, LANGMUIR, V16, P2508, DOI 10.1021/la991035j; Hoffmann H, 1996, CURR OPIN COLLOID IN, V1, P726, DOI 10.1016/S1359-0294(96)80074-4; KATCHALSKI E, 1958, ADV PROTEIN CHEM, V13, P243, DOI 10.1016/S0065-3233(08)60600-2; Kavanagh GM, 1998, PROG POLYM SCI, V23, P533, DOI 10.1016/S0079-6700(97)00047-6; KLEIN HF, 1975, CHEM BER-RECL, V108, P944, DOI 10.1002/cber.19751080327; KUBOTA S, 1974, J AM CHEM SOC, V96, P4684, DOI 10.1021/ja00821a060; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Liu L, 1999, NATURE, V397, P141, DOI 10.1038/16426; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Moffitt M, 1996, ACCOUNTS CHEM RES, V29, P95, DOI 10.1021/ar940080+; Okano T, 1998, BIORELATED POLYM GEL; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389; Tsitsilianis C, 2000, MACROMOLECULES, V33, P2936, DOI 10.1021/ma991410e; Wang C, 1999, NATURE, V397, P417, DOI 10.1038/17092; Ward A. G., 1977, SCI TECHNOLOGY GELAT; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Yu M, 1999, J AM CHEM SOC, V121, P12210, DOI 10.1021/ja993637v	28	704	737	13	717	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					424	428		10.1038/417424a	http://dx.doi.org/10.1038/417424a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024209				2022-12-28	WOS:000175730900034
J	Pignone, MP; Gaynes, BN; Rushton, JL; Burchell, CM; Orleans, CT; Mulrow, CD; Lohr, KN				Pignone, MP; Gaynes, BN; Rushton, JL; Burchell, CM; Orleans, CT; Mulrow, CD; Lohr, KN			Screening for depression in adults: A summary of the evidence for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CLINICAL-TRIAL; PRIMARY-CARE PATIENTS; GENERAL MEDICAL-CARE; LATE-LIFE DEPRESSION; QUALITY IMPROVEMENT; COST-EFFECTIVENESS; MENTAL-DISORDERS; HIGH UTILIZERS; IMPACT; QUESTIONNAIRES	Purpose: To clarify whether screening adults for depression in primary care settings improves recognition, treatment, and clinical outcomes. Data Sources: The MEDLINE database was searched from 1994 through August 2001. Other relevant articles were located through other systematic reviews; focused searches of MEDLINE from 1966 to 1994; the Cochrane depression, anxiety, and neurosis database; hand searches of bibliographies; and extensive peer review. Study Selection: The researchers reviewed randomized trials conducted in primary care settings that examined the effect of screening for depression on identification, treatment, or health outcomes, including trials that tested integrated, systematic support for treatment after identification of depression. Data Extraction: A single reviewer abstracted the relevant data from the included articles. A second reviewer checked the accuracy of the tables against the original articles. Data Synthesis: Compared with usual care, feedback of depression screening results to providers generally increased recognition of depressive illness in adults. Studies examining the effect of screening and feedback on treatment rates and clinical outcomes had mixed results. Many trials lacked power to detect clinically important differences in outcomes. Meta-analysis suggests that overall, screening and feedback reduced the risk for persistent depression (summary relative risk, 0.87 [95% CI, 0.79 to 0.95]). Programs that integrated interventions aimed at improving recognition and treatment of patients with depression and that incorporated quality improvements in clinic systems had stronger effects than programs of feedback alone. Conclusion: compared with usual care, screening for depression can improve outcomes, particularly when screening is coupled with system changes that help ensure adequate treatment and follow-up.	Res Triangle Inst, Res Triangle Pk, NC USA; Univ Michigan, Ann Arbor, MI 48109 USA; Robert Wood Johnson Fdn, Princeton, NJ USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA; Univ N Carolina Hosp, Chapel Hill, NC USA	Research Triangle Institute; University of Michigan System; University of Michigan; Robert Wood Johnson Foundation (RWJF); University of Texas System; University of Texas Health San Antonio; University North Carolina Hospital	Pignone, MP (corresponding author), Univ N Carolina Hosp, Chapel Hill, NC USA.			Pignone, Michael/0000-0002-6657-7342; Gaynes, Bradley/0000-0002-8283-5030; Lohr, Kathleen/0000-0002-3825-0713				American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; Callahan CM, 1996, J GEN INTERN MED, V11, P218, DOI 10.1007/BF02642478; CALLAHAN CM, 1994, J AM GERIATR SOC, V42, P839, DOI 10.1111/j.1532-5415.1994.tb06555.x; Dowrick C, 1995, FAM PRACT, V12, P461, DOI 10.1093/fampra/12.4.461; First M.B., 2016, STRUCTURED CLIN INTE; Gilbody SM, 2001, BRIT MED J, V322, P406, DOI 10.1136/bmj.322.7283.406; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; JOHNSTONE A, 1976, LANCET, V1, P605, DOI 10.1016/S0140-6736(76)90415-3; Katzelnick DJ, 2000, ARCH FAM MED, V9, P345, DOI 10.1001/archfami.9.4.345; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kroenke K, 2000, PSYCHOSOMATICS, V41, P39, DOI 10.1016/S0033-3182(00)71172-8; Lewis G, 1996, FAM PRACT, V13, P120, DOI 10.1093/fampra/13.2.120; LINN LS, 1980, J MED EDUC, V55, P942; MAGRUDERHABIB K, 1990, MED CARE, V28, P239, DOI 10.1097/00005650-199003000-00004; MOORE JT, 1978, J FAM PRACTICE, V7, P509; MULROW CD, 1995, ANN INTERN MED, V122, P913, DOI 10.7326/0003-4819-122-12-199506150-00004; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Penninx BWJH, 1998, JAMA-J AM MED ASSOC, V279, P1720, DOI 10.1001/jama.279.21.1720; Pignone M, 2001, BRIT MED J, V323, P167, DOI 10.1136/bmj.323.7305.167/b; PIGNONE M, 2001, PUBLICATION AGENCY H; Reifler DR, 1996, ARCH INTERN MED, V156, P2593, DOI 10.1001/archinte.156.22.2593; Robins L.N., 1991, PSYCHIAT DISORDERS A; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Schoenbaum M, 2001, JAMA-J AM MED ASSOC, V286, P1325, DOI 10.1001/jama.286.11.1325; Simon G E, 1995, Arch Fam Med, V4, P99, DOI 10.1001/archfami.4.2.99; Simon GE, 2001, ARCH GEN PSYCHIAT, V58, P181, DOI 10.1001/archpsyc.58.2.181; *US DEP HHS, 1993, DEPR PRIM CAR, V1; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P541; Valenstein M, 2001, ANN INTERN MED, V134, P345, DOI 10.7326/0003-4819-134-5-200103060-00007; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Whooley MA, 2000, J GEN INTERN MED, V15, P293, DOI 10.1046/j.1525-1497.2000.04319.x; Williams JW, 1999, AM J MED, V106, P36, DOI 10.1016/S0002-9343(98)00371-4; ZUNG WWK, 1983, J CLIN PSYCHIAT, V44, P365	34	621	636	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					765	776		10.7326/0003-4819-136-10-200205210-00013	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00013			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020146				2022-12-28	WOS:000175664600008
J	Stone, AA; Shiffman, S; Schwartz, JE; Broderick, JE; Hufford, MR				Stone, AA; Shiffman, S; Schwartz, JE; Broderick, JE; Hufford, MR			Patient non-compliance with paper diaries	BMJ-BRITISH MEDICAL JOURNAL			English	Article									SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA; Invivodata, Sci Affairs, Pittsburgh, PA 15203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Stone, AA (corresponding author), SUNY Stony Brook, Dept Psychiat & Behav Sci, Stony Brook, NY 11794 USA.	arthur.stone@sunysb.edu	Stone, Arthur A./AAC-3610-2019; Broderick, Joan/K-3167-2013; Shiffman, Saul/K-7337-2012	Schwartz, Joseph/0000-0002-8944-3566; Broderick, Joan/0000-0003-1752-0910	NATIONAL CANCER INSTITUTE [R01CA085819] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA085819, CA-85819] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Gorin AA, 2001, HANDBOOK OF HEALTH PSYCHOLOGY, P405; HULFORD MR, 2001, PROGR AMBULATORY ASS, P69; HYLAND ME, 1993, BRIT MED J, V306, P487, DOI 10.1136/bmj.306.6876.487; SHIFFMAN S, 2001, APPL CLIN TRIALS, V10, P46; Stone A, 2000, SCI SELF REPORT	5	584	594	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2002	324	7347					1193	1194		10.1136/bmj.324.7347.1193	http://dx.doi.org/10.1136/bmj.324.7347.1193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016186	Green Published, Bronze			2022-12-28	WOS:000175763200021
J	Beckman, JA; Creager, MA; Libby, P				Beckman, JA; Creager, MA; Libby, P			Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							LOW-DENSITY-LIPOPROTEIN; PERIPHERAL ARTERIAL-DISEASE; ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; SCANDINAVIAN SIMVASTATIN SURVIVAL; LATE CLINICAL-OUTCOMES; PROTEIN-KINASE-C; FACTOR-KAPPA-B; RISK-FACTOR; NITRIC-OXIDE	Context Complications of atherosclerosis cause most morbidity and mortality in patients with diabetes mellitus. Despite the frequency and severity of disease, proven medical therapy remains incompletely understood and underused. Objective To review the epidemiology, pathophysiology, and medical and invasive treatment of atherosclerosis in patients with diabetes mellitus. Data Sources Using the index terms diabetes mellitus, myocardial infarction, peripheral vascular diseases, cerebrovascular accident, endothelium, vascular smooth muscle, platelets, thrombosis, cholesterol, hypertension, hyperglycemia, insulin, angioplasty, and coronary artery bypass, we searched the MEDLINE and EMBASE databases from 1976 to 2001, Additional data sources included bibliographies of identified articles and preliminary data presented at recent cardiology conferences. Study Selection We selected original investigations and reviews of the epidemiology, pathophysiology, and therapy of atherosclerosis in diabetes. We selected randomized, double-blind, controlled studies, when available, to support therapeutic recommendations. Criteria for data inclusion (168 of 396) included publication in a peer-reviewed journal or presentation at a national cardiovascular society-sponsored meeting. Data Extraction Data quality was determined by publication in peer-reviewed literature. Data extraction was performed by one of the authors. Data Synthesis Diabetes mellitus markedly increases the risk of myocardial infarction, stroke, amputation, and death. The metabolic abnormalities caused by diabetes induce vascular dysfunction that predisposes this patient population to atherosclerosis. Blood pressure control, lipid-lowenng therapy, angiotensin-converting enzyme inhibition, and antiplatelet drugs significantly reduce the risk of cardiovascular events, Although diabetic patients undergo revascularization procedures because of acute coronary syndromes or critical limb ischemia, the outcomes are less favorable than in nondiabetic cohorts. Conclusions Since most patients with diabetes die from complications of atherosclerosis, they should receive intensive preventive interventions proven to reduce their cardiovascular risk.	Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Leducq Ctr Cardiovasc Res, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Libby, P (corresponding author), 228 Longwood Ave,Suite 307, Boston, MA 02115 USA.	plibby@rics.bwh.harvard.edu	Libby, Peter/AAY-6404-2021; Beckman, Joshua/A-7537-2016	Libby, Peter/0000-0002-1502-502X; Beckman, Joshua/0000-0001-8332-8439	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, K23HL004169] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23 HL-04169, P01 HL-48743] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT RD, 1990, AM J MED, V88, P376, DOI 10.1016/0002-9343(90)90492-V; Abizaid A, 1998, J AM COLL CARDIOL, V32, P584, DOI 10.1016/S0735-1097(98)00286-1; Achmad TH, 1997, METHOD FIND EXP CLIN, V19, P153; Adachi H, 2001, DIABETES RES CLIN PR, V51, P215, DOI 10.1016/S0168-8227(00)00236-9; Aguilar-Salinas CA, 1998, ATHEROSCLEROSIS, V141, P203, DOI 10.1016/S0021-9150(98)00198-1; Ahari A, 1999, EUR J VASC ENDOVASC, V18, P122, DOI 10.1053/ejvs.1999.0852; Akbari CM, 1997, J VASC SURG, V25, P1070, DOI 10.1016/S0741-5214(97)70131-9; Alderman E, 1997, CIRCULATION, V96, P1761, DOI 10.1161/01.CIR.96.6.1761; Alderman EL, 1996, NEW ENGL J MED, V335, P217; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; [Anonymous], 1998, MMWR-MORBID MORTAL W, V47, P649; [Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; APPLEBY P, 1994, LANCET, V343, P311, DOI 10.1016/S0140-6736(94)91161-4; Aronoff S, 2000, DIABETES CARE, V23, P1605, DOI 10.2337/diacare.23.11.1605; Assert R, 2001, DIABETOLOGIA, V44, P188, DOI 10.1007/s001250051598; Aziz I, 2001, ANN VASC SURG, V15, P243, DOI 10.1007/s100160010056; BAVENHOLM P, 1995, CIRCULATION, V92, P1422, DOI 10.1161/01.CIR.92.6.1422; Bazzino O, 1998, NEW ENGL J MED, V338, P1488; BEKS PJ, 1995, DIABETOLOGIA, V38, P86, DOI 10.1007/s001250050257; CAPEK P, 1991, CIRCULATION, V83, P70; Carr ME, 2001, J DIABETES COMPLICAT, V15, P44, DOI 10.1016/S1056-8727(00)00132-X; CARROZZA JP, 1993, ANN INTERN MED, V118, P344, DOI 10.7326/0003-4819-118-5-199303010-00004; CERIELLO A, 1995, DIABETES, V44, P924, DOI 10.2337/diabetes.44.8.924; CERIELLO A, 1988, DIABETOLOGIA, V31, P889; CERIELLO A, 1990, DIABETOLOGIA, V33, P163, DOI 10.1007/BF00404044; Chen J, 1999, J AM COLL CARDIOL, V34, P1388, DOI 10.1016/S0735-1097(99)00383-6; CHRISTLIEB AR, 1976, DIABETES, V25, P268, DOI 10.2337/diabetes.25.4.268; Cines DB, 1998, BLOOD, V91, P3527; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; COLLINS R, 2001, HEART PROTECTION STU; Cominacini L, 1997, DIABETOLOGIA, V40, P1211, DOI 10.1007/s001250050809; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; CUMMINGS MH, 1995, DIABETOLOGIA, V38, P959, DOI 10.1007/s001250050378; Dahmen R, 2001, DIABETES CARE, V24, P705, DOI 10.2337/diacare.24.4.705; Dawson DL, 2001, AM J CARDIOL, V87, p19D; Dawson DL, 1998, CIRCULATION, V98, P678, DOI 10.1161/01.CIR.98.7.678; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Detre KM, 2000, NEW ENGL J MED, V342, P989, DOI 10.1056/NEJM200004063421401; Dichtl W, 1999, CIRC RES, V84, P1085, DOI 10.1161/01.RES.84.9.1085; DIMITRIADIS E, 1995, DIABETOLOGIA, V38, P1300; Elam MB, 1998, ARTERIOSCL THROM VAS, V18, P1942, DOI 10.1161/01.ATV.18.12.1942; Elam MB, 2000, JAMA-J AM MED ASSOC, V284, P1263, DOI 10.1001/jama.284.10.1263; Elezi S, 1998, J AM COLL CARDIOL, V32, P1866, DOI 10.1016/S0735-1097(98)00467-7; FABRIS F, 1994, STROKE, V25, P1133, DOI 10.1161/01.STR.25.6.1133; Faries PL, 2001, AM J SURG, V181, P251, DOI 10.1016/S0002-9610(01)00551-7; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; FESKENS EJM, 1992, J CLIN EPIDEMIOL, V45, P1327, DOI 10.1016/0895-4356(92)90173-K; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Friedlander AH, 2000, ORAL SURG ORAL MED O, V89, P420, DOI 10.1016/S1079-2104(00)70122-3; Fukumoto H, 1998, J Atheroscler Thromb, V5, P29; GARDNER AW, 1995, JAMA-J AM MED ASSOC, V274, P975, DOI 10.1001/jama.274.12.975; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Gowri MS, 1999, ARTERIOSCL THROM VAS, V19, P2226, DOI 10.1161/01.ATV.19.9.2226; GRANGER CB, 1993, J AM COLL CARDIOL, V21, P920, DOI 10.1016/0735-1097(93)90348-5; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hennes MMI, 1996, HYPERTENSION, V28, P120, DOI 10.1161/01.HYP.28.1.120; Herlitz J, 1998, DIABETIC MED, V15, P308, DOI 10.1002/(SICI)1096-9136(199804)15:4<308::AID-DIA579>3.0.CO;2-E; Hiatt W R, 1997, Vasc Med, V2, P257; Hiatt WR, 1996, J APPL PHYSIOL, V81, P780, DOI 10.1152/jappl.1996.81.2.780; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; HIMMELMANN A, 1988, ACTA MED SCAND, V224, P439; Hopfner RL, 1999, DIABETOLOGIA, V42, P1383, DOI 10.1007/s001250051308; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; Hussain MJ, 1996, DIABETOLOGIA, V39, P60; Ikeda Y, 1999, THROMB HAEMOSTASIS, V82, P435; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jamrozik K, 2000, STROKE, V31, P863, DOI 10.1161/01.STR.31.4.863; Jirkovska A, 2001, J DIABETES COMPLICAT, V15, P63, DOI 10.1016/S1056-8727(00)00141-0; JOHNSTON KW, 1987, ANN SURG, V206, P403, DOI 10.1097/00000658-198710000-00002; JOHNSTONE MT, 1993, CIRCULATION, V88, P2510, DOI 10.1161/01.CIR.88.6.2510; JORGENSEN HS, 1994, STROKE, V25, P1977, DOI 10.1161/01.STR.25.10.1977; Jude EB, 2001, DIABETES CARE, V24, P1433, DOI 10.2337/diacare.24.8.1433; KANNEL WB, 1985, J AM GERIATR SOC, V33, P13, DOI 10.1111/j.1532-5415.1985.tb02853.x; KARIO K, 1995, ARTERIOSCL THROM VAS, V15, P1114, DOI 10.1161/01.ATV.15.8.1114; KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600; KENDALL MJ, 1995, ANN INTERN MED, V123, P358, DOI 10.7326/0003-4819-123-5-199509010-00007; Kip KE, 1996, CIRCULATION, V94, P1818, DOI 10.1161/01.CIR.94.8.1818; Kjaergaard SC, 1999, SCAND CARDIOVASC J, V33, P166; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; KUUSISTO J, 1994, STROKE, V25, P1157, DOI 10.1161/01.STR.25.6.1157; Levine GN, 1997, AM J CARDIOL, V79, P748, DOI 10.1016/S0002-9149(96)00862-4; Lewis TV, 1999, ARTERIOSCL THROM VAS, V19, P2782, DOI 10.1161/01.ATV.19.11.2782; Li Y, 2001, AM J PHYSIOL-HEART C, V280, pH1480, DOI 10.1152/ajpheart.2001.280.4.H1480; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Libby P, 1998, DRUGS, V56, P9, DOI 10.2165/00003495-199856001-00002; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; LOGERFO FW, 1984, NEW ENGL J MED, V311, P1615, DOI 10.1056/NEJM198412203112506; Luchsinger JA, 2001, AM J EPIDEMIOL, V154, P635, DOI 10.1093/aje/154.7.635; Mak KH, 1997, J AM COLL CARDIOL, V30, P171, DOI 10.1016/S0735-1097(97)00118-6; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Malmstrom R, 1997, DIABETOLOGIA, V40, P454, DOI 10.1007/s001250050700; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Marx N, 1998, AM J PATHOL, V153, P17, DOI 10.1016/S0002-9440(10)65540-X; Marx N, 2001, CIRCULATION, V103, P213; MCDAID EA, 1994, DIABETES CARE, V17, P1422, DOI 10.2337/diacare.17.12.1422; Meijer WT, 1998, ARTERIOSCL THROM VAS, V18, P185, DOI 10.1161/01.ATV.18.2.185; Miettinen H, 1998, DIABETES CARE, V21, P69, DOI 10.2337/diacare.21.1.69; Milstien S, 1999, BIOCHEM BIOPH RES CO, V263, P681, DOI 10.1006/bbrc.1999.1422; Moreno PR, 1999, J AM COLL CARDIOL, V34, P1045, DOI 10.1016/S0735-1097(99)00338-1; NEWMAN AB, 1993, CIRCULATION, V88, P837, DOI 10.1161/01.CIR.88.3.837; Nordt TK, 2000, SEMIN THROMB HEMOST, V26, P495, DOI 10.1055/s-2000-13205; Nugent AG, 1996, DIABETES, V45, P105, DOI 10.2337/diabetes.45.1.105; Panneton JM, 2000, ANN VASC SURG, V14, P640, DOI 10.1007/s100169910114; Parulkar AA, 2001, ANN INTERN MED, V134, P61, DOI 10.7326/0003-4819-134-1-200101020-00014; Pedersen TR, 1998, AM J CARDIOL, V81, P333, DOI 10.1016/S0002-9149(97)00904-1; Peters EJG, 2001, DIABETES CARE, V24, P1442, DOI 10.2337/diacare.24.8.1442; Pistolese GR, 2001, J VASC SURG, V33, P148, DOI 10.1067/mva.2001.110510; Plutzky J, 2000, Curr Atheroscler Rep, V2, P327, DOI 10.1007/s11883-000-0067-3; Pyorala K, 1997, DIABETES CARE, V20, P614, DOI 10.2337/diacare.20.4.614; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; RAMANATHAN AV, 1999, CIRCULATION S1, V100, P640; REAVEN GM, 1993, J CLIN INVEST, V92, P141, DOI 10.1172/JCI116541; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; Roffi M, 2001, CIRCULATION, V104, P2767, DOI 10.1161/hc4801.100029; Rohr J, 1996, ARCH NEUROL-CHICAGO, V53, P603, DOI 10.1001/archneur.1996.00550070041010; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Roubin GS, 2001, CIRCULATION, V103, P532, DOI 10.1161/01.CIR.103.4.532; RUBINS HB, 1995, AM J CARDIOL, V75, P1196, DOI 10.1016/S0002-9149(99)80761-9; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sarkar R, 1996, CIRC RES, V78, P225, DOI 10.1161/01.RES.78.2.225; Schaper NC, 2000, DIABETES-METAB RES, V16, pS11, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR112>3.0.CO;2-V; Schmidt A M, 2000, Curr Atheroscler Rep, V2, P430, DOI 10.1007/s11883-000-0082-4; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shindler DM, 2000, J AM COLL CARDIOL, V36, P1097, DOI 10.1016/S0735-1097(00)00877-9; SNIDERMAN A, 1978, J CLIN INVEST, V61, P867, DOI 10.1172/JCI109012; Sniderman AD, 2001, ANN INTERN MED, V135, P447, DOI 10.7326/0003-4819-135-6-200109180-00014; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; STEGMAYR B, 1995, DIABETOLOGIA, V38, P1061, DOI 10.1007/BF00402176; STEIN B, 1995, CIRCULATION, V91, P979, DOI 10.1161/01.CIR.91.4.979; STOKES KR, 1990, RADIOLOGY, V174, P977, DOI 10.1148/radiology.174.3.174-3-977; Sumpio BE, 2000, NEW ENGL J MED, V343, P787, DOI 10.1056/NEJM200009143431107; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; Tack CJJ, 1998, DIABETES CARE, V21, P796, DOI 10.2337/diacare.21.5.796; Taguchi S, 2000, J Atheroscler Thromb, V7, P132; Takahashi T, 1998, DIABETES CARE, V21, P1495, DOI 10.2337/diacare.21.9.1495; TAN KCB, 1995, ATHEROSCLEROSIS, V113, P273, DOI 10.1016/0021-9150(94)05454-Q; TASC Working Group, 2000, EUR J VASC ENDOVASC, V19, pS1; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TESFAMARIAM B, 1990, J CLIN INVEST, V85, P929, DOI 10.1172/JCI114521; TESFAMARIAM B, 1995, CARDIOVASC RES, V29, P549, DOI 10.1016/0008-6363(96)88533-6; Tuomilehto J, 1996, STROKE, V27, P210, DOI 10.1161/01.STR.27.2.210; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; Turner RC, 1998, DIABETES CARE, V21, pC35, DOI 10.2337/diacare.21.3.C35; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Uemura S, 2001, CIRC RES, V88, P1291, DOI 10.1161/hh1201.092042; UUSITUPA MIJ, 1990, CIRCULATION, V82, P27, DOI 10.1161/01.CIR.82.1.27; Verma S, 2001, Cardiol Rev, V9, P250, DOI 10.1097/00045415-200109000-00003; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; Williams KJ, 1998, CURR OPIN LIPIDOL, V9, P471, DOI 10.1097/00041433-199810000-00012; Williams SB, 1996, J AM COLL CARDIOL, V27, P567, DOI 10.1016/0735-1097(95)00522-6; Windmeier C, 1997, GEN PHARMACOL-VASC S, V29, P181, DOI 10.1016/S0306-3623(96)00314-X; Xie H, 1999, STROKE, V30, P2423, DOI 10.1161/01.STR.30.11.2423; You RX, 1997, STROKE, V28, P1913, DOI 10.1161/01.STR.28.10.1913; ZEIHER AM, 1995, CIRC RES, V76, P980, DOI 10.1161/01.RES.76.6.980; Zou MH, 1999, DRUG METAB REV, V31, P343, DOI 10.1081/DMR-100101922; ZUANETTI G, 1993, J AM COLL CARDIOL, V22, P1788, DOI 10.1016/0735-1097(93)90758-S	168	1873	1982	3	308	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2570	2581		10.1001/jama.287.19.2570	http://dx.doi.org/10.1001/jama.287.19.2570			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020339				2022-12-28	WOS:000175566200027
J	Hampe, J; Grebe, J; Nikolaus, S; Solberg, C; Croucher, PJP; Mascheretti, S; Jahnsen, J; Moum, B; Klump, B; Krawczak, M; Mirza, MM; Foelsch, UR; Vatn, M; Schreiber, S				Hampe, J; Grebe, J; Nikolaus, S; Solberg, C; Croucher, PJP; Mascheretti, S; Jahnsen, J; Moum, B; Klump, B; Krawczak, M; Mirza, MM; Foelsch, UR; Vatn, M; Schreiber, S			Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study	LANCET			English	Article							INFLAMMATORY-BOWEL-DISEASE; SOUTHEASTERN NORWAY; ULCERATIVE-COLITIS; 4 COUNTIES; POPULATION; CLASSIFICATION; SUSCEPTIBILITY; CHROMOSOME-16; LINKAGE; DIAGNOSIS	Background Crohn's disease is a heterogeneous disorder for which NOD2 (CARD 15) has been identified as a susceptibility gene. We investigate the relation between NOD2 genotype and phenotypic characteristics of patients with Crohn's disease. Methods Hypotheses about the relation between NOD2 genotype and Crohn's disease phenotype were generated retrospectively from a group of 446 German patients with this disorder. Positive findings (p<0.10) were verified in prospectively established cohorts of 106 German and 55 Norwegian patients with Crohn's disease. All patients were genotyped for the main coding mutations in NOD2, denoted SNP8, SNP12, and SNP13, with Taqman technology. Findings In the retrospective cohort, six clinical characteristics showed noteworthy haplotype association: fistulising, ileal, left colonic and right colonic disease, stenosis, and resection. In the German prospective cohort, these haplotype associations could be replicated for ileal (p=0.006) and right colonic disease (p <= 0.001). A similar trend was noted in the Norwegian patients. Interpretation We recorded a distinct relation between NOD2 genotype and phenotype of Crohn's disease. Test strategies with NOD2 variations to predict the clinical course of Crohn's disease could lead to the development of new therapeutic paradigms.	Univ Kiel, Dept Gen Internal Med, D-24105 Kiel, Germany; Univ Tubingen, Tubingen, Germany; Univ Oslo, Rikshosp, N-0027 Oslo, Norway; Cardiff Univ, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England	University of Kiel; Eberhard Karls University of Tubingen; University of Oslo; National Hospital Norway; Cardiff University; University of London; King's College London	Schreiber, S (corresponding author), Univ Kiel, Dept Gen Internal Med, Schittenhelmstr 12, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Jahnsen, Jorgen/GRO-3253-2022; Krawczak, Michael/A-8964-2010; Hampe, Jochen/A-2555-2010	Jahnsen, Jorgen/0000-0002-0419-2914; Krawczak, Michael/0000-0003-2603-1502; Hampe, Jochen/0000-0002-2421-6127				Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; GREENSTEIN RJ, 1995, MOL MED TODAY, V1, P343, DOI 10.1016/S1357-4310(95)80034-4; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 1999, AM J HUM GENET, V65, P1647, DOI 10.1086/302677; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Moum B, 1996, SCAND J GASTROENTERO, V31, P355, DOI 10.3109/00365529609006410; Moum B, 1996, SCAND J GASTROENTERO, V31, P362, DOI 10.3109/00365529609006411; Moum B, 1997, GUT, V40, P328, DOI 10.1136/gut.40.3.328; *NCBI, 2002, SINGL NUCL POL; Nikolaus S, 2000, LANCET, V356, P1475, DOI 10.1016/S0140-6736(00)02871-3; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Steinhart AH, 1998, INFLAMM BOWEL DIS, V4, P228; Thompson NP, 1996, BRIT MED J, V312, P95; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Williams CN, 1999, CAN J GASTROENTEROL, V13, P799	24	334	346	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1661	1665		10.1016/S0140-6736(02)08590-2	http://dx.doi.org/10.1016/S0140-6736(02)08590-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020527				2022-12-28	WOS:000175593300010
J	Helle, S; Lummaa, V; Jokela, J				Helle, S; Lummaa, V; Jokela, J			Sons reduced maternal longevity in preindustrial humans	SCIENCE			English	Article							BIRTH; SEX		Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland; Univ Cambridge, Dept Zool, Large Anim Res Grp, Cambridge CB2 3EJ, England; Univ Oulu, Dept Biol, FIN-90014 Oulu, Finland	University of Turku; University of Cambridge; University of Oulu	Helle, S (corresponding author), Univ Turku, Dept Biol, Sect Ecol, FIN-20014 Turku, Finland.		Jokela, Jukka/F-8626-2010; Lummaa, Virpi/AHB-0181-2022	Jokela, Jukka/0000-0002-1731-727X				Fagnoni FF, 2000, BLOOD, V95, P2860, DOI 10.1182/blood.V95.9.2860.009k35_2860_2868; HELLE S, UNPUB; ITKONEN T, 1948, LAPPS FINLAND, V2; James WH, 1996, J THEOR BIOL, V180, P271, DOI 10.1006/jtbi.1996.0102; KIRKWOOD TBL, 1991, PHILOS T R SOC B, V332, P15, DOI 10.1098/rstb.1991.0028; Loos RJF, 2001, LANCET, V358, P560, DOI 10.1016/S0140-6736(01)05716-6; Mace R, 1997, J BIOSOC SCI, V29, P499, DOI 10.1017/S0021932097004999; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547	9	107	109	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1085	1085		10.1126/science.1070106	http://dx.doi.org/10.1126/science.1070106			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004121				2022-12-28	WOS:000175565000043
J	Pelengaris, S; Khan, M; Evan, GI				Pelengaris, S; Khan, M; Evan, GI			Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression	CELL			English	Article							C-MYC; MEDIATED APOPTOSIS; TRANSGENIC MICE; DOWN-REGULATION; CYCLE ARREST; E-CADHERIN; EXPRESSION; INDUCTION; TUMORIGENESIS; PROTEIN	To explore the role of c-Myc in carcinogenesis, we have developed a reversible transgenic model of pancreatic beta cell oncogenesis using a switchable form of the c-Myc protein. Activation of c-Myc in adult, mature beta cells induces uniform beta cell proliferation but is accompanied by overwhelming apoptosis that rapidly erodes beta cell mass. Thus, the oncogenic potential of c-Myc in beta cells is masked by apoptosis. Upon suppression of c-Myc-induced beta cell apoptosis by coexpression Of Bcl-X-L, c-Myc triggers rapid and uniform progression into angiogenic, invasive tumors. Subsequent c-Myc deactivation induces rapid regression associated with vascular degeneration and beta cell apoptosis. Our data indicate that highly complex neoplastic lesions can be both induced and maintained in vivo by a simple combination of two interlocking molecular lesions.	Imperial Canc Res Fund, London WC2A 3PX, England; Univ Warwick, Dept Biol Sci, Mol Med Res Ctr, Coventry CV4 7AL, W Midlands, England; Univ Calif San Francisco, Ctr Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	Cancer Research UK; University of Warwick; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Evan, GI (corresponding author), Imperial Canc Res Fund, Lincolns Inn Fields, London WC2A 3PX, England.	gevan@cc.ucsf.edu		Khan, Michael/0000-0002-8591-384X				ASKEW DS, 1991, ONCOGENE, V6, P1915; Berkovich I, 2001, DIABETES, V50, P2260, DOI 10.2337/diabetes.50.10.2260; BIRCHMEIER W, 1995, CIBA F SYMP, V189, P124; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BLYTH K, 1995, ONCOGENE, V10, P1717; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Breit S, 2000, CANCER RES, V60, P4596; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; CHRISTOFORI G, 1994, SEMIN CANCER BIOL, V5, P3; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Eischen CM, 2001, MOL CELL BIOL, V21, P5063, DOI 10.1128/MCB.21.15.5063-5070.2001; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Folkman J, 1992, Semin Cancer Biol, V3, P65; Fotsis T, 1999, EUR J BIOCHEM, V263, P757, DOI 10.1046/j.1432-1327.1999.00575.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Harris VK, 2000, J BIOL CHEM, V275, P28539, DOI 10.1074/jbc.M001677200; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Janz A, 2000, NUCLEIC ACIDS RES, V28, P2268, DOI 10.1093/nar/28.11.2268; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Kaneto H, 2002, J BIOL CHEM, V277, P12998, DOI 10.1074/jbc.M111148200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAKE SP, 1989, TRANSPLANTATION, V48, P354; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; LOTEM J, 1995, P NATL ACAD SCI USA, V92, P9672, DOI 10.1073/pnas.92.21.9672; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; MOORE JP, 1987, ONCOGENE RES, V2, P65; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Pavelic K, 1996, ANTICANCER RES, V16, P1707; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Sherr CJ, 2000, CANCER RES, V60, P3689; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; WAGNER AJ, 1993, MOL CELL BIOL, V13, P2432, DOI 10.1128/MCB.13.4.2432; Zhou YP, 2000, AM J PHYSIOL-ENDOC M, V278, pE340, DOI 10.1152/ajpendo.2000.278.2.E340; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	51	511	528	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 3	2002	109	3					321	334		10.1016/S0092-8674(02)00738-9	http://dx.doi.org/10.1016/S0092-8674(02)00738-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015982	Bronze			2022-12-28	WOS:000175412100008
J	Miller, MJ; Wei, SH; Parker, I; Cahalan, MD				Miller, MJ; Wei, SH; Parker, I; Cahalan, MD			Two-photon imaging of lymphocyte motility and antigen response in intact lymph node	SCIENCE			English	Article							EXTRACELLULAR-MATRIX; T-CELLS; IN-VIVO; MIGRATION; ACTIVATION; INDUCTION	Lymphocyte motility is vital for trafficking within lymphoid organs and for initiating contact with antigen-presenting cells. Visualization of these processes has previously been, limited to in vitro systems. We describe the use of two-photon laser microscopy to image the dynamic behavior of individual living lymphocytes deep within intact lymph nodes. in their native environment, T cells achieved peak velocities of more than 25 micrometers per minute, displaying a motility coefficient that is five to six times that of B cells. Antigenic challenge changed T cell trajectories from random walks to "swarms" and stable clusters. Real-time two-photon imaging reveals lymphocyte behaviors that are fundamental to the initiation of the immune response.	Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.			Miller, Mark/0000-0001-5676-389X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041514, R01GM048071, R37GM048071] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-48071, GM-41514] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; DECOURSEY TE, 1987, J GEN PHYSIOL, V89, P405, DOI 10.1085/jgp.89.3.405; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dustin ML, 2001, CURR OPIN IMMUNOL, V13, P286, DOI 10.1016/S0952-7915(00)00217-X; ELENSTROMMAGNUSSON C, 1995, INT IMMUNOL, V7, P567, DOI 10.1093/intimm/7.4.567; FRIEDL P, 1994, IMMUNOLOGY, V82, P617; Friedl P, 1998, MICROSC RES TECHNIQ, V43, P369, DOI 10.1002/(SICI)1097-0029(19981201)43:5<369::AID-JEMT3>3.0.CO;2-6; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gunzer M, 2000, IMMUNITY, V13, P323, DOI 10.1016/S1074-7613(00)00032-7; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163	14	945	965	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1869	1873		10.1126/science.1070051	http://dx.doi.org/10.1126/science.1070051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12016203	Green Submitted			2022-12-28	WOS:000176054300049
J	Weber, EJ; Katz, PP; Waeckerle, JF; Callahan, ML				Weber, EJ; Katz, PP; Waeckerle, JF; Callahan, ML			Author perception of peer review - Impact of review quality and acceptance on satisfaction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				MANUSCRIPTS; PERFORMANCE; CARE	Context To determine author perception of peer review and association between quality of review-and author satisfaction. Methods Survey between May 1999 and October 2000 of 897 corresponding authors of manuscripts under consideration by the Annals of Emergency Medicine and had received final editorial decisions during the study period. A total of 576 authors (64%) returned the survey. Using a 5-point Likert scale, the survey assessed differences in satisfaction between authors whose manuscripts were accepted, reviewed and rejected, and rejected without full review. The association of author satisfaction with editor's assessment of review quality, publication decision, author sex, specialty, and publication experience were also assessed. Results Overall mean (SD) satisfaction score, indicated by agreement with "My experience with the review process will make me more likely to submit to Annals in the future, " was 3.1 (1.0) and was significantly higher among authors of accepted papers (3.7 [0.91) than among either group of rejected papers (rejected/reviewed, 2.8 [1.0]; rejected/no review, 3.0 [0.9]; P.05). Authors whose manuscripts were reviewed and rejected were the least satisfied with the time to decision (rejected/reviewed, 3.0 [1.2] vs accepted, 3.7 [1.0] and rejected/no review, 3.9 [0.9]; P<.05). Those whose papers were rejected without review were the least satisfied with the letter explaining the editorial decision (rejected/no review, 2.8 [1.2] vs accepted, 4.2 [0.7] and rejected/reviewed, 3.1 [1.2]; P<.05). Among respondents whose manuscripts underwent full review (accepted and rejected/reviewed), overall satisfaction was highly associated with acceptance of the manuscript for publication (odds ratio [OR], 6.12; 95% confidence interval [CI], 3.43-10.91) but not with quality rating of reviews (OR, 1.26; 95% Cl, 0.84-1.90). Conclusion Contributor satisfaction with peer review was modest. Authors of rejected manuscripts were dissatisfied with the time to decision and communication from the editor. Author satisfaction is associated with acceptance but not with review quality.	Univ Calif San Francisco, Dept Med, Inst Hlth Policy Studies, San Francisco, CA USA; Univ Calif San Francisco, Dept Med, Div Emergency Med, San Francisco, CA USA; Univ Missouri, Sch Med, Menorah Med Ctr, Baptist Med Ctr,Dept Emergency Med, Kansas City, MO 64108 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Missouri System; University of Missouri Kansas City	Weber, EJ (corresponding author), Univ Calif San Francisco, Emergency Dept, 505 Parnassus Ave,Box 0208, San Francisco, CA 94143 USA.		Weber, Ellen/GRR-9967-2022	Weber, Ellen/0000-0002-0094-1973; Callaham, Michael/0000-0003-2284-256X				Baxt WG, 1998, ANN EMERG MED, V32, P310, DOI 10.1016/S0196-0644(98)70006-X; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229; Callaham ML, 1998, ANN EMERG MED, V32, P318, DOI 10.1016/S0196-0644(98)70007-1; FRANK E, 1994, JAMA-J AM MED ASSOC, V272, P163, DOI 10.1001/jama.272.2.163; GARFUNKEL JM, 1990, JAMA-J AM MED ASSOC, V263, P1376, DOI 10.1001/jama.263.10.1376; Larson CO, 1996, INT J QUAL HEALTH C, V8, P447, DOI 10.1093/intqhc/8.5.447; Levinson W, 1997, JAMA-J AM MED ASSOC, V277, P553, DOI 10.1001/jama.277.7.553; Menz HB, 2001, J AM PODIAT MED ASSN, V91, P210, DOI 10.7547/87507315-91-4-210; van Rooyen S, 1999, J GEN INTERN MED, V14, P622, DOI 10.1046/j.1525-1497.1999.09058.x; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5	10	69	73	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2790	2793		10.1001/jama.287.21.2790	http://dx.doi.org/10.1001/jama.287.21.2790			4	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038913	Bronze			2022-12-28	WOS:000176002200010
J	McGill, N; O'Shaughnessy, D; Pickering, R; Herbertson, M; Gill, R				McGill, N; O'Shaughnessy, D; Pickering, R; Herbertson, M; Gill, R			Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OPEN-HEART SURGERY; AUTOLOGOUS BLOOD; NORMOVOLEMIC HEMODILUTION; ORTHOPEDIC-SURGERY; METAANALYSIS; BYPASS; AUTOTRANSFUSION; REQUIREMENTS	Objective To assess die effectiveness of two mechanical methods of blood conservation in reducing the need for allogencic red blood cells or coagulation products during cardiac surgery. Design Randomised controlled trial. Setting Regional cardiac centre in a teaching hospital in Southampton. Participants 263 adults aged 18-80 years undergoing elective coronary artery bypass surgery entered the study, of whom 252 completed die trial. All patients received routine perioperative care. Patients were allocated to one of three treatment groups: intraoperative cell salvage, intraoperative cell salvage with acute perioperative normovolaemic haemodilution, or no mechanical blood conservation. There were 84 patients in each group. Main outcome measures Numbers of patients who received allogencic blood or coagulation products, and the mean number Of units of blood transfused per patient. Results Of the patients in the intraoperative cell salvage group, 26 were given a transfusion of allogeneic blood, compared with 43 in the control group (odds ratio 0.43 (95% confidence interval 0.23 to 0.80)). The mean number of units of allogencic blood transfused per patient in the intraoperative cell salvage group was 0.68 units (SD=1.55), compared with 1.07 (1.56) units in the control group. 32 of the patients in the intraoperative cell salvage group were given any blood product, compared With 47 in the control group (odds ratio 0.47 (0.25 to 0.89); P=0.019). Combining acute perioperative normovolaemic haemodilution With intraoperative cell salvage conferred no additional benefits. Conclusions An intraoperative cell salvage device should be used in elective coronary artery bypass grafting. Pharmacological strategies may achieve further reductions in blood transfusions. Yet further reductions in blood transfusions could be achieved if the lower safe limit of haemoglobin concentration in patients undergoing cardiac surgery were known.	Southampton Univ Hosp NHS Trust, Shackleton Dept Anaesthesia, Southampton SO16 6YD, Hants, England; Univ Michigan, CS Mott Childrens Hosp, Sect Pediat Anesthesiol, Ann Arbor, MI 48109 USA; Southampton Univ Hosp NHS Trust, Dept Haematol, Southampton SO16 6YD, Hants, England; Southampton Univ Hosp NHS Trust, Med Stat Grp, Southampton SO16 6YD, Hants, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Michigan System; University of Michigan; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University Hospital Southampton NHS Foundation Trust	Gill, R (corresponding author), Southampton Univ Hosp NHS Trust, Shackleton Dept Anaesthesia, Southampton SO16 6YD, Hants, England.	ravi.gill@suht.swest.nhs.uk						Boldt J, 1991, J Cardiothorac Vasc Anesth, V5, P23; Bryson GL, 1998, ANESTH ANALG, V86, P9, DOI 10.1097/00000539-199801000-00003; DALESSANDRO G, 1987, PATHOLOGY, V19, P339, DOI 10.3109/00313028709103880; Dalrymple-Hay MJR, 1999, EUR J CARDIO-THORAC, V15, P830, DOI 10.1016/S1010-7940(99)00112-8; DIETRICH W, 1989, J THORAC CARDIOV SUR, V97, P213; Duffy G, 1996, TRANSFUSION MED, V6, P325, DOI 10.1111/j.1365-3148.1996.tb00091.x; Fergusson D, 1999, INT J TECHNOL ASSESS, V15, P717, DOI 10.1017/S0266462399154114; HALLOWELL P, 1972, J THORAC CARDIOV SUR, V64, P941; Henry DA, 2000, MED J AUSTRALIA, V172, P365, DOI 10.5694/j.1326-5377.2000.tb124007.x; HERREGODS L, 1995, ANAESTHESIA, V50, P950, DOI 10.1111/j.1365-2044.1995.tb05926.x; Huet C, 1999, ANESTH ANALG, V89, P861; KAPLAN JA, 1977, J THORAC CARDIOV SUR, V74, P4; KILLIP T, 1988, NEW ENGL J MED, V319, P366, DOI 10.1056/NEJM198808113190610; Kochamba GS, 1996, ANN THORAC SURG, V61, P900, DOI 10.1016/0003-4975(95)01155-2; LAWSON NW, 1974, ANESTH ANALG, V53, P672; LILLEAASEN P, 1977, SCAND J THORAC CARD, V11, P97; *NAT BLOOD AUTH, ANN REP 2000; RAO TLK, 1985, ANESTHESIOLOGY REV, V12, P49; Renton MC, 1997, PERFUSION-UK, V12, P157, DOI 10.1177/026765919701200302; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Spiess BD, 1998, J THORAC CARDIOV SUR, V116, P460, DOI 10.1016/S0022-5223(98)70012-1; TRIULZI DJ, 1995, TRANSFUSION, V35, P627, DOI 10.1046/j.1537-2995.1995.35895357892.x; Vedrinne C, 1992, J Cardiothorac Vasc Anesth, V6, P319, DOI 10.1016/1053-0770(92)90149-2	23	78	83	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1299	1302		10.1136/bmj.324.7349.1299	http://dx.doi.org/10.1136/bmj.324.7349.1299			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039820	Bronze, Green Published			2022-12-28	WOS:000176041500013
J	Fitter, AH; Fitter, RSR				Fitter, AH; Fitter, RSR			Rapid changes in flowering time in British plants	SCIENCE			English	Article							CLIMATE-CHANGE; TEMPERATURE; PHENOLOGY; BUTTERFLIES; RESPONSES; EARLIER; TRENDS; FLORA; UK	The average first flowering date of 385 British plant species has advanced by 4.5 days during the past decade compared with the previous four decades: 16% of species flowered significantly earlier in the 1990s than previously, with an average advancement of 15 days in a decade. Ten species (3%) flowered significantly later in the 1990s than previously. These data reveal the strongest biological signal yet of climatic change. Flowering is especially sensitive to the temperature in the previous month, and spring-flowering species are most responsive. However, large interspecific differences in this response will affect both the structure of plant communities and gene flow between species as climate warms. Annuals are more likely to flower early than congeneric perennials, and insect-pollinated species more than wind-pollinated ones.	Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; Danewood, Cambridge CB2 5AQ, England	University of York - UK	Fitter, AH (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.							Abu-Asab MS, 2001, BIODIVERS CONSERV, V10, P597, DOI 10.1023/A:1016667125469; Beaubien EG, 2000, INT J BIOMETEOROL, V44, P53, DOI 10.1007/s004840000050; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Bentham G, 1858, HDB BRIT FLORA; BONNIER G, 1925, BRIT FLORA; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Clapham AR, 1981, FLORA BRIT ISLES, V3rd; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; FITTER AH, 1994, J ECOL, V82, P415, DOI 10.2307/2261309; FITTER AH, 1995, FUNCT ECOL, V9, P55, DOI 10.2307/2390090; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; MCCLINTOCK D, 1956, POCKET GUIDE WILD FL; MCKANE RB, 1990, ECOLOGY, V71, P1126, DOI 10.2307/1937380; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Osborne CP, 2000, PLANT CELL ENVIRON, V23, P701, DOI 10.1046/j.1365-3040.2000.00584.x; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Post E, 2001, P ROY SOC B-BIOL SCI, V268, P15, DOI 10.1098/rspb.2000.1324; Rodwell, 1992, BRIT PLANT COMMUNITI, V3; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Santandreu M, 1999, CAN J BOT, V77, P734, DOI 10.1139/b99-015; Sparks TH, 1997, ECOGRAPHY, V20, P368, DOI 10.1111/j.1600-0587.1997.tb00381.x; SPARKS TH, 1995, J ECOL, V83, P321, DOI 10.2307/2261570; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Stace C., 1997, NEW FLORA BRIT ISLES; VERESOGLOU DS, 1984, J ECOL, V72, P259, DOI 10.2307/2260018; Visser ME, 2001, P ROY SOC B-BIOL SCI, V268, P289, DOI 10.1098/rspb.2000.1363	28	974	1073	14	566	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1689	1691		10.1126/science.1071617	http://dx.doi.org/10.1126/science.1071617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040195				2022-12-28	WOS:000175976200059
J	Mader, P; Fliessbach, A; Dubois, D; Gunst, L; Fried, P; Niggli, U				Mader, P; Fliessbach, A; Dubois, D; Gunst, L; Fried, P; Niggli, U			Soil fertility and biodiversity in organic farming	SCIENCE			English	Article							CONVENTIONAL AGRICULTURAL SYSTEMS; CROPPING SYSTEMS; SUSTAINABILITY; PRODUCTIVITY; BENEFITS	An understanding of agroecosystems is key to determining effective farming systems. Here we report results from a 21-year study of agronomic and ecological performance of biodynamic, bioorganic, and conventional farming systems in Central Europe. We found crop yields to be 20% Lower in the organic systems, although input of fertilizer and energy was reduced by 34 to 53% and pesticide input by 97%. Enhanced soil fertility and higher biodiversity found in organic plots may render these systems less dependent on external inputs.	Res Inst Organ Agr, CH-5070 Frick, Switzerland; Swiss Fed Res Stn Agroecol & Agr, CH-8046 Zurich, Switzerland	Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Mader, P (corresponding author), Res Inst Organ Agr, Ackerstr, CH-5070 Frick, Switzerland.		Bahrami, Layla/L-9479-2015	Fliessbach, Andreas/0000-0002-9130-7977				ALFOLDI T, UNPUB; Drinkwater LE, 1998, NATURE, V396, P262, DOI 10.1038/24376; Fliessbach A, 1997, MICROBIAL COMMUNITIES, P109; Fliessbach A, 2000, SOIL BIOL BIOCHEM, V32, P757, DOI 10.1016/S0038-0717(99)00197-2; Fliessbach A, 2000, SOIL BIOL BIOCHEM, V32, P1131, DOI 10.1016/S0038-0717(00)00028-6; INSAM H, 1989, OECOLOGIA, V79, P174, DOI 10.1007/BF00388474; Mader P, 2000, BIOL FERT SOILS, V31, P150, DOI 10.1007/s003740050638; OBERSON A, 1993, BIOL FERT SOILS, V16, P111, DOI 10.1007/BF00369411; Oberson A, 1996, BIOL FERT SOILS, V21, P138, DOI 10.1007/BF00335925; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Oehl F, 2001, BIOL FERT SOILS, V34, P31, DOI 10.1007/s003740100362; Offermann F., 2000, EC PERFORMANCE ORGAN, P5; Pfiffner L, 1996, BIOL AGRIC HORTIC, V12, P353, DOI 10.1080/01448765.1996.9754758; Pfiffner L, 1997, BIOL AGRIC HORTIC, V15, P3; Pimentel D, 1997, BIOSCIENCE, V47, P747, DOI 10.2307/1313097; PIMENTEL D, 1995, SCIENCE, V267, P1117, DOI 10.1126/science.267.5201.1117; Reganold JP, 2001, NATURE, V410, P926, DOI 10.1038/35073574; Schinner F., 1993, BODENBIOLOGISCHE ARB; Siegrist S, 1998, AGR ECOSYST ENVIRON, V69, P253, DOI 10.1016/S0167-8809(98)00113-3; SIMON P, COMMUNICATION; Smith S., 1997, MYCORRHIZAL SYMBIOSI, V2nd Edn; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932	24	1614	1754	43	1255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1694	1697		10.1126/science.1071148	http://dx.doi.org/10.1126/science.1071148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040197				2022-12-28	WOS:000175976200061
J	Obara, K				Obara, K			Nonvolcanic deep tremor associated with subduction in southwest Japan	SCIENCE			English	Article								Deep long-period tremors were recognized and located in a nonvolcanic region in southwest Japan. Epicenters of the tremors were distributed along the strike of the subducting Philippine Sea plate over a length of 600 kilometers. The depth of the tremors averaged about 30 kilometers, near the Mohorovic discontinuity. Each tremor tasted for at most a few weeks. The location of the tremors within the subduction zone indicates that the tremors may have been caused by fluid generated by dehydration processes from the slab.	Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan	National Research Institute for Earth Science & Disaster Resilience	Obara, K (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, Tenno Dai 3-1, Tsukuba, Ibaraki 3050006, Japan.							Bureau H, 1999, EARTH PLANET SC LETT, V165, P187, DOI 10.1016/S0012-821X(98)00266-0; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; HASEGAWA A, 1994, TECTONOPHYSICS, V233, P233, DOI 10.1016/0040-1951(94)90243-7; JULIAN BR, 1994, J GEOPHYS RES-SOL EA, V99, P11859, DOI 10.1029/93JB03129; KATSUMATA A, 2001, SEISM SOC JPN FALL M, pB16; Nakamura K., 1997, ANN DISASTER PREV RE, V40, P1; OBARA K, 2000, EOS S, V81, P863; OHMI S, 2001, EOS S, V82, P871; Ukawa M., 1993, B VOLCANOLOGICAL SOC, V38, P187	9	932	949	5	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1679	1681		10.1126/science.1070378	http://dx.doi.org/10.1126/science.1070378			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040191				2022-12-28	WOS:000175976200055
J	Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R				Jiang, YX; Lee, A; Chen, JY; Cadene, M; Chait, BT; MacKinnon, R			The open pore conformation of potassium channels	NATURE			English	Article							GATED K+ CHANNEL; SODIUM CHANNEL; ION CHANNELS; INACTIVATION; ACTIVATION; SITE	Living cells regulate the activity of their ion channels through a process known as gating. To open the pore, protein conformational changes must occur within a channel's membrane-spanning ion pathway. KcsA and MthK, closed and opened K+ channels, respectively, reveal how such gating transitions occur. Pore-lining 'inner' helices contain a 'gating hinge' that bends by approximately 30degrees. In a straight conformation four inner helices form a bundle, closing the pore near its intracellular surface. In a bent configuration the inner helices splay open creating a wide (12 Angstrom) entryway. Amino-acid sequence conservation suggests a common structural basis for gating in a wide range of K+ channels, both ligand- and voltage-gated. The open conformation favours high conduction by compressing the membrane field to the selectivity filter, and also permits large organic cations and inactivation peptides to enter the pore from the intracellular solution.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10021 USA.			Cadene, Martine/0000-0003-4936-2662				ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1974, Q REV BIOPHYS, V7, P179, DOI 10.1017/S0033583500001402; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Flynn GE, 2001, NAT REV NEUROSCI, V2, P643, DOI 10.1038/35090015; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	30	1012	1040	3	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					523	526		10.1038/417523a	http://dx.doi.org/10.1038/417523a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037560				2022-12-28	WOS:000175860300034
J	Chiarelli, P; Cockburn, J				Chiarelli, P; Cockburn, J			Promoting urinary continence in women after delivery: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AUSTRALIAN WOMEN; INCONTINENCE; PREVALENCE; PREGNANCY; DISTRESS; SYMPTOM	Objectives To test the effectiveness of a physiotherapist delivered intervention designed to prevent urinary incontinence among women three months after giving birth. Design Prospective randoinised controlled trial with women randomised to receive the intervention (which entailed training in pelvic floor exercises and incorporated strategies to improve adherence) or usual postpartum care. Setting Postpartum wards of three tertiary teaching hospitals in the Hunter region, New South Wales, Australia. Participants Women who had forceps or ventouse deliveries or whose babies had a high birth weight (greater than or equal to 4000 g), or both-676 (348 in the intervention group and 328 in the usual care group) provided endpoint data at three months, Main outcome measures Urinary incontinence at three months is measured as a dichotomous variable. The severity of incontinence was also measured. Self report of the frequency of performance of pelvic floor exercises was recorded. Results At three months after delivery, the prevalence of incontinence in the intervention group was 31.0% (108 women) and in the usual care group 38.4% (125 women); difference 7.4% (95% confidence interval 0.2% to 14.6%, P=0.044). At follow up significantly fewer women with incontinence were classified as severe in the intervention group (10.1%) v (17.0%), difference 7.0%, 1.6% to 11.8%). The proportions of women reporting doing pelvic floor exercises at adequate levels was 84% (80% to 88%) for the intervention group and 58% (52% to 63%) for the usual care group (P=0.001). Conclusions The intervention promoting urinary continence reduced die prevalence of urinary incontinence after giving birth, particularly its severity, and promoted the performance of pelvic floor exercises at adequate levels; both continence and adherence to die programme were measured at three months after delivery in women who had forceps or ventouse deliveries or babies weighing 4000 g or more.	Univ Newcastle, Fac Hlth, Sch Populat Hlth Sci, Callaghan, NSW 2308, Australia	University of Newcastle	Chiarelli, P (corresponding author), Univ Newcastle, Fac Hlth, Sch Populat Hlth Sci, Box 24, Callaghan, NSW 2308, Australia.	Pauline.Chiarelli@newcastle.edu.au	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X				BO K, 1994, NEUROUROL URODYNAM, V13, P35, DOI 10.1002/nau.1930130106; Chiarelli P, 1997, AUST NZ J OBSTET GYN, V37, P66, DOI 10.1111/j.1479-828X.1997.tb02220.x; Chiarelli P, 1999, NEUROUROL URODYNAM, V18, P567, DOI 10.1002/(SICI)1520-6777(1999)18:6<567::AID-NAU7>3.0.CO;2-F; Chiarelli P, 1999, AUST J PHYSIOTHER, V45, P111, DOI 10.1016/S0004-9514(14)60343-3; CHIARELLI P, 1999, AUST CONTINENCE J, V5, P41; CLARK A, 1993, J REPROD MED, V38, P679; Cummings K M, 1980, J Behav Med, V3, P123; Doran CM, 2001, MED J AUSTRALIA, V174, P456, DOI 10.5694/j.1326-5377.2001.tb143374.x; Foldspang A, 1999, AM J PUBLIC HEALTH, V89, P209, DOI 10.2105/AJPH.89.2.209; GUNTHORPE W, 1998, THESIS NEWCASTLE; HAHN I, 1993, BRIT J UROL, V72, P421, DOI 10.1111/j.1464-410X.1993.tb16170.x; HERZOG AR, 1988, PSYCHOL AGING, V3, P115, DOI 10.1037/0882-7974.3.2.115; HSU T, 1990, J AM GERIATR SOC, V38, P292; *INT CONT SOC, 1976, BR J UROL, V48, P39; LAGRO-JANSSEN T, 1992, Scandinavian Journal of Primary Health Care, V10, P211; MILLER Y, IN PRESS NEUROUROL U; NYGAARD I, 1990, OBSTET GYNECOL, V75, P848; Persson J, 2000, OBSTET GYNECOL, V96, P440, DOI 10.1016/S0029-7844(00)00950-9; POCOCK SJ, 1982, STATISTICIAN, V31, P1; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; SAYER T, 1994, PHYSIOTHERAPY, V80, P143; SAYER TR, 1990, NEUROUROL URODYNAM, V9, P319; SIMEONOVA Z, 1990, Scandinavian Journal of Primary Health Care, V8, P203, DOI 10.3109/02813439008994959; UEBERSAX JS, 1995, NEUROUROL URODYNAM, V14, P131, DOI 10.1002/nau.1930140206; VIKTRUP L, 1992, OBSTET GYNECOL, V79, P945; Wilson PD, 1996, BRIT J OBSTET GYNAEC, V103, P154, DOI 10.1111/j.1471-0528.1996.tb09668.x	26	71	76	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2002	324	7348					1241	+		10.1136/bmj.324.7348.1241	http://dx.doi.org/10.1136/bmj.324.7348.1241			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	557EJ	12028976	Bronze, Green Published			2022-12-28	WOS:000175894900016
J	Hao, B; Gong, WM; Ferguson, TK; James, CM; Krzycki, JA; Chan, MK				Hao, B; Gong, WM; Ferguson, TK; James, CM; Krzycki, JA; Chan, MK			A new UAG-encoded residue in the structure of a methanogen methyltransferase	SCIENCE			English	Article							M METHYL TRANSFER; X-RAY STRUCTURE; METHANOSARCINA-BARKERI; CORRINOID PROTEIN; CRYSTAL-STRUCTURE; COENZYME B-12; AMINO-ACID; PROGRAM; MONOMETHYLAMINE; RECONSTITUTION	Genes encoding methanogenic methylamine methyltransferases all contain an in-frame amber (UAG) codon that is read through during translation. We have identified the UAG-encoded residue in a 1.55 angstrom resolution structure of the Methanosarcina barkeri monomethylamine methyltransferase (MtmB). This structure reveals a homohexamer comprised of individual subunits with a TIM barrel fold. The electron density for the UAG-encoded residue is distinct from any of the 21 natural amino acids. Instead it appears consistent with a lysine in amide-linkage to (4R,SR)-4-substituted-pyrroline-5-carboxylate. We suggest that this amino acid be named L-pyrrolysine.	Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Chan, MK (corresponding author), Ohio State Univ, Dept Biochem, 484 W 12th Ave, Columbus, OH 43210 USA.		Ferguson, Thomas A/O-3444-2014	Ferguson, Thomas A/0000-0001-5822-3731	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043268] Funding Source: NIH RePORTER; NCRR NIH HHS [RR07707] Funding Source: Medline; NIGMS NIH HHS [GM43268] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkins J.F., 1999, RNA WORLD NATURE MOD, P637; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Doukov T, 2000, STRUCTURE, V8, P817, DOI 10.1016/S0969-2126(00)00172-6; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Ferguson DJ, 2000, J BIOL CHEM, V275, P29053, DOI 10.1074/jbc.M910218199; Furey W, 1997, METHOD ENZYMOL, V277, P590, DOI 10.1016/S0076-6879(97)77033-2; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Taylor JA, 1996, RAPID COMMUN MASS SP, V10, P679, DOI 10.1002/(SICI)1097-0231(199604)10:6<679::AID-RCM528>3.0.CO;2-Q; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377	22	295	314	3	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1462	1466		10.1126/science.1069556	http://dx.doi.org/10.1126/science.1069556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029132				2022-12-28	WOS:000175910300047
J	Harer, WB				Harer, WB			Vaginal birth after cesarean delivery - current status	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LABOR; SECTION; WOMEN; RISK		Riverside Cty Reg Med Ctr, Dept Womens Hlth Care, Moreno Valley, CA 92555 USA		Harer, WB (corresponding author), Riverside Cty Reg Med Ctr, Dept Womens Hlth Care, 26520 Cactus Ave, Moreno Valley, CA 92555 USA.	bharer@co.riverside.ca.us						*AM COLL OBST GYN, 2000, TASK FORC CES DEL RA; *AM COLL OBST GYN, 1999, ACOG PRACT B, V5; *AM COLL OBST GYN, 1995, ACOG PRACT PATT 1 VA; American College of Obstetricians and Gynecologists, 1984, ACOG COMM OP 17 GUID; Ananth CV, 1997, AM J OBSTET GYNECOL, V177, P1071, DOI 10.1016/S0002-9378(97)70017-6; BEDOYA C, 1992, INT J GYNECOL OBSTET, V39, P285, DOI 10.1016/0020-7292(92)90259-L; Bernstein S., 1998, LOS ANGELES TIM 1203, p[A1, A26]; BERNSTEIN S, 1998, LOS ANGELES TIM 0125, pA26; *CDCP, 2002, BIRTHS FIN DAT 1999; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P1073; Cragin E.B, 1916, NY MED; Davila GW, 2001, INT UROGYNECOL J, V12, P289; Faltin DL, 2000, OBSTET GYNECOL, V95, P643, DOI 10.1016/S0029-7844(99)00631-6; *FED INT GYN OBST, 2000, COMM ETH ASP HUM REP, P36; GRIFFIN LP, 1998, ACOG CLIN REV, V3, P1; GRIFFIN LP, 1998, ACOG CLIN REV, V3, P13; Harer WB, 2002, OBSTET GYNECOL SURV, V57, P61; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; MILLER DA, 1994, OBSTET GYNECOL, V84, P255; NOTZON FC, 1994, AM J OBSTET GYNECOL, V170, P495, DOI 10.1016/S0002-9378(94)70217-9; PINOTTI JA, 1994, J SOC OBSTET GYNECOL, V16, P2167; ROSS MG, 2001, LETT COLLEAGUES REGA; Schenker JG, 1999, INT J GYNECOL OBSTET, V64, P317; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; *US DEP HHS, 1981, NIH PUBL, P351	26	21	22	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 22	2002	287	20					2627	2630		10.1001/jama.287.20.2627	http://dx.doi.org/10.1001/jama.287.20.2627			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554JQ	12020285				2022-12-28	WOS:000175732400002
J	Goldberg, C				Goldberg, C			Bruce's choice	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									San Diego VA Med Ctr, Dept Internal Med, San Diego, CA 92101 USA; San Diego VA Med Ctr, San Diego, CA 92037 USA		Goldberg, C (corresponding author), San Diego VA Med Ctr, Dept Internal Med, 3350 La Jolla Village Dr, San Diego, CA 92101 USA.	charles.goldberg@med.va.gov							0	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					777	778		10.7326/0003-4819-136-10-200205210-00014	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00014			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020147				2022-12-28	WOS:000175664600009
J	Jensen, J; Lundin-Olsson, L; Nyberg, L; Gustafson, Y				Jensen, J; Lundin-Olsson, L; Nyberg, L; Gustafson, Y			Fall and injury prevention in older people living in residential care facilities - A cluster randomized trial	ANNALS OF INTERNAL MEDICINE			English	Article							EXTERNAL HIP PROTECTORS; ELDERLY-PEOPLE; EXERCISE; POPULATION; RISK; PROGRAM; REDUCE	Background: Falls and resulting injuries are particularly common in older people living in residential care facilities, but knowledge about the prevention of falls is limited. Objective: To investigate whether a multifactorial intervention program would reduce falls and fall-related injuries. Design: A cluster randomized, controlled, nonblincled trial. Setting: 9 residential care facilities located in a northern Swedish city. Patients: 439 residents 65 years of age or older. Intervention: An 11-week multidisciplinary program that included both general and resident-specific, tailored strategies. The strategies comprised educating staff, modifying the environment, implementing exercise programs, supplying and repairing aids, reviewing drug regimens, providing free hip protectors, having post-fall problem-solving conferences, and guiding staff. Measurements: The primary outcomes were the number of residents sustaining a fall, the number of falls, and the time to occurrence of the first fall. A secondary outcome was the number of injuries resulting from falls. Results: During the 34-week follow-up period, 82 residents (44%) in the intervention program sustained a fall compared with 109 residents (56%) in the control group (risk ratio, 0.78 [95% Cl, 0.64 to 0.96]). The adjusted odds ratio was 0.49 (Cl, 0.37 to 0.65), and the adjusted incidence rate ratio of falls was 0.60 (Cl, 0.50 to 0.73). Each of 3 residents in the intervention group and 12 in the control group had 1 femoral fracture (adjusted odds ratio, 0.23 [Cl, 0.06 to 0.94]). Clustering was considered in all regression models. Conclusion: An interdisciplinary and multifactorial prevention program targeting residents, staff, and the environment may reduce falls and femoral fractures.	Umea Univ, SE-90185 Umea, Sweden	Umea University	Jensen, J (corresponding author), Umea Univ, SE-90185 Umea, Sweden.	jane.jensen@germed.umu.se		Gustafson, Yngve/0000-0002-0999-377X				American Association for Automotive Medicine, 1990, ABBR INJ SCAL; BUCHNER DM, 1993, J AM GERIATR SOC, V41, P297, DOI 10.1111/j.1532-5415.1993.tb06708.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Ekman A, 1997, LANCET, V350, P563, DOI 10.1016/S0140-6736(05)63140-6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner MM, 2000, BRIT J SPORT MED, V34, P7, DOI 10.1136/bjsm.34.1.7; GILLESPIE LD, 2001, COCHRANE DB SYST REV, V3; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; LAURITZEN JB, 1993, LANCET, V341, P11, DOI 10.1016/0140-6736(93)92480-H; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Lundin-Olsson L, 1998, J AM GERIATR SOC, V46, P758, DOI 10.1111/j.1532-5415.1998.tb03813.x; Lundin-Olsson L, 2000, Physiother Res Int, V5, P190, DOI 10.1002/pri.198; LundinOlsson L, 1997, LANCET, V349, P617, DOI 10.1016/S0140-6736(97)24009-2; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; LUUKINEN H, 1994, J CLIN EPIDEMIOL, V47, P843, DOI 10.1016/0895-4356(94)90187-2; MAHONEY F I, 1965, Md State Med J, V14, P61; McMurdo MET, 2000, GERONTOLOGY, V46, P83, DOI 10.1159/000022139; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; Norton R, 1999, AGE AGEING, V28, P135, DOI 10.1093/ageing/28.2.135; Nowalk MP, 2001, J AM GERIATR SOC, V49, P859, DOI 10.1046/j.1532-5415.2001.49174.x; PARKER MJ, 2001, COCHRANE DB SYST REV, V2, P1255; PROVINCE MA, 1995, JAMA-J AM MED ASSOC, V273, P1341, DOI 10.1001/jama.273.17.1341; Ramnemark A, 2000, STROKE, V31, P1572, DOI 10.1161/01.STR.31.7.1572; Ray WA, 1997, JAMA-J AM MED ASSOC, V278, P557, DOI 10.1001/jama.278.7.557; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Wade D T, 1988, Int Disabil Stud, V10, P64	34	224	227	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					733	741		10.7326/0003-4819-136-10-200205210-00008	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553FF	12020141				2022-12-28	WOS:000175664600003
J	Santos-Eggimann, B				Santos-Eggimann, B			Increasing use of the emergency department in a Swiss hospital: observational study based on measures of the severity of cases	BRITISH MEDICAL JOURNAL			English	Article							ADMISSIONS; RISE		Univ Lausanne, Inst Social & Prevent Med, Hlth Serv Res Unit, CH-1005 Lausanne, Switzerland	University of Lausanne	Santos-Eggimann, B (corresponding author), Univ Lausanne, Inst Social & Prevent Med, Hlth Serv Res Unit, CH-1005 Lausanne, Switzerland.			Santos-Eggimann, Brigitte/0000-0001-9115-6147				Capewell S, 1996, BRIT MED J, V312, P991; Hull S A, 1997, J Health Serv Res Policy, V2, P6; Meggs WJ, 1999, ACAD EMERG MED, V6, P1030, DOI 10.1111/j.1553-2712.1999.tb01188.x; Morgan K, 1999, BRIT MED J, V319, P158, DOI 10.1136/bmj.319.7203.158; TRYBA M, 1980, ANASTH INTENSIVMED, V6, P725	5	25	26	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1186	1187		10.1136/bmj.324.7347.1186	http://dx.doi.org/10.1136/bmj.324.7347.1186			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016182	Green Published, Bronze			2022-12-28	WOS:000175763200016
J	Crowther, R				Crowther, R			Space science - Space junk - Protecting space for future generations	SCIENCE			English	Editorial Material									QinetQ, Malvern, Worcs, England	Qinetiq Group Plc	Crowther, R (corresponding author), QinetQ, Malvern, Worcs, England.							ALBY F, 2001, ESA SPEC PUBL, V473; [Anonymous], 1999, TECHN REP SPAC DEBR; BONNAL C, 1997, ESA SPEC PUBL, V393; JOHNSON NL, 2001, HIST ON ORBIT FRAGME; National Science and Technology Council Committee on Transportation Research and Development, 1995, INT REP ORB DEBR; REX D, 1997, ESA SPEC PUBL, V393	6	11	11	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1241	1242		10.1126/science.1069725	http://dx.doi.org/10.1126/science.1069725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016293				2022-12-28	WOS:000175713000027
J	Kauer, JS				Kauer, JS			On the scents of smell in the salamander	NATURE			English	Review							RAT OLFACTORY-BULB; VOLTAGE-SENSITIVE DYE; RECEPTOR-CELLS; ODOR STIMULATION; TEMPORAL PROPERTIES; TIGER SALAMANDER; CHANNEL CATFISH; SENSORY MAP; VIDEO-RATE; NEURONS		Tufts Univ, Sch Med, Dept Neurosci, Boston, MA 02111 USA	Tufts University	Kauer, JS (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, 136 Harrison Ave, Boston, MA 02111 USA.	john.kauer@tufts.edu						ACHE BW, 1991, SMELL TASTE HLTH DIS, P3; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Alkasab TK, 2002, CHEM SENSES, V27, P261, DOI 10.1093/chemse/27.3.261; Alkasab TK, 1999, TRENDS NEUROSCI, V22, P102, DOI 10.1016/S0166-2236(98)01351-4; Amoore J. E., 1962, P SCI SECT TOILET GO, V37, P1; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; BEETS MGJ, 1970, PHARMACOL REV, V22, P1; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; CHRISTENSEN TA, 2000, NEUROBIOLOGY TASTE S, P197; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2033, DOI 10.1152/jn.1995.73.5.2033; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; Dorries KM, 1997, CHEM SENSES, V22, P277, DOI 10.1093/chemse/22.3.277; DuchampViret P, 1997, PROG NEUROBIOL, V53, P561, DOI 10.1016/S0301-0082(97)00049-X; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; FIRESTEIN S, 1991, J NEUROSCI, V11, P3565; FIRESTEIN S, 1990, J PHYSIOL-LONDON, V430, P135, DOI 10.1113/jphysiol.1990.sp018286; FREEMAN WJ, 1987, BEHAV NEUROSCI, V101, P393, DOI 10.1037/0735-7044.101.3.393; FREEMAN WJ, 1991, SCI AM, V264, P78, DOI 10.1038/scientificamerican0291-78; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gelperin A., 1989, P133; GESTELAND RC, 1965, J PHYSIOL-LONDON, V181, P525, DOI 10.1113/jphysiol.1965.sp007781; GETCHELL TV, 1978, J PHYSIOL-LONDON, V282, P521, DOI 10.1113/jphysiol.1978.sp012479; GETCHELL TV, 1973, J PHYSIOL-LONDON, V234, P533, DOI 10.1113/jphysiol.1973.sp010359; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; HALASZ N, 1993, J COMP NEUROL, V337, P307, DOI 10.1002/cne.903370211; HAMILTON KA, 1985, BRAIN RES, V338, P181, DOI 10.1016/0006-8993(85)90265-3; Herrick C. J., 1948, BRAIN TIGER SALAMAND; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAISSLING KE, 1989, ARCH INSECT BIOCHEM, V10, P273, DOI 10.1002/arch.940100403; Kauer J.S., 1987, P205; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; Kauer JS, 2001, ANNU REV NEUROSCI, V24, P963, DOI 10.1146/annurev.neuro.24.1.963; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; KAUER JS, 1981, ANAT REC, V200, P331, DOI 10.1002/ar.1092000313; KAUER JS, 1991, OLFACTION, P43; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1975, BRAIN RES, V85, P108, DOI 10.1016/0006-8993(75)91014-8; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; KAUER JS, 2002, SALAM REFERENCE LIST; KAUER JS, 1973, RESPONSE PROPERTIES; KAUER JS, 1980, OLFACTION TASTE, V7, P227; Keller A, 1998, J NEUROSCI, V18, P2602; KENT PF, 1992, J NEUROPHYSIOL, V68, P1804, DOI 10.1152/jn.1992.68.5.1804; LANCET D, 1993, P NATL ACAD SCI USA, V90, P3715, DOI 10.1073/pnas.90.8.3715; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 1998, J NEUROSCI, V18, P5630; LINDQUIST SB, 1982, COPEIA, P81; LOWE G, 1993, J PHYSIOL-LONDON, V462, P175, DOI 10.1113/jphysiol.1993.sp019550; MALACINSKI GM, 2002, INDIANA U AXOLOTL CO; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MASON JR, 1981, PHYSIOL BEHAV, V26, P647, DOI 10.1016/0031-9384(81)90139-6; MATURANA HUMBERTO R., 1960, JOUR GEN PHYSIOL, V43, P129, DOI 10.1085/jgp.43.6.129; Meister M, 2001, J NEUROSCI, V21, P1351; Mellon D, 2000, J NEUROPHYSIOL, V84, P3043, DOI 10.1152/jn.2000.84.6.3043; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Nikonov AA, 2001, J NEUROPHYSIOL, V86, P1869, DOI 10.1152/jn.2001.86.4.1869; Penrose R, 1995, NATURE'S IMAGINATION, P12; POLAK EH, 1973, J THEOR BIOL, V40, P469, DOI 10.1016/0022-5193(73)90005-2; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RESTREPO D, 1993, AM J PHYSIOL, V264, pC906, DOI 10.1152/ajpcell.1993.264.4.C906; REVIAL MF, 1982, CHEM SENSES, V7, P175, DOI 10.1093/chemse/7.2.175; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Scott JW, 2000, J NEUROSCI, V20, P4721, DOI 10.1523/JNEUROSCI.20-12-04721.2000; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SIMMONS PA, 1981, J NEUROPHYSIOL, V45, P516, DOI 10.1152/jn.1981.45.3.516; Slotnick BM, 1997, BRAIN RES, V762, P89, DOI 10.1016/S0006-8993(97)00357-0; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Touhara K, 2000, P NATL ACAD SCI USA, V97, P3782; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Van Houten JL, 2000, J NUTR, V130, p946S, DOI 10.1093/jn/130.4.946S; VOSS SR, 2002, SALAMANDER GENOME PR; Warr C, 2001, CHEM SENSES, V26, P201, DOI 10.1093/chemse/26.2.201; WELLIS DP, 1993, J PHYSIOL-LONDON, V469, P315, DOI 10.1113/jphysiol.1993.sp019816; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; White J, 2001, Prog Brain Res, V130, P191; WHITE J, 1992, J NEUROSCI, V12, P1772; ZHAO H, 1994, ACHEMSABSTR; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506; [No title captured]	89	33	33	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					336	342		10.1038/417336a	http://dx.doi.org/10.1038/417336a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015614				2022-12-28	WOS:000175592100058
J	Pepys, MB; Herbert, J; Hutchinson, WL; Tennent, GA; Lachmann, HJ; Gallimore, JR; Lovat, LB; Bartfai, T; Alanine, A; Hertel, C; Hoffmann, T; Jakob-Roetne, R; Norcross, RD; Kemp, JA; Yamamura, K; Suzuki, M; Taylor, GW; Murray, S; Thompson, D; Purvis, A; Kolstoe, S; Wood, SP; Hawkins, PN				Pepys, MB; Herbert, J; Hutchinson, WL; Tennent, GA; Lachmann, HJ; Gallimore, JR; Lovat, LB; Bartfai, T; Alanine, A; Hertel, C; Hoffmann, T; Jakob-Roetne, R; Norcross, RD; Kemp, JA; Yamamura, K; Suzuki, M; Taylor, GW; Murray, S; Thompson, D; Purvis, A; Kolstoe, S; Wood, SP; Hawkins, PN			Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis	NATURE			English	Article							SYSTEMIC AMYLOIDOSIS; ALZHEIMER-DISEASE; LIVER-TRANSPLANTATION; AA AMYLOIDOSIS; IN-VIVO; X-RAY; MOUSE; DEPOSITS; PROGRAM; PROTEIN	The normal plasma protein serum amyloid P component (SAP) binds to fibrils in all types of amyloid deposits, and contributes to the pathogenesis of amyloidosis. In order to intervene in this process we have developed a drug, R-1-[6-[R-2-carboxy-pyrrolidin-1-yl]-6-oxo-hexanoyl] pyrrolidine-2-carboxylic acid, that is a competitive inhibitor of SAP binding to amyloid fibrils. This palindromic compound also crosslinks and dimerizes SAP molecules, leading to their very rapid clearance by the liver, and thus produces a marked depletion of circulating human SAP. This mechanism of drug action potently removes SAP from human amyloid deposits in the tissues and may provide a new therapeutic approach to both systemic amyloidosis and diseases associated with local amyloid, including Alzheimer's disease and type 2 diabetes.	UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England; F Hoffmann La Roche & Co Ltd, Preclin CNS Res, Div Pharmaceut, CH-4070 Basel, Switzerland; Kumamoto Univ, Inst Mol Embryol & Genet, Kumamoto 860, Japan; Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 860, Japan; Imperial Coll Sch Med, Div Med, London W12 0NN, England; Univ Southampton, Sch Biol Sci, Div Biochem & Mol Biol, Southampton SO16 7PX, Hants, England	University of London; University College London; UCL Medical School; Roche Holding; Kumamoto University; Kumamoto University; Imperial College London; University of Southampton	Pepys, MB (corresponding author), UCL Royal Free & Univ Coll Med Sch, Ctr Amyloidosis & Acute Phase Prot, London NW3 2PF, England.	m.pepys@rfc.ucl.ac.uk	Kolstoe, Simon/O-4996-2019; Hawkins, Philip N/C-5573-2008; Wood, Stephen P/B-1438-2009; Taylor, Graham Walter/R-4811-2019; Lovat, Laurence/C-1986-2009	Kolstoe, Simon/0000-0003-1472-3966; Taylor, Graham Walter/0000-0002-9672-8463; Lovat, Laurence/0000-0003-4542-3915; Lachmann, Helen/0000-0001-8378-2498				Ashton AW, 1997, J MOL BIOL, V272, P408, DOI 10.1006/jmbi.1997.1271; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Botto M, 1997, NAT MED, V3, P855, DOI 10.1038/nm0897-855; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; EMSLEY J, 1994, NATURE, V367, P338, DOI 10.1038/367338a0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gillmore JD, 1997, BRIT J HAEMATOL, V99, P245, DOI 10.1046/j.1365-2141.1997.303194.x; Gillmore JD, 2000, QJM-INT J MED, V93, P269, DOI 10.1093/qjmed/93.5.269; HAWKINS PN, 1991, CLIN EXP IMMUNOL, V84, P308; HAWKINS PN, 1988, J EXP MED, V167, P903, DOI 10.1084/jem.167.3.903; HAWKINS PN, 1988, LANCET, V1, P1413; HAWKINS PN, 1990, J CLIN INVEST, V86, P1862, DOI 10.1172/JCI114917; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; HERTEL C, 2001, Patent No. 6262089; HIND CRK, 1984, LANCET, V2, P376; Hohenester E, 1997, J MOL BIOL, V269, P570, DOI 10.1006/jmbi.1997.1075; HOLMGREN G, 1993, LANCET, V341, P1113, DOI 10.1016/0140-6736(93)93127-M; HUTCHINSON WL, 1994, J CLIN INVEST, V94, P1390, DOI 10.1172/JCI117474; Hutchinson WL, 2000, MOL MED, V6, P482, DOI 10.1007/BF03401789; IWANAGA T, 1989, DEV GENET, V10, P365, DOI 10.1002/dvg.1020100504; Jager PL, 1998, J NUCL MED, V39, P699; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEPYS MB, 1979, IMMUNOLOGY, V37, P637; PEPYS MB, 1994, P NATL ACAD SCI USA, V91, P5602, DOI 10.1073/pnas.91.12.5602; Pepys MB, 2001, PHILOS T R SOC B, V356, P203, DOI 10.1098/rstb.2000.0766; PEPYS MB, 1979, NATURE, V278, P259, DOI 10.1038/278259a0; PEPYS MB, 2001, SAMTERS IMMUNOLOGIC, P401; PEPYS MB, 2000, Patent No. 6126918; PEPYS MB, 2001, Patent No. 01193705; PEPYS MB, 1997, INT J EXP CLIN INVES, V4, P274; Rydh A, 1998, EUR J NUCL MED, V25, P709; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; TENNENT GA, 1995, P NATL ACAD SCI USA, V92, P4299, DOI 10.1073/pnas.92.10.4299; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	40	387	438	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					254	259		10.1038/417254a	http://dx.doi.org/10.1038/417254a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015594				2022-12-28	WOS:000175592100038
J	Davies, MJ; Baer, DJ; Judd, JT; Brown, ED; Campbell, WS; Taylor, PR				Davies, MJ; Baer, DJ; Judd, JT; Brown, ED; Campbell, WS; Taylor, PR			Effects of moderate alcohol intake on fasting insulin and glucose concentrations and insulin sensitivity in postmenopausal women - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARBOHYDRATE-INDUCED HYPERTRIGLYCERIDEMIA; CORONARY HEART-DISEASE; CARDIOVASCULAR-DISEASE; RISK-FACTORS; PLASMA-INSULIN; BREAST-CANCER; LOW-FAT; CONSUMPTION; RESISTANCE; MENOPAUSE	Context Epidemiologic data demonstrate that moderate alcohol intake is associated with improved insulin sensitivity in nondiabetic individuals. No controlled-diet studies have addressed the effects of daily moderate alcohol consumption on fasting insulin and glucose concentrations and insulin sensitivity. Objective To determine whether daily consumption of low to moderate amounts of alcohol influences fasting insulin and glucose concentrations and insulin sensitivity in nondiabetic postmenopausal women. Design, Setting, and Participants Randomized controlled crossover trial of 63 healthy postmenopausal women, conducted at a clinical research center in Maryland between 1998 and 1999. Interventions Participants were randomly assigned to consume 0, 15, or 30 g/d of alcohol for 8 weeks each as part of a controlled diet. All foods and beverages were provided during the intervention. An isocaloric beverage was provided in the 0-g/d arm. Energy intake was adjusted to maintain constant body weight. Main Outcome Measures Fasting insulin, triglyceride, and glucose concentrations, measured at the end of each dietary period; insulin sensitivity, estimated with a published index of glucose disposal rate corrected for fat-free mass based on fasting insulin and fasting triglyceride concentrations, compared among treatments with a mixed-model analysis of variance. Results A complete set of plasma samples was collected and analyzed for 51 women who completed all diet treatments. Consumption of 30 g/d of alcohol compared with 0 g/d reduced fasting insulin concentration by 19.2% (P=.004) and triglyceride concentration by 10.3% (P=.001), and increased insulin sensitivity by 7.2% (P=.002). Normal-weight, overweight, and obese individuals responded similarly. Only fasting triglyceride concentration was significantly reduced when comparing 0 and 15 g/d of alcohol (7.8%; P=.03), and no difference was found between consumption of 15 and 30 g/d of alcohol; however, there was a significant linear trend (P=.001). Fasting glucose concentrations were not different across treatments. Conclusions Consumption of 30 g/d of alcohol (2 drinks per day) has beneficial effects on insulin and triglyceride concentrations and insulin sensitivity in nondiabetic postmenopausal women.										Baer DJ, 2002, AM J CLIN NUTR, V75, P593, DOI 10.1093/ajcn/75.3.593; Bell RA, 2000, DIABETES CARE, V23, P1630, DOI 10.2337/diacare.23.11.1630; Cordain L, 2000, METABOLISM, V49, P1473, DOI 10.1053/meta.2000.17672; Daly ME, 1997, AM J CLIN NUTR, V66, P1072, DOI 10.1093/ajcn/66.5.1072; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; FACCHINI F, 1994, DIABETES CARE, V17, P115, DOI 10.2337/diacare.17.2.115; Flanagan DEH, 2000, EUR J CLIN INVEST, V30, P297; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GORDON T, 1978, ANN INTERN MED, V89, P157, DOI 10.7326/0003-4819-89-2-157; Hankinson SE, 1998, JNCI-J NATL CANCER I, V90, P1292, DOI 10.1093/jnci/90.17.1292; Howard G, 1996, CIRCULATION, V93, P1809, DOI 10.1161/01.CIR.93.10.1809; Hudgins LC, 2000, J LIPID RES, V41, P595; Kasim-Karakas SE, 2000, AM J CLIN NUTR, V71, P1439; KEMM J, 1993, BRIT MED J, V307, P1373, DOI 10.1136/bmj.307.6916.1373; Kiechl S, 1996, BRIT MED J, V313, P1040; LAAKSO M, 1993, AM J EPIDEMIOL, V137, P959, DOI 10.1093/oxfordjournals.aje.a116768; Lazarus R, 1997, AM J EPIDEMIOL, V145, P909, DOI 10.1093/oxfordjournals.aje.a009050; LECLERC I, 1993, METABOLISM, V42, P365, DOI 10.1016/0026-0495(93)90088-6; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; MAYER EJ, 1993, CIRCULATION, V88, P2190, DOI 10.1161/01.CIR.88.5.2190; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; McLaughlin T, 2000, J CLIN ENDOCR METAB, V85, P3085, DOI 10.1210/jc.85.9.3085; Parks EJ, 2000, AM J CLIN NUTR, V71, P412; PROUDLER AJ, 1992, CLIN SCI, V83, P489, DOI 10.1042/cs0830489; RAZAY G, 1992, Q J MED, V85, P889; RAZAY G, 1992, BRIT MED J, V304, P80, DOI 10.1136/bmj.304.6819.80; Ruige JB, 1998, CIRCULATION, V97, P996; STAMPFER MJ, 1988, AM J EPIDEMIOL, V128, P549, DOI 10.1093/oxfordjournals.aje.a115002; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; Stern MP, 1996, ANN INTERN MED, V124, P110, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00006; Vidon C, 2001, AM J CLIN NUTR, V73, P878; WALTON C, 1993, EUR J CLIN INVEST, V23, P466, DOI 10.1111/j.1365-2362.1993.tb00792.x; WING RR, 1991, ARCH INTERN MED, V151, P97, DOI 10.1001/archinte.151.1.97; Wollin SD, 2001, J NUTR, V131, P1401, DOI 10.1093/jn/131.5.1401	35	345	353	3	30	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2559	2562		10.1001/jama.287.19.2559	http://dx.doi.org/10.1001/jama.287.19.2559			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020337	Bronze			2022-12-28	WOS:000175566200025
J	Newman, DK; Banfield, JF				Newman, DK; Banfield, JF			Geomicrobiology: How molecular-scale interactions underpin biogeochemical systems	SCIENCE			English	Review							SULFATE-REDUCING BACTERIA; MINE DRAINAGE; MICROBIAL ACTIVITY; METAL REDUCTION; IRON; OXIDATION; DIVERSITY; SHEWANELLA; DISSOLUTION; RESPIRATION	Microorganisms populate every habitable environment on Earth and, through their metabolic activity, affect the chemistry and physical properties of their surroundings. They have done this for billions of years. Over the past decade, genetic, biochemical, and genomic approaches have allowed us to document the diversity of microbial life in geologic systems without cultivation, as well as to begin to elucidate their function. With expansion of culture-independent analyses of microbial communities, it will be possible to quantify gene activity at the species level. Genome-enabled biogeochemical modeling may provide an opportunity to determine how communities function, and how they shape and are shaped by their environments.	CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	California Institute of Technology; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Newman, DK (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	dkn@caltech.edu; jill@seismo.berkeley.edu	chen, qi/C-8585-2011	Banfield, Jill/0000-0001-8203-8771				Amend JP, 2001, FEMS MICROBIOL REV, V25, P175, DOI 10.1016/S0168-6445(00)00062-0; Angert ER, 1998, AM MINERAL, V83, P1583, DOI 10.2138/am-1998-11-1246; Barbeau K, 2001, NATURE, V413, P409, DOI 10.1038/35096545; Barton HA, 2001, GEOMICROBIOL J, V18, P359, DOI 10.1080/01490450152467840; Beijerinck MW., 1888, BOT ZTG, V46, P725; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2001, NATURE, V411, P786, DOI 10.1038/35081051; Beliaev Alex S., 2002, OMICS A Journal of Integrative Biology, V6, P39, DOI 10.1089/15362310252780834; Beliaev AS, 2001, MOL MICROBIOL, V39, P722, DOI 10.1046/j.1365-2958.2001.02257.x; BLAKE RC, 1993, FEMS MICROBIOL REV, V11, P9; Blaudez D, 2000, FEMS MICROBIOL ECOL, V33, P61, DOI 10.1111/j.1574-6941.2000.tb00727.x; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bond DR, 2002, SCIENCE, V295, P483, DOI 10.1126/science.1066771; Bond PL, 2000, APPL ENVIRON MICROB, V66, P4962, DOI 10.1128/AEM.66.11.4962-4971.2000; Bond PL, 2000, APPL ENVIRON MICROB, V66, P3842, DOI 10.1128/AEM.66.9.3842-3849.2000; Brooks R, 2001, NATURE, V409, P409, DOI 10.1038/35053196; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Cervini-Silva J, 2002, ENVIRON SCI TECHNOL, V36, P337, DOI 10.1021/es010901n; Chapelle FH, 2002, NATURE, V415, P312, DOI 10.1038/415312a; Cocozza C, 2002, GEOCHIM COSMOCHIM AC, V66, P431, DOI 10.1016/S0016-7037(01)00780-3; Costerton JW, 2001, SCI AM, V285, P74, DOI 10.1038/scientificamerican0701-74; Cullen JT, 1999, NATURE, V402, P165, DOI 10.1038/46007; Cummings DE, 1999, ENVIRON SCI TECHNOL, V33, P723, DOI 10.1021/es980541c; DAVEY ME, 2001, MICROBIOL MOL BIOL R, V9, P34; Devereux R, 1996, FEMS MICROBIOL ECOL, V20, P23, DOI 10.1111/j.1574-6941.1996.tb00301.x; DiChristina TJ, 2002, J BACTERIOL, V184, P142, DOI 10.1128/JB.184.1.142-151.2002; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Dubiel M, 2002, APPL ENVIRON MICROB, V68, P1440, DOI 10.1128/AEM.68.3.1440-1445.2002; Edwards KJ, 2000, SCIENCE, V287, P1796, DOI 10.1126/science.287.5459.1796; Edwards KJ, 2000, CHEM GEOL, V169, P383, DOI 10.1016/S0009-2541(00)00216-3; Fennell DE, 2001, ENVIRON SCI TECHNOL, V35, P1830, DOI 10.1021/es0016203; Francis CA, 2002, APPL ENVIRON MICROB, V68, P874, DOI 10.1128/AEM.68.2.874-880.2002; Hernandez ME, 2001, CELL MOL LIFE SCI, V58, P1562, DOI 10.1007/PL00000796; Jackson BE, 2002, NATURE, V415, P454, DOI 10.1038/415454a; Jetten MSM, 2001, CURR OPIN BIOTECH, V12, P283, DOI 10.1016/S0958-1669(00)00211-1; Jones B, 2001, GEOMICROBIOL J, V18, P345, DOI 10.1080/01490450152467831; Kashefi K, 2000, APPL ENVIRON MICROB, V66, P1050, DOI 10.1128/AEM.66.3.1050-1056.2000; Kashefi K, 2001, APPL ENVIRON MICROB, V67, P3275, DOI 10.1128/AEM.67.7.3275-3279.2001; Kasting JF, 2002, SCIENCE, V296, P1066, DOI 10.1126/science.1071184; Kirschvink JL, 2000, P NATL ACAD SCI USA, V97, P1400, DOI 10.1073/pnas.97.4.1400; Klein M, 2001, J BACTERIOL, V183, P6028, DOI 10.1128/JB.183.20.6028-6035.2001; Kluyver, 1924, CHEM WEEKBL, V2, P266; Krumholz LR, 1998, ASM NEWS, V64, P197; KRUMHOLZ LR, 1997, NATURE, V349, P233; Labrenz M, 2000, SCIENCE, V290, P1744, DOI 10.1126/science.290.5497.1744; Lloyd JR, 2001, HYDROMETALLURGY, V59, P327, DOI 10.1016/S0304-386X(00)00175-4; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567; Macrellis HM, 2001, MAR CHEM, V76, P175, DOI 10.1016/S0304-4203(01)00061-5; Magnuson TS, 2000, FEMS MICROBIOL LETT, V185, P205, DOI 10.1016/S0378-1097(00)00081-1; Melim LA, 2001, GEOMICROBIOL J, V18, P311, DOI 10.1080/01490450152467813; Metcalf WW, 1998, J BACTERIOL, V180, P5547, DOI 10.1128/JB.180.21.5547-5558.1998; Minz D, 1999, APPL ENVIRON MICROB, V65, P4666; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; NEVIN KP, 2000, APPL ENVIRON MICROB, V64, P3188; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; Olsen GJ, 2001, NAT GENET, V28, P197, DOI 10.1038/90014; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Petsch ST, 2001, SCIENCE, V292, P1127, DOI 10.1126/science.1058332; Reysenbach AL, 2002, SCIENCE, V296, P1077, DOI 10.1126/science.1072483; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000; Sarbu SM, 1996, SCIENCE, V272, P1953, DOI 10.1126/science.272.5270.1953; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schink B, 1997, MICROBIOL MOL BIOL R, V61, P262, DOI 10.1128/.61.2.262-280.1997; Schink B, 2000, NATURE, V406, P37, DOI 10.1038/35017644; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; Sharma A, 2002, SCIENCE, V295, P1514, DOI 10.1126/science.1068018; Shyu JBH, 2002, J BACTERIOL, V184, P1806, DOI 10.1128/JB.184.6.1806-1810.2002; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Sobolev D, 2001, APPL ENVIRON MICROB, V67, P1328, DOI 10.1128/AEM.67.3.1328-1334.2001; Stephens C, 2001, CURR BIOL, V11, pR222, DOI 10.1016/S0960-9822(01)00110-5; Straub KL, 1998, APPL ENVIRON MICROB, V64, P4846; Takai K, 2000, INT J SYST EVOL MICR, V50, P489, DOI 10.1099/00207713-50-2-489; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WIDDEL F, 1993, NATURE, V362, P834, DOI 10.1038/362834a0; WINOGRADSKY S, 1889, ANN I PASTEUR, V3, P49; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Zehr JP, 2002, APPL ENVIRON MICROB, V68, P1015, DOI 10.1128/AEM.68.3.1015-1024.2002; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777	86	175	223	4	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1071	1077		10.1126/science.1010716	http://dx.doi.org/10.1126/science.1010716			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004119				2022-12-28	WOS:000175565000041
J	Bloom, BR				Bloom, BR			Perspective: Tuberculosis - The global view.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.								0	35	35	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1434	1435		10.1056/NEJM200205093461902	http://dx.doi.org/10.1056/NEJM200205093461902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000812				2022-12-28	WOS:000175433200001
J	Doudna, JA; Rath, VL				Doudna, JA; Rath, VL			Structure and function of the eukaryotic ribosome: The next frontier	CELL			English	Review							ANGSTROM RESOLUTION; COMPLEX	As the catalytic and regulatory centers of protein synthesis in cells, ribosomes are central to many aspects of cell and structural biology. Recent work highlights the unique properties and complexity of eukaryotic ribosomes and their component rRNAs and proteins.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; Yale University; Yale University	Doudna, JA (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.							Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	12	97	101	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 19	2002	109	2					153	156		10.1016/S0092-8674(02)00725-0	http://dx.doi.org/10.1016/S0092-8674(02)00725-0			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007402	Green Published, Bronze			2022-12-28	WOS:000175082600005
J	Sigouin, C; Jadad, AR				Sigouin, C; Jadad, AR			Awareness of sources of peer-reviewed research evidence on the Internet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN					Context Peer-reviewed research evidence that was once available only to clinicians is now posted on the Internet and accessible to everyone, but levels of awareness of this evidence among patients and clinicians is not known. Methods Cross-sectional survey, conducted from July 1998 through January 2000, of cancer patients (n = 1998), their family physicians (n = 871), and all oncologists (n = 30) and oncology nurses (n =44) at the Hamilton Regional Cancer Centre, Hamilton, Ontario. Comparisons made between and within groups to examine use of the Internet by patients and clinicians to find health information, and their awareness of organizations using Internet-based resources to promote evidence-based decision making. Results Response rates were 72%, 44%, 97%, and 84% for patients, family physicians, oncologists, and nurses, respectively; 47% of patients, 64% of family physicians, 100% of oncologists, and 72% of nurses reported that they used the Internet. Few patients were aware of the existence of the Cochrane Collaboration (1%), MEDLINE (13%), or the Program in Evidence-Based Care of Cancer Care Ontario (3%). Oncologists had the highest reported levels of awareness of the sources of evidence on the Internet. Most family physicians had not heard of any of the sources. Conclusions The awareness of evidence sources on the Internet varies between patients and clinicians and across groups of clinicians, and some of the most rigorously developed sources of information are still unknown.	Univ Toronto, Univ Hlth Network, Ctr Global eHlth Innovat, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Jadad, AR (corresponding author), Toronto Gen Hosp, Univ Hlth Network, Ctr Global eHlth Innovat, Fraser Elliott Bldg,4th Floor,190 Elizabeth St, Toronto, ON M5G 2C4, Canada.							[Anonymous], 1978, MAIL TELEPHONE SURVE; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Jadad AR, 2000, CAN MED ASSOC J, V162, P362; Jadad AR, 2001, JAMA-J AM MED ASSOC, V286, P1451, DOI 10.1001/jama.286.12.1451; JADAD AR, 1998, RANDOMISED CONTROLLE, P93	5	30	31	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2867	2869		10.1001/jama.287.21.2867	http://dx.doi.org/10.1001/jama.287.21.2867			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038936	Bronze			2022-12-28	WOS:000176002200033
J	van der Linden, PD; Sturkenboom, MCJM; Herings, RMC; Leufkens, HGM; Stricker, BHC				van der Linden, PD; Sturkenboom, MCJM; Herings, RMC; Leufkens, HGM; Stricker, BHC			Fluoroquinolones and risk of Achilles tendon disorders: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ANTIBIOTICS; TENDINITIS; RUPTURE		Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat & Internal Med, Pharmacoepidemiol Unit, NL-3000 DR Rotterdam, Netherlands; Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmacoepidemiol & Pharmacotherapy, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University	Stricker, BHC (corresponding author), Erasmus Med Ctr Rotterdam, Dept Epidemiol & Biostat & Internal Med, Pharmacoepidemiol Unit, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Herings, Ron/AAE-4096-2021	Herings, Ron/0000-0002-2561-8734				HUSTON KA, 1994, NEW ENGL J MED, V331, P748, DOI 10.1056/NEJM199409153311116; MCEWAN SR, 1988, LANCET, V2, P900; McGarvey WC, 1996, FOOT ANKLE INT, V17, P496, DOI 10.1177/107110079601700811; SZARFMAN A, 1995, NEW ENGL J MED, V332, P193; van der Linden PD, 1999, BRIT J CLIN PHARMACO, V48, P433	5	130	131	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1306	1307		10.1136/bmj.324.7349.1306	http://dx.doi.org/10.1136/bmj.324.7349.1306			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039823	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000176041500016
J	Peoples, LL				Peoples, LL			Neuroscience: Will, anterior cingulate cortex, and addiction	SCIENCE			English	Editorial Material							COMPULSION; AVOIDANCE; BEHAVIOR; NEURONS; EMOTION; REWARD; ABUSE; PAIN		Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA	University of Pennsylvania	Peoples, LL (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.							BENES FM, 1987, ARCH GEN PSYCHIAT, V44, P608; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Childress AR, 1999, AM J PSYCHIAT, V156, P11, DOI 10.1176/ajp.156.1.11; Damasio AR, 1998, BRAIN RES REV, V26, P83, DOI 10.1016/S0165-0173(97)00064-7; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Franklin TR, 2002, BIOL PSYCHIAT, V51, P134, DOI 10.1016/S0006-3223(01)01269-0; Koyama T, 2001, NEUROSCI RES, V39, P421, DOI 10.1016/S0168-0102(01)00197-3; Koyama T, 1998, NEUROREPORT, V9, P2663, DOI 10.1097/00001756-199808030-00044; Kubota Y, 1996, BRAIN RES, V721, P22, DOI 10.1016/0006-8993(96)00091-1; Lane RD, 1998, J COGNITIVE NEUROSCI, V10, P525, DOI 10.1162/089892998562924; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; O'Brien CP, 1998, J PSYCHOPHARMACOL, V12, P15, DOI 10.1177/026988119801200103; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Procyk E, 2001, EUR J NEUROSCI, V14, P1041, DOI 10.1046/j.0953-816x.2001.01738.x; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rubinsztein JS, 2001, BRAIN, V124, P2550, DOI 10.1093/brain/124.12.2550; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Vogt BA, 1993, NEUROBIOLOGY CINGULA; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318	22	65	68	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1623	1624		10.1126/science.1072997	http://dx.doi.org/10.1126/science.1072997			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040168				2022-12-28	WOS:000175976200031
J	McMichael, A; Klenerman, P				McMichael, A; Klenerman, P			HIV/AIDS - HLA leaves its footprints on HIV	SCIENCE			English	Editorial Material							T-LYMPHOCYTE RESPONSES; IMMUNODEFICIENCY-VIRUS; ESCAPE; PROGRESSION; INFECTION; MUTATIONS; VARIANTS; SELECT; AIDS; GAG		Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, Medawar Ctr Pathogen Res, Oxford OX1 1S5, England	University of Oxford; University of Oxford	McMichael, A (corresponding author), Weatherall Inst Mol Med, Oxford OX3 9DS, England.			klenerman, paul/0000-0003-4307-9161				Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Barouch DH, 2002, NATURE, V415, P335, DOI 10.1038/415335a; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Evans DT, 1999, NAT MED, V5, P1270, DOI 10.1038/15224; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Goulder PJR, 1997, NAT MED, V3, P212, DOI 10.1038/nm0297-212; Goulder PJR, 2001, NATURE, V412, P334, DOI 10.1038/35085576; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; KLENERMAN P, 1994, NATURE, V369, P403, DOI 10.1038/369403a0; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; MCADAM S, 1995, J IMMUNOL, V155, P2729; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Parren PWHI, 1999, AIDS, V13, pS137	16	49	50	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1410	1411		10.1126/science.1072492	http://dx.doi.org/10.1126/science.1072492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029119				2022-12-28	WOS:000175910300031
J	Sommer, MA; Wurtz, RH				Sommer, MA; Wurtz, RH			A pathway in primate brain for internal monitoring of movements	SCIENCE			English	Article							FRONTAL EYE FIELD; COROLLARY DISCHARGE; SUPERIOR COLLICULUS; EFFERENCE COPY; POSITION; RESPONSES; SACCADES; MUSCLES; NEURONS; SYSTEM	It is essential to keep track of the movements we make, and one way to do that is to monitor correlates, or corollary discharges, of neuronal movement commands. We hypothesized that a previously identified pathway from brainstem to frontal cortex might carry corollary discharge signals. We found that neuronal activity in this pathway encodes upcoming eye movements and that inactivating the pathway impairs sequential eye movements consistent with loss of corollary discharge without affecting single eye movements. These results identify a pathway in the brain of the primate Macaca mulatta that conveys corollary discharge signals.	NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Sommer, MA (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA.			Sommer, Marc/0000-0001-5061-763X	NATIONAL EYE INSTITUTE [ZIAEY000109, Z01EY000109] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BECKER W, 1979, VISION RES, V19, P967, DOI 10.1016/0042-6989(79)90222-0; BELL CC, 1984, COMP PHYSL SENSORY S, P637; BRIDGEMAN B, 1995, ANN BIOMED ENG, V23, P409, DOI 10.1007/BF02584441; Donaldson IML, 2000, PHILOS T R SOC B, V355, P1685, DOI 10.1098/rstb.2000.0732; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; GAYMARD B, 1994, EXP BRAIN RES, V102, P1; GNADT JW, 1991, VISION RES, V31, P693, DOI 10.1016/0042-6989(91)90010-3; GRANTYN R, 1989, REV OCULOMOTOR RES N, V2, pCH8; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HEIDE W, 1995, ANN NEUROL, V38, P739, DOI 10.1002/ana.410380508; KOWLER E, 1990, REV OCULOMOTOR RES E, V4, pCH1; Lewis RF, 2001, EXP BRAIN RES, V141, P349; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; MCCLOSKEY DI, 1981, HDB PHYSL NERVOUS 2, V2, pCH32; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SKAVENSKI AA, 1990, REV OCULOMOTOR RES E, V4, pCH5; SPARKS DL, 1989, REV OCULOMOTOR RES N, V3, pCH5; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; STEINBACH MJ, 1987, VISION RES, V27, P1737, DOI 10.1016/0042-6989(87)90103-9; TEUBER HL, 1966, INT J NEUROL, V5, P282; Tolias AS, 2001, NEURON, V29, P757, DOI 10.1016/S0896-6273(01)00250-1; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1204, DOI 10.1152/jn.2000.84.3.1204; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; von Holst E., 1973, BEHAV PHYSL ANIMALS, V1, P139; VONHELMHOLTZ H, 2000, HELMHOLTZS TREATISE, V3, P242; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8	29	399	402	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1480	1482		10.1126/science.1069590	http://dx.doi.org/10.1126/science.1069590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029137	Green Submitted			2022-12-28	WOS:000175910300052
J	Greenspan, SL; Schneider, DL; McClung, MR; Miller, PD; Schnitzer, TJ; Bonin, R; Smith, E; DeLucca, P; Gormley, GJ; Melton, ME				Greenspan, SL; Schneider, DL; McClung, MR; Miller, PD; Schnitzer, TJ; Bonin, R; Smith, E; DeLucca, P; Gormley, GJ; Melton, ME			Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							CALCIUM SUPPLEMENTATION; POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURES; NURSING-HOME; PREVALENCE; RISK	Background: Many elderly female residents of long-term care facilities have osteoporosis and could benefit from intervention to increase bone density. Objective: To examine the efficacy and safety of alendronate for treatment of osteoporosis in elderly female residents of long-term care facilities. Design: Multicenter, randomized, double-blind, placebo-controlled 2-year study. Setting: 25 long-term care facilities. Patients: 327 elderly women with osteoporosis. Intervention: Patients were randomly assigned to receive alendronate, 10 mg/d, or placebo. All patients also received vitamin D, 400 IU/d, and some patients received supplemental calcium (total intake, approximately 1500 mg/d). Measurements: Bone mineral density (BMD) of the spine and hip and biochemical markers of bone turnover. Results: Alendronate produced significantly greater increases in BMD than did placebo (24-month differences: spine, 4.4% [95% CI, 3.3% to 5.5%]; femoral neck, 3.4% [CI, 2.3% to 4.4%]). Alendronate produced greater decreases from baseline in biochemical markers of bone turnover than did placebo (P < 0.001). Conclusion: Alendronate increased BMD at both the spine and hip in elderly female residents of long-term care facilities.	Merck & Co Inc, Whitehouse Stn, NJ 08889 USA; Beth Israel Deaconess Med Ctr, Boston, MA USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Oregon Osteoporosis Ctr, Portland, OR USA; Colorado Ctr Bone Res, Lakewood, CO USA; Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA	Merck & Company; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Diego; Oregon Osteoporosis Center; Colorado Center For Bone Research; Rush University	Melton, ME (corresponding author), Merck & Co Inc, 1 Merck Dr WS 3CD-45, Whitehouse Stn, NJ 08889 USA.	mary_melton@merck.com	McClung, Michael/ABA-4100-2021	McClung, Michael/0000-0002-7827-0778				[Anonymous], 1999, HLTH AGING CHARTBOOK; BARAN RW, 1998, CONSULTANT PHARM, V13, P685; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Bone HG, 2000, CLIN THER, V22, P15, DOI 10.1016/S0149-2918(00)87974-6; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; DAWSONHUGHES B, 1990, NEW ENGL J MED, V323, P878, DOI 10.1056/NEJM199009273231305; KOMAR L, 1993, J AM GERIATR SOC, V41, P1057, DOI 10.1111/j.1532-5415.1993.tb06452.x; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; LOOKER AC, 1995, J BONE MINER RES, V10, P796; REID IR, 1995, AM J MED, V98, P331, DOI 10.1016/S0002-9343(99)80310-6; SAS Institute Inc, 1997, SAS STAT SOFTW CHANG; Schnitzer T, 2000, AGING CLIN EXP RES, V12, P1; SUZMAN RM, 1992, OLDEST OLD; Zimmerman SI, 1999, OSTEOPOROSIS INT, V9, P151	16	84	87	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 21	2002	136	10					742	746		10.7326/0003-4819-136-10-200205210-00009	http://dx.doi.org/10.7326/0003-4819-136-10-200205210-00009			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553FF	12020142				2022-12-28	WOS:000175664600004
J	Murakami, KS; Masuda, S; Campbell, EA; Muzzin, O; Darst, SA				Murakami, KS; Masuda, S; Campbell, EA; Muzzin, O; Darst, SA			Structural basis of transcription initiation: An RNA polymerase holoenzyme-DNA complex	SCIENCE			English	Article							ALPHA-SUBUNIT; PROMOTER INTERACTIONS; SIGMA FACTORS; BINDING; RECOGNITION; ROLES	The crystal structure of Thermus aquaticus RNA polymerase holoenzyme (alpha(2)betabeta'omegasigma-(A)) complexed with a fork-junction promoter DNA fragment has been determined by fitting high-resolution x-ray structures of individual components into a 6.5-angstrom resolution map. The DNA Lies across one face of the holoenzyme, completely outside the RNA polymerase active site channel. All sequence-specific contacts with core promoter elements are mediated by the a subunit. A universally conserved tryptophan is ideally positioned to stack on the exposed face of the base pair at the upstream edge of the transcription bubble. Universally conserved basic residues of the a subunit provide critical contacts with the DNA phosphate backbone and play a role in directing the melted DNA template strand into the RNA polymerase active site. The structure explains how holoenzyme recognizes promoters containing variably spaced -10 and -35 elements and provides the basis for models of the closed and open promoter complexes.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockefeller.edu		Murakami, Katsuhiko/0000-0003-2244-0501; Campbell, Elizabeth/0000-0002-1332-128X	NIGMS NIH HHS [GM61898, GM53759, GM20470] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759, R01GM061898] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barne KA, 1997, EMBO J, V16, P4034, DOI 10.1093/emboj/16.13.4034; Buckle M, 1999, J MOL BIOL, V285, P955, DOI 10.1006/jmbi.1998.2391; Campbell EA, 2002, MOL CELL, V9, P527, DOI 10.1016/S1097-2765(02)00470-7; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; CASANPASTOR N, 1991, J AM CHEM SOC, V113, P5658, DOI 10.1021/ja00015a020; COWING DW, 1989, J MOL BIOL, V210, P521, DOI 10.1016/0022-2836(89)90128-9; CRAIG ML, 1995, BIOCHEMISTRY-US, V34, P15624, DOI 10.1021/bi00048a004; DARST SA, 1997, NUCL ACIDS MOL BIOL, V11, P27; DeHaseth PL, 1998, J BACTERIOL, V180, P3019, DOI 10.1128/JB.180.12.3019-3025.1998; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 1997, J BACTERIOL, V179, P1734, DOI 10.1128/jb.179.5.1734-1747.1997; Guo Y, 1998, P NATL ACAD SCI USA, V95, P11655, DOI 10.1073/pnas.95.20.11655; Harada Y, 2001, NATURE, V409, P113, DOI 10.1038/35051126; Huang XJ, 1997, NUCLEIC ACIDS RES, V25, P2603, DOI 10.1093/nar/25.13.2603; JEON YH, 1995, SCIENCE, V270, P1495, DOI 10.1126/science.270.5241.1495; Jeon YH, 1997, J MOL BIOL, V267, P953, DOI 10.1006/jmbi.1997.0902; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEILTY S, 1987, J BIOL CHEM, V262, P6389; KOVACIC RT, 1987, J BIOL CHEM, V262, P13654; LAVERY R, 1988, J BIOMOL STRUCT DYN, V6, P63, DOI 10.1080/07391102.1988.10506483; LONETTO M, 1992, J BACTERIOL, V174, P3843, DOI 10.1128/jb.174.12.3843-3849.1992; MECSAS J, 1991, J MOL BIOL, V220, P585, DOI 10.1016/0022-2836(91)90102-C; METZGER W, 1989, EMBO J, V8, P2745, DOI 10.1002/j.1460-2075.1989.tb08416.x; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; OZOLINE ON, 1995, NUCLEIC ACIDS RES, V23, P4533, DOI 10.1093/nar/23.22.4533; Ross W, 2001, GENE DEV, V15, P491, DOI 10.1101/gad.870001; SCHICKOR P, 1990, EMBO J, V9, P2215, DOI 10.1002/j.1460-2075.1990.tb07391.x; Tomsic M, 2001, J BIOL CHEM, V276, P31891, DOI 10.1074/jbc.M105027200; Tsujikawa L, 2002, P NATL ACAD SCI USA, V99, P3493, DOI 10.1073/pnas.062487299; WESTON SA, 1992, J MOL BIOL, V226, P1237, DOI 10.1016/0022-2836(92)91064-V; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	39	519	534	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1285	1290		10.1126/science.1069595	http://dx.doi.org/10.1126/science.1069595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016307				2022-12-28	WOS:000175713000045
J	Brochier, C; Philippe, H				Brochier, C; Philippe, H			Phylogeny - A non-hyperthermophilic ancestor for bacteria	NATURE			English	Article							ARCHAEA; LIFE		Univ Paris 06, CNRS, UMR 7622, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Brochier, C (corresponding author), Univ Paris 06, CNRS, UMR 7622, 9 Quai St Bernard, F-75005 Paris, France.		Brochier-Armanet, Celine/B-7898-2011	Brochier-Armanet, Celine/0000-0003-4669-3589				Brinkmann H, 1999, MOL BIOL EVOL, V16, P817, DOI 10.1093/oxfordjournals.molbev.a026166; Brochier C, 2002, TRENDS GENET, V18, P1, DOI 10.1016/S0168-9525(01)02522-7; Daubin V, 2001, Genome Inform, V12, P155; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J, 2001, J MOL EVOL, V53, P447, DOI 10.1007/s002390010234; Forterre P, 2000, TRENDS GENET, V16, P152, DOI 10.1016/S0168-9525(00)01980-6; FUERST JA, 1995, MICROBIOL-UK, V141, P1493, DOI 10.1099/13500872-141-7-1493; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Philippe H, 2000, CURR OPIN GENET DEV, V10, P596, DOI 10.1016/S0959-437X(00)00137-4; Stetter KO, 1996, CIBA F SYMP, V202, P1	12	184	195	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					244	244		10.1038/417244a	http://dx.doi.org/10.1038/417244a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015592				2022-12-28	WOS:000175592100036
J	Evers, K				Evers, K			European perspectives on therapeutic cloning	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Int Council Sci Standing Comm Responsibil & Eth S, N-0105 Oslo, Norway		Evers, K (corresponding author), Int Council Sci Standing Comm Responsibil & Eth S, N-0105 Oslo, Norway.							*COM CONS NAT ETH, 2001, 67 COM CONS NAT ETH; *CONC EUR, 2002, CONV PROT HUM RIGHTS; Lubchenco J, 1998, SCIENCE, V279, P491, DOI 10.1126/science.279.5350.491; Nationaler Ethikrat, 2002, STELL IMP MENSCHL EM STELL IMP MENSCHL EM; PETITNICOLAS C, 2002, ENJEUX CLONAGE THERA; Scheper-Hughes N, 2000, CURR ANTHROPOL, V41, P191, DOI 10.1086/300123; *SWED RES COUNC, 2002, SWED RES COUNC GUID; 2002, BIOETHIQUE      0213; 2001, N ENGL J MED, V345, P146	9	16	18	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1579	1582		10.1056/NEJMsb020527	http://dx.doi.org/10.1056/NEJMsb020527			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	11994550				2022-12-28	WOS:000175563900013
J	Rewers, A; Chase, HP; Mackenzie, T; Walravens, P; Roback, M; Rewers, M; Hamman, RF; Klingensmith, G				Rewers, A; Chase, HP; Mackenzie, T; Walravens, P; Roback, M; Rewers, M; Hamman, RF; Klingensmith, G			Predictors of acute complications in children with type 1 diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVED GLYCEMIC CONTROL; SEVERE HYPOGLYCEMIA; METABOLIC-CONTROL; CEREBRAL EDEMA; RISK-FACTORS; ADOLESCENTS; KETOACIDOSIS; INSULIN; MELLITUS; POPULATION	Context Diabetic ketoacidosis and severe hypoglycemia are acute complications of type 1 diabetes that are related, respectively, to insufficient or excessive insulin treatment. However, little is known about additional modifiable risk factors. Objective To examine the incidence of ketoacidosis and severe hypoglycemia in children with diabetes and to determine the factors that predict these complications. Design, Setting, and Participants A cohort of 1243 children from infancy to age 19 years with type I diabetes who resided in the Denver, Colo, metropolitan area were followed up prospectively for 3994 person-years from January 1, 1996, through December 31, 2000. Main Outcome Measures Incidence of ketoacidosis leading to hospital admission or emergency department visit and severe hypoglycemia (loss of consciousness, seizure, or hospital admission or emergency department visit). Results The incidence of ketoacidosis was 8 per 100 person-years and increased with age in girls (4 per 100 person-years in <7 8 in 7-12; and 12 in :13 years; P<.001 for trend). In multivariate analyses, sex-adjusted and stratified by age (<13 vs >= 13 years), the risk of ketoacidosis in younger children increased with higher hemoglobin A(1c) (HbA(1c)) (relative risk [RR], 1.68 per 1% increase; 95% confidence interval [CI], 1.45-1.94) and higher reported insulin dose (RR, 1.40 per 0.2 U/kg per day; 95% CI, 1.20-1.64). In older children, the risk of ketoacidosis increased with higher HbA(1c) (RR, 1.43; 95% CI, 1.30-1.58), higher reported insulin dose (RR, 1.13; 95% CI, 1.02-1.25), underinsurance (RR, 2.18; 95% CI, 1.65-2.95), and presence of psychiatric disorders (for boys, RR, 1.59; 95% CI, 0.96-2.65; for girls, RR, 3.22; 95 % CI, 2.25-4.61). The incidence of severe hypoglycemia was 19 per 100 person-years (P<.001 for trend) and decreased with age in girls (24 per 100 patient-years in <7, 19 in 7-12, and 14 in >= 13 years). In younger children, the risk of severe hypoglycemia increased with diabetes duration (RR, 1.39 per 5 years; 95% CI, 1.16-1.69) and underinsurance (RR, 1.33; 95% CI, 1.08-1.65). In older children, the risk of severe hypoglycemia increased with duration (RR, 1.34; 95% CI, 1.25-1.51), underinsurance (RR, 1.42; 95% CI, 1.11-1.81), lower HbA(1c) (RR, 1,22; 95% CI, 1.12-1.32), and presence of psychiatric disorders (RR, 1.56; 95% CI, 1.23-1.98). Eighty percent of episodes occurred among the 20% of children who had recurrent events. Conclusions Some children with diabetes remain at high risk for ketoacidosis and severe hypoglycemia. Age- and sex-specific incidence patterns suggest that ketoacidosis is a challenge in adolescent girls while severe hypoglycemia continues to affect disproportionally the youngest patients and boys of all ages. The pattern of modifiable risk factors indicates that underinsured children and those with psychiatric disorders or at the extremes of the HbA(1c) distribution should be targeted for specific interventions.	Univ Colorado, Sch Med, Childrens Hosp, Dept Pediat, Denver, CO 80218 USA; Univ Colorado, Sch Med, Barbara Davis Ctr Childhood Diabet, Denver, CO 80218 USA; Univ Colorado, Sch Med, Dept Prevent Med & Biometr, Denver, CO 80218 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Rewers, A (corresponding author), Univ Colorado, Sch Med, Childrens Hosp, Dept Pediat, B251,1056 E 19th Ave, Denver, CO 80218 USA.	rewers.arleta@tchden.org	Rewers, Arleta/AAE-2484-2019		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057516] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00069] Funding Source: Medline; NIDDK NIH HHS [P30 DK-57516] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allen C, 2001, DIABETES CARE, V24, P1878, DOI 10.2337/diacare.24.11.1878; Alvi NS, 2001, ARCH DIS CHILD, V85, P60, DOI 10.1136/adc.85.1.60; [Anonymous], 1995, DIAB AM; Barkai L, 1998, DIABETOLOGIA, V41, P898, DOI 10.1007/s001250051005; BERGADA I, 1989, DIABETES CARE, V12, P239, DOI 10.2337/diacare.12.4.239; BHATIA V, 1991, PEDIATRICS, V88, P1187; Chase HP, 2001, DIABETES CARE, V24, P430, DOI 10.2337/diacare.24.3.430; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; Danne T, 2001, DIABETES CARE, V24, P1342, DOI 10.2337/diacare.24.8.1342; Davis EA, 1998, ARCH DIS CHILD, V78, P111, DOI 10.1136/adc.78.2.111; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; DELAMATER AM, 1991, DIABETES CARE, V14, P20, DOI 10.2337/diacare.14.1.20; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; DUMONT RH, 1995, DIABETIC MED, V12, P612, DOI 10.1111/j.1464-5491.1995.tb00551.x; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; Edge JA, 2001, ARCH DIS CHILD, V85, P16, DOI 10.1136/adc.85.1.16; FAICH GA, 1983, AM J EPIDEMIOL, V117, P551, DOI 10.1093/oxfordjournals.aje.a113577; Glaser N, 2001, NEW ENGL J MED, V344, P264, DOI 10.1056/NEJM200101253440404; HEPBURN DA, 1990, DIABETIC MED, V7, P711, DOI 10.1111/j.1464-5491.1990.tb01475.x; Javor KA, 1997, DIABETES CARE, V20, P349, DOI 10.2337/diacare.20.3.349; JOHNSON DD, 1980, MAYO CLIN PROC, V55, P83; Levine BS, 2001, J PEDIATR-US, V139, P197, DOI 10.1067/mpd.2001.116283; Lteif AN, 1999, MAYO CLIN PROC, V74, P211, DOI 10.4065/74.3.211; Meltzer LJ, 2001, DIABETES CARE, V24, P678, DOI 10.2337/diacare.24.4.678; Menzin J, 2001, DIABETES CARE, V24, P51, DOI 10.2337/diacare.24.1.51; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Nordfeldt S, 1999, ACTA PAEDIATR, V88, P1184, DOI 10.1080/080352599750030275; Nordfeldt S, 1997, DIABETES CARE, V20, P497, DOI 10.2337/diacare.20.4.497; Nordfeldt S, 2001, ACTA PAEDIATR, V90, P137; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Roberts M D, 2001, Pediatr Diabetes, V2, P109, DOI 10.1034/j.1399-5448.2001.002003109.x; Rosilio M, 1998, DIABETES CARE, V21, P1146, DOI 10.2337/diacare.21.7.1146; Smith CP, 1998, ACTA PAEDIATR, V87, P537, DOI 10.1080/08035259850158245; SNORGAARD O, 1989, J INTERN MED, V226, P223, DOI 10.1111/j.1365-2796.1989.tb01384.x; Thomsett MJ, 1999, J PAEDIATR CHILD H, V35, P479, DOI 10.1046/j.1440-1754.1999.355424.x; Tupola S, 1998, DIABETIC MED, V15, P695, DOI 10.1002/(SICI)1096-9136(199808)15:8<695::AID-DIA651>3.0.CO;2-C; WILSON BE, 1995, J COMMUN HEALTH, V20, P249, DOI 10.1007/BF02260408	38	303	315	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2511	2518		10.1001/jama.287.19.2511	http://dx.doi.org/10.1001/jama.287.19.2511			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020331				2022-12-28	WOS:000175566200019
J	Wilde, GJS				Wilde, GJS			Does risk homoeostasis theory have implications for road safety - For	BRITISH MEDICAL JOURNAL			English	Editorial Material									Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Wilde, GJS (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.							Aschenbrenner K.M., 1994, CHALLENGES ACCIDENT, P81; BROWN ID, 1987, ROAD USERS TRAFFIC S, P135; CARR AF, 1980, BEHAV ASSESS, V2, P33; JANSSEN W, 1994, ACCIDENT ANAL PREV, V26, P249, DOI 10.1016/0001-4575(94)90095-7; MAY AD, 1959, HIGHWAY RES BOARD P, P493; PETERSON S, 1995, J LAW ECON, V38, P251, DOI 10.1086/467331; Vaaje T., 1991, P OECD ECMT S ENF RE, P154; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	12	44	44	1	23	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1149	1151		10.1136/bmj.324.7346.1149	http://dx.doi.org/10.1136/bmj.324.7346.1149			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552LX	12003891				2022-12-28	WOS:000175622800030
J	Neumann, HPH; Bausch, B; McWhinney, SR; Bender, BU; Gimm, O; Franke, G; Schipper, J; Klisch, J; Altehoefer, C; Zerres, K; Januszewicz, A; Smith, WM; Munk, R; Manz, T; Glaesker, S; Apel, TW; Treier, M; Reineke, M; Walz, MK; Hoang-Vu, C; Brauckhoff, M; Klein-Franke, A; Klose, P; Schmidt, H; Maier-Woelfle, M; Peczkowska, M; Szmigielski, C; Eng, C				Neumann, HPH; Bausch, B; McWhinney, SR; Bender, BU; Gimm, O; Franke, G; Schipper, J; Klisch, J; Altehoefer, C; Zerres, K; Januszewicz, A; Smith, WM; Munk, R; Manz, T; Glaesker, S; Apel, TW; Treier, M; Reineke, M; Walz, MK; Hoang-Vu, C; Brauckhoff, M; Klein-Franke, A; Klose, P; Schmidt, H; Maier-Woelfle, M; Peczkowska, M; Szmigielski, C; Eng, C		Freiburg-Warsaw-Columbus Pheochrom	Germ-line mutations in nonsyndromic pheochromocytoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENDOCRINE NEOPLASIA TYPE-2; HIPPEL-LINDAU DISEASE; TUMOR-SUPPRESSOR GENE; COMPLEX-II GENE; RET PROTOONCOGENE; HEREDITARY PARAGANGLIOMAS; FAMILIES; SDHD; SUSCEPTIBILITY	Background: The group of susceptibility genes for pheochromocytoma that included the proto-oncogene RET (associated with multiple endocrine neoplasia type 2 [MEN-2]) and the tumor-suppressor gene VHL (associated with von Hippel-Lindau disease) now also encompasses the newly identified genes for succinate dehydrogenase subunit D (SDHD) and succinate dehydrogenase subunit B (SDHB), which predispose carriers to pheochromocytomas and glomus tumors. We used molecular tools to classify a large cohort of patients with pheochromocytoma with respect to the presence or absence of mutations of one of these four genes and to investigate the relevance of genetic analyses to clinical practice. Methods: Peripheral blood from unrelated, consenting registry patients with pheochromocytoma was tested for mutations of RET, VHL, SDHD, and SDHB. Clinical data at first presentation and follow-up were evaluated. Results: Among 271 patients who presented with nonsyndromic pheochromocytoma and without a family history of the disease, 66 (24 percent) were found to have mutations (mean age, 25 years; 32 men and 34 women). Of these 66, 30 had mutations of VHL, 13 of RET, 11 of SDHD, and 12 of SDHB. Younger age, multifocal tumors, and extraadrenal tumors were significantly associated with the presence of a mutation. However, among the 66 patients who were positive for mutations, only 21 had multifocal pheochromocytoma. Twenty-three (35 percent) presented after the age of 30 years, and 17 (8 percent) after the age of 40. Sixty-one (92 percent) of the patients with mutations were identified solely by molecular testing of VHL, RET, SDHD, and SDHB; these patients had no associated signs and symptoms at presentation. Conclusions: Almost one fourth of patients with apparently sporadic pheochromocytoma may be carriers of mutations; routine analysis for mutations of RET, VHL, SDHD, and SDHB is indicated to identify pheochromocytoma-associated syndromes that would otherwise be missed.	Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany; Univ Freiburg, Dept Otolaryngol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Neuroradiol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Radiol, D-79106 Freiburg, Germany; Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Univ Aachen, Inst Human Genet, D-5100 Aachen, Germany; Inst Cardiol, Dept Hypertens, Warsaw, Poland; Univ Cambridge, Canc Res Campaign, Human Canc Genet Res Grp, Cambridge, England; Clin Albert Ludwigs Univ, Dept Nephrol, Freiburg, Germany; Clin Albert Ludwigs Univ, Dept Otolaryngol, Freiburg, Germany; Clin Albert Ludwigs Univ, Dept Gastroenterol & Endocrinol, Freiburg, Germany; Klinikum Essen Mitte, Dept Surg, Essen, Germany; Univ Halle, Dept Surg, Halle An Der Saale, Germany; Univ Gottingen, Dept Pediat, D-3400 Gottingen, Germany; City Hosp, Dept Pediat, Munich, Germany; Univ Munich, Dept Pediat, Munich, Germany; Kantonsspital, Dept Internal Med, St Gallen, Switzerland; Inst Cardiol, Dept Hypertens, Warsaw, Poland; Med Univ, Warsaw, Poland	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; RWTH Aachen University; Institute of Cardiology - Poland; CRUK Cambridge Institute; University of Cambridge; Kliniken Essen-Mitte; Martin Luther University Halle Wittenberg; University of Gottingen; University of Munich; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen; Institute of Cardiology - Poland	Neumann, HPH (corresponding author), Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany.	neumann@mm41.ukl.uni-freiburg.de	Walz, Martin/AHE-7790-2022; Gläsker, Sven/AAB-9362-2022	Eng, Charis/0000-0002-3693-5145; Szmigielski, Cezary/0000-0002-0837-6323	NCI NIH HHS [P30CA16058] Funding Source: Medline; NICHD NIH HHS [R01HD39058] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguiar RCT, 2001, J CLIN ENDOCR METAB, V86, P2890, DOI 10.1210/jc.86.6.2890; Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Bender BU, 2001, J MED GENET, V38, P508, DOI 10.1136/jmg.38.8.508; BOLINO A, 1995, ONCOGENE, V10, P2415; Brenner B, 1995, HYPERTENSION PATHOPH, V2, P2225; Eng C, 1996, NEW ENGL J MED, V335, P943, DOI 10.1056/NEJM199609263351307; ENG C, 1995, J MED GENET, V32, P934, DOI 10.1136/jmg.32.12.934; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; ENG C, 1995, ONCOGENE, V10, P509; ENG C, 1994, HUM MOL GENET, V3, P686; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Eng C, 1999, MULTIPLE PRIMARY CANCERS, P165; Gimm O, 2000, CANCER RES, V60, P6822; Glavac D, 1996, HUM GENET, V98, P271, DOI 10.1007/s004390050206; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Heutink Peter, 1994, European Journal of Human Genetics, V2, P148; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MULLIGAN LM, 1994, HUM MOL GENET, V3, P2163, DOI 10.1093/hmg/3.12.2163; Nakamura K, 1996, J BIOL CHEM, V271, P521, DOI 10.1074/jbc.271.1.521; NEUMANN HPH, 1993, NEW ENGL J MED, V329, P1531, DOI 10.1056/NEJM199311183292103; NEUMANN HPH, 1994, NEW ENGL J MED, V331, P1535; NEUMANN HPH, 1987, VASA-J VASCULAR DIS, V16, P220; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; PONDER BAJ, 1988, LANCET, V1, P397; Walther MM, 1999, J UROLOGY, V162, P659, DOI 10.1097/00005392-199909010-00004; Woodward ER, 1997, HUM MOL GENET, V6, P1051, DOI 10.1093/hmg/6.7.1051; Zbar B, 1996, HUM MUTAT, V8, P348, DOI 10.1002/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3	28	961	1008	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1459	1466		10.1056/NEJMoa020152	http://dx.doi.org/10.1056/NEJMoa020152			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000816				2022-12-28	WOS:000175433200005
J	Hindmarsh, P				Hindmarsh, P			Commentary: Exogenous glucocorticoids influence adrenal function, but assessment can be difficult	BRITISH MEDICAL JOURNAL			English	Review							INHALED FLUTICASONE PROPIONATE; BECLOMETHASONE DIPROPIONATE; ASTHMATIC-CHILDREN; CORTICOSTEROIDS; EFFICACY; SUPPRESSION; PLACEBO		Middlesex Hosp, Cobbold Labs, London W1T 3AA, England	University of London; University College London	Hindmarsh, P (corresponding author), Middlesex Hosp, Cobbold Labs, London W1T 3AA, England.							BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; BROIDE J, 1995, J CLIN ENDOCR METAB, V80, P1243, DOI 10.1210/jc.80.4.1243; CROWLEY S, 1991, J ENDOCRINOL, V130, P475, DOI 10.1677/joe.0.1300475; Fitzgerald D, 1998, THORAX, V53, P656, DOI 10.1136/thx.53.8.656; Hussain K, 2000, ANN MED, V32, P544, DOI 10.3109/07853890008998834; Jarvis B, 1999, DRUGS, V57, P769, DOI 10.2165/00003495-199957050-00016; LAW CM, 1986, LANCET, V1, P942; Li JTC, 1999, J ALLERGY CLIN IMMUN, V103, P622, DOI 10.1016/S0091-6749(99)70234-4; MACKENZIE CA, 1993, EUR J PEDIATR, V152, P856, DOI 10.1007/BF02073387; NINAN TK, 1993, THORAX, V48, P599, DOI 10.1136/thx.48.6.599; Taylor AV, 1999, ANN ALLERG ASTHMA IM, V83, P68, DOI 10.1016/S1081-1206(10)63515-6; Yiallouros PK, 1997, ARCH DIS CHILD, V76, P405, DOI 10.1136/adc.76.5.405	12	8	8	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 4	2002	324	7345					1083	1083						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YY	11993494				2022-12-28	WOS:000175476500025
J	Olson, CM; Rennie, D; Cook, D; Dickersin, K; Flanagin, A; Hogan, JW; Zhu, Q; Reiling, J; Pace, B				Olson, CM; Rennie, D; Cook, D; Dickersin, K; Flanagin, A; Hogan, JW; Zhu, Q; Reiling, J; Pace, B			Publication bias in editorial decision making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				CLINICAL RESEARCH; CONTROLLED TRIALS; ABSTRACTS; METAANALYSIS; JOURNALS; QUALITY; COHORT; FATE	Context Studies with positive results are more likely to be published than studies with negative results (publication bias). One reason this occurs is that authors are less likely to submit manuscripts reporting negative results to journals. There is no evidence that publication bias occurs once manuscripts have been submitted to a medical journal. We assessed whether submitted manuscripts that report results of controlled trials are more likely to be published if they report positive results. Methods Prospective cohort study of manuscripts submitted to JAMA from February 1996 through August 1999. We classified results as positive if there was a statistically significant difference (P<.05) reported for the primary outcome. Study characteristics and indicators for quality were also appraised. We included manuscripts that reported prospective studies in which participants were assigned to an intervention or comparison group and statistical tests compared differences between groups. Results Among 745 manuscripts, 133 (17.9%) were published: 78 (20.4%) of 383 with positive results, 51 (15.0%) of 341 with negative results, and 4 (19.0%) of 21 with unclear results. The crude relative risk for publication of studies with positive results compared with negative results was 1.36 (95% confidence interval [01, 0.99-1.88). After being adjusted simultaneously for study characteristics and quality indicators, the odds ratio for publishing studies with positive results was 1.30 (95% Cl, 0.87-1.96). Conclusions Among submitted manuscripts, we did not find a statistically significant difference in publication rates between those with positive vs negative results.	Univ Washington, Med Ctr, Dept Med, Div Emergency Med, Seattle, WA 98195 USA; JAMA, Chicago, IL USA; Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; McMaster Univ, Dept Med, Hamilton, ON, Canada; McMaster Univ, Dept Clin Epidemiol, Hamilton, ON L8S 4L8, Canada; McMaster Univ, Dept Biostat, Hamilton, ON, Canada	University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Brown University; Brown University; McMaster University; McMaster University; McMaster University	Olson, CM (corresponding author), Univ Washington, Med Ctr, Dept Med, Div Emergency Med, Box 356123, Seattle, WA 98195 USA.	colson@u.washington.edu	Hogan, Joseph/J-4579-2014; Dickersin, Kay/A-4576-2008	Hogan, Joseph/0000-0001-7959-7361				Abbot NC, 1998, PERFUSION, V11, P182; Agresti A., 1996, INTRO CATEGORICAL DA; ALTMAN LK, 1997, NY TIMES        0419, pB7; ANGELL M, 1989, NEW ENGL J MED, V321, P464, DOI 10.1056/NEJM198908173210708; BRAUN T, 1989, SCIENTOMETRICS, V17, P11, DOI 10.1007/BF02017719; Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P254, DOI 10.1001/jama.280.3.254; CAMPILLO C, 1997, INT C BIOM PEER REV; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1401, DOI 10.1001/jama.263.10.1401; DEBELLEFEUILLE C, 1992, ANN ONCOL, V3, P187, DOI 10.1093/oxfordjournals.annonc.a058147; DICKERSIN K, 1993, ANN NY ACAD SCI, V703, P135, DOI 10.1111/j.1749-6632.1993.tb26343.x; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; DICKERSIN K, 1987, CONTROL CLIN TRIALS, V8, P343, DOI 10.1016/0197-2456(87)90155-3; Dickersin K., 1993, ONLINE J CURR CLIN T, pDoc No 50; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; ERNST E, 1991, NATURE, V352, P560, DOI 10.1038/352560b0; FEINSTEIN AR, 1991, J CLIN EPIDEMIOL, V44, P339, DOI 10.1016/0895-4356(91)90071-G; GILBERT JR, 1994, JAMA-J AM MED ASSOC, V272, P139, DOI 10.1001/jama.272.2.139; Ioannidis JPA, 1997, CONTROL CLIN TRIALS, V18, P431, DOI 10.1016/S0197-2456(97)00097-4; Iverson C, 1998, AM MED ASS MANUAL ST; Link AM, 1998, JAMA-J AM MED ASSOC, V280, P246, DOI 10.1001/jama.280.3.246; Misakian AL, 1998, JAMA-J AM MED ASSOC, V280, P250, DOI 10.1001/jama.280.3.250; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Olson C M, 1994, Acad Emerg Med, V1, P207; Petticrew M, 1999, J EPIDEMIOL COMMUN H, V53, P442, DOI 10.1136/jech.53.7.442; SCHERER RW, 1994, JAMA-J AM MED ASSOC, V272, P158, DOI 10.1001/jama.272.2.158; Smith R, 1997, BRIT MED J, V315, P622, DOI 10.1136/bmj.315.7109.622; Song F, 1999, MED INFORM INTERNET, V24, P223, DOI 10.1080/146392399298429; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Stroup DF, 2001, J CLIN EPIDEMIOL, V54, P655, DOI 10.1016/S0895-4356(00)00362-0; Vogel U, 2000, DEUT MED WOCHENSCHR, V125, P110, DOI 10.1055/s-2007-1023955; WILSON A, 1992, MED J AUSTRALIA, V156, P173, DOI 10.5694/j.1326-5377.1992.tb139704.x; *WORLD MED ASS, 2002, DECL HELS; 1995, JAMA, V274, P91	33	242	244	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2825	2828		10.1001/jama.287.21.2825	http://dx.doi.org/10.1001/jama.287.21.2825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	559AP	12038924	Bronze			2022-12-28	WOS:000176002200021
J	Casey, BJ				Casey, BJ			Neuroscience - Windows into the human brain	SCIENCE			English	Editorial Material							FUNCTIONAL MRI; PREFRONTAL CORTEX; CHILDREN		Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst Dev Psychobiol, New York, NY 10021 USA	Cornell University	Casey, BJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Psychiat, Sackler Inst Dev Psychobiol, New York, NY 10021 USA.	bjc2002@med.cornell.edu						BOURGEOIS JP, 1994, CEREB CORTEX, V4, P78, DOI 10.1093/cercor/4.1.78; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Bunge SA, 2002, NEURON, V33, P301, DOI 10.1016/S0896-6273(01)00583-9; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHAPMAN LJ, 1978, J PSYCHIATR RES, V14, P303, DOI 10.1016/0022-3956(78)90034-1; DURSTON S, IN PRESS NEUROIMAGE; HertzPannier L, 1997, NEUROLOGY, V48, P1003, DOI 10.1212/WNL.48.4.1003; KARNI A, 1995, NATURE, V377, P155; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Schlaggar BL, 2002, SCIENCE, V296, P1476, DOI 10.1126/science.1069464; Spelke ES, 2002, DEVELOPMENTAL SCI, V5, P392, DOI 10.1111/1467-7687.00378; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0	16	31	31	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1408	1409		10.1126/science.1072684	http://dx.doi.org/10.1126/science.1072684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029117				2022-12-28	WOS:000175910300029
J	Gasser, SM				Gasser, SM			Nuclear architecture - Visualizing chromatin dynamics in interphase nuclei	SCIENCE			English	Review							BUDDING YEAST; CHROMOSOME DYNAMICS; CELL-NUCLEUS; DROSOPHILA; SCALE; LOCALIZATION; ORGANIZATION; MOTION; DNA	Real-time fluorescence microscopy has emerged as a powerful tool for examining chromatin dynamics. The initial lesson is that much of the genome, particularly in yeast, is highly dynamic. Its movement within the interphase nucleus is correlated with metabolic activity. Nonetheless, the nucleus is an organelle with conserved rules of organization. Determining the distribution and regulation of mobile domains in interphase chromosomes, and characterizing sites of anchorage, will undoubtedly shed new light on the function of nuclear order.	Univ Geneva, Dept Mol Biol, CH-1211 Geneva, Switzerland	University of Geneva	Gasser, SM (corresponding author), Univ Geneva, Dept Mol Biol, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.			Gasser, Susan/0000-0003-3610-9123				Belmont AS, 2001, TRENDS CELL BIOL, V11, P250, DOI 10.1016/S0962-8924(01)02000-1; Bridger JM, 2000, CURR BIOL, V10, P149, DOI 10.1016/S0960-9822(00)00312-2; Buchenau P, 1997, J CELL BIOL, V137, P291, DOI 10.1083/jcb.137.2.291; CREMER T, 1993, COLD SPRING HARB SYM, V58, P777, DOI 10.1101/SQB.1993.058.01.085; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Csink AK, 1998, J CELL BIOL, V143, P13, DOI 10.1083/jcb.143.1.13; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dundr M, 2001, BIOCHEM J, V356, P297, DOI 10.1042/0264-6021:3560297; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; HEDIGER F, UNPUB; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; HEUN P, 2000, THESIS U LAUSANNE SW; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Li G, 1998, J CELL BIOL, V140, P975, DOI 10.1083/jcb.140.5.975; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Muratani M, 2002, NAT CELL BIOL, V4, P106, DOI 10.1038/ncb740; Pirrotta V, 1999, BBA-REV CANCER, V1424, pM1; Shelby RD, 1996, J CELL BIOL, V135, P545, DOI 10.1083/jcb.135.3.545; Thrower DA, 2001, MOL BIOL CELL, V12, P2800, DOI 10.1091/mbc.12.9.2800; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; TURNBAR T, 2001, NATURE CELL BIOL, V3, P134; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6	27	257	266	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1412	1416		10.1126/science.1067703	http://dx.doi.org/10.1126/science.1067703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029120				2022-12-28	WOS:000175910300032
J	Schlaggar, BL; Brown, TT; Lugar, HM; Visscher, KM; Miezin, FM; Petersen, SE				Schlaggar, BL; Brown, TT; Lugar, HM; Visscher, KM; Miezin, FM; Petersen, SE			Functional neuroanatomical differences between adults and school-age children in the processing of single words	SCIENCE			English	Article							WORKING-MEMORY; BRAIN ACTIVITY; ACTIVATION; FMRI; ANATOMY; CORTEX; TASK; MRI	A critical issue in developmental cognitive neuroscience is the extent to which the functional neuroanatomy underlying task performance differs in adults and children. Direct comparisons of brain activation in the left frontal and extrastriate cortex were made in adults and children (aged 7 to 10 years) performing single-word processing tasks with visual presentation; differences were found in circumscribed frontal and extrastriate regions. Conceivably, these differences could be attributable exclusively to performance discrepancies; alternatively, maturational differences in functional neuroanatomy could exist despite similar performance. Some of the brain regions examined showed differences attributable to age independent of performance, suggesting that maturation of the pattern of regional activations for these tasks is incomplete at age 10.	Washington Univ, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63110 USA; Washington Univ, Dept Pediat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Schlaggar, BL (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63110 USA.	schlaggarb@neuro.wustl.edu	Brown, Timothy/A-6518-2011; anand, amit/A-7222-2009; Petersen, Steve/ABF-1368-2020; Schlaggar, Bradley/AAZ-4153-2020	Brown, Timothy/0000-0003-4475-1546; Visscher, Kristina/0000-0003-0737-4024	NINDS NIH HHS [NS55582, NS51281, NS32979] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032979] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bates E, 1999, CHANGING NERVOUS SYSTEM, P214; Booth JR, 1999, PROG NEURO-PSYCHOPH, V23, P669, DOI 10.1016/S0278-5846(99)00025-1; BURGUND ED, IN PRESS NEUROIMAGE; CASEY BJ, 1995, NEUROIMAGE, V2, P221, DOI 10.1006/nimg.1995.1029; Cepeda NJ, 2001, DEV PSYCHOL, V37, P715, DOI 10.1037/0012-1649.37.5.715; FILIPEK PA, 2000, CEREBRAL REORGANIZAT, P265; Gaillard WD, 2000, NEUROLOGY, V54, P180, DOI 10.1212/WNL.54.1.180; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Johnson MH, 2001, NAT REV NEUROSCI, V2, P475, DOI 10.1038/35081509; Klingberg T, 2002, J COGNITIVE NEUROSCI, V14, P1, DOI 10.1162/089892902317205276; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; Nelson CA, 2000, DEV PSYCHOL, V36, P109, DOI 10.1037/0012-1649.36.1.109; Palmer ED, 2001, NEUROIMAGE, V14, P182, DOI 10.1006/nimg.2001.0779; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; PETERSEN SE, 1990, SCIENCE, V249, P1041, DOI 10.1126/science.2396097; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rosen BR, 1998, P NATL ACAD SCI USA, V95, P773, DOI 10.1073/pnas.95.3.773; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Stiles J, 2000, DEV NEUROPSYCHOL, V18, P237, DOI 10.1207/S15326942DN1802_5; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomas KM, 1999, NEUROIMAGE, V10, P327, DOI 10.1006/nimg.1999.0466; Thomas KM, 2000, MED RAD DIA IMG, P513	27	331	334	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 24	2002	296	5572					1476	1479		10.1126/science.1069464	http://dx.doi.org/10.1126/science.1069464			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	557LP	12029136				2022-12-28	WOS:000175910300051
J	Pollock, AM; Shaoul, J; Vickers, N				Pollock, AM; Shaoul, J; Vickers, N			Private finance and "value for money" in NHS hospitals: a policy in search of a rationale?	BRITISH MEDICAL JOURNAL			English	Article									UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England; Univ Manchester, Sch Accounting & Finance, Manchester M13 9PL, Lancs, England	University of London; University College London; University of Manchester	Pollock, AM (corresponding author), UCL, Sch Publ Policy, Hlth Policy & Hlth Serv Res Unit, London WC1H 9QU, England.			pollock, allyson/0000-0002-7388-3110				*A AND ENT LSE, VAL MON DRIV PRIV FI; *ACC STAND BOARD, 1998, AM FRS5 REP SUBST T; BROADBENT J, 2000, PFI SAVIOUR VILLAIN, P26; BROWNE A, 2001, OBSERVER        1007; *CARL HOSP FBC, APP, V1; *DEP HLTH, BED AV OCC 2000 2001; *DEP HLTH, 2001, MEM HLTH COMM PUBL E; *DEP HLTH, 2000, EXP QUEST 2000 MEM H; Gaffney D, 1999, BMJ-BRIT MED J, V319, P48, DOI 10.1136/bmj.319.7201.48; Gaffney D, 1999, BRIT MED J, V319, P116, DOI 10.1136/bmj.319.7202.116; Gaffney D, 1999, BRIT MED J, V319, P249, DOI 10.1136/bmj.319.7204.249; GAFFNEY D, 1999, DOWNSIZING 21 CENTUR; HAWKSWORTH J, 2000, PRIVATE FINANCE INIT; HEALD D, 1996, INT ASS MANAGEMENT J, V8, P29; HELLOWELL M, 2000, PFI REPORT 2000, V45, P9; *HM TREAS, 1997, APPR EV CENTR GOV, pCH4; *NORF NORW HEALTHC, 1999, FIN BUS CAS; Pearce D.W, 1995, SOCIAL DISCOUNT RATE; POLLOCK A, 2001, PUBLIC SERVICES PRIV; Pollock A., 2000, PUBLIC FINANCE  0414, P22; Pollock AM, 1999, BMJ-BRIT MED J, V319, P179, DOI 10.1136/bmj.319.7203.179; Pollock AM, 1997, BRIT MED J, V314, P1266, DOI 10.1136/bmj.314.7089.1266; Pollock AM, 2001, BRIT MED J, V322, P964, DOI 10.1136/bmj.322.7292.964; POLLOCK AM, 2000, DEFICITS PATIENTS; PRICE D, 1999, ONLY GAME TOWN REPOR; ROWLAND D, 2002, SCH GOVERNORS ESSENT; *SEN COMM AFF REF, 2000, HEAL HOSP; Sheffi N., 2001, RING MYTHS ISRAELIS; *U COLL LOND HOSP, 2000, FIN BUS CAS; ULPH D, 2000, CONTACT THEORY PUBLI	30	114	114	0	12	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1205	1209		10.1136/bmj.324.7347.1205	http://dx.doi.org/10.1136/bmj.324.7347.1205			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554XV	12016191	Green Published			2022-12-28	WOS:000175763200026
J	Zamore, PD				Zamore, PD			Ancient pathways programmed by small RNAs	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; GERM-LINE DEVELOPMENT; C-ELEGANS EMBRYOS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; FUNCTIONAL-ANATOMY; GENE-EXPRESSION; DNA METHYLATION; INTERFERENCE; DROSOPHILA	Double-stranded RNA can now be used in a wide variety of eukaryotes to suppress the expression of virtually any gene, allowing the rapid analysis of that gene's function, a technique known as RNA interference. But how cells use the information in double-stranded RNA to suppress gene expression and why they contain the machinery to do so remain the subjects of intense scrutiny. Current evidence suggests that RNA interference and other "RNA silencing" phenomena reflect an elaborate cellular apparatus that eliminates abundant but defective messenger RNAs and defends against molecular parasites such as transposons and viruses.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Lazare Res Bldg,Room 825,364 Plantat St, Worcester, MA 01605 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Boutla A, 2001, CURR BIOL, V11, P1776, DOI 10.1016/S0960-9822(01)00541-3; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Catalanotto C, 2000, NATURE, V404, P245, DOI 10.1038/35005169; Catalanotto C, 2002, GENE DEV, V16, P790, DOI 10.1101/gad.222402; CELOTTO AM, IN PRESS RNA; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dernburg AF, 2000, GENE DEV, V14, P1578; DUDLEY NR, 2002, P NATL ACAD SCI US; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Han YH, 2002, PLANT J, V29, P509, DOI 10.1046/j.1365-313x.2002.01236.x; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; LI H, IN PRESS SCIENCE; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Martens H, 2002, MOL BIOL CELL, V13, P445, DOI 10.1091/mbc.01-04-0211; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; PADDISON PJ, GENES DEV, V16; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Parrish S, 2000, MOL CELL, V6, P1077, DOI 10.1016/S1097-2765(00)00106-4; Parrish S, 2001, RNA, V7, P1397; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; SCHWARZ DS, IN PRESS GENES DEV; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; SMITH CJS, 1990, MOL GEN GENET, V224, P447; SUI G, IN PRESS P NATL ACAD; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; TABARA H, UNPUB; Tijsterman M, 2002, SCIENCE, V295, P694, DOI 10.1126/science.1067534; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yang D, 2000, CURR BIOL, V10, P1191, DOI 10.1016/S0960-9822(00)00732-6; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	60	260	386	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1265	1269		10.1126/science.1072457	http://dx.doi.org/10.1126/science.1072457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016303				2022-12-28	WOS:000175713000040
J	O'Neill, B; Mohan, D				O'Neill, B; Mohan, D			Reducing motor vehicle crash deaths and injuries in newly motorising countries	BRITISH MEDICAL JOURNAL			English	Article							SAFETY; METAANALYSIS		Insurance Inst Highway Safety, Arlington, VA 22201 USA; Indian Inst Technol, New Delhi 110016, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi	O'Neill, B (corresponding author), Insurance Inst Highway Safety, 1005 N Glebe Rd, Arlington, VA 22201 USA.		Gomaa, Ahmed/I-6442-2017	Gomaa, Ahmed/0000-0003-0869-7888				Branas CC, 2001, ACCIDENT ANAL PREV, V33, P641, DOI 10.1016/S0001-4575(00)00078-6; Chawla A., 2000, J CRASH PREVENTION I, V2, P33, DOI [https://doi.org/10.1080/10286580008902551, DOI 10.1080/10286580008902551]; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Eastman J., 1984, STYLING VS SAFETY AM; Elvik R, 1996, ACCIDENT ANAL PREV, V28, P685, DOI 10.1016/S0001-4575(96)00041-3; Elvik R, 2001, ACCIDENT ANAL PREV, V33, P327, DOI 10.1016/S0001-4575(00)00046-4; *EUR TRANSP SAF CO, 1995, RED TRAFF INJ RES EX; HADDON W, 1968, AM J PUBLIC HEALTH N, V58, P1431, DOI 10.2105/AJPH.58.8.1431; Haddon W., 1964, ACCIDENT RES METHODS; Kwan I, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003201; MAYHEW DR, 1996, EFFECTIVENESS ROLE D, P30; Mohan D, 2000, IMECHE CONF TRANS, V2000, P155; MOHAN D, 1983, INDIAN HIGHWAYS, V11, P8; ONeill, 1974, ACCIDENT ANAL PREV, V6, P263, DOI [10.1016/0001-4575(74)90004-9, DOI 10.1016/0001-4575(74)90004-9, 10.1016/0001-4575(74)90004-9.]; PEDEN MM, 2001, WHONMHVIP0103; Radin URS, 1996, ACCIDENT ANAL PREV, V28, P325, DOI 10.1016/0001-4575(95)00071-2; RETTING RA, 1995, ACCIDENT ANAL PREV, V27, P283, DOI 10.1016/0001-4575(94)00068-W; Ross HL., 1984, DETERRING DRINKING D; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; *STAT OFF, 2001, 11 STAT OFF SEL COMM; TIWARI G, 1996, WORLD RESOURCES 1996, P90; Trinca G. W., 1988, REDUCING TRAFFIC INJ; Vernick JS, 1999, AM J PREV MED, V16, P40, DOI 10.1016/S0749-3797(98)00115-9; [No title captured]; 2001, AM J PREV MED S, V21, P1	25	48	51	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 11	2002	324	7346					1142	1145		10.1136/bmj.324.7346.1142	http://dx.doi.org/10.1136/bmj.324.7346.1142			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552LX	12003889	Green Published			2022-12-28	WOS:000175622800027
J	Lauer, MS				Lauer, MS			Aspirin for primary prevention of coronary events.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; HEART-DISEASE; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; TASK-FORCE; RISK; MORTALITY; HYPERTENSION; METAANALYSIS		Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiovasc Med, Desk F25,9500 Euclid Ave, Cleveland, OH 44195 USA.	lauerm@ccf.org	Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066004] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 66004-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Khadra AS, 1998, J AM COLL CARDIOL, V31, P419, DOI 10.1016/S0735-1097(97)00502-0; ALEXANDER RW, 1994, NEW ENGL J MED, V331, P468, DOI 10.1056/NEJM199408183310709; [Anonymous], 1991, Ophthalmology, V98, P757; Berg AO, 2002, ANN INTERN MED, V136, P157, DOI 10.7326/0003-4819-136-2-200201150-00015; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P30; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1716; *CLOP UNST ANG PRE, 2001, NEW ENGL J MED, V345, P1506; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Derry S, 2000, BMJ-BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; *EXP PAN DET EV TR, 2001, 3 EXP PAN DET EV TRE; FERRIS FL, 1992, JAMA-J AM MED ASSOC, V268, P1292; FUSTER V, 1992, NEW ENGL J MED, V326, P310; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Grundy SM, 1997, CIRCULATION, V95, P2329, DOI 10.1161/01.CIR.95.9.2329; Gum PA, 2001, AM J CARDIOL, V88, P230, DOI 10.1016/S0002-9149(01)01631-9; Gum PA, 2001, JAMA-J AM MED ASSOC, V286, P1187, DOI 10.1001/jama.286.10.1187; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; HAMMOND EC, 1975, BMJ-BRIT MED J, V2, P269, DOI 10.1136/bmj.2.5965.269; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hayden M, 2002, ANN INTERN MED, V136, P161, DOI 10.7326/0003-4819-136-2-200201150-00016; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HENNEKENS CH, 1978, CIRCULATION, V58, P35, DOI 10.1161/01.CIR.58.1.35; Hennekens CH, 1997, CIRCULATION, V96, P2751, DOI 10.1161/01.CIR.96.8.2751; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; JICK H, 1976, BRIT MED J, V1, P1057, DOI 10.1136/bmj.1.6017.1057; Johnson ES, 1999, ARCH INTERN MED, V159, P1248, DOI 10.1001/archinte.159.11.1248; Latini R, 2000, J AM COLL CARDIOL, V35, P1801, DOI 10.1016/S0735-1097(00)00638-0; Lauer MS, 2001, JAMA-J AM MED ASSOC, V285, P2508, DOI 10.1001/jama.285.19.2508; MANSON JE, 1991, JAMA-J AM MED ASSOC, V266, P521, DOI 10.1001/jama.266.4.521; Meade TW, 1998, LANCET, V351, P233; Meade TW, 2000, BMJ-BRIT MED J, V321, P13, DOI 10.1136/bmj.321.7252.13; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; MERETO E, 1994, CANCER LETT, V76, P5, DOI 10.1016/0304-3835(94)90127-9; Nguyen KN, 1997, AM J CARDIOL, V79, P115, DOI 10.1016/S0002-9149(96)00696-0; PATRONO C, 1989, TRENDS PHARMACOL SCI, V10, P453, DOI 10.1016/S0165-6147(89)80010-0; Peterson JG, 2000, AM J MED, V109, P371, DOI 10.1016/S0002-9343(00)00492-7; Peterson JG, 2001, CLEV CLIN J MED, V68, P569, DOI 10.3949/ccjm.68.6.569; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; RAURAMAA R, 1986, CIRCULATION, V74, P939, DOI 10.1161/01.CIR.74.5.939; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Sanmuganathan PS, 2001, HEART, V85, P265, DOI 10.1136/heart.85.3.265; Spaulding C, 1998, CIRCULATION, V98, P757, DOI 10.1161/01.CIR.98.8.757; STAMPFER MJ, 1986, AM J MED, V81, P400, DOI 10.1016/0002-9343(86)90289-5; THUN MJ, 1993, CANCER RES, V53, P1322; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Topol EJ, 2000, CLIN CARDIOL, V23, P23, DOI 10.1002/clc.4960231107; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Yusuf S, 2001, NEW ENGL J MED, V345, P494	52	115	121	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 9	2002	346	19					1468	1474		10.1056/NEJMcp012672	http://dx.doi.org/10.1056/NEJMcp012672			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549FE	12000818				2022-12-28	WOS:000175433200007
J	Crocco, AG; Villasis-Keever, M; Jadad, AR				Crocco, AG; Villasis-Keever, M; Jadad, AR			Analysis of cases of harm associated with use of health information on the Internet	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				READABILITY; PATIENT	Context There is concern about the potential harm associated with the use of poor quality health information on the Internet. To date, there have been no systematic attempts to examine reported cases of such harm. Methods We conducted a systematic review of the peer-reviewed literature, to evaluate the number and characteristics of reported cases of harm associated with the use of health information obtained on the Internet. Using a refined strategy, we searched MEDLINE (from 1966 to February 2001), CINAHL (from 1982 to March 2001), HealthStar (from 1975 to December 2000), PsycINFO (from 1967 to March 2001), and EMBASE (from 1980 to March 2001). This was complemented with searches of reference lists. Two authors separately reviewed the abstracts to identify articles that describe at least 1 case of harm associated with the use of health information found on the Internet. Articles of any format and in any language deemed possibly relevant by either researcher were obtained and reviewed by both researches. Results The search yielded 1512 abstracts. Of these 186 papers were reviewed in full text. Of these, 3 articles satisfied the selection criteria. One article described 2 cases in which improper Internet searches led to emotional harm. The second article described dogs being poisoned because of misinformation obtained on the Internet. The third article described hepatorenal failure in an oncology patient who obtained misinformation about the use of medication on the Internet. Conclusions Despite the popularity of publications warning of the potential harm associated with using health information from the Internet, our search found few reported cases of harm. This may be due to an actual low risk for harm associated with the use of information available on the Internet, to underreporting of cases, or to bias.	McGill Univ, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; Inst Mexicano Seguro Social, Pediat Hosp, Clin Epidemiol Unit, Mexico City, DF, Mexico; Univ Hlth Network, Ctr Global eHlth Innovat, Dept Hlth Policy, Toronto, ON, Canada; Univ Hlth Network, Ctr Global eHlth Innovat, Dept Management & Evaluat, Toronto, ON, Canada; Univ Hlth Network, Ctr Global eHlth Innovat, Dept Anaesthesia, Toronto, ON, Canada; Univ Toronto, Toronto, ON, Canada	McGill University; Instituto Mexicano del Seguro Social; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Jadad, AR (corresponding author), Toronto Gen Hosp, Ctr Global eHlth Innovat, Fraser Elliott Bldg,4th Floor,190 Elizabeth St, Toronto, ON M5G 2C4, Canada.		Villasís-Keever, Miguel Angel/ABB-7807-2020	Villasís-Keever, Miguel Angel/0000-0002-8566-0811				Berland GK, 2001, JAMA-J AM MED ASSOC, V285, P2612, DOI 10.1001/jama.285.20.2612; Challis DE, 1996, ULTRASOUND OBST GYN, V8, P68, DOI 10.1046/j.1469-0705.1996.08010068.x; D'Alessandro DM, 2001, ARCH PEDIAT ADOL MED, V155, P807, DOI 10.1001/archpedi.155.7.807; Gieger TL, 2000, J AM ANIM HOSP ASSOC, V36, P317, DOI 10.5326/15473317-36-4-317; Hainer MI, 2000, ANN INTERN MED, V133, P877, DOI 10.7326/0003-4819-133-11-200012050-00011; Libertiny G, 2000, EUR J VASC ENDOVASC, V20, P386, DOI 10.1053/ejvs.2000.1179; McClung HJ, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e2	7	153	155	1	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2869	2871		10.1001/jama.287.21.2869	http://dx.doi.org/10.1001/jama.287.21.2869			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038937	Bronze			2022-12-28	WOS:000176002200034
J	Attisano, L; Wrana, JL				Attisano, L; Wrana, JL			Signal transduction by the TGF-beta superfamily	SCIENCE			English	Editorial Material							ANAPHASE-PROMOTING COMPLEX; CANCER; SNON	Transforming growth factor-beta (TGF-beta) superfamily members regulate a plethora of developmental processes, and disruption of their activity has been implicated in a variety of human diseases ranging from cancer to chondrodysplasias and pulmonary hypertension. Intense investigations have revealed that SMAD proteins constitute the basic components of the core intracellular signaling cascade and that SMADs function by carrying signals from the cell surface directly to the nucleus. Recent insights have revealed how SMAD proteins themselves are regulated and how appropriate subcellular localization of SMADs and TGF-beta transmembrane receptors is controlled. Current research efforts investigating the contribution of SMAD-independent pathways promise to reveal advances to enhance our understanding of the signaling cascade.	Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Attisano, L (corresponding author), Univ Toronto, Dept Anat & Cell Biol, 100 Coll St, Toronto, ON M5S 1A8, Canada.		Wrana, Jeffrey/F-8857-2013					ATTISANO L, 2002, SCI STKE; ATTISANO L, 2001, GEN BIOL, V2; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moustakas A, 2001, J CELL SCI, V114, P4359; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; ROBERTS AB, 2001, SCI STKE; Stroschein SL, 2001, GENE DEV, V15, P2822; Wan M, 2002, EMBO REP, V3, P171, DOI 10.1093/embo-reports/kvf024; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1	11	1026	1163	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1646	1647		10.1126/science.1071809	http://dx.doi.org/10.1126/science.1071809			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040180				2022-12-28	WOS:000175976200043
J	Herek, JL; Wohlleben, W; Cogdell, RJ; Zeidler, D; Motzkus, M				Herek, JL; Wohlleben, W; Cogdell, RJ; Zeidler, D; Motzkus, M			Quantum control of energy flow in light harvesting	NATURE			English	Article							LASER-PULSES; PHOTOSYNTHETIC UNIT; PHASE; FREQUENCY; BACTERIA; COMPLEX; DOMAIN; LH2	Coherent light sources have been widely used in control schemes that exploit quantum interference effects to direct the outcome of photochemical processes. The adaptive shaping of laser pulses is a particularly powerful tool in this context: experimental output as feedback in an iterative learning loop refines the applied laser field to render it best suited to constraints set by the experimenter(1,2). This approach has been experimentally implemented to control a variety of processes(3-9), but the extent to which coherent excitation can also be used to direct the dynamics of complex molecular systems in a condensed-phase environment remains unclear. Here we report feedback-optimized coherent control over the energy-flow pathways in the light-harvesting antenna complex LH2 from Rhodopseudomonas acidophila, a photosynthetic purple bacterium. We show that phases imprinted by the light field mediate the branching ratio of energy transfer between intra- and intermolecular channels in the complex's donor-acceptor system. This result illustrates that molecular complexity need not prevent coherent control, which can thus be extended to probe and affect biological functions.	Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Lund Univ, S-22100 Lund, Sweden; Vrije Univ Amsterdam, Dept Biophys, NL-1081 HV Amsterdam, Netherlands; Univ Glasgow, IBLS, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Max Planck Society; Lund University; Vrije Universiteit Amsterdam; University of Glasgow	Motzkus, M (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.			Wohlleben, Wendel/0000-0003-2094-3260; Zeidler, Dirk/0000-0003-2484-6636				AMSTRUP B, 1991, J PHYS CHEM-US, V95, P8019, DOI 10.1021/j100174a007; Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Bardeen CJ, 1997, CHEM PHYS LETT, V280, P151, DOI 10.1016/S0009-2614(97)01081-6; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Brixner T, 2001, NATURE, V414, P57, DOI 10.1038/35102037; Frank HA, 1997, PURE APPL CHEM, V69, P2117, DOI 10.1351/pac199769102117; Hornung T, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.021403; Hornung T, 2000, CHEM PHYS LETT, V326, P445, DOI 10.1016/S0009-2614(00)00810-1; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Krueger BP, 1998, J PHYS CHEM B, V102, P2284, DOI 10.1021/jp973062t; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Macpherson AN, 2001, BIOPHYS J, V80, P923, DOI 10.1016/S0006-3495(01)76071-7; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Paulus GG, 2001, NATURE, V414, P182, DOI 10.1038/35102520; Pullerits T, 1996, ACCOUNTS CHEM RES, V29, P381, DOI 10.1021/ar950110o; Rabitz H, 2000, SCIENCE, V288, P824, DOI 10.1126/science.288.5467.824; Ritz T, 2001, J PHYS CHEM B, V105, P8259, DOI 10.1021/jp011032r; Sundstrom V, 1999, J PHYS CHEM B, V103, P2327, DOI 10.1021/jp983722+; Trebino R, 1997, REV SCI INSTRUM, V68, P3277, DOI 10.1063/1.1148286; Trinkunas G, 2001, PHYS REV LETT, V86, P4167, DOI 10.1103/PhysRevLett.86.4167; WARREN WS, 1983, J CHEM PHYS, V78, P2279, DOI 10.1063/1.445083; Wefers MM, 1996, IEEE J QUANTUM ELECT, V32, P161, DOI 10.1109/3.481933; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Wilhelm T, 1997, OPT LETT, V22, P1494, DOI 10.1364/OL.22.001494; Zeidler D, 2000, APPL PHYS B-LASERS O, V70, pS125, DOI 10.1007/s003400000306; Zeidler D, 2002, J CHEM PHYS, V116, P5231, DOI 10.1063/1.1450549; Zeidler D, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.023420; Zinth W, 1996, BER BUNSEN PHYS CHEM, V100, P1962, DOI 10.1002/bbpc.19961001206	30	581	597	1	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					533	535		10.1038/417533a	http://dx.doi.org/10.1038/417533a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037563				2022-12-28	WOS:000175860300037
J	Herold, KC; Hagopian, W; Auger, JA; Poumian-Ruiz, E; Taylor, L; Donaldson, D; Gitelman, SE; Harlan, DM; Xu, DL; Zivin, RA; Bluestone, JA				Herold, KC; Hagopian, W; Auger, JA; Poumian-Ruiz, E; Taylor, L; Donaldson, D; Gitelman, SE; Harlan, DM; Xu, DL; Zivin, RA; Bluestone, JA			Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							T-CELLS; OKT3 ANTIBODY; RECEPTOR; CYCLOSPORINE; REMISSION; MICE; IMMUNOSUPPRESSION; INDUCTION; SUBSETS; DISEASE	Background: Type 1 diabetes mellitus is a chronic autoimmune disease caused by the pathogenic action of T lymphocytes on insulin-producing beta cells. Previous clinical studies have shown that continuous immune suppression temporarily slows the loss of insulin production. Preclinical studies suggested that a monoclonal antibody against CD3 could reverse hyperglycemia at presentation and induce tolerance to recurrent disease. Methods: We studied the effects of a nonactivating humanized monoclonal antibody against CD3 - hOKT3gamma1(Ala-Ala) - on the loss of insulin production in patients with type 1 diabetes mellitus. Within 6 weeks after diagnosis, 24 patients were randomly assigned to receive either a single 14-day course of treatment with the monoclonal antibody or no antibody and were studied during the first year of disease. Results: Treatment with the monoclonal antibody maintained or improved insulin production after one year in 9 of the 12 patients in the treatment group, whereas only 2 of the 12 controls had a sustained response (P=0.01). The treatment effect on insulin responses lasted for at least 12 months after diagnosis. Glycosylated hemoglobin levels and insulin doses were also reduced in the monoclonal-antibody group. No severe side effects occurred, and the most common side effects were fever, rash, and anemia. Clinical responses were associated with a change in the ratio of CD4+ T cells to CD8+ T cells 30 and 90 days after treatment. Conclusions: Treatment with hOKT3gamma1(Ala-Ala) mitigates the deterioration in insulin production and improves metabolic control during the first year of type 1 diabetes mellitus in the majority of patients. The mechanism of action of the anti-CD3 monoclonal antibody may involve direct effects on pathogenic T cells, the induction of populations of regulatory cells, or both.	Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; Columbia Univ, Coll Phys & Surg, Dept Med, Div Endocrinol, New York, NY USA; Pacific NW Res Inst, Seattle, WA USA; Univ Chicago, Chicago, IL 60637 USA; Univ Utah, Salt Lake City, UT USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; NIDDKD, Bethesda, MD 20892 USA; RW Johnson Pharmaceut Res Inst, Raritan, NJ 08869 USA	Columbia University; Columbia University; University of Chicago; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Johnson & Johnson; Johnson & Johnson USA	Herold, KC (corresponding author), Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, 1150 St Nicholas Ave, New York, NY 10032 USA.	kh318@columbia.edu			NCRR NIH HHS [M01 RR00645, M01 RR01271] Funding Source: Medline; NIDDK NIH HHS [P60 DK20595, R01DK57846] Funding Source: Medline; PHS HHS [U19A146132] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000645, M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020595, R01DK057846, Z01DK062001, Z01DK062000] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Atkinson MA, 2001, LANCET, V358, P766; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; BOUGNERES PF, 1988, NEW ENGL J MED, V318, P663, DOI 10.1056/NEJM198803173181103; Chatenoud L, 1997, J IMMUNOL, V158, P2947; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; CHATENOUD L, 1990, TRANSPLANTATION, V49, P697, DOI 10.1097/00007890-199004000-00009; CHATENOUD L, 1993, TRANSPLANT P, V25, P68; DCCT Res Grp, 1987, J CLIN ENDOCR METAB, V65, P30; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; EISENBARTH GS, 1986, NEW ENGL J MED, V314, P1360; ERLICH H, 1991, EUR J IMMUNOGENET, V18, P33, DOI 10.1111/j.1744-313X.1991.tb00005.x; FABER OK, 1978, DIABETES, V27, P170, DOI 10.2337/diab.27.1.S170; GRAJWER LA, 1977, J PEDIATR-US, V90, P42, DOI 10.1016/S0022-3476(77)80762-2; Herold KC, 1996, J IMMUNOL, V156, P3521; HEROLD KC, 1992, DIABETES, V41, P385, DOI 10.2337/diabetes.41.3.385; Izuhara K, 1999, INT J MOL MED, V3, P3; Jiang SP, 1998, HUM IMMUNOL, V59, P690, DOI 10.1016/S0198-8859(98)00073-1; KARJALAINEN J, 1989, NEW ENGL J MED, V320, P881, DOI 10.1056/NEJM198904063201401; KATZ JD, 1995, SCIENCE, V268, P1185, DOI 10.1126/science.7761837; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Parving HH, 1999, DIABETES CARE, V22, P478, DOI 10.2337/diacare.22.3.478; Rabinovitch A, 1998, BIOCHEM PHARMACOL, V55, P1139, DOI 10.1016/S0006-2952(97)00492-9; RAPOPORT MJ, 1993, J EXP MED, V178, P87, DOI 10.1084/jem.178.1.87; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; SJOBERG S, 1991, Journal of Diabetic Complications, V5, P18, DOI 10.1016/0891-6632(91)90005-A; Skyler Jay S., 1992, Journal of Diabetes and its Complications, V6, P77, DOI 10.1016/1056-8727(92)90016-E; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; Smith JA, 1998, J IMMUNOL, V160, P4841; Smith JA, 1997, CURR OPIN IMMUNOL, V9, P648, DOI 10.1016/S0952-7915(97)80044-1; Smith JA, 1997, J EXP MED, V185, P1413, DOI 10.1084/jem.185.8.1413; STILLER CR, 1984, SCIENCE, V223, P1362, DOI 10.1126/science.6367043; Tyden G, 1996, NEW ENGL J MED, V335, P860, DOI 10.1056/NEJM199609193351205; Tyden G, 1996, NEW ENGL J MED, V335, P1778; WARE R, 1995, IMMUNITY, V2, P177, DOI 10.1016/S1074-7613(95)80066-2; Woo W, 2000, J IMMUNOL METHODS, V244, P91, DOI 10.1016/S0022-1759(00)00259-3; Woodle ES, 1999, TRANSPLANTATION, V68, P608, DOI 10.1097/00007890-199909150-00003; Woodle ES, 1998, TRANSPLANT P, V30, P1369, DOI 10.1016/S0041-1345(98)00278-4; YILMAZ MT, 1993, DIABETES RES CLIN PR, V19, P151, DOI 10.1016/0168-8227(93)90108-H; Zipris D, 1996, J IMMUNOL, V156, P1315	40	857	1011	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1692	1698		10.1056/NEJMoa012864	http://dx.doi.org/10.1056/NEJMoa012864			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037148				2022-12-28	WOS:000175834100003
J	Cummings, DE; Weigle, DS; Frayo, RS; Breen, PA; Ma, MK; Dellinger, EP; Purnell, JQ				Cummings, DE; Weigle, DS; Frayo, RS; Breen, PA; Ma, MK; Dellinger, EP; Purnell, JQ			Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERTICAL BANDED GASTROPLASTY; QUALITY-OF-LIFE; MORBID-OBESITY; FOOD-INTAKE; ACYLATED PEPTIDE; HORMONE; BEHAVIOR; PERSPECTIVE; RESPONSES; EXERCISE	Background: Weight loss causes changes in appetite and energy expenditure that promote weight regain. Ghrelin is a hormone that increases food intake in rodents and humans. If circulating ghrelin participates in the adaptive response to weight loss, its levels should rise with dieting. Because ghrelin is produced primarily by the stomach, weight loss after gastric bypass surgery may be accompanied by impaired ghrelin secretion. Methods: We determined the 24-hour plasma ghrelin profiles, body composition, insulin levels, leptin levels, and insulin sensitivity in 13 obese subjects before and after a six-month dietary program for weight loss. The 24-hour ghrelin profiles were also determined in 5 subjects who had lost weight after gastric bypass and 10 normal-weight controls; 5 of the 13 obese subjects who participated in the dietary program were matched to the subjects in the gastric-bypass group and served as obese controls. Results: Plasma ghrelin levels rose sharply shortly before and fell shortly after every meal. A diet-induced weight loss of 17 percent of initial body weight was associated with a 24 percent increase in the area under the curve for the 24-hour ghrelin profile (P=0.006). In contrast, despite a 36 percent weight loss after gastric bypass, the area under the curve for the ghrelin profile in the gastric-bypass group was 77 percent lower than in normal-weight controls (P<0.001) and 72 percent lower than in matched obese controls (P=0.01). The normal, meal-related fluctuations and diurnal rhythm of the ghrelin level were absent after gastric bypass. Conclusions: The increase in the plasma ghrelin level with diet-induced weight loss is consistent with the hypothesis that ghrelin has a role in the long-term regulation of body weight. Gastric bypass is associated with markedly suppressed ghrelin levels, possibly contributing to the weight-reducing effect of the procedure. (N Engl J Med 2002;346:1623-30.) Copyright (C) 2002 Massachusetts Medical Society.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Surg, Seattle, WA 98195 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Hosp, Seattle, WA 98104 USA; Oregon Hlth Sci Univ, Dept Med, Portland, OR 97201 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle; Oregon Health & Science University	Cummings, DE (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, Seattle Div, 1660 S Columbian Way,S-111-Endo, Seattle, WA 98108 USA.		Purnell, Jonathan Q/GVS-8854-2022	Purnell, Jonathan Q/0000-0001-5505-6333	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK002689, K24DK002860, R01DK055460] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00037] Funding Source: Medline; NIDDK NIH HHS [R01 DK55460, K24 DK02860, K23 DK02689] Funding Source: Medline; NIH HHS [P3ODK17047] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; BERGMAN RN, 1979, AM J PHYSIOL, V236, P667; Bray GA, 1999, OBES RES, V7, P189, DOI 10.1002/j.1550-8528.1999.tb00701.x; Bray GA, 2000, NATURE, V404, P672, DOI 10.1038/35007544; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Goldman R., 1961, TECHNIQUES MEASURING, P78; GOLDRICK RB, 1967, AM J PHYSIOL, V212, P777, DOI 10.1152/ajplegacy.1967.212.4.777; HAFNER RJ, 1991, INT J OBESITY, V15, P555; HALMI KA, 1981, INT J OBESITY, V5, P457; Hell E, 2000, OBES SURG, V10, P214, DOI 10.1381/096089200321643485; HOWARD L, 1995, OBES SURG, V5, P55, DOI 10.1381/096089295765558169; KELLUM JM, 1990, ANN SURG, V211, P763, DOI 10.1097/00000658-199006000-00016; KENLER HA, 1990, AM J CLIN NUTR, V52, P87, DOI 10.1093/ajcn/52.1.87; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; LEIBEL RL, 1995, NEW ENGL J MED, V333, P399; LEW EA, 1985, ANN INTERN MED, V103, P1024, DOI 10.7326/0003-4819-103-6-1024; Lissner L, 1998, EUR J CLIN NUTR, V52, P316, DOI 10.1038/sj.ejcn.1600567; MORGAN CR, 1963, DIABETES, V12, P115, DOI 10.2337/diab.12.2.115; Mun EC, 2001, GASTROENTEROLOGY, V120, P669, DOI 10.1053/gast.2001.22430; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; NASLUND I, 1987, ACTA CHIR SCAND    S, V536, P44; PAPPAS TN, 1992, AM J CLIN NUTR, V55, P571, DOI 10.1093/ajcn/55.2.571s; PORIES WJ, 1982, ANN SURG, V196, P389, DOI 10.1097/00000658-198210000-00002; RAND CSW, 1987, SOUTHERN MED J, V80, P961, DOI 10.1097/00007611-198708000-00007; Riley RE, 1999, CLIN SPORT MED, V18, P691, DOI 10.1016/S0278-5919(05)70176-9; RITTMASTER RS, 1987, NEUROENDOCRINOLOGY, V45, P118, DOI 10.1159/000124713; SAFER DJ, 1991, SOUTHERN MED J, V84, P1470, DOI 10.1097/00007611-199112000-00015; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; SHUMAN WP, 1986, INVEST RADIOL, V21, P483, DOI 10.1097/00004424-198606000-00007; Sjostrom L, 1998, LANCET, V352, P167, DOI 10.1016/S0140-6736(97)11509-4; SUGERMAN HJ, 1987, ANN SURG, V205, P613, DOI 10.1097/00000658-198706000-00002; SUGERMAN HJ, 1993, SURG SCI PRINCIPLES, P702; Taubes G, 1998, SCIENCE, V280, P1367, DOI 10.1126/science.280.5368.1367; TROSTLER N, 1995, OBES SURG, V5, P39, DOI 10.1381/096089295765558141; Tschop M, 2001, DIABETES, V50, P707, DOI 10.2337/diabetes.50.4.707; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; WADDEN TA, 1989, INT J OBESITY, V13, P39; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540	43	1716	1833	5	99	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 23	2002	346	21					1623	1630		10.1056/NEJMoa012908	http://dx.doi.org/10.1056/NEJMoa012908			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554GZ	12023994				2022-12-28	WOS:000175728600004
J	Kelly, CK; Bowler, MG				Kelly, CK; Bowler, MG			Coexistence and relative abundance in forest trees	NATURE			English	Article							LIMITING SIMILARITY; LONG-TERM; COMPETITION; TRENDS	Contemporary acceleration of biodiversity loss makes increasingly urgent the need to understand the controls of species coexistence(1,2). Tree diversity in particular plays a pivotal role in determining terrestrial biodiversity, through maintaining diversity of its dependent species(3,4) and with them, their predators and parasites. Most theories of coexistence based on the principle of limiting similarity suggest that coexistence of competing species is inherently unstable; coexistence of competitors must be maintained by external forces such as disturbance(5,6), immigration(7) or 'patchiness' of resources in space and time(8,9). In contrast, storage theory postulates stable coexistence of competing species through temporal alternation of conditions favouring recruitment of one species over the other(10,11). Here we use storage theory to develop explicit predictions for relative differences between competitors that allow us to discriminate between coexistence models. Data on tree species from a primary forest on the Mexican Pacific coast support a general dynamic of storage processes determining coexistence of similar tree species in this community, and allow us to reject all other theories of coexistence.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Dept Phys, Oxford OX1 3RH, England	University of Oxford; University of Oxford	Kelly, CK (corresponding author), Univ Southampton, Sch Biol Sci, Div Biodivers & Ecol, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	c.k.kelly@soton.ac.uk						Becerra JX, 1999, AM J BOT, V86, P1047, DOI 10.2307/2656622; CHESSON P, 1994, THEOR POPUL BIOL, V45, P227, DOI 10.1006/tpbi.1994.1013; CHESSON P, 1989, TRENDS ECOL EVOL, V4, P293, DOI 10.1016/0169-5347(89)90024-4; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CHESSON PL, 1981, AM NAT, V117, P923, DOI 10.1086/283778; Condit R, 1998, AM NAT, V152, P495, DOI 10.1086/286186; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Harvey PH, 1996, J ANIM ECOL, V65, P255, DOI 10.2307/5872; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Kelly CK, 1999, P NATL ACAD SCI USA, V96, P8013, DOI 10.1073/pnas.96.14.8013; Kelly CK, 2001, ECOL LETT, V4, P618, DOI 10.1046/j.1461-0248.2001.00278.x; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Lusk CH, 1998, ECOLOGY, V79, P795, DOI 10.1890/0012-9658(1998)079[0795:LHDATS]2.0.CO;2; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; May Robert M., 1995, P1; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; PACALA SW, 1994, AM NAT, V143, P222, DOI 10.1086/285602; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Rzedowski J., 1978, VEGETACION MEXICO; Siegal S., 1956, NONPARAMETRIC STAT; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; TILMAN D, 1988; WARNER RR, 1985, AM NAT, V125, P769, DOI 10.1086/284379; WOODWARD FI, 1997, PLANT FUNCTIONAL TYP	30	92	97	8	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 23	2002	417	6887					437	440		10.1038/417437a	http://dx.doi.org/10.1038/417437a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554HZ	12024212				2022-12-28	WOS:000175730900037
J	Shigetani, Y; Sugahara, F; Kawakami, Y; Murakami, Y; Hirano, S; Kuratani, S				Shigetani, Y; Sugahara, F; Kawakami, Y; Murakami, Y; Hirano, S; Kuratani, S			Heterotopic shift of epithelial-mesenchymal interactions in vertebrate jaw evolution	SCIENCE			English	Article							NEURAL CREST; AGNATHAN VERTEBRATE; LAMPETRA-JAPONICA; ORIGIN; EXPRESSION; LAMPREY; EMBRYOS	Genes involved in Late specification of the mandibular arch, the source of the vertebrate jaw, are expressed with similar patterns in the oral regions of chick and lamprey embryos. However, morphological comparisons indicate that apparently orthologous homeobox genes were expressed in different subdivisions of the ectomesenchyme in the two species. Therefore, the homology and gene expression of the oral region are uncoupled during the transition from agnathan to gnathostome; we conclude that a heterotopic shift of tissue interaction was involved in the evolution of the jaw.	RIKEN, Ctr Dev Biol, Lab Evolut Morphol, Wako, Saitama 6500047, Japan; Okayama Univ, Dept Biol, Okayama 7008530, Japan; Niigata Univ, Dept Med Technol, Niigata 9518518, Japan	RIKEN; Okayama University; Niigata University	Kuratani, S (corresponding author), RIKEN, Ctr Dev Biol, Lab Evolut Morphol, Wako, Saitama 6500047, Japan.	saizo@cdb.riken.go.jp	Sugahara, Fumiaki/C-5379-2017; Sugahara, Fumiaki/ABA-7542-2021; Kuratani, Shigeru/J-4146-2014	Sugahara, Fumiaki/0000-0001-8445-1703; Kuratani, Shigeru/0000-0001-9717-7221				COULY GF, 1993, DEVELOPMENT, V117, P409; Ferguson CA, 2000, DEVELOPMENT, V127, P403; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Haeckel E., 1875, JENAISCHE Z FR NATUR, V9, P402; Hall B.K., 1998, EVOLUTIONARY DEV BIO; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; Kontges G, 1996, DEVELOPMENT, V122, P3229; Kuratani S, 1999, DEV BIOL, V210, P381, DOI 10.1006/dbio.1999.9266; Kuratani S, 2001, PHILOS T ROY SOC B, V356, P1615, DOI 10.1098/rstb.2001.0976; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MULLER GB, 1991, ANNU REV ECOL SYST, V22, P229, DOI 10.1146/annurev.es.22.110191.001305; Murakami Y, 2001, DEVELOPMENT, V128, P3521; MYOJIN M, 2001, MECH DEV EVOL, V291, P58; Neubuser A, 1997, CELL, V90, P247, DOI 10.1016/S0092-8674(00)80333-5; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Shigetani Y, 2000, DEV BIOL, V228, P73, DOI 10.1006/dbio.2000.9932; Ueki T, 1998, DEV GENES EVOL, V208, P223, DOI 10.1007/s004270050176; Wagner Gunter P., 1994, P273	21	143	147	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 17	2002	296	5571					1316	1319		10.1126/science.1068310	http://dx.doi.org/10.1126/science.1068310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016315				2022-12-28	WOS:000175713000054
J	Locher, KP; Lee, AT; Rees, DC				Locher, KP; Lee, AT; Rees, DC			The E-coli BtuCD structure: A framework for ABC transporter architecture and mechanism	SCIENCE			English	Article							ATP-BINDING-CASSETTE; CRYSTAL-STRUCTURE; CYSTIC-FIBROSIS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; ACTIVE-SITE; PROTEINS; IDENTIFICATION; NUCLEOTIDE; SUBUNIT	The ABC transporters are ubiquitous membrane proteins that couple adenosine triphosphate (ATP) hydrolysis to the translocation of diverse substrates across cell membranes. Clinically relevant examples are associated with cystic fibrosis and with multidrug resistance of pathogenic bacteria and cancer cells. Here, we report the crystal structure at 3.2 angstrom resolution of the Escherichia coli BtuCD protein, an ABC transporter mediating vitamin B-12 uptake. The two ATP-binding cassettes (BtuD) are in close contact with each other, as are the two membrane-spanning subunits (BtuC); this arrangement is distinct from that observed for the E. coli lipid flippase MsbA. The BtuC subunits provide 20 transmembrane helices grouped around a translocation pathway that is closed to the cytoplasm by a gate region whereas the dimer arrangement of the BtuD subunits resembles the ATP-bound form of the Rad50 DNA repair enzyme. A prominent cytoplasmic loop of BtuC forms the contact region with the ATP-binding cassette and appears to represent a conserved motif among the ABC transporters.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Locher, KP (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 147-75CH, Pasadena, CA 91125 USA.	locher@caltech.edu; dcrees@caltech.edu						Abele R, 1999, BBA-BIOMEMBRANES, V1461, P405, DOI 10.1016/S0005-2736(99)00171-6; AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7; AVERBUCHPOUCHOT MT, 1994, EUR J SOL STATE INOR, V31, P567; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOOS W, 1996, ESCHERICHIA COLI SAL, V1, P1175; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadieux N, 2002, J BACTERIOL, V184, P706, DOI 10.1128/JB.184.3.706-717.2002; Chang G, 2001, SCIENCE, V293, P1793, DOI 10.1126/science.293.5536.1793; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chen HL, 1996, NAT GENET, V13, P210, DOI 10.1038/ng0696-210; Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498; Cotten JF, 1996, J BIOL CHEM, V271, P21279, DOI 10.1074/jbc.271.35.21279; CURRIER SJ, 1992, J BIOL CHEM, V267, P25153; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEVEAUX LC, 1985, J BACTERIOL, V162, P888, DOI 10.1128/JB.162.3.888-896.1985; Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Gaudet R, 2001, EMBO J, V20, P4964, DOI 10.1093/emboj/20.17.4964; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; Groeger W, 1998, MICROBIOL-SGM, V144, P2759, DOI 10.1099/00221287-144-10-2759; HEATH E, 1981, J CHEM SOC DALTON, P1105, DOI 10.1039/dt9810001105; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; Koster W, 2001, RES MICROBIOL, V152, P291, DOI 10.1016/S0923-2508(01)01200-1; Lankat-Buttgereit B, 2002, PHYSIOL REV, V82, P187, DOI 10.1152/physrev.00025.2001; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; REYNOLDS PR, 1980, J BIOL CHEM, V255, P4313; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Rosenberg MF, 2001, J BIOL CHEM, V276, P16076, DOI 10.1074/jbc.M100176200; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8; Saveanu L, 2001, J BIOL CHEM, V276, P22107, DOI 10.1074/jbc.M011221200; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schneider E, 1998, FEMS MICROBIOL REV, V22, P1; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thomas PJ, 2001, NAT STRUCT BIOL, V8, P920, DOI 10.1038/nsb1101-920; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; van Veen HW, 2000, EMBO J, V19, P2503, DOI 10.1093/emboj/19.11.2503; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200	55	916	946	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1091	1098		10.1126/science.1071142	http://dx.doi.org/10.1126/science.1071142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004122				2022-12-28	WOS:000175565000045
J	Rasmussen, B; Bengtson, S; Fletcher, IR; McNaughton, NJ				Rasmussen, B; Bengtson, S; Fletcher, IR; McNaughton, NJ			Discoidal impressions and trace-like fossils more than 1200 million years old	SCIENCE			English	Article							CAMBRIAN EXPLOSION; U-PB; WESTERN-AUSTRALIA; METAZOAN PHYLA; STIRLING RANGE; MONAZITE; FUSE	The Stirling Range Formation of southwestern Australia contains discoidal impressions and trace-like fossils in tidal sandstones. The various disks have previously been linked to the Ediacaran biota, younger than 600 million years old. From this unit, we report U-Th-Pb geochronology of detrital zircon and monazite, as well as low-grade metamorphic monazite, constraining the depositional age to between 2016+/-6 and 1215+/-20 million years old. Although nonbiological origins for the discoidal impressions cannot be completely discounted, the structures resembling trace fossils clearly have a biological origin and suggest the presence of vermiform, mucus-producing, motile organisms.	Univ Western Australia, Ctr Global Met, Dept Geol & Geophys, Crawley, WA 6009, Australia; Swedish Museum Nat Hist, Dept Palaeozool, SE-10405 Stockholm, Sweden	University of Western Australia; Swedish Museum of Natural History	Rasmussen, B (corresponding author), Univ Western Australia, Ctr Global Met, Dept Geol & Geophys, Crawley, WA 6009, Australia.		McNaughton, Neal/AAV-9941-2020; McNaughton, Neal/E-3884-2014; McNaughton, Neal/AAD-7067-2022	Bengtson, Stefan/0000-0003-0206-5791; Rasmussen, Birger/0000-0002-2745-0904				Ayala FJ, 1998, P NATL ACAD SCI USA, V95, P606, DOI 10.1073/pnas.95.2.606; BEESON J, 1991, THESIS U W AUSTR CRA; BLACK LP, 1992, PRECAMBRIAN RES, V59, P117; BOULTER CA, 1979, J STRUCT GEOL, V1, P207, DOI 10.1016/0191-8141(79)90040-3; Bromham L, 1998, P NATL ACAD SCI USA, V95, P12386, DOI 10.1073/pnas.95.21.12386; Bromley R.G., 1996, TRACE FOSSILS, V2nd ed.; Budd GE, 2000, BIOL REV, V75, P253, DOI 10.1017/S000632310000548X; CLOUD P, 1973, Geology (Boulder), V1, P123, DOI 10.1130/0091-7613(1973)1<123:PAPFC>2.0.CO;2; Collins AG, 2000, PALEOBIOLOGY, V26, P47, DOI 10.1666/0094-8373(2000)026<0047:MMCTAT>2.0.CO;2; Collins AG, 1998, P NATL ACAD SCI USA, V95, P15458, DOI 10.1073/pnas.95.26.15458; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; CRUSE T, 1993, AUST J EARTH SCI, V40, P293, DOI 10.1080/08120099308728081; CRUSE T, 1991, THESIS U W AUSTR CRA; DAWSON GR, UNPUB; Evans J, 1996, EARTH PLANET SC LETT, V144, P421, DOI 10.1016/S0012-821X(96)00177-X; Foster G, 2000, EARTH PLANET SC LETT, V181, P327, DOI 10.1016/S0012-821X(00)00212-0; Gehling JG, 2000, PALAEONTOLOGY, V43, P427, DOI 10.1111/j.0031-0239.2000.00134.x; GLAESSNER MF, 1969, LETHAIA, V2, P369, DOI 10.1111/j.1502-3931.1969.tb01258.x; HARRIS LB, 1994, J GEOL SOC LONDON, V151, P901, DOI 10.1144/gsjgs.151.6.0901; HARRISON JF, 1994, PHYSIOL ZOOL, V67, P1; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; KITAZATO H, 1988, J FORAMIN RES, V18, P344, DOI 10.2113/gsjfr.18.4.344; Morris SC, 2000, P NATL ACAD SCI USA, V97, P4426, DOI 10.1073/pnas.97.9.4426; MYERS JS, 1990, GEOLOGY MINERAL RESO, P255; Rasmussen B, 2001, GEOLOGY, V29, P963, DOI 10.1130/0091-7613(2001)029<0963:DLGMEB>2.0.CO;2; Rauprich O, 1996, J BACTERIOL, V178, P6525, DOI 10.1128/jb.178.22.6525-6538.1996; Seilacher A, 1998, SCIENCE, V282, P80, DOI 10.1126/science.282.5386.80; Smith JB, 1998, PRECAMBRIAN RES, V88, P143, DOI 10.1016/S0301-9268(97)00067-3; Stephenson N., 1966, J GEOL SOC AUST, V13, P449; Valentine JW, 1999, DEVELOPMENT, V126, P851; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	31	107	111	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 10	2002	296	5570					1112	1115		10.1126/science.1070166	http://dx.doi.org/10.1126/science.1070166			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004128				2022-12-28	WOS:000175565000051
J	Klopfenstein, DR; Tomishige, M; Stuurman, N; Vale, RD				Klopfenstein, DR; Tomishige, M; Stuurman, N; Vale, RD			Role of phosphatidylinositol(4,5)bisphosphate organization in membrane transport by the Unc104 kinesin motor	CELL			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; SUPERFAMILY PROTEIN KIF1A; AXONAL-TRANSPORT; PHOSPHOINOSITIDE BINDING; ORGANELLE TRANSPORT; VESICLE TRANSPORT; LIPID RAFTS; HEAVY-CHAIN; C-ELEGANS; K-LOOP	Unc104 (KIF1A) kinesin transports membrane vesicles along microtubules in lower and higher eukaryotes. Using an in vitro motility assay, we show that Unc104 uses a lipid binding pleckstrin homology (PH) domain to dock onto membrane cargo. Through its PH domain, Unc104 can transport phosphatidylinositol(4,5)bisphosphate (Ptdins(4,5)P-2)-containing liposomes with similar properties to native vesicles. Interestingly, liposome movement by monomeric Unc104 motors shows a very steep dependence on Ptdins(4,5)P-2 concentration (Hill coefficient of similar to20), even though liposome binding is noncooperative. This switch-like transition for movement can be shifted to lower Ptdins(4,5)P-2 concentrations by the addition of cholesterol/sphingomyelin or GM1 ganglioside/cholera toxin, conditions that produce raft-like behavior of Unc104 bound to lipid bilayers. These studies suggest that clustering of Unc104 in Ptdins(4,5)P-2-containing rafts provides a trigger for membrane transport.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Stuurman, Nico/AAV-4894-2021	Stuurman, Nico/0000-0002-6179-8613	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM038499-14, R01 GM038499] Funding Source: Medline; PHS HHS [NIH 38499] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Berg JS, 2000, J CELL SCI, V113, P3439; Bloom GS, 2001, CURR OPIN CELL BIOL, V13, P36, DOI 10.1016/S0955-0674(00)00171-X; Caroni P, 2001, EMBO J, V20, P4332, DOI 10.1093/emboj/20.16.4332; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; COHN RC, 1988, J LAB CLIN MED, V111, P336; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; Goldstein LSB, 2001, TRENDS CELL BIOL, V11, P477, DOI 10.1016/S0962-8924(01)02143-2; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Kavran JM, 1998, J BIOL CHEM, V273, P30497, DOI 10.1074/jbc.273.46.30497; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Laux T, 2000, J CELL BIOL, V149, P1455, DOI 10.1083/jcb.149.7.1455; Lemmon MA, 1999, BIOCHEM SOC T, V27, P617, DOI 10.1042/bst0270617; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; Miki H, 2001, P NATL ACAD SCI USA, V98, P7004, DOI 10.1073/pnas.111145398; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Pierce DW, 1999, BIOCHEMISTRY-US, V38, P5412, DOI 10.1021/bi9830009; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Pollock N, 1999, J CELL BIOL, V147, P493, DOI 10.1083/jcb.147.3.493; Pollock N, 1998, CELL MOTIL CYTOSKEL, V40, P304, DOI 10.1002/(SICI)1097-0169(1998)40:3<304::AID-CM8>3.0.CO;2-C; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Reilein AR, 2001, INT REV CYTOL, V204, P179, DOI 10.1016/S0074-7696(01)04005-0; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Sakowicz R, 1999, PROTEIN SCI, V8, P2705; Sandhoff R, 1999, J LIPID RES, V40, P126; SCHROER TA, 1991, J CELL BIOL, V115, P1309, DOI 10.1083/jcb.115.5.1309; Sheetz MP, 1999, EUR J BIOCHEM, V262, P19, DOI 10.1046/j.1432-1327.1999.00340.x; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; van Heyningen W E, 1976, Adv Exp Med Biol, V71, P205; VANDERKAAY J, 1990, P NATL ACAD SCI USA, V87, P9197, DOI 10.1073/pnas.87.23.9197; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Wang JY, 2001, J BIOL CHEM, V276, P5012, DOI 10.1074/jbc.M008355200; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	47	231	235	1	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					347	358		10.1016/S0092-8674(02)00708-0	http://dx.doi.org/10.1016/S0092-8674(02)00708-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015984	Green Accepted, Bronze			2022-12-28	WOS:000175412100010
J	Dian, BC; Longarte, A; Zwier, TS				Dian, BC; Longarte, A; Zwier, TS			Conformational dynamics in a dipeptide after single-mode vibrational excitation	SCIENCE			English	Article							SPECTROSCOPY; SIMULATION; MOLECULES	The dynamics of conformational isomerization are explored in methyl-capped dipeptide, N-acetyl-tryptophan methyl amide (NATMA), using infrared-ultraviolet (IR-UV) hole-filling and IR-induced population transfer spectroscopies. IR radiation selectively excites individual NH stretch vibrational fundamentals of single conformations of the molecule in the early portions of gas-phase expansion, and then this excited population is collisionally recooled into its conformational minima for subsequent conformation-specific detection. Efficient isomerization is induced by the IR excitation that redistributes population between the same conformations that have population in the absence of IR excitation. The quantum yields for transfer of the population into the various conformational minima depend uniquely on which conformation is excited and on which NH stretch vibration is excited within given conformation.	Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Zwier, TS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.		Longarte, Asier/K-3623-2014	Longarte, Asier/0000-0001-6191-4576				CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crim FF, 1996, J PHYS CHEM-US, V100, P12725, DOI 10.1021/jp9604812; DIAN BC, UNPUB; EVANS DJF, COMMUNICATION; HEADGORDON T, 1991, J AM CHEM SOC, V113, P5989, DOI 10.1021/ja00016a010; Mortenson PN, 2001, J CHEM PHYS, V114, P6443, DOI 10.1063/1.1343486; Nesbitt DJ, 1996, J PHYS CHEM-US, V100, P12735, DOI 10.1021/jp960698w; Richards F. M., 1992, P1; TUBERGEN MJ, 1990, J CHEM PHYS, V92, P51, DOI 10.1063/1.458453; VACHEV VD, 1995, J PHYS CHEM-US, V99, P5247, DOI 10.1021/j100015a004; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+	11	172	179	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 28	2002	296	5577					2369	2373		10.1126/science.1071563	http://dx.doi.org/10.1126/science.1071563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CE	12029064				2022-12-28	WOS:000176467200034
J	Callahan, ML; Knopp, RK; Gallagher, EJ				Callahan, ML; Knopp, RK; Gallagher, EJ			Effect of written feedback by editors on quality of reviews - Two tandomized trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	4th International Congress on Peer Review in Biomedical Publication	SEP 14-16, 2001	BARCELONA, SPAIN				PEER REVIEWS; MANUSCRIPTS	Context Better peer review is needed, but proven methods to improve quality are unknown. Our objective was to determine whether written feedback to reviewers improves subsequent reviews. Methods Eligible reviewers were randomized to intervention or control (receiving other reviewers' unscored reviews and the editor's decision letter). Study I (September 1998-September 2000) included reviewers with a median quality score of 3 or lower; study 2 (April 2000-January 2002), reviewers with median score of 4 or lower. Study I was designed with a power of 0.80 to detect a difference in score of 1; study 2, with a power of 0.80 to detect a difference of 0.5. All reviewers were at a peer-reviewed journal (Annals of Emergency Medicine). The main outcome measure was the editor's routine quality rating (1-5) of all reviews (blinded to study enrollment). Results For study 1, 51 reviewers were eligible and randomized and 35 had sufficient data (182 reviews) for analysis. The mean individual reviewer rating change was 0.16 (95% confidence interval [CI], -0.26 to 0,58) for control and -0.13 (-0.49 to 0.23) for intervention. For study 2, 127 reviewers were eligible and randomized, and 95 had sufficient data (324 reviews). Controls had a mean individual rating change of 0.12 (95% Cl, -0.20 to 0.26) and intervention reviewers, 0.06 (-0.19 to 0.31). Conclusions In study 1, minimal feedback from editors on review quality had no effect on subsequent performance of poor-quality reviewers, and the trend was toward a negative effect. In study 2, feedback to average reviewers was more extensive and supportive but produced no improvement in reviewer performance. Simple written feedback to reviewers seems to be an ineffective educational tool.	Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; Univ Minnesota, Dept Emergency Med, Minneapolis, MN USA; Albert Einstein Coll Med, Dept Emergency Med, Bronx, NY 10467 USA	University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; Yeshiva University; Albert Einstein College of Medicine	Callahan, ML (corresponding author), Univ Calif San Francisco, Dept Emergency Med, Box 0208, San Francisco, CA 94143 USA.			Callaham, Michael/0000-0003-2284-256X				Callaham ML, 1998, JAMA-J AM MED ASSOC, V280, P229, DOI 10.1001/jama.280.3.229; Callaham ML, 1998, ANN EMERG MED, V32, P318, DOI 10.1016/S0196-0644(98)70007-1; CALLAHAM ML, IN PRESS ANN EMERG M; MACDONALD RB, 1991, REV RES DEV ED, V8, P143; Norman GR, 1998, CAN MED ASSOC J, V158, P177; SHORTREED I, 1986, TESOL Q, V20, P83; van Rooyen S, 1999, J CLIN EPIDEMIOL, V52, P625, DOI 10.1016/S0895-4356(99)00047-5	7	55	56	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 5	2002	287	21					2781	2783		10.1001/jama.287.21.2781	http://dx.doi.org/10.1001/jama.287.21.2781			3	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559AP	12038910	Bronze			2022-12-28	WOS:000176002200007
J	Nicoll, A; Hamers, FF				Nicoll, A; Hamers, FF			Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEISSERIA-GONORRHOEAE; SURVEILLANCE; TRANSMISSION; EPIDEMIOLOGY		Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; European Ctr Epidemiol Monitoring AIDS EuroHIV, Inst Veille Sanit, F-94415 St Maurice, France	Public Health England; Institute of Public Health Surveillance	Nicoll, A (corresponding author), Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England.	anicoll@phls.org.uk						Catchpole MA, 1996, GENITOURIN MED, V72, P321; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P773; *COMM DIS SURV CTR, 2000, CDR WKLY, V10, P453; *COMM DIS SURV CTR, 2001, COMM DIS REP CDR WKL, V11; *DEP HLTH, 2001, NATL STRAT SEX HLTH; DOHERTY L, 2000, EUROSURVEILLANCE WEE, V4; *EUR CTR EP MON AI, 2001, HIV AIDS SURV EUR EN, V64; Fennema J S, 2000, Ned Tijdschr Geneeskd, V144, P602; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Goulet V, 2000, Euro Surveill, V5, P2; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; *JOINT UN PROGR HI, 2000, AIDS EP UPD DEC 2000; Kyriakis KP, 1999, SEX TRANSM DIS, V26, P43, DOI 10.1097/00007435-199901000-00007; Nicoll A, 2001, SEX TRANSM INFECT, V77, P242, DOI 10.1136/sti.77.4.242; *PUBL HLTH LAB SER, 2001, TRENDS SEX TRANSM IN; RENTON AM, 1994, SOC SCI MED, V38, P1153, DOI 10.1016/0277-9536(94)90230-5; *SWED I INF DIS CO, 2001, COMM DIS SWED 2000; van de Laar MJW, 1997, GENITOURIN MED, V73, P510; Van der Heyden JHA, 2000, SEX TRANSM INFECT, V76, P110, DOI 10.1136/sti.76.2.110; van Duynhoven YTHP, 1999, MICROBES INFECT, V1, P455, DOI 10.1016/S1286-4579(99)80049-5; WELLINGS K, 1996, STOPPING AIDS AIDS H; *WHO EUR STI TASK, 2002, OV HIV AIDS STI SIT	22	118	119	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 1	2002	324	7349					1324	1327		10.1136/bmj.324.7349.1324	http://dx.doi.org/10.1136/bmj.324.7349.1324			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039830	Green Published			2022-12-28	WOS:000176041500023
J	Aaronson, DS; Horvath, CM				Aaronson, DS; Horvath, CM			A road map for those who don't know JAK-STAT	SCIENCE			English	Editorial Material							DNA-BINDING; IFN-GAMMA; C-JUN; DIFFERENTIAL REGULATION; GENE-EXPRESSION; CELL-GROWTH; ACTIVATION; PHOSPHATASE; PROTEINS; TRANSCRIPTION	The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway transmits information received from extracellular polypeptide signals, through transmembrane receptors, directly to target gene promoters in the nucleus, providing a mechanism for transcriptional regulation without second messengers. Evolutionarily conserved in eukaryotic organisms from slime molds to humans, JAK-STAT signaling appears to be an early adaptation to facilitate intercellular communication that has co-evolved with myriad cellular signaling events. This co-evolution has given rise to highly adapted, ligand-specific signaling pathways that control gene expression. In addition, the JAK-STAT signaling pathways are regulated by a vast array of intrinsic and environmental stimuli, which can add plasticity to the response of a cell or tissue.	Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Horvath, CM (corresponding author), Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA.			Horvath, Curt/0000-0003-2449-225X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI048722, R01AI050707, R01AI048722] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-48722, AI-50707] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AARONSON DS, 2002, SCI STKE; Ahmed ST, 2000, J IMMUNOL, V165, P5227, DOI 10.4049/jimmunol.165.9.5227; Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; Chin YE, 1996, SCIENCE, V272, P719, DOI 10.1126/science.272.5262.719; Darnell JE, 1997, P NATL ACAD SCI USA, V94, P11767, DOI 10.1073/pnas.94.22.11767; DAVID M, 1993, MOL CELL BIOL, V13, P7515, DOI 10.1128/MCB.13.12.7515; DAVID M, 1995, MOL CELL BIOL, V15, P7050; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Irie-Sasaki J, 2001, NATURE, V409, P349, DOI 10.1038/35053086; Ivanov VN, 2001, MOL CELL, V7, P517, DOI 10.1016/S1097-2765(01)00199-X; Kaplan DH, 1998, P NATL ACAD SCI USA, V95, P7556, DOI 10.1073/pnas.95.13.7556; Krebs DL, 2001, STEM CELLS, V19, P378, DOI 10.1634/stemcells.19-5-378; Leonard WJ, 2001, INT J HEMATOL, V73, P271, DOI 10.1007/BF02981951; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Ouchi T, 2000, P NATL ACAD SCI USA, V97, P5208, DOI 10.1073/pnas.080469697; Parisien JP, 2002, J VIROL, V76, P4190, DOI 10.1128/JVI.76.9.4190-4198.2002; Ram PT, 2001, ONCOGENE, V20, P1601, DOI 10.1038/sj.onc.1204186; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shuai K, 2000, ONCOGENE, V19, P2638, DOI 10.1038/sj.onc.1203522; Vinkemeier U, 1996, EMBO J, V15, P5616, DOI 10.1002/j.1460-2075.1996.tb00946.x; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yoo JY, 2001, J BIOL CHEM, V276, P26421, DOI 10.1074/jbc.M009935200; Zhang XK, 1999, MOL CELL BIOL, V19, P7138; Zhang XK, 2001, J BIOL CHEM, V276, P33576, DOI 10.1074/jbc.M104978200	33	989	1070	2	179	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1653	1655		10.1126/science.1071545	http://dx.doi.org/10.1126/science.1071545			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040185				2022-12-28	WOS:000175976200048
J	Beaugrand, G; Reid, PC; Ibanez, F; Lindley, JA; Edwards, M				Beaugrand, G; Reid, PC; Ibanez, F; Lindley, JA; Edwards, M			Reorganization of North Atlantic marine copepod biodiversity and climate	SCIENCE			English	Article							CALANOID COPEPODS; SEA; RANGES; COD	We provide evidence of large-scale changes in the biogeography of calanoid copepod crustaceans in the eastern North Atlantic Ocean and European shelf seas. We demonstrate that strong biogeographical shifts in all copepod assemblages have occurred with a northward extension of more than 10degrees latitude of warm-water species associated with a decrease in the number of colder-water species. These biogeographical shifts are in agreement with recent changes in the spatial distribution and phenology detected for many taxonomic groups in terrestrial European ecosystems and are related to both the increasing trend in Northern Hemisphere temperature and the North Atlantic Oscillation.	Sir Alister Hardy Fdn Ocean Sci, Lab Citadel Hill, Plymouth PL1 2PB, Devon, England; Observ Oceanol, Lab Oceanol Biol & Ecol Plancton Marin, F-06230 Villefranche Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite	Beaugrand, G (corresponding author), Sir Alister Hardy Fdn Ocean Sci, Lab Citadel Hill, Plymouth PL1 2PB, Devon, England.			BEAUGRAND, GREGORY/0000-0002-0712-5223; Edwards, Martin/0000-0002-5716-4714				Barnett TP, 2001, SCIENCE, V292, P270, DOI 10.1126/science.1058304; BARRY JP, 1995, SCIENCE, V267, P672, DOI 10.1126/science.267.5198.672; Beaugrand G, 2000, MAR ECOL PROG SER, V204, P299, DOI 10.3354/meps204299; Beaugrand G, 2001, MAR ECOL PROG SER, V219, P189, DOI 10.3354/meps219189; BEAUGRAND G, IN PRESS MAR ECOL PR; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Dickson R.R., 2000, P92; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Hurrell JW, 1997, CLIMATIC CHANGE, V36, P301, DOI 10.1023/A:1005314315270; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Quero JC, 1998, OCEANOL ACTA, V21, P345, DOI 10.1016/S0399-1784(98)80021-2; Reid PC, 2001, MAR ECOL PROG SER, V215, P283, DOI 10.3354/meps215283; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6	19	864	907	5	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1692	1694		10.1126/science.1071329	http://dx.doi.org/10.1126/science.1071329			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040196				2022-12-28	WOS:000175976200060
J	Brightling, CE; Bradding, P; Symon, FA; Holgate, ST; Wardlaw, AJ; Pavord, ID				Brightling, CE; Bradding, P; Symon, FA; Holgate, ST; Wardlaw, AJ; Pavord, ID			Mast-cell infiltration of airway smooth muscle in asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EOSINOPHILIC BRONCHITIS; CHRONIC COUGH; IMMUNOHISTOCHEMISTRY	Background: Asthma and eosinophilic bronchitis are characterized by similar inflammatory infiltrates in the submucosa of the lower airway. However, eosinophilic bronchitis differs from asthma in that there is no variable airflow obstruction or airway hyperresponsiveness in the former condition. We tested the hypothesis that there were differences between the two conditions in the microlocalization of mast cells within the airway smooth muscle. Methods: Immunohistochemical analysis of bronchial-biopsy specimens was completed in 17 subjects with asthma, 13 subjects with eosinophilic bronchitis, and 11 normal controls recruited from two centers. Results: Both groups with disease had a similar degree of submucosal eosinophilia and thickening of the basement membrane and lamina reticularis. By contrast, the number of tryptase-positive mast cells in the bundles of airway smooth muscle from subjects with asthma (median, 5.1 mast cells per square millimeter of smooth muscle [range, 0 to 33.3]) was substantially higher than that in subjects with eosinophilic bronchitis (median, 0 mast cells per square millimeter; range, 0 to 4.8) and that in normal controls (median, 0 mast cells per square millimeter [range, 0 to 6.4]; P<0.001 for the comparison among the three groups). T cells and eosinophils were not usually seen in the airway smooth muscle in any of the groups. Conclusions: The infiltration of airway smooth muscle by mast cells is associated with the disordered airway function found in asthma.	Univ Hosp Leicester, Dept Resp Med, Leicester LE3 9QP, Leics, England; Leicester Warwick Med Sch, Inst Lung Hlth, Div Resp Med, Leicester, Leics, England; Univ Southampton, Southampton, Hants, England; Southampton Gen Hosp, Southampton SO9 4XY, Hants, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; University of Southampton; University of Southampton	Pavord, ID (corresponding author), Univ Hosp Leicester, Dept Resp Med, Groby Rd, Leicester LE3 9QP, Leics, England.			brightling, chris/0000-0002-9345-4903; Bradding, Peter/0000-0001-8403-0319; Wardlaw, Andrew/0000-0001-6583-0791; Pavord, Ian/0000-0002-4288-5973				Ammit AJ, 1997, AM J RESP CRIT CARE, V155, P1123, DOI 10.1164/ajrccm.155.3.9116997; Brichtling CE, 2000, AM J RESP CRIT CARE, V162, P878, DOI 10.1164/ajrccm.162.3.9909064; Brightling CE, 2000, ANN MED, V32, P446, DOI 10.3109/07853890009002019; Brightling CE, 1999, AM J RESP CRIT CARE, V160, P406, DOI 10.1164/ajrccm.160.2.9810100; BRITTEN KM, 1993, BIOTECH HISTOCHEM, V68, P271, DOI 10.3109/10520299309105629; Brusasco V, 1998, THORAX, V53, P992, DOI 10.1136/thx.53.11.992; Chanez P, 1997, AM J RESP CRIT CARE, V155, P1529, DOI 10.1164/ajrccm.155.5.9154853; CLARK JM, 1995, AM J RESP CRIT CARE, V152, P2076, DOI 10.1164/ajrccm.152.6.8520778; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; GIBSON PG, 1989, LANCET, V1, P1346; Gibson PG, 1998, J ALLERGY CLIN IMMUN, V101, P320, DOI 10.1016/S0091-6749(98)70242-8; Hauck RW, 1999, AM J PHYSIOL-LUNG C, V277, pL22, DOI 10.1152/ajplung.1999.277.1.L22; Juniper E, 1994, HISTAMINE METHACHOLI; KOSHINO T, 1993, CLIN EXP ALLERGY, V23, P919, DOI 10.1111/j.1365-2222.1993.tb00276.x; Ordonez C, 2000, AM J RESP CRIT CARE, V162, P2324, DOI 10.1164/ajrccm.162.6.2001041; Page S, 2001, AM J PHYSIOL-LUNG C, V281, pL1313, DOI 10.1152/ajplung.2001.281.6.L1313; Pavord ID, 1997, THORAX, V52, P498, DOI 10.1136/thx.52.6.498; Sullivan P, 1998, EUR RESPIR J, V12, P811, DOI 10.1183/09031936.98.12040811; TAM EK, 1990, AM J RESP CELL MOL, V3, P27, DOI 10.1165/ajrcmb/3.1.27; Wardlaw AJ, 2000, BRIT MED BULL, V56, P985, DOI 10.1258/0007142001903490	20	895	930	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1699	1705		10.1056/NEJMoa012705	http://dx.doi.org/10.1056/NEJMoa012705			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037149				2022-12-28	WOS:000175834100004
J	Hajjar, RJ; Kradin, RL; Januzzi, JL; Mark, EJ				Hajjar, RJ; Kradin, RL; Januzzi, JL; Mark, EJ			A 55-year-old man with second-degree atrioventricular block and chest pain - Lymphocytic myocarditis due to Borrelia burgdorferi infection (Lyme disease).	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARDIAC INVOLVEMENT; CORONARY-ARTERIES; AV BLOCK; PREVALENCE; DIAGNOSIS; HEART; HEMOCHROMATOSIS; ABNORMALITIES; MRI		Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hajjar, RJ (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.		Januzzi, James/Y-2436-2019					Barold SS, 2001, MAYO CLIN PROC, V76, P44, DOI 10.4065/76.1.44; BASSAN R, 1986, J AM COLL CARDIOL, V8, P773, DOI 10.1016/S0735-1097(86)80416-8; BERGLERKLEIN J, 1993, ARCH INTERN MED, V153, P2696, DOI 10.1001/archinte.153.23.2696; CAGLAR N, 1993, INT J CARDIOL, V38, P199, DOI 10.1016/0167-5273(93)90183-H; Chandra M, 1996, CHEST, V110, P562, DOI 10.1378/chest.110.2.562; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; DINUBILE MJ, 1986, AM J CARDIOL, V58, P1213, DOI 10.1016/0002-9149(86)90384-X; DiSalvo TG, 2000, NEW ENGL J MED, V342, P264, DOI 10.1056/NEJM200001273420408; EISENBERG MJ, 1993, EUR HEART J, V14, P122, DOI 10.1093/eurheartj/14.1.122; Ferrans V J, 1985, Heart Vessels Suppl, V1, P256, DOI 10.1007/BF02072405; FISH D, 1995, AM J MED, V98, pS2, DOI 10.1016/S0002-9343(99)80038-2; FOLLANSBEE WP, 1985, AM J MED, V79, P183, DOI 10.1016/0002-9343(85)90008-7; Gerber MA, 1996, NEW ENGL J MED, V335, P1270, DOI 10.1056/NEJM199610243351703; GLOBITS S, 1994, CARDIOLOGY, V85, P415, DOI 10.1159/000176743; HAYWOOD LJ, 1991, J ELECTROCARDIOL, V24, P177, DOI 10.1016/0022-0736(91)90009-B; HOFMAN P, 1993, BRIT HEART J, V70, P376, DOI 10.1136/hrt.70.4.376; JACKMAN JD, 1989, AM J MED, V87, P425, DOI 10.1016/S0002-9343(89)80826-5; JACOBS JC, 1984, J PEDIATR-US, V105, P950, DOI 10.1016/S0022-3476(84)80086-4; KLEIN J, 1991, EUR HEART J, V12, P73, DOI 10.1093/eurheartj/12.suppl_D.73; MAGNARELLI LA, 1995, AM J MED, V98, pS10, DOI 10.1016/S0002-9343(99)80039-4; Moder KG, 1999, MAYO CLIN PROC, V74, P275, DOI 10.4065/74.3.275; MORGERA T, 1992, AM HEART J, V124, P455, DOI 10.1016/0002-8703(92)90613-Z; NOCTON JJ, 1994, NEW ENGL J MED, V330, P229, DOI 10.1056/NEJM199401273300401; OLSON LJ, 1989, J AM COLL CARDIOL, V13, P116, DOI 10.1016/0735-1097(89)90558-5; ONEILL TW, 1992, ANN RHEUM DIS, V51, P705, DOI 10.1136/ard.51.6.705; Orloski K A, 2000, MMWR CDC Surveill Summ, V49, P1; Parada H, 1997, INT J CARDIOL, V60, P49, DOI 10.1016/S0167-5273(97)02952-5; ROTMAN M, 1972, Circulation, V45, P703; Schwartz I, 1997, NEW ENGL J MED, V337, P49, DOI 10.1056/NEJM199707033370111; Sekiguchi M, 1996, CARDIOVASC DRUG THER, V10, P495, DOI 10.1007/BF00050989; SIGAL LH, 1995, AM J MED, V98, pS25, DOI 10.1016/S0002-9343(99)80041-2; STEERE AC, 1980, ANN INTERN MED, V93, P8, DOI 10.7326/0003-4819-93-1-8; Unverdorben M, 1997, CATHETER CARDIO DIAG, V41, P430, DOI 10.1002/(SICI)1097-0304(199708)41:4<430::AID-CCD21>3.0.CO;2-O; van der Wall EE, 2000, HERZ, V25, P356, DOI 10.1007/s000590050028; VANDERLINDE MR, 1991, SCAND J INFECT DIS, P81; WAXMAN S, 1994, AM HEART J, V128, P1047, DOI 10.1016/0002-8703(94)90609-2	36	21	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1732	1738		10.1056/NEJMcpc020017	http://dx.doi.org/10.1056/NEJMcpc020017			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037154				2022-12-28	WOS:000175834100009
J	Matsuda, M; Nagahama, Y; Shinomiya, A; Sato, T; Matsuda, C; Kobayashi, T; Morrey, CE; Shibata, N; Asakawa, S; Shimizu, N; Hori, H; Hamaguchi, S; Sakaizumi, M				Matsuda, M; Nagahama, Y; Shinomiya, A; Sato, T; Matsuda, C; Kobayashi, T; Morrey, CE; Shibata, N; Asakawa, S; Shimizu, N; Hori, H; Hamaguchi, S; Sakaizumi, M			DMY is a Y-specific DM-domain gene required for male development in the medaka fish	NATURE			English	Article							SEX-CHROMOSOMES; ORYZIAS-LATIPES; TELEOST FISH; GERM-CELLS; EXPRESSION; DMRT1; DNA; DIFFERENTIATION; SPERMATOGENESIS; CONSTRUCTION	Although the sex-determining gene Sry has been identified in mammals(1), no comparable genes have been found in non-mammalian vertebrates. Here, we used recombinant breakpoint analysis to restrict the sex-determining region in medaka fish (Oryzias latipes) to a 530-kilobase (kb) stretch of the Y chromosome. Deletion analysis of the Y chromosome of a congenic XY female further shortened the region to 250 kb. Shotgun sequencing of this region predicted 27 genes. Three of these genes were expressed during sexual differentiation. However, only the DM-related(2) PG17 was Y specific; we thus named it DMY. Two naturally occurring mutations establish DMY's critical role in male development. The first heritable mutant-a single insertion in exon 3 and the subsequent truncation of DMY-resulted in all XY female offspring. Similarly, the second XY mutant female showed reduced DMY expression with a high proportion of XY female offspring. During normal development, DMY is expressed only in somatic cells of XY gonads. These findings strongly suggest that the sex-specific DMY is required for testicular development and is a prime candidate for the medaka sex-determining gene.	Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; Shinshu Univ, Fac Sci, Dept Biol, Nagano 3908621, Japan; Keio Univ, Sch Med, Dept Mol Biol, Shinjuku Ku, Tokyo 1608582, Japan; Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Niigata University; Shinshu University; Keio University; Nagoya University	Nagahama, Y (corresponding author), Natl Inst Basic Biol, Reprod Biol Lab, Okazaki, Aichi 4448585, Japan.	nagahama@nibb.ac.jp		SHINOMIYA, Ai/0000-0003-3784-0532				Aida T, 1921, GENETICS, V6, P554; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Brunner B, 2001, GENOMICS, V77, P8, DOI 10.1006/geno.2001.6615; De Grandi A, 2000, MECH DEVELOP, V90, P323, DOI 10.1016/S0925-4773(99)00282-8; Guan GJ, 2000, BIOCHEM BIOPH RES CO, V272, P662, DOI 10.1006/bbrc.2000.2840; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; HYODOTAGUCHI Y, 1993, MEDAKA, V5, P29; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Kobayashi T, 2000, MECH DEVELOP, V99, P139, DOI 10.1016/S0925-4773(00)00464-0; Kondo M, 2001, GENET RES, V78, P23, DOI 10.1017/S0016672301005109; Marchand O, 2000, BBA-GENE STRUCT EXPR, V1493, P180, DOI 10.1016/S0167-4781(00)00186-X; Matsuda M, 1999, GENET RES, V73, P225, DOI 10.1017/S0016672399003754; Matsuda M, 1998, CYTOGENET CELL GENET, V82, P257, DOI 10.1159/000015113; Matsuda M, 1997, ZOOL SCI, V14, P517, DOI 10.2108/zsj.14.517; Matsuda M, 2001, GENES GENET SYST, V76, P61, DOI 10.1266/ggs.76.61; Matsuda M, 1997, GENES GENET SYST, V72, P263, DOI 10.1266/ggs.72.263; Moniot B, 2000, MECH DEVELOP, V91, P323, DOI 10.1016/S0925-4773(99)00267-1; RAGOUSSIS J, 1997, GENOME MAPPING PRACT, P253; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; SAKAIZUMI M, 1983, COPEIA, P311, DOI 10.2307/1444373; Sato T, 2001, GENETICA, V111, P71, DOI 10.1023/A:1013755701696; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; UWA H, 1981, P JPN ACAD B-PHYS, V57, P39, DOI 10.2183/pjab.57.39; YAMAMOTO T, 1961, J EXP ZOOL, V146, P163, DOI 10.1002/jez.1401460206	27	1023	1118	17	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					559	563		10.1038/nature751	http://dx.doi.org/10.1038/nature751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037570				2022-12-28	WOS:000175860300045
J	Murdoch, WW; Kendall, BE; Nisbet, RM; Briggs, CJ; McCauley, E; Bolser, R				Murdoch, WW; Kendall, BE; Nisbet, RM; Briggs, CJ; McCauley, E; Bolser, R			Single-species models for many-species food webs	NATURE			English	Article							POPULATION-CYCLES; SPECTRAL-ANALYSIS; DYNAMICS; PATTERNS; BEHAVIOR	Most species live in species-rich food webs; yet, for a century, most mathematical models for population dynamics have included only one or two species(1-3). We ask whether such models are relevant to the real world. Two-species population models of an interacting consumer and resource collapse to one-species dynamics when recruitment to the resource population is unrelated to resource abundance, thereby weakening the coupling between consumer and resource(4-6). We predict that, in nature, generalist consumers that feed on many species should similarly show one-species dynamics. We test this prediction using cyclic populations, in which it is easier to infer underlying mechanisms(7), and which are widespread in nature(8). Here we show that one-species cycles can be distinguished from consumer-resource cycles by their periods. We then analyse a large number of time series from cyclic populations in nature and show that almost all cycling, generalist consumers examined have periods that are consistent with one-species dynamics. Thus generalist consumers indeed behave as if they were one-species populations, and a one-species model is a valid representation for generalist population dynamics in many-species food webs.	Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Donald Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Univ Calgary, Div Ecol, Calgary, AB T2N 1N4, Canada	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Berkeley; University of Calgary	Murdoch, WW (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	murdoch@lifesci.ucsb.edu	Kendall, Bruce/C-1871-2008; Briggs, Cheryl/F-7456-2013; Nisbet, Roger M/B-6951-2014	Kendall, Bruce/0000-0003-1782-8106; 				Berryman AA, 1996, TRENDS ECOL EVOL, V11, P28, DOI 10.1016/0169-5347(96)81066-4; Bjornstad ON, 2001, NATURE, V409, P1001, DOI 10.1038/35059003; BLYTHE SP, 1982, THEOR POPUL BIOL, V22, P147, DOI 10.1016/0040-5809(82)90040-5; Briggs CJ, 1999, J MATH BIOL, V38, P317, DOI 10.1007/s002850050151; BULMER MG, 1974, J ANIM ECOL, V43, P701, DOI 10.2307/3532; Finerty J. P, 1980, POPULATION ECOLOGY C; GINZBURG LR, 1994, J ANIM ECOL, V63, P79, DOI 10.2307/5585; GURNEY WSC, 1985, THEOR POPUL BIOL, V28, P150, DOI 10.1016/0040-5809(85)90026-7; GURNEY WSC, 1998, ECOLOGICAL DYNAMICS; HASSELL MP, 1976, J ANIM ECOL, V45, P471, DOI 10.2307/3886; Higgins K, 1997, AM NAT, V149, P247, DOI 10.1086/285989; JONES AE, 1988, J MATH ANAL APPL, V135, P354, DOI 10.1016/0022-247X(88)90160-6; Kendall BE, 1998, ECOL LETT, V1, P160; Kendall BE, 1999, ECOLOGY, V80, P1789, DOI 10.1890/0012-9658(1999)080[1789:WDPCAS]2.0.CO;2; LAUWERIER H A, 1986, IMA Journal of Mathematics Applied in Medicine and Biology, V3, P191; LEES JM, 1995, COMPUT GEOSCI, V21, P199, DOI 10.1016/0098-3004(94)00067-5; LINDSTROM ER, 1994, ECOLOGY, V75, P1042, DOI 10.2307/1939428; LOTKA AJ, 1925, ELEMENTS PHYSICAL BI; McCauley E, 1996, ECOL MONOGR, V66, P479, DOI 10.2307/2963491; *NERC, 1999, IMP COLL GLOB POP DY; NISBET RM, 1989, AM NAT, V134, P377, DOI 10.1086/284987; Nisbet RM, 1982, MODELLING FLUCTUATIN; O'Donoghue M, 2001, ECOSYSTEM DYNAMICS OF THE BOREAL FOREST, P324; PARK J, 1987, J GEOPHYS RES-SOLID, V92, P12675, DOI 10.1029/JB092iB12p12675; Persson L, 1998, THEOR POPUL BIOL, V54, P270, DOI 10.1006/tpbi.1998.1380; Stenseth NC, 1997, P NATL ACAD SCI USA, V94, P5147, DOI 10.1073/pnas.94.10.5147; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433	27	130	134	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 30	2002	417	6888					541	543		10.1038/417541a	http://dx.doi.org/10.1038/417541a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037520				2022-12-28	WOS:000175860300040
J	Sun, JY; Wu, XS; Wu, LG				Sun, JY; Wu, XS; Wu, LG			Single and multiple vesicle fusion induce different rates of endocytosis at a central synapse	NATURE			English	Article							FROG NEUROMUSCULAR-JUNCTION; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; CHROMAFFIN CELLS; TIME-COURSE; CALCIUM; EXOCYTOSIS; CALYX; KINETICS; CAPACITANCE	During synaptic transmission, neurotransmitter-laden vesicles fuse with the presynaptic membrane and discharge their contents into the synaptic cleft. After fusion, the vesicular membrane is retrieved by endocytosis for reuse. This recycling mechanism(1) ensures a constant supply of releasable vesicles at the nerve terminal(1). The kinetics of endocytosis have been measured mostly after intense or non-physiological stimulation(2-13). Here we use capacitance measurements to resolve the fusion and retrieval of single and multiple vesicles following mild physiological stimulation at a mammalian central synapse. The time constant of endocytosis after single vesicle fusion was 56 ms; after a single action potential or trains at less than or equal to2 Hz it was about 115 ms, but increased gradually to tens of seconds as the frequency and the number of action potentials increased. These results indicate that an increase in the rate of exocytosis at the active zone induces a decrease in the rate of endocytosis. Existing models(5,10), including inhibition of endocytosis by Ca2+, could not account for these results-our results suggest that an accumulation of unretrieved vesicles at the plasma membrane slows endocytosis. These findings may resolve the debate about the dependence of endocytosis kinetics on the stimulation frequency(2,3), and suggest a potential role of regulation of endocytosis in short-term synaptic depression.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wu, LG (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.							Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ALVAREZ DT, 1993, NATURE, V363, P554, DOI DOI 10.1038/363554A0; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Gentet LJ, 2000, BIOPHYS J, V79, P314, DOI 10.1016/S0006-3495(00)76293-X; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Meyer AC, 2001, J NEUROSCI, V21, P7889, DOI 10.1523/JNEUROSCI.21-20-07889.2001; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SATZLER K, 2001, SOC NEUR ABSTR, V27; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8	30	181	187	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 30	2002	417	6888					555	559		10.1038/417555a	http://dx.doi.org/10.1038/417555a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556QK	12037569				2022-12-28	WOS:000175860300044
J	Metodiev, MV; Matheos, D; Rose, MD; Stone, DE				Metodiev, MV; Matheos, D; Rose, MD; Stone, DE			Regulation of MAPK function by direct interaction with the mating-specific G alpha in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TYROSINE-KINASE; PROTEIN; PHEROMONE; PATHWAY; SIGNAL; PHOSPHORYLATION; ADAPTATION; EXPRESSION; MUTATION	The mating response of the budding yeast Saccharomyces cerevisiae is mediated by a prototypical heterotrimeric GTP-binding protein (G protein) and mitogen-activated protein kinase (MAPK) cascade. Although signal transmission by such pathways has been modeled in detail, postreceptor down-regulation is less well understood. The pheromone-responsive G protein alpha subunit (Galpha) of yeast down-regulates the mating signal, but its targets are unknown. We have found that Galpha binds directly to the mating-specific MAPK in yeast cells responding to pheromone. This interaction contributes both to modulation of the mating signal and to the chemotropic response, and it demonstrates direct communication between the top and bottom of a Galpha-MAPK pathway.	Univ Illinois, Dept Biol Sci, Mol Biol Lab, Chicago, IL 60607 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Princeton University	Stone, DE (corresponding author), Univ Illinois, Dept Biol Sci, Mol Biol Lab, 900 S Ashland Ave,M-C 567, Chicago, IL 60607 USA.			Metodiev, Metodi V/0000-0001-6810-0719; Rose, Mark/0000-0003-1112-4765	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037739] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM037739] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Choi YS, 1999, INT J MOD PHYS C, V10, P1, DOI 10.1142/S0129183199000024; Cismowski MJ, 2001, BIOCHEM BIOPH RES CO, V284, P247, DOI 10.1006/bbrc.2001.4959; COLE GM, 1991, CELL, V64, P703, DOI 10.1016/0092-8674(91)90500-X; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; DORER R, 1995, J CELL BIOL, V131, P854; FUJIMURA HA, 1994, J CELL SCI, V107, P2617; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Jiang Y, 1998, NATURE, V395, P808, DOI 10.1038/27454; Li E, 1998, GENETICS, V148, P947; Li E, 1998, MOL GEN GENET, V258, P608, DOI 10.1007/s004380050774; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MADURA K, 1994, SCIENCE, V265, P1454, DOI 10.1126/science.8073290; MIYAJIMA I, 1989, MOL CELL BIOL, V9, P2289, DOI 10.1128/MCB.9.6.2289; Offermanns S, 1997, SCIENCE, V275, P533, DOI 10.1126/science.275.5299.533; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Schrick K, 1997, GENETICS, V147, P19; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Stratton HF, 1996, MOL CELL BIOL, V16, P6325; Zhou Jianlong, 1999, Cell Biochemistry and Biophysics, V30, P193, DOI 10.1007/BF02738067	22	76	79	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 24	2002	296	5572					1483	1486		10.1126/science.1070540	http://dx.doi.org/10.1126/science.1070540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	557LP	12029138				2022-12-28	WOS:000175910300053
J	Graham, A; Moore, L; Sharp, D; Diamond, I				Graham, A; Moore, L; Sharp, D; Diamond, I			Improving teenagers' knowledge of emergency contraception: cluster randomised controlled trial of a teacher led intervention	BRITISH MEDICAL JOURNAL			English	Article							SEX-EDUCATION; PREGNANCY	Objective To assess the effectiveness of a teacher led intervention to improve teenagers' knowledge about emergency contraception. Design Cluster randomised controlled trial. Setting 24 mixed sex, state secondary schools in Avon, south west England. Participants 1974 boys and 1820 girls in year 10 (14-15 year olds). Intervention Teachers gave a single lesson on emergency contraception to year 10 pupils. The teachers had previously received in-service training on giving the lesson. The pupils were actively involved during the lesson. Main outcome measures Questionnaires distributed to pupils at baseline and six months after the intervention assessed their knowledge of the correct time limits for hormonal emergency contraception and for use of the intrauterine device as emergency contraception, the proportion of pupils who were not virgins, the proportion who had used emergency contraception, and the pupils' intention to use emergency contraception in the future. Results The proportion of pupils knowing the correct time limits for both types of emergency contraception was significantly higher in the intervention group than in the control group at six months' follow up (hormonal contraception: proportion of boys 15.9% higher (95% confidence interval 6.5% to 25.3%), girls 20.4% (10.4% to 30.4%); intrauterine device used as emergency contraception: boys 4.2% (0.7% to 7.7% girls 10.7% (0.4% to 21.0%). The number of pupils needed to be taught for one more pupil to know the correct time limits was six for boys and five for girls. The intervention and control groups did not differ in the proportion of pupils who were not virgins, in the proportion who had used emergency contraception, and in the proportion intending to use emergency contraception in the future. Conclusions The intervention significantly improved the proportion of boys and girls knowing the correct time limits for both types of emergency contraception. The intervention did not change the pupils' sexual activity or use of emergency contraception.	Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England; Cardiff Univ, Sch Social Sci, Cardiff CF10 3WT, S Glam, Wales; Univ Southampton, Dept Social Stat, Southampton SO17 1BL, Hants, England	University of Bristol; Cardiff University; University of Southampton	Graham, A (corresponding author), Univ Bristol, Div Primary Hlth Care, Bristol BS6 6JL, Avon, England.			Moore, Laurence/0000-0003-2182-823X				ALLEN I, 1987, ED SEX PERS REL; DONNER A, 2000, DESIGN ANAL CLUSTER, P87; Graham A, 1996, BRIT MED J, V312, P1567, DOI 10.1136/bmj.312.7046.1567; Graham A., 2000, HLTH ED J, V59, P329, DOI 10.1177/001789690005900406; Grimes D, 1998, LANCET, V352, P428; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; KIRBY D, 1994, PUBLIC HEALTH REP, V109, P339; McEwan J, 1997, BRIT J FAM PLAN, V23, P5; *NAT CHILDR BUR, 1997, LETS HEAR BOYS SUPP; OAKLEY A, 1995, BRIT MED J, V310, P158, DOI 10.1136/bmj.310.6973.158; *OFF STAND TEACH, 2001, OFSTED SUBJ REP 1999; *SOC EXCL UN, 1999, TEEN PREGN; Stammers T, 2000, BMJ-BRIT MED J, V321, P1520, DOI 10.1136/bmj.321.7275.1520; Treasure T, 1998, BRIT MED J, V317, P362; Trussell J, 1997, AM J PUBLIC HEALTH, V87, P932, DOI 10.2105/AJPH.87.6.932; Trussell J, 1999, CONTRACEPTION, V59, P147, DOI 10.1016/S0010-7824(99)00018-9; Vasilakis C, 1999, CONTRACEPTION, V59, P79, DOI 10.1016/S0010-7824(99)00011-6; WELLINGS K, 1995, BRIT MED J, V311, P417, DOI 10.1136/bmj.311.7002.417; WELLINGS K, 1994, SEXUAL BEHAV BRIT; WENT D, 1998, UNDERSTANDING CONTRA; Wight D, 2000, HEALTH EDUC RES, V15, P25, DOI 10.1093/her/15.1.25; Ziebland S, 1996, BRIT J FAM PLAN, V22, P84	22	44	45	1	13	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAY 18	2002	324	7347					1179	1183		10.1136/bmj.324.7347.1179	http://dx.doi.org/10.1136/bmj.324.7347.1179			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554XV	12016180	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000175763200014
J	Jayaram, H; Taraporewala, Z; Patton, JT; Prasad, BVV				Jayaram, H; Taraporewala, Z; Patton, JT; Prasad, BVV			Rotavirus protein involved in genome replication and packaging exhibits a HIT-like fold	NATURE			English	Article							TEMPERATURE-SENSITIVE MUTANTS; SINGLE-STRANDED RNA; NONSTRUCTURAL PROTEIN; BLUETONGUE VIRUS; BINDING-PROTEINS; NSP2; MULTIMERS; LOCALIZATION; CORE; NS2	Rotavirus, the major cause of life-threatening infantile gastroenteritis, is a member of the Reoviridae(1). Although the structures of rotavirus 2 and other members of the Reoviridae(3,4) have been extensively studied, little is known about the structures of virus-encoded non-structural proteins that are essential for genome replication and packaging. The non-structural protein NSP2 of rotavirus, which exhibits nucleoside triphosphatase, single-stranded RNA binding(5), and nucleic-acid helix-destabilizing(6) activities, is a major component of viral replicase complexes(7,8). We present here the X-ray structure of the functional octamer(9) of NSP2 determined to a resolution of 2.6 Angstrom. The NSP2 monomer has two distinct domains. The amino-terminal domain has a new fold. The carboxy-terminal domain resembles the ubiquitous cellular histidine triad (HIT) group of nucleotidyl hydrolases(10). This structural similarity suggests that the nucleotide-binding site is located inside the cleft between the two domains. Prominent grooves that run diagonally across the doughnut-shaped octamer are probable locations for RNA binding. Several RNA binding sites, resulting from the quaternary organization of NSP2 monomers, may be required for the helix destabilizing activity of NSP2 and its function during genome replication and packaging.	Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Prasad, BVV (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.		Patton, John T/P-1390-2014; Patton, John/V-7651-2018	Prasad, B.V.Venkataram/0000-0002-1172-2071; Patton, John/0000-0003-1572-0732	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000754, ZIAAI000754] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aponte C, 1996, J VIROL, V70, P985, DOI 10.1128/JVI.70.2.985-991.1996; Brenner C, 1999, J CELL PHYSIOL, V181, P179, DOI 10.1002/(SICI)1097-4652(199911)181:2<179::AID-JCP1>3.0.CO;2-8; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN DY, 1990, VIROLOGY, V178, P143, DOI 10.1016/0042-6822(90)90387-7; Cohen J, 2001, SCIENCE, V293, P1576, DOI 10.1126/science.293.5535.1576; ESTES MK, 1996, VIROLOGY, P1625; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Gillian AL, 2000, J VIROL, V74, P5939, DOI 10.1128/JVI.74.13.5939-5948.2000; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Holm L, 1999, NUCLEIC ACIDS RES, V27, P244, DOI 10.1093/nar/27.1.244; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATTOURA MD, 1994, VIROLOGY, V202, P803, DOI 10.1006/viro.1994.1402; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lima CD, 1997, SCIENCE, V278, P286, DOI 10.1126/science.278.5336.286; LIMA CD, 1906, P NATL ACAD SCI USA, V28, P5357; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETRIE BL, 1984, VIRUS RES, V1, P133, DOI 10.1016/0168-1702(84)90069-8; Prasad BVV, 1996, NATURE, V382, P471, DOI 10.1038/382471a0; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; RAMIG RF, 1984, J VIROL, V49, P665, DOI 10.1128/JVI.49.3.665-673.1984; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Schuck P, 2001, J BIOL CHEM, V276, P9679, DOI 10.1074/jbc.M009398200; Taraporewala Z, 1999, J VIROL, V73, P9934, DOI 10.1128/JVI.73.12.9934-9943.1999; Taraporewala ZF, 2001, VIROLOGY, V280, P221, DOI 10.1006/viro.2000.0764; TATAPOREWALA Z, 2001, J VIROL, V75, P4519; UITENWEERDE JM, 1995, VIROLOGY, V209, P624, DOI 10.1006/viro.1995.1294	30	73	81	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 16	2002	417	6886					311	315		10.1038/417311a	http://dx.doi.org/10.1038/417311a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015608				2022-12-28	WOS:000175592100053
J	Torsvik, V; Ovreas, L; Thingstad, TF				Torsvik, V; Ovreas, L; Thingstad, TF			Prokaryotic diversity - Magnitude, dynamics, and controlling factors	SCIENCE			English	Article							MICROBIAL DIVERSITY; VIRUSES; SOIL	There are probably millions of species in the microorganismal domains Bacteria and Archaea (the prokaryotes), and we are only just beginning to work out the basic principles governing their distribution and abundance in natural environments. One characteristic that has become clear is that prokaryote diversity in aquatic environments is orders of magnitude less than in sediments and soils. Hypotheses and models explaining such differences are under development and are beginning to offer promising insights into the mechanisms governing prokaryote diversity and ecosystem function.	Univ Bergen, Dept Microbiol, N-5020 Bergen, Norway	University of Bergen	Torsvik, V (corresponding author), Univ Bergen, Dept Microbiol, Jahnebakken 5, N-5020 Bergen, Norway.	vigdis.torsvik@im.uib.no	Thingstad, Tron Frede/B-2254-2008; Øvreås, Lise/H-8651-2016; Carneiro, Fernanda/E-9513-2013	Thingstad, Tron Frede/0000-0002-5593-819X; Carneiro, Fernanda/0000-0001-6389-4564				ATLAS RM, 1984, ADV MICROB ECOL, V7, P1; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Bohannan BJM, 2000, AM NAT, V156, P329, DOI 10.1086/303393; COLWELL RR, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P3; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CURTIS TP, 2001, 9 INT S MICR EC INT; DRAKE LC, 1988, AQUAT MICROB ECOL, V16, P17; Dykhuizen DE, 1998, ANTON LEEUW INT J G, V73, P25, DOI 10.1023/A:1000665216662; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; HUTCHINSON G, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Ovreas L, 1998, MICROB ECOL, V36, P303, DOI 10.1007/s002489900117; OVREAS L, 2001, 9 INT S MICR EC INT; Pedersen K, 2000, FEMS MICROBIOL LETT, V185, P9, DOI 10.1016/S0378-1097(00)00061-6; Ritz K, 1997, FEMS MICROBIOL LETT, V149, P151, DOI 10.1111/j.1574-6968.1997.tb10322.x; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Simek K, 1999, LIMNOL OCEANOGR, V44, P1634; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tiedje J. M., 2001, Sustainable management of soil organic matter, P393, DOI 10.1079/9780851994659.0393; Torsvik V, 1998, J BIOTECHNOL, V64, P53, DOI 10.1016/S0168-1656(98)00103-5; TORSVIK V, 1995, NUCL ACIDS ENV METHO, P29; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	22	755	823	6	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 10	2002	296	5570					1064	1066		10.1126/science.1071698	http://dx.doi.org/10.1126/science.1071698			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551MG	12004116				2022-12-28	WOS:000175565000038
J	Tree, DRP; Shulman, JM; Rousset, R; Scott, MP; Gubb, D; Axelrod, JD				Tree, DRP; Shulman, JM; Rousset, R; Scott, MP; Gubb, D; Axelrod, JD			Prickle mediates feedback amplification to generate asymmetric planar cell polarity signaling	CELL			English	Article							TISSUE POLARITY; DROSOPHILA EYE; HAIR MORPHOGENESIS; NOTCH ACTIVATION; GENETIC MOSAICS; WINGLESS; PROTEIN; ENCODES; FATE; POLARIZATION	Planar cell polarity signaling in Drosophila requires the receptor Frizzled and the cytoplasmic proteins Dishevelled and Prickle. From initial, symmetric subcellular distributions in pupal wing cells, Frizzled and Dishevelled become highly enriched at the distal portion of the cell cortex. We describe a Prickle-dependent intercellular feedback loop that generates asymmetric Frizzled and Dishevelled localization. In the absence of Prickle, Frizzled and Dishevelled remain symmetrically distributed. Prickle localizes to the proximal side of pupal wing cells and binds the Dishevelled DEP domain, inhibiting Dishevelled membrane localization and antagonizing Frizzled accumulation. This activity is linked to Frizzled activity on the adjacent cell surface. Prickle therefore functions in a feedback loop that amplifies differences between Frizzled levels on adjacent cell surfaces.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Howard Hughes Med Inst,Dept Genet, Stanford, CA 94305 USA	Stanford University; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Axelrod, JD (corresponding author), Stanford Univ, Sch Med, Dept Pathol, 300 Pasteur Dr, Stanford, CA 94305 USA.		Gubb, David/F-9793-2011; Rousset, Raphael/E-5908-2017	Rousset, Raphael/0000-0002-4999-403X	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		ADLER PN, 1994, MECH DEVELOP, V46, P101, DOI 10.1016/0925-4773(94)90079-5; ADLER PN, 1992, BIOESSAYS, V14, P735, DOI 10.1002/bies.950141103; Adler PN, 1997, CURR BIOL, V7, P940, DOI 10.1016/S0960-9822(06)00413-1; ADLER PN, 1994, GENETICS, V137, P829; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Axelrod JD, 1996, SCIENCE, V271, P1826, DOI 10.1126/science.271.5257.1826; Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; AXELROD JD, 2002, IN PRESS SCI WORLD; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bhat KM, 1998, CELL, V95, P1027, DOI 10.1016/S0092-8674(00)81726-2; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chae J, 1999, DEVELOPMENT, V126, P5421; Chen CM, 1999, DEVELOPMENT, V126, P5441; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; deCelis JF, 1997, DEVELOPMENT, V124, P3241; Eaton S, 1997, CURR OPIN CELL BIOL, V9, P860, DOI 10.1016/S0955-0674(97)80089-0; Fanto M, 1999, NATURE, V397, P523, DOI 10.1038/17389; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; GUBB D, 1982, J EMBRYOL EXP MORPH, V68, P37; Gubb D, 1998, INT J DEV BIOL, V42, P369; GUBB D, 1993, DEVELOPMENT, P269; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Reifegerste R, 1999, BIOESSAYS, V21, P275, DOI 10.1002/(SICI)1521-1878(199904)21:4<275::AID-BIES3>3.0.CO;2-5; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Shulman JM, 1998, TRENDS GENET, V14, P452, DOI 10.1016/S0168-9525(98)01584-4; Strutt H, 1999, CURR OPIN GENET DEV, V9, P442, DOI 10.1016/S0959-437X(99)80067-7; Taylor J, 1998, GENETICS, V150, P199; THIESEN H, 1994, DEVELOPMENT, V120, P347; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; VINSON CR, 1989, NATURE, V338, P263, DOI 10.1038/338263a0; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Wolff T, 1998, DEVELOPMENT, V125, P1149; WONG LL, 1993, J CELL BIOL, V123, P209, DOI 10.1083/jcb.123.1.209; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	47	334	337	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAY 3	2002	109	3					371	381		10.1016/S0092-8674(02)00715-8	http://dx.doi.org/10.1016/S0092-8674(02)00715-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	548WD	12015986	Bronze			2022-12-28	WOS:000175412100012
J	Soussi-Yanicostas, N; de Castro, F; Julliard, AK; Perfettini, I; Chedotal, A; Petit, C				Soussi-Yanicostas, N; de Castro, F; Julliard, AK; Perfettini, I; Chedotal, A; Petit, C			Anosmin-1, defective in the X-linked form of Kallmann syndrome, promotes axonal branch formation from olfactory bulb output neurons	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; MITRAL CELL AXONS; SENSORY PROJECTIONS; NEUROTROPHIC FACTOR; SEMAPHORIN-III; SYNDROME GENE; GROWTH; GUIDANCE; PROTEIN; EXPRESSION	The physiological role of anosmin-1, defective in the X chromosome-linked form of Kallmann syndrome, is not yet known. Here, we show that anti-anosmin-1 antibodies block the formation of the collateral branches of rat olfactory bulb output neurons (mitral and tufted cells) in organotypic cultures. Moreover, anosmin-1 greatly enhances axonal branching of these dissociated neurons in culture. In addition, coculture experiments with either piriform cortex or anosmin-1-producing CHO cells demonstrate that anosmin-1 is a chemoattractant for the axons of these neurons, suggesting that this protein, which is expressed in the piriform cortex, attracts their collateral branches in vivo. We conclude that anosmin-1 has a dual branch-promoting and guidance activity, which plays an essential role in the patterning of mitral and tufted cell axon collaterals to the olfactory cortex.	Inst Pasteur, Unite Genet Deficits Sensoriels, CNRS, Unite Rech Associee 1968, F-75724 Paris 15, France; Hop La Pitie Salpetriere, INSERM, U106, F-75651 Paris 13, France; Hosp Ramon & Cajal, Dept Invest, Serv Neurobiol, E-28034 Madrid, Spain; Univ Lyon 1, Lab Neurosci & Syst Sensoriels, CNRS, Unite Rech Mixte 5020, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario Ramon y Cajal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Soussi-Yanicostas, N (corresponding author), Inst Pasteur, Unite Genet Deficits Sensoriels, CNRS, Unite Rech Associee 1968, 25 Rue Dr Roux, F-75724 Paris 15, France.	nyani@pasteur.fr; cpetit@pasteur.fr	de Castro, Fernando/Q-8624-2018; Julliard, Andrée Karyn/N-8082-2017; Chedotal, Alain/F-2750-2017; Soussi-Yanicostas, Nadia/GPF-8264-2022; Soussi-Yanicostas, Nadia/U-6339-2018	de Castro, Fernando/0000-0002-7018-8032; Julliard, Andrée Karyn/0000-0002-3464-7529; Chedotal, Alain/0000-0001-7577-3794; Soussi-Yanicostas, Nadia/0000-0001-7734-9401; Petit, Christine/0000-0002-9069-002X				Ardouin O, 2000, MECH DEVELOP, V90, P89, DOI 10.1016/S0925-4773(99)00222-1; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BUELOW HE, 2002, IN PRESS P NATL ACAD; Chedotal A, 1998, DEVELOPMENT, V125, P4313; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; de Castro F, 1999, J NEUROSCI, V19, P4428; De Morster G, 1954, SCHWEIZ ARCH NEUROL, V74, P309; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; FRANCO B, 1991, NATURE, V353, P529, DOI 10.1038/353529a0; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Graves JAM, 1998, HUM MOL GENET, V7, P1991, DOI 10.1093/hmg/7.13.1991; Hardelin JP, 1999, DEV DYNAM, V215, P26, DOI 10.1002/(SICI)1097-0177(199905)215:1<26::AID-DVDY4>3.3.CO;2-4; HEFFNER CD, 1990, SCIENCE, V247, P217, DOI 10.1126/science.2294603; HERNDON ME, 1990, NEURON, V4, P949, DOI 10.1016/0896-6273(90)90148-9; Hirata T, 1999, J NEUROBIOL, V38, P93; Hirata T, 1997, J NEUROBIOL, V32, P415, DOI 10.1002/(SICI)1097-4695(199704)32:4<415::AID-NEU5>3.0.CO;2-9; Hirata T, 2001, J NEUROSCI, V21, P2373, DOI 10.1523/JNEUROSCI.21-07-02373.2001; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Kallmann FJ, 1944, AM J MENT DEF, V48, P203; Kennedy Timothy E., 1995, Current Opinion in Neurobiology, V5, P83, DOI 10.1016/0959-4388(95)80091-3; Krams M, 1999, NEUROLOGY, V52, P816, DOI 10.1212/WNL.52.4.816; LEGOUIS R, 1991, CELL, V67, P423, DOI 10.1016/0092-8674(91)90193-3; LEGOUIS R, 1993, GENOMICS, V17, P516, DOI 10.1006/geno.1993.1360; LEGOUIS R, 1993, P NATL ACAD SCI USA, V90, P2461, DOI 10.1073/pnas.90.6.2461; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LopezMascaraque L, 1996, NEUROSCIENCE, V70, P255, DOI 10.1016/0306-4522(95)00360-U; Maestre de San Juan A., 1856, SIGLO MED, V3, P211; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NAFTOLIN F, 1971, NATURE, V232, P496, DOI 10.1038/232496a0; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; OLEARY DDM, 1991, DEVELOPMENT, P123; Patel K, 2001, DEVELOPMENT, V128, P5031; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Rugarli EI, 1996, HUM MOL GENET, V5, P1109, DOI 10.1093/hmg/5.8.1109; Salido EC, 1996, NAT GENET, V13, P83, DOI 10.1038/ng0596-83; Sato Y, 1998, J NEUROSCI, V18, P7800; SCHWANKHAUS JD, 1989, NEUROLOGY, V39, P223, DOI 10.1212/WNL.39.2.223; SCHWANZELFUKUDA M, 1989, MOL BRAIN RES, V6, P311, DOI 10.1016/0169-328X(89)90076-4; SCHWOB JE, 1984, J COMP NEUROL, V223, P177, DOI 10.1002/cne.902230204; Shipley Michael T., 1995, P899; Soussi-Yanicostas N, 1998, J CELL SCI, V111, P2953; SoussiYanicostas N, 1996, J CELL SCI, V109, P1749; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Sugisaki N, 1996, J NEUROBIOL, V29, P127, DOI 10.1002/(SICI)1097-4695(199602)29:2<127::AID-NEU1>3.0.CO;2-C; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Yang XM, 1998, J NEUROSCI, V18, P8369; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	54	151	155	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 19	2002	109	2					217	228		10.1016/S0092-8674(02)00713-4	http://dx.doi.org/10.1016/S0092-8674(02)00713-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	543CB	12007408	Bronze			2022-12-28	WOS:000175082600011
J	Min, JH; Yang, HF; Ivan, M; Gertler, F; Kaelin, WG; Pavletich, NP				Min, JH; Yang, HF; Ivan, M; Gertler, F; Kaelin, WG; Pavletich, NP			Structure of an HIF-1 alpha-pVHL complex: Hydroxyproline recognition in signaling	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; HIPPEL-LINDAU PROTEIN; PROLYL HYDROXYLATION; PROLINE HYDROXYLATION; UBIQUITIN LIGASE; HIF-ALPHA; VHL; HYPOXIA; FAMILY; GENE	The ubiquitination of the hypoxia-inducible factor (HIF) by the von Hippel-Lindau tumor suppressor (pVHL) plays a central role in the cellular response to changes in oxygen availability. pVHL binds to HIF only when a conserved proline in HIF is hydroxylated, a modification that is oxygen-dependent. The 1.85 angstrom structure of a 20-residue HIF-1alpha peptide-pVHL-ElonginB-ElonginC complex shows that HIF-1alpha binds to pVHL in an extended beta strand-like conformation. The hydroxyproline inserts into a gap in the pVHL hydrophobic core, at a site that is a hotspot for tumorigenic mutations, with its 4-hydroxyl group recognized by buried serine and histidine residues. Although the beta sheet-like interactions contribute to the stability of the complex, the hydroxyproline contacts are central to the strict specificity characteristic of signaling.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.		Ivan, Mircea/A-8109-2012	Ivan, Mircea/0000-0003-3424-6642; Min, Jung-Hyun/0000-0002-4221-9321				ARAVIND L, 2001, GENOME BIOL, V2; Beroud C, 1998, NUCLEIC ACIDS RES, V26, P256, DOI 10.1093/nar/26.1.256; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601; Clifton IJ, 2001, EUR J BIOCHEM, V268, P6625, DOI 10.1046/j.0014-2956.2001.02617.x; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; ESSAR L, COMMUNICATION; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	27	543	624	8	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 7	2002	296	5574					1886	1889		10.1126/science.1073440	http://dx.doi.org/10.1126/science.1073440			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	559YP	12004076				2022-12-28	WOS:000176054300054
J	Bucheler, R; Schwab, M; Morike, K; Kalchthaler, B; Mohr, H; Schroder, H; Schwoerer, P; Gleiter, CH				Bucheler, R; Schwab, M; Morike, K; Kalchthaler, B; Mohr, H; Schroder, H; Schwoerer, P; Gleiter, CH			Off label prescribing to children in primary care in Germany: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PEDIATRIC WARDS; DRUG-USE		Univ Tubingen Hosp, Div Clin Pharmacol, D-72076 Tubingen, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; Krankenversicherung Baden Wurtttemberg, Med Dienst, D-77933 Lahr, Germany; AOK, Wissensch Inst, D-53177 Bonn, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Gleiter, CH (corresponding author), Univ Tubingen Hosp, Div Clin Pharmacol, D-72076 Tubingen, Germany.							Chalumeau M, 2000, ARCH DIS CHILD, V83, P502, DOI 10.1136/adc.83.6.502; Collier J, 1999, BRIT J CLIN PHARMACO, V48, P5, DOI 10.1046/j.1365-2125.1999.00983.x; Conroy S, 2000, BRIT MED J, V320, P79, DOI 10.1136/bmj.320.7227.79; McIntyre J, 2000, ARCH DIS CHILD, V83, P498, DOI 10.1136/adc.83.6.498; Turner S, 1999, ACTA PAEDIATR, V88, P965, DOI 10.1080/08035259950168469	5	83	86	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 1	2002	324	7349					1311	1312		10.1136/bmj.324.7349.1311	http://dx.doi.org/10.1136/bmj.324.7349.1311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559TM	12039825	Green Published, Bronze			2022-12-28	WOS:000176041500018
J	Cohen, BE; McAnaney, TB; Park, ES; Jan, YN; Boxer, SG; Jan, LY				Cohen, BE; McAnaney, TB; Park, ES; Jan, YN; Boxer, SG; Jan, LY			Probing protein electrostatics with a synthetic fluorescent amino acid	SCIENCE			English	Article							SOLVATION DYNAMICS; DIELECTRIC-CONSTANTS; SPECTROSCOPY; SOLVENT; MATRIX; SITE	Electrostatics affect virtually all aspects of protein structure and activity and are particularly important in proteins whose primary function is to stabilize charge. Here we introduce a fluorescent amino acid, Aladan, which can probe the electrostatic character of a protein at multiple sites. Aladan is exceptionally sensitive to the polarity of its surroundings and can be incorporated site-selectively at buried and exposed sites, in both soluble and membrane proteins. Steady-state and time-resolved fluorescence measurements of Aladan residues at different buried and exposed sites in the B1 domain of protein G suggest that its interior is polar and heterogeneous.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA; Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University	Cohen, BE (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Boxer, Steven/0000-0001-9167-4286; Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027738, R01GM027738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065334, R37MH065334] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM27738] Funding Source: Medline; NIMH NIH HHS [MH65334] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Castner EW, 1998, J MOL LIQ, V77, P1, DOI 10.1016/S0167-7322(98)00066-X; Changenet-Barret P, 2000, J PHYS CHEM B, V104, P9322, DOI 10.1021/jp001634v; COHEN BW, UNPUB; CORNISH VW, 1994, P NATL ACAD SCI USA, V91, P2910, DOI 10.1073/pnas.91.8.2910; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; HORNG ML, 1995, J PHYS CHEM-US, V99, P17311, DOI 10.1021/j100048a004; Jordanides XJ, 1999, J PHYS CHEM B, V103, P7995, DOI 10.1021/jp9910993; KING G, 1991, J CHEM PHYS, V95, P4366, DOI 10.1063/1.461760; Kobayashi N, 2000, BIOCHEMISTRY-US, V39, P6564, DOI 10.1021/bi000013p; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; MACGREGOR RB, 1986, NATURE, V319, P70, DOI 10.1038/319070a0; Malakauskas SM, 1998, NAT STRUCT BIOL, V5, P470, DOI 10.1038/nsb0698-470; Mertz EL, 2000, P NATL ACAD SCI USA, V97, P2081, DOI 10.1073/pnas.050316997; MINOR DL, 1994, NATURE, V371, P264, DOI 10.1038/371264a0; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pal SK, 2002, P NATL ACAD SCI USA, V99, P1763, DOI 10.1073/pnas.042697899; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; PIERCE DW, 1992, J PHYS CHEM-US, V96, P5560, DOI 10.1021/j100192a069; Pitera JW, 2001, BIOPHYS J, V80, P2546, DOI 10.1016/S0006-3495(01)76226-1; Riter RR, 1996, J PHYS CHEM-US, V100, P14198, DOI 10.1021/jp960453j; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Simonson T, 1996, J AM CHEM SOC, V118, P8452, DOI 10.1021/ja960884f; STANLEY RJ, 1995, J PHYS CHEM-US, V99, P859, DOI 10.1021/j100003a003; STEFFEN MA, 1994, SCIENCE, V264, P810, DOI 10.1126/science.264.5160.810; Turcatti G, 1996, J BIOL CHEM, V271, P19991, DOI 10.1074/jbc.271.33.19991; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; WARSHEL A, 1984, Q REV BIOPHYS, V17, P283, DOI 10.1017/S0033583500005333; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Wohlfarth C., 1991, STATIC DIELECTRIC CO	32	351	368	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 31	2002	296	5573					1700	1703		10.1126/science.1069346	http://dx.doi.org/10.1126/science.1069346			4	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	558PR	12040199				2022-12-28	WOS:000175976200063
J	Chen, XM; Keithly, JS; Paya, CV; LaRusso, NF				Chen, XM; Keithly, JS; Paya, CV; LaRusso, NF			Current concepts: Cryptosporidiosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTESTINAL EPITHELIAL-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; PARVUM INFECTION; BILIARY EPITHELIA; DOUBLE-BLIND; DIARRHEA; AIDS; PAROMOMYCIN; APOPTOSIS; PLACEBO		Mayo Clin & Mayo Fdn, Mayo Med Sch, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Mayo Med Sch, Div Expt Pathol, Rochester, MN 55905 USA; David Axelrod Inst, Wadsworth Ctr, Albany, NY USA	Mayo Clinic; Mayo Clinic; Wadsworth Center	LaRusso, NF (corresponding author), Mayo Clin & Mayo Fdn, Mayo Med Sch, Ctr Basic Res Digest Dis, Div Gastroenterol & Hepatol, 200 1st St SW, Rochester, MN 55905 USA.				NIAID NIH HHS [AI40384] Funding Source: Medline; NIDDK NIH HHS [DK57993, DK24031] Funding Source: Medline; PHS HHS [OI40320] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI040384, R01AI040384, R21AI040384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK024031, R37DK024031, R01DK057993] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARGENZIO RA, 1990, GASTROENTEROLOGY, V98, P1129, DOI 10.1016/0016-5085(90)90325-U; Carr A, 1998, LANCET, V351, P256, DOI 10.1016/S0140-6736(97)07529-6; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Chen XM, 2000, GASTROENTEROLOGY, V118, P368, DOI 10.1016/S0016-5085(00)70219-8; Chen XM, 1998, HEPATOLOGY, V28, P906, DOI 10.1002/hep.510280402; Chen XM, 1999, AM J PHYSIOL-GASTR L, V277, pG599, DOI 10.1152/ajpgi.1999.277.3.G599; Chen XM, 2001, GASTROENTEROLOGY, V120, pA325; Chen XM, 2001, GASTROENTEROLOGY, V120, P1774, DOI 10.1053/gast.2001.24850; Clark DP, 1999, CLIN MICROBIOL REV, V12, P554, DOI 10.1128/CMR.12.4.554; COCKERILL FR, 1986, AM J MED, V80, P1237, DOI 10.1016/0002-9343(86)90695-9; Colford JM, 1996, AM J EPIDEMIOL, V144, P807, DOI 10.1093/oxfordjournals.aje.a009015; DUPONT HL, 1995, NEW ENGL J MED, V332, P855, DOI 10.1056/NEJM199503303321304; Elliott DA, 2001, INFECT IMMUN, V69, P5940, DOI 10.1128/IAI.69.9.5940-5942.2001; Farthing MJG, 2000, CONTRIB MICROBIOL, V6, P50, DOI 10.1159/000060368; Forney JR, 1999, INFECT IMMUN, V67, P844, DOI 10.1128/IAI.67.2.844-852.1999; GOODGAME RW, 1995, GASTROENTEROLOGY, V108, P1075, DOI 10.1016/0016-5085(95)90205-8; GRIFFITHS JK, 1994, INFECT IMMUN, V62, P4506, DOI 10.1128/IAI.62.10.4506-4514.1994; Griffiths JK, 1998, J INFECT DIS, V178, P915, DOI 10.1086/515380; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Guerrant RL, 1997, EMERG INFECT DIS, V3, P51, DOI 10.3201/eid0301.970106; Hewitt RG, 2000, CLIN INFECT DIS, V31, P1084, DOI 10.1086/318155; Keithly JS, 1997, MOL BIOCHEM PARASIT, V88, P35, DOI 10.1016/S0166-6851(97)00063-7; Laurent F, 1998, INFECT IMMUN, V66, P1787, DOI 10.1128/IAI.66.4.1787-1790.1998; Laurent F, 1997, INFECT IMMUN, V65, P5067, DOI 10.1128/IAI.65.12.5067-5073.1997; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P1035; Manabe YC, 1998, CLIN INFECT DIS, V27, P536, DOI 10.1086/514701; MARCIAL MA, 1986, GASTROENTEROLOGY, V90, P583, DOI 10.1016/0016-5085(86)91112-1; McCole DF, 2000, INFECT IMMUN, V68, P1710, DOI 10.1128/IAI.68.3.1710-1713.2000; McDonald V, 2000, CONTRIB MICROBIOL, V6, P75, DOI 10.1159/000060371; Meinhardt PL, 1996, EPIDEMIOL REV, V18, P118, DOI 10.1093/oxfordjournals.epirev.a017920; Miller JR, 1998, J URBAN HEALTH, V75, P601, DOI 10.1007/BF02427707; Mosier DA, 2000, ANN NY ACAD SCI, V916, P102, DOI 10.1111/j.1749-6632.2000.tb05279.x; ODONOGHUE PJ, 1995, INT J PARASITOL, V25, P139, DOI 10.1016/0020-7519(94)E0059-V; Okhuysen PC, 1999, J INFECT DIS, V180, P1275, DOI 10.1086/315033; Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723; Rossignol JFA, 2001, J INFECT DIS, V184, P103, DOI 10.1086/321008; Rotte C, 2001, MOL BIOL EVOL, V18, P710, DOI 10.1093/oxfordjournals.molbev.a003853; SAEZLLORENS X, 1989, PEDIATR INFECT DIS J, V8, P136, DOI 10.1097/00006454-198912000-00046; Tarver AP, 1998, INFECT IMMUN, V66, P1045, DOI 10.1128/IAI.66.3.1045-1056.1998; Tarver AP, 1998, INFECT IMMUN, V66, P2399; Tzipori S, 2000, CONTRIB MICROBIOL, V6, P1, DOI 10.1159/000060370; Vakil NB, 1996, NEW ENGL J MED, V334, P19, DOI 10.1056/NEJM199601043340104; Vollenweider JM, 2001, HEPATOLOGY, V34, p268A; WHITE AC, 1994, J INFECT DIS, V170, P419, DOI 10.1093/infdis/170.2.419; White AC, 2001, CLIN INFECT DIS, V32, P1803; White AC, 2001, CLIN INFECT DIS, V32, P1516, DOI 10.1086/320171; Wilcox CM, 1998, DIGEST DIS, V16, P205, DOI 10.1159/000016868; WITTENBERG DF, 1989, J INFECT DIS, V159, P131, DOI 10.1093/infdis/159.1.131; Woods KM, 1998, FEMS MICROBIOL LETT, V168, P59, DOI 10.1111/j.1574-6968.1998.tb13255.x; Xiao L, 2000, PARASITOL TODAY, V16, P287, DOI 10.1016/S0169-4758(00)01699-9; Zhu G, 2000, MOL BIOCHEM PARASIT, V105, P253, DOI 10.1016/S0166-6851(99)00183-8; Zhu G, 2000, INT J SYST EVOL MICR, V50, P1673, DOI 10.1099/00207713-50-4-1673	52	326	354	3	20	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 30	2002	346	22					1723	1731		10.1056/NEJMra013170	http://dx.doi.org/10.1056/NEJMra013170			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556DM	12037153				2022-12-28	WOS:000175834100008
J	Della Valle, M; Gilmozzi, R				Della Valle, M; Gilmozzi, R			Rebirth of novae as distance indicators due to efficient, large telescopes	SCIENCE			English	Review							CLASSICAL NOVAE; GALAXIES		Arcetri Astrophys Observ, Florence, Italy; European So Observ, Paranal, Antofagasta, Chile	Istituto Nazionale Astrofisica (INAF); European Southern Observatory	Della Valle, M (corresponding author), Arcetri Astrophys Observ, Largo E Fermi 5, Florence, Italy.		Della Valle, Massimo/AAE-8884-2021	Della Valle, Massimo/0000-0003-3142-5020				Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Branch D, 1996, ASTROPHYS J, V465, P73, DOI 10.1086/177402; Della Valle M., 1997, Early Universe with the VLT. Proceedings of the ESO Workshop, P380; DELLAVALLE M, 1995, ASTROPHYS J, V452, P704, DOI 10.1086/176342; DELLAVALLE M, 1994, ASTRON ASTROPHYS, V287, P403; Gehrz RD, 1998, PUBL ASTRON SOC PAC, V110, P3, DOI 10.1086/316107; Gomez-Gomar J, 1998, MON NOT R ASTRON SOC, V296, P913, DOI 10.1046/j.1365-8711.1998.01421.x; VANDENBERGH S, 1986, PUBL ASTRON SOC PAC, V98, P110, DOI 10.1086/131728; Zwicky F, 1942, ASTROPHYS J, V96, P28, DOI 10.1086/144430	10	19	19	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 17	2002	296	5571					1275	1275		10.1126/science.1070939	http://dx.doi.org/10.1126/science.1070939			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554BL	12016305	Green Submitted			2022-12-28	WOS:000175713000042
J	Boyden, LM; Mao, JH; Belsky, J; Mitzner, L; Farhi, A; Mitnick, MA; Wu, DQ; Insogna, K; Lifton, RP				Boyden, LM; Mao, JH; Belsky, J; Mitzner, L; Farhi, A; Mitnick, MA; Wu, DQ; Insogna, K; Lifton, RP			High bone density due to a mutation in LDL-receptor-related protein 5	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL DOMINANT OSTEOSCLEROSIS; PARATHYROID-HORMONE; TRANSFORMING GROWTH-FACTOR-BETA-1; MINERAL DENSITY; FIBRONECTIN; MASS; GROWTH; GENE; HYPEROSTOSIS; DICKKOPF-1	Background: Osteoporosis is a major public health problem of largely unknown cause. Loss-of-function mutations in the gene for low-density lipoprotein receptor-related protein 5 (LRP5), which acts in the Wnt signaling pathway, have been shown to cause osteoporosis-pseudoglioma. Methods: We performed genetic and biochemical analyses of a kindred with an autosomal dominant syndrome characterized by high bone density, a wide and deep mandible, and torus palatinus. Results: Genetic analysis revealed linkage of the syndrome to chromosome 11q12-13 (odds of linkage, >1 million to 1), an interval that contains LRP5. Affected members of the kindred had a mutation in this gene, with valine substituted for glycine at codon 171 (LRP5(V171)). This mutation segregated with the trait in the family and was absent in control subjects. The normal glycine lies in a so-called propeller motif that is highly conserved from fruit flies to humans. Markers of bone resorption were normal in the affected subjects, whereas markers of bone formation such as osteocalcin were markedly elevated. Levels of fibronectin, a known target of signaling by Wnt, a developmental protein, were also elevated. In vitro studies showed that the normal inhibition of Wnt signaling by another protein, Dickkopf-1 (Dkk-1), was defective in the presence of LRP5(V171) and that this resulted in increased signaling due to unopposed Wnt activity. Conclusions: The LRP5(V171) mutation causes high bone density, with a thickened mandible and torus palatinus, by impairing the action of a normal antagonist of the Wnt pathway and thus increasing Wnt signaling. These findings demonstrate the role of altered LRP5 function in high bone mass and point to Dkk as a potential target for the prevention or treatment of osteoporosis.	Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT USA	Yale University; Yale University; University of Connecticut	Lifton, RP (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06510 USA.			Insogna, Karl/0000-0001-6973-5679	NATIONAL CANCER INSTITUTE [R01CA085420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015345] Funding Source: NIH RePORTER; NCI NIH HHS [CA85420] Funding Source: Medline; NCRR NIH HHS [RR00125] Funding Source: Medline; NIAMS NIH HHS [AR46032] Funding Source: Medline; NIA NIH HHS [AG15345] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ADES LC, 1994, AM J MED GENET, V51, P46, DOI 10.1002/ajmg.1320510111; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; CENTRELLA M, 1991, MOL CELL BIOL, V11, P4490, DOI 10.1128/MCB.11.9.4490; Dong Y, 1998, BIOCHEM BIOPH RES CO, V251, P784, DOI 10.1006/bbrc.1998.9545; EIELSON C, 1994, ENDOCRINOLOGY, V135, P1639, DOI 10.1210/en.135.4.1639; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; GELMAN MI, 1977, RADIOLOGY, V125, P289, DOI 10.1148/125.2.289; Globus RK, 1998, J CELL SCI, V111, P1385; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gong YQ, 1996, AM J HUM GENET, V59, P146; GORLIN RJ, 1977, RADIOLOGY, V125, P547, DOI 10.1148/125.2.547; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Heaney C, 1998, HUM MOL GENET, V7, P1407, DOI 10.1093/hmg/7.9.1407; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Johnson ML, 1997, AM J HUM GENET, V60, P1326, DOI 10.1086/515470; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; Kerstetter JE, 1997, AM J CLIN NUTR, V66, P1188, DOI 10.1093/ajcn/66.5.1188; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Koller DL, 1998, J BONE MINER RES, V13, P1903, DOI 10.1359/jbmr.1998.13.12.1903; Lips Paul, 1997, American Journal of Medicine, V103, p3S, DOI 10.1016/S0002-9343(97)90021-8; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MAROTEAUX P, 1971, ARCH FR PEDIATR, V28, P685; MERIC F, 1990, AM J KIDNEY DIS, V16, P459, DOI 10.1016/S0272-6386(12)80059-X; Moursi AM, 1996, J CELL SCI, V109, P1369; OWEN RH, 1976, BRIT J RADIOL, V49, P126, DOI 10.1259/0007-1285-49-578-126; PEREZVICENTE JA, 1987, CLIN GENET, V31, P161; POOR G, 1995, CLIN ORTHOP RELAT R, P260; RUSSELL WJ, 1968, RADIOLOGY, V90, P70, DOI 10.1148/90.1.70; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115; Sun BH, 1997, ENDOCRINOLOGY, V138, P3918, DOI 10.1210/en.138.9.3918; Takacs I, 1999, AM J MED GENET, V85, P9, DOI 10.1002/(SICI)1096-8628(19990702)85:1<9::AID-AJMG4>3.0.CO;2-3; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; VERHAAR HJJ, 1995, MATURITAS, V21, P237, DOI 10.1016/0378-5122(94)00883-9; Whyte MP, 1996, J BONE MINER RES, V11, P1438, DOI 10.1002/jbmr.5650111010; Worth H M, 1966, J Can Assoc Radiol, V17, P67; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307; 1996, MMWR MORB MORTAL WKL, V45, P877	40	1205	1369	1	57	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1513	1521		10.1056/NEJMoa013444	http://dx.doi.org/10.1056/NEJMoa013444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551LV	12015390	Bronze			2022-12-28	WOS:000175563900002
J	Goodman, DC; Fisher, ES; Little, GA; Stukel, TA; Chang, CH; Schoendorf, KS				Goodman, DC; Fisher, ES; Little, GA; Stukel, TA; Chang, CH; Schoendorf, KS			The relation between the availability of neonatal intensive care and neonatal mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Meeting of the American-Academy-of-Pediatrics	OCT 28-NOV 01, 2000	CHICAGO, ILLINOIS	Amer Acad Pediat			BIRTH-WEIGHT INFANTS; PERINATAL-MORTALITY; HOSPITAL LEVEL; UNITED-STATES; REGIONALIZATION; PEDIATRICS; DELIVERY; RATES	Background: There is marked regional variation in the availability of neonatal intensive care in the United States. We conducted a study to determine whether a greater supply of neonatologists or neonatal intensive care beds is associated with lower neonatal mortality. Methods: We used the 1996 master files of the American Medical Association and the American Osteopathic Association and 1998 and 1999 surveys of neonatal intensive care units to calculate the supply of neonatologists and neonatal intensive care beds in 246 neonatal intensive care regions. We used linked birth and death records from the 1995 U.S. birth cohort to assess associations between the supply of both neonatologists and neonatal intensive care beds per capita (in quintiles) and the risk of death within the first 27 days of life. Results: Among 3,892,208 newborns with a birth weight of 500 g or greater, the mortality rate was 3.4 per 1000 births. After adjustment for neonatal and maternal characteristics associated with an increased risk of neonatal death, the rate was lower in the regions with 4.3 neonatologists per 10,000 births than in those with 2.7 neonatologists per 10,000 births (odds ratio for death, 0.93; 95 percent confidence interval, 0.88 to 0.99). Further increases in the number of neonatologists were not associated with greater reductions in the risk of death. There was no consistent relation between the number of neonatal intensive care beds and neonatal mortality. Conclusions: A minority of regions in the United States may have inadequate neonatal intensive care resources, whereas many others may have more resources than are needed to prevent the death of high-risk newborns. The effect of the availability of neonatologists on other health outcomes is not known.	Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH 03755 USA; Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Ctr Evaluat Clin Sci, Hanover, NH 03755 USA; Vet Affairs Outcomes Grp, White River Jct, VT USA; Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Dartmouth College; Dartmouth College; Dartmouth College; Dartmouth College; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Goodman, DC (corresponding author), Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Med, 7251 Strasenburgh Hall, Hanover, NH 03755 USA.		Goodman, David/AAG-7497-2020	Stukel, Therese/0000-0002-2951-1360				*AM AC PED, 1996, US NEON DIR SECT PER; *AM AC PED COMM FE, 1985, PEDIATRICS, V76, P132; *AM COLL OBST GYN, 1995, INT J GYNECOL OBSTET, V53, P86; *AM HOSP ASS, 1995, ANN SURV HOSP DAT BA; BENNETT T, 1994, FAM PLANN PERSPECT, V26, P252, DOI 10.2307/2135890; BENNETT T, 1994, FAMILY PLANNING PERS, V26, P271; CHANCE G, 1995, PEDIATR ANN, V24, P527; CHANCE GW, 1995, PEDIATR ANN, V24, P519, DOI 10.3928/0090-4481-19951001-07; *COMM PER HLTH, 1976, IMPR OUTC PREG REC R; Committee on Perinatal Health, 1993, IMPR OUTC PREGN 90S; *DARTM MED SCH CTR, 1996, DARTM ATL HLTH CAR; Din-Dzietham R, 1998, AM J PUBLIC HEALTH, V88, P651, DOI 10.2105/AJPH.88.4.651; GAGNON D, 1988, PEDIATR ANN, V17, P447, DOI 10.3928/0090-4481-19880701-06; Glied SA, 1996, HEALTH SERV RES, V31, P593; Goodman D C, 2001, Eff Clin Pract, V4, P143; Goodman DC, 1998, PEDIATRICS, V102, P396, DOI 10.1542/peds.102.2.396; Goodman DC, 2001, PEDIATRICS, V108, P426, DOI 10.1542/peds.108.2.426; Graduate Medical Education National Advisory Committee, 1980, REP GRAD MED ED NAT, V1; Hall R T, 1997, J Perinatol, V17, P423; HARRISON H, 1993, PEDIATRICS, V92, P643; Horbar JD, 1997, PEDIATRICS, V99, P149, DOI 10.1542/peds.99.2.149; Horbar JD, 2001, PEDIATRICS, V107, P14, DOI 10.1542/peds.107.1.14; HOSMER DW, 1989, APPL LOGISTIC REGRES; JACOBSEN SJ, 1987, HEALTH AFFAIR, V6, P48, DOI 10.1377/hlthaff.6.2.48; Johnson K A, 1999, Pediatrics, V103, P233; KATZMAN GH, 1994, PEDIATRICS, V94, P133; Kiely J L, 1991, Paediatr Perinat Epidemiol, V5, P243, DOI 10.1111/j.1365-3016.1991.tb00707.x; KIELY JL, 1993, STAT MED, V12, P377, DOI 10.1002/sim.4780120319; KLEINMAN JC, 1991, AM J DIS CHILD, V145, P194, DOI 10.1001/archpedi.1991.02160020086023; KLEINMAN JC, 1991, AM J EPIDEMIOL, V133, P133, DOI 10.1093/oxfordjournals.aje.a115852; LEFEVRE M, 1992, J FAM PRACTICE, V35, P259; LIANG KY, 1993, ANNU REV PUBL HEALTH, V14, P43, DOI 10.1146/annurev.pu.14.050193.000355; LITTLE GA, 1993, PEDIATRICS, V92, P611; MCCORMICK MC, 1985, JAMA-J AM MED ASSOC, V253, P799; Menard MK, 1998, AM J OBSTET GYNECOL, V179, P374, DOI 10.1016/S0002-9378(98)70367-9; Merenstein G B, 2001, Eff Clin Pract, V4, P178; MERENSTEIN GB, 1985, PEDIATRICS, V76, P454; *NAT CTR HLTH STAT, 1995, LINK BIRTH DEATH DAT; PANETH N, 1987, AM J DIS CHILD, V141, P60, DOI 10.1001/archpedi.1987.04460010060024; Phelan ST, 1998, AM J PUBLIC HEALTH, V88, P1236, DOI 10.2105/AJPH.88.8.1236; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; Rappo PD, 1996, PEDIATRICS, V98, P786; Richardson DK, 1998, PEDIATRICS, V102, P893, DOI 10.1542/peds.102.4.893; SCHOENDORF KC, 1992, NEW ENGL J MED, V326, P1522, DOI 10.1056/NEJM199206043262303; Schwartz R M, 1996, J Perinatol, V16, P483; Schwartz R M, 2000, J Perinatol, V20, P520, DOI 10.1038/sj.jp.7200421; SILVERMAN WA, 1992, PEDIATRICS, V90, P971; SILVERMAN WA, 1993, PEDIATRICS, V92, P612; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; WILLIAMS RL, 1982, NEW ENGL J MED, V306, P207, DOI 10.1056/NEJM198201283060404; Yeast JD, 1998, AM J OBSTET GYNECOL, V178, P131, DOI 10.1016/S0002-9378(98)70639-8	51	122	123	1	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 16	2002	346	20					1538	1544		10.1056/NEJMoa011921	http://dx.doi.org/10.1056/NEJMoa011921			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551LV	12015393	Bronze			2022-12-28	WOS:000175563900005
J	Wyatt, MB; McSween, HY				Wyatt, MB; McSween, HY			Spectral evidence for weathered basalt as an alternative to andesite in the northern lowlands of Mars	NATURE			English	Article							MARTIAN SURFACE; ROCKS	Mineral abundances derived from the analysis of remotely sensed thermal emission data from Mars have been interpreted to indicate that the surface is composed of basalt (Surface Type 1) and andesite (Surface Type 2)(1). The global distribution of these rock types is divided roughly along the planetary dichotomy which separates ancient, heavily cratered crust in the southern hemisphere (basalt) from younger lowland plains in the north (andesite)(1). But the existence of such a large volume of andesite is difficult to reconcile with our present understanding of the geological evolution of Mars. Here we reinterpret martian surface rock lithologies using mineral abundances from previous work(1) and new mineralogies derived from a spectral end-member set representing minerals common in unaltered and low-temperature aqueously altered basalts. Our results continue to indicate the dominance of unaltered basalt in the southern highlands, but reveal that the northern lowlands can be interpreted as weathered basalt as an alternative to andesite. The coincidence between locations of such altered basalt and a suggested northern ocean basin implies that lowland plains material may be composed of basalts weathered under submarine conditions or weathered basaltic sediments transported into this depocentre.	Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	McSween, HY (corresponding author), Univ Tennessee, Dept Geol Sci, Knoxville, TN 37996 USA.	mcsween@utk.edu						Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9609, DOI 10.1029/1999JE001127; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; FREY HV, 2001, LUN PLAN SCI C, V32; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; McSween HY, 2001, NATURE, V409, P487, DOI 10.1038/35054011; McSween HY, 2000, GEOCHIM COSMOCHIM AC, V64, P2155, DOI 10.1016/S0016-7037(99)00401-9; Merenyi E, 1996, ICARUS, V124, P280, DOI 10.1006/icar.1996.0204; MINITTI ME, 2000, LUN PLAN SCI C, V31; Murchie S, 2000, ICARUS, V147, P444, DOI 10.1006/icar.2000.6446; MURCHIE S, 1993, ICARUS, V105, P454, DOI 10.1006/icar.1993.1141; Mustard JF, 1997, J GEOPHYS RES-PLANET, V102, P25605, DOI 10.1029/97JE02354; NOBLE SK, 2001, LUN PLAN SCI C, V32; PARKER TJ, 1989, ICARUS, V82, P111, DOI 10.1016/0019-1035(89)90027-4; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thompson G., 1983, HYDROTHERMAL PROCESS, P225; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	20	218	220	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 16	2002	417	6886					263	266		10.1038/417263a	http://dx.doi.org/10.1038/417263a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551YT	12015596				2022-12-28	WOS:000175592100040
J	Genuth, S; Lipps, J; Lorenzi, G; Nathan, DM; Davis, MD; Lachin, JM; Cleary, PA				Genuth, S; Lipps, J; Lorenzi, G; Nathan, DM; Davis, MD; Lachin, JM; Cleary, PA		Writing Team Diabet Control Compli	Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								The purpose of this report is to summarize and integrate the findings of the Diabetes Control and Complications Trial (DCCT), a randomized controlled clinical trial, and the succeeding observational follow-up of the DCCT cohort in the Epidemiology of Diabetes Interventions and Complications (EDIC) study, regarding the effects of intensive treatment on the microvascular complications of type 1 diabetes mellitus. The DCCT proved that intensive treatment reduced the risks of retinopathy, nephropathy, and neuropathy by 35% to 90% compared with conventional treatment. The absolute risks of retinopathy and nephropathy were proportional to the mean glycosylated hemoglobin (HbA(1c)) level over the follow-up period preceding each event. Intensive treatment was most effective when begun early, before complications were detectable. These risk reductions, achieved at a median HbA(1c) level difference of 9.1% for conventional treatment vs 7.3% for intensive treatment have been maintained through 7 years of EDIC, even though the difference in mean HbA(1c) levels of the 2 former randomized treatment groups was only 0.4% at 1 year (P<.001) (8.3% in the former conventional treatment group vs 7.9% in the former intensive treatment group), continued to narrow, and became statistically nonsignificant by 5 years (8.1% vs 8.2%, P=.09). The further rate of progression of complications from their levels at the end of the DCCT remains less in the former intensive treatment group. Thus, the benefits of 6.5 years of intensive treatment extend well beyond the period of its most intensive implementation. Intensive treatment should be started as soon as is safely possible after the onset of type 1 diabetes mellitus and maintained thereafter, aiming for a practicable target HbA(1c) level of 7.0% or less.	Case Western Reserve Univ, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA	Case Western Reserve University	Genuth, S (corresponding author), Case Western Reserve Univ, Div Clin & Mol Endocrinol, 10900 Euclid Ave, Cleveland, OH 44106 USA.		Hramiak, Irene/G-3305-2011; Zinman, Bernard/E-7266-2013	Lachin, John/0000-0001-9838-2841	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK062204] Funding Source: NIH RePORTER; NIDDK NIH HHS [N01 DK062204-007] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albers JW, 1995, ANN NEUROL, V38, P869, DOI 10.1002/ana.410380607; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; [Anonymous], 1996, DIABETES, V45, P1289; [Anonymous], 1995, DIABETES, V44, P968; CAHILL GF, 1976, NEW ENGL J MED, V294, P1004, DOI 10.1056/NEJM197604292941811; *DCCT RES GROUP, 1995, ANN INTERN MED, V113, P49; DCCT Res Grp, 1986, DIABETES, V35, P530; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; DCCT Res Grp, 1988, DIABETES CARE, V11, P567; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Diabet Control Complications Trial Res Grp, 1995, OPHTHALMOLOGY, V102, P647; Diabet Control Complications Trial Res Grp, 1995, DIABETES CARE, V18, P1415; Diabet Control Complications Trial Res Grp, 1998, DIABETOLOGIA, V41, P416; *EDIC RES GROUP, 2000, DIABETES CARE, V22, P99; Genuth S M, 1995, Adv Intern Med, V40, P573; INGELFINGER FJ, 1977, NEW ENGL J MED, V296, P1228, DOI 10.1056/NEJM197705262962111; King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8; Monnier VM, 1999, DIABETES, V48, P870, DOI 10.2337/diabetes.48.4.870; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Orchard TJ, 1997, ARCH INTERN MED, V157, P1851, DOI 10.1001/archinte.157.16.1851; SHAMOON H, 1995, DIABETES CARE, V18, P361; SHAMOON H, 1995, ARCH OPHTHALMOL-CHIC, V113, P36; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shannon H, 2000, NEW ENGL J MED, V342, P381; SIPERSTEIN MD, 1983, NEW ENGL J MED, V309, P1577, DOI 10.1056/NEJM198312223092511; SIPERSTEIN MD, 1977, NEW ENGL J MED, V296, P1060, DOI 10.1056/NEJM197705052961812; WHITE P, 1932, DIABETES CHILDHOOD A, P192	29	655	670	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 15	2002	287	19					2563	2569						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551MV	12020338				2022-12-28	WOS:000175566200026
J	Kaski, JC				Kaski, JC			"Normal" coronary arteriograms, "abnormal" haemodynamics	LANCET			English	Editorial Material							PRESSURE MEASUREMENT; STENOSES; PLAQUE; HUMANS		Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, Coronary Artery Dis Res Unit, London SW17 0RE, England	St Georges University London	Kaski, JC (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, Coronary Artery Dis Res Unit, London SW17 0RE, England.							Cox ID, 1999, J AM COLL CARDIOL, V34, P455, DOI 10.1016/S0735-1097(99)00224-7; De Bruyne B, 2001, CIRCULATION, V104, P2401, DOI 10.1161/hc4501.099316; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Hasdai D, 1997, CIRCULATION, V96, P3390; KASKI JC, 1991, J AM COLL CARDIOL, V17, P627, DOI 10.1016/S0735-1097(10)80175-5; Kern MJ, 2000, CIRCULATION, V101, P1344, DOI 10.1161/01.CIR.101.11.1344; Kern MJ, 2001, CIRCULATION, V103, P3142, DOI 10.1161/01.CIR.103.25.3142; Pijls NHJ, 2000, CIRCULATION, V102, P2371, DOI 10.1161/01.CIR.102.19.2371; Pijls NHJ, 1998, HEART, V80, P539, DOI 10.1136/hrt.80.6.539; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333	10	4	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 11	2002	359	9318					1631	1632		10.1016/S0140-6736(02)08543-4	http://dx.doi.org/10.1016/S0140-6736(02)08543-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020520				2022-12-28	WOS:000175593300003
J	Oudkerk, M; van Beek, EJR; Wielopolski, P; van Ooijen, PMA; Brouwers-Kuyper, EMJ; Bongaerts, AHH; Berghout, A				Oudkerk, M; van Beek, EJR; Wielopolski, P; van Ooijen, PMA; Brouwers-Kuyper, EMJ; Bongaerts, AHH; Berghout, A			Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study	LANCET			English	Article							VENTILATION-PERFUSION SCINTIGRAPHY; HELICAL CT; SPIRAL CT; VEIN THROMBOSIS; LUNG-SCAN; COMPLICATIONS; THERAPY; UTILITY	Background Diagnostic strategies for pulmonary embolism are complex and consist of non-invasive diagnostic tests done to avoid conventional pulmonary angiography as much as possible. We aimed to assess the diagnostic accuracy of magnetic resonance angiography (MRA) for the diagnosis of pulmonary embolism, using conventional pulmonary angiography as a reference method. Methods In a prospective study, we enrolled 141 patients with suspected pulmonary embolism and an abnormal perfusion scan. Patients underwent MRA before conventional pulmonary angiography. Two reviewers, masked with respect to the results of conventional pulmonary angiography, assessed MRA images independently. Statistical analyses used chi(2) and 95% CI. Findings MRA was contraindicated in 13 patients (9%), and images were not interpretable in eight (6%). MRA was done in two patients in whom conventional pulmonary angiography was contraindicated. Thus, MRA and conventional pulmonary angiography results were available in 118 patients (84%). Prevalence of pulmonary embolism was 30%. Images were read independently in 115 patients, and agreement obtained in 105 (91%), kappa=0.75. MRA identified 27 of 35 patients with proven pulmonary embolism (sensitivity 77%, 95% CI 61-90). Sensitivity of MRA for isolated subsegmental, segmental, and central or lobar pulmonary embolism was 40%, 84%, and 100%, respectively (p<0.01 for isolated subsegmental vs segmental or larger pulmonary embolism). However, subgroups contained small numbers. MRA identified pulmonary embolism in two patients with normal angiogram (98%, 92-100). Interpretation MRA is sensitive and specific for segmental or larger pulmonary embolism. Results are similar to those obtained with helical computed tomography, but MRA has safer contrast agents and does not involve ionising radiation. MRA could become part of the diagnostic strategy for pulmonary embolism.	Univ Groningen, Univ Med Ctr Groningen, Acad Hosp Groningen, Daniel den Hoed Clin, Dept Radiol, NL-9700 RB Groningen, Netherlands; Royal Hallamshire Hosp, Unit Acad Radiol, Sheffield S10 2JF, S Yorkshire, England; Med Ctr Rijnmond Zuid, Dept Internal Med, Rotterdam, Netherlands; State Univ, Dept Radiol, Groningen, Netherlands	University of Groningen; University of Sheffield; University of Groningen	Oudkerk, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Acad Hosp Groningen, Daniel den Hoed Clin, Dept Radiol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	m-oudkerk@rad.azg.nl	van Ooijen, Peter/B-9150-2008	van Ooijen, Peter/0000-0002-8995-1210; Oudkerk, Matthijs/0000-0003-2800-4110				ANDERSON CM, 1990, AM J ROENTGENOL, V154, P623, DOI 10.2214/ajr.154.3.2106232; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Berghout A, 2000, QJM-INT J MED, V93, P335, DOI 10.1093/qjmed/93.6.335; BRANDJES DPM, 1992, NEW ENGL J MED, V327, P1485, DOI 10.1056/NEJM199211193272103; DALEN JE, 1971, AM HEART J, V81, P175, DOI 10.1016/0002-8703(71)90128-1; Drucker EA, 1998, RADIOLOGY, V209, P235, DOI 10.1148/radiology.209.1.9769837; Ferretti GR, 1997, RADIOLOGY, V205, P453, DOI 10.1148/radiology.205.2.9356628; Ginsberg JS, 1996, NEW ENGL J MED, V335, P1816, DOI 10.1056/NEJM199612123352407; GOLDHABER SZ, 1992, JAMA-J AM MED ASSOC, V268, P1727, DOI 10.1001/jama.268.13.1727; GOODMAN LR, 1995, AM J ROENTGENOL, V164, P1369, DOI 10.2214/ajr.164.6.7754875; Hagspiel KD, 1998, RADIOLOGY, V207, P139, DOI 10.1148/radiology.207.1.9530309; Hany TF, 1998, AM J ROENTGENOL, V170, P907, DOI 10.2214/ajr.170.4.9530032; Hudson ER, 1996, RADIOLOGY, V198, P61, DOI 10.1148/radiology.198.1.8539407; Kim KI, 1999, RADIOLOGY, V210, P693, DOI 10.1148/radiology.210.3.r99mr01693; LEVINE MN, 1995, CHEST, V108, pS276, DOI 10.1378/chest.108.4_Supplement.276S; LEYENDECKER JR, 1997, AJR, V167, P1145; Mayo JR, 1997, RADIOLOGY, V205, P447, DOI 10.1148/radiology.205.2.9356627; MEANEY JF, 1997, NEW ENGL J MED, V336, P1449; Perrier A, 1999, LANCET, V353, P190, DOI 10.1016/S0140-6736(98)05248-9; Prokop M, 1997, RADIOGRAPHICS, V17, P433, DOI 10.1148/radiographics.17.2.9084083; RemyJardin M, 1996, RADIOLOGY, V200, P699, DOI 10.1148/radiology.200.3.8756918; Sijens PE, 2000, THROMB HAEMOSTASIS, V84, P156; STEIN PD, 1992, CIRCULATION, V85, P462, DOI 10.1161/01.CIR.85.2.462; Van Beek Edwin J. R., 1996, P93; vanBeek EJR, 1996, RADIOLOGY, V198, P721, DOI 10.1148/radiology.198.3.8628860; vanBeek EJR, 1996, EUR RADIOL, V6, P415, DOI 10.1007/BF00182453; VANDERMEER FJM, 1993, ARCH INTERN MED, V153, P1557, DOI 10.1001/archinte.153.13.1557; VANOOIJEN PMA, 2000, MRI, V4, P2; vanRossum AB, 1996, THORAX, V51, P23, DOI 10.1136/thx.51.1.23	29	194	211	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 11	2002	359	9318					1643	1647		10.1016/S0140-6736(02)08596-3	http://dx.doi.org/10.1016/S0140-6736(02)08596-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	551ZF	12020524				2022-12-28	WOS:000175593300007
J	Kohler, R; Tredicucci, A; Beltram, F; Beere, HE; Linfield, EH; Davies, AG; Ritchie, DA; Iotti, RC; Rossi, F				Kohler, R; Tredicucci, A; Beltram, F; Beere, HE; Linfield, EH; Davies, AG; Ritchie, DA; Iotti, RC; Rossi, F			Terahertz semiconductor-heterostructure laser	NATURE			English	Article							QUANTUM-CASCADE LASERS; MU-M; INTERSUBBAND EMISSION; SUPERLATTICES; RADIATION; LAMBDA; CYCLE	Semiconductor devices have become indispensable for generating electromagnetic radiation in everyday applications. Visible and infrared diode lasers are at the core of information technology, and at the other end of the spectrum, microwave and radiofrequency emitters enable wireless communications. But the terahertz region (1-10 THz; 1 THz 5 10(12) Hz) between these ranges has remained largely underdeveloped, despite the identification of various possible applications-for example, chemical detection, astronomy and medical imaging(1-4). Progress in this area has been hampered by the lack of compact, low-consumption, solid-state terahertz sources(5-9). Here we report a monolithic terahertz injection laser that is based on interminiband transitions in the conduction band of a semiconductor (GaAs/AlGaAs) heterostructure. The prototype demonstrated emits a single mode at 4.4 THz, and already shows high output powers of more than 2 mW with low threshold current densities of about a few hundred A cm(-2) up to 50 K. These results are very promising for extending the present laser concept to continuous-wave and high-temperature operation, which would lead to implementation in practical photonic systems.	INFM, NEST, I-56126 Pisa, Italy; Scuola Normale Super Pisa, I-56126 Pisa, Italy; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Politecn Torino, INFM, I-10129 Turin, Italy; Politecn Torino, Dipartimento Fis, I-10129 Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Scuola Normale Superiore di Pisa; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Polytechnic University of Turin; Polytechnic University of Turin	Kohler, R (corresponding author), INFM, NEST, Piazza Cavalieri 7, I-56126 Pisa, Italy.	koehler@nest.sns.it	Beltram, Fabio/F-2920-2013; Tredicucci, Alessandro/M-6166-2015; Iotti, Rita C/E-8792-2012; Ritchie, David/K-2206-2014; Rossi, Fausto/H-7308-2013; Beltram, Fabio/L-9486-2019	Beltram, Fabio/0000-0002-6081-436X; Tredicucci, Alessandro/0000-0003-3619-3011; Iotti, Rita C/0000-0002-5532-5422; Ritchie, David/0000-0002-9844-8350; Rossi, Fausto/0000-0001-6729-0928; Beltram, Fabio/0000-0002-6081-436X; Linfield, Edmund/0000-0001-6912-0535; Davies, Alexander/0000-0002-1987-4846				Brundermann E, 2000, APPL PHYS LETT, V76, P2991, DOI 10.1063/1.126555; Colombelli R, 2001, APPL PHYS LETT, V78, P2620, DOI 10.1063/1.1367304; FAIST J, 1994, SCIENCE, V264, P553, DOI 10.1126/science.264.5158.553; Han PY, 2000, OPT LETT, V25, P242, DOI 10.1364/OL.25.000242; HELM M, 1989, PHYS REV LETT, V63, P74, DOI 10.1103/PhysRevLett.63.74; Hofstetter D, 2001, APPL PHYS LETT, V78, P396, DOI 10.1063/1.1340865; HU BB, 1991, PHYS REV LETT, V67, P2709, DOI 10.1103/PhysRevLett.67.2709; Iotti RC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.146603; Iotti RC, 2001, APPL PHYS LETT, V78, P2902, DOI 10.1063/1.1370537; Kersting R, 1997, PHYS REV LETT, V79, P3038, DOI 10.1103/PhysRevLett.79.3038; Kohler R, 2002, APPL PHYS LETT, V80, P1867, DOI 10.1063/1.1461054; Kohler R, 2001, APPL PHYS LETT, V79, P3920, DOI 10.1063/1.1423777; Matsuura S, 1997, APPL PHYS LETT, V70, P559, DOI 10.1063/1.118337; Mittleman DM, 1997, OPT LETT, V22, P904, DOI 10.1364/OL.22.000904; Mittleman DM, 1996, IEEE J SEL TOP QUANT, V2, P679, DOI 10.1109/2944.571768; Pavlov SG, 2000, PHYS REV LETT, V84, P5220, DOI 10.1103/PhysRevLett.84.5220; Rochat M, 1998, APPL PHYS LETT, V73, P3724, DOI 10.1063/1.122895; Rochat M, 2001, APPL PHYS LETT, V78, P1967, DOI 10.1063/1.1357444; Sirtori C, 1998, OPT LETT, V23, P1366, DOI 10.1364/OL.23.001366; Tredicucci A, 1998, APPL PHYS LETT, V73, P2101, DOI 10.1063/1.122391; Ulrich J, 2000, APPL PHYS LETT, V77, P1928, DOI 10.1063/1.1312864; Williams BS, 1999, APPL PHYS LETT, V75, P2927, DOI 10.1063/1.125192; [No title captured]	23	2282	2364	34	899	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 9	2002	417	6885					156	159		10.1038/417156a	http://dx.doi.org/10.1038/417156a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549RH	12000955				2022-12-28	WOS:000175460200038
